Citrus Sinensis ID: 007442
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY67 | 708 | Wall-associated receptor | yes | no | 0.940 | 0.800 | 0.519 | 1e-168 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.850 | 0.824 | 0.491 | 1e-133 | |
| Q9LZM4 | 657 | Wall-associated receptor | no | no | 0.656 | 0.602 | 0.395 | 6e-75 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.653 | 0.616 | 0.396 | 1e-73 | |
| P0C5E2 | 654 | Probable serine/threonine | no | no | 0.701 | 0.646 | 0.363 | 2e-72 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.625 | 0.476 | 0.374 | 2e-69 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.651 | 0.511 | 0.372 | 2e-68 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.679 | 0.548 | 0.359 | 2e-65 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.623 | 0.522 | 0.364 | 1e-64 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.477 | 0.383 | 0.437 | 1e-64 |
| >sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 590 bits (1522), Expect = e-168, Method: Compositional matrix adjust.
Identities = 325/626 (51%), Positives = 407/626 (65%), Gaps = 59/626 (9%)
Query: 14 CNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNSIKCDSSSNSS 73
C R I+ ++ LF +N+APTS N L+ +CN + C I + CD++ N
Sbjct: 102 CTRKIEDMNPLFGENFAPTSENSFLMENCNRT-TDGCSIKQKFLENVLKLKSCDATGN-- 158
Query: 74 SISCYSEEKNDR-----EFIDYENATKQQCKFLLSAISSELFNTSAASINISAA-SLDVK 127
ISC+S + N +F + C L S+I+ E S+ ++A +L+ +
Sbjct: 159 -ISCFSLDSNSSSKNSAKFFSMKTLRNSSCSLLFSSIAFE-------SVGVNAGIALEFE 210
Query: 128 VLEVGWWLNGHCH---CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKA--S 182
+ +GWWL G C C+ N +CT V TPHG +G RC C GF GDGY + C++A
Sbjct: 211 RVRLGWWLKGGCESGTCAANTDCTDVETPHGYAGHRCSCLDGFHGDGYT--NPCQRALPE 268
Query: 183 CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSY-YRARKSTKRCLK 241
C +K + C + I+GG+ GA L+ ++ RRRS R+ S KR L
Sbjct: 269 CRGSKLVWRHCRSNL---ITIVGGTVGGAFLLAALAFFFFCKRRRSTPLRSHLSAKRLLS 325
Query: 242 EARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDG 301
EA G S++ +PY+EIEKAT GFSEKQ+LG GA+GTVY GKLQND VAIKR++HRD++
Sbjct: 326 EAAGNSSVAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSES 385
Query: 302 IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPI 361
+ QV+NEIKL+S VSHPNLVRLLGC IE+G+ +LVYE+MPNGTL +HLQR+RG GL W +
Sbjct: 386 LDQVMNEIKLLSSVSHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGSGLPWTL 445
Query: 362 RLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421
RLTVA +TA+AIA+LHS++NPPIYHRDIKS+NILLDY+F SKVADFGLSRLGMTE SHIS
Sbjct: 446 RLTVATQTAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHIS 505
Query: 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481
TAPQGTPGYLDPQYHQ FHLSDKSDVYSFGVVL EIIT LKVVDF+RP E+NLAALA D
Sbjct: 506 TAPQGTPGYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVD 565
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+I G +DEIIDP++ DA TL+S+H VAELAFRCLAFH DMRP+MTEVA ELE
Sbjct: 566 KIGSGCIDEIIDPILDLDL---DAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQ 622
Query: 542 IRTRTMEDINCTASLEASLCSSSYNAS--------------------------ERMKDNS 575
IR S SL SS + E + D+S
Sbjct: 623 IRLSGWIPSMSLDSPAGSLRSSDRGSERSVKQSSIGSRRVVIPQKQPDCLASVEEISDSS 682
Query: 576 PPSVQDSWSSEQSSSSPLSNSLLSNV 601
P SVQD W S Q SSP +N+LL N+
Sbjct: 683 PISVQDPWLSAQ--SSPSTNTLLGNI 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1226), Expect = e-133, Method: Compositional matrix adjust.
Identities = 270/549 (49%), Positives = 346/549 (63%), Gaps = 36/549 (6%)
Query: 5 HIKIIMEPICNRSIQTLHQLFSQNYAPTS-RNGILLSSCN-SSKVTACKIPLIDVRTQFN 62
+I + + P+C R+I+ + QLF +N AP+ +N IL+ C +K + C I V + N
Sbjct: 72 NIYVEIPPVCKRNIRKIEQLFRENLAPSKLQNIILVQGCKKQNKSSNCLIRNKFVENRLN 131
Query: 63 SIKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAA 122
KC S +SC +D T L ++ +SI+ S
Sbjct: 132 LSKC-----KSPVSC----------LDGATTTTADVMSLGDVVNGSGCKYWFSSISQSQV 176
Query: 123 SLDVKVLEVGWWLNGHCH---CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCR 179
S+++ L++ WWL G C CS+NA+C V G G RC C +GF G + GC
Sbjct: 177 SVNLGRLKLDWWLKGSCSNTTCSENADCAKVKLDDGGLGHRCTCREGFSGKAFTVPGGCH 236
Query: 180 KASCNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKS-TKR 238
+ + + G ++ VL G G +I+ + ++S R S R
Sbjct: 237 R--------LVYKRKGLHKLVVLGTAGILVGVLVIVVLIATYFFRNKQSASSERASIANR 288
Query: 239 CLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD 298
L E G S++P Y Y+EIEKAT FS+K LGTGA+GTVYAG+ N VAIKR+KH+D
Sbjct: 289 LLCELAGNSSVPFYTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKD 348
Query: 299 TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GL 357
T I QVVNEIKL+S VSHPNLVRLLGC GE LVYEFMPNGTL QHLQ ERG L
Sbjct: 349 TTSIDQVVNEIKLLSSVSHPNLVRLLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPL 408
Query: 358 SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-- 415
SW +RL +A +TA AIAHLHS++NPPIYHRDIKSSNILLD+ F SK++DFGLSRLGM+
Sbjct: 409 SWQLRLAIACQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTD 468
Query: 416 -EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474
E SHISTAPQGTPGYLDPQYHQ+F LSDKSDVYSFGVVLVEII+ KV+DF+RP +EVN
Sbjct: 469 FEASHISTAPQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVN 528
Query: 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534
LA+LA DRI +GR+ +IIDP + + AS+H +AELAFRCL+FHR+MRP+M E
Sbjct: 529 LASLAVDRIGRGRVVDIIDPCL---NKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVE 585
Query: 535 VATELEHIR 543
+ +L I+
Sbjct: 586 ITEDLHRIK 594
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 6e-75, Method: Compositional matrix adjust.
Identities = 175/442 (39%), Positives = 245/442 (55%), Gaps = 46/442 (10%)
Query: 129 LEVGWWLNGHCHCSQNANCTPVL-------TPHGRSGFRCGCNKGFEGDGYPAGSGCRKA 181
LE+ W L C + +C +L P RC C KG E D P + C K
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWD--PVNAICGK- 279
Query: 182 SCNAAKYISGQCGGKTR-------------IAVLIIGGSTAGASLIISMRLLCCLMRRRS 228
C K+ + IAV +IG T + + + +++ R
Sbjct: 280 -CRHGKHCKKKKKTVVFAGAAVAVVGVTLAIAVAVIG--TKHSHQKVKKDIHKNIVKERE 336
Query: 229 YYRARKSTKRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLL 288
+ ST K +R I+ REI KAT FS+ +GTG FG V+ L++ +
Sbjct: 337 EMLSANSTG---KSSR------IFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTI 387
Query: 289 VAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQH 348
AIKR K +T G Q++NE++++ V+H +LVRLLGC ++ +L+YEF+PNGTL +H
Sbjct: 388 TAIKRAKLNNTKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEH 447
Query: 349 LQ---RERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405
L L+W RL +A +TA+ +A+LHSA PPIYHRD+KSSNILLD +KV+
Sbjct: 448 LHGSSDRTWKPLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVS 507
Query: 406 DFGLSRL-GMTEI----SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA 460
DFGLSRL +TE SHI T QGT GYLDP+Y++NF L+DKSDVYSFGVVL+E++T+
Sbjct: 508 DFGLSRLVDLTETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTS 567
Query: 461 LKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFR 520
K +DF+R +VNL + + RL E IDPL+ + D + ++ ++ LA
Sbjct: 568 KKAIDFTREEEDVNLVMYINKMMDQERLTECIDPLLKKTANKID---MQTIQQLGNLASA 624
Query: 521 CLAFHRDMRPSMTEVATELEHI 542
CL R RPSM EVA E+E+I
Sbjct: 625 CLNERRQNRPSMKEVADEIEYI 646
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 166/419 (39%), Positives = 241/419 (57%), Gaps = 25/419 (5%)
Query: 137 GHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPA----GSGCRKASCNAAKYISGQ 192
G C N+ C+ T G+ RC C KGF+ D A ++ SC +
Sbjct: 229 GDCRDLLNSVCSNDSTNLGQK--RCFCKKGFQWDSVNAVCEVNRCSKRKSCKRWSNLPLL 286
Query: 193 CGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKSTKRCLKEARGISNIP-- 250
G + ++I G I+ ++ RR + ++ S ++ + I++
Sbjct: 287 GGLAGGVGAILIAG-------FITKTIVSKQNRRIAGNQSWASVRKLHRNLLSINSTGLD 339
Query: 251 -IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEI 309
I+ +EI KAT F++ LG G FG V+ G L + VA+KR K + I Q+VNE+
Sbjct: 340 RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEV 399
Query: 310 KLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG------DGLSWPIRL 363
+++ VSH NLV+LLGC IE +LVYEF+PNGTL +H+ G D L RL
Sbjct: 400 QILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRL 459
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
+A +TAQ + +LHS+ +PPIYHRD+KSSNILLD N KVADFGLSRLG++++SH++T
Sbjct: 460 MIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTTC 519
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483
QGT GYLDP+Y+ NF L+DKSDVYSFGVVL E++T K +DF+R +VNL +
Sbjct: 520 AQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKAL 579
Query: 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+GRL ++IDP+I + ++ ++ +AEL C+ R RP+M A E+E+I
Sbjct: 580 KEGRLMDVIDPVIGIGATEKEIESMKALGVLAEL---CVKETRQCRPTMQVAAKEIENI 635
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 178/490 (36%), Positives = 258/490 (52%), Gaps = 67/490 (13%)
Query: 126 VKVLEVGWWLNGHCHCSQNANCTPVLTPHGRSG-----FRCGCNKGFEGDGYPAGSGCRK 180
V++L+ G+ LN + +C +T GR G F C C P G
Sbjct: 203 VEILKRGFVLNWTAN-----SCFRCITSGGRCGTDQQEFVCLC---------PDGPKLHD 248
Query: 181 ASCNAAKYISGQCGGKTRIAVLI---IGGSTAGASLIISMRLLCCLMRRRSYYRARKSTK 237
N G+ + R+ V I I G++A +I+ + + RR R S+
Sbjct: 249 TCTN------GKNDKRRRVIVKITKSISGASAAVVGLIAASIFWYVYHRRKTKSYRNSSA 302
Query: 238 RCLKEARGISNIP------------------IYPYREIEKATIGFSEKQRLGTGAFGTVY 279
R IS+ P I+ Y E+E+AT F + LG G FGTVY
Sbjct: 303 LL---PRNISSDPSAKSFDIEKAEELLVGVHIFSYEELEEATNNFDPSKELGDGGFGTVY 359
Query: 280 AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-EQILVYE 338
GKL++ VA+KR+ + +Q NE+++++ + HPNLV L GCS ++ + +LVYE
Sbjct: 360 YGKLKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLRHPNLVALFGCSSKQSRDLLLVYE 419
Query: 339 FMPNGTLCQHLQRERGD--GLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396
++ NGTL HL + + L W IRL +A+ETA A+ +LH++ I HRD+KS+NILL
Sbjct: 420 YVANGTLADHLHGPQANPSSLPWSIRLKIAVETASALKYLHAS---KIIHRDVKSNNILL 476
Query: 397 DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVE 456
D NF KVADFGLSRL + +H+STAPQGTPGY+DP YH + LS+KSDVYSF VVL+E
Sbjct: 477 DQNFNVKVADFGLSRLFPMDKTHVSTAPQGTPGYVDPDYHLCYQLSNKSDVYSFAVVLME 536
Query: 457 IITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAE 516
+I++L VD +RP E+NL+ +A +I L +++DP + +D +V VAE
Sbjct: 537 LISSLPAVDITRPRQEINLSNMAVVKIQNHELRDMVDPSL---GFDTDTRVRQTVIAVAE 593
Query: 517 LAFRCLAFHRDMRPSMTEVATELEHIRTRTMEDINCTASLEASLCSSSYNASERMKDNSP 576
LAF+CL +D+RP M+ V L I+ + + N S + SP
Sbjct: 594 LAFQCLQSDKDLRPCMSHVQDTLTRIQNN---------GFGSEMDVVDVNKSGPLVAQSP 644
Query: 577 PSVQDSWSSE 586
SV W S+
Sbjct: 645 DSVIVKWDSK 654
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 154/411 (37%), Positives = 235/411 (57%), Gaps = 34/411 (8%)
Query: 160 RCGCNKGFEGDGYPAGSGCRKAS----------CNAAKYISGQCGGKT-----RIAVLII 204
RC C +GF+G+ Y G GC+ + C K ++ Q K R + +
Sbjct: 319 RCSCTRGFQGNPYRLG-GCKDINECKEEEGMTYCGTNKCVNLQGHFKCVYNNHRPLAIGL 377
Query: 205 GGSTAGASLIISMRLLCCLMRR-RSYYRARKSTKR---CLKEARGISNIP------IYPY 254
G S ++ + LL +++ R + +K KR L + + IS + ++
Sbjct: 378 GASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSS 437
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC 314
RE+EKAT FS + LG G GTVY G L + +VA+K+ K D D +++ +NE+ ++S
Sbjct: 438 RELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQ 497
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL--SWPIRLTVAMETAQA 372
++H N+V+LLGC +E +LVYEF+PNG L +HL E + + +W IRL +A++ A A
Sbjct: 498 INHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGA 557
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
+++LHS+ + PIYHRD+KS+NI+LD +++KV+DFG SR + +H++T GT GY+D
Sbjct: 558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMD 617
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492
P+Y Q+ +DKSDVYSFGVVLVE+IT K + F R LA + + +L +II
Sbjct: 618 PEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDII 677
Query: 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
D I D L+ V A++A +CL RPSM EV+ EL+ IR
Sbjct: 678 DARI------RDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 165/443 (37%), Positives = 238/443 (53%), Gaps = 50/443 (11%)
Query: 139 CHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKAS-----------CNAAK 187
C C N+ T T C C GFEG+ Y G C+ + C A K
Sbjct: 291 CLCDYNSTTTGYAT--------CSCASGFEGNPYIPGE-CKDINECVRGIDGNPVCTAGK 341
Query: 188 ---YISGQCGGKTRIAVLIIGGSTAGASLII--SMRLLCCLMRRRSYYRARKSTKRCLKE 242
+ G T L+IG ST+ ++L+ + L +RR+ R K+ K
Sbjct: 342 CVNLLGGYTCEYTNHRPLVIGLSTSFSTLVFIGGIYWLYKFIRRQ---RRLNQKKKFFKR 398
Query: 243 ARG-------------ISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLV 289
G + + ++ RE+EKAT FS + LG G GTVY G L + +V
Sbjct: 399 NGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIV 458
Query: 290 AIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL 349
A+K+ K D D +++ +NE+ ++S ++H N+V+LLGC +E ILVYEF+PNG L +HL
Sbjct: 459 AVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHL 518
Query: 350 QRERGD--GLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407
+ D +W +RL +A++ A A+++LHSA + PIYHRDIKS+NI+LD ++KV+DF
Sbjct: 519 HDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDF 578
Query: 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFS 467
G SR + +H++T GT GY+DP+Y Q+ +DKSDVYSFGVVL E+IT K V F
Sbjct: 579 GTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFL 638
Query: 468 RPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRD 527
R LA + + RL +IID I D L V A++A +CL
Sbjct: 639 RSQEYRTLATYFTLAMKENRLSDIIDARI------RDGCKLNQVTAAAKIARKCLNMKGR 692
Query: 528 MRPSMTEVATELEHIRTRTMEDI 550
RPSM +V+ ELE IR+ + ED+
Sbjct: 693 KRPSMRQVSMELEKIRSYS-EDM 714
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 166/462 (35%), Positives = 251/462 (54%), Gaps = 52/462 (11%)
Query: 129 LEVGWWLNGH-------CHCSQNANCTPVLT------PHGR-SGFR---CGCNK-GFEGD 170
+E+GW+ + C ++ TP + +G SGF C CN G++G+
Sbjct: 236 VELGWFFDTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCNSPGYKGN 295
Query: 171 GY-PAG-------------SGCRKASC-NAAKYISGQCGGKTRIAVLIIGGSTAGASLII 215
+ P G + C+ SC N + Q ++ +I G A L+
Sbjct: 296 PFLPGGCVDVDECKLDIGRNQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSALLLF 355
Query: 216 SMRLLCC---LMRRRSYYRARKSTKR----CLKE--ARGISNIP---IYPYREIEKATIG 263
+ + + +RR R RK +R LK+ AR N+ I+ E+EKAT
Sbjct: 356 AFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDN 415
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
F++ + LG G GTVY G L + +VA+KR K D D +++ +NE+ +++ ++H N+V+L
Sbjct: 416 FNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKL 475
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMETAQAIAHLHSAINP 382
LGC +E +LVYEF+PNG LC+ L E D ++W +RL +A+E A A+++LHSA +
Sbjct: 476 LGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASF 535
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
PIYHRDIK++NILLD ++KV+DFG SR + +H++T GT GY+DP+Y Q+ +
Sbjct: 536 PIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFT 595
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
+KSDVYSFGVVLVE++T K R LAA + + + R+ +I+D I
Sbjct: 596 EKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRI------ 649
Query: 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
D + V VA LA RCL RP+M EV+ ELE IR+
Sbjct: 650 KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRS 691
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 151/414 (36%), Positives = 234/414 (56%), Gaps = 38/414 (9%)
Query: 159 FRCGCNKGFEGDGYPAGSGCRKAS---------CNAAKYI----SGQCGGKTRIAVLIIG 205
++C C+ G+EG+ Y G GC+ C K + S +C KT A+L
Sbjct: 264 YQCSCHNGYEGNPYIPG-GCQDIDECRDPHLNKCGKRKCVNVLGSYRCE-KTWPAILSGT 321
Query: 206 GSTAGASLIISMRLLCCLMRRRSYYRARKSTKRCLKEARG-------------ISNIPIY 252
S+ LI M LLC R+R + K ++ + G ++ ++
Sbjct: 322 LSSGLLLLIFGMWLLCKANRKR---KVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVF 378
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
++E AT F+ + LG G GTVY G L++ ++VA+K+ K + +++ +NEI L+
Sbjct: 379 SSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILL 438
Query: 313 SCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMETAQ 371
S ++H N+V++LGC +E ILVYEF+PN L HL D +SW +RL +A E A
Sbjct: 439 SQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVAD 498
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
A+++LHSA++ PIYHRD+KS+NILLD ++KV+DFG+SR + +H++T QGT GY+
Sbjct: 499 ALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYV 558
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491
DP+Y Q+ H + KSDVYSFGV+L+E++T K V R L A + + RL EI
Sbjct: 559 DPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEI 618
Query: 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545
+D I E + V VA+LA RCL+ + + RP+M +V EL+ ++++
Sbjct: 619 LDARIKEECDREE------VLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSK 666
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 129/295 (43%), Positives = 189/295 (64%), Gaps = 7/295 (2%)
Query: 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK 310
I+ +E+EKAT F+ + LG G GTVY G L + +VA+KR K D D +++ +NE+
Sbjct: 408 IFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVG 467
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMET 369
++S ++H N+V+L+GC +E ILVYE +PNG L + L + D ++W +RL +++E
Sbjct: 468 VLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEI 527
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG 429
A A+A+LHSA + P+YHRD+K++NILLD +++KV+DFG SR + +H++T GT G
Sbjct: 528 AGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFG 587
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
YLDP+Y Q +DKSDVYSFGVVLVE+IT K RP L + + + + R+
Sbjct: 588 YLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVL 647
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
+I+D I E TL V VA+LA RCL+ RP+M EV+ ELE IR+
Sbjct: 648 DIVDSRIKE------GCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| 359492649 | 754 | PREDICTED: wall-associated receptor kina | 0.928 | 0.742 | 0.627 | 0.0 | |
| 302142412 | 694 | unnamed protein product [Vitis vinifera] | 0.928 | 0.806 | 0.627 | 0.0 | |
| 356518062 | 709 | PREDICTED: wall-associated receptor kina | 0.958 | 0.815 | 0.606 | 0.0 | |
| 356510316 | 712 | PREDICTED: wall-associated receptor kina | 0.902 | 0.764 | 0.656 | 0.0 | |
| 224063575 | 694 | predicted protein [Populus trichocarpa] | 0.927 | 0.805 | 0.614 | 0.0 | |
| 224137274 | 686 | predicted protein [Populus trichocarpa] | 0.930 | 0.817 | 0.609 | 0.0 | |
| 255538508 | 627 | kinase, putative [Ricinus communis] gi|2 | 0.933 | 0.897 | 0.602 | 0.0 | |
| 255562745 | 701 | kinase, putative [Ricinus communis] gi|2 | 0.963 | 0.828 | 0.590 | 0.0 | |
| 356502214 | 699 | PREDICTED: wall-associated receptor kina | 0.973 | 0.839 | 0.549 | 0.0 | |
| 224094560 | 715 | predicted protein [Populus trichocarpa] | 0.950 | 0.801 | 0.559 | 0.0 |
| >gi|359492649|ref|XP_003634449.1| PREDICTED: wall-associated receptor kinase-like 14-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/617 (62%), Positives = 445/617 (72%), Gaps = 57/617 (9%)
Query: 4 DHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNS 63
+ I + +E CNRSI++L LF+ NYAPT+RNGILL C S T C IP V T F S
Sbjct: 137 ESILVNLEVRCNRSIKSLDHLFNTNYAPTTRNGILLKHCKSPAST-CTIPTTKVNTHFES 195
Query: 64 IKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAAS 123
I C S++ SISCYSEE ++ F+ N +K C++LLS+IS + FNTS+
Sbjct: 196 IDC--GSDNYSISCYSEE-HENGFLSQANVSKSHCQYLLSSISVDAFNTSSVV------- 245
Query: 124 LDVKVLEVGWWLNGHCHCSQNANCTPVLTP-HGRSGFRCGCNKGFEGDGYPAGSGCRKAS 182
LDV ++++GWWL G C C Q A CT + TP G+ GFRC C GF+GDGY AG GCRKAS
Sbjct: 246 LDVGIVQLGWWLLGECKCHQEATCTEIQTPVAGQQGFRCKCRDGFDGDGYQAGVGCRKAS 305
Query: 183 --CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKSTKRCL 240
CN ++YISGQCGG +R VL G +L+IS+ +CC MRR +AR ST+R L
Sbjct: 306 SGCNPSRYISGQCGGPSRFFVL-----AGGIALMISISAICCFMRRCLTSKARNSTRRRL 360
Query: 241 KEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD 300
EA G +IPIYPYR IEKAT FSEKQRLGTGA+GTVY+GKL N VAIKRIKHRDTD
Sbjct: 361 SEATGKCSIPIYPYRAIEKATSSFSEKQRLGTGAYGTVYSGKLHNQW-VAIKRIKHRDTD 419
Query: 301 GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWP 360
I++V+NEIKLIS VSHPNLVRLLGCSIE+GEQILVYEFM NGTL QHLQRERG+GL W
Sbjct: 420 SIEEVLNEIKLISSVSHPNLVRLLGCSIEKGEQILVYEFMANGTLSQHLQRERGNGLVWA 479
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+RL++A +TAQAIAHLHSA+NPPIYHRDIKSSNILLD+NF K+ADFGLSRLGM E SHI
Sbjct: 480 VRLSIATQTAQAIAHLHSALNPPIYHRDIKSSNILLDHNFIPKLADFGLSRLGMAESSHI 539
Query: 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP NEVNLAALA
Sbjct: 540 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPQNEVNLAALAI 599
Query: 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
DRI KGRLDEIIDP + HR DA +L+S+HKVAELAFRCLAFHRDMRPSM EVA ELE
Sbjct: 600 DRIGKGRLDEIIDPFLEPHR---DAWSLSSLHKVAELAFRCLAFHRDMRPSMMEVAAELE 656
Query: 541 HIRT---RTMEDINCTA--------------------SLEASLCSS-----------SYN 566
I+ T ED CTA ++E S S N
Sbjct: 657 QIKLCKWATSEDNMCTASSETSSCSSSSNVSEIPLSMTVEKGGLGSEGLFVLPTKVISMN 716
Query: 567 ASERMKDNSPPSVQDSW 583
+ R+KD SP SVQD W
Sbjct: 717 SLGRLKDTSPVSVQDPW 733
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142412|emb|CBI19615.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/617 (62%), Positives = 445/617 (72%), Gaps = 57/617 (9%)
Query: 4 DHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNS 63
+ I + +E CNRSI++L LF+ NYAPT+RNGILL C S T C IP V T F S
Sbjct: 77 ESILVNLEVRCNRSIKSLDHLFNTNYAPTTRNGILLKHCKSPAST-CTIPTTKVNTHFES 135
Query: 64 IKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAAS 123
I C S++ SISCYSEE ++ F+ N +K C++LLS+IS + FNTS+
Sbjct: 136 IDC--GSDNYSISCYSEE-HENGFLSQANVSKSHCQYLLSSISVDAFNTSSVV------- 185
Query: 124 LDVKVLEVGWWLNGHCHCSQNANCTPVLTP-HGRSGFRCGCNKGFEGDGYPAGSGCRKAS 182
LDV ++++GWWL G C C Q A CT + TP G+ GFRC C GF+GDGY AG GCRKAS
Sbjct: 186 LDVGIVQLGWWLLGECKCHQEATCTEIQTPVAGQQGFRCKCRDGFDGDGYQAGVGCRKAS 245
Query: 183 --CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKSTKRCL 240
CN ++YISGQCGG +R VL G +L+IS+ +CC MRR +AR ST+R L
Sbjct: 246 SGCNPSRYISGQCGGPSRFFVL-----AGGIALMISISAICCFMRRCLTSKARNSTRRRL 300
Query: 241 KEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD 300
EA G +IPIYPYR IEKAT FSEKQRLGTGA+GTVY+GKL N VAIKRIKHRDTD
Sbjct: 301 SEATGKCSIPIYPYRAIEKATSSFSEKQRLGTGAYGTVYSGKLHNQW-VAIKRIKHRDTD 359
Query: 301 GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWP 360
I++V+NEIKLIS VSHPNLVRLLGCSIE+GEQILVYEFM NGTL QHLQRERG+GL W
Sbjct: 360 SIEEVLNEIKLISSVSHPNLVRLLGCSIEKGEQILVYEFMANGTLSQHLQRERGNGLVWA 419
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+RL++A +TAQAIAHLHSA+NPPIYHRDIKSSNILLD+NF K+ADFGLSRLGM E SHI
Sbjct: 420 VRLSIATQTAQAIAHLHSALNPPIYHRDIKSSNILLDHNFIPKLADFGLSRLGMAESSHI 479
Query: 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP NEVNLAALA
Sbjct: 480 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPQNEVNLAALAI 539
Query: 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
DRI KGRLDEIIDP + HR DA +L+S+HKVAELAFRCLAFHRDMRPSM EVA ELE
Sbjct: 540 DRIGKGRLDEIIDPFLEPHR---DAWSLSSLHKVAELAFRCLAFHRDMRPSMMEVAAELE 596
Query: 541 HIRT---RTMEDINCTA--------------------SLEASLCSS-----------SYN 566
I+ T ED CTA ++E S S N
Sbjct: 597 QIKLCKWATSEDNMCTASSETSSCSSSSNVSEIPLSMTVEKGGLGSEGLFVLPTKVISMN 656
Query: 567 ASERMKDNSPPSVQDSW 583
+ R+KD SP SVQD W
Sbjct: 657 SLGRLKDTSPVSVQDPW 673
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518062|ref|XP_003527703.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/627 (60%), Positives = 454/627 (72%), Gaps = 49/627 (7%)
Query: 1 MKSDHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQ 60
+ +D + + +E CNR +LH LFS YAPTSRN ILL +C + + C IP VRT
Sbjct: 78 VNTDSMIVSIEAQCNRPFDSLHHLFSHKYAPTSRNVILLENCTGTPL-PCFIPETLVRTH 136
Query: 61 FNSIKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISS-ELFNTSAASINI 119
F S+ C+++S + +SCY E + + F+D + CK+ +S++++ ++ N S A +
Sbjct: 137 FESVGCNNASGTGELSCYFENRTN-GFVDRRTLDEIGCKYFMSSLAAPDIKNISGAPL-- 193
Query: 120 SAASLDVKVLEVGWWLNG-HCHCSQNANCTPVLTP-HGRSGFRCGCNKGFEGDGYPAGSG 177
SLDV ++++GWWL G C CS +ANCT + +P G+ GFRC C GF GDG+ AG+G
Sbjct: 194 ---SLDVNIIQLGWWLQGDQCLCSDHANCTTLQSPMDGKPGFRCRCRDGFVGDGFLAGTG 250
Query: 178 CRKAS-CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKST 236
CRKAS CN AKYISG+CGG TR VLI GG G SL++++ LCC RRRS R ST
Sbjct: 251 CRKASSCNPAKYISGRCGGTTRFIVLI-GGFVVGVSLMVTLGSLCCFYRRRSKLRVTNST 309
Query: 237 KRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKH 296
KR L EA G +++PIYPY++IEKAT FSEKQRLGTGA+GTVYAGKL N+ VAIKRIKH
Sbjct: 310 KRRLTEATGKNSVPIYPYKDIEKATNSFSEKQRLGTGAYGTVYAGKLYNNEWVAIKRIKH 369
Query: 297 RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG 356
RDTD I+QV+NEIKL+S VSH NLVRLLGCSIE GEQILVYEFMPNGTL QHLQ+ERG G
Sbjct: 370 RDTDSIEQVMNEIKLLSSVSHTNLVRLLGCSIEYGEQILVYEFMPNGTLSQHLQKERGSG 429
Query: 357 LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416
L WPIRLT+A ETAQAIA+LHSAI PPIYHRDIKSSNILLDYNF+SKVADFGLSRLGMTE
Sbjct: 430 LPWPIRLTIATETAQAIAYLHSAICPPIYHRDIKSSNILLDYNFRSKVADFGLSRLGMTE 489
Query: 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476
ISHIST PQGTPGY+DPQYHQ+FHLSDKSDVYS GVVLVEIIT LKVVDFSRP NEVNLA
Sbjct: 490 ISHISTTPQGTPGYVDPQYHQDFHLSDKSDVYSLGVVLVEIITGLKVVDFSRPHNEVNLA 549
Query: 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
+LAAD+I KG L+EIIDP +E SDA TL+S+HKVAELAFRC+AFHRDMRPSMTEVA
Sbjct: 550 SLAADKIGKGLLNEIIDPF-LEPEVRSDAWTLSSIHKVAELAFRCIAFHRDMRPSMTEVA 608
Query: 537 TELEHIRT---RTMEDINCTASLEA--------------SLCSSSYNAS----------- 568
+ELE +R T+ D NC S E S+ + ++ A
Sbjct: 609 SELEQLRLSRWTTLGDNNCATSTELSSCSSSSNECEKPLSIATRNFGAKGKGHLKLQTGP 668
Query: 569 ------ERMKDNSPPSVQDS--WSSEQ 587
+R NSP SVQD W SEQ
Sbjct: 669 INLKSLQRPNSNSPVSVQDQDLWLSEQ 695
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510316|ref|XP_003523885.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1854), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/559 (65%), Positives = 428/559 (76%), Gaps = 15/559 (2%)
Query: 1 MKSDHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQ 60
+ +D + + +E CNRS + H LFS YAPTSRN ILL +C ++ + C IP VRT
Sbjct: 79 VNTDSLIVSIEAQCNRSFDSFHHLFSHKYAPTSRNVILLDNCTATPL-PCSIPETLVRTH 137
Query: 61 FNSIKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAIS-SELFNTSAASINI 119
F S+ C ++S + +SCY E K F+D + +CK+ +S++S ++ N S +
Sbjct: 138 FESVGCGNASGTGELSCYFE-KITNGFMDQRMLDEIRCKYFMSSLSVPDIKNISGTA--- 193
Query: 120 SAASLDVKVLEVGWWLNG-HCHCSQNANCTPVLTPHGRS-GFRCGCNKGFEGDGYPAGSG 177
SL V V+E+GWWL G C CS +ANCT + +P R GFRC C GF GDG+ G+G
Sbjct: 194 -PLSLGVNVIELGWWLQGDRCLCSDHANCTTLQSPVDRKPGFRCRCRDGFVGDGFLVGTG 252
Query: 178 CRKAS-CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKST 236
C+KAS CN AKY+SG+CGG TR VLI GG G SL++++ LCC RRRS R KST
Sbjct: 253 CQKASSCNPAKYMSGRCGGTTRFIVLI-GGFVIGVSLMVTLGSLCCFYRRRSKLRVTKST 311
Query: 237 KRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKH 296
KR L EA G +++PIYPY++IEKAT FSEKQRLGTGA+GTVYAGKL ND VAIKRIKH
Sbjct: 312 KRRLTEATGNNSVPIYPYKDIEKATNSFSEKQRLGTGAYGTVYAGKLYNDEWVAIKRIKH 371
Query: 297 RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG 356
RDTD I+QV+NEIKL+S VSH NLVRLLGCSIE GEQILVYEFMPNGT QHLQ+ERG G
Sbjct: 372 RDTDSIEQVMNEIKLLSSVSHTNLVRLLGCSIEYGEQILVYEFMPNGTRSQHLQKERGSG 431
Query: 357 LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416
L WP+RLT+A ETAQAIAHLHSAI PPIYHRDIKSSNILLDYNF+SKVADFGLSRLGMTE
Sbjct: 432 LPWPVRLTIATETAQAIAHLHSAICPPIYHRDIKSSNILLDYNFRSKVADFGLSRLGMTE 491
Query: 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476
ISHISTAPQGTPGY+DPQYHQ+FHLSDKSDVYS GVVLVEIIT KVVDFSRP NEVNLA
Sbjct: 492 ISHISTAPQGTPGYVDPQYHQDFHLSDKSDVYSLGVVLVEIITGQKVVDFSRPHNEVNLA 551
Query: 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
+LAADRI KG L+EIIDP +E SDA TL+S+HKVAELAFRCLAFHRDMRPSMTEVA
Sbjct: 552 SLAADRIGKGLLNEIIDPF-LEAEARSDAWTLSSIHKVAELAFRCLAFHRDMRPSMTEVA 610
Query: 537 TELEHI---RTRTMEDINC 552
+ELE + R TM D NC
Sbjct: 611 SELEQLSLSRWTTMGDNNC 629
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224063575|ref|XP_002301212.1| predicted protein [Populus trichocarpa] gi|222842938|gb|EEE80485.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/620 (61%), Positives = 443/620 (71%), Gaps = 61/620 (9%)
Query: 6 IKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNSIK 65
IKII+EP CNR ++ L LF++NYAP S N ILL +C S+ V+ C IP I+V+T F S+K
Sbjct: 75 IKIILEPKCNRPLEALDNLFTKNYAPKSTNAILLHNCTSA-VSPCNIPSINVQTHFESLK 133
Query: 66 CDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAASLD 125
C SN+SS+SC+S+E F DY A QC++ LS+IS+E F S S L+
Sbjct: 134 C---SNNSSLSCFSKEVTANGFFDYNMANISQCQYFLSSISAESFTGSGVS-------LE 183
Query: 126 VKVLEVGWWLNGHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKAS--- 182
++++E+ WWL G C CS++A CT V +P G SGFRC C G GDGY AG GCRK S
Sbjct: 184 IQMMELWWWLQGDCRCSKDAICTQVESPAG-SGFRCQCRDGLIGDGYLAGVGCRKGSFLD 242
Query: 183 ------CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKST 236
CN AKY+SGQCGG + AVL+ A + +S+ L CCL+RR S +A+
Sbjct: 243 VKASAGCNPAKYLSGQCGGGSGAAVLL---GGVVAGVGVSLGLFCCLVRRNSASKAKSFR 299
Query: 237 KRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKH 296
K L EA I NIPIYPY+EIEKAT FSEKQR+GTGA+GTVYAGKL +D VAIKRIKH
Sbjct: 300 KLHLSEAADI-NIPIYPYKEIEKATNSFSEKQRIGTGAYGTVYAGKLNSDSWVAIKRIKH 358
Query: 297 RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG 356
D D I+QV+NEIKLIS VSHPNLVRLLGCSIE GEQILVYEFMPNGTLCQHLQRERGDG
Sbjct: 359 GDMDNIEQVMNEIKLISSVSHPNLVRLLGCSIENGEQILVYEFMPNGTLCQHLQRERGDG 418
Query: 357 LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416
L WP+RL +A +TA+AIAHLHSA++PPIYHRDIKSSNILLDY+F+SKVADFGLSR GMTE
Sbjct: 419 LDWPVRLAIAADTAKAIAHLHSAMDPPIYHRDIKSSNILLDYHFRSKVADFGLSRHGMTE 478
Query: 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476
ISHIST PQGTPGYLDPQYH NFHLSDKSDVYSFGVVLVEIITA KVVDFSRP NEVNLA
Sbjct: 479 ISHISTVPQGTPGYLDPQYHLNFHLSDKSDVYSFGVVLVEIITAKKVVDFSRPQNEVNLA 538
Query: 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
ALA DRI +GRLDEIIDP + HSDA T +SVHKVAE+AFRCLAFH+DMRPSM EVA
Sbjct: 539 ALATDRIGRGRLDEIIDPFL---DLHSDAWTFSSVHKVAEVAFRCLAFHKDMRPSMMEVA 595
Query: 537 TELEHI---RTRTMEDINCTASLEASL------------------------------CSS 563
ELE I R + E+ NC SL+ S +
Sbjct: 596 AELEQILLSRWASSEETNCAISLDFSPCSSSSNVSDKPLNSTVKKTEIERRGLFVLQTQT 655
Query: 564 SYNASERMKDNSPPSVQDSW 583
S ++ER NSP SVQD W
Sbjct: 656 SKKSTERANHNSPVSVQDPW 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137274|ref|XP_002327085.1| predicted protein [Populus trichocarpa] gi|222835400|gb|EEE73835.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/614 (60%), Positives = 438/614 (71%), Gaps = 53/614 (8%)
Query: 4 DHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNS 63
D IKI +EP C R ++ L+ L ++NYAP S N ILL++C +S + C IP I VRT F S
Sbjct: 73 DTIKINLEPRCYRPVEALYNLSTKNYAPKSTNAILLNNC-TSGFSPCNIPSISVRTHFES 131
Query: 64 IKCDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAAS 123
+ C SN+SS+SC+S+ F DY A QCK+LLS+IS+E F S S
Sbjct: 132 LNC---SNNSSVSCFSKADTANGFFDYNMANISQCKYLLSSISAESFTGSGVS------- 181
Query: 124 LDVKVLEVGWWLNGHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKAS- 182
L+ +++E+ WWL G C CS++A CT V +P G SGFRC C G GDGY AG GCRKA+
Sbjct: 182 LETQMMELWWWLQGDCQCSKDAICTKVESPAG-SGFRCQCRDGLIGDGYLAGVGCRKAAG 240
Query: 183 CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSYYRARKSTKRCLKE 242
CN AKY+SGQCG R AVL+ GG A + + L CCL RR S +A+ K E
Sbjct: 241 CNPAKYLSGQCGAGARPAVLL-GGIVAAVG--VGLGLFCCLTRRNSISKAKSFRKLHRAE 297
Query: 243 ARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI 302
A IS IPIYPY+EIEKAT FSEKQR+GTGA+GTVYAGKL +D VAIKRIKHRD D I
Sbjct: 298 AADIS-IPIYPYKEIEKATNSFSEKQRIGTGAYGTVYAGKLSSDSWVAIKRIKHRDVDSI 356
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR 362
+QV+NEIKLIS VSHPNLVRLLGCSIE EQILVYEFMPNGTLCQHLQR RGDGL WP+R
Sbjct: 357 EQVINEIKLISSVSHPNLVRLLGCSIENDEQILVYEFMPNGTLCQHLQRVRGDGLDWPVR 416
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422
L +A ETA+AIAHLHSAI+PPIYHRDIKSSNILLD++FKSKVADFGLSR GMT++SHIST
Sbjct: 417 LAIATETAKAIAHLHSAIDPPIYHRDIKSSNILLDFDFKSKVADFGLSRHGMTDMSHIST 476
Query: 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482
PQGTPGYLDPQYHQNFHLSDK+DVYSFGVVL+EIITA KV+DFSRP +EVNLA+LA D+
Sbjct: 477 VPQGTPGYLDPQYHQNFHLSDKTDVYSFGVVLIEIITAKKVLDFSRPQDEVNLASLAIDK 536
Query: 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
I +G LDEIIDP + H+DA T +SVHKVAELAFRCLAFH+D+RPSM EVA ELE I
Sbjct: 537 IGRGLLDEIIDPFL---DLHNDAWTFSSVHKVAELAFRCLAFHKDIRPSMMEVAAELEQI 593
Query: 543 ---RTRTMEDINCTASL------------EASL------------------CSSSYNASE 569
R E+INCT SL E +L +S ++E
Sbjct: 594 MLTRWPPSEEINCTTSLDFSQCSSSSHVSEKALNLTVKKTEIERRGLLVLQTQASRKSTE 653
Query: 570 RMKDNSPPSVQDSW 583
R NSP SVQD W
Sbjct: 654 RTDHNSPMSVQDPW 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538508|ref|XP_002510319.1| kinase, putative [Ricinus communis] gi|223551020|gb|EEF52506.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/619 (60%), Positives = 445/619 (71%), Gaps = 56/619 (9%)
Query: 1 MKSDHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQ 60
+ + I+I + P C+R I T LF++N+AP S N ILL++C SS + C IP I V+T
Sbjct: 11 VNQEKIRIDLRPKCDRPIDTFKSLFTKNFAPMSTNAILLNNC-SSTLLPCSIPDISVQTH 69
Query: 61 FNSIKCDSSSNSSSISCYSEEKNDREFIDYENATKQ--QCKFLLSAISSELFNTSAASIN 118
F S+ C SS SS ++ +++ F D T Q C + LS+ISSE S+N
Sbjct: 70 FESLNCSKSSRSSISCLFNLTRDN--FFDSGKYTDQLKYCDYFLSSISSE-------SVN 120
Query: 119 ISAASLDVKVLEVGWWLNGHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGC 178
S SLD+ VL++GWWL G C CS+ A+C + +P G G+RC C GF GDGY AG+GC
Sbjct: 121 GSGVSLDILVLDLGWWLPGKCQCSEQADCIKIASPKG-PGYRCRCKDGFSGDGYSAGTGC 179
Query: 179 RKASCNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRR-SYYRARKSTK 237
RK SCN K++SGQCG RIAVLI G++L++++ L+CC +RRR S +A+ K
Sbjct: 180 RKGSCNLEKHLSGQCGETIRIAVLI-----GGSALMVALGLVCCFIRRRFSTSKAKGFRK 234
Query: 238 RCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR 297
L EA GI NIPIYPY+EIEKAT FS+KQRLGTGA+GTVYAGKL ND+ VAIKRIKHR
Sbjct: 235 LSLSEATGI-NIPIYPYKEIEKATNSFSDKQRLGTGAYGTVYAGKLHNDIWVAIKRIKHR 293
Query: 298 DTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG 356
D D ++QV+NEIKLIS V+HP+LVRLLGCSIE GEQ+LVYEFMPNGTLCQHLQRE+GDG
Sbjct: 294 DIDDSVEQVMNEIKLISSVNHPSLVRLLGCSIENGEQVLVYEFMPNGTLCQHLQREKGDG 353
Query: 357 LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416
L+WP+RLT+A ETAQAIA+LHSAI+PPIYHRDIKSSNILLDYNF+SKVADFGLSRLG TE
Sbjct: 354 LAWPVRLTIAAETAQAIAYLHSAIDPPIYHRDIKSSNILLDYNFRSKVADFGLSRLGRTE 413
Query: 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476
ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVL+EIITALKVVDFSR NEVNLA
Sbjct: 414 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLIEIITALKVVDFSRQYNEVNLA 473
Query: 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
ALA DRI KGRL EIIDPL+ H DA T ++VHKVAELAFRCLAF +D RPSM EVA
Sbjct: 474 ALATDRIGKGRLAEIIDPLL---DIHCDAWTFSTVHKVAELAFRCLAFDKDTRPSMMEVA 530
Query: 537 TELEHIRTRTM---EDINCTASL-------------EASLCSSSYN-------------- 566
ELE +R E+I AS E L S++ N
Sbjct: 531 AELEQLRISRWSPEEEIKFRASSVESSCSTSSSNISEKPLSSTNNNGELGNISLFTQVRS 590
Query: 567 --ASERMKDNSPPSVQDSW 583
+++ KD+SP SVQD W
Sbjct: 591 VKSTDEAKDDSPVSVQDPW 609
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562745|ref|XP_002522378.1| kinase, putative [Ricinus communis] gi|223538456|gb|EEF40062.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/637 (59%), Positives = 444/637 (69%), Gaps = 56/637 (8%)
Query: 6 IKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNSIK 65
I + + CNRS++ + LF +YAP RNG+LL +C + +++C IP Q +
Sbjct: 82 ILVSLPAKCNRSLEAISPLFGDHYAPAWRNGLLLQNCTRT-LSSCYIPTSSFANQLHIPS 140
Query: 66 CDSSSNSSSISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAASLD 125
C+ S++ I+CYS E+ + + Y N CKFL F++ A N + SL+
Sbjct: 141 CNPRSDN--ITCYSRERLGMDVLSYNNLNSAGCKFL--------FSSFAVGSNNPSVSLE 190
Query: 126 VKVLEVGWWLNGHC-----HCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRK 180
+ +E+ WWL+G C +CS++ANCT + G+ GFRC C +GF GDG+ G GCR
Sbjct: 191 FERVELDWWLDGSCKLNRSNCSKHANCTDIKLGDGKGGFRCWCQEGFTGDGFRNGDGCRS 250
Query: 181 AS-CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRSY-YRARKSTKR 238
S CNA+KYI+GQCGG TR+ VL+ GG AGASL+ + L+ +R+RS R R S KR
Sbjct: 251 VSGCNASKYINGQCGGTTRVGVLV-GGIIAGASLMAGLALIWYFVRQRSTSLRNRLSAKR 309
Query: 239 CLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD 298
L EA G S++P YPYREIEKAT GFSEKQRLG GA+GTVYAGKL N+ VAIK+I+HRD
Sbjct: 310 LLCEAAGNSSVPFYPYREIEKATNGFSEKQRLGIGAYGTVYAGKLHNEEWVAIKKIRHRD 369
Query: 299 TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLS 358
TD I QV+NEIKL+S VSHPNLVRLLGC IE GE ILVYEFMP+GTLCQHLQRERG GL
Sbjct: 370 TDSIDQVMNEIKLLSSVSHPNLVRLLGCCIEEGEPILVYEFMPHGTLCQHLQRERGKGLP 429
Query: 359 WPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418
W IRLT+A ETA AIA+LHSA+NPPIYHRDIKSSNILLDYN+KSKVADFGLSRLGMTE S
Sbjct: 430 WTIRLTIAAETANAIAYLHSAMNPPIYHRDIKSSNILLDYNYKSKVADFGLSRLGMTESS 489
Query: 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478
HISTAPQGTPGYLDPQYHQ FHLSDKSDVYSFGVVLVEIIT LKVVDFSRP +EVNLAAL
Sbjct: 490 HISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLVEIITGLKVVDFSRPHSEVNLAAL 549
Query: 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538
A DRI +G +DEIIDP + +R DA TL+S+H VAELAFRCLAFHRDMRP+M EVA E
Sbjct: 550 AIDRIGRGCVDEIIDPYLDPNR---DAWTLSSIHNVAELAFRCLAFHRDMRPTMMEVAEE 606
Query: 539 LEHIRTRTMEDINCTASLEASLCSSSYNASER---------------------------- 570
LEHIR AS AS CSS N SER
Sbjct: 607 LEHIRLSAWVPNMYMASPAASSCSSPDNGSERSLGVHSIKKAGVVSRRLLVPQRPADCLT 666
Query: 571 ----MKDNSPPSVQDSWSSEQSSSSPLSNSLLSNVVQ 603
+KD+SP SVQD W SEQ SSP +NSLL N VQ
Sbjct: 667 SLEEIKDSSPVSVQDPWCSEQ--SSPSANSLLGNAVQ 701
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502214|ref|XP_003519915.1| PREDICTED: wall-associated receptor kinase-like 14-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/650 (54%), Positives = 439/650 (67%), Gaps = 63/650 (9%)
Query: 1 MKSDHIKIIMEPICNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQ 60
+ SD I + + CNR++ L LF N+AP+ N L+ SC S+ ++ C IP
Sbjct: 66 VTSDGIFVSLPVQCNRNVSFLDPLFRHNFAPSWSNTFLVQSCESN-LSGCVIPTSSFAGG 124
Query: 61 FNSIK-CDSSSNSSSISCYSE--------EKNDREFIDYENATKQQCKFLLSAISSELFN 111
N ++ CD S + C+++ + D + + + + CKFL SA++ F+
Sbjct: 125 RNKVEGCDRESED--LHCFTQMRKSKSNGSREDDDVLMRLDWERVGCKFLFSALA---FD 179
Query: 112 TSAASINISAASLDVKVLEVGWWLNGHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDG 171
S + SL +++E+GWWL G+C CS NA+CT V G+ GFRC C++GF GDG
Sbjct: 180 RS----KVKELSLQFQMVELGWWLEGNCSCSNNASCTEVNHGGGKLGFRCRCDEGFVGDG 235
Query: 172 YPAGSGCRKAS-CNAAKYISGQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMRRRS-Y 229
+ G GCR+ S C A+ S C +I V + GG GA L+ ++ L+C RRRS +
Sbjct: 236 FKDGDGCRRVSECKASTLWSRGCRKAVKIGVFV-GGIIVGAILVAALSLVCYFNRRRSSW 294
Query: 230 YRARKSTKRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLV 289
R + + KR L+EA G S +P+YPY+EIE+AT FSEK RLGTGAFGTVYAG L ND V
Sbjct: 295 LRKQVTVKRLLREAAGDSTVPLYPYKEIERATSFFSEKHRLGTGAFGTVYAGHLHNDECV 354
Query: 290 AIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL 349
AIK+IK+RDT+ + QV+NEIKL+S VSHPNLVRLLGC IE GEQILVYE+MPNGTL QHL
Sbjct: 355 AIKKIKYRDTNSVDQVMNEIKLLSSVSHPNLVRLLGCCIEGGEQILVYEYMPNGTLSQHL 414
Query: 350 QRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409
QRERG L W IRLT+A ETA AIA+LHS INPPIYHRDIKSSNILLDY+F+SKVADFGL
Sbjct: 415 QRERGGVLPWTIRLTIATETANAIAYLHSEINPPIYHRDIKSSNILLDYSFQSKVADFGL 474
Query: 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP 469
SRLGM+E SHISTAPQGTPGY+DPQYHQNFHLSDKSDVYSFGVVLVEIITA+KVVDF+RP
Sbjct: 475 SRLGMSETSHISTAPQGTPGYVDPQYHQNFHLSDKSDVYSFGVVLVEIITAMKVVDFARP 534
Query: 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529
+E+NLAALA DRI KG +D+IIDP + HR DA TL S+HKVAELAFRCLAFH DMR
Sbjct: 535 QSEINLAALAVDRIRKGCIDDIIDPFLEPHR---DAWTLYSIHKVAELAFRCLAFHSDMR 591
Query: 530 PSMTEVATELEHIRTR---TMEDINCTASLEASLCSSSYNAS------------------ 568
P+M EVA ELE IR TME+ CTAS S+CSS N S
Sbjct: 592 PTMIEVAEELELIRRSGWATMEETICTASSVGSVCSSPRNGSVNSLRGVSFERAAGLGSE 651
Query: 569 ---------------ERMKDNSPPSVQDSWSSEQSSSSPLSNSLLSNVVQ 603
E +KD+SP SVQD+W S +SSP +NSLL +VVQ
Sbjct: 652 TLIVPHKTDMFLQSIEEVKDSSPVSVQDTWLS--GTSSPSTNSLLGHVVQ 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094560|ref|XP_002310180.1| predicted protein [Populus trichocarpa] gi|222853083|gb|EEE90630.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/638 (55%), Positives = 431/638 (67%), Gaps = 65/638 (10%)
Query: 14 CNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIPLIDVRTQFNSIKCDSSSNSS 73
CNRSI+ + LF +N+ P+S N +LL +C+ + +C IP +R CD + N
Sbjct: 95 CNRSIERIKPLFGKNFGPSSNNSLLLQNCDK-PLNSCVIPTSSLRRDLKLTNCDKNDN-- 151
Query: 74 SISCYSEEKNDREFIDYENATKQQCKFLLSAISSELFNTSAASINISAASLDVKVLEVGW 133
++CYS+ D + + Y+N T CK ++ S LF SA S +E+ W
Sbjct: 152 -LNCYSQVPRDFDTLGYDNMTSTSCK----SVFSSLF----LGWEGSAVSFQFGRVELEW 202
Query: 134 WLNGHCH--CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKAS-CNAAKYIS 190
WL G + CS NAN T V +GR GFRC C GF GDG+ AG+GCRK S C+A+KY+S
Sbjct: 203 WLEGGYNNLCSNNANSTKVKLWNGRVGFRCHCADGFAGDGFAAGNGCRKVSKCSASKYMS 262
Query: 191 GQCGGKTRIAVLI--------------IGGSTAGASLIISMRLLCCLMRRRSY-YRARKS 235
G+CGG TR+ VL+ G AGA L+ + LC +RR+S R R S
Sbjct: 263 GECGGTTRVGVLVGVFAVTAPAFLAVHFSGLIAGALLMAGLAFLCYYVRRKSTSLRNRLS 322
Query: 236 TKRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIK 295
KR L EA G S++P + Y+EIEKAT GFSEK RLG GA+GTVYAGKL +D LVAIK+++
Sbjct: 323 AKRLLCEAAGNSSVPFFQYKEIEKATNGFSEKHRLGIGAYGTVYAGKLNSDDLVAIKKLR 382
Query: 296 HRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD 355
HRDTD I QV+NEIKL+S VSHPNLVRLLGC IE GE ILVYEFMPNGTLCQHLQ+ERG
Sbjct: 383 HRDTDSIDQVMNEIKLLSSVSHPNLVRLLGCCIEEGEPILVYEFMPNGTLCQHLQQERGT 442
Query: 356 GLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415
GL W +RLTVA ETA+AIA+LHSA+NPPIYHRDIKSSNILLDYN++SKVADFGLSRLGM
Sbjct: 443 GLPWTVRLTVATETAKAIAYLHSAMNPPIYHRDIKSSNILLDYNYRSKVADFGLSRLGMV 502
Query: 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475
E SHISTAPQGTPGYLDPQYHQ FHLSDKSDVYSFGVVLVEIITALK VDFSRP +EVNL
Sbjct: 503 ESSHISTAPQGTPGYLDPQYHQYFHLSDKSDVYSFGVVLVEIITALKAVDFSRPHSEVNL 562
Query: 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEV 535
AALA DRI +G +DEIIDP + +R DA TL S+ VAELAFRCLAFHRDMRP+M EV
Sbjct: 563 AALAIDRIGRGCVDEIIDPYLDPNR---DAWTLTSILSVAELAFRCLAFHRDMRPTMLEV 619
Query: 536 ATELEHI---------------------RTRTMEDINCTASLEASLC---------SSSY 565
A ELE I + + + ++ + +A L + S
Sbjct: 620 AGELEQIMLSAWIPTMYMASPSASSCSSQNGSQKSLSVSIGRKAGLARGKLLLPQRTDSL 679
Query: 566 NASERMKDNSPPSVQDSWSSEQSSSSPLSNSLLSNVVQ 603
+ E KD+SP S QD+W SEQ SSP +NSLL NVV+
Sbjct: 680 TSLEETKDSSPVSEQDTWLSEQ--SSPSTNSLLGNVVR 715
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| TAIR|locus:2046728 | 708 | AT2G23450 [Arabidopsis thalian | 0.907 | 0.772 | 0.517 | 2.8e-146 | |
| TAIR|locus:2174994 | 622 | AT5G66790 [Arabidopsis thalian | 0.669 | 0.649 | 0.560 | 1.9e-125 | |
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.669 | 0.614 | 0.414 | 1.4e-74 | |
| TAIR|locus:2084425 | 639 | AT3G53840 [Arabidopsis thalian | 0.651 | 0.615 | 0.411 | 7.7e-71 | |
| TAIR|locus:2031230 | 629 | AT1G25390 [Arabidopsis thalian | 0.505 | 0.484 | 0.466 | 3.3e-70 | |
| TAIR|locus:2176667 | 686 | AT5G38210 [Arabidopsis thalian | 0.489 | 0.430 | 0.460 | 4.2e-69 | |
| TAIR|locus:2014154 | 654 | AT1G18390 [Arabidopsis thalian | 0.477 | 0.440 | 0.464 | 7.4e-66 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.475 | 0.362 | 0.433 | 2e-65 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.661 | 0.506 | 0.371 | 2.7e-65 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.485 | 0.398 | 0.427 | 1.4e-64 |
| TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
Identities = 295/570 (51%), Positives = 369/570 (64%)
Query: 14 CNRSIQTLHQLFSQNYAPTSRNGILLSSCNSSKVTACKIP--LIDVRTQFXXXXXXXXXX 71
C R I+ ++ LF +N+APTS N L+ +CN + C I ++ +
Sbjct: 102 CTRKIEDMNPLFGENFAPTSENSFLMENCNRT-TDGCSIKQKFLENVLKLKSCDATGNIS 160
Query: 72 XXXXXXXXXXXNDREFIDYENATKQQCKFLLSAISSELFNTXXXXXXXXXXXLDVKVLEV 131
N +F + C L S+I+ E L+ + + +
Sbjct: 161 CFSLDSNSSSKNSAKFFSMKTLRNSSCSLLFSSIAFESVGVNAGIA------LEFERVRL 214
Query: 132 GWWLNGHCH---CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKA--SCNAA 186
GWWL G C C+ N +CT V TPHG +G RC C GF GDGY + C++A C +
Sbjct: 215 GWWLKGGCESGTCAANTDCTDVETPHGYAGHRCSCLDGFHGDGYT--NPCQRALPECRGS 272
Query: 187 KYISGQCGGKTRIAVLIIGGSTAGASLIIXXXXXXXXXXXXXX-XXARKSTKRCLKEARG 245
K + C ++ + + I+GG+ GA L+ + S KR L EA G
Sbjct: 273 KLVWRHC--RSNL-ITIVGGTVGGAFLLAALAFFFFCKRRRSTPLRSHLSAKRLLSEAAG 329
Query: 246 ISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQV 305
S++ +PY+EIEKAT GFSEKQ+LG GA+GTVY GKLQND VAIKR++HRD++ + QV
Sbjct: 330 NSSVAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQV 389
Query: 306 VNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV 365
+NEIKL+S VSHPNLVRLLGC IE+G+ +LVYE+MPNGTL +HLQR+RG GL W +RLTV
Sbjct: 390 MNEIKLLSSVSHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGSGLPWTLRLTV 449
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A +TA+AIA+LHS++NPPIYHRDIKS+NILLDY+F SKVADFGLSRLGMTE SHISTAPQ
Sbjct: 450 ATQTAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQ 509
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485
GTPGYLDPQYHQ FHLSDKSDVYSFGVVL EIIT LKVVDF+RP E+NLAALA D+I
Sbjct: 510 GTPGYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGS 569
Query: 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545
G +DEIIDP++ DA TL+S+H VAELAFRCLAFH DMRP+MTEVA ELE IR
Sbjct: 570 GCIDEIIDPILDLDL---DAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLS 626
Query: 546 TMEDINCTASLEASLCSSSYNASERMKDNS 575
S SL SS + +K +S
Sbjct: 627 GWIPSMSLDSPAGSLRSSDRGSERSVKQSS 656
|
|
| TAIR|locus:2174994 AT5G66790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 1.9e-125, Sum P(2) = 1.9e-125
Identities = 237/423 (56%), Positives = 286/423 (67%)
Query: 129 LEVGWWLNGHCH---CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKASCNA 185
L++ WWL G C CS+NA+C V G G RC C +GF G + GC +
Sbjct: 183 LKLDWWLKGSCSNTTCSENADCAKVKLDDGGLGHRCTCREGFSGKAFTVPGGCHRLVYKR 242
Query: 186 AKYISGQCGGKTRIAVLIIGGSTAGASLIIXXXXXXXXXXXXXXXXARKS-TKRCLKEAR 244
G ++ VL G G +I+ R S R L E
Sbjct: 243 K--------GLHKLVVLGTAGILVGVLVIVVLIATYFFRNKQSASSERASIANRLLCELA 294
Query: 245 GISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQ 304
G S++P Y Y+EIEKAT FS+K LGTGA+GTVYAG+ N VAIKR+KH+DT I Q
Sbjct: 295 GNSSVPFYTYKEIEKATDSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQ 354
Query: 305 VVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-LSWPIRL 363
VVNEIKL+S VSHPNLVRLLGC GE LVYEFMPNGTL QHLQ ERG LSW +RL
Sbjct: 355 VVNEIKLLSSVSHPNLVRLLGCCFADGEPFLVYEFMPNGTLYQHLQHERGQPPLSWQLRL 414
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT---EISHI 420
+A +TA AIAHLHS++NPPIYHRDIKSSNILLD+ F SK++DFGLSRLGM+ E SHI
Sbjct: 415 AIACQTANAIAHLHSSVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHI 474
Query: 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
STAPQGTPGYLDPQYHQ+F LSDKSDVYSFGVVLVEII+ KV+DF+RP +EVNLA+LA
Sbjct: 475 STAPQGTPGYLDPQYHQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAV 534
Query: 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
DRI +GR+ +IIDP + + + AS+H +AELAFRCL+FHR+MRP+M E+ +L
Sbjct: 535 DRIGRGRVVDIIDPCLNKE---INPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLH 591
Query: 541 HIR 543
I+
Sbjct: 592 RIK 594
|
|
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 733 (263.1 bits), Expect = 1.4e-74, Sum P(2) = 1.4e-74
Identities = 180/434 (41%), Positives = 248/434 (57%)
Query: 129 LEVGWWLNGHCHCSQNANCTPVL-----TPHGRS-GF-RCGCNKGFEGDGYPAGSGCRKA 181
LE+ W L C + +C +L P S G RC C KG E D P + C K
Sbjct: 223 LELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWD--PVNAICGK- 279
Query: 182 SCNAAKYISGQCGGKTRI----AVLIIGGSTAGASLIIXXXXXXXXXXXXXXXXARKSTK 237
C K+ + KT + AV ++G + A A +I K +
Sbjct: 280 -CRHGKHCKKK--KKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKERE 336
Query: 238 RCLK-EARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKH 296
L + G S+ I+ REI KAT FS+ +GTG FG V+ L++ + AIKR K
Sbjct: 337 EMLSANSTGKSS-RIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKL 395
Query: 297 RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQ--RERG 354
+T G Q++NE++++ V+H +LVRLLGC ++ +L+YEF+PNGTL +HL +R
Sbjct: 396 NNTKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRT 455
Query: 355 -DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL- 412
L+W RL +A +TA+ +A+LHSA PPIYHRD+KSSNILLD +KV+DFGLSRL
Sbjct: 456 WKPLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 515
Query: 413 GMTEI----SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR 468
+TE SHI T QGT GYLDP+Y++NF L+DKSDVYSFGVVL+E++T+ K +DF+R
Sbjct: 516 DLTETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTR 575
Query: 469 PPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM 528
+VNL + + RL E IDPL+ + D T + ++ LA CL R
Sbjct: 576 EEEDVNLVMYINKMMDQERLTECIDPLLKKTANKIDMQT---IQQLGNLASACLNERRQN 632
Query: 529 RPSMTEVATELEHI 542
RPSM EVA E+E+I
Sbjct: 633 RPSMKEVADEIEYI 646
|
|
| TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 717 (257.5 bits), Expect = 7.7e-71, P = 7.7e-71
Identities = 173/420 (41%), Positives = 238/420 (56%)
Query: 137 GHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAG---SGCRKA-SCNA---AKYI 189
G C N+ C+ T G+ RC C KGF+ D A + C K SC +
Sbjct: 229 GDCRDLLNSVCSNDSTNLGQK--RCFCKKGFQWDSVNAVCEVNRCSKRKSCKRWSNLPLL 286
Query: 190 SGQCGGKTRIAVLIIGGSTAGASLIIXXXXXXXXXXXXXXXXARKSTKRCLK-EARGISN 248
G GG A+LI G T I RK + L + G+
Sbjct: 287 GGLAGGVG--AILIAGFITK----TIVSKQNRRIAGNQSWASVRKLHRNLLSINSTGLDR 340
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNE 308
I + +EI KAT F++ LG G FG V+ G L + VA+KR K + I Q+VNE
Sbjct: 341 I--FTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNE 398
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW----PIR-- 362
++++ VSH NLV+LLGC IE +LVYEF+PNGTL +H+ G G P+R
Sbjct: 399 VQILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRR 458
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422
L +A +TAQ + +LHS+ +PPIYHRD+KSSNILLD N KVADFGLSRLG++++SH++T
Sbjct: 459 LMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTT 518
Query: 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482
QGT GYLDP+Y+ NF L+DKSDVYSFGVVL E++T K +DF+R +VNL
Sbjct: 519 CAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKA 578
Query: 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+ +GRL ++IDP+I + ++ ++ +AEL C+ R RP+M A E+E+I
Sbjct: 579 LKEGRLMDVIDPVIGIGATEKEIESMKALGVLAEL---CVKETRQCRPTMQVAAKEIENI 635
|
|
| TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 711 (255.3 bits), Expect = 3.3e-70, P = 3.3e-70
Identities = 148/317 (46%), Positives = 221/317 (69%)
Query: 232 ARKSTKRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAI 291
+R ++K ++ ++ IPI+ Y+E++ AT FS+ + LG G FGTVY GK+++ VA+
Sbjct: 259 SRDNSKSDVEFSQVFFKIPIFSYKELQAATDNFSKDRLLGDGGFGTVYYGKVRDGREVAV 318
Query: 292 KRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-EQILVYEFMPNGTLCQHLQ 350
KR+ + ++Q +NEI++++ + H NLV L GC+ R E +LVYEF+PNGT+ HL
Sbjct: 319 KRLYEHNYRRLEQFMNEIEILTRLHHKNLVSLYGCTSRRSRELLLVYEFIPNGTVADHLY 378
Query: 351 RERG--DG-LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407
E G L+W +RL++A+ETA A+A+LH++ I HRD+K++NILLD NF KVADF
Sbjct: 379 GENTPHQGFLTWSMRLSIAIETASALAYLHAS---DIIHRDVKTTNILLDRNFGVKVADF 435
Query: 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFS 467
GLSRL ++++H+STAPQGTPGY+DP+YH+ +HL+DKSDVYSFGVVLVE+I++ VD S
Sbjct: 436 GLSRLLPSDVTHVSTAPQGTPGYVDPEYHRCYHLTDKSDVYSFGVVLVELISSKPAVDIS 495
Query: 468 RPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS-DAGTLASVHKVAELAFRCLAFHR 526
R +E+NL++LA ++I E+ID ++ G++ + G VAELAF+CL
Sbjct: 496 RCKSEINLSSLAINKIQNHATHELID----QNLGYATNEGVRKMTTMVAELAFQCLQQDN 551
Query: 527 DMRPSMTEVATELEHIR 543
MRP+M +V EL+ I+
Sbjct: 552 TMRPTMEQVVHELKGIQ 568
|
|
| TAIR|locus:2176667 AT5G38210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 4.2e-69, Sum P(2) = 4.2e-69
Identities = 141/306 (46%), Positives = 202/306 (66%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVV 306
S I ++ Y E+E+AT FS++ LG G FGTVY G L++ VA+KR+ R ++Q
Sbjct: 343 SGIQVFSYEELEEATENFSKE--LGDGGFGTVYYGTLKDGRAVAVKRLFERSLKRVEQFK 400
Query: 307 NEIKLISCVSHPNLVRLLGCSIERG-EQILVYEFMPNGTLCQHLQRERGDG--LSWPIRL 363
NEI ++ + HPNLV L GC+ E +LVYE++ NGTL +HL + + WP RL
Sbjct: 401 NEIDILKSLKHPNLVILYGCTTRHSRELLLVYEYISNGTLAEHLHGNQAQSRPICWPARL 460
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
+A+ETA A+++LH++ I HRD+K++NILLD N++ KVADFGLSRL + +HISTA
Sbjct: 461 QIAIETASALSYLHAS---GIIHRDVKTTNILLDSNYQVKVADFGLSRLFPMDQTHISTA 517
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483
PQGTPGY+DP+Y+Q + L++KSDVYSFGVVL E+I++ + VD +R +++NLA +A +I
Sbjct: 518 PQGTPGYVDPEYYQCYRLNEKSDVYSFGVVLSELISSKEAVDITRHRHDINLANMAISKI 577
Query: 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
+ E+ D + R S ++SV AELAFRCL RD+RPSM E+ L I+
Sbjct: 578 QNDAVHELADLSLGFARDPSVKKMMSSV---AELAFRCLQQERDVRPSMDEIVEVLRVIQ 634
Query: 544 TRTMED 549
+ D
Sbjct: 635 KDGISD 640
|
|
| TAIR|locus:2014154 AT1G18390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
Identities = 139/299 (46%), Positives = 197/299 (65%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNE 308
+ I+ Y E+E+AT F + LG G FGTVY GKL++ VA+KR+ + +Q NE
Sbjct: 329 VHIFSYEELEEATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDNNFKRAEQFRNE 388
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQIL-VYEFMPNGTLCQHLQRERGD--GLSWPIRLTV 365
+++++ + HPNLV L GCS ++ +L VYE++ NGTL HL + + L W IRL +
Sbjct: 389 VEILTGLRHPNLVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANPSSLPWSIRLKI 448
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A+ETA A+ +LH++ I HRD+KS+NILLD NF KVADFGLSRL + +H+STAPQ
Sbjct: 449 AVETASALKYLHAS---KIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDKTHVSTAPQ 505
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485
GTPGY+DP YH + LS+KSDVYSF VVL+E+I++L VD +RP E+NL+ +A +I
Sbjct: 506 GTPGYVDPDYHLCYQLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSNMAVVKIQN 565
Query: 486 GRLDEIIDPLIIEHRGH-SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
L +++DP + G +D +V VAELAF+CL +D+RP M+ V L I+
Sbjct: 566 HELRDMVDPSL----GFDTDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLTRIQ 620
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 2.0e-65, Sum P(2) = 2.0e-65
Identities = 128/295 (43%), Positives = 189/295 (64%)
Query: 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK 310
++ RE+EKAT FS + LG G GTVY G L + +VA+K+ K D D +++ +NE+
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL--SWPIRLTVAME 368
++S ++H N+V+LLGC +E +LVYEF+PNG L +HL E + + +W IRL +A++
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP 428
A A+++LHS+ + PIYHRD+KS+NI+LD +++KV+DFG SR + +H++T GT
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
GY+DP+Y Q+ +DKSDVYSFGVVLVE+IT K + F R LA + + +L
Sbjct: 614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKL 673
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
+IID I D L+ V A++A +CL RPSM EV+ EL+ IR
Sbjct: 674 FDIIDARI------RDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 2.7e-65, Sum P(3) = 2.7e-65
Identities = 158/425 (37%), Positives = 224/425 (52%)
Query: 138 HCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRKA-SCNAAKYISGQCGGK 196
+C CSQ P L P G C + + Y CR++ +C G K
Sbjct: 320 NCGCSQGYEGNPYL-PGGCKDIN-ECLR----NSYGQRQNCRESDTCVNLPGTFNCIGNK 373
Query: 197 TRIAVLIIGGSTAGASLIIXXX-XXXXXXXXXXXXXARKSTKRC--------LKEARG-I 246
TR+ ++ +G + L++ RK KR L +G +
Sbjct: 374 TRVTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNV 433
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVV 306
I+ RE+EKAT FSE + LG G GTVY G L + VA+K+ K D D +++ +
Sbjct: 434 EKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFI 493
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL-SWPIRLTV 365
NE+ ++S ++H ++V+LLGC +E LVYEF+PNG L QH+ E D +W +RL +
Sbjct: 494 NEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRI 553
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A++ A A+++LHSA + PIYHRDIKS+NILLD +++KV+DFG SR + +H +T
Sbjct: 554 AVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVIS 613
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALK-VVDFSRPPNEVNLAALAADRIS 484
GT GY+DP+Y+ + +DKSDVYSFGVVLVE+IT K V+ S LA +
Sbjct: 614 GTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMK 673
Query: 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
+ R EI+D I D V VA LA RCL RP M +V T+LE I
Sbjct: 674 ENRFFEIMDARI------RDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILA 727
Query: 545 RTMED 549
+ ED
Sbjct: 728 -SQED 731
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 1.4e-64, Sum P(2) = 1.4e-64
Identities = 129/302 (42%), Positives = 190/302 (62%)
Query: 245 GISNIPIYPYRE--IEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI 302
G SN+ + + E ++KAT G++E + LG G GTVY G L ++ +VAIK+ + D+ +
Sbjct: 388 GPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQV 447
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-LSWPI 361
+Q +NE+ ++S ++H N+V+LLGC +E +LVYEF+ NGTL HL D L+W
Sbjct: 448 EQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEH 507
Query: 362 RLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421
RL +A+E A +A+LHS+ + PI HRDIK++NILLD N +KVADFG SRL + +
Sbjct: 508 RLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELE 567
Query: 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481
T QGT GYLDP+Y+ L++KSDVYSFGVVL+E+++ K + F RP + +L + A
Sbjct: 568 TMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFAT 627
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ RLDEII ++ + D L + + A +A C + RP M EVA +LE
Sbjct: 628 ATKENRLDEIIGGEVM----NED--NLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEA 681
Query: 542 IR 543
+R
Sbjct: 682 LR 683
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RY67 | WAKLO_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5191 | 0.9402 | 0.8008 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00021214 | hypothetical protein (694 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 603 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| pfam12947 | 36 | pfam12947, EGF_3, EGF domain | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 71/200 (35%), Positives = 110/200 (55%), Gaps = 9/200 (4%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLVRLLGCS 327
LG G FGTVY + + VAIK IK D+ + ++++ EI+++ ++HPN+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ LV E+ G+L L+ G LS L + ++ + + +LHS I HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 388 DIKSSNILLDY-NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-QYHQNFHLSDKS 445
D+K NILLD N K K+ADFGLS+L +T + GTP Y+ P + S+KS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 446 DVYSFGVVLVEIITALKVVD 465
D++S GV+L E+ ++
Sbjct: 176 DIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-46
Identities = 86/286 (30%), Positives = 133/286 (46%), Gaps = 37/286 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNL 320
+ ++LG+G+FGTVY K + +VA+K +K R Q EI+++ +SHPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
VRL+ ++ LV E+ G L +L R LS +A++ + + +LHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN- 117
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP---QYHQ 437
I HRD+K NILLD N K+ADFGL++ + S T GTP Y+ P
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGN 174
Query: 438 NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAALAADRISKGRLDEIIDPL 495
+ K DV+S GV+L E++T +PP E L L + I+ P
Sbjct: 175 GY--GPKVDVWSLGVILYELLTG-------KPPFSGENILDQLQ-------LIRRILGPP 218
Query: 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ +G+ +L +CL RP+ E+ L+H
Sbjct: 219 LEFDEPKWSSGSEE----AKDLIKKCLNKDPSKRPTAEEI---LQH 257
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 41/286 (14%)
Query: 270 LGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLVRLL 324
LG GAFG VY GKL+ VA+K +K ++ + + E +++ + HPN+VRLL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRER-------GDGLSWPIRLTVAMETAQAIAHLH 377
G E LV E+M G L +L++ R LS L+ A++ A+ + +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYH 436
S HRD+ + N L+ + K++DFGLSR + + P ++ P+
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP-NEVNLAALAADRISKG-RLDEIIDP 494
++ + KSDV+SFGV+L EI T P ++ + + + KG RL P
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNEEV-LEYLRKGYRLP---KP 229
Query: 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
++ EL C + RP+ +E+ LE
Sbjct: 230 EYCP-------------DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLV 321
+ ++LG G+FG VY + + LVAIK IK + ++++ EIK++ + HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
RL + + LV E+ G L L++ R + + A+ +LHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-ARFYLR-QILSALEYLHSK-- 116
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I HRD+K NILLD + K+ADFGL+R + ++T GTP Y+ P+
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTT-FVGTPEYMAPEVLLGKGY 173
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAALAADRISKGRLDEIIDPLIIEH 499
D++S GV+L E++T +PP + L L +I K + I
Sbjct: 174 GKAVDIWSLGVILYELLT-------GKPPFPGDDQLLEL-FKKIGKPKPPFPPPEWDI-- 223
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
S +L + L + R + E L+H
Sbjct: 224 ---SPE--------AKDLIRKLLVKDPEKRLTAEEA---LQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 62/295 (21%)
Query: 267 KQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKH-RDTDGIQQVVNEIKLISCVSHPNL 320
++LG GAFG VY G L ++ VA+K +K I++ + E +++ + HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LLG E ++V E+MP G L +L++ R LS L+ A++ A+ + +L S
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH---- 436
HRD+ + N L+ N K++DFGLSR Y D Y
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRD----------------LYDDDYYKVKGG 164
Query: 437 ------------QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484
+ + KSDV+SFGV+L EI T P ++ A +
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEVLEYLKK 219
Query: 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
RL + + +L +C A + RP+ +E+ L
Sbjct: 220 GYRLP-------KPPNCPPE---------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 37/282 (13%)
Query: 267 KQRLGTGAFGTVYAGKL-----QNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNL 320
++LG GAFG VY GKL + + VA+K +K I++ + E +++ + HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LLG E +V E+M G L +L R+ LS L+ A++ A+ + +L S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG---YLDPQYHQ 437
HRD+ + N L+ N K++DFGLSR +G ++ P+ +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLK 176
Query: 438 NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497
+ KSDV+SFGV+L EI T +P ++ + + RL
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEEVLEYLKNGYRLP-------Q 224
Query: 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
+ + +L +C A + RP+ +E+ L
Sbjct: 225 PPNCPPE---------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 46/286 (16%)
Query: 268 QRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLV 321
++LG GAFG VY G L + VA+K +K ++ ++ + E ++ +SHPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
RLLG + +V E+MP G L L R+ G+ L+ L +A++ A+ + +L S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD-----PQYH 436
HRD+ + N L+ N K++DFGLSR I + G L P+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLD--EIID 493
++ + KSDV+SFGV+L EI T P + + G RL E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
++ EL +C A+ + RP+ +E+ +L
Sbjct: 231 D------------------ELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F +++G G FG VY + + VAIK IK + ++++NEI+++ HPN+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHL 376
G +++ E +V EF G+L L+ S LT V E + + +L
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK-------STNQTLTESQIAYVCKELLKGLEYL 114
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA--PQGTPGYLDPQ 434
HS I HRDIK++NILL + + K+ DFGLS ++S GTP ++ P+
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNTMVGTPYWMAPE 167
Query: 435 YHQNFHLSDKSDVYSFGVVLVE 456
K+D++S G+ +E
Sbjct: 168 VINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 268 QRLGTGAFGTVYAGKLQND-LLVAIK--RIKHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+ LG G+FG+VY ++ L+A+K + + ++ + EI+++S + HPN+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 325 GCSIER-GEQILVY-EFMPNGTLCQHLQRERGDGLSWP-IRLTVAMETAQAIAHLHSAIN 381
G + + ++ E++ G+L L ++ L P IR + +A+LHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLHSN-- 120
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQ-YHQNF 439
I HRDIK +NIL+D + K+ADFG ++ LG E + + +GTP ++ P+
Sbjct: 121 -GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 440 HLSDKSDVYSFGVVLVEIITA 460
+ +D++S G ++E+ T
Sbjct: 180 Y-GRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 74/233 (31%), Positives = 119/233 (51%), Gaps = 28/233 (12%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+G G+FG VY + + L +K I + + +NE+K++ ++HPN+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDG--------LSWPIRLTVAMETAQAIAHLHS 378
E+G+ +V E+ G L Q +++++ +G L W ++L +A++ +LHS
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------YLHS 121
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
I HRDIK NI L N K+ DFG+S++ + + T GTP YL P+ QN
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQN 177
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491
+ KSD++S G VL E+ T LK P NL L A +I KG+ I
Sbjct: 178 KPYNYKSDIWSLGCVLYELCT-LK-----HPFEGENLLEL-ALKILKGQYPPI 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 53/298 (17%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
+E++ +G G FG V G + VA+K +K D+ Q + E ++
Sbjct: 4 NSKELKL-------GATIGKGEFGDVMLGDYRGQK-VAVKCLK-DDSTAAQAFLAEASVM 54
Query: 313 SCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-LSWPIRLTVAMETAQ 371
+ + HPNLV+LLG ++ +V E+M G+L +L R RG ++ +L A++ +
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCE 113
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS-------TAP 424
+ +L HRD+ + N+L+ + +KV+DFGL++ S TAP
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTAP 168
Query: 425 QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484
+ + F S KSDV+SFG++L EI + F R P RI
Sbjct: 169 EALR-------EKKF--STKSDVWSFGILLWEIYS------FGRVPYP---------RIP 204
Query: 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
L +++ + +R + G V+KV + C RP+ ++ +L I
Sbjct: 205 ---LKDVVPHVEKGYRMEAPEGCPPEVYKVMK---DCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 14/208 (6%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
EI++ +I ++LG G FG V+ G N VA+K +K T + + E +++ +
Sbjct: 2 EIDRTSIQL--LRKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKL 58
Query: 316 SHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
HP L++L C++E E I +V E M G+L ++LQ G L P + +A + A +
Sbjct: 59 RHPKLIQLYAVCTLE--EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 374 AHL--HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
A+L + I HRD+ + N+L+ N KVADFGL+R+ +I + +
Sbjct: 117 AYLEAQNYI-----HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ S KSDV+SFG++L EI+T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 5/221 (2%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
Q +G+G FG V+ G VAIK I+ + + E +++ +SHP LV+L G
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
ER LV+EFM +G L +L+ +RG S L + ++ + +A+L S+ + HR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDV 447
D+ + N L+ N KV+DFG++R + + ST + + P+ S KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 448 YSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
+SFGV++ E+ + K +R +EV A R+ K RL
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRL 225
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 9/209 (4%)
Query: 270 LGTGAFG--TVYAGKLQNDLLVAIKRIKHRDTD--GIQQVVNEIKLISCVSHPNLVRLLG 325
LG GAFG T+Y + ++D LV K + + +NEI ++S + HPN++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
++ ++ E+ GTL + R++G + L + A++++H A I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GIL 123
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRDIK+ NI L K+ DFG+S++ +E S T GTP Y+ P+ Q + KS
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS 182
Query: 446 DVYSFGVVLVEIITALKVVDFSRPPNEVN 474
D+++ G VL E++T + D + P N V
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 71/208 (34%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISC 314
E+E+ I + K +LG G +G VY G + L VA+K +K DT +++ + E ++
Sbjct: 2 EMERTDI--TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 58
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
+ HPNLV+LLG ++ EFM G L +L+ ++ + L +A + + A+
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYL 431
+L HRD+ + N L+ N KVADFGLSRL MT TA G +
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTG--DTYTAHAGAKFPIKWT 172
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ S KSDV++FGV+L EI T
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNL 320
+ +G GAFG VY G L+ VAIK+I + ++ ++ EI L+ + HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+ +G ++ E+ NG+L Q +++ + + Q +A+LH
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH--- 116
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
+ HRDIK++NIL + K+ADFG++ + ++S + GTP ++ P+ +
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
S SD++S G ++E++T PP
Sbjct: 176 ASTASDIWSLGCTVIELLT-------GNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
F+ +++LG+G FG V+ G +N + VAIK +K D Q E++ + + H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 324 LG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
CS GE + ++ E M G+L L+ G L + +A + A+ +A+L
Sbjct: 68 FAVCS--VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRL--------GMTEISHISTAPQGTPGYLDP 433
HRD+ + NIL+ + KVADFGL+RL +I + TAP+
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS----- 177
Query: 434 QYHQNFHLSDKSDVYSFGVVLVEIIT 459
H F S KSDV+SFG++L E+ T
Sbjct: 178 --HGTF--STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G+FG V K L A+K +K + ++ + E ++S ++HP +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ + E++ LV E+ P G L HL +E R A E A+ +LHS I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLHSL---GI 114
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
+RD+K NILLD + K+ DFGL++ +E S +T GTP YL P+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKA 173
Query: 445 SDVYSFGVVLVEIIT 459
D +S GV+L E++T
Sbjct: 174 VDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 24/229 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+ LG+G FG V+ GK + + VAIK I+ + D I+ E K++ +SHPNLV+L
Sbjct: 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLY 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G ++ +V E+M NG L +L+ +G + L + + +A+ +L S
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT-EWLLDMCSDVCEAMEYLESN---GF 121
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQYHQNFHL 441
HRD+ + N L+ + KV+DFGL+R + + T+ QGT + P+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD---QYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLD 489
S KSDV+SFGV++ E+ + K+ +EV + +S G RL
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGYRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ +++G GA G VY + VAIK+++ R + ++NEI ++ HPN+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW-PIRLT------VAMETAQAIAH 375
+ E +V E+M G+L D ++ +R+ V E Q + +
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT--------DIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY 435
LHS + HRDIKS NILL + K+ADFG + E S ++ GTP ++ P+
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAPEV 187
Query: 436 HQNFHLSDKSDVYSFGVVLVEII 458
+ K D++S G++ +E+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
EI + ++ +++LG G FG V+ G VA+K +K T + + E +++ +
Sbjct: 2 EIPRESL--KLERKLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKL 58
Query: 316 SHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
H LV+L CS E I +V E+M G+L L+ G L P + +A + A+ +
Sbjct: 59 RHDKLVQLYAVCS--EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI--SHIS-------TAP 424
A+L S HRD+ + NIL+ N K+ADFGL+RL + + TAP
Sbjct: 117 AYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 425 QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + F + KSDV+SFG++L EI+T
Sbjct: 174 EAA-------NYGRF--TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 8e-25
Identities = 88/356 (24%), Positives = 152/356 (42%), Gaps = 31/356 (8%)
Query: 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHP 318
+ ++LG G+FG VY + + LVA+K + + + +++ + EI+ L S P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIAHLH 377
N+V+L + G LV E++ G+L L + R LS L + + A+ +LH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 378 SAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRL-----GMTEISHISTAPQGTPGYL 431
S I HRDIK NILLD + K+ DFGL++L + I + + GTPGY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 432 DPQYHQNF---HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
P+ + S SD++S G+ L E++T L + + + + I +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS---QTLKIILELPT 232
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIRTRT 546
+ PL + ++L + LA R S + + L H++ +
Sbjct: 233 PSLASPLSPSNPELIS-------KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
Query: 547 MEDINCTASLEASLCSSSYNASERMKDNSPPSVQDSWSSEQSSSSPLSNSLLSNVV 602
+ + +++ S S +S S+ S S + S S L N V
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGV 341
|
Length = 384 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 28/204 (13%)
Query: 269 RLGTGAFGTVYAGK-LQNDLLVAIKRIKHR-DTDGIQQV-VNEIKLISCVSHPNLVRLLG 325
++G G +G VY + +VAIK+IK R +++GI + + EIKL+ ++HPN+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+G+ LV+EFM + L + ++ R GL + + + Q +A HS I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLG------MTEISHIST----APQGTPGYLDPQY 435
HRD+K N+L++ K+ADFGL+R T ++ T AP+ G D Y
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--YVVTRWYRAPELLLG--DKGY 176
Query: 436 HQNFHLSDKSDVYSFGVVLVEIIT 459
D++S G + E+++
Sbjct: 177 STPV------DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 7/199 (3%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLV-AIKRIKHRDTDGIQQ--VVNEIKLISCVSHPNL 320
F ++G G+FG V+ + D V A+K+I + ++ ++E ++++ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+R +++G+ +V E+ NG L + L+ +RG L ++ +AHLHS
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
I HRDIKS N+ LD K+ D G+++L +++ ++ + GTP YL P+ ++
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 441 LSDKSDVYSFGVVLVEIIT 459
++KSDV++ GVVL E T
Sbjct: 178 YNEKSDVWALGVVLYECCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ QR+G+G +G VY + + LVAIK IK D + + EI ++ HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
G + R + +V E+ G+L Q RG LS V ET + +A+LH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLHET--- 120
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQYHQNF 439
HRDIK +NILL + K+ADFG+S +++ + GTP ++ P+
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 440 HLSD---KSDVYSFGVVLVE 456
K D+++ G+ +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 37/279 (13%)
Query: 270 LGTGAFGTVYAG-----KLQNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRL 323
LG+GAFGTVY G + + VAIK ++ +++++E +++ V HP++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 324 LGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
LG + Q+ L+ + MP G L ++ R D + L ++ A+ +++L
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHL 441
+ HRD+ + N+L+ K+ DFGL++L + P ++ + +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLDEIIDPLIIEHR 500
+ KSDV+S+GV + E++T F P E A D + KG RL + P I
Sbjct: 189 THKSDVWSYGVTVWELMT------FGAKPYEGIPAVEIPDLLEKGERLPQ---PPICT-- 237
Query: 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
V+ V +C + RP+ E+ E
Sbjct: 238 --------IDVYMVLV---KCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 268 QRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDTDG--IQQVVNEIKLISCVSHPNLVRLL 324
++G G FG VY L L+A+K I+ +D D I+++ +E+K++ + HPNLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G + R + + E+ GTL + L+ R T+ + + +A+LHS I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAP-------QGTPGYLDPQYHQ 437
HRDIK +NI LD+N K+ DFG + + + +T GTP Y+ P+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK----LKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 438 NFHLSDK---SDVYSFGVVLVEIIT 459
+D++S G V++E+ T
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 56/194 (28%), Positives = 103/194 (53%), Gaps = 11/194 (5%)
Query: 270 LGTGAFGTVYAGKLQNDL---LVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G+ G VY K+++ + A+K+I D + +Q++ E+K + P +V+ G
Sbjct: 9 LGQGSSGVVY--KVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ GE +V E+M G+L L++ + P+ +A + + + +LH+ + I
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRDIK SN+L++ + K+ADFG+S++ + +T GT Y+ P+ Q S +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSYAA 181
Query: 446 DVYSFGVVLVEIIT 459
D++S G+ L+E
Sbjct: 182 DIWSLGLTLLECAL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 70/285 (24%), Positives = 133/285 (46%), Gaps = 47/285 (16%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLVRLLGC 326
+++G G FG VY G L+ + VA+K + + ++ + E +++ HPN+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+++ +V E +P G+L L R++ + L+ L ++++ A + +L S H
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIH 116
Query: 387 RDIKSSNILLDYNFKSKVADFGLSR----------LGMTEISHISTAPQGTPGYLDPQYH 436
RD+ + N L+ N K++DFG+SR G+ +I TAP+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--------- 167
Query: 437 QNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495
N+ + +SDV+S+G++L E + L + P N +RI G
Sbjct: 168 -NYGRYTSESDVWSYGILLWETFS-LGDTPY---PGMSN--QQTRERIESG--------- 211
Query: 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
+R + ++++ C A+ + RPS +E+ EL+
Sbjct: 212 ---YRMPAPQLCPEEIYRLMLQ---CWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 31/215 (14%)
Query: 268 QRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDTDG-----IQQVVNEIKLISCVSHPNLV 321
+ LG+G+FG+VY G L + A+K + D ++Q+ EI L+S + HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 322 RLLGCSIERGEQILVY-EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ---AIAHLH 377
+ LG E + + ++ E +P G+L + L++ P+ + + T Q + +LH
Sbjct: 66 QYLGTERE-EDNLYIFLELVPGGSLAKLLKKY--GSFPEPV---IRLYTRQILLGLEYLH 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY-- 435
+ HRDIK +NIL+D N K+ADFG+++ + E S + +G+P ++ P+
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ-VVEFSFAKSF-KGSPYWMAPEVIA 174
Query: 436 HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
Q + +D++S G ++E+ T +PP
Sbjct: 175 QQGGY-GLAADIWSLGCTVLEMAT-------GKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKR------IKHRDTDGIQQVVNEIKLISCVS 316
F + +G G+F TV K + + AIK IK + ++ V E ++++ ++
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK---VKYVKIEKEVLTRLN 59
Query: 317 -HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
HP +++L + V E+ PNG L Q++++ G L A E A+ +
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YG-SLDEKCTRFYAAEILLALEY 117
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---------- 425
LHS I HRD+K NILLD + K+ DFG +++ S S
Sbjct: 118 LHS-KG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 426 ---------GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
GT Y+ P+ SD+++ G ++ +++T
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG-C 326
+ LGTG FG V GK + VAIK IK + + E K++ +SH LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+ +R I V E+M NG L +L RE G L + + + +A+L S H
Sbjct: 69 TKQRPIYI-VTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSD 446
RD+ + N L+D KV+DFGLSR + + S + + P+ S KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 447 VYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDA 505
V++FGV++ E+ + K+ P E + +++S+G RL +R H
Sbjct: 184 VWAFGVLMWEVYSLGKM------PYERFNNSETVEKVSQGLRL----------YRPH--- 224
Query: 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
LAS KV + + C + RP+ ++ + +E
Sbjct: 225 --LAS-EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
E+ + T+ +K LG G FG V+ G VAIK +K + + + + E L+ +
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQL 58
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
HP LVRL + + ++ E+M NG+L L+ G L+ + +A + A+ +A
Sbjct: 59 QHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLD 432
+ HRD++++NIL+ K+ADFGL+RL E + TA +G +
Sbjct: 118 IERK---NYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEY-TAREGAKFPIKWTA 171
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ + KSDV+SFG++L EI+T
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
++K T+G + +G G FG V G+ VA+K IK T Q + E +++ +
Sbjct: 4 NLQKLTLG----EIIGEGEFGAVLQGEYTGQK-VAVKNIKCDVT--AQAFLEETAVMTKL 56
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL-SWPIRLTVAMETAQAIA 374
H NLVRLLG + G I V E M G L L R RG L S L +++ A+ +
Sbjct: 57 HHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGME 114
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
+L S + HRD+ + NIL+ + +KV+DFGL+R+G + + + T P+
Sbjct: 115 YLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PE 167
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
++ S KSDV+S+GV+L E+ + + R P
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFS------YGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 81/275 (29%), Positives = 132/275 (48%), Gaps = 32/275 (11%)
Query: 266 EKQRL-GTGAFGTVYAGKLQND-LLVAIKRIK-HRDT-DGIQQVVNEIKLISCVSHPNLV 321
EK R+ G GAFG V+ + + D LV IK+I + T D NE +++ +SHPN++
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+E ++V E+ P GTL +++Q+ L L ++ A+ H+H+ +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 382 PPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
I HRD+K+ NILLD + K+ DFG+S++ ++ S T GTP Y+ P+ +
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKI-LSSKSKAYTV-VGTPCYISPELCEGKP 177
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500
+ KSD+++ G VL E + +LK R NL AL +I G I D + R
Sbjct: 178 YNQKSDIWALGCVLYE-LASLK-----RAFEAANLPALVL-KIMSGTFAPISDRYSPDLR 230
Query: 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEV 535
+L L RP ++++
Sbjct: 231 ---------------QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 268 QRLGTGAFGTVYAGKL--QND---LLVAIKRIKHRDTDGIQQVVN----EIKLISCVSHP 318
++LG G FG V + D VA+K + H G +Q + EI+++ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHE 66
Query: 319 NLVRLLGCSIERGEQI--LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
N+V+ G + G + L+ E++P+G+L +LQR R D ++ L + + + + +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYL 125
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA--PQGTPG-YLDP 433
S HRD+ + NIL++ K++DFGL+++ + E P +P + P
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWYAP 181
Query: 434 QYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + S SDV+SFGV L E+ T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC 314
E E E+ LG G +G VYA + L + +AIK I RD+ +Q + EI L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL---TVAMETAQ 371
+ H N+V+ LG E G + E +P G+L L+ + G P++ T+ T Q
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQ 116
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
+ L + I HRDIK N+L++ Y+ K++DFG S+ + I+ + GT Y
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQY 175
Query: 431 LDPQYHQNFHLSDK--------SDVYSFGVVLVEIITALKVVDFSRPP 470
+ P+ + DK +D++S G +VE+ T +PP
Sbjct: 176 MAPE------VIDKGPRGYGAPADIWSLGCTIVEMAT-------GKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 263 GFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHP 318
F ++++G G F VY A L + +VA+K+++ D Q + EI L+ + HP
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL--TVAMETAQAIAHL 376
N+++ L IE E +V E G L + ++ + P R ++ A+ H+
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDP 433
HS I HRDIK +N+ + K+ D GL R S +TA GTP Y+ P
Sbjct: 123 HSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSP 175
Query: 434 QYHQNFHLSDKSDVYSFGVVLVEI 457
+ + KSD++S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 269 RLGTGAFGTVY-AGKLQNDLLVAIKRIKHRD-TDGIQ-QVVNEIKLISCVSHPNLVRLLG 325
R+G GA G V+ A + VA+K++ R GI Q + EIK + HP +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+LV E+MP+ + R+ L + + +A++H+ I
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ--YHQNFHLSD 443
HRD+K +N+L+ + K+ADFGL+RL E + + T Y P+ Y +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY-DP 180
Query: 444 KSDVYSFGVVLVEII 458
D+++ G + E++
Sbjct: 181 GVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 32/207 (15%)
Query: 270 LGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQV--VNEIKLISCVSHPNLVRL 323
+G G FG V G+L+ ++ VAIK +K +D Q++ + E ++ HPN++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-QRLDFLTEASIMGQFDHPNIIRL 70
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
G + +++ E+M NG+L + L RE + + + IA ++
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTV----GQLVGMLRGIASGMKYLSEM 125
Query: 384 IY-HRDIKSSNILLDYNFKSKVADFGLSR-LGMTE---------ISHISTAPQGTPGYLD 432
Y HRD+ + NIL++ N KV+DFGLSR L +E I TAP+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA---- 181
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIIT 459
++ F + SDV+SFG+V+ E+++
Sbjct: 182 ---YRKF--TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 80/290 (27%), Positives = 139/290 (47%), Gaps = 29/290 (10%)
Query: 268 QRLGTGAFGTVYAGK---LQNDL--LVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
Q+LG G FG+V + LQ++ +VA+K+++H + ++ EI+++ + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 323 LLGCSIERG--EQILVYEFMPNGTLCQHLQ--RERGDG---LSWPIRLTVAMETAQAIAH 375
G G LV E++P G+L +LQ RER D L + ++ ME + +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRY 129
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGY-LDP 433
+H RD+ + NIL++ + K+ DFGL++ L + + P +P + P
Sbjct: 130 VH---------RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 434 QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493
+ S SDV+SFGVVL E+ T D S P + + D+ + + +I+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
L R + G A ++ + C RPS +E+A ++E IR
Sbjct: 238 LLKNNGRLPAPPGCPAEIY---AIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
EI + +I +K LG G FG V+ G N VA+K +K T +Q + E L+ +
Sbjct: 2 EIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTL 58
Query: 316 SHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
H LVRL + + E I ++ E+M G+L L+ + G + P + + + A+ +A
Sbjct: 59 QHDKLVRLYAV-VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYL 431
++ HRD++++N+L+ + K+ADFGL+R+ E + TA +G +
Sbjct: 118 YIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAKFPIKWT 171
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463
P+ + KSDV+SFG++L EI+T K+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 79/277 (28%), Positives = 133/277 (48%), Gaps = 34/277 (12%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
Q +G G FG V G + + VA+K IK+ T Q + E +++ + H NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 328 IE-RGEQILVYEFMPNGTLCQHLQRERGDG-LSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+E +G +V E+M G+L +L R RG L L +++ +A+ +L +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRD+ + N+L+ + +KV+DFGL++ E S + + P+ + S KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 446 DVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505
DV+SFG++L EI + F R P RI L +++ + ++ +
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYP---------RIP---LKDVVPRVEKGYKMDAPD 222
Query: 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
G V+ V + +C RPS ++ +LEHI
Sbjct: 223 GCPPVVYDVMK---QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+G GA VYA L N+ VAIKRI + T + ++ E++ +S +HPN+V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ E LV ++ G+ + + GL I TV E + + +LHS N I
Sbjct: 68 FVVGDELWLVMPYLSGGS-LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI 124
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQGTPGYLDPQYHQNFHL 441
HRDIK+ NILL + K+ADFG+S G + GTP ++ P+ + H
Sbjct: 125 -HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 442 SD-KSDVYSFGVVLVEIIT 459
D K+D++SFG+ +E+ T
Sbjct: 184 YDFKADIWSFGITAIELAT 202
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 8/196 (4%)
Query: 268 QRLGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGIQQVV--NEIKLISCVSHPNLVRLL 324
+++G G+FG +Y K ++D IK I ++ E+ L++ + HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
E G +V E+ G L + + R+RG S L+ ++ + + H+H + I
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKI 122
Query: 385 YHRDIKSSNILLDYNFK-SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
HRDIKS NI L N +K+ DFG++R + + ++ GTP YL P+ QN ++
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 444 KSDVYSFGVVLVEIIT 459
K+D++S G VL E+ T
Sbjct: 182 KTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 19/238 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-LLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNL 320
+ + +G G+FGTV + ++D ++ K I + QQ+V+E+ ++ + HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 321 VRLLGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDGLSWP----IRLTVAMETAQAIA 374
VR I+R Q L V E+ G L Q +Q+ + + R+ + A
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
H S + HRD+K +NI LD N K+ DFGL+++ + S + GTP Y+ P+
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPE 180
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP-NEVNLAALAADRISKGRLDEI 491
+ +KSD++S G ++ E + AL PP N LA+ +I +G+ I
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYE-LCAL------SPPFTARNQLQLAS-KIKEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 9e-21
Identities = 47/151 (31%), Positives = 84/151 (55%), Gaps = 8/151 (5%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH-RDTDGIQQ-VVNEIKLISCVSHPNL 320
+ + ++LG G +G VY + + +VA+K+I+ + +GI + EI L+ + HPN+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LL + LV+E+ L ++L + G LS + ++ + + +A+ HS
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCHSH- 117
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I HRD+K NIL++ + K+ADFGL+R
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-21
Identities = 71/226 (31%), Positives = 116/226 (51%), Gaps = 15/226 (6%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+ LG+G FG V+ GK + + VAIK I + D I+ E K++ +SHP LV+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLY 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G ++ +V EFM NG L +L++ +G LS + L++ + + + +L
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH-LSD 443
HRD+ + N L+ KV+DFG++R + + + S++ P P NF S
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPN-EVNLAALAADRISKGRL 488
KSDV+SFGV++ E+ T K + F + N EV R+ + +L
Sbjct: 181 KSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKL 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 23/154 (14%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIK--HR--DTDGIQQV-VNEIKLISCVSHPNLVRL 323
LG G + VY + + +VAIK+IK R DGI + EIKL+ + HPN++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA------METAQAIAHLH 377
L + LV+EFM T + + +++ I LT A + T + + +LH
Sbjct: 68 LDVFGHKSNINLVFEFME--TDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLH 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
S I HRD+K +N+L+ + K+ADFGL+R
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 269 RLGTGAFGTVY-AGKLQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLLG 325
++G G +G VY A + LVA+K+I+ + +G + EIKL+ + HPN+VRL
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 326 --CSIERGEQILVYEFMP---NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
S +G +V+E+M G L + + + + + +LHS
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQYLHSN- 119
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I HRDIK SNIL++ + K+ADFGL+R
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIK-LISCVSHP 318
+ ++LG G FG+VY A + LVAIK++K + + + + E+K L HP
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHP 58
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
N+V+L E E V+E+M G L Q ++ +G S + ++ + Q +AH+H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI-------SHIST----APQGT 427
+HRD+K N+L+ K+ADFGL+R EI ++ST AP+
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPE-- 168
Query: 428 PGYL--DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
L Y S D+++ G ++ E+ T
Sbjct: 169 --ILLRSTSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 11/194 (5%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
LG GAFG VY K + L A K I+ + + ++ + EI++++ +HP +V+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388
G+ ++ EF P G + + E GL+ P + + +A+ +LHS I HRD
Sbjct: 80 WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 389 IKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD----- 443
+K+ N+LL + K+ADFG+S + + + GTP ++ P+ + D
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYDY 194
Query: 444 KSDVYSFGVVLVEI 457
K+D++S G+ L+E+
Sbjct: 195 KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
LG GAFG VY A + L A K I+ + ++ + EI ++S HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388
+ ++ EF G L + E GL+ P V + +A+ LHS + HRD
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128
Query: 389 IKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD----- 443
+K+ NILL + K+ADFG+S + + T GTP ++ P+ D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYDY 187
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPN 471
K+D++S G+ L+E+ PP+
Sbjct: 188 KADIWSLGITLIELAQM-------EPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 270 LGTGAFGTVYAGKLQNDL----LVAIKRIKHRDTDG-----IQQVVNEIKLISCVSHPNL 320
LG GAFG VY L D+ +A+K++ + + EI+L+ + H +
Sbjct: 10 LGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+ GC + + E+MP G++ L + G L+ + + + + +LHS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYG-ALTETVTRKYTRQILEGVEYLHSNM 124
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--GTPGYLDPQYHQN 438
I HRDIK +NIL D K+ DFG S+ T S + GTP ++ P+
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
K+DV+S G +VE++T +PP A+AA
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTE-------KPP-WAEFEAMAA 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
++LG G FG V+ G + VA+K +K T + + E +++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
E I V E+M G+L L+ G L P + +A + A +A++ +N HR
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MN--YIHR 126
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQYHQNFHLSDK 444
D++S+NIL+ K+ADFGL+RL E + TA QG + P+ + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 445 SDVYSFGVVLVEIITALKV 463
SDV+SFG++L E++T +V
Sbjct: 184 SDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 62/239 (25%), Positives = 113/239 (47%), Gaps = 28/239 (11%)
Query: 263 GFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQ--VVNEIKLISCVSHPN 319
F ++LG G++G+VY +L ++ A+K + ++ VNEI++++ V+HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 320 LVR-----LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL--TVAMETAQA 372
++ L G + +V E+ P G L + + + + P + + ++ +
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
+ LH I HRD+KS+NILL N K+ D G+S++ ++ GTP Y+
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMA 169
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491
P+ + S KSD++S G +L E+ T PP E ++ +G+ I
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATF-------APPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 33/227 (14%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGIQQ-VVNE 308
EI + + F E+ LG GAFG VY G+L + VAIK +K +QQ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL--------------QRERG 354
+L+S + HPN+V LLG + +++E++ +G L + L
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414
L L +A++ A + +L S HRD+ + N L+ K++DFGLSR
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 415 T----EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEI 457
+ + S P ++ P+ + +SD++SFGVVL EI
Sbjct: 176 SADYYRVQSKSLLPV---RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 21/223 (9%)
Query: 269 RLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
+LG G FG V+ G VAIK +K T + + E +++ + H LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 329 ERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
E E I +V E+M G+L L+ E G L P + +A + A +A++ HR
Sbjct: 72 E--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQYHQNFHLSDK 444
D++++NIL+ N KVADFGL+RL E + TA QG + P+ + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 445 SDVYSFGVVLVEIITALKVVDFSRP-PNEVNLAALAADRISKG 486
SDV+SFG++L E+ T +V P P VN L D++ +G
Sbjct: 184 SDVWSFGILLTELTTKGRV-----PYPGMVNREVL--DQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 26/271 (9%)
Query: 270 LGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLGCSI 328
LG G FG V+ G L++ VA+K K ++ + ++E +++ HPN+V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388
+R +V E +P G L++++ D L + A++ A +A+L S HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 389 IKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVY 448
+ + N L+ N K++DFG+SR I S Q + P+ S +SDV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 449 SFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTL 508
S+G++L E + L V + N+ A +++ KG +R
Sbjct: 179 SYGILLWETFS-LGVCPYPGMTNQ-----QAREQVEKG------------YRMSCPQKCP 220
Query: 509 ASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
V+KV + RC + + RP +E+ EL
Sbjct: 221 DDVYKVMQ---RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 60/232 (25%), Positives = 112/232 (48%), Gaps = 38/232 (16%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND------LLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
+ + +++G G+FG K + D + I ++ ++ ++ E+ ++S + H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER---EESRKEVAVLSNMKH 58
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG------DGLSWPIRLTVAMETAQ 371
PN+V+ E G +V ++ G L + + +RG L W +++ +A++
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--- 115
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
H+H + I HRDIKS NI L + K+ DFG++R+ + ++ GTP YL
Sbjct: 116 ---HVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYL 168
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT-------------ALKVVDFSRPP 470
P+ +N ++KSD+++ G VL E+ T LK++ S PP
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
EI + ++ +++LG G FG V+ VA+K +K + ++ + E ++ +
Sbjct: 2 EIPRESLKL--EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTL 58
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
H LV+L + + ++ EFM G+L L+ + G P + + + A+ +A
Sbjct: 59 QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQ 434
+ HRD++++NIL+ + K+ADFGL+R+ + + + + P + P+
Sbjct: 118 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 173
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIIT 459
+ KSDV+SFG++L+EI+T
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 84/277 (30%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 269 RLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
+LG G FG V+ G VAIK +K T + + E +++ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 329 ERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
E E I +V EFM G+L L+ G L P + +A + A +A++ HR
Sbjct: 72 E--EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQYHQNFHLSDK 444
D++++NIL+ N K+ADFGL+RL E + TA QG + P+ + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 445 SDVYSFGVVLVEIITALKVVDFSRP-PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
SDV+SFG++L E++T +V P P VN L +++ +G +R
Sbjct: 184 SDVWSFGILLTELVTKGRV-----PYPGMVNREVL--EQVERG------------YRMPC 224
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
G S+H EL C D RP+ + + LE
Sbjct: 225 PQGCPESLH---ELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 273 GAFGTVY-AGKLQNDLLVAIKRIKHRDTDG---IQQVVNEIKLISCVSHPNLVRLLGCSI 328
GA+G V+ A K + AIK IK D + QV+ E ++S P +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWP---IRLTVAMETAQAIAHLHSAINPPIY 385
+ LV E++P G L G S R+ +A E A+ +LHS I
Sbjct: 64 GKKNLYLVMEYLPGGD-LASLLENVG---SLDEDVARIYIA-EIVLALEYLHS-NG--II 115
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-------GTPGYLDPQYHQN 438
HRD+K NIL+D N K+ DFGLS++G+ + GTP Y+ P+
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
S D +S G +L E +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 6/192 (3%)
Query: 270 LGTGAFG-TVYAGKLQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
+G G+FG + + +D A+K I+ + + ++ E L++ + HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
G +V E+ G L Q ++ +RG L ++ + H+H + HR
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHR 124
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDV 447
DIKS NI L N K K+ DFG +RL + ++ T GTP Y+ P+ +N ++KSD+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNNKSDI 183
Query: 448 YSFGVVLVEIIT 459
+S G +L E+ T
Sbjct: 184 WSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDL------LVAIKRIK-------HRDTDGI 302
+++ TI K+ LG GAFG V+ G+ + LVA+K +K +D +
Sbjct: 1 HVQRDTIVL--KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFE-- 56
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL----- 357
E +L++ H N+V+ G E I+V+E+M +G L + L+ D
Sbjct: 57 ----REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 358 -SWPIRLT------VAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410
S LT +A++ A + +L S HRD+ + N L+ Y+ K+ DFG+S
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 411 R-LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
R + T+ + ++ P+ + +SDV+SFGVVL EI T
Sbjct: 170 RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 37/292 (12%)
Query: 263 GFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQVVN-EIKLISCV 315
E LG G FG V+ K + + LV +K ++ + +Q E+ + +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-------LSWPIRLTVAME 368
SH N+VRLLG E ++ E+ G L Q L+ + LS ++ + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP 428
A + HL N HRD+ + N L+ + KV+ LS+ +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
+L P+ Q S KSDV+SFGV++ E+ T + F +E L L A G+L
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEEVLNRLQA-----GKL 236
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
E G + ++K L RC A + RPS +E+ + L
Sbjct: 237 ---------ELPVPE--GCPSRLYK---LMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAG------KLQNDLLVAIKRIKHRDTD-G 301
+P+ P E+ + + + LG GAFG V VA+K +K T+
Sbjct: 1 LPLDPEWELPRDRLTLGK--PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 302 IQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER------- 353
+ +V+E++++ + H N++ LLG + G +V E+ +G L L+ R
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 354 -------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406
+ L+ ++ A + A+ + L S HRD+ + N+L+ + K+AD
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIAD 175
Query: 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK-----SDVYSFGVVLVEIIT 459
FGL+R +I HI + T G L ++ L D+ SDV+SFGV+L EI T
Sbjct: 176 FGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 270 LGTGAFGTVYAG-KLQNDLLVAIKRI---------KHRDTDGIQQVVNEIKLISCVSHPN 319
+G+G+FG+VY G + L+A+K++ K R + + EI L+ + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V+ LG S++ + E++P G++ L G + + + + +LH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYG-AFEETLVRNFVRQILKGLNYLH-- 123
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAP-------QGTPGYLD 432
N I HRDIK +NIL+D K++DFG+S+ E + +ST QG+ ++
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ + + K+D++S G ++VE++T
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLT 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 270 LGTGAFGTVYAGKLQND----LLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPNLVR 322
LG G FG+V G+L D L VA+K +K H ++ I++ ++E + HPN+++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMK 65
Query: 323 LLGCSIERGEQ------ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETA 370
L+G E +++ FM +G L L R GL P +L + + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL--PEKLPLQTLLKFMVDIA 123
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
+ +L N HRD+ + N +L + VADFGLS+ +I QG
Sbjct: 124 LGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSK----KIYSGDYYRQGRIAK 176
Query: 431 LDPQYHQNFHLSD-----KSDVYSFGVVLVEIIT 459
+ ++ L+D KSDV++FGV + EI T
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 270 LGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI------QQVVNEIKLISCVSHPNLVRL 323
LG GA+GTVY G L+A+K+++ ++ + +++ E+ L+ + H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
LG ++ + EF+P G++ L R L P+ + +A+LH N
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLH---NNC 122
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEI----SHISTAPQGTPGYLDPQYHQN 438
+ HRDIK +N++L N K+ DFG + RL + S++ + GTP ++ P+
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
KSD++S G + E+ T
Sbjct: 183 SGYGRKSDIWSIGCTVFEMAT 203
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 268 QRLGTGAFGTVYAGKLQND----LLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLVR 322
++LG G+FG V G+ + VA+K +K + +D + + E ++ + H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L G + ++V E P G+L L+++ A++ A + +L S
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTP-GYLDPQYHQNFH 440
HRD+ + NILL + K K+ DFGL R L E ++ P + P+ +
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 441 LSDKSDVYSFGVVLVEIIT 459
S SDV+ FGV L E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 263 GFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRI---KHRDTDGIQQVVNEIKLISCVSHP 318
F + +G GAFG V K + A+K + K + ++ V+NE +++ ++HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 319 NLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQR------ERGDGLSWPIRLTVAMETAQ 371
LV L S + E + LV + + G L HL + E+ ++ + E
Sbjct: 61 FLVNLWY-SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-------VKFWIC-EIVL 111
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
A+ +LHS I HRDIK NILLD + DF ++ ++T+ GTPGY+
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYM 166
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ S D +S GV E +
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLR 194
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCS 327
+G G +G VY + + LVAIK I D +++ E ++ S HPN+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 328 IERGEQI------LVYEFMPNGT---LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
I++ LV E G+ L + L R++G L + ET + +A+LH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-RKKGKRLKEEWIAYILRETLRGLAYLH- 130
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ---- 434
+ HRDIK NILL N + K+ DFG+S + + +T GTP ++ P+
Sbjct: 131 --ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIAC 187
Query: 435 -YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
+ +SDV+S G ITA+++ D +PP
Sbjct: 188 DEQPDASYDARSDVWSLG------ITAIELAD-GKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 269 RLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLLG 325
+G GA+G V + + +VAIK+ K + D + + E+K++ + H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWP--IRLTVAMETAQAIAHLHSAINPP 383
+G LV+E++ TL + L+ G GL P +R + + QAIA+ HS
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPG-GLP-PDAVRSYI-WQLLQAIAYCHSH---N 120
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE------ISHIST----APQGTPGYLDP 433
I HRDIK NIL+ + K+ DFG +R + +++T AP+ G D
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVATRWYRAPELLVG--DT 177
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
Y K DV++ G ++ E++
Sbjct: 178 NY-------GKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 21/225 (9%)
Query: 267 KQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL 320
K+ LG GAFG V+ + Q+ +LVA+K +K + + E +L++ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL-----SWPIRLT------VAMET 369
V+ G +E I+V+E+M +G L + L+ D + + P LT +A +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTP 428
A + +L S HRD+ + N L+ N K+ DFG+SR + T+ +
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
++ P+ + +SDV+S GVVL EI T K + NEV
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 270 LGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
LGTG+FG V + + A+K + ++ V+NE +++ + HP LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ LV E++P G L HL++ P+ A + A+ +LHS I
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSL---DIV 123
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
+RD+K N+LLD + K+ DFG ++ + GTP YL P+ + K+
Sbjct: 124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILS-KGYGKA 178
Query: 446 -DVYSFGVVLVEII 458
D ++ G+++ E++
Sbjct: 179 VDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 268 QRLGTGAFGTVYAG-KLQNDLLVAIK------RIKHRDTDGIQQVV----NEIKLISCVS 316
+ +G G +G VY + ++A+K I R + +V +EI+ + +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 317 HPNLVRLLGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
H N+V+ LG E E+ L E++P G++ L R G + + + +A
Sbjct: 67 HLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLA 122
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAP-QGTPGYLDP 433
+LHS I HRD+K+ N+L+D + K++DFG+S+ + QG+ ++ P
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 434 QYHQNFH--LSDKSDVYSFGVVLVEI 457
+ ++ S K D++S G V++E+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 264 FSEKQR-LGTGAFGTV--YAGKLQND---LLVAIKRIK----HRDTDGIQQVVNEIKLIS 313
+ +K R LG G FG V Y ND +VA+K +K ++T G ++ EI ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILK 61
Query: 314 CVSHPNLVRLLGCSIERGEQI--LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ H N+V+ GC E+G + L+ E++P G+L +L + + L+ L A + +
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICE 118
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT--EISHISTAPQGTPG 429
+A+LHS HRD+ + N+LLD + K+ DFGL++ E +
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + + S SDV+SFGV L E++T
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKH-RDTDGIQQVV-----NEIKLISCVSHPNL 320
Q+LGTGAF + Y + ++ L+A+K++ + R+T Q+ V EI+L++ ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+R+LG + E L E+M G++ HL + G + + + + +++LH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYG-AFKEAVIINYTEQLLRGLSYLH--- 120
Query: 381 NPPIYHRDIKSSNILLDYNFKS-KVADFGLS-RLG--MTEISHISTAPQGTPGYLDPQYH 436
I HRD+K +N+L+D + ++ADFG + RL T GT ++ P+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 437 QNFHLSDKSDVYSFGVVLVEIITA 460
+ DV+S G V++E+ TA
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 267 KQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL 320
K LG GAFG V+ + Q+ +LVA+K +K Q E +L++ + H ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-------------LSWPIRLTVAM 367
VR G E ++V+E+M +G L + L+ D L+ L +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQG 426
+ A + +L S HRD+ + N L+ K+ DFG+SR + T+ +
Sbjct: 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
++ P+ + +SD++SFGVVL EI T
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 13/211 (6%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQ-VVNEIK 310
EI + I ++++ +G G FG V+ G L+ ++ VAIK +K T+ +Q ++E
Sbjct: 1 EIHPSHI--TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEAS 58
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA 370
++ SH N++RL G + +++ E+M NG L ++L+ DG +L +
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGI 116
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTP 428
A S +N HRD+ + NIL++ N + KV+DFGLSR+ E ++ ++ +
Sbjct: 117 AAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ P+ + SDV+SFG+V+ E+++
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 74/247 (29%), Positives = 109/247 (44%), Gaps = 35/247 (14%)
Query: 240 LKEARGISNI--PIYPYREIEKATIGFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKH 296
L++ R I ++ P Y EK +G GA GTVY A + VAIK++
Sbjct: 5 LEKLRTIVSVGDPKKKYTRFEK----------IGQGASGTVYTAIDVATGQEVAIKQMNL 54
Query: 297 RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ---HLQRER 353
+ + ++NEI ++ HPN+V L + E +V E++ G+L +
Sbjct: 55 QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 114
Query: 354 GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413
G V E QA+ LHS + HRDIKS NILL + K+ DFG
Sbjct: 115 G------QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165
Query: 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--N 471
E S ST GTP ++ P+ K D++S G++ +E++ PP N
Sbjct: 166 TPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-------EPPYLN 217
Query: 472 EVNLAAL 478
E L AL
Sbjct: 218 ENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 55/213 (25%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F ++LG G++G+VY + +VAIK + + +Q+++ EI ++ P +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
G + + +V E+ G++ + + L+ + +T + + +LHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHSN--- 118
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ----GTPGYLDPQYHQN 438
HRDIK+ NILL+ ++K+ADFG+S +++ + A + GTP ++ P+ Q
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----GQLTD-TMAKRNTVIGTPFWMAPEVIQE 173
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
++K+D++S G ITA+++ + +PP
Sbjct: 174 IGYNNKADIWSLG------ITAIEMAE-GKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLL 324
LG G+FG V +L+ D L A+K +K D ++ + E ++++ HP L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
C + V E++ G L H+QR P A E + LH I
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GI 117
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
+RD+K N+LLD K+ADFG+ + G+ ST GTP Y+ P+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGPA 176
Query: 445 SDVYSFGVVLVEII 458
D ++ GV+L E++
Sbjct: 177 VDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 66/222 (29%), Positives = 87/222 (39%), Gaps = 24/222 (10%)
Query: 273 GAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-----PNLVRLLGC 326
GAFG+VY A K AIK +K D QV N +K + P + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKLYYS 65
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+ LV E++ G C L + G GL E + LH I H
Sbjct: 66 FQSKDYLYLVMEYLNGGD-CASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIH 120
Query: 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSD 446
RDIK N+L+D K+ DFGLSR G+ + GTP YL P+ SD
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 447 VYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
+S G V+ E + F PP D I R+
Sbjct: 176 WWSLGCVIFEFL-------FGYPPFHAETPDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNL 320
F + +++G G +G VY + +VA+K+I+ +T+G+ + EI L+ ++HPN+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LL + LV+EF+ + L + + G+ P+ + + Q +A HS
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR---LGMTEISH-IST----APQ---GTPG 429
+ HRD+K N+L++ K+ADFGL+R + + +H + T AP+ G
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
Y S D++S G + E++T
Sbjct: 178 Y-----------STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 30/245 (12%)
Query: 267 KQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL 320
K+ LG GAFG V+ + N +LVA+K +K + E +L++ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL----SWPIR----------LTVA 366
V+ G + I+V+E+M +G L + L+ D + P + L +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQ 425
+ A + +L S HRD+ + N L+ N K+ DFG+SR + T+ +
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485
++ P+ + +SDV+SFGV+L EI T K F EV + I++
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------IECITQ 240
Query: 486 GRLDE 490
GR+ E
Sbjct: 241 GRVLE 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNL 320
E RLG GA G+V +L ++ A+K I +Q Q++ E+++ P +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 321 VRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQ--RERGDGLSWPIRLTVAMETAQAIAHL 376
V+ G E I + E+ G+L + ++RG + + +A + +++L
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
HS I HRDIK SNILL + K+ DFG+S + ++ T GT Y+ P+
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERI 175
Query: 437 QNFHLSDKSDVYSFGVVLVEI 457
Q S SDV+S G+ L+E+
Sbjct: 176 QGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
F ++++G G F VY A L + VA+K+++ D Q V EI L+ ++HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETAQAIAHLH 377
+++ L IE E +V E G L Q ++ + P R ++ A+ H+H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQ 434
S + HRDIK +N+ + K+ D GL R S +TA GTP Y+ P+
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
Query: 435 -YHQNFHLSDKSDVYSFGVVLVEI 457
H+N + + KSD++S G +L E+
Sbjct: 177 RIHENGY-NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 270 LGTGAFGTVYAGKLQND--LLVAIKRI-----------KHRDTDGIQQVVNEIKLI-SCV 315
LG+GAFG VY + +N+ L+A+K I + RD I +V+E+ +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-IGDIVSEVTIIKEQL 66
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQ--RERGDGLS----WPIRLTVAMET 369
HPN+VR +E +V + + L +H +E+ + W I + + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG 429
A+ +LH I HRD+ +NI+L + K + DFGL++ E S GT
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTIL 178
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
Y P+ +N +K+DV++FG +L ++ T P N+ +LA +I + +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLAT-KIVEAVYE 231
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
+ + + E V ++ CL + RP + +V+
Sbjct: 232 PLPEGMYSE--------------DVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 32/167 (19%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLLGC 326
+G+GA+G V + + VAIK+I + D I ++++ EIKL+ + H N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL-- 65
Query: 327 SIERGEQI-------LVYEFMPNGT-LCQHLQRERGDGLSWPIRLT---VAMETAQ---A 372
I R +V E M T L + ++ P LT + Q
Sbjct: 66 DILRPPSPEDFNDVYIVTELME--TDLHKVIKS--------PQPLTDDHIQYFLYQILRG 115
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419
+ +LHSA N + HRD+K SNIL++ N K+ DFGL+R +
Sbjct: 116 LKYLHSA-N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 270 LGTGAFG-----TVYA-GKLQNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLV 321
LG GAFG T Y K + VA+K +K + + +++E+K++S + +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
LLG G +++ E+ G L L+R+R L+ L+ + + A+ +A L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-- 160
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFH 440
HRD+ + N+LL + K+ DFGL+R M + +++ P ++ P+ N
Sbjct: 161 -NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 441 LSDKSDVYSFGVVLVEIIT 459
+ +SDV+S+G++L EI +
Sbjct: 220 YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 270 LGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLG 325
LG G G V K+ ++A+K I+ + IQ Q++ E+ ++ + P +V G
Sbjct: 9 LGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
G+ + E+M G+L + L+ +G + I +A+ + + +LH I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR-----LGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRD+K SNIL++ + K+ DFG+S L T + GT Y+ P+ Q
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV--------GTSSYMAPERIQGND 175
Query: 441 LSDKSDVYSFGVVLVEIIT 459
S KSD++S G+ L+E+ T
Sbjct: 176 YSVKSDIWSLGLSLIELAT 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
LG GAFG VY A + +L A K I + + ++ + EI +++ HPN+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 329 ERGEQILVYEFMPNGTL-CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
++ EF G + L+ ER L+ P V +T +A+ +LH I HR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD---- 443
D+K+ NIL + K+ADFG+S I + GTP ++ P+ D
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 444 -KSDVYSFGVVLVEI 457
K+DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 15/155 (9%)
Query: 269 RLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCV---SHPNLVR 322
+G GA+GTVY + L VA+K+++ +GI + EI L+ + HPN+VR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 323 LL----GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
LL G +R ++ LV+E + + L +L + GL + + + + LH
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
S I HRD+K NIL+ + + K+ADFGL+R+
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 268 QRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDG-IQQVVNE---IKLISCVSH 317
+ LG G+FG VY G + + VAIK + + + +NE +K +C
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC--- 68
Query: 318 PNLVRLLGCSIERGEQILV-YEFMPNGTLCQHLQRERGD-----GLSWPIR---LTVAME 368
++VRLLG + G+ LV E M G L +L+ R + GL P + +A E
Sbjct: 69 HHVVRLLGV-VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP 428
A +A+L + HRD+ + N ++ + K+ DFG++R +I +G
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 429 GYLDPQYHQNFHLSD-----KSDVYSFGVVLVEIIT 459
G L ++ L D KSDV+SFGVVL E+ T
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
F ++++G G F VY A L + + VA+K+++ D + EI L+ ++HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETAQAIAHLH 377
+++ IE E +V E G L + ++ + P + ++ A+ H+H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQ 434
S + HRDIK +N+ + K+ D GL R S +TA GTP Y+ P+
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
Query: 435 -YHQNFHLSDKSDVYSFGVVLVEI 457
H+N + + KSD++S G +L E+
Sbjct: 177 RIHENGY-NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 44/219 (20%)
Query: 270 LGTGAFGTVYAGKLQNDLL---VAIKRIK-------HRDTDGIQQVVNEIKLISCVSHPN 319
+G G FG V +++ D L AIKR+K HRD G +V+ ++ HPN
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPN 69
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTV 365
++ LLG RG L E+ P+G L L++ R LS L
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A + A+ + +L HRD+ + NIL+ N+ +K+ADFGLSR + +
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------K 179
Query: 426 GTPGYLDPQYHQ----NFHL-SDKSDVYSFGVVLVEIIT 459
T G L ++ N+ + + SDV+S+GV+L EI++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 270 LGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQ-VVNEIKLISCVSHPNLVRLL 324
+G G FG V G+L+ ++ VAIK +K T+ ++ ++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G + +++ EFM NG L L++ DG I+L + A S +N
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN--Y 127
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQGTP-GYLDPQYHQNFH 440
HRD+ + NIL++ N KV+DFGLSR ++ ++ S+ P + P+
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 441 LSDKSDVYSFGVVLVEIIT 459
+ SDV+S+G+V+ E+++
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/198 (29%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 270 LGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQ-VVNEIKLISCVSHPNLVRLL 324
+G G FG V +G+L+ ++ VAIK +K T+ ++ ++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G + ++V E+M NG+L L++ DG I+L V M + IA ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKH--DGQFTVIQL-VGM--LRGIASGMKYLSDMG 126
Query: 385 Y-HRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDPQYHQNFHL 441
Y HRD+ + NIL++ N KV+DFGLSR+ E ++ + + + P+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 442 SDKSDVYSFGVVLVEIIT 459
+ SDV+S+G+V+ E+++
Sbjct: 187 TSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 268 QRL---GTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSH---PN 319
QRL G GA+G VY GK + +VA+K I D + + E+ L+S + PN
Sbjct: 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+ + G ++ ++ E+ G++ + ++ + E A+ ++H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV---RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ HRDIK++NIL+ K+ DFG++ L S ST GTP ++ P+
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEG 176
Query: 440 HLSD-KSDVYSFGVVLVEIIT---------ALKVVDF---SRPP 470
D K+D++S G+ + E+ T A + + S+PP
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP 220
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 260 ATIGFSEKQR---LGTGAFGTVY------AGKLQNDLLVAIKRIKHRDTDGIQ-QVVNEI 309
A SE +R +G+GA GTVY G+L A+K I D ++ Q+ EI
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRL-----YALKVIYGNHEDTVRRQICREI 123
Query: 310 KLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL-CQHLQRERGDGLSWPIRLTVAME 368
+++ V+HPN+V+ GE ++ EFM G+L H+ E+ L+ VA +
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF--LA-----DVARQ 176
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP 428
IA+LH I HRDIK SN+L++ K+ADFG+SR+ + + + GT
Sbjct: 177 ILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPCNSSVGTI 232
Query: 429 GYLDPQYHQNFHLSD------KSDVYSFGVVLVE 456
Y+ P+ N L+ D++S GV ++E
Sbjct: 233 AYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAG---KLQNDLL-VAIKRIKHRDTDGI-QQVVNEIK 310
EI++ I +G G FG VY G +N+ + VA+K K+ + + ++ + E
Sbjct: 2 EIQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA 370
++ HP++V+L+G I +V E P G L +LQ + L + + + +
Sbjct: 60 IMRQFDHPHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLS 117
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-G 429
A+A+L S HRDI + N+L+ K+ DFGLSR + + S+ + P
Sbjct: 118 TALAYLES-KR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIK 173
Query: 430 YLDPQYHQNF-HLSDKSDVYSFGVVLVEII 458
++ P+ NF + SDV+ FGV + EI+
Sbjct: 174 WMAPE-SINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 30/188 (15%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRI-KHRDTDGIQ-QVVNEIKLISCVSHPNL 320
+ +LG G FG VY +++ +VA+K+I H + DG + EIK++ + HPN+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 321 VRLLGCSIERGEQIL-----VYEFMP--NGTLCQHLQRERGDGLSWPIRLTVA------M 367
V L+ ++ER ++ VY P + L L+ ++LT + +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS-------VKLTESQIKCYML 122
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGT 427
+ + I +LH I HRDIK++NIL+D K+ADFGL+R P+G
Sbjct: 123 QLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP----PNPKGG 175
Query: 428 PGYLDPQY 435
G +Y
Sbjct: 176 GGGGTRKY 183
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 268 QRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDT----DGIQQVVNEIKLISCV-SHPNLV 321
+ LG G+FG V +L ++ L A+K +K +D D ++ + E +++S +HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+L C V EF+ G L H+Q+ R A E A+ LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK-- 115
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I +RD+K N+LLD+ K+ADFG+ + G+ ST GTP Y+ P+ Q
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLY 173
Query: 442 SDKSDVYSFGVVLVEII 458
D ++ GV+L E++
Sbjct: 174 GPSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 270 LGTGAFGTVYAGKL----QNDLLVAIK---RIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+G G FG VY G L + A+K RI D + ++Q + E ++ SHPN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 323 LLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAH 375
LLG C G ++V +M +G L ++ E + P TV ++ A+ + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN----P---TVKDLIGFGLQVAKGMEY 113
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-- 433
L S HRD+ + N +LD +F KVADFGL+R + + + S G P
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLAR-DIYDKEYYS--VHNHTGAKLPVK 167
Query: 434 ----QYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ Q + KSDV+SFGV+L E++T
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 65/198 (32%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 270 LGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-----LISCVSHPNLVRLL 324
+G G+FG V K ++D ++ + T ++ N I L+ + HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 325 GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
S + E++ V +++ G L HLQRER P A E A AI +LHS +N
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHS-LN-- 116
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
I +RD+K NILLD + DFGL + G+ ST GTP YL P+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYDR 175
Query: 444 KSDVYSFGVVLVEIITAL 461
D + G VL E++ L
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLV 321
F++ +R+G G+FG V+ G + +VAIK I + D I+ + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+ G ++ + ++ E++ G+ L+ D T+ E + + +LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA---TMLKEILKGLDYLHSEKK 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRDIK++N+LL K+ADFG++ +L T+I + GTP ++ P+ Q
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSA 177
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
K+D++S G+ +E+ PPN
Sbjct: 178 YDSKADIWSLGITAIELAKG-------EPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 41/212 (19%)
Query: 269 RLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRL 323
LG G FG+V G ++ VA+K +K G ++ + E +++ + HP +VRL
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 324 LGCSIERGEQ-ILVYEFMPNGTLCQHLQRERG----DGLSWPIRLTVAMETAQAIAHLHS 378
+G + +GE +LV E P G L ++L++ R D A + A +A+L S
Sbjct: 62 IG--VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHIST----------APQGT 427
HRD+ + N+LL ++K++DFG+SR LG + +T AP+
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 428 PGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ F S KSDV+S+GV L E +
Sbjct: 171 -------NYGKF--SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++ +++G GA GTV+ A + VAIK+I + + ++NEI ++ + +PN+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + E +V E++ G+L + D V E QA+ LH+
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA---AVCRECLQALEFLHAN--- 134
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
+ HRDIKS N+LL + K+ DFG E S ST GTP ++ P+
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAAL 478
K D++S G++ +E++ PP NE L AL
Sbjct: 194 PKVDIWSLGIMAIEMVEG-------EPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLV 321
F++ +R+G G+FG VY G + +VAIK I + D I+ + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
R G ++ + ++ E++ G+ L + L T+ E + + +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRDIK++N+LL K+ADFG++ +L T+I + GTP ++ P+ +
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSA 177
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
K+D++S G+ +E+ PPN
Sbjct: 178 YDFKADIWSLGITAIELAKG-------EPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPN 319
F++ + +G G+FG VY A ++ + +VAIK++ + + + Q ++ E+K + + HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+ GC + LV E+ G+ L+ + I + Q +A+LHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSH 144
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY---H 436
+ HRDIK+ NILL + K+ADFG + + S + GTP ++ P+
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
K DV+S G+ +E+ R P N+ A++A
Sbjct: 197 DEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSA 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT---DGIQQVVNEIKL---ISCVSHPNLVR 322
LG G FG V + + L AIK +K D D ++ ++ E ++ + HP LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L C V E+ G L H+ + S P + A + +LH N
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLGLQYLHE--NK 121
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
+Y RD+K N+LLD K+ADFGL + GM ST GTP +L P+ L+
Sbjct: 122 IVY-RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV-----LT 174
Query: 443 DKS-----DVYSFGVVLVEII 458
+ S D + GV++ E++
Sbjct: 175 ETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 51/231 (22%)
Query: 267 KQRLGTGAFGTVY------------AGKLQND-----LLVAIKRIKHRDTDGI-QQVVNE 308
++LG G FG V+ +ND +LVA+K ++ +D + + E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR---------ERGDGLSW 359
+K++S +S PN+ RLLG ++ E+M NG L Q LQ+ LS+
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEIS 418
L +A + A + +L S +N HRD+ + N L+ N+ K+ADFG+SR L ++
Sbjct: 130 STLLYMATQIASGMRYLES-LN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 419 HISTAPQGTP----------GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ QG L ++ + KSDV++FGV L EI+T
Sbjct: 187 RV----QGRAPLPIRWMAWESVLLGKF------TTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 270 LGTGAFGTVYAGKLQND-----LLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRL 323
LG+GAFGTVY G D + VAIK ++ + +++++E +++ V P + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERG-----DGLSWPIRLTVAMETAQAIAHLHS 378
LG + Q LV + MP G L +++ + D L+W +++ M + +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---- 129
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQY 435
+ HRD+ + N+L+ K+ DFGL+RL + + P L+
Sbjct: 130 -----LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 436 HQNFHLSDKSDVYSFGVVLVEIIT 459
H+ F + +SDV+S+GV + E++T
Sbjct: 185 HRRF--THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 267 KQRLGTGAFGTVYAGK----LQNDLLVAIKRIKHRDTDGIQ--QVVNEIKLISCVSHPNL 320
+QRLG G+FGTVY K + + L +K I + + + Q E +L+S + HP +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--------LSWPIRLTVAMETAQA 372
V+ +ER ++ E+ L L+ + G W I+L + +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH---- 120
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
++H I HRD+K+ NI L N K+ DFG+SRL M ++T GTP Y+
Sbjct: 121 --YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-LATTFTGTPYYMS 173
Query: 433 PQY--HQNFHLSDKSDVYSFGVVLVEI 457
P+ HQ + KSD++S G +L E+
Sbjct: 174 PEALKHQGY--DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 56/287 (19%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPN 319
F++ + +G G+FG VY A ++ + +VAIK++ + + + Q ++ E++ + + HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR----LTVAMETAQAIAH 375
+ GC + LV E+ C + + P++ + Q +A+
Sbjct: 77 TIEYKGCYLREHTAWLVMEY------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY 435
LHS HRDIK+ NILL K+ADFG + L S + GTP ++ P+
Sbjct: 131 LHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 436 ---HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492
K DV+S G+ +E+ R P N+ A++A
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSA------------ 222
Query: 493 DPLIIEHRGHSDAGTLASVHKVAELAFR-----CLAFHRDMRPSMTE 534
+ H +D+ TL+S FR CL RPS E
Sbjct: 223 ----LYHIAQNDSPTLSSND--WSDYFRNFVDSCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDGI-QQVVNEIKLISCVSH 317
F + + LG+GAFGTVY G + + VAIK ++ + +++++E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P++ RLLG + Q L+ + MP G L ++ RE D + L ++ A+ + +L
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQYH 436
+ HRD+ + N+L+ K+ DFGL++ LG E + + + ++ +
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 437 QNFHLSDKSDVYSFGVVLVEIIT 459
+ + +SDV+S+GV + E++T
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 54/301 (17%)
Query: 270 LGTGAFGTVYAGK------LQNDLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLVR 322
LG G FG V VA+K +K + ++ +++E L+ V+HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG----------------------LSWP 360
L G + G +L+ E+ G+L L+ R G L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
++ A + ++ + +L + HRD+ + N+L+ K K++DFGLSR E S++
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 421 STAPQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479
+ P ++ + + + +SDV+SFGV+L EI+T L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------LGGNP 229
Query: 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
I+ RL ++ G+ ++ L C D RP+ +++ EL
Sbjct: 230 YPGIAPERLFNLLKT------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
Query: 540 E 540
E
Sbjct: 284 E 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 31/204 (15%)
Query: 268 QRLGTGAFGTVYAGKLQND-LLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRL 323
+R+G G FG V++G+L+ D VA+K R+T D + + E +++ SHPN+VRL
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+G ++ +V E + G L+ E G L + + A + +L S
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---H 114
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL----------GMTEISHISTAPQGTPGYLDP 433
HRD+ + N L+ K++DFG+SR GM +I TAP+
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL------ 168
Query: 434 QYHQNF-HLSDKSDVYSFGVVLVE 456
N+ S +SDV+SFG++L E
Sbjct: 169 ----NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 270 LGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDGIQ---QVVNEIKLISCVSHPNLV 321
LG+GAFGTVY G + + VAIK + +T G + + ++E +++ + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
RLLG + Q LV + MP+G L ++ E D + + L ++ A+ + +L
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER-- 128
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP---GYLDPQYHQN 438
+ HRD+ + N+L+ K+ DFGL+RL + + P L+ +++
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
F + +SDV+S+GV + E++T
Sbjct: 188 F--THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-15
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 266 EKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
E+ + G G Y GK ++N + +K I D + I +EI + + HPN+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSIPS--SEIADMGKLQHPNIVKLI 749
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G L++E++ L + L+ LSW R +A+ A+A+ LH +P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
++ I++D D RL + + T + Y+ P+ + +++K
Sbjct: 805 VVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSD 504
SD+Y FG++L+E++T D + ++ A S LD IDP I
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGD----- 912
Query: 505 AGTLASVHK-----VAELAFRCLAFHRDMRPSMTEVATELE 540
SV++ V LA C A RP +V LE
Sbjct: 913 ----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 270 LGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVR 322
+G GAFG V+ + + +VA+K +K + +Q E L++ HPN+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQR--------------------ERGDGLSWPIR 362
LLG L++E+M G L + L+ LS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422
L +A + A +A+L HRD+ + N L+ N K+ADFGLSR + + ++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 423 APQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P ++ P+ + +SDV+++GVVL EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 268 QRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
QR+G+G +G VY A L L A+K IK D + EI ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+ R + + E+ G+L Q + G LS V ET Q +A+LHS H
Sbjct: 75 YLSREKLWICMEYCGGGSL-QDIYHVTGP-LSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ---YHQNFHLSD 443
RDIK +NILL N K+ADFG++ +T + GTP ++ P+ +N +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 444 KSDVYSFGVVLVEI 457
D+++ G+ +E+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 39/242 (16%)
Query: 267 KQRLGTGAFGTVYAGKLQN-----------------DLLVAIKRIKHRDTDGIQQ-VVNE 308
K++LG G FG V+ ++ N LLVA+K ++ + + E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ-----HLQRERGDG------- 356
+K++S + PN++RLLG ++ ++ E+M NG L Q HL + +G
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 357 -----LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+S+ L VA++ A + +L S++N HRD+ + N L+ N K+ADFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL-SSLN--FVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 412 -LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
L + I ++ + + SDV++FGV L EI+ K +
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246
Query: 471 NE 472
+E
Sbjct: 247 DE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 270 LGTGAFGTVYAGKLQNDLL---VAIKRIK-------HRDTDGIQQVVNEIKLISCVSHPN 319
+G G FG V +++ D L AIKR+K HRD G +V+ ++ HPN
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPN 57
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQ------------RERGDGLSWPIR--LTV 365
++ LLG RG L E+ P+G L L+ + + L
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A + A+ + +L HRD+ + NIL+ N+ +K+ADFGLSR + ++
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171
Query: 426 GTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIIT 459
P N+ + + SDV+S+GV+L EI++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 270 LGTGAFGTVYAGKLQNDLL-------VAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLV 321
LG+GAFG VY G + L VA+K ++ TD + + + E L+S +HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRER-----GDGLSWPIRLTVAMETAQAIAHL 376
+LLG + Q ++ E M G L +L+ R L+ L + ++ A+ +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 377 HSAINPPIYHRDIKSSNILL---DYNFKS--KVADFGLSRLGMTEISHISTAPQG--TPG 429
HRD+ + N L+ Y+ K+ DFGL+R + + + +G
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
++ P+ + + +SDV+SFGV++ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 270 LGTGAFGTVYAG--------KLQNDLLVAIKRIKHRDTD-GIQQVVNEIKLISCV-SHPN 319
LG G FG V K VA+K +K T+ + +++E++++ + H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW-------PIRL-------TV 365
++ LLG + G ++ E+ G L ++L+ R G+ + P +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A + A+ + +L S HRD+ + N+L+ + K+ADFGL+R +I HI +
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 426 GTPGYLDPQYHQNFHLSDK-----SDVYSFGVVLVEIIT 459
T G L ++ L D+ SDV+SFGV+L EI T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++ +++G GA GTVY A + VAIK++ + + ++NEI ++ +PN+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + E +V E++ G+L + D V E QA+ LHS
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALDFLHSN--- 134
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
+ HRDIKS NILL + K+ DFG E S ST GTP ++ P+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 193
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAAL 478
K D++S G++ +E++ PP NE L AL
Sbjct: 194 PKVDIWSLGIMAIEMVEG-------EPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 270 LGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G FG V A GK+ + KR+K R G Q +NE K++ VS +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK--GEQMALNEKKILEKVSSRFIVSL 58
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+ + LV M G L H+ G + A + + HLH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
I +RD+K N+LLD + +++D GL+ + + I GTPGY+ P+ Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI-KGRAGTPGYMAPEVLQGEVYDF 173
Query: 444 KSDVYSFGVVLVEIITA 460
D ++ G L E+I
Sbjct: 174 SVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 17/161 (10%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIK 310
Y+++EK +G G +G VY + +VA+K+I+ + +G+ + EI
Sbjct: 1 YQKVEK----------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS 50
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA 370
L+ ++HPN+VRLL + LV+EF+ + L +++ GL P+ + +
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
Q IA+ HS + HRD+K N+L+D K+ADFGL+R
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKH-RDTDGIQ---QVVNEIKLISCVSHPNLVRL 323
+G G FG V G+ + A +K R + + E++ ++HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERG--DGLSWP-IRLTVAMETAQAIAHLHSAI 380
LG IE +LV EF P G L +L+ RG ++ + +A E A + LH A
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQ----Y 435
H D+ N L + K+ D+GL+ E +I+ P +L P+
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 436 HQNFHLSD---KSDVYSFGVVLVEIITALKVVDFSRP-PNEVNLAALA 479
Q+ D KS+++S GV + E+ TA +P P+ + L
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLK 220
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 270 LGTGAFGTVYAGK------------LQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVS 316
+G G+FG V K LQ ++ K KH ++ E L+ V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKH--------IMAERNVLLKNVK 54
Query: 317 HPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
HP LV L S + +++ V +++ G L HLQRER P A E A A+ +
Sbjct: 55 HPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGY 111
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ- 434
LHS +N I +RD+K NILLD + DFGL + G+ E S ++ GTP YL P+
Sbjct: 112 LHS-LN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEV 167
Query: 435 -YHQNFHLSDKS-DVYSFGVVLVEIITAL 461
Q + D++ D + G VL E++ L
Sbjct: 168 LRKQPY---DRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 13/193 (6%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLG 325
+GTG FG V+ ++ A+K + + Q V NE +++ VSHP ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
++ ++ E++P G L +L R G S L A E A+ +LHS I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGR-FSNSTGLFYASEIVCALEYLHSK---EIV 123
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
+RD+K NILLD K+ DFG ++ ++ + GTP YL P+ Q+ +
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAV 179
Query: 446 DVYSFGVVLVEII 458
D ++ G+++ E++
Sbjct: 180 DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 71/297 (23%), Positives = 133/297 (44%), Gaps = 56/297 (18%)
Query: 268 QRLGTGAFGTVYAG------KLQNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNL 320
+ LG G+FG VY G K + + VAIK + + + + +NE ++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR--------LTVAMETAQA 372
VRLLG + +++ E M G L +L+ R + + P++ + +A E A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG--- 429
+A+L++ HRD+ + N ++ +F K+ DFG++R +I +G G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 430 --YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487
++ P+ ++ + SDV+SFGVVL EI T A++ +G
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------------------LAEQPYQGM 225
Query: 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFR----CLAFHRDMRPSMTEVATELE 540
+E + ++E G L ++ F C ++ MRPS E+ + ++
Sbjct: 226 SNEQVLRFVME------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 59/241 (24%), Positives = 115/241 (47%), Gaps = 24/241 (9%)
Query: 269 RLGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
++G G+ G V +++ LVA+K++ R + + NE+ ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ E +V EF+ G L + R ++ V + +A++ LH+ + HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDV 447
DIKS +ILL ++ + K++DFG E+ + GTP ++ P+ + D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 448 YSFGVVLVEII------------TALKVVDFSRPPNEVNLAALAADRISKGRLDEII--D 493
+S G++++E++ A+K++ + PP NL ++ KG LD ++ D
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSP--SLKGFLDRLLVRD 257
Query: 494 P 494
P
Sbjct: 258 P 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 270 LGTGAFGTVYAGKLQND---LLVAIKRIK-------HRDTDGIQQVVNEIKLISCVSHPN 319
+G G FG V ++ D + AIK +K HRD G +V+ ++ HPN
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPN 64
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTV 365
++ LLG RG + E+ P G L L++ R L+ L
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A + A + +L HRD+ + N+L+ N SK+ADFGLSR E ++
Sbjct: 125 ASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMG 178
Query: 426 GTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIIT 459
P N+ + + KSDV+SFGV+L EI++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F QR+G+G +G VY A + L AIK IK + V EI ++ H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
G + R + + EF G+L Q + G LS V+ ET Q + +LH +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGP-LSESQIAYVSRETLQGLYYLH---SK 125
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ---YHQNF 439
HRDIK +NILL N K+ADFG+S I+ + GTP ++ P+ +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAAVERKG 184
Query: 440 HLSDKSDVYSFGVVLVEI 457
+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLV 321
F+ + +G G+FG VY + + +VAIK I D I+ + EI+ +S P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS--A 379
+ G ++ + ++ E+ G+ C L + L + E + +LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS-CLDLLKPGK--LDETYIAFILREVLLGLEYLHEEGK 119
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQN 438
I HRDIK++NILL K+ADFG+S +L T + GTP ++ P+ +
Sbjct: 120 I-----HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQ 172
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+K+D++S G+ +E+
Sbjct: 173 SGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 273 GAFGTVYAGKLQNDLL-----VAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
G FG ++ G L ++ V +K +K H + ++ E L+ +SH N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 327 SIERGEQILV-YEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHSA 379
IE GE V Y +M G L LQ+ R + P L+ +A++ A +++LH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSR---------LGMTEISHISTAPQGTPGY 430
+ H+DI + N ++D + K+ D LSR LG E + +
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--------W 185
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + N S SDV+SFGV+L E++T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKH-----RDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG GAFG VY + +A K+++ + + + EI+L+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 324 LGCSIERGEQILV--YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
GC +R E+ L E+MP G++ L+ L+ + + + +++LHS +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHIST-APQGTPGYLDPQYHQNF 439
I HRDIK +NIL D K+ DFG S RL +S + GTP ++ P+
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
K+DV+S G +VE++T +PP
Sbjct: 185 GYGRKADVWSLGCTVVEMLT-------EKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 270 LGTGAFGTVYAGKLQND-----LLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRL 323
LG+G FGTV+ G + + VAIK I+ R Q++ + + + + H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 324 LGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
LG I G + LV + P G+L H+ R+ D L L ++ A+ + +L
Sbjct: 75 LG--ICPGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL- 441
+ HR++ + NILL + ++ADFG++ L + + TP + ++
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP--IKWMALESILFG 186
Query: 442 --SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
+ +SDV+S+GV + E+++ A+ + R E+ D L
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS------------------YGAEPYAGMRPHEVPDLL---E 225
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTMED 549
+G A V + +C ++RP+ E+A E TR D
Sbjct: 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF----TRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 53/197 (26%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLV 321
F++ +++G G+FG V+ G + +VAIK I + D I+ + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+ G ++ + ++ E++ G+ L+ D T+ E + + +LHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLHSEKK 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRDIK++N+LL + + K+ADFG++ +L T+I + GTP ++ P+ +
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSA 177
Query: 441 LSDKSDVYSFGVVLVEI 457
K+D++S G+ +E+
Sbjct: 178 YDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 50/294 (17%)
Query: 268 QRLGTGAFGTVYAG------KLQNDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPN 319
+ LG G+FG VY G K + + VA+K + + + I+ +NE ++ + +
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHH 70
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR--------LTVAMETAQ 371
+VRLLG + ++V E M +G L +L+ R + + P R + +A E A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
+A+L++ HRD+ + N ++ ++F K+ DFG++R +I +G G L
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 432 DPQYHQNFHLSD-----KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486
++ L D SD++SFGVVL E IT+L + NE L + + G
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFV----MDGG 238
Query: 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
LD+ P R L C F+ MRP+ E+ L+
Sbjct: 239 YLDQ---PDNCPERVTD-------------LMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 34/228 (14%)
Query: 258 EKATIGFSEKQRLGTGAFGTVYAG--------KLQNDLLVAIKRIKHRDTD-GIQQVVNE 308
+K T+G + LG G FG V K + + VA+K +K T+ + +V+E
Sbjct: 15 DKLTLG----KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 309 IKLISCVS-HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
++++ + H N++ LLG + G ++ E+ G L ++L+ R G+ + +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 368 E-----------TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416
+ T Q + + HRD+ + N+L+ N K+ADFGL+R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 186
Query: 417 ISHISTAPQGTPGYLDPQYHQNFHLSDK-----SDVYSFGVVLVEIIT 459
+++I + T G L ++ L D+ SDV+SFGV++ EI T
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 267 KQRLGTGAFGTVY---AGKLQNDL------------LVAIKRIKHRDTDGIQQ-VVNEIK 310
K++LG G FG V+ A L L LVA+K ++ T + + EIK
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL-QRERGDGL---------SWP 360
++S + +PN++RLLG + ++ E+M NG L Q L QRE S
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISH 419
L +A++ A + +L S +N HRD+ + N L+ ++ K+ADFG+SR L +
Sbjct: 130 NLLYMAVQIASGMKYLAS-LN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFS 467
I ++ + + SDV++FGV L E+ T K +S
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 81/293 (27%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 270 LGTGAFGTVYAGKLQND---LLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLL 324
LG G FG+V G+L D L VA+K +K ++ ++E + HPN++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 325 GCSIERGEQ------ILVYEFMPNGTLCQHLQRER-GDG-LSWPIRLTVAMET--AQAIA 374
G ++ E +++ FM +G L L R GD P ++ V T A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
+L S HRD+ + N +L+ N VADFGLS+ +I + QG + +
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK----KIYNGDYYRQGRIAKMPVK 179
Query: 435 YHQNFHLSD-----KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
+ L+D KSDV+SFGV + EI T + + P N
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ----TPYPGVEN--------------S 221
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
EI D L +R L ++ L C + RPS + ELE
Sbjct: 222 EIYDYLRQGNRLKQPPDCLDGLY---SLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPN 319
FS+ + +G G+FG VY A ++N +VAIK++ + + + Q ++ E++ + + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++ GC + LV E+ G+ L+ + I V Q +A+LH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLH-- 132
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY---H 436
+ + HRD+K+ NILL K+ DFG + + + GTP ++ P+
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
K DV+S G+ +E+ R P N+ A++A
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSA 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 67/198 (33%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 270 LGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+G G+FG V K + D + V K+I + + L+ V HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 325 GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
S + E++ V +F+ G L HLQRER P A E A A+ +LHS IN
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHS-IN-- 116
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
I +RD+K NILLD + DFGL + G+ S +T GTP YL P+ + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 444 KSDVYSFGVVLVEIITAL 461
D + G VL E++ L
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 270 LGTGAFGTVYAGKLQNDLLV-AIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+G G+FG V + ++ + A+K I+ + + E +++ V+ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ LV F+ G L HLQRE G R A E A+ +LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTA-ELLCALENLHKF---NVI 115
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
+RD+K NILLDY + DFGL +L M + +T GTP YL P+ +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAV 174
Query: 446 DVYSFGVVLVEIITAL 461
D ++ GV+L E++T L
Sbjct: 175 DWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 8e-14
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++ +++G GA GTVY A + VAI+++ + + ++NEI ++ +PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + E +V E++ G+L + D V E QA+ LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---AVCRECLQALEFLHSN--- 135
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
+ HRDIKS NILL + K+ DFG E S ST GTP ++ P+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYG 194
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAAL 478
K D++S G++ +E+I PP NE L AL
Sbjct: 195 PKVDIWSLGIMAIEMIEG-------EPPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 267 KQRLGTGAFGTVYAGKLQ-----------------NDLLVAIKRIKH-RDTDGIQQVVNE 308
K++LG G FG V+ + + +LVA+K ++ + + + E
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG---------LSW 359
IK++S + PN++RLL I ++ E+M NG L Q L R +S+
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEIS 418
+ +A + A + +L S++N HRD+ + N L+ N+ K+ADFG+SR L +
Sbjct: 130 STLIFMATQIASGMKYL-SSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE 472
I ++ + + SDV++FGV L EI+T K +S+ +E
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNL 320
+++ +++G G +G VY G+ + +VA+K+I+ + +G+ + EI L+ + HPN+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL-TVAMETAQAIAHLHSA 379
V L ++ L++EF+ + L ++L + + + Q I HS
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSR---LGMTEISH-IST----APQ---GTP 428
+ HRD+K N+L+D K+ADFGL+R + + +H + T AP+ G+P
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
Y P D++S G + E+ T
Sbjct: 178 RYSTP-----------VDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKH----RDTDGIQQVVNEIKLISCVSHPNLVRLL 324
LG G+FG V +L+ + AIK +K D D +V L HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 325 GCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTV-AMETAQAIAHLHSAINP 382
C+ + E + V E++ G L H+Q + R A E + LH
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---RARFYAAEIICGLQFLHK--KG 116
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
IY RD+K N+LLD + K+ADFG+ + M ST GTP Y+ P+ + +
Sbjct: 117 IIY-RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYN 174
Query: 443 DKSDVYSFGVVLVEII 458
+ D +SFGV+L E++
Sbjct: 175 ESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLL--VAIKR------IKHRDTDGIQQ 304
P R+ + F+ + LGTG+FG V +N+ VAIKR IK + D
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD---H 77
Query: 305 VVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER---GD-GLSWP 360
V +E K+++ ++HP V L G + LV EF+ G L+R + D G +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
++ + E Q++ I +RD+K N+LLD + K+ DFG +++ T +
Sbjct: 138 AQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL 188
Query: 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
GTP Y+ P+ N +D ++ G+ + EI+ PP N L
Sbjct: 189 C----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC-------PPFYANEPLLIY 237
Query: 481 DRISKG 486
+I +G
Sbjct: 238 QKILEG 243
|
Length = 340 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 269 RLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
++G G+ G V A VA+K++ R + + NE+ ++ HPN+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ E +V EF+ G L + R ++ TV + +A++ LH+ + HR
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQ---GVIHR 139
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-----GTPGYLDPQYHQNFHLS 442
DIKS +ILL + + K++DFG ++S P+ GTP ++ P+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFC----AQVS--KEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 443 DKSDVYSFGVVLVEII 458
+ D++S G++++E++
Sbjct: 194 TEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLV 321
F LG G G V + + L+ +++ H + Q++ E++++ + P +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
G GE + E M G+L Q L+ + + I V++ + +A+L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLRE--K 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I HRD+K SNIL++ + K+ DFG+S I ++ + GT Y+ P+ Q H
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478
S +SD++S G+ LVE+ + PP+ L A+
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V K+++ + A+K +K R +T + + +E +++ +HP +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ + + I ++ E+ G L L R+RG + R +A A +LH+ I
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIACVV-LAFEYLHN--RGII 115
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
Y RD+K N+LLD N K+ DFG ++ L + + GTP Y+ P+ N
Sbjct: 116 Y-RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGYDF 171
Query: 444 KSDVYSFGVVLVEIIT 459
D +S G++L E++T
Sbjct: 172 SVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 71/241 (29%), Positives = 107/241 (44%), Gaps = 34/241 (14%)
Query: 270 LGTGAFGTVYAGK---LQND---LLVAIKRIKHRDTDGIQQ-VVNEIKLISCVSHPNLVR 322
LG GAFG VY G D L VA+K + ++ + + E ++S +H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHL 376
L+G S ER + ++ E M G L L+ R P LT A + A+ +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENR-PRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYL-- 431
HRDI + N LL K+ADFG++R +I S +G L
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPI 185
Query: 432 ---DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
P+ + + K+DV+SFGV+L EI + L + + N+ + + GRL
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-LGYMPYPGRTNQEVMEFV----TGGGRL 240
Query: 489 D 489
D
Sbjct: 241 D 241
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR-DTDGIQQVVN----EIKLISCVSHPNLVRL 323
LG GAFG VY +A+K++ D+ + VN EI+L+ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 324 LGC---SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
GC E+ I V E+MP G++ L+ L+ + + Q +++LHS +
Sbjct: 70 YGCLRDPEEKKLSIFV-EYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM 126
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR------LGMTEISHISTAPQGTPGYLDPQ 434
I HRDIK +NIL D K+ DFG S+ + T I ++ GTP ++ P+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMSPE 179
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
K+DV+S +VE++T +PP
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT-------EKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 38/240 (15%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAG--------KLQNDLLVAIKRIKHRDTD 300
+P P E+ + + + LG G FG V K + VA+K +K TD
Sbjct: 1 LPADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 301 -GIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLS 358
+ +V+E++++ + H N++ LLG + G ++ E+ G L ++L+ R G+
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 359 WPIR--------------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404
+ ++ A + A+ + +L S HRD+ + N+L+ + K+
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKI 175
Query: 405 ADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK-----SDVYSFGVVLVEIIT 459
ADFGL+R ++ +I + T G L ++ L D+ SDV+SFGV+L EI T
Sbjct: 176 ADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 270 LGTGAFGTVYAG---KLQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+G+GA G V A + VAIK++ ++ ++ E+ L+ V+H N++ LL
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 325 GC-----SIERGEQI-LVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLH 377
S+E + + LV E M + LCQ +Q + + +S+ L M I HLH
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSY---LLYQMLCG--IKHLH 135
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
SA I HRD+K SNI++ + K+ DFGL+R T T T Y P+
Sbjct: 136 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVIL 190
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ D++S G ++ E+I
Sbjct: 191 GMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVS-HPNLVRL 323
LG G+FG V +L+ D + AIK +K +D D + + E ++++ + HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK-KDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
C + V E++ G L +QR R P A E A+ LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHR--HGV 117
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
IY RD+K NILLD K+ADFG+ + G+ +T GTP Y+ P+ Q
Sbjct: 118 IY-RDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474
D ++ GV++ E++ +PP E +
Sbjct: 176 SVDWWALGVLMYEMMAG-------QPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 270 LGTGAFGTV-----------YAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
LG G FG V YA K L+ ++++A + H + E +++ H
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAH--------TLTESRVLKNTRH 54
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P L L + V E++ G L HL RER S E A+ +LH
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLH 112
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
S I +RD+K N++LD + K+ DFGL + G+T+ + + T GTP YL P+ +
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLE 168
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ D + GVV+ E++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 30/244 (12%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR-DTDGIQQVVN----EIKLISCVSHPNLVRL 323
LG GAFG VY +A+K+++ ++ + VN EI+L+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 324 LGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
GC + E+ L E MP G++ L+ L+ + + + +++LHS +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM- 126
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSR------LGMTEISHISTAPQGTPGYLDPQY 435
I HRDIK +NIL D K+ DFG S+ L T + ++ GTP ++ P+
Sbjct: 127 --IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSPEV 180
Query: 436 HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495
K+D++S G +VE++T +PP A A +I+ + ++ P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT-------EKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 496 IIEH 499
+ +H
Sbjct: 234 VSDH 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 270 LGTGAFGTV-----YAGKLQND---LLVAIKRIKHRDTD-GIQQVVNEIKLISCVS-HPN 319
LG G FG V Y + VA+K +K TD + +++E++L+ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--------------LSWPIRLTV 365
++ LLG + G ++ E+ G L + L+ R G LS+ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
A + A+ + +L S HRD+ + N+L+ + K+ADFGL+R + I +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 426 GTPGYLDPQYHQNFHLSDK-----SDVYSFGVVLVEIIT 459
+ G L ++ L D+ SDV+SFG+++ EI T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT----DGIQQVVNEIKLISCV-SHPNLVRL 323
LG G+FG V+ +L+ + AIK +K +D D ++ + E +++S HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 324 LGCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTV-AMETAQAIAHLHSAIN 381
C+ + E + V E++ G L H+Q L R T A E + LHS
Sbjct: 62 Y-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP---RATFYAAEIICGLQFLHSK-- 115
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I +RD+K NILLD + K+ADFG+ + M + T GTP Y+ P+
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 442 SDKSDVYSFGVVLVEII 458
+ D +SFGV+L E++
Sbjct: 174 NTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 76/301 (25%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHR--DTDGIQQVVNEIKLISCVSH 317
F+ + LG G FG+V +L+++ VA+K +K + I++ + E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 318 PNLVRLLGCSIERGEQ------ILVYEFMPNGTLCQHLQRER-GD---GLSWPIRLTVAM 367
PN+++L+G S+ + +++ FM +G L L R G+ L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGT 427
+ A + +L S HRD+ + N +L+ N VADFGLS+ +I QG
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK----KIYSGDYYRQGC 173
Query: 428 PGYLDPQYHQNFHLSD-----KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482
L ++ L+D SDV++FGV + EI+T + P V + +
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT-----PYAGVENSEIYNYL 228
Query: 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
I RL + D L V EL +C + RPS + +LE I
Sbjct: 229 IKGNRLKQPPDCL----------------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
Query: 543 R 543
Sbjct: 273 W 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSH-PNLVRLLGC 326
LG GA+G V + + ++A+KRI+ Q +++ ++ + P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 327 SIERGEQILVYEFMPNGTLCQHLQR---ERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
G+ + E M T + ++G + I +A+ +A+ +LHS ++
Sbjct: 69 LFREGDVWICMEVM--DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-- 124
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQGTPGYLDPQYHQNFH 440
+ HRD+K SN+L++ N + K+ DFG+S + + P P ++P+ +Q
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK-G 183
Query: 441 LSDKSDVYSFGVVLVEIIT 459
KSDV+S G+ ++E+ T
Sbjct: 184 YDVKSDVWSLGITMIELAT 202
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 28/230 (12%)
Query: 258 EKATIGFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKH---RDTDGIQQVVNEIKLIS 313
E+ +G E +G G+FG VY A + +VA+K++ + + + Q ++ E+K +
Sbjct: 20 EEIFVGLHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
+ HPN + GC ++ LV E+ G+ L+ + I + Q +
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGL 134
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP 433
A+LHS + HRDIK+ NILL + K+ADFG + S + GTP ++ P
Sbjct: 135 AYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186
Query: 434 QY---HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480
+ K DV+S G+ +E+ R P N+ A++A
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELA--------ERKPPLFNMNAMSA 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 278 VYAGKLQNDLLVAIKRIKHRDTDG---IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ- 333
+Y G N+ V I+ K I NEIK + + N++++ G I+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 334 ---ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIK 390
L+ E+ G L + L +E+ LS+ +L +A++ + + +L+ N P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 391 SSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF--HLSDKSDVY 448
S + L+ N+K K+ GL ++ +S Y + + + K D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206
Query: 449 SFGVVLVEIIT 459
S GVVL EI T
Sbjct: 207 SLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 270 LGTGAFGTVY---------AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL 320
LG G+FG V+ AG+L ++ +K RD + E +++ V+HP +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR---VRTKMERDILAEVNHPFI 60
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRE----RGDGLSWPIRLTVAMETAQAIAHL 376
V+L G+ L+ +F+ G L L +E D + L +A++ HL
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------HL 114
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--GTPGYLDPQ 434
HS I +RD+K NILLD K+ DFGLS+ I H A GT Y+ P+
Sbjct: 115 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 168
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIIT 459
+ +D +SFGV++ E++T
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 45/147 (30%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 268 QRLGTGAFGTVYAGKLQNDL-LVAIKRIKHRDTD-GI-QQVVNEIKLISCVSHPNLVRLL 324
+++G G +GTV+ K + +VA+KR++ D D G+ + EI L+ + H N+VRL
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ LV+E+ + L ++ GD + I + + + +A HS +
Sbjct: 66 DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ N + K+ADFGL+R
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 270 LGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G FG V A GKL + KR+K R G + + E ++++ V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK--GYEGAMVEKRILAKV-HSRFIVS 57
Query: 324 LGCSIE-RGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
L + + + + LV M G L H+ E G P + + HLH
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
I +RD+K N+LLD + +++D GL+ + + + + GTPG++ P+ Q
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 441 LSDKSDVYSFGVVLVEIITA 460
D ++ GV L E+I A
Sbjct: 174 YDFSVDYFALGVTLYEMIAA 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 52/216 (24%)
Query: 269 RLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVN--EIKLISCVS-HPNLVRLL 324
++G G F V + + AIK +K ++QV N EI+ + +S HPN++RL+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 325 GCSIER--GEQILV--------YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
+R G LV YE + + L +R S+ +L +++
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK--RPLPEKRV--KSYMYQLLKSLD------ 114
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG-----LSRLGMTEISHIST----APQ 425
H+H I+HRDIK NIL+ + K+ADFG S+ TE +IST AP+
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE--YISTRWYRAPE 168
Query: 426 G--TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
T GY P K D+++ G V EI++
Sbjct: 169 CLLTDGYYGP----------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLV 321
F + LG G G V+ + L+ +++ H + Q++ E++++ + P +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
G GE + E M G+L Q L++ + I V++ + + +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--K 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I HRD+K SNIL++ + K+ DFG+S I ++ + GT Y+ P+ Q H
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 442 SDKSDVYSFGVVLVEI 457
S +SD++S G+ LVE+
Sbjct: 180 SVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 270 LGTGAFGTV-----------YAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
LG G FG V YA K L+ ++++A + H + E +++ H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAH--------TLTESRVLQNTRH 54
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P L L V E+ G L HL RER S E A+ +LH
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLH 112
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
S + +RD+K N++LD + K+ DFGL + G+++ + + T GTP YL P+ +
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ D + GVV+ E++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 270 LGTGAFGTV-----------YAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
LG G FG V YA K L+ ++++A + H V E +++ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH--------TVTESRVLQNTRH 54
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P L L V E+ G L HL RER + E A+ +LH
Sbjct: 55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH 112
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
S + +RDIK N++LD + K+ DFGL + G+++ + + T GTP YL P+ +
Sbjct: 113 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ D + GVV+ E++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 9/203 (4%)
Query: 269 RLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
++G G+ G V A + VA+K++ R + + NE+ ++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ E +V EF+ G L + R ++ TV + +A+++LH N + HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDV 447
DIKS +ILL + + K++DFG E+ + GTP ++ P+ + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 448 YSFGVVLVEIITALKVVDFSRPP 470
+S G++++E+I + F+ PP
Sbjct: 202 WSLGIMVIEMIDG-EPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLLG 325
LG G G+V K V K++ H +Q++ E++++ P +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH----LHSAIN 381
+ + EFM G+L + ++ G PI + + + A A+ L++
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I HRDIK SNIL++ + K+ DFG+S I+ I+ GT Y+ P+ Q
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPP 470
+ KSDV+S G+ ++E+ AL F+
Sbjct: 180 TVKSDVWSLGISIIEL--ALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR 362
Q++ E+K++ + P +V G GE + E M G+L Q L++ + I
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENIL 101
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422
+++ + + +L I HRD+K SNIL++ + K+ DFG+S G I ++
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQL-IDSMAN 156
Query: 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482
+ GT Y+ P+ Q H + +SD++S G+ LVE+ + PP+ L A+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKELEAMFGRP 213
Query: 483 ISKGRLDEIIDPL 495
+S+G E P+
Sbjct: 214 VSEGEAKESHRPV 226
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIK--RIKHRDTDGIQQVVNEIKLISCVSHPNL 320
F + +G G +G VY G+ ++ L AIK + + + I+Q +N +K S H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNI 65
Query: 321 VRLLGCSIERG-----EQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
G I++ +Q+ LV EF G++ ++ +G+ L + E + ++
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
HLH + HRDIK N+LL N + K+ DFG+S + +T GTP ++ P+
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181
Query: 435 Y-----HQNFHLSDKSDVYSFGVVLVEI 457
+ + KSD++S G+ +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 22/159 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQ-QVVNEIKLISCVSHPNL 320
F + R+G G +G VY + + +VA+K+++ + DGI + EI L+ + HPN+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 321 VRLLGCSIERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLT----VAMETAQA 372
V L + G+ + LV E+ C+ D + P + + ++ +
Sbjct: 69 VELK--EVVVGKHLDSIFLVMEY------CEQDLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ +LH I HRD+K SN+LL K+ADFGL+R
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 289 VAIKRIKHRDTDGIQQVVN---EIKLISCVSHPNLVRLLGCSIERGEQIL--VYEFMPNG 343
VAIK ++ + Q E L + + HPN+V LL S E +L V+E++P
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD-SGEAPPGLLFAVFEYVPGR 64
Query: 344 TLCQHLQRERGDGLSWPIRLTVAM-ETAQAIAHLHSAINPPIYHRDIKSSNILL---DYN 399
TL + L DG M + A+A H+ I HRD+K NI++
Sbjct: 65 TLREVLA---ADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118
Query: 400 FKSKVADFGLSRLGM-TEISHISTAPQ-----GTPGYLDPQYHQNFHLSDKSDVYSFGVV 453
+KV DFG+ L + ++T + GTP Y P+ + ++ SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 454 LVEIITALKVV 464
+E +T +VV
Sbjct: 179 FLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 270 LGTGAFGTVYAGKL---QNDLLVAIKRIKHRDTDG--IQQVVNEIKLISCVSH-PNLVRL 323
+G GAFGTV K+ + ++A+KRI+ D ++++ ++ ++ S P +V+
Sbjct: 12 IGRGAFGTVN--KMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 324 LGCSIERGEQILVYEFMPNG-TLCQHLQRERGDG-LSWPIRLTVAMETAQAIAHLHSAIN 381
G G+ + E M E + I +A+ T +A+ +L +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA---PQGTPGYLDPQYHQN 438
I HRD+K SNILLD N K+ DFG+S + I+ A P P +DP
Sbjct: 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+ + +SDV+S G+ L E+ T
Sbjct: 187 YDV--RSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 15/195 (7%)
Query: 270 LGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLL 324
LG+G FGTV G + ++ VA+K +K+ + D +++ E ++ + +P +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 325 G-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
G C E +LV E G L + LQ+ + L + + +
Sbjct: 63 GICEAE--SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV--- 117
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTP-GYLDPQYHQNFHL 441
HRD+ + N+LL +K++DFGLS+ LG E + + P + P+ +
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 442 SDKSDVYSFGVVLVE 456
S KSDV+SFGV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIK--RIKHRDTDGIQQVVNEIKLISCVSHPNL 320
F + +G G +G VY G+ ++ L AIK + + + I+ +N +K S H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS--HHRNI 75
Query: 321 VRLLGCSIERG-----EQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
G I++ +Q+ LV EF G++ ++ +G+ L + E + +A
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
HLH+ + HRDIK N+LL N + K+ DFG+S + +T GTP ++ P+
Sbjct: 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 191
Query: 435 Y-----HQNFHLSDKSDVYSFGVVLVEI 457
+ + +SD++S G+ +E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 31/228 (13%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQ---VVN 307
E+ + + F E+ LG AFG +Y G L + LVAIK +K D + QQ
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQ 56
Query: 308 EIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL------------QRERG- 354
E L++ + HPN+V LLG + +++E++ G L + L E G
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 355 --DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR- 411
L L +A++ A + +L S H+D+ + NIL+ K++D GLSR
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + + ++ P+ S SD++SFGVVL EI +
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLV 321
+ + ++LG G++ TVY GK + N LVA+K I+ ++ +G + E L+ + H N+V
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
L + LV+E++ + LCQ++ + G ++L + + + ++++H
Sbjct: 67 LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQRY- 123
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ-YHQNFH 440
I HRD+K N+L+ + K+ADFGL+R + SH + T Y P +
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 441 LSDKSDVYSFGVVLVEIITAL 461
S D++ G + VE+I +
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPN 319
F + LGTG+FG V K + AIK +K R+ +Q V E ++ +SHP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 320 LVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWP--IRLTVAMETAQAIAHL 376
+V ++ CS + ++ + EF+ G L HL R+ G +P + E A +L
Sbjct: 80 IVNMM-CSFQDENRVYFLLEFVVGGELFTHL-RKAG---RFPNDVAKFYHAELVLAFEYL 134
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
HS I +RD+K N+LLD KV DFG ++ ++ + GTP YL P+
Sbjct: 135 HSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPEVI 187
Query: 437 QNFHLSDKSDVYSFGVVLVEII 458
Q+ D ++ GV+L E I
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGC 326
+ +G G +G V+ + + A +I D +++ E ++ +S HPN+V+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 327 ----SIERGEQI-LVYEFMPNGTLCQHLQ--RERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++ G+Q+ LV E G++ ++ +RG+ + PI + E + HLH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-- 141
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY---H 436
+N I HRD+K +NILL K+ DFG+S +T GTP ++ P+
Sbjct: 142 VNKTI-HRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 437 QNFHLS--DKSDVYSFGVVLVEI 457
Q + + DV+S G+ +E+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVSHPNLVRLL 324
LG G+FG V +L+ A+K +K +D D ++ + E ++++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 325 GCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTV-AMETAQAIAHLHSAINP 382
C+ + E + V EF+ G L H+Q + L R T A E + LHS
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL---YRATFYAAEIVCGLQFLHSK--- 115
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
I +RD+K N++LD + K+ADFG+ + + + ST GTP Y+ P+ Q +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYT 174
Query: 443 DKSDVYSFGVVLVEII 458
D +SFGV+L E++
Sbjct: 175 FSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSH--PNLVRLLG 325
+G+G G VY + + ++A+K++ + + + ++++ ++ ++ SH P +V+ G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPI--RLTVAMETAQAIAHL---HSAI 380
I + + E M T L + + I ++TVA +A+ +L H I
Sbjct: 82 YFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKEKHGVI 137
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY-----LDPQ- 434
HRD+K SNILLD + K+ DFG+S G S T G Y +DP
Sbjct: 138 -----HRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITAL 461
+ + + ++DV+S G+ LVE+ T
Sbjct: 191 PNPKYDI--RADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 270 LGTGAFGTVYAGKLQND-LLVAIKRI------KHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+G G+FG V + + + A+K + K ++ I N L+ V HP LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNVKHPFLVG 60
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + V +++ G L HLQRER P A E A A+ +LHS +N
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHS-LN- 116
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
I +RD+K NILLD + DFGL + + ST GTP YL P+
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 443 DKSDVYSFGVVLVEIITAL 461
D + G VL E++ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 269 RLGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLL 324
++G G +G V+ A K +VA+KR+K + ++ V+ E +++ LV+LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 325 GCSIERGEQI-LVYEFMPNG---TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+ + E + L E++P G TL +L D R +A E +A+ LH
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMA-EMFEAVDALHEL- 120
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRD+K N L+D + K+ DFGLS I + + G+P Y+ P+ +
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLS----KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
D +S G +L E + S PNE
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGST-PNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 70/285 (24%), Positives = 110/285 (38%), Gaps = 68/285 (23%)
Query: 268 QRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRL 323
+ +G GAFG V+ + A+K ++ D + I V E +++ P +V+L
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 324 LGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA--I 380
S + E + LV E+MP G L L R+ R +A E A+ +H I
Sbjct: 67 Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIA-ELVLALDSVHKLGFI 123
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLS--------RLGMTEISHISTAPQ------- 425
HRDIK NIL+D + K+ADFGL R SH
Sbjct: 124 -----HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 426 -------------GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEII-------------T 459
GTP Y+ P+ + + D +S GV+L E++ T
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 460 ALKVVDFSRP---PNEVNLAALAADRISK---------GRLDEII 492
K++++ P + ++ A D I + G +EI
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIK 283
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLV 321
+ +G GA+G V + + VAIK+I + Q+ + EIK++ H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 322 RLLGC----SIERGEQI-LVYEFMPNGTLCQHL--QRERGDGLSWPIRLTVAMETAQAIA 374
+L S E + +V E M L + + Q D + + + + + +
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFL-----YQILRGLK 120
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS--TAPQGTPGYLD 432
++HSA + HRD+K SN+LL+ N K+ DFGL+R+ E H T T Y
Sbjct: 121 YIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 433 PQYHQNFHLSDKS-DVYSFGVVLVEIIT 459
P+ N K+ D++S G +L E+++
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 270 LGTGAFGTVYAG-KLQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+G+GA G V A D VAIK++ ++ ++ E+ L+ CV+H N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 327 -----SIERGEQI-LVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSA 379
S+E + + LV E M + LCQ +Q E + +S+ + + I HLHSA
Sbjct: 85 FTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSA 138
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
I HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 440 HLSDKSDVYSFGVVLVEII 458
+ D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 18/207 (8%)
Query: 264 FSEKQRLGTGAFGTVYA--GKLQNDLLVAIKRIKHRDTDGIQQVV---NEIKLISCVSHP 318
F K +G G FG V K D+ A+K +K + V E ++S + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIY-AMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
+ +L ++ LV E+ P G L L R + +A E AI +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQ 120
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI-STAPQGTPGYLDPQYHQ 437
HRDIK N+L+D K+ADFG S +T + S P GTP Y+ P+
Sbjct: 121 M---GYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 438 NFHLSDKS------DVYSFGVVLVEII 458
+ K D +S GV+ E+I
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 8/194 (4%)
Query: 270 LGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGIQQVV--NEIKLISCVSHPNLVRLL-G 325
+G G++G V + + D IK++ R+ ++ E +L+S + HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
E G +V F G L L+ ++G L + ++ A A+ +LH I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HIL 124
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRD+K+ N+ L KV D G++R+ + ST GTP Y+ P+ N + KS
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYKS 183
Query: 446 DVYSFGVVLVEIIT 459
DV++ G + E+ T
Sbjct: 184 DVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 270 LGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQ-VVNEIKLISCVSHPNLVRLL 324
LGTG FG + G L+ +L VAI ++ +D ++ + E + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 325 GCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTVA--METAQAIAHLHSAIN 381
G I RG ++ V E+M NG L L++ G +L M +A ++
Sbjct: 73 GV-ITRGNTMMIVTEYMSNGALDSFLRKHEG-------QLVAGQLMGMLPGLASGMKYLS 124
Query: 382 PPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL--DPQYHQN 438
Y H+ + + +L++ + K++ F RL + I T G L P+ Q
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
H S SDV+SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 270 LGTGAFGTV---YAGKLQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+G+GA G V Y L+ + VAIK++ ++ ++ E+ L+ CV+H N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 325 GC-----SIERGEQILVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHS 378
S+E + + + + + LCQ +Q E + +S+ + + I HLHS
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
A I HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 199
Query: 439 FHLSDKSDVYSFGVVLVEII 458
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIK----HRDTDGIQQVVNEIKLI-SCVSHPNLVRL 323
+G G++ V +L+ ND + A+K +K H D D I V E + S+P LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED-IDWVQTEKHVFEQASSNPFLVGL 61
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
C LV E++ G L H+QR+R L A E A+ LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHER---G 116
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
I +RD+K N+LLD + K+ D+G+ + G+ ST GTP Y+ P+ +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGF 175
Query: 444 KSDVYSFGVVLVEIITALKVVD 465
D ++ GV++ E++ D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 25/201 (12%)
Query: 270 LGTGAFGTV-----------YAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
LG G FG V YA K L+ +++VA + H + E +++ H
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH--------TLTENRVLQNSRH 54
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P L L V E+ G L HL RER S E A+ +LH
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH 112
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
S N + +RD+K N++LD + K+ DFGL + G+ + + + T GTP YL P+ +
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLE 169
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ D + GVV+ E++
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVSHPN-LVRL 323
LG G+FG V A + D L AIK +K +D D ++ + E ++++ P L +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
C V E++ G L H+Q+ P + A E A + LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---G 121
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY--HQNFHL 441
I +RD+K N++LD K+ADFG+ + + T GTP Y+ P+ +Q +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY-- 178
Query: 442 SDKS-DVYSFGVVLVEII 458
KS D ++FGV+L E++
Sbjct: 179 -GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 18/202 (8%)
Query: 270 LGTGAFGTV----YAGKLQND-LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRL 323
LG G FG V Y + N VA+K +K + I + EI+++ + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 324 LG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
G C+ + G I L+ EF+P+G+L ++L R + + ++ +L A++ + + +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-GTPGY-LDPQ--YHQ 437
HRD+ + N+L++ + K+ DFGL++ T+ + + +P + P+
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 438 NFHLSDKSDVYSFGVVLVEIIT 459
F+++ SDV+SFGV L E++T
Sbjct: 188 KFYIA--SDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 33/206 (16%)
Query: 270 LGTGAFGTV---YAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLL 324
+G+GA+G V + K VAIK++ I ++ E++L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK--VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 325 GC-----SIERGEQI-LVYEFMP---NGTL-CQHLQRERGDGLSWPIRLTVAMETAQAIA 374
S+E + + LV M N + CQ L + I+ V + + +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH-------IQFLV-YQILRGLK 132
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
++HSA I HRD+K SNI ++ + + K+ DFGL+R E+ T T Y P+
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 185
Query: 435 YHQNF-HLSDKSDVYSFGVVLVEIIT 459
N+ H + D++S G ++ E++T
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKH-RDTDGIQ---QVVNEIKLISCVSHPNLVRL 323
+ +G G FG V G++ + A +K R + +Q + + E + + H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV---AMETAQAIAHLHSAI 380
LG E +LV EF P G L +L+ R L P T+ A E A + HLH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG-------TPGYLDP 433
H D+ N LL + K+ D+GLS E ++ T Q P +D
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-TPDQLWVPLRWIAPELVD- 175
Query: 434 QYHQNFHLSDK---SDVYSFGVVLVEI 457
+ H N + D+ S+V+S GV + E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ + + +G+GA G V A + VA+K++ ++ ++ E+ L+ CV+H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 321 VRLLGC-----SIERGEQI-LVYEFMPNGTLCQ----HLQRERGDGLSWPIRLTVAMETA 370
+ LL S+E + + LV E M + LCQ L ER L + +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC------- 134
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
I HLHSA I HRD+K SNI++ + K+ DFGL+R T + T T Y
Sbjct: 135 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYY 188
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEII 458
P+ + D++S G ++ E++
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLL 324
+G G++ V +L+ + + A+K +K D + I V E + S HP LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
C V E++ G L H+QR+R L + E + A+ +LH I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GI 117
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
+RD+K N+LLD K+ D+G+ + G+ ++ GTP Y+ P+ +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 445 SDVYSFGVVLVEII---TALKVVDFSRPPNE 472
D ++ GV++ E++ + +V S P++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLL 324
+G G++ V +L+ + A+K IK D + I V E + S HP LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHS 378
C V EF+ G L H+QR+R +L + E + A+ LH
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQR--------KLPEEHARFYSAEISLALNFLHE 114
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
I +RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P+ +
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRG 170
Query: 439 FHLSDKSDVYSFGVVLVEII 458
D ++ GV++ E++
Sbjct: 171 EDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 270 LGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLLGC 326
LG+GA GTV A ++ + A+K + D +G+ + C+ + + ++ C
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVV---DMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 327 ------SIERGEQ-----ILVYEFMPNGTLCQHLQ---------RERGDGLSWPIRLTVA 366
R + LV ++ G L Q ++ RE GL +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-------LF 149
Query: 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQ 425
++ A+ H+HS + HRDIKS+NILL N K+ DFG S++ +S +
Sbjct: 150 IQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
GTP Y+ P+ + S K+D++S GV+L E++T
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLG 325
++LG G++ TVY G + N LVA+K I + +G+ + E L+ + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ V+E+M + L Q++ + G + +RL + + + +A++H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIH---GQHIL 125
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L+ Y + K+ADFGL+R
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 37/163 (22%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVS-HPNLV 321
Q+LG GA+G V+ A + +VA+K+I TD Q+ EI + + HPN+V
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA-QRTFREIMFLQELGDHPNIV 70
Query: 322 RLLGCSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME------TAQ 371
+LL ++ + E LV+E+M D L IR + + Q
Sbjct: 71 KLL--NVIKAENDKDIYLVFEYMET------------D-LHAVIRANILEDVHKRYIMYQ 115
Query: 372 ---AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
A+ ++HS + HRD+K SNILL+ + + K+ADFGL+R
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 269 RLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
++G G+ G V A + + VA+K + R + + NE+ ++ H N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ E ++ EF+ G L + + R L+ TV QA+ +LHS + HR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQ---GVIHR 141
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-----GTPGYLDPQYHQNFHLS 442
DIKS +ILL + + K++DFG +IS P+ GTP ++ P+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFC----AQIS--KDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 443 DKSDVYSFGVVLVEI------------ITALKVVDFSRPPNEVN 474
+ D++S G++++E+ + A+K + S PP N
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLL----VAIKRI-KHRDTDGI-QQVVNEIKLISC 314
T + + Q +G GAFG V + + D L VAIK+I K T + ++ E+KL+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSAR---DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 315 VSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
+ H N++ L I E I V E + GT L R L + + +
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGL 121
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP 433
++HSA + HRD+K SNIL++ N K+ DFGL+R+ PQ T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI---------QDPQMT-GYVST 168
Query: 434 QYH---------QNFHLSDKSDVYSFGVVLVEII 458
+Y+ Q + + + D++S G + E++
Sbjct: 169 RYYRAPEIMLTWQKYDV--EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLV 321
F + ++LG G + TVY G+ + +VA+K I +G + EI L+ + H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQR---ERGDGLSWPIRLTVAM--ETAQAIAHL 376
RL + +LV+E+M + L++ G + + + + IA
Sbjct: 62 RLHDVIHTENKLMLVFEYMD-----KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST--------APQ--- 425
H + HRD+K N+L++ + K+ADFGL+R ++ S AP
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITAL 461
G+ Y S D++S G ++ E+IT
Sbjct: 174 GSRTY-----------STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 40/153 (26%), Positives = 81/153 (52%), Gaps = 20/153 (13%)
Query: 269 RLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQ-QVVNEIKLISCVSHPNLVRL-- 323
R+ G +G VY + + +VA+K++K ++ +G + EI ++ + HPN+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 324 --LGCSIERGEQI-LVYEFMPNG--TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
+G +++ +I +V E++ + +L + +++ + ++ +AHLH
Sbjct: 72 VVVGSNLD---KIYMVMEYVEHDLKSLMETMKQP----FLQSEVKCLMLQLLSGVAHLHD 124
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I HRD+K+SN+LL+ K+ DFGL+R
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 270 LGTGAFGTV--------------YAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
LGTGA+G V YA K+ + K T +QV+ ++
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR----- 62
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIA 374
P LV L + L+ +++ G L HL QRE +R+ +A E A+
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLALD 119
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
HLH I +RDIK NILLD + DFGLS+ + E + + GT Y+ P+
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 435 Y---HQNFHLSDKSDVYSFGVVLVEIIT 459
H D +S GV+ E++T
Sbjct: 177 VIRGGSGGH-DKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 38/208 (18%)
Query: 270 LGTGAFGTVY------------AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
+G G FG VY L +VA K + H + E ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH--------TIGERNILVRTLL 52
Query: 318 ---PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
P +V L + LV ++M G L HLQ+E G + +A E A+
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIA-ELVLALE 110
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
HLH I +RD+K NILLD + DFGLS+ +T+ +T GT YL P+
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPE 166
Query: 435 YHQNFHLSDKS-----DVYSFGVVLVEI 457
L +K D +S GV++ E+
Sbjct: 167 ----VLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ + + LG G+ G V+ A D VA+K+I D ++ + EIK+I + H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 323 L---LGCSIER-----GEQI------LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
+ LG S G +V E+M L L E+G RL +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARL-FMYQ 122
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEISHISTAPQG- 426
+ + ++HSA + HRD+K +N+ ++ + K+ DFGL+R+ SH +G
Sbjct: 123 LLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 427 -TPGYLDPQ--YHQNFHLSDKSDVYSFGVVLVEIIT 459
T Y P+ N + + D+++ G + E++T
Sbjct: 180 VTKWYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 268 QRLGTGAFGTVYAGKLQN-----------DLLVAIKRIK--HRDTDGIQQVVNEIKLISC 314
+ LG G F +Y G L+ ++ V +K + HRD+ + L+S
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET---ASLMSQ 57
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMETAQAI 373
+SH +LV+L G + R E I+V E++ G L L RE+ + L W +L VA + A A+
Sbjct: 58 LSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASAL 114
Query: 374 AHLHSAINPPIYHRDIKSSNILL-------DYNFKSKVADFGLSRLGMTEISHISTAPQG 426
+L + + H ++ NIL+ Y K++D G+ ++ + P
Sbjct: 115 HYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-- 169
Query: 427 TPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEI 457
++ P+ +N L+ +D +SFG L+EI
Sbjct: 170 ---WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 268 QRLGTGAFGTVY-AGKLQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSH-PNLVRL 323
+++G G +G VY A LVA+K+ + D +GI + EI L+ +S +VRL
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 324 LGCSIERGEQ-------ILVYEFMPNGTLCQHLQRER---GDGLSWPIRLTVAMETAQAI 373
L +E E+ LV+E++ + L + + G L + + + +
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSR 411
AH H + HRD+K N+L+D K+AD GL R
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 48/177 (27%), Positives = 89/177 (50%), Gaps = 31/177 (17%)
Query: 252 YPY-REIEKATIGFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIK-HRDTDGIQ-QVVN 307
+P+ E+ K + + ++G G FG V+ A + +VA+K++ + +G +
Sbjct: 5 FPFCDEVSK----YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 308 EIKLISCVSHPNLVRLLG-CSIE-------RGEQILVYEFMPNGTLCQHLQRERGDGLSW 359
EIK++ + H N+V L+ C + +G LV+EF C+H + LS
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF------CEH---DLAGLLSN 111
Query: 360 P-IRLTVAMETAQAIAHLHSAIN----PPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
++ T++ E + + L + + I HRD+K++NIL+ + K+ADFGL+R
Sbjct: 112 KNVKFTLS-EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-----LISCVSHPNLVR 322
+ +G G +G VY + D +A +I D I V EI+ L S +HPN+V+
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKI----LDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 323 LLGC-----SIERGEQILVYEFMPNGTLCQHLQ--RERGDGLSWPIRLTVAMETAQAIAH 375
G + G+ LV E G++ + ++ G L + + + H
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQ 434
LH N I HRD+K +NILL K+ DFG+S +L T + ++ GTP ++ P+
Sbjct: 144 LH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPE 198
Query: 435 Y---HQNFHLS--DKSDVYSFGVVLVEI 457
Q + S + DV+S G+ +E+
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 273 GAFGTVYAGKLQNDLL-VAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
GA+G VY + + A+K+I ++ + IQQV E +++ +P +V + CS
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSF 70
Query: 329 E-RGEQILVYEFMPNGTLCQHLQRERGDGLSWPI---RLTVAMETAQAIAHLHSAINPPI 384
E + +V E++ G C L + G + P+ R+ A ET A+ +LH N I
Sbjct: 71 ETKRHLCMVMEYVEGGD-CATLLKNIG---ALPVDMARMYFA-ETVLALEYLH---NYGI 122
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS------HISTAPQ--------GTPGY 430
HRD+K N+L+ K+ DFGLS++G+ ++ HI + GTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEII 458
+ P+ D ++ G++L E +
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 270 LGTGAFGTVY-AGKLQ---NDLLVAIKRIKH----RDTDGIQQVVNEIKLISCVSHPNLV 321
LG G +G V+ K+ + A+K +K R+ E ++ V HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
L+ G+ L+ E++ G L HL+RE G + ++ E + A+ HLH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLS-EISLALEHLHQQ-- 119
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I +RD+K NILLD K+ DFGL + + E + T GT Y+ P+
Sbjct: 120 -GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSGH 177
Query: 442 SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
D +S G ++ +++T PP D+I KG+L
Sbjct: 178 GKAVDWWSLGALMYDMLTG-------APPFTAENRKKTIDKILKGKL 217
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIK-HRDTDGIQ-QVVNEIKLI---SCVSHPNLVRL 323
+G GA+GTVY A + VA+K ++ + DG+ V E+ L+ HPN+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 324 LG-CSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
+ C+ R ++ LV+E + + L +L + GL + + + + LH+
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
I HRD+K NIL+ + K+ADFGL+R+
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIKR-IKHRDTDGIQQV-VNEIKLISCVSHPNLVRLLGC 326
+G G++G V K + +VAIK+ ++ D ++++ + EI+++ + H NLV L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+ LV+EF+ + T+ L++ GL + + I HS I H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NIIH 123
Query: 387 RDIKSSNILLDYNFKSKVADFGLSR 411
RDIK NIL+ + K+ DFG +R
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLL 324
++ LG G GTVY A L ++A+K I T +Q Q+++E++++ P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
G + EFM G+L + + + + +A+ + + +L S I
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAVVKGLTYLWSL---KI 116
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
HRD+K SN+L++ + K+ DFG+S ++ I+ GT Y+ P+
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 445 SDVYSFGVVLVEI 457
SDV+S G+ +E+
Sbjct: 174 SDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVSHPN-LVRL 323
LG G+FG V + + D L AIK +K +D D ++ + E ++++ P L +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
C V E++ G L H+Q+ P + A E + + LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---G 121
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY--HQNFHL 441
I +RD+K N++LD K+ADFG+ + M + T GTP Y+ P+ +Q +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQPYGK 180
Query: 442 SDKSDVYSFGVVLVEII 458
S D +++GV+L E++
Sbjct: 181 S--VDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 270 LGTGAFGTV-YAGKLQNDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVSHPN-LVRL 323
LG G+FG V A + D L AIK +K +D D ++ + E ++++ P L +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
C V E++ G L +Q+ P + A E A + LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---G 121
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAP-QGTPGYLDPQYHQNFHLS 442
I +RD+K N++LD K+ADFG+ + M + ++T GTP Y+ P+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 443 DKSDVYSFGVVLVEII 458
D ++FGV+L E++
Sbjct: 180 KSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 271 GTGAFGTVYAGKLQN---DLLVAIKRIK--HRDTDGIQQ-VVNEIKLISCVSHPNLVRLL 324
G G +G VY K +N AIK+ K GI Q EI L+ + H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 325 GCSIERGEQI--LVYEFMPN--GTLCQHLQRERGDGLSWPIRLTVAMETAQ---AIAHLH 377
+E ++ L++++ + + + ++ + + V Q + +LH
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP---PSMVKSLLWQILNGVHYLH 125
Query: 378 SAINPPIYHRDIKSSNILL----DYNFKSKVADFGLSRL 412
S + HRD+K +NIL+ K+ D GL+RL
Sbjct: 126 SNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 61/225 (27%)
Query: 270 LGTGAFGTVYAG--KLQNDLLVAIKRIK-HRDTDGIQ-QVVNEIKLISCVSHPNLVRLLG 325
+G G +G VY K +L VA+K+++ + +G + EIK++ ++H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL-- 71
Query: 326 CSI------------ERGEQILVYEFMPN---GTL-----------CQHLQRERGDGLSW 359
I ++G LV+E+M + G L + ++ +GL+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN- 130
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419
+ H HRDIK SNILL+ + K+ADFGL+RL +E S
Sbjct: 131 ---------------YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 420 ISTAPQGTPGYLDPQYHQNFHLSDKS-----DVYSFGVVLVEIIT 459
T T Y P+ L ++ DV+S G +L E+ T
Sbjct: 173 PYTNKVITLWYRPPE----LLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 270 LGTGAFGTVYAGK-LQND-LLVAIKRIK-HRDTDGIQ----QVVNEIKLISCVSHPNLVR 322
+G GA+G V+ + L+N VA+KR++ +G+ + V ++ + HPN+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 323 LLG-CSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
L C++ R ++ LV+E + + L +L + G+ + + + + LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
S + HRD+K NIL+ + + K+ADFGL+R+ T+ T Y P+
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVLL 182
Query: 438 NFHLSDKSDVYSFGVVLVEI 457
+ D++S G + E+
Sbjct: 183 QSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 72/251 (28%), Positives = 109/251 (43%), Gaps = 48/251 (19%)
Query: 270 LGTGAFGTVY---------AGKL-------QNDLLVAIKRIKHRDTDGIQQVVNEIKLIS 313
LGTGA+G V+ +GKL + ++ K +H T+ +QV+ I+
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTE--RQVLEHIR--- 62
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQA 372
P LV L + L+ +++ G L HL QRER +++ E A
Sbjct: 63 --QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK--EQEVQIYSG-EIVLA 117
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
+ HLH I +RDIK NILLD N + DFGLS+ + + + GT Y+
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 433 PQYHQNFHLS-DKS-DVYSFGVVLVEIITALK--VVD--------------FSRPPNEVN 474
P + DK+ D +S GV++ E++T VD S PP
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234
Query: 475 LAALAADRISK 485
++ALA D I +
Sbjct: 235 MSALAKDIIQR 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 19/197 (9%)
Query: 270 LGTGAFGTVYAG-----KLQNDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRL 323
LG+G FG V G K Q D VAIK +K+ + ++ +++ E +++ + +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 324 LG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
+G C E +LV E G L + L ++ D ++ + + + + + +L
Sbjct: 61 IGVCEAE--ALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK--- 114
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTP-GYLDPQYHQNFH 440
HRD+ + N+LL +K++DFGLS+ LG + + + + P + P+ NF
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC-INFR 173
Query: 441 -LSDKSDVYSFGVVLVE 456
S +SDV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 44/151 (29%), Positives = 83/151 (54%), Gaps = 16/151 (10%)
Query: 269 RLGTGAFGTVYAGKLQND---LLVAIKR-IKHRDTDGIQQV-VNEIKLISCVSHPNLVRL 323
++G G++G V+ K +N +VAIK+ ++ D I+++ + EI+++ + HPNLV L
Sbjct: 8 KIGEGSYGVVF--KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI--AHLHSAIN 381
+ + + LV+E+ + T+ L++ G+ + + +T QA+ H H+ I
Sbjct: 66 IEVFRRKRKLHLVFEYCDH-TVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCI- 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
HRD+K NIL+ + K+ DFG +R+
Sbjct: 123 ----HRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQV----VNEIKLISCVSHPNLVRLL 324
+G GA+G V + + +VAIK+ K D++ ++V + E+K++ + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
RG+ LV+E++ L L E +G+ P + V Q I +H I
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVP-PEK--VRSYIYQLIKAIHWCHKNDI 121
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS-TAPQGTPGYLDPQYHQNFHLSD 443
HRDIK N+L+ +N K+ DFG +R ++E S+ + T T Y P+
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 444 KSDVYSFGVVLVEI 457
D++S G +L E+
Sbjct: 181 AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 264 FSEKQRLGTGAFG-----------TVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
F + +G GAFG VYA KL L + IK D+ + E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWE---ERDIM 97
Query: 313 SCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ + +V+L + + + + +V E+MP G L +L W T E
Sbjct: 98 AHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYT--AEVVL 153
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGY 430
A+ +HS HRD+K N+LLD + K+ADFG ++ + TA GTP Y
Sbjct: 154 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDY 209
Query: 431 LDP-----QYHQNFHLSDKSDVYSFGVVLVEII 458
+ P Q ++ + D +S GV L E++
Sbjct: 210 ISPEVLKSQGGDGYY-GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 33/163 (20%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIK----HRDTDGIQQ----------VVNEIKLISC 314
LG G +G V A +VAIK++K D +Q + E+K+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA------ME 368
+ H N++ L+ +E LV + M L + + R+ IRLT + ++
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--------IRLTESQVKCILLQ 127
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ LH HRD+ +NI ++ K+ADFGL+R
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 264 FSEKQRLGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
F + + LG G FG V A GK+ + KRIK R G +NE +++ V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GESMALNEKQILEKVNS 59
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
+V L + LV M G L H+ G + A E + LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
I +RD+K NILLD + +++D GL+ + + E I GT GY+ P+ +
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIK-GRVGTVGYMAPEVVK 174
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
N + D ++ G +L E+I
Sbjct: 175 NERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 40/245 (16%)
Query: 240 LKEARGISNIPIYPYREIEKATIGFSEKQR-------LGTGAFG-----------TVYAG 281
L++ + I N + Y +I + K +G GAFG VYA
Sbjct: 15 LRKNKNIDNF-LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAM 73
Query: 282 KLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI-LVYEFM 340
KL L + IK D+ + E +++ + P +V+L C+ + + + +V E+M
Sbjct: 74 KL----LSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYM 125
Query: 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400
P G L +L W TA+ + L + + + HRD+K N+LLD +
Sbjct: 126 PGGDLV-NLMSNYDVPEKW-----AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179
Query: 401 KSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQ----NFHLSDKSDVYSFGVVLV 455
K+ADFG ++ T + TA GTP Y+ P+ + + + + D +S GV L
Sbjct: 180 HLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 456 EIITA 460
E++
Sbjct: 239 EMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 31/211 (14%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDG---IQQVVNEIKLISCVSHPN 319
+ + +++G+GA+GTV A + VAIK++ +R ++ E++L+ + H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 320 LVRLLGC-----SIERGEQI-LVYEFMPN--GTLCQH--LQRERGDGLSWPIRLTVAMET 369
++ LL S++R LV FM G L +H L +R L + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM-------- 127
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG 429
+ + ++H+A I HRD+K N+ ++ + + K+ DFGL+R +E+ T T
Sbjct: 128 LKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----TGYVVTRW 180
Query: 430 YLDPQYHQNF-HLSDKSDVYSFGVVLVEIIT 459
Y P+ N+ H + D++S G ++ E++T
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 269 RLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLGC 326
+LG G + TVY G+ + D LVA+K I+ +G + E+ L+ + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL-TVAMETAQAIAHLHSAINPPIY 385
LV+E++ + L Q+L D I + V + Q + L+ +
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYL-----DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ + K+ADFGL+R
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 53/227 (23%), Positives = 105/227 (46%), Gaps = 40/227 (17%)
Query: 268 QRLGTGAFGTVYAGKLQNDL------LVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLV 321
+++G G FG V+ K + ++ + +K R+ Q+V E+ ++ + H N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK---SQLVIEVNVMRELKHKNIV 75
Query: 322 RLLGCSIERGEQIL--VYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLH 377
R + + + Q L + EF G L +++Q+ + + + + + A+A+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 378 SAINPP----IYHRDIKSSNILLDYNFK-----------------SKVADFGLSR-LGMT 415
+ + P + HRD+K NI L + +K+ DFGLS+ +G+
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195
Query: 416 EISHISTAPQGTPGYLDPQY--HQNFHLSDKSDVYSFGVVLVEIITA 460
++H GTP Y P+ H+ DKSD+++ G ++ E+ +
Sbjct: 196 SMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 31/206 (15%)
Query: 270 LGTGAFGTVYAG-KLQNDLLVAIKRIKHRDTDGI---QQVVNEIKLISCVSHPNLVRLL- 324
+G+GA+G+V A + L VA+K++ R I ++ E++L+ + H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 325 ----GCSIERGEQI-LVYEFM----PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
S+E + LV M N CQ L + L + I + + +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKY 135
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY 435
+HSA I HRD+K SN+ ++ + + K+ DFGL+R E+ T T Y P+
Sbjct: 136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEI 188
Query: 436 HQNF-HLSDKSDVYSFGVVLVEIITA 460
N+ H + D++S G ++ E++T
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 270 LGTGAFGTVYAGKLQND-LLVAIKRI---KHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V A +++N + A K++ + + G + + E +++ V+ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+ LV M G L H+ ERG + I + + I HLHS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA--QITCGILHLHSM---D 115
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
I +RD+K N+LLD +++D GL+ + + + I T GT GY+ P+ + S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI-TQRAGTNGYMAPEILKEEPYSY 173
Query: 444 KSDVYSFGVVLVEII 458
D ++ G + E++
Sbjct: 174 PVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 13/201 (6%)
Query: 264 FSEKQRLGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
F + + LG G FG V A GK+ + KRIK R G +NE +++ V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK--GESMALNEKQILEKVNS 59
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
+V L + LV M G L H+ G L A E + LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
+RD+K NILLD +++D GL+ + + E I GT GY+ P+
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIR-GRVGTVGYMAPEVLN 174
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
N + D + G ++ E+I
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 264 FSEKQRLGTGAFGTVYAG--KLQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPN 319
+ + +++G G +G VY ++ N+ +A+K+I+ ++ +G+ + EI L+ + H N
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+VRL LV+E++ + L +H+ + + T + + IA+ HS
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 380 INPPIYHRDIKSSNILLDYNFKS-KVADFGLSR-LGM---TEISHIST----APQGTPGY 430
+ HRD+K N+L+D + K+ADFGL+R G+ T + T AP+ G
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG- 177
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ H S D++S G + E++
Sbjct: 178 -------SRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 29/75 (38%), Positives = 46/75 (61%), Gaps = 1/75 (1%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDK 444
HRD+KS+NI L K+ DFG S+ +S ++++ GTP YL P+ + S K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 445 SDVYSFGVVLVEIIT 459
+D++S GV+L E++T
Sbjct: 252 ADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 270 LGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLL-- 324
+G+GA+G+V A + VAIK++ I ++ E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 325 --GCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
Q LV +M LQ+ G LS + + + ++HSA
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQT-----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA- 136
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF- 439
I HRD+K N+ ++ + + K+ DFGL+R E+ T T Y P+ N+
Sbjct: 137 --GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWM 190
Query: 440 HLSDKSDVYSFGVVLVEIIT 459
H + D++S G ++ E++T
Sbjct: 191 HYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 40/146 (27%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLG 325
++LG G + TV+ G+ + + LVA+K I+ +G + E+ L+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
LV+E++ + L Q++ + G+ +S + + +A+ H +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ + K+ADFGL+R
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 264 FSEKQRLGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
F + LG G FG V A GK+ + KRIK R + + +NE +++ V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNS 59
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
+V L + LV M G L H+ G + A E + LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST--APQGTPGYLDPQY 435
I +RD+K NILLD +++D GL+ EI T GT GY+ P+
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEV 172
Query: 436 HQNFHLSDKSDVYSFGVVLVEII 458
+N + D + G ++ E+I
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIK-HRDTDGIQQVVNEIKLI-SCVSHPNLVRLLGC 326
LG G +G+VY + + +A+K I+ D Q++ E+ ++ VS P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGA 67
Query: 327 SIERGEQILVYEFMPNGTLCQ-HLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
G + E+M G+L + + +G+ + + + + L N I
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY------HQNF 439
HRD+K +N+L++ N + K+ DFG+S G S ++ G Y+ P+ +QN
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS--GNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 440 HLSDKSDVYSFGVVLVEI 457
+ +SDV+S G+ ++E+
Sbjct: 183 TYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 56/179 (31%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI-----KHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+G GA+G V + K + + VAIK+I D ++ + EIKL+ + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVIAI 69
Query: 324 LGCSIERGEQI-----LVYEFM---------PNGTL----CQHL--QRERGDGLSWPIRL 363
+ +VYE M + TL CQ+ Q RG
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG--------- 120
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG------MTE 416
+ ++HSA + HRD+K SN+LL+ N K+ DFGL+R MTE
Sbjct: 121 ---------LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 33/205 (16%)
Query: 270 LGTGAFGTV---YAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLL 324
+G+GA+G+V Y +L+ VA+K++ I ++ E++L+ + H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 325 -----GCSIER-GEQILVYEFM----PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
SIE E LV M N CQ L E L + + + +
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY--------QLLRGLK 132
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
++HSA I HRD+K SN+ ++ + + ++ DFGL+R E+ T T Y P+
Sbjct: 133 YIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPE 185
Query: 435 YHQNF-HLSDKSDVYSFGVVLVEII 458
N+ H + D++S G ++ E++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGI-QQVVNE 308
EI +T+ F E+ LG FG VY G L + VAIK +K + + ++ +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL--------------QRERG 354
+ S + HPN+V LLG + +++ + + L + L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414
L + + + A + L S + H+D+ + N+L+ K++D GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 415 TEISHISTAPQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ P ++ P+ S SD++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 45/226 (19%)
Query: 270 LGTGAFGTVYAGKLQNDLL----VAIKRIKHRDTDGI---QQVVNEIKLISCVSHPNLVR 322
+G G G VY L D + VA+K+I+ ++ ++ + E K+ + + HP +V
Sbjct: 10 IGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 323 LLGCSIERGEQILVYEFMP---NGTL---------CQHLQRERGDGLSWPIRLTVAMETA 370
+ SI + VY MP TL + L +E + S L++ +
Sbjct: 67 VY--SIC-SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL-------------SRLGMTEI 417
I ++HS + HRD+K NILL + + D+G + I
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 418 SHIS-TAPQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ S T P GTP Y+ P+ S+ +D+Y+ GV+L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 270 LGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH---PNL 320
+G G FG VY GK+ + KRIK + + + +NE ++S VS P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDCPFI 59
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V + + + + M G L HL + G +R A E + H+H
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH--- 114
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
N + +RD+K +NILLD + +++D GL+ + H S GT GY+ P+ Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 441 LSDKS-DVYSFGVVLVEII 458
D S D +S G +L +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 42/238 (17%)
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMET 369
L+S VSH +L + G + E I+V EF+ +G L L++E+G ++W ++TVA +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS-------KVADFGLSRLGMTEISHIST 422
A A+++L + + H ++ + NILL + K++D G+S ++ +
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183
Query: 423 APQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481
P ++ P+ LS +D +SFG L+EI +V R P+E
Sbjct: 184 IP-----WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--------- 229
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
K R E +HR S ++A L +CL + RPS + +L
Sbjct: 230 ---KERFYE------KKHRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+G GAFG V++ ++ VA+K++ + ++ ++V E+K++ H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL-- 65
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT---VAMETAQ---AIAHLHSAI 380
I + I +E + + + +Q + + P L+ V + Q + +LHSA
Sbjct: 66 DILQPPHIDPFEEIY--VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA- 122
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF- 439
I HRDIK N+L++ N K+ DFGL+R+ + S T T Y P+
Sbjct: 123 --GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR 180
Query: 440 HLSDKSDVYSFGVVLVEII 458
H + D++S G + E++
Sbjct: 181 HYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 83/295 (28%)
Query: 270 LGTGAFGTV--YAGKLQNDLLVAIKRIKHRDTDGIQQVVN---EIKLISCVSHPNLVRLL 324
+G GAFG V K + A+K+++ + +QV + E +++ +P +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHI-YAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 325 GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPI-RLTVAMETAQAI--AHLHSAI 380
S + + L+ E++P G + L ++ D + R +A ET AI H I
Sbjct: 68 -YSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIA-ETILAIDSIHKLGYI 123
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLS-------------RLGMTEISHISTAPQ-- 425
HRDIK N+LLD K++DFGL L S+
Sbjct: 124 -----HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 426 ----------------------GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEII----- 458
GTP Y+ P+ + + D +S GV++ E++
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 459 --------TALKVVDFSRP---PNEVNLAALAAD-----------RISKGRLDEI 491
T K++++ P+EV L+ A D R+ ++EI
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEI 293
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 270 LGTGAFGTVY---------AGKL-------QNDLLVAIKRIKHRDTDGIQQVVNEIKLIS 313
LGTGA+G V+ GKL + L+ K ++H T+ + V+ ++
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE--RNVLEHVR--- 62
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
P LV L + L+ +++ G + HL +R + +R E A+
Sbjct: 63 --QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSG-EIILAL 118
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP 433
HLH I +RDIK NILLD + DFGLS+ ++E + + GT Y+ P
Sbjct: 119 EHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ + K+ D +S G+++ E++T
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G G V+ +L+ L A+K + ++ + +++V+ E ++++ + HP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY- 67
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSW-PIRLTVAMETAQAIAHLHSAINPP 383
S + + LV ++ P G L + LQR+ G LS R A E A+ +LH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLH---LLG 123
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLS 410
I +RD+K NILL + ++DF LS
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 44/201 (21%), Positives = 80/201 (39%), Gaps = 26/201 (12%)
Query: 273 GAFGTVYAGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330
+ K + LVA+K+I + ++ + EI + HPN++ + I
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIK 390
E +V M G+ L+ +GL + + A+ ++HS HR +K
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVK 128
Query: 391 SSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH-------------Q 437
+S+ILL + K ++ GL +S I + + P+ Q
Sbjct: 129 ASHILLSGDGKVVLS--GLR----YSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 438 NFH-LSDKSDVYSFGVVLVEI 457
N ++KSD+YS G+ E+
Sbjct: 183 NLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 269 RLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLGC 326
+LG G++ TVY G+ + LVA+K I+ +G + E L+ + H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWP-IRLTVAMETAQAIAHLHSAINPPIY 385
+ LV+E++ + L Q++ G GLS +RL + + + +A+ H +
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFL-FQLLRGLAYCHQR---RVL 125
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L+ + K+ADFGL+R
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 269 RLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRLLGC 326
+LG G + TV+ G+ + + LVA+K I+ +G + E+ L+ + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
LV+E++ + L Q+L G+ +S + + +++ H I H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILH 126
Query: 387 RDIKSSNILLDYNFKSKVADFGLSR 411
RD+K N+L++ + K+ADFGL+R
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVA---IKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLVRL 323
Q +G G FG V ++ D VA +K +K + Q + + + + HPN+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 324 LGCSIERGEQILVYEFMPNGTL----CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
LG +E +LV+E+ G L Q Q R + ++ +A E A + H+H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQE-QWHRRNSQLLLLQ-RMACEIAAGVTHMHKH 118
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQN 438
H D+ N L + KV D+G+ E + + P +L P+
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 439 FH-------LSDKSDVYSFGVVLVEI 457
FH + S+V++ GV L E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+G G++G V + VAIK+I +++ EIKL+ + HP++V +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 327 SI-----ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+ E + +V+E M + H + D L+ + +A+ ++H+A
Sbjct: 68 MLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHHQFFLYQLLRALKYIHTA-- 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM--TEISHISTAPQGTPGYLDPQYHQNF 439
++HRD+K NIL + + K K+ DFGL+R+ T + T T Y P+ +F
Sbjct: 123 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 181
Query: 440 H--LSDKSDVYSFGVVLVEIIT 459
+ D++S G + E++T
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 270 LGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH---PNL 320
+G G FG VY GK+ + KRIK + G +NE ++S VS P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFI 59
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V + + + + M G L HL + G +R A E + H+H
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRF-YAAEIILGLEHMH--- 114
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
N + +RD+K +NILLD + +++D GL+ + H S GT GY+ P+ Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 441 LSDKS-DVYSFGVVLVEII 458
D S D +S G +L +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 270 LGTGAFG-----------TVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP 318
+G GAFG VYA KL L + IK D+ + E +++ + P
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWE---ERDIMAFANSP 103
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
+V+L + +V E+MP G L + W R A E A+ +HS
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWA-RFYTA-EVVLALDAIHS 160
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFG----LSRLGMTEISHISTAPQGTPGYLDPQ 434
HRD+K N+LLD + K+ADFG +++ GM GTP Y+ P+
Sbjct: 161 M---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD----TAVGTPDYISPE 213
Query: 435 YHQ----NFHLSDKSDVYSFGVVLVEIITA 460
+ + + + D +S GV L E++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 21/156 (13%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPN 319
F + + LG GAFG V A K+ L A+K ++ +D + + V E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET------AQAI 373
+VRL ++ V +++P G D +S IR+ + E A+
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGG-----------DMMSLLIRMGIFPEDLARFYIAELT 111
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409
+ S HRDIK NIL+D + K+ DFGL
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 264 FSEKQRLGTGAFGTVYA------GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH 317
F + LG G FG V A GK+ + KRIK R G +NE +++ V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKRILEKVNS 59
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
+V L + LV M G L H+ G + A E + L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST--APQGTPGYLDPQY 435
I +RD+K NILLD +++D GL+ +I T GT GY+ P+
Sbjct: 120 RE---RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEV 172
Query: 436 HQNFHLSDKSDVYSFGVVLVEII 458
N + D + G ++ E+I
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 270 LGTGAFGTVYAGKL----------QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN 319
LG G F ++ G + ++L+ + HR+ + ++S +SH +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYS--ESFFEAASMMSQLSHKH 60
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD-GLSWPIRLTVAMETAQAIAHLHS 378
LV G + E I+V E++ G+L +L++ + +SW +L VA + A A+ L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE- 117
Query: 379 AINPPIYHRDIKSSNILL--DYNFKS------KVADFGLSRLGMTEISHISTAPQGTPGY 430
+ + H ++ + N+LL + + K+ K++D G+S + + + P P
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 431 L-DPQYHQNFHLSDKSDVYSFGVVLVEI 457
+ +PQ +LS +D +SFG L EI
Sbjct: 176 IENPQ-----NLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 69/258 (26%)
Query: 270 LGTGAFGTVYAG------KLQNDLLVAIKRIKHRDTDGIQQ-VVNEIK-LISCVSHPNLV 321
LG GAFG V K + VA+K +K T + +++E+K LI +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 322 RLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLS--------WPIRLTVAMETAQA 372
LLG C+ G +++ EF G L L R + + S R +E ++
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFL-RAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 373 ----------------IAHLHSAINPP--------------------------------- 383
+ NPP
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 384 -IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHL 441
HRD+ + NILL N K+ DFGL+R + ++ P ++ P+ +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 442 SDKSDVYSFGVVLVEIIT 459
+ +SDV+SFGV+L EI +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI-STAPQGTP 428
A+ + +HS HRDIK N+LLD N ++ADFG S L M + + S+ GTP
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 429 GYLDPQYHQNFH-----LSDKSDVYSFGVVLVEII 458
Y+ P+ Q + D +S GV + E++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN 319
A++G++ + L G+ G V+ + +I + T I E L+ V+HP+
Sbjct: 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAMLLQNVNHPS 118
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW--------PIR--LTVAMET 369
++R+ LV C L D ++ PI L + +
Sbjct: 119 VIRMK--------DTLVS----GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG 429
+ + +LH+ I HRD+K+ NI ++ + + D G ++ + + + A GT
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVE 221
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
P+ + K+D++S G+VL E++ + F PP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI-FEDPP 261
|
Length = 357 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVN---EIKLISCVSHPN 319
F + + LG GAFG V A K+ L A+K ++ +D QV + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQA--IAHLH 377
+V+L ++ V +++P G D +S IR+ V E IA L
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGG-----------DMMSLLIRMEVFPEVLARFYIAELT 111
Query: 378 SAINP----PIYHRDIKSSNILLDYNFKSKVADFGL 409
AI HRDIK NIL+D + K+ DFGL
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 49/212 (23%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 268 QRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCVSHPNLVRLL 324
+ +G+GA+G V A ++ VAIK+I H ++ + E+K++ H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 325 GCSIERGEQ------ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
I R +V + M + H+ IR + + + + ++HS
Sbjct: 71 --DILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQPLTEEHIRYFL-YQLLRGLKYIHS 125
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG----------MTEISHISTAPQGTP 428
A + HRD+K SN+L++ + + ++ DFG++R MTE +++T P
Sbjct: 126 A---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE--YVATRWYRAP 180
Query: 429 GYL--DPQYHQNFHLSDKSDVYSFGVVLVEII 458
L P+Y D++S G + E++
Sbjct: 181 ELLLSLPEYTT------AIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH----- 440
HRDIK NIL+D N ++ADFG M + + S+ GTP Y+ P+ Q
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 441 LSDKSDVYSFGVVLVEII 458
+ D +S GV + E++
Sbjct: 185 YGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 268 QRLGTGAFGTVYAGKL------QNDLLVAIKRIK---------HRDTDGIQQVVNEIKLI 312
+ LG G +YAG L ++D K IK HRD ++
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDIS--LAFFETASMM 58
Query: 313 SCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQA 372
VSH ++V L G + E I+V EF+ G L + R + D L+ P + VA + A A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASA 117
Query: 373 IAHLHSAINPPIYHRDIKSSNILL-------DYNFKSKVADFGLSRLGMTEISHISTAPQ 425
+++L + + H ++ + NILL + K++D G+ ++ + P
Sbjct: 118 LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPW 174
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEI 457
P ++ + +LS +D +SFG L EI
Sbjct: 175 IAPECVE----DSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 70/293 (23%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVN---EIKLISCVSHPN 319
F + +G GAFG V K + A+K ++ D +QV + E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V++ ++ L+ EF+P G + L ++ D LS ET AI +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADF----GLSRLGMTE----ISH------------ 419
HRDIK N+LLD K++DF GL + TE ++H
Sbjct: 121 ---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 420 --------------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEII------- 458
++ + GTP Y+ P+ + D +S GV++ E++
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 459 ------TALKVVDFSRP---PNEVNLAALAAD-----------RISKGRLDEI 491
T KV+++ P EV ++ A D RI ++EI
Sbjct: 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 22/122 (18%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-----H 440
HRDIK N+LLD N ++ADFG + + + S GTP Y+ P+ Q
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 441 LSDKSDVYSFGVVLVEII-------------TALKVVD----FSRPPNEVNLAALAADRI 483
+ D +S GV + E++ T K+++ F PP+ +++ A D I
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244
Query: 484 SK 485
+
Sbjct: 245 RR 246
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 4/124 (3%)
Query: 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396
Y+ + + L + +GL+ L+ + A+ + L S HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270
Query: 397 DYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLV 455
K+ DFGL+R M + +++S P ++ P+ + + SDV+S+G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 456 EIIT 459
EI +
Sbjct: 331 EIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 27/204 (13%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC-- 326
+G G+FG VY A + VAIK++ Q E+ ++ ++H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 327 --SIERGEQIL----VYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETAQAIAHLHS 378
++ E+ + V EF+P T+ ++++ + + P+ L + + +A+A++HS
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 379 AINPPIYHRDIKSSNILLDYNFKS-KVADFGLSR---LGMTEISHISTAPQGTPGYLDPQ 434
I HRD+K N+L+D N + K+ DFG ++ G +S+I + P +
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 435 YHQNFHLSDKSDVYSFGVVLVEII 458
+ H+ D++S G ++ E+I
Sbjct: 246 TNYTTHI----DLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 273 GAFGTVYAG-KLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
GAFG VY G K N L A+K +K D + + QV E ++ P +V L S+
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 329 ERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
+ + LV E++ G + + L G + + E A A+ +LH I HR
Sbjct: 74 QSANNVYLVMEYLIGGDV-KSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHR 128
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMT---EISHISTAP 424
D+K N+L+ K+ DFGLS++ + + I T P
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTP 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVN---EIKLISCVSHPN 319
F + + +G GAFG V K+ + L A+K ++ D Q + E +++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQA--IAHLH 377
+V+L ++ V +++P G D +S IRL + E IA L
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGG-----------DMMSLLIRLGIFEEDLARFYIAELT 111
Query: 378 SAI----NPPIYHRDIKSSNILLDYNFKSKVADFGL 409
AI HRDIK NIL+D + K+ DFGL
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 27/75 (36%), Positives = 43/75 (57%), Gaps = 1/75 (1%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDK 444
HRD+ + N+L+ K+ DFGL+R M + ++IS P ++ P+ N +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321
Query: 445 SDVYSFGVVLVEIIT 459
SDV+SFG++L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 30/153 (19%), Positives = 53/153 (34%), Gaps = 18/153 (11%)
Query: 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNE---IKLISCVSHPNLV 321
S + L G VY L + +I G E ++L++ V
Sbjct: 1 SSIKLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGAD-REREVAILQLLA--RKGLPV 55
Query: 322 -RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
++L G L+ E++ TL + +A + A+ +A LH
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETL------DEVSEEEKED---IAEQLAELLAKLHQLP 106
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413
+ H D+ NIL+D + D+ + G
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 268 QRLGTGAFGTVYAGK---LQNDLLVAIKRIKHRDTDGI--QQVVNEIKLISCV-SHPNLV 321
+ LG GA+G V + + + VAIK+I + + I ++ + E+KL+ H N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 322 RLLGCSIERGEQ---ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA------METAQA 372
L I + +YE + L Q ++ + LT A +
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--------PLTDAHFQSFIYQILCG 117
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR---LGMTEISHISTAPQGTPG 429
+ ++HSA + HRD+K N+L++ + + K+ DFGL+R E + T T
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 430 YLDPQYHQNFHLSDKS-DVYSFGVVLVEII 458
Y P+ +F K+ DV+S G +L E++
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 1/75 (1%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDK 444
HRD+ + NILL N K+ DFGL+R + ++ P ++ P+ + + +
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255
Query: 445 SDVYSFGVVLVEIIT 459
SDV+SFGV+L EI +
Sbjct: 256 SDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 270 LGTGAFGTVYA------GKLQNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLV 321
LG GAFG V GK N L VA+K +K TD + +++E+K++S + H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRE 352
LLG G +++ E+ G L L+++
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 43/233 (18%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDTDGIQQVVN---EIKLISCVSHPN 319
F + +G GAFG V K + A+K ++ D +QV + E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V++ ++ L+ EF+P G + L ++ D L+ ET AI +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADF----GLSRLGMTE----ISH------------ 419
HRDIK N+LLD K++DF GL + TE ++H
Sbjct: 121 ---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 420 --------------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEII 458
++ + GTP Y+ P+ + D +S GV++ E++
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 44/151 (29%), Positives = 64/151 (42%), Gaps = 9/151 (5%)
Query: 264 FSEKQRLGTGAFGTV-YAGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPN 319
F + +G GAFG V K + A+K + + D + V E +++ P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V L + L+ EF+P G L L + D S + E AI +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLS 410
HRDIK NIL+D K++DFGLS
Sbjct: 121 ---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 39/216 (18%)
Query: 257 IEKATIGFSEKQRLGTGAFGTVYA----GKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
IEKA GFS + GA G +A ++ ++ A +R E ++
Sbjct: 89 IEKA--GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHIL 137
Query: 313 SCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW-------PIRLTV 365
++HP++++L G F N C L R + D + I +
Sbjct: 138 RAINHPSIIQLKGT------------FTYNKFTCLILPRYKTDLYCYLAAKRNIAICDIL 185
Query: 366 AMETA--QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
A+E + +AI +LH I HRDIK+ NI +++ + DFG + + ++
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
GT P+ D++S G+VL E+ T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 1/75 (1%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDK 444
HRD+ + NILL N K+ DFGL+R + ++ P ++ P+ + + +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 445 SDVYSFGVVLVEIIT 459
SDV+SFGV+L EI +
Sbjct: 262 SDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 44/210 (20%)
Query: 266 EKQRLGTGAFGTVYAGK---LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+K +L G FG V K Q + K IK ++ + I+ +V++ L+ +PN ++
Sbjct: 20 KKLKLIDGKFGKVSVLKHKPTQKLFVQ--KIIKAKNFNAIEPMVHQ--LMKD--NPNFIK 73
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA------METAQAIAHL 376
L +L+ +++ +G L L++E +L+ A + +A+ L
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--------KLSEAEVKKIIRQLVEALNDL 125
Query: 377 HSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ- 434
H I H DIK N+L D + + D+GL ++ T + GT Y P+
Sbjct: 126 HKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEK 177
Query: 435 -----YHQNFHLSDKSDVYSFGVVLVEIIT 459
Y +F D ++ GV+ E++T
Sbjct: 178 IKGHNYDVSF------DWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 31/107 (28%), Positives = 58/107 (54%), Gaps = 8/107 (7%)
Query: 358 SWPIR----LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413
SWP+ L + + AQ + L ++ N HRD+ + N+LL +K+ DFGL+R
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL-ASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 414 MTEISHISTAPQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
M + +++ P ++ P+ + + +SDV+S+G++L EI +
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDK 444
HRD+ + NILL + +K+ DFGL+R + +++ P ++ P+ N + +
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 296
Query: 445 SDVYSFGVVLVEIIT 459
SDV+S+G++L EI +
Sbjct: 297 SDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|205157 pfam12947, EGF_3, EGF domain | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.001
Identities = 15/37 (40%), Positives = 16/37 (43%), Gaps = 7/37 (18%)
Query: 136 NGHCHCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGY 172
NG CH NA CT F C C G+ GDG
Sbjct: 5 NGGCH--PNATCTNTG-----GSFTCTCKSGYTGDGV 34
|
This family includes a variety of EGF-like domain homologues. This family includes the C-terminal domain of the malaria parasite MSP1 protein. Length = 36 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 270 LGTGAFGTVYAG------KLQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCV-SHPNL 320
LG+GAFG V G + Q + VA+K +K R ++ Q +++E+K+++ + H N+
Sbjct: 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK-QALMSELKIMTHLGPHLNI 103
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLS 358
V LLG + G ++ E+ G L +L + R + LS
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 266 EKQRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRDTDGIQ-QVVNEIKLISCVSHPNLV 321
E ++G G +G VY K ++ D A+K+I + GI EI L+ + HPN++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHPNVI 61
Query: 322 RLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSW-PIRLTVAM------ETAQA 372
L + ++ L++++ + L ++ R + P++L M +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 373 IAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVADFGLSRLGMTEISHISTAPQ--G 426
I +LH+ + HRD+K +NIL+ + K+AD G +RL + + ++
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 427 TPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITA 460
T Y P+ H + D+++ G + E++T+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.16 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.08 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.02 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.21 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 96.03 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.79 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.72 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.64 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.58 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.27 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.02 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.94 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.85 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-63 Score=523.35 Aligned_cols=292 Identities=47% Similarity=0.783 Sum_probs=260.6
Q ss_pred CCCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeE
Q 007442 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327 (603)
Q Consensus 248 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 327 (603)
..+.|+++||++||++|+..++||+|+||.||+|.+.+++.||||++.....+...+|.+|++++++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999999999999988876443146699999999999999999999999
Q ss_pred eecCc-eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 007442 328 IERGE-QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406 (603)
Q Consensus 328 ~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~D 406 (603)
.+.+. ++||||||+||+|.++|+.....+|+|.+|++||.++|+||+|||+.+.|+||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 99994 99999999999999999986433799999999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 407 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
||+|+.......+..+...||.+|+||||+..+.++.|+|||||||+|+||+||+++.+...+..+..+..|+...+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99998754312222222289999999999999999999999999999999999999999877667777999999999999
Q ss_pred CcccccchhhhhccCCCCccch-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTL-ASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
++.+++|+.+.. ..... +++.+++.+|.+|++.+|++||+|.||+++|+.+..
T Consensus 301 ~~~eiiD~~l~~-----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 301 KLREIVDPRLKE-----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred chhheeCCCccC-----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999998853 12222 688889999999999999999999999999976654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=414.60 Aligned_cols=255 Identities=34% Similarity=0.513 Sum_probs=213.2
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChh--hHHHHHHHHHHHhccCCCceeeeeeeEeecC-ceEEEEeeCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD--GIQQVVNEIKLISCVSHPNLVRLLGCSIERG-EQILVYEFMPNG 343 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~g 343 (603)
.+.||+|+||+||+|.+.....||||++...+.. ..++|.+|+.+|++++|||||+|+|+|.+.. ...||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999987766999999876432 2569999999999999999999999999887 799999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeeecCCC-cEEEeeccCccccccccccee
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP-IYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|.++|+......++|..+++||.|||+||.|||+. + ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999986556799999999999999999999998 6 99999999999999997 99999999998633211 334
Q ss_pred ccCCCCCCCcCccccc--cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 422 TAPQGTPGYLDPQYHQ--NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~--~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+ ...+......+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R----------- 264 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR----------- 264 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-----------
Confidence 4578999999999999 66999999999999999999999999964322 1111222222211
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
...+..+...+..|+.+||+.+|+.||++.|++..|+.+....
T Consensus 265 ----p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 265 ----PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ----CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 1222236678999999999999999999999999999987653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=400.46 Aligned_cols=253 Identities=29% Similarity=0.389 Sum_probs=219.6
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
.+.||+|-||.||.|.++....||||.++.. ....++|.+|+++|++|+|+|||+|+|+|...+..+||||||++|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 5679999999999999998889999999986 334578999999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCC
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 426 (603)
+||....+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+||||||...++.........-
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf 366 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF 366 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence 999986667799999999999999999999999 99999999999999999999999999999655555556666677
Q ss_pred CCCCcCccccccCCCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 427 t~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
...|.|||.+..+.++.|||||||||+||||+|- +.|+.. .....+.+.+.+|. +-.
T Consensus 367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-------msn~ev~~~le~Gy---------------Rlp 424 (468)
T KOG0197|consen 367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-------MSNEEVLELLERGY---------------RLP 424 (468)
T ss_pred CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-------CCHHHHHHHHhccC---------------cCC
Confidence 8899999999999999999999999999999994 444331 22333455555542 223
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+..++.++.+|+..||+.+|++|||+..+...|+.+...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 3456788999999999999999999999999999988653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=411.09 Aligned_cols=260 Identities=29% Similarity=0.391 Sum_probs=220.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
+.+....+.||+|.||+||+|... +.+.||||.+|+.... ..++|.+|+++|..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344455678999999999999854 3478999999988655 789999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhc--------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 334 ILVYEFMPNGTLCQHLQRER--------GDG----LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
++|+|||..|+|.+||.... +.+ |+..+.+.||.|||.|++||-++ .+|||||..+|+||.+++.
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999997532 123 88999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCcccccccccceec-cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHIST-APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALA 479 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~ 479 (603)
+||+||||+|-....+.+... ...-.++||+||.|..++||.+||||||||||||++| |+.|+.... .+.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------n~EV 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------NQEV 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------hHHH
Confidence 999999999865443333322 3345679999999999999999999999999999998 666765322 2445
Q ss_pred HHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
++.+.+|++.+ .+..++.++..|+.+||+.+|++||+++||-..|+.....
T Consensus 715 Ie~i~~g~lL~---------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLS---------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCccc---------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 67777776532 3446788999999999999999999999999999987653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=369.21 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=211.1
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
.+..||++ .+.||+|..|+|||++++ +++.+|+|.+... +....+++.+|++++.+.+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 55666665 567999999999999996 5789999999644 45566889999999999999999999999999
Q ss_pred cCc-eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 330 RGE-QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 330 ~~~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
.+. ..|+||||.+|+|++++... +.+++...-+|+.++++||.|||+. ++||||||||+|||++..+.+||+|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 984 99999999999999999765 4599999999999999999999963 299999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.++..... ......||..|||||.+++..|+.++||||||++|+|+.+|+.|+....+.. .... ....++-.+..
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~-~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIF-ELLCAIVDEPP 299 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHH-HHHHHHhcCCC
Confidence 99864332 4456789999999999999999999999999999999999999986531111 1111 11222222211
Q ss_pred ccccchhhhhccCCCCccch-HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 DEIIDPLIIEHRGHSDAGTL-ASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+..+. .+..++..++..||+.||.+||+++|+++.
T Consensus 300 ---------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 ---------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122 467889999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=370.39 Aligned_cols=266 Identities=28% Similarity=0.437 Sum_probs=201.9
Q ss_pred CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--cCCCceeeeeeeEeecC----ceEEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC--VSHPNLVRLLGCSIERG----EQILVY 337 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~lV~ 337 (603)
....++||+|.||.||||.+.+ +.||||++.. +..+.|.+|-.|.+. ++|+||+++++.-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3346689999999999999966 7999999975 445677777777765 57999999999866544 889999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI------NPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~------~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
||.++|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||.+|++..|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999865 4999999999999999999999864 5789999999999999999999999999998
Q ss_pred cccccccc-eeccCCCCCCCcCccccccC-CCC-----cccccccHHHHHHHHHhCCCccCC-CCCcchhhHHH------
Q 007442 412 LGMTEISH-ISTAPQGTPGYLDPQYHQNF-HLS-----DKSDVYSFGVVLVEIITALKVVDF-SRPPNEVNLAA------ 477 (603)
Q Consensus 412 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~s-----~ksDVySfGvvL~elltg~~p~~~-~~~~~~~~l~~------ 477 (603)
.+...... ..-..+||.+|||||++.+. .+. .+.||||+|.|||||+++-+.++. ..++....+..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 75543222 22236799999999998764 233 268999999999999998776642 12222211111
Q ss_pred ---HHHHHhhcCCc-ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 478 ---LAADRISKGRL-DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 478 ---~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..+..+...+. ..+.|... ...-+..+.+.+..||..|++-|.|+.=|.+++.++....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~----------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWR----------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhh----------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111111111 11222211 1134667889999999999999999999999998886543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.40 Aligned_cols=271 Identities=23% Similarity=0.374 Sum_probs=228.7
Q ss_pred CCCChHHHHHHhcCCC---------ccCcccCCCceEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcc
Q 007442 250 PIYPYREIEKATIGFS---------EKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHRD-TDGIQQVVNEIKLISCV 315 (603)
Q Consensus 250 ~~~~~~el~~at~~f~---------~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l 315 (603)
..++|+|...|...|. +.++||.|.||.||+|+++- ...||||.+|... .....+|+.|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 3567877666655553 45789999999999999863 3689999999874 45668999999999999
Q ss_pred CCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 316 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
+||||++|.|+.......+||+|||+||+|+.||..+.+ .++|.+...++.+||.|+.||-.. ++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 999999999999999999999999999999999987754 499999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEeeccCcccccccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcch
Q 007442 396 LDYNFKSKVADFGLSRLGMTEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNE 472 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~ 472 (603)
++.++..||+||||+|...++... .+....-..+|.|||.+...++|.+|||||||||+||.++ |.+|+.....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--- 840 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--- 840 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---
Confidence 999999999999999986554322 2233345679999999999999999999999999999987 7777643222
Q ss_pred hhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 473 VNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 473 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..+++.+.+|- +-..+++++..|.+|++.||++|..+||.+.+|+..|+++.+.+
T Consensus 841 ----QdVIkaIe~gy---------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 841 ----QDVIKAIEQGY---------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ----HHHHHHHHhcc---------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 23444554431 23457889999999999999999999999999999999998754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=362.21 Aligned_cols=201 Identities=30% Similarity=0.494 Sum_probs=180.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.+|...+.||+|+|++||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||+|++++...+..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777888999999999999986 4789999999876 56666778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------CcEEEeeccCccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN------FKSKVADFGLSRL 412 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~------~~~kl~DFGla~~ 412 (603)
||.+|+|.+||+.+. .+++.....++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999998764 599999999999999999999999 99999999999999765 4589999999997
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCC
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP 469 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~ 469 (603)
... ........|++-|||||+++..+|+.|+|+||.|++|||+++|+.||+...+
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 543 2334556899999999999999999999999999999999999999985443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=378.81 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=211.2
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..|...++||+|||.+||+++. ..|..||+|.+.+. .....+.+.+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 78999999999763 3455688999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
|+|++|+|..++++ .+++++.+...+..||+.||.|||+. +|+|||||..|+||++++++||+|||||.....+.
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999983 46799999999999999999999999 99999999999999999999999999998754432
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......|||.|+|||++.....+..+||||+|||||-||.|+.||+... .......++....
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y--------- 235 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEY--------- 235 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCc---------
Confidence 33455689999999999999899999999999999999999999996321 1222233332211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+.....+..+|+..+|+.+|.+|||+.+|+..
T Consensus 236 -------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112345567899999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=350.17 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=209.1
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeee-EeecCc-eEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGC-SIERGE-QILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~-~~~~~~-~~lV~ 337 (603)
+|.+.++||+|.||+|||+.. .+|..||.|.++-. +....++...|+.+|++|+|||||++++. +.++.+ +.|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 455677899999999999975 68999999999843 56667889999999999999999999994 444444 88999
Q ss_pred eeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINP-PIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~-~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
||+..|+|.+.++..+ .+.+++...|+++.|+++||.++|+.... -|+||||||.||+|++++.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997543 34599999999999999999999994322 38999999999999999999999999999854
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......+|||.||+||.+....|+.||||||+||++|||..-+.||... ++ ...-+.+.+|....+.|.
T Consensus 180 s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~-~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 180 SK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NL-LSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred ch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cH-HHHHHHHHcCCCCCCcHH
Confidence 43 23345668999999999999999999999999999999999999999743 22 233456667755443332
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
-.+..+.+|+..|+..||+.||+.-.++..+
T Consensus 252 --------------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 252 --------------HYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --------------HhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 2455788999999999999999965444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=359.16 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=205.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
.+.|...+.||+|+||.|-+|..+ +|+.||||+++.... .....+.+|+++|++|+|||||++++++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345677889999999999999864 689999999976421 123446799999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccC
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGL 409 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGl 409 (603)
.|||+||+.+|.|.+++-.+.. +.+..-..++.|++.|+.|||+. +|+||||||+||||..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999987543 66666788999999999999999 99999999999999665 7899999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCC---CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFH---LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
|+... ....+....||+.|.|||++.+.. +..|.|+||+|||||-+++|..||....... ...+.+.+|
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKG 397 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcC
Confidence 99743 345566779999999999998653 3348899999999999999999997543321 123444455
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+... .+....+..++..+|+.++|..||++|||+.|+++
T Consensus 398 ~y~f------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYAF------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccc------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 4422 11233456778999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=372.21 Aligned_cols=267 Identities=25% Similarity=0.411 Sum_probs=216.2
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
.++++..-+.+.....||+|.||+||+|++.+ .||||.++.. ..+..+.|.+|+.++++.+|.||+-+.|||...+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35555555666677899999999999999976 4999999865 4567899999999999999999999999999887
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
. .||+-++++-+|+.|||-.+ ..++..+.++||.|||+|+.|||.+ +|||||||+.||||.+++++||+||||+.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 7 99999999999999999764 4589999999999999999999999 99999999999999999999999999986
Q ss_pred cccc-cccceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 412 LGMT-EISHISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 412 ~~~~-~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
.-.. ..........|...|||||+++. .+|+..|||||||+|+|||+||..|+. ....+.. +-.+.+|.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI------ifmVGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI------IFMVGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe------EEEecccc
Confidence 5211 11122233457889999999874 479999999999999999999999987 2222221 11122332
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+. .|.. .....+.++|.+|+..||.+++++||.+.+|+..|+.+...
T Consensus 610 l~--pd~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LM--PDLS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cC--ccch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 21 1211 12345678899999999999999999999999999887653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=407.07 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=218.0
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
...|...+.||+|+||.||+|+. .++..||||+++..... ...|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 44677888999999999999997 57899999999754322 23468899999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.++++. ++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.......
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999999952 8999999999999999999997777799999999999999999988876 666543211
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....+|+.|+|||++.+..++.|+|||||||++|||+||+.|++.... .......|............++|+.+..
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 911 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG- 911 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC-
Confidence 1223688999999999999999999999999999999999999864322 2234556665555555566677776643
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......++..++.+++.+||+.+|++||+|.||+++|+++...
T Consensus 912 ---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 912 ---DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ---CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 1123446677899999999999999999999999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=362.90 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=206.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
..++|...++||+|+||.||+|.+ .++..||||+++... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788889999999999999974 234689999997643 34456799999999999 8999999999887654
Q ss_pred -ceEEEEeeCCCCCHHHHhhhhc---------------------------------------------------------
Q 007442 332 -EQILVYEFMPNGTLCQHLQRER--------------------------------------------------------- 353 (603)
Q Consensus 332 -~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 353 (603)
..++||||+++|+|.++|....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5789999999999999997532
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc-eeccCCCCCC
Q 007442 354 ---GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPG 429 (603)
Q Consensus 354 ---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~ 429 (603)
..++++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 12488899999999999999999998 9999999999999999999999999999864322211 1223356788
Q ss_pred CcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccch
Q 007442 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTL 508 (603)
Q Consensus 430 Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 508 (603)
|+|||++.+..++.++||||||++||||++ |+.||....... .+...+..+.... ...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~---------------~~~ 300 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR---------------APE 300 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC---------------CCC
Confidence 999999999999999999999999999997 888886432211 1122222222111 011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 509 ASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 509 ~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.....+.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=349.24 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=202.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
-++|+..++||+|+||+||.++.+ +++.+|+|.+++. .....+...+|..+|.+++||.||+|+-.|.+.+.++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357888999999999999999875 4789999999865 334567788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
+||+.||.|..+|+++. .+++....-++.+|+.||.|||+. +||||||||+|||||++|+++|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998753 488888888999999999999999 9999999999999999999999999999964333
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
...+....||+.|||||++....|+..+|.||+|+++|||++|..||..... ....+.+.++++..
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k~~~------ 244 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGKLPL------ 244 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCcCCC------
Confidence 2334457999999999999999999999999999999999999999974321 22233444443111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCC
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP 530 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 530 (603)
.+.-...+..+++.+.|+.+|++|-
T Consensus 245 ---------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 ---------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 0111234677899999999999995
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=368.63 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=212.0
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC--C--cE-EEEEEecc---CChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN--D--LL-VAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~--~--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
.++-...++||+|+||.||+|++.. + .. ||||..+. ...+.+.+|++|+++|++++|||||+|+|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444445899999999999999753 2 23 89999985 347788999999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
++||||+++||+|.+||..... .++..++++++.++|.||+|||++ ++|||||.++|+|++.+..+||+||||++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999987643 699999999999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHh-hcCCccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRI-SKGRLDE 490 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~~ 490 (603)
... .........-..+|+|||.+..+.|+.++|||||||++||+++ |..|+..... . .+...+ ..+...
T Consensus 312 ~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~-~v~~kI~~~~~r~- 382 (474)
T KOG0194|consen 312 GSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------Y-EVKAKIVKNGYRM- 382 (474)
T ss_pred Ccc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------H-HHHHHHHhcCccC-
Confidence 431 1111112246789999999999999999999999999999999 6777653211 1 222333 222111
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhccc
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTM 547 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~~ 547 (603)
..+...+.++..++.+||..+|++||+|.+|.+.|+.+.....
T Consensus 383 --------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 --------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1122345678889999999999999999999999999876544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=386.79 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=215.4
Q ss_pred CCCccCcccCCCceEEEEEEEcC--C----cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN--D----LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~--~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
+.+..+.||+|.||.||.|...+ + ..||||.++.. +.+...+|.+|..+|+.++|||||+++|+|.+.+.++|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999999754 3 35999999876 56778899999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 336 VYEFMPNGTLCQHLQRER-----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
++|||++|+|..||.+.+ ...|+....+.++.|||+|+.||+++ ++|||||..+|+||++...+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998753 23489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccC-CCCCCCcCccccccCCCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 411 RLGMTEISHISTAP-QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 411 ~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+...+...+..... .-..+|||||.+..+.+|.|||||||||+||||+|. ..|+.. .+........+..|++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~------~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS------RSNFEVLLDVLEGGRL 923 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC------cchHHHHHHHHhCCcc
Confidence 95444333332222 334689999999999999999999999999999995 445432 2222333334445543
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhccc
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTM 547 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~~ 547 (603)
. .+..++..+.+|+..||+.+|++||++..+++.++.+.....
T Consensus 924 ~----------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 924 D----------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred C----------------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 2 244678889999999999999999999999999999876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.13 Aligned_cols=254 Identities=29% Similarity=0.417 Sum_probs=205.4
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC--ceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG--EQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 338 (603)
.++...+.||+|.||+||++...+ |...|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456678899999999999999865 8899999998764444677899999999999999999999855544 5889999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCcccccc--
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMT-- 415 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~~~~-- 415 (603)
|+++|+|.+++.+..+ .|++....+++.||++||+|||++ +|+|+||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998765 799999999999999999999998 9999999999999999 79999999999986442
Q ss_pred cccceeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.........+||+.|||||++..+. ...++|||||||+++||+||+.||... .....+......++....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~---- 243 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE---- 243 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC----
Confidence 2223344578999999999998643 335999999999999999999998642 111222222222221111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.+...+.+..+++.+|++.+|++|||+.|+++..
T Consensus 244 -----------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 244 -----------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1222455778899999999999999999988654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.38 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=207.9
Q ss_pred CCCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhh---HHHHHHHHHHHhccCCCceeeee
Q 007442 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDG---IQQVVNEIKLISCVSHPNLVRLL 324 (603)
Q Consensus 248 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~ 324 (603)
+++.++.++++ +.....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++|||||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 45556666663 33346799999999999998 67899999998653322 57788999999999999999999
Q ss_pred eeEee----cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 325 GCSIE----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 325 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
|++.+ ....++||||+++|+|.+++... ..++|..+++++.+++.||+|||+.. +++||||||+|||+++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence 99877 34678999999999999999764 45899999999999999999999742 688999999999999999
Q ss_pred cEEEeeccCcccccccccceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 401 KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 161 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~ 230 (283)
T PHA02988 161 KLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEI 230 (283)
T ss_pred cEEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHH
Confidence 9999999998753221 123468899999999976 6899999999999999999999999974321 111
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
. ..+..+.... ..+......+.+++.+||+.||++||||.||++.|+.+.
T Consensus 231 ~-~~i~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 Y-DLIINKNNSL--------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred H-HHHHhcCCCC--------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1111111100 011134567889999999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=345.02 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=202.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-----------------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRL 323 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 323 (603)
.+|...++||+|+||.||++.+++ +..||+|.++... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999998643 2479999998653 4455789999999999999999999
Q ss_pred eeeEeecCceEEEEeeCCCCCHHHHhhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007442 324 LGCSIERGEQILVYEFMPNGTLCQHLQRER-----------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH 386 (603)
++++.+.+..+|||||+++|+|.+++.... ...++|..+++++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999986532 12478999999999999999999998 9999
Q ss_pred cCCCCCCeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCC--Cc
Q 007442 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITAL--KV 463 (603)
Q Consensus 387 ~Dik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~--~p 463 (603)
|||||+|||+++++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975332211 1222344678999999999889999999999999999999754 45
Q ss_pred cCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 464 VDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 464 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
+...... .........+........ ......++..+.+|+.+||+.+|++||||.||.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVY------------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcccccc------------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5422111 111111111111100000 00112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.92 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=209.8
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...++||+|+||.||+|...++..||+|.++... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5677889999999999999998888899999987543 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++.......+++..++.++.+++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999876566799999999999999999999998 999999999999999999999999999986433222222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||++....++.++||||||+++|||+| |+.|+...... .....+..+....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------- 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGYRMP---------- 224 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCCCC----------
Confidence 33446778999999998899999999999999999998 88887532111 1122222221100
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.....+.++.+++.+||+.+|++||++.++.+.|+++
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 -----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.79 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=206.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778889999999999999864 35789999998653 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...++|..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999764 34689999999999999999999998 9999999999999999999999999987653222
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.........++..|+|||++.+..++.++||||||+++||+++ |+.||...... ...+.+.++...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~~------ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFRL------ 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCC------
Confidence 1111222345678999999999999999999999999999875 98888633221 122223322111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
......+..+.+++.+||+.+|++||++.||.+.|+++
T Consensus 228 ---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01123455788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.82 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=202.6
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.|...+.||+|+||+||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366788999999999999987 468999999987542 2334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 99999999998765455699999999999999999999998 9999999999999999999999999999763221
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......||..|+|||++.+..++.++||||||++||||++|+.||........ .......+....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~----------- 221 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ----------- 221 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc-----------
Confidence 122345689999999999999999999999999999999999999975332211 111111111111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
..........+.+|+.+||+.+|++||+ +.|+++
T Consensus 222 -----~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -----EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111223457889999999999999997 677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.81 Aligned_cols=248 Identities=32% Similarity=0.489 Sum_probs=196.4
Q ss_pred cCcccCCCceEEEEEEEc-----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKLQ-----NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+.||.|.||.||+|.+. .+..|+||.++.. ..+..++|.+|++.+++++||||++++|++.+.+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 567999999999999987 2478999999764 3445789999999999999999999999999888899999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc-cccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-EISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~-~~~~ 419 (603)
++|+|.++|.......+++..++.|+.|+|.||+|||+. +|+|+||+++|||+++++.+||+|||+++.... ....
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999987556799999999999999999999998 999999999999999999999999999986422 1122
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
..........|+|||.+....++.++||||||+++|||++ |+.|+... .. ..+...+.++.....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~-~~~~~~~~~~~~~~~------- 226 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DN-EEIIEKLKQGQRLPI------- 226 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CH-HHHHHHHHTTEETTS-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc------cc-cccccccccccccee-------
Confidence 2333457788999999999889999999999999999999 56676422 11 112233333322111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.......+.+++.+||+.+|++||+|.++++.|
T Consensus 227 --------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 --------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112355688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.73 Aligned_cols=269 Identities=23% Similarity=0.326 Sum_probs=207.7
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 337 (603)
.|+..++||+|.||.||||+. .+|+.||+|+++... ........+||.||++|+||||++|.+...+. +..|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 345566799999999999985 578999999998664 34456678999999999999999999998876 6899999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
|||++ +|..++... .-.++..+...++.|++.||+|+|+. +|+|||||.+|||||.++.+||+|||||+++....
T Consensus 198 eYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99976 788887643 34699999999999999999999999 99999999999999999999999999999877666
Q ss_pred cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH-----HhhcCCcc--
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD-----RISKGRLD-- 489 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~-----~~~~~~~~-- 489 (603)
....|..+-|.-|.|||.+.+. .|+.+.|+||.||||.||++|+..+......++......+-. .|...++.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 6667888899999999998865 799999999999999999999888865444333222111100 01111111
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+.+.-...+ ...+.........++|+..+|..||.+|.|+.++++
T Consensus 353 ~~~kp~~~y~r-~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKR-RLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccc-hHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111110000 001112334566789999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.40 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=209.9
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+.|+....||.|.-++||+|+. ..+..||||++.... ....+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5677888999999999999986 457999999998653 33468899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc-
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS- 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~- 418 (603)
|.+|++.+.+...-...+++..+..|..++++||.|||.+ +.||||||+.|||||.+|.+||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999988777899999999999999999999999 999999999999999999999999998765433211
Q ss_pred --ceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 419 --HISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 419 --~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......+||+.|||||++.. ..|+.|+||||||+..+||.+|..||....+ .......+ ++......-.
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tL-qn~pp~~~t~ 255 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTL-QNDPPTLLTS 255 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHh-cCCCCCcccc
Confidence 11155689999999999543 3699999999999999999999999964322 11112222 2222111100
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ...+........+.+++..||+.||++|||+.++++
T Consensus 256 ~------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 G------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred c------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 111223345568999999999999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.37 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=204.3
Q ss_pred hcCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
.++|...+.||+|+||+||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45678889999999999999974 235689999997543 34456789999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhc-----------------------------------------------------------
Q 007442 333 QILVYEFMPNGTLCQHLQRER----------------------------------------------------------- 353 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 353 (603)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999996432
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 354 --------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 354 --------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
...++|..+++++.|++.||+|||+. +|+||||||+|||++++..+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478999999999999999999998 9999999999999999999999999999764322211
Q ss_pred -eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 420 -ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 420 -~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......++..|+|||++.+..++.++||||||+++|||++ |..||...... ....+.+..+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~------- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRML------- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCC-------
Confidence 1122345678999999999999999999999999999998 77777532211 11122222221100
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.......++.+|+.+||+.+|++||+|.||++.|++.
T Consensus 338 --------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 --------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.12 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=203.9
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||.||++.++++..+|+|.++... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3467778899999999999999888899999987543 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.++++... ..++|..++.++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999997543 3589999999999999999999998 999999999999999999999999999876433222222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... . .....+.++... ..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~-~~~~~i~~~~~~--~~~------ 223 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------Y-EVVEMISRGFRL--YRP------ 223 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------H-HHHHHHHCCCCC--CCC------
Confidence 23345678999999998889999999999999999999 8888753221 1 112222222110 011
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
......+.+++.+||+.+|++||+|.|+++.|
T Consensus 224 -------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 -------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=334.89 Aligned_cols=255 Identities=29% Similarity=0.404 Sum_probs=207.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||+|... .++.||+|.++.. ....+++.+|++++.+++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677889999999999999875 4788999998754 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++.......++|..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999766556699999999999999999999998 99999999999999999999999999998643322222
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......+..|+|||++.+..++.++||||||+++|||++ |..|+..... . .....+..+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~-~~~~~~~~~~~~---------- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------S-QVYELLEKGYRM---------- 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------H-HHHHHHHCCCCC----------
Confidence 222334678999999999999999999999999999998 8888753211 1 111222221100
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
......+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 225 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=352.25 Aligned_cols=238 Identities=27% Similarity=0.390 Sum_probs=197.8
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
.+-||.|+.|-||.|++++ +.||||+++... ..+|+.|++|+|+||+.|.|+|.....++||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 5679999999999999975 489999987532 34788999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCC
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 426 (603)
..|... .+++-.....|..+||.|+.|||.+ .|||||||+-||||..+..+||+|||.++...+ . .......|
T Consensus 201 ~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~-~-STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD-K-STKMSFAG 273 (904)
T ss_pred HHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh-h-hhhhhhhh
Confidence 999764 4588888899999999999999999 999999999999999999999999999986332 2 34456789
Q ss_pred CCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCcc
Q 007442 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAG 506 (603)
Q Consensus 427 t~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 506 (603)
|..|||||++++.+.++|.|||||||||||||||..|+...... ..+|. +..+.+ .-..
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwG-VGsNsL--------------~Lpv 332 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWG-VGSNSL--------------HLPV 332 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEe-ccCCcc--------------cccC
Confidence 99999999999999999999999999999999999998532110 00000 000000 0122
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 507 TLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 507 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
+..+++-+.-|+.+||+..|.+||++++++..|+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 3456778889999999999999999999998875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.99 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=209.1
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..++|...+.||+|+||.||+|...+++.||||.++... ...++|.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688889999999999999998888899999997653 3357789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++.......++|..++.++.+++.||.|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999766555699999999999999999999998 9999999999999999999999999999864422211
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......+..|+|||++.+..++.++||||||+++|||+| |+.|+..... ......+..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~--------- 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGYRM--------- 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC---------
Confidence 1122233468999999999899999999999999999999 8888753211 1111222221100
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.........+.+++.+||+.+|++||+|.++.+.|+.+
T Consensus 224 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=350.45 Aligned_cols=264 Identities=29% Similarity=0.410 Sum_probs=221.6
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
++++--..+....++||-|-||.||.|.++. ...||||.++.. ....++|+.|+.+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444444556678899999999999999975 578999999875 45679999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
|||+|||.+|+|.+||.......++-...+.+|.||+.|++||..+ ++|||||..+|.|+.++..+||+||||+|++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999987777799999999999999999999999 9999999999999999999999999999997
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
..+.........-.+.|.|||-+....++.|||||+|||+||||.| |..|+.. +.+. .+...+.+|.
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlS-qVY~LLEkgy----- 483 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLS-QVYGLLEKGY----- 483 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHH-HHHHHHhccc-----
Confidence 6655444444456789999999999999999999999999999998 6666532 2222 2223333332
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
+.+.+..|+..+.+|+..||+.+|.+||++.|+-+.+|.+..
T Consensus 484 ----------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 484 ----------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ----------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 112344578899999999999999999999999999988753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=336.47 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=213.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.+..+|...++||.|+||.||+|...++..+|+|.++.......+++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34566888899999999999999998899999999987766667889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.+++.......++|..++.++.+++.||+|||+. +|+|+||||+|||+++++.+||+|||++...... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-V 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc-c
Confidence 99999999999876666799999999999999999999998 9999999999999999999999999999764322 1
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......++..|++||++....++.++||||||++++||++ |+.|+...... . ....+..+...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~-------- 223 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------E-VYDQITAGYRM-------- 223 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------H-HHHHHHhCCcC--------
Confidence 22223456778999999988899999999999999999998 78887532211 1 11111111100
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11123445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.16 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=205.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
.++|...+.||+|+||.||+|... ++..||||+++... .+..+.+.+|+.+++.+ +|+|||+++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 356888899999999999998742 33589999997643 34456788999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhc-----------------------------------------------------------
Q 007442 333 QILVYEFMPNGTLCQHLQRER----------------------------------------------------------- 353 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 353 (603)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986431
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc-ceecc
Q 007442 354 ---------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTA 423 (603)
Q Consensus 354 ---------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~ 423 (603)
..+++|...++|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478899999999999999999998 999999999999999999999999999975432211 11222
Q ss_pred CCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....... .....+..+...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~------------- 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQM------------- 334 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCc-------------
Confidence 345678999999998899999999999999999997 998886432211 111111111000
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
......+.++.+++.+||+.+|++||++.+|+++|+++.
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 --SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001112457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=348.91 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=209.9
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.|..-.+||+|+.|.||.+.- .+++.||||++........+-+++|+.+|+..+|+|||+++.-|...+++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 355567899999999999975 5678999999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.|.+.... +++.+...|+.+++.||+|||.. +|+|||||++||||+.++.+||+|||++..+..+.. ..
T Consensus 354 ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999997543 99999999999999999999999 999999999999999999999999999987544333 45
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....||+.|||||+.....|+.|.||||||++++||+-|+.||-...+-. + ...+...-..++-
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr----A---lyLIa~ng~P~lk--------- 490 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----A---LYLIATNGTPKLK--------- 490 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH----H---HHHHhhcCCCCcC---------
Confidence 66689999999999999999999999999999999999999986433321 1 1122221111111
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.++..+||+.|+++||++.|+++.
T Consensus 491 ----~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 ----NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 122345678899999999999999999999863
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.11 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=207.9
Q ss_pred cCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|+..+.||+|+||+||+|.+.. ...||||.++... .....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998753 4689999987653 34457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc-
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT- 415 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~- 415 (603)
|||+++|+|.+++.... ..++|..+++++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999997653 3689999999999999999999998 999999999999999999999999999987542
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
..........++..|+|||++.+..++.++||||||+++|||++ |..|+..... ......+.++....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRLP---- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCC----
Confidence 22222223345678999999998899999999999999999998 8888753211 11122222221100
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.....+..+.+++.+||+.+|++||++.||++.|+++
T Consensus 229 -----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.33 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=207.3
Q ss_pred CCCccCcccCCCceEEEEEEEcCC------cEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQND------LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
+|...+.||+|+||.||+|..... ..||+|.++... ....++|.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 567788999999999999986432 579999997543 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 336 VYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
+|||+++|+|.+++..... ..+++...+.++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999975421 3488999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHH
Q 007442 402 SKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALA 479 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~ 479 (603)
+||+|||+++...... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~~ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EV 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence 9999999997543221 122233456789999999998899999999999999999998 98888643221 11
Q ss_pred HHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
...+..+.... .....+.++.+|+.+||+.+|.+||++.||++.|+.+
T Consensus 236 ~~~i~~~~~~~---------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLLP---------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcCC---------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 22233322211 1123456889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=322.78 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=202.7
Q ss_pred CCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.|+...++|+|+||+|||.+.++ |+.||||++..... ...+-.++||++|++++|+|||.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999875 89999999987633 3345568999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++.--|+ -|... ...++.....+++.|++.|+.|+|++ ++|||||||+||||+.++.+||+|||+||.... ...
T Consensus 83 ~dhTvL~-eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 83 CDHTVLH-ELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred cchHHHH-HHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9774444 44433 34589999999999999999999999 999999999999999999999999999997543 334
Q ss_pred eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh-----------cC-
Q 007442 420 ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS-----------KG- 486 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~~- 486 (603)
..|..+.|.-|.|||.+.+ -+|+...|||+.||++.||++|..-|.....-+... .+...+. ..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy---~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY---LIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH---HHHHHHcccCHHHHHHhccCC
Confidence 4567788999999999987 689999999999999999999987775433222222 1111111 11
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+..+.=|.... ....+.........+++++..||+.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~-~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEH-PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCC-ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111100 00011112334557899999999999999999999874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.50 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=205.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...+.||+|+||+||+|++. ++. .||||.++... ....++|.+|+.+++.++||||++++|+|... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 333 48999997543 34567899999999999999999999999764 5779
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997643 4589999999999999999999998 999999999999999999999999999986443
Q ss_pred cccce-eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EISHI-STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.|++..... . ....+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~---- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL---- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC----
Confidence 22221 122335678999999999999999999999999999998 88887532111 1 11122221100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.....+...+.+++.+||+.+|++||++.+++..|..+....
T Consensus 231 -----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 -----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001123456889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=330.96 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=203.8
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+|...+.||+|+||+||+|...++..+|||.++.... ..++|.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4666788999999999999988777899999875432 346799999999999999999999999999899999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++.... ..++|..++.++.+++.||+|||+. +++|+||||+|||+++++.+||+|||+++...........
T Consensus 84 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 84 GCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999997643 3689999999999999999999998 9999999999999999999999999998764332222222
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...++..|++||++.+..++.++||||||+++|||++ |+.|+...... .....+..+....
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~----------- 221 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLRLY----------- 221 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCCCC-----------
Confidence 3346678999999998889999999999999999999 88887532211 1112222221110
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
........+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112457889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=335.28 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=211.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||++... ++..+|+|.++.......+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999852 346799999987766677889999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 007442 336 VYEFMPNGTLCQHLQRER-----------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl 404 (603)
||||+++++|.+++.... ...++|..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 12489999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHH
Q 007442 405 ADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 405 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
+|||+++....... .......++..|+|||++.+..++.++||||||++++||+| |+.|+..... ......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence 99999975432211 11223345788999999998899999999999999999999 8888753221 112233
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+..+..... .......+.+|+.+||+.+|.+|||+.||+..|+.+...
T Consensus 235 i~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQR---------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCC---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 333322111 112345689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.30 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=208.0
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCceeeeeeeEeec
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIER 330 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 330 (603)
...++|...++||+|+||.||+|+... +..||||+++... ....+.|.+|+++|+++. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 335678888999999999999998631 3479999997643 334567999999999996 99999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhc---------------------------------------------------------
Q 007442 331 GEQILVYEFMPNGTLCQHLQRER--------------------------------------------------------- 353 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 353 (603)
+..+|||||+++|+|.++|+...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999986531
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 354 -------------------------------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 354 -------------------------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
...++|..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478899999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~ 474 (603)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++||||++ |..|+......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---- 346 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---- 346 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----
Confidence 99999999999999764332221 1223346788999999998899999999999999999997 88887532211
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..+...+..+... .........+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 347 --~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 --STFYNKIKSGYRM---------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHHhcCCCC---------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1112222222110 0112235578899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.51 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=211.1
Q ss_pred CCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4667789999999999999753 3467999999877666678899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
|||+++++|.+++.... ...++|..++.++.+++.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999997542 13489999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||+| |+.|+...... ...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVI 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHH
Confidence 999999997533221 112233456788999999999999999999999999999999 88887543221 122
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+.+..+...+. ....+..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 236 ~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLER---------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCC---------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 23333322211 112345788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.72 Aligned_cols=256 Identities=27% Similarity=0.332 Sum_probs=209.1
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC----Ch-hhHHHHHHHHHHHhccC-CCceeeeeeeEeecC
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR----DT-DGIQQVVNEIKLISCVS-HPNLVRLLGCSIERG 331 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 331 (603)
....+|...+.||+|.||+|+.|... ++..||||.++.. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567888999999999999999764 6799999977653 12 23456668999999999 999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLS 410 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla 410 (603)
..++||||+.+|+|.+++.. ..++.+....+++.|++.|++|+|+. +|+||||||+|||||.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999987 34588999999999999999999999 99999999999999999 99999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCC-CC-cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFH-LS-DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +...... .+..+..
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~-ki~~~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYR-KIRKGEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHH-HHhcCCc
Confidence 8753 2234456678999999999999876 76 6899999999999999999999851 1122211 2333322
Q ss_pred ccccchhhhhccCCCCccchHH-HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 489 DEIIDPLIIEHRGHSDAGTLAS-VHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
. .+... ..++..|+.+||..+|.+|+++.||+ .-.-++.
T Consensus 241 ~----------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 241 K----------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred c----------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 11112 55788999999999999999999999 4444443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=338.06 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=205.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||.||+++.. ++..||+|.++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999986 5788999998765 33445789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.+++... ..+++..+..++.+++.||+|||+.. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999999764 34899999999999999999999852 6999999999999999999999999998753221
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc----------
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL---------- 488 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------- 488 (603)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+......+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccCccc
Confidence 223446899999999999989999999999999999999999998632221 111111110000000
Q ss_pred --------------------ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 --------------------DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 --------------------~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+..+...... ...........++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0000111245678999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=334.76 Aligned_cols=271 Identities=20% Similarity=0.219 Sum_probs=201.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+++.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888899999999999999986 57899999997542 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++++.|..+... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998777655432 34589999999999999999999998 999999999999999999999999999986433222
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH--------HHH-hhcCCcc
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA--------ADR-ISKGRLD 489 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~--------~~~-~~~~~~~ 489 (603)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||............... ... .......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2223456899999999999889999999999999999999999998643221111000000 000 0000000
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+...................+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000001123557899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.98 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=204.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|++++.+++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999986 4789999999754 2234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999754 3589999999999999999999998 999999999999999999999999999975332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|+|||++.+..++.++||||||++||||++|+.||......+. ...+.... ..+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~--~~~~~~-- 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK--ETLQRP-- 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc--ccccCC--
Confidence 23345799999999999998999999999999999999999999864322111 11111100 000000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...........++.+++.+||+.+|++||++.|+++.
T Consensus 221 ----~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 ----VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000012335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.78 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=212.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.......++||+|-||.|.......+..||||.++..... ...+|.+||++|.+++|||||+|+|+|..++.+.+|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3445557889999999999999988899999999987544 458999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
|++|+|.+||..+....+.-..-++|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||++|.......+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999887544455667778999999999999999 9999999999999999999999999999965443333
Q ss_pred -eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh--CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 420 -ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT--ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 420 -~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
......-.++|||||.+..+++|.+||||+||++|||+++ ..+|+.....+.. .+-.......+....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~------ 764 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV------ 764 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce------
Confidence 3333455789999999999999999999999999999875 6667753222111 111111111111110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
....+.-++..+.+++.+||..+.++||+++++...|++.
T Consensus 765 ------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112345677899999999999999999999999988764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.53 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=207.1
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHH--HHHHHHHhccC-CCceeeeeeeEeecC-ceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQV--VNEIKLISCVS-HPNLVRLLGCSIERG-EQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~lV 336 (603)
++|...++||.|.||.||+|+. .++..||||+++..-.. +++. ++|++.|++|+ |||||+|..++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 5677788999999999999986 46889999999876332 3443 57999999999 999999999999988 99999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||| ..+|.+++..+ +..+++..+..|+.||.+||+|+|.+ |++|||+||+|||+..+..+||+||||||.. .
T Consensus 89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev--~ 161 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV--R 161 (538)
T ss_pred HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc--c
Confidence 9999 56999999876 67899999999999999999999999 9999999999999999999999999999963 3
Q ss_pred ccceeccCCCCCCCcCcccc-ccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc--
Q 007442 417 ISHISTAPQGTPGYLDPQYH-QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID-- 493 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 493 (603)
.....|..+.|.-|.|||++ +.+-|+.+.|+|++|+|++||.+-+.-|......++.... -+.+......++..
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCccccchhHH
Confidence 34456777899999999976 5678999999999999999999998877543332222221 12221111111100
Q ss_pred ---hhhhhccC-----CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 494 ---PLIIEHRG-----HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 494 ---~~l~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+.-... ...........+.++++.+|++.||++|||+.|.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000000 0111122367789999999999999999999998875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=341.02 Aligned_cols=241 Identities=24% Similarity=0.296 Sum_probs=196.5
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||.||++... +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 6789999999753 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceecc
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 423 (603)
+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 999999754 4589999999999999999999998 9999999999999999999999999998753221 122234
Q ss_pred CCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCC
Q 007442 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 503 (603)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~--------------- 212 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI--------------- 212 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC---------------
Confidence 5699999999999999999999999999999999999999863211 111111211111
Q ss_pred CccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 504 DAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 504 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
........++.+++.+||+.||++|| ++.|+++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 01112345688999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=333.90 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=205.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-----CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-----NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 334 (603)
.+|...+.||+|+||+||++..+ ++..||||+++.......+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999753 5789999999887777778999999999999999999999987543 4678
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+|+||+++|+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999754 24589999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 415 TEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 415 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
..... ......++..|+|||++.+..++.++||||||+++|||++|..+...... .+...+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 231 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--------EFMRMMGNDKQGQMI 231 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--------hhhhhcccccccccc
Confidence 32211 11122344569999999988999999999999999999998766532110 011111111100001
Q ss_pred chhhhhc--cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 493 DPLIIEH--RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 493 d~~l~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
...+... ..............+.+|+.+||+.+|++||||.||++.|+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000000 00000111234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.37 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=202.3
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+|...+.||+|+||.||+|..+++..+|+|.++.... ..++|.+|++++++++||||+++++++.+.+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4667889999999999999988778899999875432 345788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
++|.+++.... ..++|..++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999997643 3689999999999999999999998 9999999999999999999999999999764322211222
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...++..|+|||++.+..++.++||||||+++|||++ |+.|++.....+ ....+..+...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------------ 220 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGYRL------------ 220 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcCCcC------------
Confidence 2234568999999998899999999999999999999 777775322211 11122221100
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
......+.++.+++.+||+.+|++||||.||++.|
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 ---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01112455789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=343.26 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=219.8
Q ss_pred cCCCccCcccCCCceEEEEEEEcC---C--cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN---D--LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~---~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
......++||.|-||.||+|.+.+ | -.||||..|.. +.+..+.|+.|..+|++++|||||+|+|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999998643 2 46999999874 56778999999999999999999999999965 57899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|||.++.|.|..||+.++ ..|+......++.||..||+|||+. ++|||||..+|||+...-.+||+||||+|...+
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998763 5699999999999999999999999 999999999999999999999999999999877
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
+..+..+...-.+.|||||.+...++|.+||||-|||.+||++. |.+||......+.. ..++.|
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnG-------- 608 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENG-------- 608 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCC--------
Confidence 77777676677889999999999999999999999999999986 89999754443221 111121
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.+...+..++..+..|+.+||+++|.+||.+.|+...|+.+..
T Consensus 609 -------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 -------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3345567788999999999999999999999999999988875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.73 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=204.4
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||.||+|...++..||+|.++.... ..+.|.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777889999999999999988888899999986533 3467999999999999999999999875 456889999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.++++......+++..++.++.+++.||+|||+. +|+||||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999875555699999999999999999999998 999999999999999999999999999976433222222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... . .....+..+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~-~~~~~~~~~~~~----------- 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------R-EVLEQVERGYRM----------- 222 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------H-HHHHHHHcCCCC-----------
Confidence 22345678999999988899999999999999999999 7777753211 1 111222211100
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.........+.+|+.+||+.+|++|||+.++.+.|++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=339.19 Aligned_cols=241 Identities=25% Similarity=0.339 Sum_probs=195.1
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||+||++... +++.||+|.++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999986 4789999999753 334556788999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ........
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccccc
Confidence 9999764 3589999999999999999999998 9999999999999999999999999999853222 22233456
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..+..+.. .
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~-~~~~~~~~----------------~ 211 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMY-RKILQEPL----------------R 211 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHH-HHHHcCCC----------------C
Confidence 99999999999999999999999999999999999999863211 1111 12212111 0
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
........+.+++.+||+.+|++||++..+.+.|
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1112345678899999999999998754444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.44 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=207.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
.+|...+.||+|+||.||+|...+ +..||||.++..... ..+.|.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998743 478999999876444 5678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 335 LVYEFMPNGTLCQHLQRER------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+||||+++|+|.++|.... ...+++...+.++.+++.||+|||+. +++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997542 13489999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++...... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence 999999987532211 112233346788999999999999999999999999999999 98887533221 112
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
..+..+..... .......+.+++.+||+.+|++||++.||++.|++
T Consensus 235 ~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLLQR---------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22223322111 11234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=336.47 Aligned_cols=243 Identities=26% Similarity=0.331 Sum_probs=199.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999986 57899999997532 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999999754 3589999999999999999999998 9999999999999999999999999998764321
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....||+.|+|||++.+..++.++||||||++||||++|+.||..... ....+.+..+...
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~-------- 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKLE-------- 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcC--------
Confidence 2234689999999999988899999999999999999999999864221 1112222222210
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVA 536 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~ 536 (603)
........+.+|+.+||+.||.+||+ +.|++
T Consensus 217 --------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 217 --------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred --------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 11122446789999999999999995 66555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.18 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=205.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.+|...++||+|+||.||+|+..+...||+|+++.... ..++|.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888899999999999999987777899999986432 3467899999999999999999999874 456899999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++.......++|..++.++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999865555689999999999999999999998 999999999999999999999999999976433222222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|++||+..+..++.++||||||+++|||+| |+.|+...... .....+..+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~------------ 221 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR------------ 221 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCC------------
Confidence 23346778999999998899999999999999999999 77777532111 11112211110
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.......+..+.+|+.+|++.+|++||++.++++.|+..
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.97 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=208.9
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEe
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSI 328 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 328 (603)
++...++|...+.||+|+||.||++...+ ...+|+|.++.. ......++.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34445678888999999999999998642 368999999754 334456789999999999 7999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRE--------------RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNI 394 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NI 394 (603)
+.+..++||||+++|+|.++++.. ....++|..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999999753 134589999999999999999999998 999999999999
Q ss_pred eecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcch
Q 007442 395 LLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNE 472 (603)
Q Consensus 395 Lld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~ 472 (603)
|+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999999986433221 11223345678999999988899999999999999999998 88777532111
Q ss_pred hhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 473 VNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 473 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
...+.+..+... .........+.+|+.+||+.+|++||||.||++.|+.+.
T Consensus 242 -----~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 -----ELFKLLKEGYRM---------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHHcCCcC---------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111222222110 111233457889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.80 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=204.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
.++++|+..+.||+|+||.||+|... .+..||||+++... .....+|.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999763 24679999986542 334567899999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 007442 332 EQILVYEFMPNGTLCQHLQRERG--------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSK 403 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~k 403 (603)
..++||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 99999999999999999975321 2368899999999999999999998 999999999999999999999
Q ss_pred EeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHH
Q 007442 404 VADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 404 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~ 481 (603)
|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+...... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHH
Confidence 999999875332211 11223345788999999998899999999999999999999 56776532211 1112
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.+..+..... .......+.+++.+||+.+|++||++.|+++.|++
T Consensus 233 ~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222211110 11234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.45 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=196.0
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||.||++... ++..||+|.++.. .......+.+|+.++++++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 6889999999754 2344567789999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceecc
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 423 (603)
+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 999998754 3589999999999999999999998 9999999999999999999999999998753221 112234
Q ss_pred CCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCC
Q 007442 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 503 (603)
..||+.|+|||++.+..++.++||||||++||||++|+.||...... . ....+..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~~~~~~~--------------- 212 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------R-LFELILMEEI--------------- 212 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCC---------------
Confidence 56999999999999999999999999999999999999998632211 1 1111111111
Q ss_pred CccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 504 DAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 504 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
..+.....++.+++.+||+.+|++|| ++.++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 01112345678999999999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=338.01 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=205.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
-++|...+.||+|+|++||+|+.. .++.+|||++.+. .....+-+..|-.+|.+| .||.|++|+-.|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 467888899999999999999865 5799999999754 223345566788999999 79999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||++||+|.++|++. ..+++.....+|.+|+.||+|||+. +||||||||+|||||+|+++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999876 3489999999999999999999999 999999999999999999999999999987543
Q ss_pred cccc----------ee--ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 416 EISH----------IS--TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 416 ~~~~----------~~--~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
.... .+ ...+||..|.+||++..+..+..+|+|+|||+||+|+.|+.||..... . ...+++
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---y----liFqkI 299 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---Y----LIFQKI 299 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---H----HHHHHH
Confidence 2111 11 346899999999999999999999999999999999999999963211 1 111121
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+ - .-+.+...++.+.+|+.+.|..||.+|+|..||.+.
T Consensus 300 ~~--------l--------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA--------L--------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH--------h--------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 0 012223344678899999999999999999888764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=324.04 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=209.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||.||+|+.. +++.||||.++.. +......|.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999875 6789999988642 3445567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++|+|.+++.... ...+++...+.++.+++.||+|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999986432 34588999999999999999999998 999999999999999999999999999876432
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.. .......+++.|+|||++.+..++.++||||||+++|||++|+.|+...... ... ....+.......
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~----- 227 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDYPP----- 227 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCCCC-----
Confidence 21 1122346888999999999888999999999999999999999998532211 111 112222211111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.........+.+++.+||+.+|++||++.||++.|++++
T Consensus 228 ---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 ---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011133467889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.11 Aligned_cols=243 Identities=28% Similarity=0.355 Sum_probs=199.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|+.. +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56778899999999999999986 5789999999753 2234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999999754 3588999999999999999999998 9999999999999999999999999999754221
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....+ ....+.+.++.+.
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~-------- 233 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLK-------- 233 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcC--------
Confidence 1234689999999999999999999999999999999999999863221 1112233333211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVA 536 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~ 536 (603)
.+......+.+|+.+||+.||++||+ +.+++
T Consensus 234 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 --------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 01112346788999999999999997 45555
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=323.83 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=207.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.++|...++||+|+||.||+|..++++.||+|.+..... ..++|.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 356778899999999999999998999999999986543 346889999999999999999999986 456789999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++....+..+++.+++.++.+++.||+|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999999876566799999999999999999999998 99999999999999999999999999997643222222
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....++..|+|||++....++.++||||||++++||++ |+.||...... .....+..+....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~--------- 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGYRMP--------- 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCCCCC---------
Confidence 233446788999999998899999999999999999999 88888632211 1111222211100
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.....+.++.+++.+||+.+|++||++.++...|+.
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=338.51 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=209.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|.||+||||+-+ +.+.||+|.+.+. ....++.+.+|++|+++++|||||.++++|....+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777888999999999999876 4689999999765 34456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+.+ +|+.+|... ..|++.....|+.++..||.|||+. +|+|||+||.||||+.++.+|++|||+|+... ...
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS-TNT 154 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc-cCc
Confidence 9976 999999865 4599999999999999999999999 99999999999999999999999999999743 345
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
...+...||+-|||||...+..|+..+|.||+||+|||+++|+.||... . .....+.+.....
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------s-i~~Lv~~I~~d~v---------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------S-ITQLVKSILKDPV---------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------H-HHHHHHHHhcCCC----------
Confidence 6677889999999999999999999999999999999999999998621 1 1122222222111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.++......+..++...|..||.+|-+..+++.
T Consensus 218 ------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123355667889999999999999999998764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=326.60 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=202.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||+||+|.+. +++ .+++|.+.... .....++..|+.++++++||||+++++++. ....+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 4566788999999999999874 343 48888886443 334567888999999999999999999875 4567899
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
+||+++|+|.+++... ...++|..++.|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999764 34599999999999999999999998 9999999999999999999999999999864332
Q ss_pred c-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 417 I-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 417 ~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
. ........++..|+|||++.+..++.++||||||+++|||++ |+.|+....+. ...+.+..+.... .+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA--QP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--CC
Confidence 2 122234457789999999998899999999999999999998 88887533221 1112222222111 01
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 234 -------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 -------------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11234578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.71 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=205.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec-C
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER-G 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 331 (603)
.++|...+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346788899999999999999642 24789999997543 33456788999999999 799999999988754 5
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcC---------------------------------------------------------
Q 007442 332 EQILVYEFMPNGTLCQHLQRERG--------------------------------------------------------- 354 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 354 (603)
..++++||+++|+|.++|.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce-eccCCCCCCCc
Q 007442 355 --DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI-STAPQGTPGYL 431 (603)
Q Consensus 355 --~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 431 (603)
.+++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2589999999999999999999998 99999999999999999999999999998643322211 22345677899
Q ss_pred CccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHH
Q 007442 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLAS 510 (603)
Q Consensus 432 aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 510 (603)
|||++.+..++.++|||||||+||||++ |+.||......+ .....+..+.... .....
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~---------------~~~~~ 301 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMR---------------APEYA 301 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCC---------------CCccC
Confidence 9999999999999999999999999998 888875422211 1122222221100 01123
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 511 VHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 511 ~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..++.+|+.+||+.+|++||++.||++.|+++..
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.42 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=196.2
Q ss_pred CCCccCcccCCCceEEEEEEEc--CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CCCceeeeeeeEee-----c
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ--NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCV---SHPNLVRLLGCSIE-----R 330 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~ 330 (603)
+|...+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++++ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999873 46889999987542 22234566777777665 69999999999852 3
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
...++||||++ ++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 46899999996 6999999876556699999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---C
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---R 487 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 487 (603)
+..... .......||+.|+|||++....++.++||||||+++|||++|+.||......+ ............ .
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEED 232 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhh
Confidence 753322 22334568999999999988899999999999999999999999987433221 111111111100 0
Q ss_pred ccc---ccchhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDE---IIDPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~---~~d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... .....+..... ............+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000000 000001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.28 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=206.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|++|.||+|... +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 5789999998643 345667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++.......+++..++.++.+++.||.|||+. +|+|+||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 9999999999876556799999999999999999999998 99999999999999999999999999987643321 1
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+..... ......+.++....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-------- 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPPV-------- 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC--------
Confidence 22334688999999999999999999999999999999999999864321 111222222221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++.+||+.+|++||+|.++++.
T Consensus 222 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11234578899999999999999999998863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.01 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=197.0
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||.||++... +++.||||.++.. .......+.+|+.+++.++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 5789999999754 2345577889999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceecc
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 423 (603)
+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 999998754 3589999999999999999999998 9999999999999999999999999998753221 112234
Q ss_pred CCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCC
Q 007442 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 503 (603)
..||+.|+|||++.+..++.++||||||++||||++|+.||...... .. ...+..+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~-~~~~~~~~~--------------- 212 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KL-FELILMEDI--------------- 212 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HH-HHHhccCCc---------------
Confidence 56999999999999889999999999999999999999998642211 11 111111110
Q ss_pred CccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 504 DAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 504 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
..+......+.+++.+||+.+|++|| ++.|+++.
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01112345678899999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=335.36 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=198.4
Q ss_pred CCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccC----ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCce
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHR----DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 333 (603)
+|...+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.++.+++ |+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4777889999999999998753 5789999999743 2233466888999999995 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999999754 3589999999999999999999998 9999999999999999999999999999864
Q ss_pred cccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
............||+.|+|||++.+. .++.++||||||++||||+||+.||........ ...+...+....
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~~----- 227 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKCD----- 227 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcCC-----
Confidence 33333333345799999999998865 478899999999999999999999964322111 111222221111
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
+ .........+.+++.+||+.||++|| ++.++++
T Consensus 228 -~----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 -P----------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -C----------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 01112345678899999999999999 5556654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.72 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=210.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|... +++.||+|.++.. +....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 7899999988643 3344678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++|+|.+++... ....+++..++.++.+++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998653 234589999999999999999999998 999999999999999999999999999875332
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.. .......++..|+|||++.+..++.++||||||+++|||++|+.|+..... ..... .+.+..+......
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~~~--- 229 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCDYPPLP--- 229 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCCCCCCC---
Confidence 21 112234688899999999988899999999999999999999999853221 11111 1222222111110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.......+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 230 -----------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 -----------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1133457889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=324.16 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=202.4
Q ss_pred CCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc-----
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE----- 332 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 332 (603)
|...+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|++.++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998753 367999999854 33456789999999999999999999999876554
Q ss_pred -eEEEEeeCCCCCHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 333 -QILVYEFMPNGTLCQHLQRER----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 333 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
.++|+||+++|+|.+++.... ...+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999986542 23589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 408 GLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 408 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
|+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..|+...... . ..+.+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~-~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------E-IYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHc
Confidence 999864332221 1222345678999999988899999999999999999999 77777532211 1 1222222
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
+.... ........+.+++.+||+.+|++||++.||++.|+++
T Consensus 231 ~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21111 1123455789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.96 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=200.6
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
++||+|+||.||+|...++..||+|.++... ......|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987653 334457899999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCC
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 426 (603)
+++.... ..++|..++.++.+++.||.|||+. +++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9997543 4589999999999999999999998 99999999999999999999999999987532222112222345
Q ss_pred CCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 427 t~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
+..|+|||++.+..++.++||||||+++||+++ |..||...... .....+..+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~--------------- 214 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYRMS--------------- 214 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCCCC---------------
Confidence 678999999999999999999999999999998 88887532111 1112222221100
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.....+..+.+++.+||+.+|++||++.|++++|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=328.26 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=203.7
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|+..+.||+|+||+||+|.+ .++..||+|.++.. ......+|.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3566778999999999999985 24578999999754 34455789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 336 VYEFMPNGTLCQHLQRER---------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
||||+++|+|.+++.... ...+++...+.++.+++.||+|||+. +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999996432 12488999999999999999999998 999999999999999999
Q ss_pred cEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHH
Q 007442 401 KSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~ 478 (603)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||++||||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 99999999997643221 122233346778999999988889999999999999999999 8777753211 11
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
+.+.+..+.... ........+.+++.+||+.+|++||++.+|.++|..
T Consensus 235 ~~~~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 122222222111 111234578889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.24 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=205.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-C--cEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-D--LLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888899999999999998754 3 35799988853 344567899999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999997532 12488999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~ 481 (603)
||+|||++..... .........+..|+|||++....++.++||||||+++|||++ |+.||...... . ...
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~-~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------E-LYE 229 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHH
Confidence 9999999864211 111122234567999999998899999999999999999998 98888532221 1 111
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.+..+... .........+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus 230 ~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQGYRM---------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 22221100 011123457889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.78 Aligned_cols=199 Identities=27% Similarity=0.394 Sum_probs=175.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...++||+|+||.||++... ++..+|+|.++.. .....+++.+|++++++++||||+++++++.+.+..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888999999999999999986 5788999988764 33445779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.+++... ..+++.....++.+++.||+|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999999754 35899999999999999999999742 6999999999999999999999999998753221
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12334689999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.07 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=202.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||++... +++.||||+++... ....+.+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999875 67899999997542 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999765 24699999999999999999999998 99999999999999999999999999997644333
Q ss_pred cceeccCCCCCCCcCccccc------cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 418 SHISTAPQGTPGYLDPQYHQ------NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
........||+.|+|||++. ...++.++||||||++||||++|+.||...... ......+........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~ 230 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF 230 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC
Confidence 33334457999999999986 456788999999999999999999998643221 111111111111110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+|+..||+ +|++||++.+++.
T Consensus 231 -------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 -------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0011234567889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.94 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=206.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-C---cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-D---LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.++|+..+.||+|+||.||+|++.. + ..+|+|.++.. .....+++.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999999753 3 37999998765 34456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++++|.+++.... ..++|..++.++.+++.||+|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997643 4589999999999999999999998 999999999999999999999999999876432
Q ss_pred cccce--eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 416 EISHI--STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 416 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
..... ......+..|+|||++....++.++||||||+++|||++ |+.|+..... ......+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCCC---
Confidence 21111 112234567999999998889999999999999999998 9999853221 1112222221100
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.........+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 230 ------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112356788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.83 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=194.5
Q ss_pred CcccCCCceEEEEEEE----cCCcEEEEEEeccC----ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKL----QNDLLVAIKRIKHR----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+.||+|+||.||+++. .+++.||||.++.. .......+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999986 35789999999753 223345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++... ..+.+.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 9999999999754 3588889999999999999999998 99999999999999999999999999987532221 2
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+..+...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~~---------- 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKLN---------- 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC----------
Confidence 22345699999999999988899999999999999999999999864221 1112222222210
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.+......+.+++.+||+.+|++|| ++.++++
T Consensus 219 ------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 ------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0112244678999999999999999 6777655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.63 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=205.2
Q ss_pred CCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
+|...+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667789999999999999863 23579999887543 3445789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 336 VYEFMPNGTLCQHLQRER----------------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
|+||+++|+|.+++.... ...++|..++.++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 13488999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+| |+.|+....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999754332221 1223346778999999988889999999999999999999 88887532211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.....+.++... .........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 ------~~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 ------RLFNLLKTGYRM---------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------HHHHHHhCCCCC---------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112222221100 0011234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=353.02 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=203.6
Q ss_pred CCCccCcccCCCceEEEEEEEc-C-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-N-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.|...+.||+|+||.||+|... + +..||+|.+...+......+.+|+.+|+.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999764 3 5788999887666666677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 341 PNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 341 ~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
++|+|.++|... ...++++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998653 234588999999999999999999998 999999999999999999999999999986433211
Q ss_pred -ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 419 -HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 419 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||++|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+..+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~-~~~~~~~~~~~~------- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------RE-IMQQVLYGKYDP------- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHhCCCCC-------
Confidence 123345699999999999999999999999999999999999999863211 11 112222221110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||++.+++.
T Consensus 291 --------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11123457889999999999999999999864
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.91 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=206.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||.||+|... ++.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777889999999999999875 67899999987644 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.+++.......++|..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++..... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----~ 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----Q 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc----c
Confidence 99999999876545699999999999999999999998 9999999999999999999999999999864221 1
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+..|+|||++....++.++||||||+++|||++ |+.|+..... ......+..+...+
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---------- 219 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKGYRME---------- 219 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCCC----------
Confidence 13345678999999998899999999999999999997 8888753211 11122222211100
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.....+..+.+++.+||+.+|++||++.||+++|+.+
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=324.03 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=209.3
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..++|...+.||+|+||.||+|..++++.||||.++... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999998643 3357799999999999999999999999988999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++.......+++..++.++.+++.||+|||+. +|+|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999876556799999999999999999999998 9999999999999999999999999998764332222
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......+..|+|||.+.+..++.++||||||++++||++ |+.|+..... ......+..+.. .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~-~-------- 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERGYR-M-------- 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-C--------
Confidence 2223345678999999998899999999999999999999 8888753211 111122221110 0
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
......+.++.+++.+||+.+|++||+++|+.+.|+.
T Consensus 224 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=322.76 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=203.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||.||+|...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999998877789999987543 33467899999999999999999999875 456889999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.++++......++|..++.++.+++.||+|||+. +|+|+||||+|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999875555689999999999999999999998 999999999999999999999999999976432221222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||++.+..++.++||||||+++|||+| |+.|+...... .....+..+...
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~----------- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGYRM----------- 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCC-----------
Confidence 23346778999999998899999999999999999999 88887532211 111122221100
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
......+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=339.97 Aligned_cols=246 Identities=27% Similarity=0.322 Sum_probs=192.2
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
|...+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 334578999999999999875 57899999997543 3345778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+.. .+.+..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc-cccc
Confidence 99986532 256778889999999999999998 9999999999999999999999999999864322 1122
Q ss_pred ccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 422 TAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
....||..|+|||++.. ...+.++|||||||+||||++|+.||......+. ... ...+.....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~-~~~~~~~~~-------- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASL-MCAICMSQP-------- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHH-HHHHhccCC--------
Confidence 34579999999998743 2345689999999999999999999873322111 111 111111100
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........++.+|+.+||+.+|++||++.||++.
T Consensus 294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112334578899999999999999999998863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=311.47 Aligned_cols=236 Identities=27% Similarity=0.385 Sum_probs=200.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|+..+.||.|+||+|..++.+ +|..+|+|.++... ..+.+...+|..+|+.+.||.+++|.+.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35666788999999999999985 57899999998763 345567789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|.|..+|++. .+++++...-+|.+|+.||+|||+. .|++|||||+|||||.+|.+||.|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999865 3499999999999999999999999 999999999999999999999999999986432
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.+....||+.|+|||.++...+..++|.|+|||++|||+.|..||....+ ....+.+.++++.
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~-------- 259 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVK-------- 259 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCccc--------
Confidence 24556899999999999999999999999999999999999999975444 2223444444331
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCC
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 529 (603)
.+.-...++.+|+...|+.|-.+|
T Consensus 260 --------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 --------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 122234467788999999998888
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=338.61 Aligned_cols=200 Identities=25% Similarity=0.367 Sum_probs=174.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|+..+.||+|+||+||++... +++.||||.++... ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 57899999997532 334467888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999764 4599999999999999999999998 99999999999999999999999999987532110
Q ss_pred c----------------------------------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCc
Q 007442 418 S----------------------------------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463 (603)
Q Consensus 418 ~----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p 463 (603)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred cCC
Q 007442 464 VDF 466 (603)
Q Consensus 464 ~~~ 466 (603)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.75 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=208.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||.||++.. .++..+|||.+... +....++|.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999996 47889999988653 2344568899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++++|.+++.... ...++|..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987432 34589999999999999999999998 999999999999999999999999999876432
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.. .......++..|+|||++.+..++.++||||||+++|||++|..|+...... .. .....+..... +.
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~-----~~ 227 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIEQCDY-----PP 227 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HH-HHhhhhhcCCC-----CC
Confidence 21 1122346889999999999888999999999999999999999998532211 11 11111111110 10
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 228 ---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 ---------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011234567889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=327.43 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=202.1
Q ss_pred CccCcccCCCceEEEEEEE-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEE
Q 007442 265 SEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILV 336 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 336 (603)
...+.||+|+||+||++.. .++..||+|.++... ......|.+|++++++++||||+++++++.+. ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999987653 357889999997653 23457789999999999999999999998764 357899
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... .++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999753 499999999999999999999998 9999999999999999999999999999864322
Q ss_pred cc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 417 IS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 417 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......++..|+|||.+....++.++||||||+++|||+||+.|+......... .............+.+.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhhc
Confidence 11 1122234567799999999889999999999999999999999987543221100 00000000000011111111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.. ........+.++.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 240 ~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GM------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CC------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 10 01112234568999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=326.04 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=209.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 333 (603)
.++|...+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999866 688999998754 34456778999999999999999999999876 4678
Q ss_pred EEEEeeCCCCCHHHHhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 334 ILVYEFMPNGTLCQHLQRERG------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
++++||+++|+|.+++..... ..+++..++.++.+++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 4589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 408 GLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 408 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
|+++.......+ ......++..|+|||++.+..++.++||||||+++||+++ |+.|+....+. . ....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~----~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---E----MAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---H----HHHHHHc
Confidence 999864332222 2233456778999999998889999999999999999999 98888643221 1 1122222
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
+... ......+..+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 235 ~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRL---------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCC---------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1100 0011234578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=332.74 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=207.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER 330 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 330 (603)
.++|...+.||+|+||.||++... +...+|+|.++.. .....+++.+|++++..+ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888999999999999999753 2357999999864 234557789999999999 799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
+..++||||+++|+|.+++..... ..++|..+++++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976432 2489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~ 474 (603)
++++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+... +.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~---- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PV---- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CH----
Confidence 9999999999999875432111 11222335578999999998889999999999999999998 77776422 11
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+..+...+ .......++.+|+.+||+.+|++||+|.||++.|+++...
T Consensus 249 --~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 --EELFKLLKEGHRMD---------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHHHcCCCCC---------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11122222221111 1112345788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=345.48 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=209.7
Q ss_pred cCcccCCCceEEEEEEE-cCC----cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKL-QND----LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~-~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
..+||+|+||+||||.+ ..| .+||||.+... .....++|+.|+-+|.+++||||+||+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 67899999999999986 333 57999998765 3455689999999999999999999999998776 88999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc-
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH- 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~- 419 (603)
|.|+|.||++.++ .++.-...+.|..|||+||.|||.+ +++||||.++|||+..-..+||.|||++++...+...
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998764 5689999999999999999999998 9999999999999999999999999999986554333
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......-.+.|||-|.+....++.+||||||||.+|||+| |.+|++.. + +..+.+.++.|.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-~------~~eI~dlle~ge----------- 917 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-P------AEEIPDLLEKGE----------- 917 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-C------HHHhhHHHhccc-----------
Confidence 3333445678999999999999999999999999999998 77777532 1 122223333321
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+-..+..+...+..++.+||..|++.||+++|+..++.++.+.
T Consensus 918 ----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 ----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1233456778899999999999999999999999999887654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=333.67 Aligned_cols=237 Identities=27% Similarity=0.344 Sum_probs=188.2
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIK-LISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
++||+|+||.||+|+.. +++.||+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 57899999987532 223345555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 9999988653 4588889999999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||++||||++|+.||..... .. ....+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~i~~~~~-------------- 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQ-MYDNILHKPL-------------- 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HH-HHHHHhcCCC--------------
Confidence 45689999999999988999999999999999999999999863211 11 1122222111
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
.........+.+++.+||+.+|.+||+..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.23 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=195.5
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||+||++... +++.||+|.++.. .......+.+|++++..++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 6789999999753 2344567789999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccc
Confidence 999998654 358999999999999999999997 5 89999999999999999999999999987532221 1223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||++||||+||+.||...... .....+..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~~-------------- 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEI-------------- 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCCC--------------
Confidence 446999999999999999999999999999999999999998632211 01111111111
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
........++.+++.+||+.||++|+ ++.++++.
T Consensus 214 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 --RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00112345678899999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.53 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=197.1
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
+.||+|+||.||+|+.. +++.||+|.+... ..+....|.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 6889999988654 344567899999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce-eccC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI-STAP 424 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~~ 424 (603)
.+++... ...++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999754 34589999999999999999999998 99999999999999999999999999987532211110 1111
Q ss_pred CCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCC
Q 007442 425 QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503 (603)
Q Consensus 425 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 503 (603)
..+..|+|||++.+..++.++||||||+++|||++ |..|+...... .....+..+...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~-------------- 215 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRL-------------- 215 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC--------------
Confidence 23467999999999899999999999999999998 77777532111 111111111000
Q ss_pred CccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 504 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
......+..+.+++.+||+.+|++||++.||+++|+
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 -PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.61 Aligned_cols=267 Identities=22% Similarity=0.353 Sum_probs=196.7
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ceE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQI 334 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 334 (603)
+|...+.||+|+||.||+|+.. ++..||||+++.. .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999975 6789999998743 2334467889999999999999999999886432 479
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 7899998654 3599999999999999999999999 99999999999999999999999999997532
Q ss_pred cccc--ceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH---------
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD--------- 481 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~--------- 481 (603)
.... .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||........ ...+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCHHH
Confidence 2111 11234568999999999876 6789999999999999999999999864322111 111111
Q ss_pred --HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 482 --RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 482 --~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+......+.++....................+.+++.+||+.+|++||++.|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111111000100000000000000011224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.19 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=199.8
Q ss_pred CCccCcccCCCceEEEEEEEcCC---cEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------Cc
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQND---LLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------GE 332 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~---~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 332 (603)
|...+.||+|+||.||+|...+. ..||+|.++.. .....+.|.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34567899999999999997653 26999988754 345567899999999999999999999987542 24
Q ss_pred eEEEEeeCCCCCHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 333 QILVYEFMPNGTLCQHLQRER----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
.++|+||+++|+|.+++...+ ...++|...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999985332 23489999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 409 LSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 409 la~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
+++........ ......+++.|++||++.+..++.++||||||+++|||++ |+.||..... ....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence 99864322111 1223346778999999999999999999999999999999 7777753211 1122223332
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.... ........+.+++.+||+.+|++|||+.||++.|+++
T Consensus 231 ~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2111 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.40 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=201.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
+|...++||+|+||+||++... +++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999999999999875 67899999997532 2233567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999998765445699999999999999999999998 99999999999999999999999999987632211
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ....+...+..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------- 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------- 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc-----------
Confidence 1233468999999999998899999999999999999999999997432211 1111112221111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
..........+.+|+.+||+.||++|| ++.++++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 -----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011122455688999999999999999 6777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=326.82 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=205.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...++||+|+||.||++... ++..+|+|.++.......+.|.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666789999999999999642 356899999987777777899999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 336 VYEFMPNGTLCQHLQRERG-------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
|+||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999976432 2489999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence 9999999875332211 11222345788999999999999999999999999999998 888875322111 11
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
..+..+.... .....+..+.+|+.+||+.+|++||++.||++.|+.
T Consensus 235 ~~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELE---------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCC---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1122221110 011234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.15 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=194.7
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999999754 334456678899988877 799999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 9999988654 4599999999999999999999998 9999999999999999999999999998753221 11223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcc--hhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN--EVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+..+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------- 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----------
Confidence 4568999999999999999999999999999999999999996422211 112223333333332211
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+......+.+++.+||+.+|++||+.
T Consensus 224 -----~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -----IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111234567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.41 Aligned_cols=243 Identities=24% Similarity=0.341 Sum_probs=195.4
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||.||++... +++.||||.++.. .....+.+..|+.++.++ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999875 5789999999753 233456788999999998 699999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 9999998654 4599999999999999999999998 9999999999999999999999999998742221 12223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcc--hhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN--EVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||+...... ......+..+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----------
Confidence 4578999999999999999999999999999999999999997432221 112223333333332211
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+......+.+++.+||+.+|.+||++
T Consensus 224 -----~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 -----IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 011234568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=326.17 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=203.1
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999998854 5689999887543 3445679999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEE
Q 007442 333 QILVYEFMPNGTLCQHLQRERG-----DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KSKV 404 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~kl 404 (603)
.++||||+++|+|.+++..... ..++|..+++++.|++.||+|||+. +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 2489999999999999999999998 999999999999998754 5999
Q ss_pred eeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHH
Q 007442 405 ADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 405 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
+|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 999999864221111 1112233568999999999999999999999999999997 888876432211 1111
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
+..+.. .......+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~~---------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGR---------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCc---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100 0111223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.77 Aligned_cols=264 Identities=21% Similarity=0.212 Sum_probs=198.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||++... +++.||+|.... +.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56889999999999999999874 578999997542 45688999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
. ++|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 166 ~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 166 K-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 5 7899988654 3589999999999999999999998 99999999999999999999999999997533222222
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcch----hhHHHHHHHHhhcCCcc------c
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE----VNLAALAADRISKGRLD------E 490 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~----~~l~~~~~~~~~~~~~~------~ 490 (603)
.....||+.|+|||++.+..++.++||||||++||||++|+.|+........ ......+.......... .
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 3345799999999999998999999999999999999999988753322111 00111111111000000 0
Q ss_pred ccchhh----hhcc---CCCC--ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IIDPLI----IEHR---GHSD--AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d~~l----~~~~---~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.++... .... .... ........++.+|+.+||+.||++|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0000 0000 001134567889999999999999999999885
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=329.95 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=199.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.+|...++||+|+||+||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45788899999999999999875 57899999997543 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ |+|.+++... ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TK 158 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC-Cc
Confidence 97 5999998654 34588999999999999999999998 9999999999999999999999999998753221 11
Q ss_pred eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---Ccc------
Q 007442 420 ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---RLD------ 489 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~------ 489 (603)
......+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+... .....+... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccch
Confidence 2233467999999998865 568999999999999999999999986433222111 111111100 000
Q ss_pred ---cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 ---EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ---~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+..... ...........+..+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQ--PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCC--chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000001122456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.17 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=205.8
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 46778889988999999999999999865 56889999998777777788999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGL--SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~ 411 (603)
+|+||+++++|.+++.... ..+ ++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999997642 234 8888999999999999999998 9999999999999986 6799999999987
Q ss_pred cccccccceeccCCCCCCCcCccccccCC--CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
...... .......++..|+|||++.... ++.++||||||+++|||++|+.|+......... .+..... . .
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~--~-~- 229 (268)
T cd06624 158 RLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF--K-I- 229 (268)
T ss_pred ecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh--c-c-
Confidence 532211 1223345889999999987643 788999999999999999999998632221110 0000000 0 0
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+.....++.+++.+||+.+|++|||+.||++
T Consensus 230 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 -------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111223456888999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=330.00 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=203.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CC--cEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-ND--LLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|.+. ++ ..+|+|+++.. .....+.|.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777889999999999999875 34 35688887754 344567889999999999 899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+||+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997542 12488999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~ 481 (603)
||+|||+++.... ........++..|+|||++.+..++.++||||||++||||+| |..||...... . ...
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~-~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYE 234 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H-HHH
Confidence 9999999864211 111122234678999999988889999999999999999998 88887532211 1 111
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+..+... .........+.+|+.+||+.+|++||++.++++.|+++...
T Consensus 235 ~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQGYRL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhcCCcC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 12111000 01112345688999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.00 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=197.5
Q ss_pred cccCCCceEEEEEEEc---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 269 RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.||+|+||.||+|.+. ++..||+|.++... ....+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 34579999997653 334567999999999999999999999885 457899999999999
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc--eec
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--IST 422 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~--~~~ 422 (603)
|.+++... ...+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++........ ..+
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999754 34699999999999999999999998 9999999999999999999999999999753322221 122
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...++..|+|||++....++.++||||||+++|||++ |+.|+...... .+...+..+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~------------ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKRL------------ 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCC------------
Confidence 2334678999999988889999999999999999996 88888632211 112222232211
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
........++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 218 ---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 ---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11123356788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=330.13 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=207.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER 330 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 330 (603)
..+|...+.||+|+||.||+++.. ++..||+|.++.. .....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778899999999999999742 2457999998754 244567899999999999 799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
...++||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999976421 3488999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~ 474 (603)
++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||++||||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 99999999999999864322211 2223456778999999998889999999999999999998 666664221
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
. ....+.+..+.... ........+.+++.+||+.+|++||+|.||++.|+++...
T Consensus 245 ~-~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 V-EELFKLLKEGHRMD---------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11122222221110 1123456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.49 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=196.4
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||+||++..+ +++.||+|.+.... ......+..|++++.+++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999996432 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 9999766556699999999999999999999998 9999999999999999999999999998754322 2223456
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... .......+.+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~-~~~~~~~~~~~~--------------- 217 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEE-LKRRTLEDEVKF--------------- 217 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHH-HHHHhhcccccc---------------
Confidence 8999999999998889999999999999999999999986432211 1111 111111111100
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.......++.+|+.+||+.+|++||+++|+++.+
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0012345688999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=333.01 Aligned_cols=238 Identities=28% Similarity=0.367 Sum_probs=189.8
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIK-LISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+|+.. +++.||||.+.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 68899999997532 223345555555 56789999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 9999999754 4589999999999999999999998 9999999999999999999999999998753221 22233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... .+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~-~~~i~~~~~~------------- 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEM-YDNILNKPLR------------- 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHH-HHHHHcCCCC-------------
Confidence 45689999999999999999999999999999999999999863211 111 1122121110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
........+.+++.+||+.+|++||++.+
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 215 ---LKPNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 01122456889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.49 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=200.5
Q ss_pred cCCCccCcccCCCceEEEEEEEcC---------------CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN---------------DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~---------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
++|...+.||+|+||.||++...+ ...||+|.++.. .....+.|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 567888899999999999987642 235899999764 3445578999999999999999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRERG----------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
++...+..++||||+++++|.+++..... ..++|..++.++.+++.||+|||+. +++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999965321 2378999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhC--CCccCCCCCcch
Q 007442 396 LDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA--LKVVDFSRPPNE 472 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg--~~p~~~~~~~~~ 472 (603)
+++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||++++||+++ ..|+..... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence 99999999999999975432211 112233457789999999988999999999999999999984 445432111 1
Q ss_pred hhHHHHHHHHhhc-CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 473 VNLAALAADRISK-GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 473 ~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
. ......+.... +..... ......+..+.+|+.+||+.+|++||+|.+|++.|++
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 Q-VIENTGEFFRNQGRQIYL-------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H-HHHHHHHhhhhccccccC-------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 11111111110 000000 0011234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.88 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=204.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-----------------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVR 322 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 322 (603)
..+|...+.||+|+||.||++...+ +..||+|.+.... ....++|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567888999999999999998643 2468999987653 445678999999999999999999
Q ss_pred eeeeEeecCceEEEEeeCCCCCHHHHhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRER---------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 323 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
+++++...+..++|+||+++++|.++|.... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999997643 12589999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh--CCCccCCCCCc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT--ALKVVDFSRPP 470 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt--g~~p~~~~~~~ 470 (603)
||++.++.++|+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 999999999999999987533221 122334456789999999998899999999999999999998 5555542211
Q ss_pred chhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 471 NEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 471 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
. ............+...... ......+.++.+++.+||+.+|++|||+.||++.|++
T Consensus 240 -~-~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -Q-QVIENAGHFFRDDGRQIYL------------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -H-HHHHHHHhccccccccccC------------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111111111110000 0111234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=337.60 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=200.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC--CcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN--DLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998654 368999998643 234456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999999764 3589999999999999999999998 9999999999999999999999999999763221
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ......+..+... +
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~---- 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGIIY--F---- 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCC--C----
Confidence 2234689999999999988899999999999999999999999964221 1112222222210 0
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
+......+.+++.+||+.+|++|+ +++|+++.
T Consensus 248 ----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 ----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111234577899999999999995 77777653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.61 Aligned_cols=240 Identities=26% Similarity=0.353 Sum_probs=191.0
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHH---hccCCCceeeeeeeEeecCceEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLI---SCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456788999999999999875 57899999997542 23345666676654 567899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|..+++. ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999998864 3599999999999999999999998 9999999999999999999999999998753221
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........|++.|+|||++.+..++.++||||||++||||++|+.||...... . ....+..+..
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~-~~~~i~~~~~-------- 218 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------E-VFDSIVNDEV-------- 218 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC--------
Confidence 12223456899999999999989999999999999999999999998632211 1 1112222111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
.........+.+++.+||+.+|++||++.
T Consensus 219 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 219 --------RYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 01112345678899999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.56 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=212.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCC-cEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeee-eEee------cC
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQND-LLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLG-CSIE------RG 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g-~~~~------~~ 331 (603)
..+..+.+.|.+|||+.||.+....+ ..+|+|++-..+....+.+.+||++|++|. |+|||.+++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34566788999999999999998776 999999998889999999999999999997 999999999 3321 13
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
+.+|.||||++|.|-|+|..+....|++.++++|+.++++|+++||.. .|+|||||||-+||||+.++..||+|||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 678999999999999999876556699999999999999999999986 7889999999999999999999999999986
Q ss_pred cccccc--ccee------ccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 412 LGMTEI--SHIS------TAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 412 ~~~~~~--~~~~------~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
-..... .... -...-|+-|+|||.+. +..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 321111 0000 1123689999999764 66899999999999999999999999974321
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..|++....- .........|..||..||+.+|++||++.+|++.+-+++..
T Consensus 264 --------laIlng~Y~~------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 --------LAILNGNYSF------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------eeEEeccccC------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1223222211 12246778899999999999999999999999999988765
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.86 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=197.8
Q ss_pred CcccCCCceEEEEEEEcC-C--cEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN-D--LLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||.||+|.+.+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999854 3 35789988754 345567899999999999 799999999999999999999999999
Q ss_pred CCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 343 GTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 343 gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999997542 12488999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
+++.... .........+..|+|||++....++.++||||||+++|||++ |+.||..... .. ....+..+.
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~-~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LYEKLPQGY 228 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HH-HHHHHhCCC
Confidence 9863211 111122234668999999988899999999999999999997 8888853211 11 111221111
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.. +........+.+|+.+||+.+|.+||++.|++..|+++.
T Consensus 229 ~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 011123456889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.48 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=207.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
..++|...+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999742 34579999987653 34456789999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++||||+++|+|.++++......+++.+++.++.+++.||+|||+. +|+|+||||+|||++.+..+||+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999999865444589999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 412 LGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 412 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
....... .......++..|+|||++....++.++||||||+++|||++ |+.|+...... ..+...+..+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcCCcC
Confidence 5432221 11222346788999999999899999999999999999998 88887532221 1111222222100
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
. .......++.+++.+||+.+|++||++.||++.|+++
T Consensus 264 ~---------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 A---------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0111245788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.64 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=207.7
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCceeeeeeeEe
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNLVRLLGCSI 328 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 328 (603)
++...++|...++||+|+||.||+|++. .+..||||+++... ....+.+.+|+++|.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4444556777899999999999999864 24689999998653 333457899999999997 999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcC------------------------------------------------------
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERG------------------------------------------------------ 354 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 354 (603)
..+..++|+||+++|+|.++|+....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007442 355 ------------------------------------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSS 392 (603)
Q Consensus 355 ------------------------------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~ 392 (603)
..++|...+.|+.|++.||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 1368888999999999999999988 9999999999
Q ss_pred CeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCc
Q 007442 393 NILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPP 470 (603)
Q Consensus 393 NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~ 470 (603)
|||+++++.+||+|||+++....... .......++..|+|||++....++.++||||||++||||++ |+.|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986432211 11223356788999999998889999999999999999998 78887532211
Q ss_pred chhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 471 NEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 471 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
......+..+... ..+.....++.+|+.+||+.+|++||++.||++.|+++.
T Consensus 349 ------~~~~~~~~~~~~~---------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ------EQFYNAIKRGYRM---------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHHcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111222222100 001123457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.41 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=201.9
Q ss_pred CCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
|...+.||+|+||+||+|...+ +..||||+++.... ...+.|.+|+.++++++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4556789999999999998643 47899999986543 3346788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+||+++++|.+++.... ...+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 99999999999985321 12488999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++...... ........+++.|+|||++.++.++.++||||||+++|||++ |..|+..... ....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~ 236 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDVI 236 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 999999987643221 112233456789999999998899999999999999999998 7667643211 1122
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
+.+..+.... .....+..+.+++.+||+.+|++||++.||+..|+.
T Consensus 237 ~~i~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVLP---------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcCC---------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3333322211 112345568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=338.86 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=208.3
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||+|+-|.|-.|++ .+|+.+|||.+... .......+.+||.+|+.++|||+++|++++.+..++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 55677899999999999987 57999999999765 223345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|-|+++|-.+ .+|++.+..+++.||..|+.|.|.. +|+||||||+|+|||.++++||+|||+|.+... ..
T Consensus 94 v~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GK 166 (786)
T ss_pred cCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Cc
Confidence 9999999999865 4599999999999999999999999 999999999999999999999999999987333 23
Q ss_pred eeccCCCCCCCcCccccccCCCC-cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLS-DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.....+|.+.|.+||++.+..|. .++||||.|||||.||||+.||+. .+ ......++..|.++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dN-ir~LLlKV~~G~f~--------- 230 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DN-IRVLLLKVQRGVFE--------- 230 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------cc-HHHHHHHHHcCccc---------
Confidence 34556899999999999998875 589999999999999999999972 22 23334455555431
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
-+...+.+..+|+.+||..||++|-|++||++.
T Consensus 231 -------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 -------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 123445678899999999999999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.59 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=205.2
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
..+++|...+.||+|+||.||+|..++ +..||+|.++... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456788899999999999999997642 4589999987553 234456889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 007442 332 EQILVYEFMPNGTLCQHLQRERG--------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSK 403 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~k 403 (603)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 2367888999999999999999998 999999999999999999999
Q ss_pred EeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHH
Q 007442 404 VADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 404 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~ 481 (603)
|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+..... .. +..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~-~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQ-VLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHH
Confidence 999999985332111 11222345678999999998899999999999999999999 6667643211 11 111
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.+..+.... ........+.+++.+||+.+|++||||.++++.|++..
T Consensus 233 ~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYLD---------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCCC---------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 221221110 01123457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.64 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=204.2
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--Cce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 333 (603)
..|...+.||+|+||.||.+++ .++..||+|.++... ....+.+.+|++++++++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999975 246889999997553 44457899999999999999999999998875 568
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++++|.+++... ...++|..++.++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999999654 23589999999999999999999998 9999999999999999999999999999864
Q ss_pred ccccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCC--------cchhhHHHHHHHHh
Q 007442 414 MTEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP--------PNEVNLAALAADRI 483 (603)
Q Consensus 414 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~--------~~~~~l~~~~~~~~ 483 (603)
..... .......++..|+|||++.+..++.++||||||+++|||+|++.|...... .............+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 33221 112234567789999999888899999999999999999998766432110 00000011111122
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
..+... .........+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 240 ~~~~~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL---------------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC---------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 221110 01122456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.63 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=205.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.+|...+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777889999999999999864 23479999987543 34457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.... ..+++.+++.|+.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997643 4589999999999999999999998 9999999999999999999999999999864432
Q ss_pred cccee--ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 ISHIS--TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
..... ....++..|++||++.+..++.++||||||+++||+++ |+.|+......+ ....+.++...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYRL---- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCcC----
Confidence 22221 12234568999999998899999999999999999887 988885432211 12222222100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
......+..+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=318.13 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=206.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
..+|...+.||+|+||.||+|...++..+|+|.++.. ....+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3567888999999999999999888888999988754 3345789999999999999999999999887 7889999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.......++|..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999876556689999999999999999999998 99999999999999999999999999987543222222
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....++..|+|||++....++.++||||||++++|++| |+.|+...... .....+..+...+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--------- 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGYRMP--------- 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCCCC---------
Confidence 223345678999999998889999999999999999999 88887532111 1112222221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.......++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 224 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0112345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.20 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=197.2
Q ss_pred cccCCCceEEEEEEEc---CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 269 RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5999999999999753 56889999987543 345678999999999999999999999885 45778999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc--ee
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--IS 421 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~--~~ 421 (603)
+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999754 3589999999999999999999998 9999999999999999999999999999764332221 11
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+.++...+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~---------- 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERME---------- 218 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCC----------
Confidence 22344678999999988889999999999999999998 88888632111 1122233322111
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.+.....++.+++.+||+.+|++||+|.+|.+.|++.
T Consensus 219 -----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.27 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=203.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999986 68899999997542 244567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 4589999999999999999999998 99999999999999999999999999997643322
Q ss_pred ----------------------------cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCC
Q 007442 418 ----------------------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP 469 (603)
Q Consensus 418 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~ 469 (603)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999864332
Q ss_pred cchhhHHHHHHHHhhc--CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 007442 470 PNEVNLAALAADRISK--GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-MTEVATE 538 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eV~~~ 538 (603)
. . ....+.. ..+. + .........+.+++.+||+ +|++||+ +.|+++.
T Consensus 236 ~------~-~~~~i~~~~~~~~------~--------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q------E-TYNKIINWKESLR------F--------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------H-HHHHHhccCCccc------C--------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1 1111111 0000 0 0011135578889999997 9999999 9998864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.93 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=201.5
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec-----
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER----- 330 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----- 330 (603)
+.++..|...+.||+|+||.||+|... +++.||+|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356778888999999999999999875 57889999987553 3346788999999999 699999999998753
Q ss_pred -CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 331 -GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 331 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
...++||||+++|+|.+++.......++|..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999999875556799999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
++..... ........|+..|+|||++. ...++.++||||||+++|||++|+.|+....+... . ....
T Consensus 158 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~--~~~~ 229 (272)
T cd06637 158 SAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L--FLIP 229 (272)
T ss_pred ceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H--HHHh
Confidence 8753221 12233456899999999986 33588899999999999999999999863221110 0 0111
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....... ........+.+|+.+||+.+|.+|||+.||++
T Consensus 230 ~~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPAPRL--------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCCCCC--------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111110 01123456889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=352.15 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
.+.+...++|...+.||+|+||+||+++. .+++.||||.++.. .......+.+|+.++..++|+||+++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34555667999999999999999999986 46899999998754 3455677889999999999999999988765432
Q ss_pred --------ceEEEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 332 --------EQILVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 332 --------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
..++||||+++|+|.++|.... ...+++.....++.|++.||+|||+. +|+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 3679999999999999997542 34589999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCccccccc-ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 402 SKVADFGLSRLGMTE-ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 402 ~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
+||+|||+++..... .........||+.|+|||++.+..++.++||||||++||||++|+.||.... .... .
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~-~ 254 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEV-M 254 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHH-H
Confidence 999999999764322 1122334579999999999999999999999999999999999999986321 1111 1
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+..+.... .......++.+++.+||+.+|++||++.+++..
T Consensus 255 ~~~~~~~~~~---------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGRYDP---------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2222222111 112234578899999999999999999998753
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.20 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=204.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...++||+|+||+||+|++. ++. .||+|.++.. .....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46777889999999999999853 443 4899999754 34456788999999999999999999999975 45779
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999754 24589999999999999999999998 999999999999999999999999999986433
Q ss_pred cccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..|++.... ..+ ...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~~--- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REI----PDLLEKGERLP--- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCCcCC---
Confidence 2221 1122345678999999998899999999999999999998 8888753221 111 11222221110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
........+.+++.+||+.+|++||++.|+++.|+.+...+
T Consensus 232 ------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01123457889999999999999999999999998886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=323.36 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=205.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.++|...+.||+|+||.||++... ++..||+|.++... ....++|.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 46789999997653 34457799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 334 ILVYEFMPNGTLCQHLQRER--------------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997432 12478999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
||+++++.+||+|||+++...... .........+..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999987532211 111222345678999999998899999999999999999998 7777642211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
. .....+..+..... ......++.+++.+||+.+|++||++.||++.|++
T Consensus 239 ----~-~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----E-EVIYYVRDGNVLSC---------------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----H-HHHHHHhcCCCCCC---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11223333322110 11234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=333.52 Aligned_cols=238 Identities=26% Similarity=0.297 Sum_probs=192.9
Q ss_pred CcccCCCceEEEEEEE----cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 268 QRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999997542 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 99999999654 4589999999999999999999998 99999999999999999999999999987533221 222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....||+.|+|||.+....++.++||||||+++|||++|+.||...... .....+......
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~~~~~------------ 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILKAKLG------------ 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHcCCCC------------
Confidence 3456899999999999888999999999999999999999998642211 111122221110
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ----~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 ----MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01122446788999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.30 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=196.6
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 5689999999854 234456788999999988 599999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 9999998654 3599999999999999999999998 9999999999999999999999999998752221 12223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||++||||++|+.||+............+....+......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR------------- 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-------------
Confidence 4569999999999999999999999999999999999999997543332223333333333322111
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
.+......+.+++.+||+.||++||++.
T Consensus 222 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 ---IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0112234677899999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.96 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=199.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|... +++.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999986 678999999975432 233567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 995 7888888654 34589999999999999999999998 9999999999999999999999999998753221 1
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---cc-----
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR---LD----- 489 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~----- 489 (603)
.......+++.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........+.... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhc
Confidence 22234568999999998865 4588899999999999999999999974322111 1111111110000 00
Q ss_pred cccchhhhhccCCCC----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSD----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...++.-........ -........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 000012346779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.88 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=205.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998753 3689999987553 34456789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 334 ILVYEFMPNGTLCQHLQRERG--------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
++||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999975321 2478999999999999999999998 99999999999999999999999
Q ss_pred eccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHh
Q 007442 406 DFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 406 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||+| |+.|+...... ...+.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHHHH
Confidence 9999875432211 12233456789999999998899999999999999999998 88777532211 112222
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
..+..... +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDL---------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22211111 11235678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.71 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=196.3
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|++++.+++||||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999875 5789999999754 23445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc-
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI- 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~- 417 (603)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999764 3588999999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeccCCCCCCCcCccccccCCCCcccccccHHH
Q 007442 418 ---------------------------------------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGV 452 (603)
Q Consensus 418 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGv 452 (603)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999888999999999999
Q ss_pred HHHHHHhCCCccCCCCCcchhhHHHHHHHHhh-cCCcccccchhhhhccCCCCccchHHHHHHHHHHHH--HhccCCCCC
Q 007442 453 VLVEIITALKVVDFSRPPNEVNLAALAADRIS-KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFR--CLAFHRDMR 529 (603)
Q Consensus 453 vL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~R 529 (603)
+||||+||+.||....+.+. ....+. ...+ .+ ........++.+++.+ |+..+|..|
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~-~~-------------~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINWENTL-HI-------------PPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHcccccc-CC-------------CCCCCCCHHHHHHHHHHccCcccccCC
Confidence 99999999999964332111 011111 0000 00 0011223456677777 556666779
Q ss_pred CCHHHHHHH
Q 007442 530 PSMTEVATE 538 (603)
Q Consensus 530 Psm~eV~~~ 538 (603)
|++.|++..
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.72 Aligned_cols=253 Identities=26% Similarity=0.323 Sum_probs=201.6
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4678889999999999999997 467899999998665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 999999999753 4589999999999999999999998 99999999999999999999999999997532211 11
Q ss_pred eccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 421 STAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+....+..... .+....+ ..+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~- 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL- 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC-
Confidence 23346889999999874 4457889999999999999999999885332211100 0001000 00000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 232 -------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0011234578899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.04 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=194.0
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
++||+|+||.||+|+.. +++.||||.++.. .....+.+..|++++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 4789999999753 234456678899999876 799999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccccc
Confidence 9999998754 3589999999999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ..+.+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~-~~~~i~~~~~~------------- 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------D-LFESILHDDVL------------- 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC-------------
Confidence 456899999999999989999999999999999999999999643211 1 11222222110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCC-------CHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRP-------SMTEVAT 537 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-------sm~eV~~ 537 (603)
.+.....++.+++.+||+.+|++|| ++.++++
T Consensus 215 ---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0111245678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.27 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=201.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEe-ecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI-ERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||++... +..||+|.++... ..+.|.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35777889999999999999875 6689999987542 3467899999999999999999999865 446789999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.......++|..++.++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 999999999876555689999999999999999999998 9999999999999999999999999998753221
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......+..|+|||++....++.++||||||+++|||++ |+.|+.... +.. ....+..+....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~-~~~~~~~~~~~~--------- 219 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKD-VVPRVEKGYKMD--------- 219 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHH-HHHHHhcCCCCC---------
Confidence 123345678999999998899999999999999999998 887775221 111 112222221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 ------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112355788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=340.04 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=201.5
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
...++|...+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567888999999999999999875 5789999999643 2234456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999998653 478888889999999999999998 99999999999999999999999999997643
Q ss_pred ccccceeccCCCCCCCcCccccccC----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNF----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
...........||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ... ...+..+...-
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~-~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT-YSKIMDHKNSL 266 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHH-HHHHHcCCCcC
Confidence 3222223345799999999998653 478899999999999999999999864322 111 11221111000
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
.+ ........++.+++.+||+.+|++ ||++.|++..
T Consensus 267 ~~------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 001123557888999999999988 9999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.60 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=201.1
Q ss_pred CcccCCCceEEEEEEEcC--C--cEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN--D--LLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~--~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|++|.||+|.+.+ + ..||||.++.... ...+.|.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3699999987765 667889999999999999999999999988 889999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc--e
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--I 420 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~--~ 420 (603)
|+|.+++.......++|...+.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999875435689999999999999999999998 9999999999999999999999999999864332211 1
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .........+...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~---------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGERL---------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCcC----------
Confidence 223457889999999999899999999999999999999 99888533221 1111111111000
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
......+..+.+++.+||+.+|++||++.||++.|.
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.02 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=206.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER 330 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 330 (603)
..+|...+.||+|+||.||+++.. ....||+|.++.. ......++.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999752 2457999998854 344567889999999999 599999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 331 GEQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
+..++|+||+++|+|.+++.... ...++|..+++++.|++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999997532 13489999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~ 474 (603)
++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999986432111 11122234567999999998899999999999999999999 7777743211
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+..+...+ .......++.+++.+||+.+|++||++.|+++.|+++...
T Consensus 243 --~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 --EELFKLLREGHRMD---------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --HHHHHHHHcCCCCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11222222221111 1112345688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=322.19 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=194.0
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||+||++... +++.||+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 67899999987532 22346678899999999999999999999999999999999999999
Q ss_pred HHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceecc
Q 007442 346 CQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423 (603)
Q Consensus 346 ~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 423 (603)
.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 9988643 234599999999999999999999998 99999999999999999999999999987533221 22234
Q ss_pred CCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCC
Q 007442 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 503 (603)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ . ......+..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~--------------- 218 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILNDSV--------------- 218 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhcccCC---------------
Confidence 5789999999999999999999999999999999999999864322111 0 111111111100
Q ss_pred CccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 504 DAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 504 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.........+.+++.+||+.+|++|| ++.|+++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 -TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11122455788999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=317.62 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=193.6
Q ss_pred CcccCCCceEEEEEEEcC---CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998754 3579999987654 234457899999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc-
Q 007442 344 TLCQHLQRERG---DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH- 419 (603)
Q Consensus 344 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~- 419 (603)
+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 2467888899999999999999998 9999999999999999999999999999753322211
Q ss_pred eeccCCCCCCCcCccccccC-------CCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-------HLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+. .. ..+ .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~---~~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT---YTV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHh-hcccCCC
Confidence 12234578889999988642 35789999999999999996 9888864322211 01 111 1111112
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.++.+ .......+.+++.+|+ .+|++|||+.||++.|+
T Consensus 231 ~~~~~----------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22211 1123446778999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.71 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=190.2
Q ss_pred CcccCCCceEEEEEEEcC-------------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 268 QRLGTGAFGTVYAGKLQN-------------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++.+++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998642 2358999887766666678899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-------EEEeec
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK-------SKVADF 407 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~-------~kl~DF 407 (603)
+||||+++|+|..++... ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999988754 34589999999999999999999998 9999999999999987664 899999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccc-cCCCCcccccccHHHHHHHHH-hCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQ-NFHLSDKSDVYSFGVVLVEII-TALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvL~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
|++..... .....++..|+|||++. ...++.++||||||+++|||+ +|+.|+......+. .....
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--------~~~~~ 223 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--------ERFYE 223 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------HHHHh
Confidence 99865322 12335788999999886 467899999999999999998 57766643211110 01111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
+.. .. .......+.+|+.+||+.+|++||++.+|++.|
T Consensus 224 ~~~-~~---------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQC-ML---------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCc-cC---------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 110 00 011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.85 Aligned_cols=238 Identities=24% Similarity=0.337 Sum_probs=189.8
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+|... +++.||||.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 4788999999753 223445566777777654 799999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999999754 3589999999999999999999998 99999999999999999999999999997532221 2233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~-~~~~i~~~~~-------------- 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DE-LFDSILNDRP-------------- 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHcCCC--------------
Confidence 45689999999999998999999999999999999999999863221 11 1111211110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
..+.....++.+++.+||+.+|++||++.+
T Consensus 214 --~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 --HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 011123446788999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=317.80 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=202.5
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+|...+.||+|+||.||+|...++..+|+|.++.... ...+|.+|++++++++||||+++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5667789999999999999987788999999875433 346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
++|.+++.... ..++|..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++...........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999997543 3589999999999999999999998 9999999999999999999999999998754322211122
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...++.+|+|||++.+..++.++||||||+++|||++ |+.|+..... ....+.+.++. ...++
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~--~~~~~------- 223 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF--RLYKP------- 223 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC--CCCCC-------
Confidence 3345678999999998899999999999999999998 8888753211 11112222211 00111
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
......+.+|+.+||+.+|++||++.||+++|.
T Consensus 224 ------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112457889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.05 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCCccCcccCCCceEEEEEEEcC-C---cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-D---LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.|...+.||+|+||.||+|.+.. + ..||||.++.. .....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 35677899999999999999753 2 36999999765 4455678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999754 34589999999999999999999998 99999999999999999999999999987643221
Q ss_pred cc-eecc-C--CCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 418 SH-ISTA-P--QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 418 ~~-~~~~-~--~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.. .... . ..+..|+|||++.+..++.++||||||+++||+++ |+.|+...... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i~~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCc----
Confidence 11 1111 1 12457999999999999999999999999999987 88887532211 11222211100
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.....+.+..+.+++.+||+.+|++||+|.+|+..|+.+
T Consensus 230 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.14 Aligned_cols=239 Identities=26% Similarity=0.377 Sum_probs=189.3
Q ss_pred cccCCCceEEEEEEEcC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeee
Q 007442 269 RLGTGAFGTVYAGKLQN-------------------------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 323 (603)
.||+|+||.||+|.+.. ...||+|.++........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 14689999976655556788999999999999999999
Q ss_pred eeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---
Q 007442 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF--- 400 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~--- 400 (603)
++++.+....+|||||+++|+|..++... ...+++..+++++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998654 34589999999999999999999998 999999999999997643
Q ss_pred ----cEEEeeccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHH-hCCCccCCCCCcchhh
Q 007442 401 ----KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEII-TALKVVDFSRPPNEVN 474 (603)
Q Consensus 401 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~ell-tg~~p~~~~~~~~~~~ 474 (603)
.+|++|||++...... ....++..|+|||++.+ ..++.++||||||+++|||+ +|+.|+....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 3799999988642211 22357788999998875 56899999999999999995 68888764322111
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
... +.... .+ .......+.+++.+||+.+|++||+|.+|++.|.
T Consensus 231 -~~~----~~~~~-------~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -ERF----YEKKH-------RL----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHH----HHhcc-------CC----------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 11000 00 0011236889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=322.50 Aligned_cols=262 Identities=25% Similarity=0.338 Sum_probs=201.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-----------------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-----------------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRL 323 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l 323 (603)
++|+..+.||+|+||.||++... +...||+|.++.. .....++|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998532 2357999999864 34455789999999999999999999
Q ss_pred eeeEeecCceEEEEeeCCCCCHHHHhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 007442 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERG---------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNI 394 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NI 394 (603)
++++...+..++||||+++|+|.+++..... ..+++...+.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999976421 2378899999999999999999998 999999999999
Q ss_pred eecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh--CCCccCCCCCcc
Q 007442 395 LLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT--ALKVVDFSRPPN 471 (603)
Q Consensus 395 Lld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt--g~~p~~~~~~~~ 471 (603)
|+++++.+||+|||+++........ ......++..|++||+...+.++.++||||||+++|||++ |..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999754322211 1122334678999999888899999999999999999998 555664322111
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
. ............... .. .....++..+.+++.+||+.+|++||+|.||.+.|++
T Consensus 242 ~---~~~~~~~~~~~~~~~-~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGRQV-YL-----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhccccc-cC-----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111111111100000 00 0111234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=319.80 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=205.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-----CCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEee--cCceE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-----NDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQI 334 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 334 (603)
.|...+.||+|+||.||+|++. ++..||||.++..... ..++|.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4556678999999999999864 3578999999866443 56789999999999999999999999887 55789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++++|.+++.... ..++|..++.++.+++.||+|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999997653 3599999999999999999999998 99999999999999999999999999998654
Q ss_pred cccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchh--------hHHHHHHHHhh
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV--------NLAALAADRIS 484 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~--------~l~~~~~~~~~ 484 (603)
.... .......++..|++||++.+..++.++||||||++++||+||+.|+......... .........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2211 1112234566799999999889999999999999999999999887532211100 00111111111
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.+. .......+..++.+|+.+||+.+|++||+|.||+++|+.++
T Consensus 241 ~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 241 EGE---------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cCC---------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 110 00111223467899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.09 Aligned_cols=248 Identities=29% Similarity=0.362 Sum_probs=209.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|+..+.||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|++|-+.|+||||+++++++.+....+|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57888999999999999999975 56889999996542 233467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||.++|+|...|...+...+++.....+..|+|.||.|+|.. ++|||||||+|+|++.++..||+|||.+-...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999977777799999999999999999999998 99999999999999999999999999986422
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||..|++||...+...+.+.|+|++|++.+|++.|.+||.... .....+++.+- ++.+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~---~~~~p--- 242 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKV---DLKFP--- 242 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHc---cccCC---
Confidence 334556689999999999999999999999999999999999999997432 11112222221 11111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+++.+|+..+|.+|.+..||++.
T Consensus 243 ----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2345578899999999999999999998753
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=302.05 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=212.0
Q ss_pred hcCCCccCcccCCCceEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ceE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQI 334 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 334 (603)
.++|.+.+.||+|||.-||.++ +.++..+|+|++.....++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3578889999999999999998 4678899999999888888899999999999999999999999987544 489
Q ss_pred EEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 335 LVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
|+++|...|||.+++.... +..+++.+.+.|+.++.+||++||+. .|+++||||||.|||+.+++.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998653 34599999999999999999999997 45799999999999999999999999999876
Q ss_pred ccccccc--------eeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 413 GMTEISH--------ISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 413 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
....... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 3321111 112234789999999875 456889999999999999999999999732110
Q ss_pred HhhcCCc-ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 482 RISKGRL-DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 482 ~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.|.+ ..+..+.+.. ......++.+.+++.+||+.||.+||+..|++..++.+.
T Consensus 248 ---GgSlaLAv~n~q~s~------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 ---GGSLALAVQNAQISI------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---CCeEEEeeecccccc------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 1112222221 111226778999999999999999999999999998763
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.81 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=206.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcCC----cEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|...+. ..||||...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577788999999999999987542 579999987654 4566789999999999999999999998865 567899
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.... ..++|..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997542 3589999999999999999999998 9999999999999999999999999999864433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.....+...++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~----- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGRIENGERLP----- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCCcCC-----
Confidence 2222333345678999999988889999999999999999996 998886432211 111222221100
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.....+..+.+++.+|+..+|++|||+.|+++.|+.++.
T Consensus 229 ----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011234578899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.99 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=199.9
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
+....++|...+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578899999999999999999986 4789999998642 22334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999643 488899999999999999999998 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCccccccC----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC-
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNF----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR- 487 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~- 487 (603)
.............||+.|+|||++... .++.++||||||++||||++|+.||..... .... ..+....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~-~~i~~~~~ 264 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTY-SKIMDHKN 264 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHH-HHHHhCCc
Confidence 432222223455799999999998754 378899999999999999999999964321 1111 1111111
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
...+ .........+.+++.+||..++.+ ||++.|+++.
T Consensus 265 ~~~~-------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNF-------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCC-------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 001123456778889999855544 8899888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.23 Aligned_cols=238 Identities=25% Similarity=0.374 Sum_probs=192.7
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+|+.+ +++.||||.++.. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 5789999999753 234456778899998877 699999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence 9999999754 3589999999999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~------------- 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEVV------------- 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCCC-------------
Confidence 456999999999999989999999999999999999999998642211 112222222110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
........+.+++.+||+.||++||++.+
T Consensus 215 ---~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 ---YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 01123446788999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.48 Aligned_cols=268 Identities=23% Similarity=0.308 Sum_probs=204.9
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChh--hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTD--GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.+|...++||+|.||.||+|+. .+|+.||||+++..... -.....+||+.|+.++|+||+.|++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566778999999999999986 56899999999876432 13456899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
||+. +|+..+... ...|+-.+...++.++++||+|+|++ .|+||||||.|+|++.++.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred eccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 9964 898888754 45688889999999999999999999 99999999999999999999999999999865432
Q ss_pred ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc------ccc
Q 007442 419 HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL------DEI 491 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~ 491 (603)
...+..+.|.-|.|||.+.+. +|+...|+||.|||+.||+-|..-|... . +......+...+..... ..+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-s--DidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-S--DIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-c--hHHHHHHHHHHcCCCCcccCcccccc
Confidence 333444788999999988764 7999999999999999999876544322 1 22222333333332211 112
Q ss_pred cchhhhhcc--CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 492 IDPLIIEHR--GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 492 ~d~~l~~~~--~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
-|-.-.... ...............+|+..++.+||.+|.++.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 221111100 01111233445667999999999999999999998764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.22 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=198.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||+++.. .......+.+|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999985 5789999999753 2344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999999754 3599999999999999999999998 99999999999999999999999999986432110
Q ss_pred cc-------------------------------------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhC
Q 007442 418 SH-------------------------------------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA 460 (603)
Q Consensus 418 ~~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg 460 (603)
.. ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01123589999999999998999999999999999999999
Q ss_pred CCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 007442 461 LKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS---MTEVAT 537 (603)
Q Consensus 461 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~eV~~ 537 (603)
+.||....+. .. ...+......-.+ .........+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~------~~-~~~i~~~~~~~~~------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQ------ET-YRKIINWKETLQF------------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHH------HH-HHHHHcCCCccCC------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9998643221 11 1111111100000 0011224467788999996 8999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.87 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=198.4
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|...++||+|+||.||+|.. .+++.||+|.+... .....++|.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 566778999999999999986 46789999998654 3445577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|..+. .+++.....++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 999997653 378889999999999999999998 9999999999999999999999999998753221 2
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....++..|+|||++.+..++.++||||||+++|||++|+.||..................+....... +
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---- 220 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L---- 220 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C----
Confidence 2345789999999999988999999999999999999999999864322211111111111111111000 0
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......++.+++.+||+.+|++||++.|+++.
T Consensus 221 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011133468899999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.35 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=194.4
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 337 (603)
+|...+.||+|+||+||+|... +++.||||.++... ....+.+..|..++..+ +|++|+++++++.+.+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777889999999999999876 46899999997542 23345677788888877 5899999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 999999999998754 3589999999999999999999998 9999999999999999999999999998753221
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..... . .....+.....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~----~~~~~i~~~~~--------- 218 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D----ELFQSIMEHNV--------- 218 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---H----HHHHHHHhCCC---------
Confidence 1222345689999999999999999999999999999999999999864221 1 11122222211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
..+.....++.+++.+||+.+|++|++.
T Consensus 219 -------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.78 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=206.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcC--------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
.+|...+.||+|+||.||++.... +..||+|.++... ....+++.+|++++.++ +||||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467888999999999999997421 2479999887543 34567899999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 007442 332 EQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD 397 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld 397 (603)
..++|+||+++|+|.++|.... ...++|..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997532 23489999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhH
Q 007442 398 YNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNL 475 (603)
Q Consensus 398 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l 475 (603)
+++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++||||++ |..|+.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 9999999999999754321111 1222344578999999999999999999999999999998 777764321 1
Q ss_pred HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 476 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.. ....+..+...+ .......++.+++.+||+.+|++||+|.|+++.|+++....
T Consensus 243 ~~-~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EE-LFKLLKEGHRMD---------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH-HHHHHHcCCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 122222221111 11123457889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=315.18 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=195.4
Q ss_pred CcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cCceEEEEeeCC
Q 007442 268 QRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQILVYEFMP 341 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 341 (603)
+.||+|+||.||+|.+.+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. .+..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998642 367999998643 34556788999999999999999999998764 556889999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc---
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS--- 418 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~--- 418 (603)
+|+|.+++.... ..+++..++.++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997542 3478888999999999999999998 999999999999999999999999999975332111
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......++..|+|||++.+..++.++||||||+++|||++|..|...... ...+ ...+..+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~----~~~~~~~~~~~-------- 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDI----TVYLLQGRRLL-------- 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH----HHHHhcCCCCC--------
Confidence 111233467789999999988999999999999999999996554322111 1111 11222221100
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.....+..+.+++.+||+.+|++||++.||+++|+++.
T Consensus 223 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01122456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.41 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=196.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||++... +++.||||.+... .....+.+.+|++++.+++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999874 6789999998643 2344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999999754 4588999999999999999999998 99999999999999999999999999986321100
Q ss_pred c------------c----------------------------------eeccCCCCCCCcCccccccCCCCcccccccHH
Q 007442 418 S------------H----------------------------------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFG 451 (603)
Q Consensus 418 ~------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfG 451 (603)
. . ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999998999999999999
Q ss_pred HHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC-cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCC-
Q 007442 452 VVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR-LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR- 529 (603)
Q Consensus 452 vvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R- 529 (603)
|+||||++|+.||......+ . ...+.... ...+ + .......++.+++.+||. +|.+|
T Consensus 236 vil~elltG~~Pf~~~~~~~------~-~~~i~~~~~~~~~--p-----------~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE------T-YRKIINWRETLYF--P-----------DDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH------H-HHHHHccCCccCC--C-----------CCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 99999999999986432211 1 11111100 0000 0 001124567889999997 66665
Q ss_pred --CCHHHHHHH
Q 007442 530 --PSMTEVATE 538 (603)
Q Consensus 530 --Psm~eV~~~ 538 (603)
|++.|+++.
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 588887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.48 Aligned_cols=241 Identities=25% Similarity=0.341 Sum_probs=194.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCC-ceeeeeeeEeecCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHP-NLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 337 (603)
+|...+.||+|+||.||+|... +++.||||.++.. .....+.+..|++++..++|+ +|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777889999999999999876 4688999999753 234556788999999999765 6888999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999999754 3589999999999999999999998 9999999999999999999999999998742211
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++.+..++.++||||||+++|||+||+.||..... ......+.+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--------- 218 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--------- 218 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC---------
Confidence 1122345689999999999999999999999999999999999999863221 111112222111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
..+.....++.+++.+||+.+|.+||+.
T Consensus 219 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.03 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=201.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|++|.||++... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999874 57899999986442 2234678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++++|.+++... ..+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999999754 3488999999999999999999998 999999999999999999999999999875322
Q ss_pred ccccee--ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EISHIS--TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~--- 226 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP-TNP--- 226 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccC-CCC---
Confidence 111111 2345788999999999989999999999999999999999998532111 1111111111 000
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++|||+.|+++.
T Consensus 227 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112234567889999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.30 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=202.8
Q ss_pred cCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec-Cc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER-GE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 332 (603)
++|...+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688899999999999999973 346889999997643 34456788999999999 689999999988754 46
Q ss_pred eEEEEeeCCCCCHHHHhhhhcC----------------------------------------------------------
Q 007442 333 QILVYEFMPNGTLCQHLQRERG---------------------------------------------------------- 354 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 354 (603)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc-ceeccCCC
Q 007442 355 -------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQG 426 (603)
Q Consensus 355 -------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 426 (603)
..++|..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2378899999999999999999998 999999999999999999999999999876432211 11122345
Q ss_pred CCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 427 t~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
+..|+|||++.+..++.++||||||+++|||++ |..|+....... .....+..+.....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------------- 303 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------------- 303 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC--------------
Confidence 678999999998899999999999999999997 888875322211 11222222211110
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
......++.+++.+||+.+|++||++.||++.|+.+..
T Consensus 304 -~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=314.64 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=198.1
Q ss_pred CcccCCCceEEEEEEEcC----CcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN----DLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
++||+|+||.||+|+... +..+|+|.++.... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997632 26899999986543 35578999999999999999999999875 5568999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce--
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI-- 420 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~-- 420 (603)
|+|.++|.... .++|..++.++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997653 689999999999999999999998 99999999999999999999999999998643322211
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+...+..+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~--------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGERLP--------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCcCC---------
Confidence 112234568999999998899999999999999999998 88888643211 1122222221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 219 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.92 Aligned_cols=242 Identities=29% Similarity=0.373 Sum_probs=191.8
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHH-HHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+++.. +++.||||.+... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999875 6889999999753 2233455666655 56779999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 9999998653 4589999999999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ...+..+.+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~-~~~~~~~~~~--~---------- 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEM-YDNILHKPLV--L---------- 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHH-HHHHHcCCcc--C----------
Confidence 45699999999999999999999999999999999999999864321 111 1122221110 0
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++.+||+.+|++||++++.+++
T Consensus 216 ----~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 ----RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred ----CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 11234467789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.86 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=191.7
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+|... +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999986 46899999997541 23345667788888764 899999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCcee
Confidence 9999999753 3589999999999999999999998 9999999999999999999999999998742211 11223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~-------------- 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNP-------------- 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--------------
Confidence 45689999999999998999999999999999999999999864221 111112211110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMT-EVA 536 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eV~ 536 (603)
..+......+.+++.+||+.+|++||++. ++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 00111234678899999999999999997 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.47 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=204.6
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|...+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 5789999998653 3445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.......+++...+.++.+++.||.|||+. +|+|+||||+|||+++++.++|+|||+++..... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccc
Confidence 999999999765556689999999999999999999998 9999999999999999999999999998764322 122
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ... ...+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNL-ILKVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHH-HHHHhcCCCCCC---------
Confidence 2345688999999999988899999999999999999999999863211 111 112222222111
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++.+||+.+|++||++.||+..
T Consensus 221 ------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233467889999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.32 Aligned_cols=248 Identities=31% Similarity=0.453 Sum_probs=203.9
Q ss_pred CcccCCCceEEEEEEEcC----CcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN----DLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||.||++.... +..|++|.++..... ..+.+.+|++++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999864 788999999876443 368899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 343 GTLCQHLQRER-------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 343 gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
++|.+++.... ...+++..++.++.+++.||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 35699999999999999999999998 999999999999999999999999999986443
Q ss_pred cc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ........++..|+|||.+....++.++||||||++++||++ |+.|+..... ....+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC----
Confidence 22 122334567889999999988899999999999999999999 5888864311 1122222222110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
........++.+++.+||+.+|++||++.|+++.|+
T Consensus 227 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.44 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=197.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...++||+|+||+||+++.+. ++.+|+|.+... .....+.|.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999864 678999998642 2233456888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999764 34589999999999999999999998 99999999999999999999999999987543333
Q ss_pred cceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 418 SHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
........||+.|+|||++. ...++.++|||||||+||||++|+.||..... ..... .+........+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~-~i~~~~~~~~~ 229 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYG-KIMNHKERFQF 229 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHH-HHhCCCccccC
Confidence 33334457999999999986 34688999999999999999999999863221 11111 11111100000
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
..........+.+++.+|+..++++ ||++.|+++.
T Consensus 230 -----------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -----------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0111123456778888888654444 6888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.34 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=196.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||.++.. .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999975 5789999999742 2334566889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999753 34589999999999999999999999 99999999999999999999999999987543322
Q ss_pred cceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 418 SHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .......+.......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~- 229 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF- 229 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC-
Confidence 222333469999999999863 4578899999999999999999999863221 1111111111110000
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCC--CCCCCHHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHR--DMRPSMTEVATE 538 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p--~~RPsm~eV~~~ 538 (603)
. .........+.+++.+||..++ ..||++.++++.
T Consensus 230 ~-----------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 P-----------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-----------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0011234567778888775433 337888887765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.43 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=204.9
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCc
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGE 332 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 332 (603)
....++|....+||+|.||+|+++.++ +++.+|||.+++. ..+..+..+.|..|+...+ ||.|++|+.+|...+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578899999999999999999986 4689999999976 3556677888988888885 9999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+++||||+.+|++..+.+ ...+++....-+|.+++.||.|||++ +|||||||.+|||||.+|.+||+||||++.
T Consensus 444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999444333 34599999999999999999999999 999999999999999999999999999997
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
..... ..+....||+.|||||++....|+...|.|||||+|||||.|+.||.....+ +++
T Consensus 518 ~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~F 577 (694)
T KOG0694|consen 518 GMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVF 577 (694)
T ss_pred cCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHH
Confidence 44332 3456679999999999999999999999999999999999999999643221 122
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
|..+.. ...++...+.+.+.|+.+.|..+|++|..+
T Consensus 578 dsI~~d----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVND----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcC----CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222211 123445567789999999999999999877
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.92 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=206.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..|+..++||+|.||.||||... .++.||+|.+... ..+.++++.+|+.+|++++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666788999999999999874 5789999999865 456678999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+.+|++.+.|... ..+.+....-|..++..||.|||+. +.+|||||+.|||+..++.+||+|||.+-.......
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999999753 3357777788999999999999999 999999999999999999999999999876443332
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......||+.|||||++....|+.|+||||||++.+||.+|..|+....+.....+ + .+-.-|
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------I-----pk~~PP----- 229 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------I-----PKSAPP----- 229 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------c-----cCCCCC-----
Confidence 33667899999999999988999999999999999999999999875444221110 0 000111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++..||+.+|+.||++.++++
T Consensus 230 -----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 -----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 112245667889999999999999999998774
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.19 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=200.0
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||+|+||+||++... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999875 57899999986542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999999765555699999999999999999999998 99999999999999999999999999987533221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-------------- 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh--------------
Confidence 122346899999999999999999999999999999999999999743221111001100000000
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
.........+.+|+.+||+.+|++||| +.|+++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 -----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 001123346788999999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.13 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=199.5
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
|...+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++.+.+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4456789999999999999864 678999999877667778899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .....
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-ccccc
Confidence 9999988653 34699999999999999999999998 9999999999999999999999999998753221 12223
Q ss_pred cCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 423 APQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
...++..|+|||++. +..++.++|||||||++|||++|+.|+....+ ....... .......+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~~----- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKI-AKSEPPTLA----- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHH-hhcCCCCCC-----
Confidence 456899999999974 34577899999999999999999998753221 1111111 111111110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||++.++++
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 --------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123457889999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=327.95 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=194.8
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||++... +++.||||.++.. .....+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999886 4789999999754 234456778899999888 699999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 9999998754 3599999999999999999999998 99999999999999999999999999987522211 1223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~-------------- 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEV-------------- 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCC--------------
Confidence 34689999999999999999999999999999999999999863221 111122222111
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSM-----TEVAT 537 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm-----~eV~~ 537 (603)
.........+.+|+.+||+.+|++||++ .++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0111234568899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=313.96 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|+..+.||+|+||.||++... +++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777889999999999999875 5789999998753 334456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++.......+++..+++++.|++.||+|||+. +++|+||+|+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 9999999999865555689999999999999999999998 99999999999999999999999999987533221 1
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......+++.|+|||++.+..++.++||||||++++||++|+.|+..... ...+... ..+....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~--------- 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSYPP--------- 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCCCC---------
Confidence 12234588899999999988999999999999999999999999863211 1112211 1221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||+|.||++
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 ------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11233557889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.89 Aligned_cols=267 Identities=24% Similarity=0.329 Sum_probs=200.0
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ceE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQI 334 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 334 (603)
+|+..+.||+|+||+||++... +++.||||++... +....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 6899999998753 3345577899999999999999999999998776 789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+|+||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6888888543 4599999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc-
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII- 492 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 492 (603)
...........+++.|+|||++.+. .++.++||||||+++|||++|+.||....+.... ..+...+......++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHH
Confidence 3322233345688999999998764 5789999999999999999999999754332111 1111111100000000
Q ss_pred -----chhhhhccCC------CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 493 -----DPLIIEHRGH------SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 493 -----d~~l~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...+...... ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 000011225578899999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.99 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=204.1
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||.|+||-||.++. .+...||||++... ..+.++++++|+..|.+++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56677899999999999986 46789999999754 456789999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
| -|+-.|.|.-+ .++|.+..+..|..+.+.||+|||+. +.||||||..||||++.+.+||+|||.+....+
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 9 57888888655 46799999999999999999999999 999999999999999999999999999876332
Q ss_pred eeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 420 ISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
....+|||.|||||++. .++|+.|.||||+||+-.||.-++.|... ..+..+...|.++.. |.|
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-------MNAMSALYHIAQNes-----PtL 245 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNES-----PTL 245 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-------chHHHHHHHHHhcCC-----CCC
Confidence 34568999999999874 68999999999999999999999888642 123334445544322 111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+-...+..++..||+.-|.+|||..++++
T Consensus 246 ---------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 ---------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12345678999999999999999999977553
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.84 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred CcccCCCceEEEEEEEcC---CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||+||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997644 3578899876543 344567899999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc-
Q 007442 344 TLCQHLQRERG---DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH- 419 (603)
Q Consensus 344 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~- 419 (603)
+|.+++..... ...++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976532 2357888899999999999999998 9999999999999999999999999998753222111
Q ss_pred eeccCCCCCCCcCcccccc-------CCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 420 ISTAPQGTPGYLDPQYHQN-------FHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+...... ......+..+. ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccC
Confidence 1223346778999998753 356889999999999999999 66676432111 11112222221 112
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.++.+ .......+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~----------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22211 1223456677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.00 Aligned_cols=240 Identities=23% Similarity=0.316 Sum_probs=192.0
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||.||+|... ++..||||.++... ....+.+..|..++... +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999986 57899999997531 23445667788888765 899999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 9999999754 4589999999999999999999998 9999999999999999999999999998742211 12234
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~~-------------- 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDTP-------------- 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--------------
Confidence 45789999999999999999999999999999999999999863221 111122221110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMT-EVA 536 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eV~ 536 (603)
........++.+++.+||+.||++||++. ++.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00112344678899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.82 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=203.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46777889999999999999864 67899999998766666688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 99999999864 2489999999999999999999998 99999999999999999999999999987532221 11
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||....+.. .+ ......+. ...
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~-~~~~~~~~-~~~--------- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----AL-YLIATNGT-PEL--------- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hH-HHHhcCCC-CCC---------
Confidence 233468899999999998889999999999999999999999986432211 11 11111110 000
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||..+|++||++.||++
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 ----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011123456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.16 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=197.4
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|+||+++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 67899999986542 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999999765555699999999999999999999998 9999999999999999999999999998753221 1
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .......+..+..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~----------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE----------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc-----------
Confidence 12344689999999999988999999999999999999999999864322111 1111111111110
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
.........+.+|+.+||+.+|++||++.
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 -----VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred -----ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 01112344678899999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.15 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=204.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
.+|...+.||+|+||+||+|+.+ +...|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999864 2467999998765433 5678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 335 LVYEFMPNGTLCQHLQRERG-------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
+||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976542 1589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
|+++..............++..|+|||.+.+..++.++||||||++++||++ |..||..... .........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcC
Confidence 9987533222222233346778999999988889999999999999999999 6667642211 1112222222
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.+.... ....+..+.+++.+||+.+|++||++.|++..|.
T Consensus 235 ~~~~~~--------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV--------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC--------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 221110 1123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.53 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=190.7
Q ss_pred CcccCCCceEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+.||+|+||.||+|.... ...||+|.+........+.|.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 235889988766556667899999999999999999999999998999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--------EEEeeccCcc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK--------SKVADFGLSR 411 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~--------~kl~DFGla~ 411 (603)
+++|+|.++++... ..++|..++.++.|++.||+|||+. +|+||||||+|||++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997653 3589999999999999999999998 9999999999999987765 5999999886
Q ss_pred cccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCC-ccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALK-VVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
.... .....++..|+|||++.+. .++.++||||||+++|||++|.. |+....+. . . .... ....
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~-----~-~~~~-~~~~- 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-K-----K-LQFY-EDRH- 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-H-----H-HHHH-Hccc-
Confidence 4322 2234678899999999864 58999999999999999999954 43321111 0 0 0000 0000
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 223 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ---------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.12 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=197.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 5788999998652 2334456888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999764 24589999999999999999999998 99999999999999999999999999997643332
Q ss_pred cceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 418 SHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
........||+.|+|||++.. +.++.++||||||++||||++|+.||..... .... ..+......--+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~-~~i~~~~~~~~~ 229 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETY-GKIMNHEERFQF 229 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHH-HHHHcCCCcccC
Confidence 222334569999999999875 5688899999999999999999999863221 1111 111111000000
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
.+ .......++.+++.+|+..++++ |+++.++++.
T Consensus 230 p~-----------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PS-----------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CC-----------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 01123456788999998865544 4577777643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.03 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=203.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||.||++... ++..+|+|.++.. ......++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999875 5788999998754 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++... ..+++..+..++.|++.||+|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999764 45899999999999999999999732 8999999999999999999999999998753221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc-----------
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL----------- 488 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------- 488 (603)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..............
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 1233468899999999988889999999999999999999999986432111 11111000000000
Q ss_pred ---------ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 ---------DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 ---------~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+..+....... ..........++.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 000011134568899999999999999999998875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.62 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=203.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|+..+.||+|+||.||+|...+ +..+++|.++.... .+++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999875 78999999976533 688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... ...++|..++.++.+++.||+|||+. +|+||||+|+||++++++.+||+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~-~~~ 155 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT-MAK 155 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC-ccc
Confidence 999999999654 35689999999999999999999998 9999999999999999999999999998764322 112
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+....+.... ..+..... +.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~~----- 218 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-----PT----- 218 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-----CC-----
Confidence 23345889999999999889999999999999999999999998643221110 00000000 00
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..........+.+++.+||+.+|++||++.||++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 ---LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0011123456889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=313.54 Aligned_cols=238 Identities=24% Similarity=0.369 Sum_probs=190.5
Q ss_pred CcccCCCceEEEEEEEcCCc-----------EEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 268 QRLGTGAFGTVYAGKLQNDL-----------LVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+.||+|+||.||+|.+.+.. .|++|.++..... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999986533 5888887655433 6889999999999999999999999988 788999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-------cEEEeeccC
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-------KSKVADFGL 409 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-------~~kl~DFGl 409 (603)
+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999998653 2689999999999999999999998 999999999999999887 799999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccC--CCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
+..... .....++..|+|||++... .++.++||||||+++|||++| ..|+........ . ......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~----~~~~~~ 222 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---E----RFYQDQ 222 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---H----HHHhcC
Confidence 875322 2233567789999999876 789999999999999999995 555543321110 0 011110
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
... .......+.+++.+||+.+|++||++.||++.|+
T Consensus 223 ~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRL-----------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC-----------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0011257889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=308.74 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=199.5
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
++||+|+||.||++...+++.||+|.++..... ..+.|.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998865443 5678999999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee-ccCC
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS-TAPQ 425 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 425 (603)
+++... ...+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999754 33589999999999999999999998 999999999999999999999999999875332111111 1223
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCC
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSD 504 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 504 (603)
.+..|+|||++.++.++.++||||||++++||+| |..|+...... .....+..+. ..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~~--~~------------- 214 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESGY--RM------------- 214 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcCC--CC-------------
Confidence 4667999999998899999999999999999999 77776432211 1111111110 00
Q ss_pred ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 505 AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 505 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
......+.++.+++.+||+.+|++||++.||++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.76 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=202.5
Q ss_pred CCCccCcccCCCceEEEEEEEcC--CcEEEEEEeccC----------ChhhHHHHHHHHHHHhc-cCCCceeeeeeeEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN--DLLVAIKRIKHR----------DTDGIQQVVNEIKLISC-VSHPNLVRLLGCSIE 329 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 329 (603)
+|+..+.||+|+||.||+|.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999865 688999988632 23345678889998875 799999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. .+++|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999998643 234689999999999999999999963 17999999999999999999999999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
|++....... ......++..|++||++.+..++.++||||||+++|||++|+.|+..... .. ....+.++.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~-~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LS-LATKIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HH-HHHHHhhcc
Confidence 9997643322 23445689999999999988899999999999999999999998853211 11 111222221
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
..... .......+.+++.+||+.+|++||++.||..+|+
T Consensus 230 ~~~~~--------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLP--------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCC--------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11100 1123456889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=333.33 Aligned_cols=260 Identities=20% Similarity=0.243 Sum_probs=202.8
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
..+++...++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556666789999999999999999999986 5789999998642 22344567899999999999999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998643 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccC----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNF----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
++..............||+.|+|||++... .++.++|||||||+||||++|+.||..... .......+..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcC
Confidence 986433322233455799999999998753 378899999999999999999999964221 1111111111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
.....+.+ .......+.+++.+||..++.+ ||++.|+++.
T Consensus 263 ~~~~~~~~-------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPD-------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCC-------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111 1123456788999999844433 6788887764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=316.30 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=197.9
Q ss_pred CcccCCCceEEEEEEEcC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQN-------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+.||+|+||.||+|+..+ +..+|||.+.... .....+|.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998753 2579999886543 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-----cEEEeeccC
Q 007442 340 MPNGTLCQHLQRER-----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-----KSKVADFGL 409 (603)
Q Consensus 340 ~~~gsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-----~~kl~DFGl 409 (603)
+++|+|.+++.... ...++|..++.++.|++.||+|||+. +++|+||||+|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997542 23489999999999999999999998 999999999999999877 899999999
Q ss_pred ccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 410 SRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 410 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
++....... .......++..|+|||++.++.++.++||||||+++|||+| |+.|+..... .. ....+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~----~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QE----VLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HH----HHHHHhcCC
Confidence 875332211 11223345788999999999999999999999999999998 8888753221 11 111111111
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.. ......+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ~~---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0112235678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.60 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=205.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|+..+.||.|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777889999999999988864 5789999998754 345567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.......+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876555689999999999999999999998 999999999999999999999999999976433221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......+++.|+|||++.+..++.++||||||+++|||++|+.|+...... .. ...+..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~-~~~~~~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NL-VVKIVQGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHcCCCCCC--------
Confidence 223456899999999998888999999999999999999999998642221 11 112222222111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
......++.+++.+||+.+|++||++.|+++.
T Consensus 222 -------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.92 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=189.9
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHH-HHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEI-KLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+++.. +++.||+|.+.... .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 56789999997532 22233444454 456889999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+.+.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 9999999754 3478888889999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+..+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-~~~i~~~~~~------------- 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EM-YDNILNKPLQ------------- 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HH-HHHHHhCCcC-------------
Confidence 456999999999999999999999999999999999999998632211 11 1111111110
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.+|.+||++.+.+.+
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 011234567889999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.48 Aligned_cols=261 Identities=19% Similarity=0.247 Sum_probs=196.1
Q ss_pred cCcccCC--CceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 267 KQRLGTG--AFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 267 ~~~LG~G--~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
..+||+| +|++||++... +++.||||+++.. .....+.+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78999999874 6899999999754 23444667789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc---
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS--- 418 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~--- 418 (603)
+|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999765555699999999999999999999998 999999999999999999999999986543211110
Q ss_pred ---ceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 419 ---HISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 419 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ...... .+.....+|
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~-~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKL-NGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHHh-cCCcccccc
Confidence 01122346778999999876 468999999999999999999999986322111 011111 111111111
Q ss_pred h-------------------hhhhc-----------cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 P-------------------LIIEH-----------RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~-------------------~l~~~-----------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .+... ..............+.+++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 00000 00001112234567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.85 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=205.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-C----cEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-D----LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...+.||+|+||+||+|...+ + ..||+|.++... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345667899999999999998753 3 368999887653 3456789999999999999999999999987 78899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997653 3499999999999999999999998 999999999999999999999999999986443
Q ss_pred cccce-eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EISHI-STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
..... .....++..|+|||.+....++.++||||||+++|||++ |+.|++..... . ..+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~--- 231 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------E-IPDLLEKGERLP--- 231 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHhCCCCCC---
Confidence 22211 112234678999999988899999999999999999999 99988643221 1 112222221100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
....+...+.+++.+||..+|++||++.++++.|+++...
T Consensus 232 ------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 232 ------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0111334678899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.75 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=201.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 338 (603)
+|...+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777889999999999999875 4688999999754 23455678999999999999999999998764 345789999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.+++.......+++.+++.++.+++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999876556699999999999999999999998 99999999999999999999999999987643221
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......+++.|+|||++.+..++.++||||||++++||++|+.|++... ...... .+..+.+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~-~~~~~~~~~-------- 221 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVY-RIIEGKLPP-------- 221 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHH-HHHhcCCCC--------
Confidence 22234468899999999999999999999999999999999999886321 111111 122222211
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||++.|+++
T Consensus 222 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11224457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.15 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=172.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.|...++||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 57899999997542 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc-
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI- 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~- 417 (603)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999754 3588889999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeccCCCCCCCcCccccccCCCCcccccccHHH
Q 007442 418 ---------------------------------------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGV 452 (603)
Q Consensus 418 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGv 452 (603)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCCccCCC
Q 007442 453 VLVEIITALKVVDFS 467 (603)
Q Consensus 453 vL~elltg~~p~~~~ 467 (603)
+||||++|+.||...
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=324.21 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=198.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||+|+.. ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788889999999999999875 57889999997543 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP-TK 159 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC-cc
Confidence 974 898888654 34589999999999999999999998 9999999999999999999999999998753221 11
Q ss_pred eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---Cccccc---
Q 007442 420 ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---RLDEII--- 492 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~--- 492 (603)
......+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+.... ....+... ....+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchh
Confidence 2233467899999998865 4688999999999999999999999864433222111 11111000 000000
Q ss_pred ---chhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 ---DPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 ---d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+........ ...........++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000001123456789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.97 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=202.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||.||+|+... +..|++|.+...+....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 456778899999999999999864 7899999998877777888999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|..++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..... ....
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~-~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc-cccc
Confidence 9999999886543 4599999999999999999999998 999999999999999999999999999875322 1122
Q ss_pred eccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 421 STAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+....+ ...... +.........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~--- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK-IAKSEPPTLS--- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHH-HhcCCCccCC---
Confidence 23446888999999984 34578899999999999999999998853221 111111 1111111110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......++.+++.+||+.+|++||++.||++
T Consensus 237 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 ----------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123456888999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.75 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=195.4
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
+|...+.||+|+||+||+++.. +++.||||.+.... ....+.+.+|+.+|.+++|+||+++++.+.+.+..+||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999875 57899999986532 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc--
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE-- 416 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~-- 416 (603)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999764 3588888999999999999999998 9999999999999999999999999997421100
Q ss_pred ----------------------------------------ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHH
Q 007442 417 ----------------------------------------ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVE 456 (603)
Q Consensus 417 ----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~e 456 (603)
.........||+.|+|||++.+..++.++|||||||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123469999999999999999999999999999999
Q ss_pred HHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC---CHH
Q 007442 457 IITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP---SMT 533 (603)
Q Consensus 457 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---sm~ 533 (603)
|++|+.||....+.+. . ..+...... ... ........++.+++.+|+ .+|++|+ ++.
T Consensus 237 ll~G~~Pf~~~~~~~~------~-~~i~~~~~~-~~~-----------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 237 MLVGQPPFLADTPAET------Q-LKVINWETT-LHI-----------PSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred hhhCCCCCCCCCHHHH------H-HHHhccCcc-ccC-----------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 9999999974332111 0 111111000 000 001123445667787866 4999999 778
Q ss_pred HHHHH
Q 007442 534 EVATE 538 (603)
Q Consensus 534 eV~~~ 538 (603)
|++..
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.13 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=211.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc-eEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE-QILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 337 (603)
++|...+++|+|+||.++..+++ ++..+++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999988875 56789999997553 3334577899999999999999999999999998 99999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
+|++||+|.+.|...++..+++...++++.|++.|+.|||++ .|+|||||+.|||++.+..+||+|||+|+....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999988777799999999999999999999988 99999999999999999999999999999865543
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
. ......||+.||.||.+.+.+|..|+|||||||++|||++-+.+|..... ...+.+ +.++. ++
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~k-i~~~~----~~---- 224 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILK-INRGL----YS---- 224 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHH-Hhhcc----CC----
Confidence 2 33456899999999999999999999999999999999999999864322 222221 11111 11
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+.....++..|+..||+.+|+.||++.+++.+
T Consensus 225 -------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 -------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223456678899999999999999999999976
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.56 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=202.8
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|...+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999975 57899999997553 445577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 999999999754 689999999999999999999998 99999999999999999999999999997643321 22
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....++..|+|||++.+..++.++||||||+++|||+||+.|+....+. .....+..+....+.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~-------- 219 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLE-------- 219 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCc--------
Confidence 33446888999999999888999999999999999999999998643211 011111111111100
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||..+|++||+++++++
T Consensus 220 ------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 ------GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0013456889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.56 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=207.4
Q ss_pred CCCChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeE
Q 007442 250 PIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCS 327 (603)
Q Consensus 250 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 327 (603)
.+++..++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +||||+++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34667788889999999999999999999999874 57899999987542 2346678899999999 799999999998
Q ss_pred eecC-----ceEEEEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 328 IERG-----EQILVYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 328 ~~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
.+.+ ..++|+||+++|+|.++++.. ....++|..++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 7543 579999999999999998643 235689999999999999999999998 999999999999999999
Q ss_pred cEEEeeccCcccccccccceeccCCCCCCCcCccccccC-----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH
Q 007442 401 KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l 475 (603)
.+||+|||++...... ........++..|+|||++... .++.++||||||+++|||++|+.|+....+...
T Consensus 166 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--- 241 (291)
T cd06639 166 GVKLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--- 241 (291)
T ss_pred CEEEeecccchhcccc-cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---
Confidence 9999999998753321 1122334688999999987644 368899999999999999999999863222111
Q ss_pred HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 476 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ..+..+....+.++ ......+.+++.+||+.+|++||++.|+++
T Consensus 242 ---~-~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 ---L-FKIPRNPPPTLLHP-------------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---H-HHHhcCCCCCCCcc-------------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11112211111111 122346889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.16 Aligned_cols=267 Identities=22% Similarity=0.241 Sum_probs=199.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..+|...+.||+|+||.||++.... ++.||||.... ..+.+|+++|++++|+|||++++++...+..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578899999999999999999864 68899996432 3467899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc-c
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI-S 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~-~ 418 (603)
+ .++|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 242 ~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 57999998654 34699999999999999999999998 99999999999999999999999999997643221 1
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC-CcchhhHHHHHHHHhhcCCcc--c---cc
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR-PPNEVNLAALAADRISKGRLD--E---II 492 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~--~---~~ 492 (603)
.......||+.|+|||++.+..++.++|||||||+||||++|..++.... ..........+...+...... + ..
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 12234569999999999999999999999999999999999887654321 111111112222222221110 0 00
Q ss_pred chhhhhc---------cC--CCCcc--chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 493 DPLIIEH---------RG--HSDAG--TLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 493 d~~l~~~---------~~--~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...+... .. ....+ .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 00 00000 00123367889999999999999999999863
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.95 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=202.9
Q ss_pred CCccCcccCCCceEEEEEEEcC-----CcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
|...+.||.|+||.||++...+ +..||+|.++..... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999998864 378999999766433 5678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++.......+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865443499999999999999999999999 99999999999999999999999999997644332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........+++.|+|||.+.+..++.++||||||++++||++ |+.|+..... ....+.+..+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~------ 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRLP------ 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCCC------
Confidence 222222347889999999988889999999999999999998 6666653111 11112222222111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.......++.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ---------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112455788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.66 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=194.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 337 (603)
+|+..+.||+|+||+||++... +++.||||.++.. .....+.+..|+.++..+. |++|+++.+++.+.+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999875 5789999999753 2334566788999998886 577888999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 999999999999654 3599999999999999999999998 9999999999999999999999999998753221
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+.+..+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--------- 218 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--------- 218 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---------
Confidence 1122344689999999999988999999999999999999999999864221 111122222111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
..+......+.+++.+||+.+|.+|++..
T Consensus 219 -------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 01112345678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=311.11 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=190.4
Q ss_pred CcccCCCceEEEEEEEcCC---cEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQND---LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
+.||+|+||+||+|...++ ..+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 356677776543 345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc-ccce
Q 007442 344 TLCQHLQRERG--DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE-ISHI 420 (603)
Q Consensus 344 sL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~-~~~~ 420 (603)
+|.+++..... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 3467778889999999999999998 9999999999999999999999999998642211 1112
Q ss_pred eccCCCCCCCcCcccccc-------CCCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 421 STAPQGTPGYLDPQYHQN-------FHLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .......+. +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 234467889999998753 2457899999999999999985 445542211 111112222 2222333
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
++.+.. .....+.+++..|| .+|++||++.||++.|.
T Consensus 231 ~~~~~~----------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 332211 13346778899999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.70 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=194.3
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CCCceeeeeeeEeec-----C
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCV---SHPNLVRLLGCSIER-----G 331 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 331 (603)
+|...+.||+|+||+||+|... +++.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999876 57899999987542 12224556677777665 799999999988642 3
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999997 5899999765555699999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---c
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR---L 488 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~ 488 (603)
..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||........ +. .....+.... .
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~-~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LG-KIFDLIGLPPEDDW 231 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HH-HHHHHhCCCChhhC
Confidence 64321 122344689999999999988999999999999999999999988853322111 11 1111110000 0
Q ss_pred c-------cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 D-------EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~-------~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ..+.+.... ............+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPR---PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCC---chHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000000 000111234556889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.87 Aligned_cols=247 Identities=28% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.+|...+.||+|+||.||+|.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3467788999999999999975 56789999987543 346789999999999999999999998654 5799999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++.......+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~ 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence 99999999876555689999999999999999999998 9999999999999999999999999998753221 1
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+...... .....+..+...+
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------- 217 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------EVKECVEKGYRME---------- 217 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------HHHHHHhCCCCCC----------
Confidence 22234578999999998899999999999999999998 88887532221 1122222221110
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.....+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 218 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=308.51 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=200.3
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC------hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||+||+|...+++.+|||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999998888999999987542 22346688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
+||+++++|.+++... .++++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999754 3589999999999999999999998 9999999999999999999999999998753211
Q ss_pred -----ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 417 -----ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 417 -----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.........++..|+|||++.+..++.++||||||++++||++|+.||........ ........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~- 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRGLMPR- 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccCCCCC-
Confidence 11112334689999999999988899999999999999999999999863221110 0000000011100
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......++.+++.+||+.+|++||++.||+.
T Consensus 230 --------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 --------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11123456889999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.57 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=202.4
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
..++|+....||+|+||.||.++-+ .|..+|+|++++.. ..+.+.+..|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4567888999999999999999875 58999999999764 4456778889999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+|||++..+|... ..|++.....++.+++.|++-||+. ++|||||||+|+|||..|++||+||||+.-...
T Consensus 219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999864 4599999999999999999999999 999999999999999999999999999843111
Q ss_pred ----c-------------------cc----ceec-------------------cCCCCCCCcCccccccCCCCccccccc
Q 007442 416 ----E-------------------IS----HIST-------------------APQGTPGYLDPQYHQNFHLSDKSDVYS 449 (603)
Q Consensus 416 ----~-------------------~~----~~~~-------------------~~~gt~~Y~aPE~~~~~~~s~ksDVyS 449 (603)
+ .. ...+ ..+|||.|||||++.+..|+...|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 00 0000 235999999999999999999999999
Q ss_pred HHHHHHHHHhCCCccCCCCCcchh-hHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC
Q 007442 450 FGVVLVEIITALKVVDFSRPPNEV-NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM 528 (603)
Q Consensus 450 fGvvL~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~ 528 (603)
+|+|+||||.|-.||....+.+.. .+..|... +.. ........+..+||.+|+. ||++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------l~f--------------P~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------LKF--------------PEEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------ccC--------------CCcCcccHHHHHHHHHHhc-CHHH
Confidence 999999999999999866554321 12222110 000 0111223678899999999 9999
Q ss_pred CCC---HHHHH
Q 007442 529 RPS---MTEVA 536 (603)
Q Consensus 529 RPs---m~eV~ 536 (603)
|-. +.||.
T Consensus 433 RLG~~G~~EIK 443 (550)
T KOG0605|consen 433 RLGSKGAEEIK 443 (550)
T ss_pred hcCcccHHHHh
Confidence 975 44444
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.99 Aligned_cols=236 Identities=24% Similarity=0.325 Sum_probs=185.3
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcc---CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCV---SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
||+|+||+||+|+.. +++.||||++.... ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 57899999986432 22334556677777665 699999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCcc
Confidence 9999998753 4589999999999999999999998 9999999999999999999999999998753221 12233
Q ss_pred cCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ......+..+... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~-~~--------- 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVR-FP--------- 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCC-CC---------
Confidence 45699999999998754 489999999999999999999999863221 1112222222211 00
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
.......+.+++.+||+.+|++||++.
T Consensus 218 -----~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 -----KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred -----CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 011234677899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=317.69 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=201.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...+.||+|+||.||+|... ++. .||+|.++... .....++.+|+.++++++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 34666788999999999999864 343 57999887653 33345789999999999999999999998754 5679
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999999754 33589999999999999999999998 999999999999999999999999999986432
Q ss_pred cccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ....+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERLP--- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCCC---
Confidence 2211 1223345778999999998899999999999999999998 8888753211 11111222221100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
........+.+++.+||..+|++||+|.+|++.|+.+...
T Consensus 232 ------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 ------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111234688999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.46 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=200.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45667788999999999999875 57899999998766556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ...
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 999999998654 3589999999999999999999998 9999999999999999999999999998753221 122
Q ss_pred eccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 421 STAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....|+..|+|||++. ...++.++||||||+++|||++|+.|+....+.... . ........ .+..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~-~~~~~~~~---~~~~- 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMTKSNFQ---PPKL- 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------H-hhhccCCC---CCcc-
Confidence 23456899999999874 456889999999999999999999988533221110 0 01111110 0000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.+|++
T Consensus 232 -------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001122346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=312.43 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=204.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||.|+||.||+|... ++..||+|.++.......+.|.+|++++++++||||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356778889999999999999975 5789999999877777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++... ...+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQ 158 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc-cc
Confidence 9999999998754 34699999999999999999999998 9999999999999999999999999998753222 11
Q ss_pred eeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 420 ISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......+++.|++||++. ...++.++||||||+++|||++|+.|+...... ... ..+..+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~--- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVL-LKILKSEPPTL--- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHH-HHHhcCCCCCc---
Confidence 223346899999999875 345778999999999999999999998643211 111 11112111100
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++||++.+|++.
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 ----------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011234568899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.95 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4577888999999999999986 468899999998766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... .++|.+++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-SK 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc-cc
Confidence 999999998643 489999999999999999999998 99999999999999999999999999987533221 12
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....+.... . .+........
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~-~~~~~~~~~~--------- 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------Y-LIATNGTPEL--------- 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHHhcCCccc---------
Confidence 23346889999999999888999999999999999999999998643321111 0 1111110000
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||..+|++||++.+|+.
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 ----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011123446788999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.04 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=197.6
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG----- 331 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 331 (603)
..++|...+.||+|+||.||++... ++..||||+++.. .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478888999999999999999875 5789999999753 3345577889999999999999999999986443
Q ss_pred -ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 332 -EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 332 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46899999964 67776643 388899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH---------------
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL--------------- 475 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l--------------- 475 (603)
+.... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 171 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 75322 1223345789999999999999999999999999999999999999964322110000
Q ss_pred -HHHHHHHhhc-CCc-----ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 476 -AALAADRISK-GRL-----DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 476 -~~~~~~~~~~-~~~-----~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......... ... .+........ ............+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFP---SESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccc---cccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 000 0000000000 0000111224568899999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=306.41 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=200.6
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||+||+|... ++..|++|.+.... .+..+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999986 78899999986543 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
+||+++++|.+++... ..+++..++.++.+++.||+|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999754 3589999999999999999999998 9999999999999999999999999998763322
Q ss_pred ccceeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ......++..|++||.+.... ++.++|+||||+++|||++|+.||..... ...............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-----
Confidence 1 223456889999999987766 89999999999999999999999864321 111111111111111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||++.+++.
T Consensus 223 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01123456788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.09 Aligned_cols=267 Identities=22% Similarity=0.311 Sum_probs=198.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|++|.||+|+.. ++..||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 58899999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
++ ++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-V 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC-c
Confidence 97 799999875433 5699999999999999999999998 9999999999999999999999999998753221 1
Q ss_pred ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc---CC---cccc
Q 007442 419 HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK---GR---LDEI 491 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~~~~ 491 (603)
.......+++.|+|||++.+. .++.++||||||++++||+||+.|+........ .... ...+.. .. ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRI-FRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HHHhCCCChhhhhcchhh
Confidence 122334578899999988654 578899999999999999999998864322111 0000 000000 00 0000
Q ss_pred cc--hhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 ID--PLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d--~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+ +..... .............++.+++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000 00000001123557789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.88 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=203.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999996 468899999998766566678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++.. ..+++..++.++.+++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 99999999864 3489999999999999999999998 99999999999999999999999999987533221 12
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||....+..... .+..+.....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~~~~~~~~~--------- 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPEL--------- 235 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------eeccCCCCCC---------
Confidence 233468889999999998889999999999999999999999986432211100 0000000000
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.+|++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 ----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.71 Aligned_cols=262 Identities=21% Similarity=0.341 Sum_probs=204.4
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEe-
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSI- 328 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~- 328 (603)
+.++++..++++|...+.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445667788899999999999999999999875 57899999886532 2236788899999999 6999999999985
Q ss_pred ----ecCceEEEEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 329 ----ERGEQILVYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 329 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
..+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 335689999999999999988643 234589999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~ 477 (603)
||+|||+++..... ........|++.|+|||++.. ..++.++||||||+++|||++|+.|+....+...
T Consensus 164 kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 99999998764322 122234468999999998753 4578899999999999999999999864322111
Q ss_pred HHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 478 LAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 478 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
. ..+..+......++ ......+.+++.+||+.+|++||++.||++.
T Consensus 238 -~-~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -L-FKIPRNPPPTLHQP-------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -H-hhccccCCCcccCC-------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 01111111111111 1123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.15 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=199.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45778889999999999999875 57899999997543 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ ++|.+++... ...+++.....++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 97 6999998754 34589999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh---cCCcccccchh
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS---KGRLDEIIDPL 495 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~~ 495 (603)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||......+. ...+...+. ......+++..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccc
Confidence 12234578899999988654 578899999999999999999999864332211 111111110 00001110000
Q ss_pred ------hhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 ------IIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 ------l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...... ............+.+|+.+||+.||.+|||+.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000011123456789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=307.09 Aligned_cols=253 Identities=27% Similarity=0.360 Sum_probs=205.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 56889999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++...... ...
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~ 157 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAK 157 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh-hhc
Confidence 999999998764 24589999999999999999999998 9999999999999999999999999998753321 112
Q ss_pred eccCCCCCCCcCccccccC---CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 421 STAPQGTPGYLDPQYHQNF---HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....++..|+|||.+... .++.++||||||+++|||+||+.|+....+.... ..+....+. .+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------~~~~~~~~~---~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------FLISKSNFP---PPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccCC---Cccc-
Confidence 2345688899999998776 8899999999999999999999998643221110 011111000 0000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|.+||++.+|+.
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=313.18 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=204.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||++... +++.||+|.+.... ....+.+.+|++++..++||||+++++++...+..+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666788999999999999875 57899999887543 34457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++... ..+++.....++.+++.||.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999998653 35899999999999999999999732 7999999999999999999999999998653221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcch-----hhHHHHHHHHhhcCCcccccch
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE-----VNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......++..|+|||++.+..++.++||||||+++|||+||+.||+......+ .....+....+. ... +
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~ 231 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPP-----P 231 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccC-----C
Confidence 12234689999999999888999999999999999999999999975333211 011111111111 100 0
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
. .........+.+++.+||+.+|++||++.||++...-+
T Consensus 232 ~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 R---------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred C---------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0 00112455788999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.42 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=198.4
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--------------hhhHHHHHHHHHHHhccCCCceee
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--------------TDGIQQVVNEIKLISCVSHPNLVR 322 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~H~niv~ 322 (603)
.+..+.|.....||+|.||.|-+|... +++.||||++.+.. ...+++..+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578888999999999999999874 68999999996431 112468899999999999999999
Q ss_pred eeeeEee--cCceEEEEeeCCCCCHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 007442 323 LLGCSIE--RGEQILVYEFMPNGTLCQHLQRERGDG-LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN 399 (603)
Q Consensus 323 l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~ 399 (603)
|+.+..+ .+..|||+||+..|.+..-= ...+ |+..+.++++.++..||+|||.+ +||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9999875 45789999999988764422 1233 89999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccCccccccc----ccceeccCCCCCCCcCccccccCC----CCcccccccHHHHHHHHHhCCCccCCCCCcc
Q 007442 400 FKSKVADFGLSRLGMTE----ISHISTAPQGTPGYLDPQYHQNFH----LSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471 (603)
Q Consensus 400 ~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvL~elltg~~p~~~~~~~~ 471 (603)
+++||+|||.+...... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 99999999998754211 111122367999999999887632 3458899999999999999999996321
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.....+.+....+.- ....++.+.+.+|+.++|..||+.|-+..+|....
T Consensus 324 ----~~~l~~KIvn~pL~f--------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ----ELELFDKIVNDPLEF--------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----HHHHHHHHhcCcccC--------------CCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111222332222211 11224556788999999999999999999987654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.24 Aligned_cols=265 Identities=24% Similarity=0.341 Sum_probs=199.3
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--cCCCceeeeeeeEeecC----ceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC--VSHPNLVRLLGCSIERG----EQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 335 (603)
......+.||+|.||.||+|.++ |+.||||++...++. .+.+|.+|... |+|+||+.+++.-..+. +++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34556788999999999999996 558999999876543 45566776654 59999999999755433 6899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-----NPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
|++|.++|||+|||.. ..++-...++++..+|.||+|||... .|.|.|||||+.|||+..++...|+|+|||
T Consensus 287 vTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999986 35899999999999999999999754 689999999999999999999999999999
Q ss_pred cccccccc---ceeccCCCCCCCcCccccccCC------CCcccccccHHHHHHHHHhC----------CCccCCCCCcc
Q 007442 411 RLGMTEIS---HISTAPQGTPGYLDPQYHQNFH------LSDKSDVYSFGVVLVEIITA----------LKVVDFSRPPN 471 (603)
Q Consensus 411 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVySfGvvL~elltg----------~~p~~~~~~~~ 471 (603)
-....+.. .......||.+|||||++...- --..+||||||+|+||+.-+ +.||....+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 65333222 2234567999999999986431 12368999999999999753 23443322211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
. + .+...+.+-..++...++... ...+.+..+.+|+..||..+|.-|-|+--+.+.|.++..
T Consensus 444 P-s-~eeMrkVVCv~~~RP~ipnrW---------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 P-S-FEEMRKVVCVQKLRPNIPNRW---------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred C-C-HHHHhcceeecccCCCCCccc---------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1 1 111111222223333332221 234678899999999999999999999999999988864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.79 Aligned_cols=270 Identities=19% Similarity=0.269 Sum_probs=194.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--------C
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--------G 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~ 331 (603)
..+|...+.||+|+||+||+|... +++.||||++.... ....+|+.+|++++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457888999999999999999975 57899999986432 2345799999999999999999986432 1
Q ss_pred ceEEEEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeecc
Q 007442 332 EQILVYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFG 408 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFG 408 (603)
..++||||++ ++|.+++... ....+++...+.++.|++.||+|||+. +|+||||||+||||+.+. .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 3568999997 5788877542 235699999999999999999999998 999999999999998664 79999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
+++...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+.. . .....+....
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~-~i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--V-RIIQVLGTPT 291 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--H-HHHHHhCCCC
Confidence 998643221 22345689999999988654 6899999999999999999999998643322111 1 1111111000
Q ss_pred ccc--ccchhhhhcc-CC------CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 007442 488 LDE--IIDPLIIEHR-GH------SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 488 ~~~--~~d~~l~~~~-~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~ 543 (603)
... .+++...... .. ....+...+.++.+|+.+||+.+|.+|||+.|+++. ++.++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000 0000000000 00 000011234578899999999999999999998843 44443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=347.83 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=205.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...++||+|+||.||+|... +++.||||+++.. .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999975 5789999999753 2234567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 338 EFMPNGTLCQHLQRER---------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
||+++|+|.+++.... ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999997421 13467888999999999999999998 99999999999999999999999999
Q ss_pred Cccccccccc-----------------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcc
Q 007442 409 LSRLGMTEIS-----------------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471 (603)
Q Consensus 409 la~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~ 471 (603)
+++....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976411100 01112468999999999999999999999999999999999999986421110
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhh
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIRT 544 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eV~~~L~~i~~ 544 (603)
. ..... +.++.-. ......+..+.+++.+||+.+|++|| ++.++.+.|+....
T Consensus 239 -i----~~~~~--------i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 -I----SYRDV--------ILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred -h----hhhhh--------ccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00000 0111000 00113345688999999999999995 77888888888754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.48 Aligned_cols=266 Identities=19% Similarity=0.179 Sum_probs=199.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.+|...+.||+|+||.||++... .+..||||.+... ..+.+|+++|++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46888899999999999999764 3578999988653 345689999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
++. ++|.+++.. ...++|..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 995 789999843 35699999999999999999999998 999999999999999999999999999975332211
Q ss_pred -ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc-----
Q 007442 419 -HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII----- 492 (603)
Q Consensus 419 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----- 492 (603)
.......||+.|+|||++....++.++|||||||+||||++|+.||..............+...+....+.-..
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22234579999999999999999999999999999999999999987544332111111111111111100000
Q ss_pred -chhhhhc-cCCCCcc-------chHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 493 -DPLIIEH-RGHSDAG-------TLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 493 -d~~l~~~-~~~~~~~-------~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...+... ....... .......+.+++.+||..+|++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000000 01123467789999999999999999998865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.19 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=208.0
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|+..+.||+|.||+|-++.. ..|+.||||.+++. +.+.+-.+.+||+||+.|+||||+.++.+|...+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3466677899999999999985 67999999999765 4556667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||..+|.|.||+... ..|++.....++.||..|+.|.|.+ +++|||||.+|||||+++++||+||||+.++...
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999875 3499999999999999999999999 9999999999999999999999999999875432
Q ss_pred cceeccCCCCCCCcCccccccCCCC-cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLS-DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
...+...|++-|.+||.+.+..|. +..|-||+||+||-|+.|.-||+.... ......+..|...+-
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaYrEP----- 273 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAYREP----- 273 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccccCC-----
Confidence 344667899999999999988764 689999999999999999999974322 122334445544332
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+.+....-|+.+||..||++|.|+.+|+..
T Consensus 274 ------------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ------------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ------------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 223345679999999999999999998864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.13 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=199.8
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
|...+.||+|+||.||+|.+. ++..||+|.++... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445667999999999999875 57889999987543 4456788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.+++.. ..+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++....... ...
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 9999999864 3589999999999999999999998 99999999999999999999999999987643221 122
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....++..|+|||++.+..++.++||||||+++|||++|+.|+....+.. ....+..+. .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~~-----~~------- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKNS-----PP------- 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcCC-----CC-------
Confidence 33468899999999999899999999999999999999999875322211 011111111 01
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++||+|.+|+..
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111234578899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.10 Aligned_cols=192 Identities=20% Similarity=0.310 Sum_probs=166.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..+|...+.||+|+||.||+|+... +..||+|..... ....|+.++++++||||+++++++.+.+..++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3578899999999999999999864 678999975432 235699999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+ .|+|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 139 ~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred c-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 9 57999998654 34699999999999999999999998 9999999999999999999999999999752221 1
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccC
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
......||+.|+|||++.+..++.++||||||++||||+++..++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 2234568999999999999999999999999999999999777654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.84 Aligned_cols=252 Identities=31% Similarity=0.435 Sum_probs=200.4
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHH--HHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQ--QVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|...+.||+|+||+||+++... ++.||+|.+......... ...+|+.++.+++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3456789999999999999865 568999999887544333 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.++|... ..+++..++.++.|+++||+|||+. +|+|+||||+|||+++++.++|+|||.+... ......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999833 4589999999999999999999999 9999999999999999999999999998753 222233
Q ss_pred eccCCCCCCCcCccccc-cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQ-NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....++..|+|||++. +..++.++||||+|+++|+|++|..|+..... ............ ..+.. . .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~-~~~~~---~-~--- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILK-RPLPS---S-S--- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHH-THHHH---H-T---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhccc-ccccc---c-c---
Confidence 45567899999999998 88899999999999999999999999874311 111111111111 00000 0 0
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111368999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.83 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=198.9
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER----- 330 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 330 (603)
...++|...+.||+|+||.||++... .++.||||+++.. .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 5789999999754 334456788999999999999999999988643
Q ss_pred -CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 331 -GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 331 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 34689999996 467777753 388999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH-------------
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA------------- 476 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~------------- 476 (603)
++.... ........+|..|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 166 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 975322 22223456899999999999889999999999999999999999998643221110000
Q ss_pred ---HHHHHHhhc-CCcccccchhhhhc--cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 477 ---ALAADRISK-GRLDEIIDPLIIEH--RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 477 ---~~~~~~~~~-~~~~~~~d~~l~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
......+.. .....+..+..... ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000000000 000001112234578899999999999999999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.84 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEee
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE 329 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 329 (603)
.++.++..+...|+..+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 356677778889999999999999999999974 57899999986543 3446788999999999 69999999999863
Q ss_pred ------cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 007442 330 ------RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSK 403 (603)
Q Consensus 330 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~k 403 (603)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45679999999999999999876556689999999999999999999998 999999999999999999999
Q ss_pred EeeccCcccccccccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 404 VADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 404 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....+....
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 99999987532111 1123346889999999875 346788999999999999999999998643221111
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.. +..... +. .........+.+++.+||+.+|.+||++.|+++
T Consensus 236 -~~-~~~~~~-----~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FL-IPRNPP-----PK---------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hh-HhhCCC-----CC---------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 00 001123457889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=310.25 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=198.8
Q ss_pred CCccCcccCCCceEEEEEEEc----CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
|...+.||+|+||.||+|.+. +++.||||.++.. .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999864 3588999998754 3445678999999999999999999999886542
Q ss_pred ceEEEEeeCCCCCHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 332 EQILVYEFMPNGTLCQHLQRER----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
..++++||+++|+|.+++.... ...+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999999886432 12488999999999999999999998 9999999999999999999999999
Q ss_pred cCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 408 GLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 408 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
|+++....... .......+++.|++||.+....++.++||||||+++|||++ |+.|+..... ..+ ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHH----HHHHHc
Confidence 99886432211 11223345678999999998889999999999999999999 7777653211 111 111212
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
+.... ........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 231 ~~~~~---------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK---------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 0112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.62 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=202.7
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.|+..+.||.|+||.||+|... ++..||+|.++... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999975 57899999987543 455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.. .++++.....++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 99999999864 3589999999999999999999998 99999999999999999999999999997643221 22
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....++..|+|||++.+..++.++||||||+++|||+||+.|+....+... ...+..+.
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~------------- 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKNN------------- 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcCC-------------
Confidence 2334678899999999988899999999999999999999999864322110 01111111
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...........+.+++.+||+.+|++||++.+++..
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 --PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011122456678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.12 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=205.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999865 57889999997543 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
+++++|.+++..... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976543 5689999999999999999999998 999999999999999999999999999876433221
Q ss_pred c---eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 419 H---ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 419 ~---~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
. ......++..|+|||++... .++.++||||||+++|||++|+.|+....+.. ...+.+.... +
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP------P 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCC------C
Confidence 1 22334688999999998877 78999999999999999999999986432211 1111111110 0
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+. ...........+.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLE-----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcC-----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00001234567889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.93 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=200.6
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|+..+.||+|+||.||++... ++..||+|.++.. .....+.+.+|++++.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999986 6889999998754 3445578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 341 PNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++++|.+++.... ...+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 9999999987532 23599999999999999999999963 28999999999999999999999999998753221
Q ss_pred eeccCCCCCCCcCccccccC------CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 420 ISTAPQGTPGYLDPQYHQNF------HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .......+..+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~---- 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAIVDGDPP---- 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHHHhhcCCC----
Confidence 22334688899999998654 35889999999999999999999986422111 11111111121111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........++.+++.+||+.+|++||++.+++..
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 -----------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1112345678899999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.78 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=201.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999999874 5789999998754 334567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla~~~~~~~~ 418 (603)
+++++|.+++.......+++..++.++.+++.||+|||+. +|+|+||||+||+++++ ..+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9999999999876556699999999999999999999998 99999999999999865 46899999999764322
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......++..|+|||.+....++.++||||||+++|||++|+.|+...... ..+. .+..+....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~-~~~~~~~~~~------- 221 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVL-KIMSGTFAPI------- 221 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHH-HHHhcCCCCC-------
Confidence 1122346889999999999888999999999999999999999998643221 1111 1111111111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||+.+|++|||+.|++.
T Consensus 222 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.99 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=198.8
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
+|.....||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3566788999999999999874 578999998865422 123568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++|+||+++++|.+++... ..+++..+..++.+++.||+|||+. +++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999754 4589999999999999999999998 999999999999999999999999999876
Q ss_pred ccccccc-----eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 413 GMTEISH-----ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 413 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~--~~~~~~~~ 228 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA--IFKIGENA 228 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH--HHHHhccC
Confidence 4321111 112235788999999999888999999999999999999999998642211 00 11111110
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. + .........+.+++.+||+.+|++||++.||++
T Consensus 229 ~-----~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 S-----P----------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred C-----C----------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0 111223457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.71 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=174.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|+..+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999875 5789999999753 2334567888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999999754 3589999999999999999999998 99999999999999999999999999986432110
Q ss_pred ----------------------------------cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCc
Q 007442 418 ----------------------------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463 (603)
Q Consensus 418 ----------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p 463 (603)
........||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0001234699999999999999999999999999999999999999
Q ss_pred cCCC
Q 007442 464 VDFS 467 (603)
Q Consensus 464 ~~~~ 467 (603)
|...
T Consensus 236 f~~~ 239 (360)
T cd05627 236 FCSE 239 (360)
T ss_pred CCCC
Confidence 9643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=312.71 Aligned_cols=272 Identities=23% Similarity=0.303 Sum_probs=203.4
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ce
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQ 333 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 333 (603)
.+..|...+++|.|+||.||+|++. ++..||||++....... -+|+++|+.+.|||||+|+-++.... ..
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3445677889999999999999985 46899999997654321 35899999999999999999887533 23
Q ss_pred EEEEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCc
Q 007442 334 ILVYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLS 410 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla 410 (603)
.|||||||. ||.+++... .+..++.....-+..|+.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 589999986 899988742 234577777888999999999999998 99999999999999987 89999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG--- 486 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 486 (603)
+........ .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|...... +....+.+.+...
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTRE 248 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHH
Confidence 975543332 344678899999988765 7999999999999999999998887643322 2222233332211
Q ss_pred -------CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhhc
Q 007442 487 -------RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIRTR 545 (603)
Q Consensus 487 -------~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~~~ 545 (603)
...+.-.|.+...... .........+.++++.++|+++|.+|.++.|++.. ++.++..
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~-~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWH-KVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHhhcCcccccccCcccccccce-eecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1112223333221110 11334556789999999999999999999998853 5555543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.75 Aligned_cols=266 Identities=20% Similarity=0.287 Sum_probs=199.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|+....||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36778889999999999999986 58899999986542 2234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|..++... ..++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888877543 3599999999999999999999998 999999999999999999999999999986433211
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh-----------cC
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS-----------KG 486 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~~ 486 (603)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... ....... .+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY---LIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChHHhhhcccc
Confidence 2223457889999999876 468899999999999999999999986433222111 0000000 00
Q ss_pred Cc-ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RL-DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~-~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.. .....+...... ............+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETRE-PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCccccc-CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000000 000001123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.86 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=194.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--Cce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 333 (603)
.+|...+.||+|+||.||+|... ++..||+|+++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999875 57899999986432 23456788999999999999999999988753 567
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 8999999999999999754 3489999999999999999999988 9999999999999999999999999998753
Q ss_pred cccc--cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 414 MTEI--SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 414 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~---- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT---- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC----
Confidence 2211 1111234588999999999988899999999999999999999999863211 111111111110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+. ........+..++ +||..+|++||+|+||++
T Consensus 227 -~~~----------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -NPQ----------LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCC----------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 010 1112233455565 788899999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.52 Aligned_cols=275 Identities=19% Similarity=0.250 Sum_probs=197.6
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCC------Cceeeeee
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH------PNLVRLLG 325 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g 325 (603)
..+++...+.+|...++||+|+||+||+|... .++.||||+++... ...+++..|+.++..++| .+|+++++
T Consensus 120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34556667789999999999999999999875 57889999997542 223455667777777654 45899999
Q ss_pred eEeec-CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----
Q 007442 326 CSIER-GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---- 400 (603)
Q Consensus 326 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---- 400 (603)
++... ...+||||++ +++|.+++... ..+++..+..|+.|++.||+|||+. .+||||||||+||||+.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 88754 4678899988 78999998754 4599999999999999999999973 1899999999999998765
Q ss_pred ------------cEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC
Q 007442 401 ------------KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR 468 (603)
Q Consensus 401 ------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~ 468 (603)
.+||+|||++... ....+...||+.|+|||++.+..++.++|||||||+||||++|+.||+...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4999999987642 122345679999999999999999999999999999999999999997543
Q ss_pred CcchhhHHHHHHH----Hhh--------------cCCcccccchhhh-hccCCCCccchHHHHHHHHHHHHHhccCCCCC
Q 007442 469 PPNEVNLAALAAD----RIS--------------KGRLDEIIDPLII-EHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529 (603)
Q Consensus 469 ~~~~~~l~~~~~~----~~~--------------~~~~~~~~d~~l~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 529 (603)
..+...+...... .+. .+.+....++... ................+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 3221111110000 000 0011111111100 00000000011123567899999999999999
Q ss_pred CCHHHHHH
Q 007442 530 PSMTEVAT 537 (603)
Q Consensus 530 Psm~eV~~ 537 (603)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999886
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.00 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=207.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|++|.||+++..+ ++.|+||++..... ...+++.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999874 89999999987644 4568899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999764 458999999999999999999999 8 999999999999999999999999999876432221
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......++..|+|||.+.+..++.++||||||+++|||+||+.|+..........+ ...+.......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~-------- 222 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL----MQAICDGPPPS-------- 222 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH----HHHHhcCCCCC--------
Confidence 12244688999999999998999999999999999999999999865432111111 11111111110
Q ss_pred ccCCCCccchH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 499 HRGHSDAGTLA-SVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 499 ~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 223 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 45678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.32 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=198.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh----------hhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT----------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 688999998864211 12356788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 4589999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc-ceeccCCCCCCCcCccccccCC--CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 412 LGMTEIS-HISTAPQGTPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 412 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
....... .......++..|+|||++.... ++.++||||||+++|||++|..|+...... ....+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG-NKRS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh-cccc
Confidence 5332111 1223456889999999987654 889999999999999999999998532111 1111111 1111
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+++ .........+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPP----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCc----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 111234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.22 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=201.7
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER- 330 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~- 330 (603)
.+.+...++|...+.||+|+||+||+++.. ++..||+|.+... .......|..|+.++.+++|||||++++++.+.
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344555678999999999999999999975 4678999998754 334567889999999999999999999988653
Q ss_pred -CceEEEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeeecCC----
Q 007442 331 -GEQILVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAIN----PPIYHRDIKSSNILLDYN---- 399 (603)
Q Consensus 331 -~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~----~~ivH~Dik~~NILld~~---- 399 (603)
...+|||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+... .+||||||||+||||+.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 46889999999999999997532 2469999999999999999999998521 359999999999999643
Q ss_pred -------------CcEEEeeccCcccccccccceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCcc
Q 007442 400 -------------FKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 400 -------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
..+||+|||+++..... .......||+.|+|||++.. ..++.++|||||||+||||+||+.||
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 34899999999764221 12234579999999999854 45889999999999999999999998
Q ss_pred CCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 465 DFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 465 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..... .. .+...+..+.... .......+.+|+.+||+.+|.+||++.|++.
T Consensus 244 ~~~~~-----~~-qli~~lk~~p~lp----------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANN-----FS-QLISELKRGPDLP----------------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCc-----HH-HHHHHHhcCCCCC----------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 64222 11 1122222221000 0112456889999999999999999999984
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.07 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=200.0
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC------hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
+|+..+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 567899999987532 2245788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGM 414 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~ 414 (603)
|+||+++++|.+++... .++++..++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999754 3589999999999999999999998 999999999999998775 59999999987643
Q ss_pred cccc---ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 415 TEIS---HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 415 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... .......++..|+|||++.+..++.++||||+|++++||++|+.|+........ ..... .+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~-~~~~~~~~-- 229 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIF-KIASATTA-- 229 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHH-HHhccCCC--
Confidence 3211 111234578899999999888899999999999999999999999864322111 11111 11110000
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..........+.+++.+||+.+|++||++.|++.
T Consensus 230 ------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 ------------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111233457888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.02 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=203.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667788999999999999986 57899999987653 345578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++++|.+++.... ..+++....+++.+++.||+|||+ . +++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999997653 568999999999999999999999 7 999999999999999999999999999875432211
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
....++..|+|||++.+..++.++||||||+++|||++|+.|+......... .... .+.+..+....
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~--------- 223 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFEL-LQYIVNEPPPR--------- 223 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHH-HHHHhcCCCCC---------
Confidence 1256889999999999889999999999999999999999998643221111 1111 11111111100
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||..+|++|||+.|++.
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 -----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 001114556889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=312.31 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=202.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999986 4789999998754 23345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++++.|..++.. ...+++...+.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9998777665543 24589999999999999999999998 999999999999999999999999999887544332
Q ss_pred ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh---------cC--
Q 007442 419 HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS---------KG-- 486 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~---------~~-- 486 (603)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+......+...........+. ..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233445678899999999888 889999999999999999999988864322111100000000000 00
Q ss_pred ---CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 ---RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ---~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+.+..++.... .........++.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLE-----RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHH-----HhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000111110000 0011123677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.10 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=198.8
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
...||+|+||.||++... +++.||+|.++.......+.+.+|+.++..++||||+++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346999999999999875 6889999999766555567789999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 178 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLV 178 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccccee
Confidence 998754 3489999999999999999999998 99999999999999999999999999987533221 2223456
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
++..|+|||++.+..++.++||||||+++|||++|+.||....+... ...+....... . .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~--------~ 238 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------MKRLRDSPPPK-----L--------K 238 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCCC-----c--------c
Confidence 89999999999988899999999999999999999999864322111 11111111000 0 0
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.+|++||++.||++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011223467889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.80 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=201.9
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC-----
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG----- 331 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~----- 331 (603)
.++++|...+.||+|+||.||+|... +++.+++|.+..... ..++|.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46788999999999999999999985 568899999876543 347799999999999 6999999999997655
Q ss_pred -ceEEEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 332 -EQILVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 332 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 3899999999999999997643 45699999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
++...... ........++..|+|||++.. ..++.++||||||++|+||++|+.||...... .... .+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~ 230 (275)
T cd06608 159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALF-KI 230 (275)
T ss_pred cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHH-Hh
Confidence 98753221 122234568899999998753 34678999999999999999999998632111 1111 11
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+....+. ........+.+++.+||..||++|||+.||++
T Consensus 231 ~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLK-------------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCC-------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111110 11124557889999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=323.82 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=197.6
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------ 330 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 330 (603)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568889999999999999999875 5788999999754 334456788999999999999999999987543
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 578777753 388999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh------
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS------ 484 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~------ 484 (603)
+.... ........+|..|+|||++.+..++.++||||||++||||++|+.||......+.. ..+...+.
T Consensus 174 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEF 248 (364)
T ss_pred cccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHH
Confidence 75322 12223456899999999999999999999999999999999999998643321111 00110000
Q ss_pred ------------cC--Ccccc-cchhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 485 ------------KG--RLDEI-IDPLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 485 ------------~~--~~~~~-~d~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+. ..... .+...... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000 00000000 000000111224567899999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.76 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=198.7
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|+..+.||.|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 57899999987542 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+. ++|.+++.......+++..++.++.+++.||+|||+. +++||||+|+||++++++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 95 6899999776556799999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred eeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||....... .+.. ..... +...+.+.+....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~-~~~~~--~~~~~~~~~~~~~ 230 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFR-IFRTL--GTPDEVVWPGVTS 230 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHh--CCCChhhhhhhhH
Confidence 123335688999999887644 6889999999999999999999986432111 1111 11110 0000000000000
Q ss_pred ------ccC-----CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 ------HRG-----HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ------~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... ............+.+++.+||+.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000001122356778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.71 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=202.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 337 (603)
+|+..+.||.|+||.||++... ++..||+|.++.. .....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999864 6789999998754 34456778999999999999999999998764 34578999
Q ss_pred eeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 338 EFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAI--NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
||+++++|.+++.... ...+++...+.++.+++.||+|||... ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999997642 346999999999999999999999322 239999999999999999999999999999864
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.... .......+++.|++||++.+..++.++||||||+++++|++|+.|+..... ....+.+..+....
T Consensus 161 ~~~~-~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~--- 229 (265)
T cd08217 161 GHDS-SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFRR--- 229 (265)
T ss_pred cCCc-ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCCC---
Confidence 3322 112344689999999999988899999999999999999999999864321 11222233322211
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.+|++||++.+|++.
T Consensus 230 ------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.14 Aligned_cols=194 Identities=23% Similarity=0.352 Sum_probs=160.0
Q ss_pred cCcccCCCceEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEEEeeCC
Q 007442 267 KQRLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILVYEFMP 341 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 341 (603)
..+||+|+||+||+|+.. +++.||+|.++... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999875 45789999987542 23457889999999999999999999864 346789999985
Q ss_pred CCCHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeccCc
Q 007442 342 NGTLCQHLQRER-------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVADFGLS 410 (603)
Q Consensus 342 ~gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl----d~~~~~kl~DFGla 410 (603)
++|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875321 22488999999999999999999998 99999999999999 45678999999999
Q ss_pred cccccccc--ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 411 RLGMTEIS--HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 411 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
+....... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 86432211 12234568999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.01 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=199.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999986 478999999865422 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.++.... ..++|..++.++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998877543 3489999999999999999999998 99999999999999999999999999987643322
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc----cccc
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD----EIID 493 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~d 493 (603)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+. ........ +.+. +..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~ 229 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ---LYHIIKCL--GNLIPRHQEIFQ 229 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH---HHHHHHHh--CCCchhhHHHhc
Confidence 22233457889999999875 4578899999999999999999988863322111 00001000 0000 0000
Q ss_pred ------hhhhhccCC---CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 ------PLIIEHRGH---SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ------~~l~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......... ...........+.+++.+||+.+|++||++.||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 00001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.97 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=204.5
Q ss_pred cCcccCCCceEEEEEEEcC--C--cEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 267 KQRLGTGAFGTVYAGKLQN--D--LLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~--~--~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.++||+|.||.|++|.+.. | ..||||.++..... ...+|++|+.+|-+|+|+|+++|+|+..+ ...+||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4679999999999998853 3 56999999977544 77899999999999999999999999887 78899999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc-cccce
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-EISHI 420 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~-~~~~~ 420 (603)
.|+|.+.|++.....|.-.....++.|||.||.||.++ ++|||||..+|+||-..-.+||+||||.|.+.. +..+.
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999985556688888999999999999999999 999999999999999999999999999997543 33333
Q ss_pred ec-cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 421 ST-APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 421 ~~-~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.. ...-.+.|.|||.++...++.+||||+|||+||||+| |..||-.... ..+++.+.++
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~~iD~~------------ 331 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILKNIDAG------------ 331 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHHhcccc------------
Confidence 32 2345678999999999999999999999999999998 4556542211 1222222222
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
+.-.....+.+.+.+++.+||..+|.+|||+..|.+.+-
T Consensus 332 ---erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 ---ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 122335568899999999999999999999999985543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.07 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=198.4
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999875 5789999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.. ..+++..++.++.+++.||+|||+. +|+||||||+||++++++.+||+|||++....... .......
T Consensus 107 ~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 179 (292)
T cd06658 107 TDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLV 179 (292)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceee
Confidence 999854 3489999999999999999999998 99999999999999999999999999987533221 1123346
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
++..|+|||++.+..++.++||||||+++|||++|+.|+........ ...+... +.+.+.
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~-----~~~~~~-------- 239 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRDN-----LPPRVK-------- 239 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-----CCCccc--------
Confidence 88999999999888899999999999999999999999863222110 1111110 111110
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+..++.+||+.+|++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011233467789999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.23 Aligned_cols=259 Identities=25% Similarity=0.322 Sum_probs=202.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 337 (603)
++|...+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999985 57899999997543 24557799999999999999999999998654 3689999
Q ss_pred eeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++++|.+++... ....+++...+.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988643 234589999999999999999999998 999999999999999999999999999875322
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ... ....+.......+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIE-LLSYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHH-HHHHHhcCCchhhccC-
Confidence 11 12345788999999999989999999999999999999999998754321111 111 1111111111111000
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..........+.+++.+||+.+|++||||.||++
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 --------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0101123567889999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.00 Aligned_cols=267 Identities=22% Similarity=0.284 Sum_probs=201.7
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999975 68899999997654 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999997653 5699999999999999999999998 9999999999999999999999999998864433222
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc------cccc
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL------DEII 492 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~~ 492 (603)
......++..|+|||++.+. .++.++||||||++++||++|+.++..... ..........+..... .+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 468899999999999999999766643221 1111111111111000 0000
Q ss_pred chhhhhccCCC----CccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHS----DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.......... .....+....+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0001123478899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.38 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=201.6
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999875 678999999986644 3678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++... ..+++..+..|+.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999999754 3488999999999999999999998 9999999999999999999999999998764332222
Q ss_pred eec---cCCCCCCCcCccccccCC---CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 420 IST---APQGTPGYLDPQYHQNFH---LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 420 ~~~---~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... ...++..|++||++.... ++.++||||||+++|||++|+.||....... .... .+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~--- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMF-HVGAGHKPP--- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHH-HHhcCCCCC---
Confidence 111 346788999999998766 8899999999999999999999986432111 1111 111111100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+ .........+.+++.+||+.+|++||++.|++.
T Consensus 227 --~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 --I--------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --C--------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 001122456778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.31 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh---hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||++...+ ++.||+|.+..... ...+.+.+|++++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999864 88999999976532 35567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+.+++|.+++.......+++..++.++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999866556799999999999999999999998 99999999999999999999999999986532111
Q ss_pred c----------------------------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCC
Q 007442 418 S----------------------------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP 469 (603)
Q Consensus 418 ~----------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~ 469 (603)
. .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 011123578899999999988899999999999999999999999864322
Q ss_pred cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.. ...... .....- .........+.+++.+||+.+|++||+++..+++|-
T Consensus 238 ~~------~~~~~~-~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 238 DE------TFSNIL-KKEVTF--------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HH------HHHHHh-cCCccC--------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 11 111111 111100 001114567899999999999999999555444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=306.48 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=206.0
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..+++|...+.||+|+||.||+|... ++..|++|.++.... ..+.+.+|++++++++|+||+++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888889999999999999986 678999999987654 5678899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++.... ..+++..++.++.+++.||+|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999998753 4699999999999999999999998 99999999999999999999999999886532221
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......++..|++||++.+..++.++||||||+++|||++|+.|+....+.. ... .+.........+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~~~---- 238 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALF-LITTKGIPPLKN---- 238 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhcCCCCCcc----
Confidence 12233457889999999988889999999999999999999999985322211 111 111111111100
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||+.+|.+||++.+|++
T Consensus 239 ---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 ---------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.75 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=202.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||++... .++.||+|.++... ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999986 46899999987653 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... ..+++..+..++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 3589999999999999999999998 99999999999999999999999999987421100
Q ss_pred --------------cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 418 --------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 418 --------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
........++..|+|||++....++.++||||||+++|||++|+.||..... .. +....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~-~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EE-LFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHH
Confidence 0011224578899999999888899999999999999999999999863221 11 11121
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
..+... .+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIE---WPE----------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccC---CCC----------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 010 001234568899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.72 Aligned_cols=265 Identities=20% Similarity=0.261 Sum_probs=195.5
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER----- 330 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 330 (603)
...++|...+.||+|+||+||+|... ++..||||+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34577888999999999999999874 57899999997542 23446678999999999999999999987543
Q ss_pred -CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 331 -GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 331 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 7899888753 3499999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
++.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ......... ...
T Consensus 165 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~-~~~ 236 (343)
T cd07878 165 ARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVG-TPS 236 (343)
T ss_pred ceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhC-CCC
Confidence 975322 1234468999999999876 5789999999999999999999999864321110 000000000 000
Q ss_pred ccccch--------hhhhccCCCC----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 DEIIDP--------LIIEHRGHSD----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 ~~~~d~--------~l~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+.+.. .+........ .........+.+|+.+||+.||++|||+.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 0000122357799999999999999999998853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=306.16 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=202.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999986 47889999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~~~ 418 (603)
+++++|.+++.......++|..++.++.+++.||+|||+. +++|+||||+||++++++ .+||+|||.+...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-M 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC-c
Confidence 9999999999876555689999999999999999999998 999999999999999885 4699999998764322 2
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......|++.|+|||++.+..++.++||||||+++|||++|+.|+.... ......... .+....+
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~------- 222 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYFAPI------- 222 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccCCCC-------
Confidence 22233468999999999988889999999999999999999999985321 122222221 2211111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||+.+|++|||+.||++
T Consensus 223 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.41 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=198.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD-----GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||.||+|... +++.||||+++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999975 5889999999765322 345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997643 3699999999999999999999999 9999999999999999999999999999764322
Q ss_pred ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---------
Q 007442 417 ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG--------- 486 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 486 (603)
. .......+++.|+|||.+.+ ..++.++||||||++++||++|..++......+. +. .....+...
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 N-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LG-KIFEALGTPTEENWPGVT 231 (298)
T ss_pred C-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HH-HHHHHcCCCchhhhhhcc
Confidence 1 12233356788999998865 4678999999999999999999666643222111 11 111111000
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+.......... ..............+.+++.+||+.+|++|||+.||++
T Consensus 232 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFP-PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccC-CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000 00000111233567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=301.61 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=195.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--Cce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 333 (603)
.+|...+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999875 57899999886321 23456788999999999999999999998764 457
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++++|.+++... ..+++...++++.+++.||+|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 7999999999999999754 3488899999999999999999998 9999999999999999999999999998753
Q ss_pred cccc--cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 414 MTEI--SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 414 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.|+...... ..... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~-- 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFK-IATQPTN-- 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHH-HhcCCCC--
Confidence 2211 11123345889999999998888999999999999999999999998532111 11111 1111100
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+......+.+++.+|+. +|++||++.||++
T Consensus 228 ------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 ------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01122334567788999985 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.94 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=203.7
Q ss_pred cccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHH
Q 007442 269 RLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 347 (603)
+||+|.||+||.|+..+ ...+|||.+...+....+-+.+||.+-++++|.|||+++|.+.+.+..-+.||-+|+|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999765 56799999998888888899999999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeccCcccccccccceeccC
Q 007442 348 HLQRERGDGL--SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAP 424 (603)
Q Consensus 348 ~l~~~~~~~l--~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~ 424 (603)
+|... -.+| ++...-.+..||++||.|||.. .|||||||-.|||++ -.|.+||+|||.++.. ......+...
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL-AginP~TETF 736 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL-AGINPCTETF 736 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh-ccCCcccccc
Confidence 99754 3455 7778888999999999999999 999999999999995 5789999999999763 3344556677
Q ss_pred CCCCCCcCccccccC--CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 425 QGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 425 ~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
.||..|||||++..+ .|+.++|||||||.+.||.||+.||.....+....+ +-|-. ..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGmy------------Kv 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGMY------------KV 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcce------------ec
Confidence 899999999999876 588899999999999999999999964333322111 01100 01
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.++-+.+...+...++.+|+..+|.+||+++++++.
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 112344567788899999999999999999998853
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.53 Aligned_cols=243 Identities=26% Similarity=0.452 Sum_probs=198.1
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccC----ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc--eEEEEee
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE--QILVYEF 339 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~E~ 339 (603)
..+||+|+|-+||||... +|..||--.++.. .....+.|..|+.+|+.|+|||||+++..|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999875 4777876655532 45567899999999999999999999999987665 7789999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla~~~~~~~~ 418 (603)
+..|+|..|+.+.+. ++......|+.||++||.|||++ .|+|||||||-.||||+.+ |.+||+|+|||.+... .
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--S 199 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--c
Confidence 999999999987754 78889999999999999999997 8899999999999999876 7899999999987432 2
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
+ ...+.|||.|||||.+. ..|.+..||||||+.++||+|+..|+..-+. ...+.+++..|.....++..
T Consensus 200 ~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 200 H-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV--- 268 (632)
T ss_pred c-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc---
Confidence 2 23378999999999887 7899999999999999999999999864333 22334444455433322221
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...++.++|.+||.. .++|||+.|++.
T Consensus 269 -----------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 -----------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 123677899999999 999999999885
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.03 Aligned_cols=194 Identities=23% Similarity=0.354 Sum_probs=159.4
Q ss_pred cCcccCCCceEEEEEEEcC---CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEEEeeCC
Q 007442 267 KQRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILVYEFMP 341 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 341 (603)
..+||+|+||+||+|+..+ +..||+|.++... ....+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 4789999987543 23467889999999999999999999864 456789999986
Q ss_pred CCCHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeccCc
Q 007442 342 NGTLCQHLQRER-------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVADFGLS 410 (603)
Q Consensus 342 ~gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl----d~~~~~kl~DFGla 410 (603)
++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 58888875321 22488999999999999999999998 99999999999999 56678999999999
Q ss_pred cccccccc--ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 411 RLGMTEIS--HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 411 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
+....... .......+|+.|+|||++.+ ..++.++||||||+++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 86433211 11233468999999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.16 Aligned_cols=267 Identities=22% Similarity=0.249 Sum_probs=197.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677789999999999999985 68899999997542 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ ++|.+++... ...+++...+.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 96 5888888654 34599999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC------ccccc
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR------LDEII 492 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 492 (603)
......++..|+|||++.+. .++.++||||||+++|||+||+.|+.......+ .+ ......+.... +....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhcc
Confidence 12334578899999998764 478999999999999999999998753322111 11 11111110000 00000
Q ss_pred chhhhhccCCC---CccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHS---DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.......... .........++.+++.+||+.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 0111224567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.58 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=197.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..|...+.||+|+||+||+|... +++.||+|.+... .....+++.+|+++++.++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999875 5789999998643 2344567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9996 6888877644 34599999999999999999999998 999999999999999999999999999875322
Q ss_pred cceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.....++..|+|||++. ...++.++||||||+++|||+||+.|+...... .. ...+..+....
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~-~~~~~~~~~~~---- 233 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA-LYHIAQNDSPT---- 233 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HH-HHHHhcCCCCC----
Confidence 12346788999999874 456889999999999999999999988532111 10 11111111000
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++||+|.+|+..
T Consensus 234 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ----------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0112245578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.74 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=204.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.|...+.||+|++|.||++... ++..+++|+++.......+++.+|++++++++|+||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 678999999987765567889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.+++.... ..+++..++.++.+++.||+|||.. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999997643 4699999999999999999999998 999999999999999999999999999876433221 3
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....++..|++||++....++.++||||||++++||++|+.|+........ .. ...........+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~~~~-------- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LF-KIATNGPPGLRN-------- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HH-HHHhcCCCCcCc--------
Confidence 345688999999999988899999999999999999999999864321111 00 111111111111
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 220 -----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112457889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.36 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=197.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999976 6789999998754322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ ++|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SK 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC-Cc
Confidence 97 59999987653 3689999999999999999999998 9999999999999999999999999998753211 11
Q ss_pred eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---cccc----
Q 007442 420 ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR---LDEI---- 491 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~---- 491 (603)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.......+ ........+.... ....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcc
Confidence 1223356889999998865 4588999999999999999999999864321111 1111111111100 0000
Q ss_pred ---------c-chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 ---------I-DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ---------~-d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ...+.. ..........+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLIN-----HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHH-----hCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000 0001111257789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=304.87 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=200.9
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
|...+.||+|++|.||++... +++.+++|+++.......+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 6789999999876666667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
++|.+++.. ..+++..++.++.+++.||+|||+. +|+||||+|+||+++.++.++|+|||++....... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 999999976 3489999999999999999999998 99999999999999999999999999887533221 1223
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...|+..|+|||.+.+..++.++||||||+++|||++|+.|+....+. .. ...+..+.. +.+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~-~~~~~~~~~-----~~~------ 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QA-MKRIRDNLP-----PKL------ 235 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HH-HHHHHhcCC-----CCC------
Confidence 346889999999998888999999999999999999999998642221 11 111221111 000
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.++++
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001123457889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=306.21 Aligned_cols=260 Identities=24% Similarity=0.280 Sum_probs=198.9
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEEEe
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILVYE 338 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 338 (603)
|...+.||+|+||.||+|... +++.+|+|+++... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456778999999999999976 47899999998763 33456788999999999999999999999888 88999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++ ++|.+++.... ..+++..++.++.+++.||+|||+. +++|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48999886542 4699999999999999999999998 999999999999999999999999999986443322
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc---CCcc-----
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK---GRLD----- 489 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~----- 489 (603)
...+...++..|+|||.+.+ ..++.++||||||+++|||+||+.|+........ .......... ....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 22334457889999997764 4678999999999999999999999864332211 1111111100 0000
Q ss_pred ---------cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 ---------EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ---------~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+.. .....+...+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLRE------FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHH------HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 000112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.09 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|+..+.||.|++|.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999875 68999999987543 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
+ ++|.+++.......+++..++.++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cc
Confidence 4 7999999776545699999999999999999999998 99999999999999999999999999997532211 11
Q ss_pred eccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc------
Q 007442 421 STAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID------ 493 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------ 493 (603)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ +... .+.. +...+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~-~~~~--~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRI-FRTL--GTPDEDVWPGVTSL 230 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHh--CCCChHHhhhhhhc
Confidence 2233568899999987654 578899999999999999999998864322111 1110 1100 00000000
Q ss_pred hhhh-----hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 PLII-----EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~~l~-----~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+... ................+.+++.+||+.+|++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000000111223457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.40 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=194.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHH-HhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKL-ISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||.||++... +++.||+|+++... .....++..|+.+ ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999985 58999999997652 2333456666665 566789999999999999999999999
Q ss_pred eCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 339 FMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|++ |+|.+++.... ...+++...+.++.|++.||+|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 78988886532 346899999999999999999999752 7999999999999999999999999998764321
Q ss_pred ccceeccCCCCCCCcCcccccc----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 417 ISHISTAPQGTPGYLDPQYHQN----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
...+...++..|+|||++.+ ..++.++||||||+++|||++|+.|+.......+ .....+ .+....+.
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~-~~~~~~~~ 229 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QLKQVV-EEPSPQLP 229 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HHHHHH-hcCCCCCC
Confidence 12233468899999998864 4568899999999999999999999853221111 111111 11111100
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+.++.+++.+||+.+|++||++.+|++
T Consensus 230 --------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 --------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123457889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.49 Aligned_cols=270 Identities=23% Similarity=0.273 Sum_probs=198.0
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++.+|...+.||+|+||.||+|... ++..||+|+++.... .....+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578889999999999999999874 578999999975532 22346788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP- 156 (291)
T ss_pred eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC-
Confidence 9995 7888877543 24588889999999999999999998 9999999999999999999999999998753221
Q ss_pred cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---------C
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---------R 487 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 487 (603)
........+++.|+|||++.+. .++.++||||||++||||++|+.||+......+. ....+..+... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhhhh
Confidence 1112333578999999998754 5788999999999999999999998643321111 00111110000 0
Q ss_pred cccccchhhhhccCC---CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDEIIDPLIIEHRGH---SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.............. ...........+.+++.+|++.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 00000112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.75 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=203.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999864 67889999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++++|.+++... .+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc-cc
Confidence 999999999643 488999999999999999999998 99999999999999999999999999987533222 12
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....+++.|++||++....++.++||||||+++||+++|+.||.......... .....+. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~-~~---------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT-PE---------- 234 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC-CC----------
Confidence 233468889999999988889999999999999999999999996432211110 0000000 00
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..........+.+++.+||+.+|++||++.+++..
T Consensus 235 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 ---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111234568889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.17 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
|...+.||+|+||.||+|... ++..||||.+.... ....+.|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556778999999999999874 67899999986543 3445778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.+++.. ..+++...+.++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~~ 158 (277)
T cd06641 86 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKR 158 (277)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc-hhhh
Confidence 9999999864 3589999999999999999999998 9999999999999999999999999998754322 1122
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....++..|+|||++.+..++.++||||||+++|||++|+.|+...... .....+..+...
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------------ 219 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPP------------ 219 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcCCCC------------
Confidence 3346888999999998888999999999999999999999998532211 111111111110
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111234568889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.50 Aligned_cols=272 Identities=22% Similarity=0.274 Sum_probs=201.9
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhccCCCc-eeeeeeeEeecC------c
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD--GIQQVVNEIKLISCVSHPN-LVRLLGCSIERG------E 332 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------~ 332 (603)
.|...++||+|.||+||+|+.+ +|+.||+|+++....+ .-..-.+|+.+|++++|+| ||+|.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3445567999999999999874 6889999999876432 2345689999999999999 999999998877 7
Q ss_pred eEEEEeeCCCCCHHHHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 333 QILVYEFMPNGTLCQHLQRERG--DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
.+||+||+ .-+|..++..... ..++-.....++.|+++||+|||++ +|+||||||+||||++++.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 88999999 5599999987643 3577788999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG--- 486 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 486 (603)
+..... ....+...+|.-|.|||++.+. .|+...||||+|+++.||++++..|..... ......+.+.+...
T Consensus 168 ra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 168 RAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCcc
Confidence 863321 2224555788889999999876 799999999999999999998877764332 22222222222211
Q ss_pred Ccccc---cchhhhhccCC-CCccc---hHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhh
Q 007442 487 RLDEI---IDPLIIEHRGH-SDAGT---LASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHI 542 (603)
Q Consensus 487 ~~~~~---~d~~l~~~~~~-~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i 542 (603)
.+... .|-........ ..... ........+++.+||+.+|.+|.|++..++. +..+
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11110 01100000000 00000 1111467899999999999999999998875 5444
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=303.20 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=198.9
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhccC---CCceeeeeeeEeecCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVS---HPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 337 (603)
.|+..+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999997 46889999998754 3445677889999999997 999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... .+++...+.++.+++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998643 589999999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......|+..|+|||++.++ .++.++||||||+++|||++|+.|+........ . ..+.... .+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~-----~~~~ 222 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSK-----PPRL 222 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCC-----CCCC
Confidence 222334688999999998754 468899999999999999999999864322111 0 0111110 0111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ......++.+++.+||+.+|++||++.|+++
T Consensus 223 ~---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 E---------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C---------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 0113457889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.65 Aligned_cols=237 Identities=25% Similarity=0.378 Sum_probs=195.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999875 5789999998653 2334577889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999764 4589999999999999999999998 9999999999999999999999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+..... ......+..+...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-------- 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKVR-------- 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcc--------
Confidence 2334688999999999888889999999999999999999999864321 1111122222110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP 530 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 530 (603)
........+.+++.+||+.+|.+||
T Consensus 217 --------~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 217 --------FPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred --------CCccCCHHHHHHHHHHccCCHHHcc
Confidence 0111245678899999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.62 Aligned_cols=272 Identities=24% Similarity=0.315 Sum_probs=199.3
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec--Cce
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 333 (603)
..++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999976 5789999998642 334456778899999999 999999999998654 367
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||++ ++|.+++... .++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 6999988653 589999999999999999999998 9999999999999999999999999999864
Q ss_pred ccccc----ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH--------H
Q 007442 414 MTEIS----HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA--------A 480 (603)
Q Consensus 414 ~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~--------~ 480 (603)
..... .......++..|+|||++.+ ..++.++||||||+++|||+||+.||............... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 33221 12233468899999998764 46788999999999999999999998643222111000000 0
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+......++++...................++.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001111000000000001111245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.97 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=204.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 337 (603)
+|...+.||+|++|.||+|... ++..|++|.++.... ...+.+.+|++++++++|+||+++++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 688999999976542 5578899999999999999999999999988 8899999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++.... .++|..++.++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997653 699999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.. ......++..|++||.+.....+.++||||||++++||++|+.|+..... ...........+...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEPP------- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCCc-------
Confidence 10 12345688999999999888899999999999999999999999864331 111111111001111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+|++.+|++||++.|++.
T Consensus 224 --------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 --------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111123567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=288.73 Aligned_cols=254 Identities=24% Similarity=0.277 Sum_probs=206.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--------hhhHHHHHHHHHHHhccC-CCceeeeeeeEe
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--------TDGIQQVVNEIKLISCVS-HPNLVRLLGCSI 328 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 328 (603)
..-+.|...+.||+|..++|-+..++ ++..+|+|++.... ....+.-.+|+.||+++. ||+|++|.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456788889999999999887764 57889999986431 122345568999999995 999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
.+.-.++|+|.|+.|.|+|+|... -.+++....+|+.|+.+|++|||.. +||||||||+|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999999764 4589999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCcccccc------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQN------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
++..... ........||++|+|||.+.- ..|+...|.|+.||++|-|+.|..||.. .........
T Consensus 169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-------RkQmlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-------RKQMLMLRM 239 (411)
T ss_pred eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-------HHHHHHHHH
Confidence 9986433 334456789999999998753 3578899999999999999999999862 123344556
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+.+|+..- -. +.-.+....+.+|+.+||+.||.+|-|.+|++..
T Consensus 240 ImeGkyqF-~s-----------peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQF-RS-----------PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhccccc-CC-----------cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 66665421 11 1122445678899999999999999999998853
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.82 Aligned_cols=273 Identities=23% Similarity=0.276 Sum_probs=203.0
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEecc--CChhhHHHHHHHHHHHhccCCCceeeeeeeEee-----cC
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-----RG 331 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~ 331 (603)
....|...+.||+|+||.|.++... +|..||||++.. .+.-..++-.+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445555788999999999999874 689999999973 345556778899999999999999999998765 45
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++|+|+| .-+|...|+.. ..|+......+..|+++||.|+|+. +|+||||||+|+|++.+...||+|||+||
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 789999999 66888888754 3489999999999999999999999 99999999999999999999999999999
Q ss_pred ccccc-ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH--------HH
Q 007442 412 LGMTE-ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA--------AD 481 (603)
Q Consensus 412 ~~~~~-~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~--------~~ 481 (603)
..... .....|....|.-|.|||.+.+ ..||.+.||||.||+|.||++|+.-|.+....+...+.... ..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 75322 2233466788999999998764 58999999999999999999999888654433332222111 11
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+........+.......+..............++|+.+||..||.+|+|++|.++.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111000000000000000112334567899999999999999999997754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=300.48 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=202.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
+|...+.||.|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999999999999986 58899999997542 2456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.+++... .++++...+.|+.++++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999764 4689999999999999999999998 99999999999999999999999999987643321
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......++..|+|||++.+..++.++||||||+++|+|++|+.|+...... ....+....... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--~~-------- 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA--DV-------- 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc--cc--------
Confidence 223456888999999999888999999999999999999999998754332 111112221110 00
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM--TEVA 536 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm--~eV~ 536 (603)
.........+.+++.+||+.+|.+||++ +|++
T Consensus 220 ------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 ------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111234678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=303.83 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=199.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+|+..+.||.|++|.||+|+.. ++..||||.++.... ...+.+.+|++++++++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999985 578999999986533 23467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 341 PNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+ |+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VN 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC-cc
Confidence 8 48999887543 24589999999999999999999998 9999999999999999999999999999753221 11
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---------Ccc
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---------RLD 489 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~ 489 (603)
......++..|++||++.+. .++.++||||||+++|||++|+.|+......+... ......... ...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL---KIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCChhhHHHHhcCc
Confidence 22334578899999988654 57889999999999999999999986443322111 111110000 000
Q ss_pred cccchhhhhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... ....... .............+.+++.+||+.+|.+||++.||++
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000 0000001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.17 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=198.1
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||+|+||.||+|+.. ++..||+|++... ..+..+++.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556778999999999999975 5789999998743 233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ |+|.+++... ..+++|..+..++.+++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5888887654 34599999999999999999999998 999999999999999999999999999875322
Q ss_pred eeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 420 ISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+..... ... ...+..+....
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~-~~~~~~~~~~~------ 243 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA-LYHIAQNESPT------ 243 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHH-HHHHHhccCCC------
Confidence 22346888999999974 45789999999999999999999998753211 111 11111111100
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.........+.+++.+||+.+|++||++.+|++.+-.+.
T Consensus 244 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 --------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 001123456889999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.22 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=211.2
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh---hhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT---DGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 334 (603)
....|...+.||+|.||.||+++.+. |+.+|+|.++.... ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34567778899999999999999875 89999999976633 24568999999999998 999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEeeccCc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN----FKSKVADFGLS 410 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~----~~~kl~DFGla 410 (603)
+|||++.+|.|.+.|... .+++.....++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999776 399999999999999999999998 99999999999999543 47999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
..... ........||+.|+|||++....|+...||||.||++|.|++|..||......... ..+..+.+.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~~- 256 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDFD- 256 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCCC-
Confidence 87544 44556678999999999999999999999999999999999999999743332211 144444431
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+- .+.-......+.+++..++..||.+|+|+.++++.
T Consensus 257 f~-----------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FT-----------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-----------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 12223346678899999999999999999999884
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.84 Aligned_cols=267 Identities=21% Similarity=0.248 Sum_probs=197.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|++|+||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 67899999987542 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCcccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~~~~~~ 417 (603)
|++ ++|.+++.......+++...+.++.|++.||+|||+. +|+|+||||+||+++. +..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 995 6888888655444578888899999999999999998 9999999999999985 567999999999753221
Q ss_pred cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc----
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII---- 492 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 492 (603)
....+...+++.|+|||++.+. .++.++||||||+++|||+||+.||......+.. ......+... ..+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~ 232 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL---FKIFRILGTP-NEETWPGVT 232 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC-Chhhccccc
Confidence 1112334578899999988764 5789999999999999999999998643222111 1111111100 00000
Q ss_pred ---chhh--hhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 ---DPLI--IEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 ---d~~l--~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
|-.. .... ............++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 0000001123456889999999999999999999886
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=305.59 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=197.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 336 (603)
++|...+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...+||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999986 578999999975432 2234677899999999999999999998877 889999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 59999987643 3699999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh-----------
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS----------- 484 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~----------- 484 (603)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ......+.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhh
Confidence 1 112334578899999988754 4689999999999999999999988643221111 00000000
Q ss_pred ------cCCcccccchhhhhccCCCCccchH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 485 ------KGRLDEIIDPLIIEHRGHSDAGTLA-SVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 485 ------~~~~~~~~d~~l~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...........+.. ..... ....+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRK------KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhc------cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000100 01111 3566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=293.93 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=197.8
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh-h-HHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD-G-IQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILVY 337 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 337 (603)
+|...+.|++|.||.||+|+.+ +++.||+|+++..... + --.-++||.+|.+.+|||||.+..+.+- -+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4556788999999999999975 6789999999865321 1 1234789999999999999999888663 45789999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||++. +|...|+... .++...+...+..|+++||+|||.. .|+|||||++|+|+.+.|.+||+||||||.+...
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 99976 8999987653 6788999999999999999999999 8999999999999999999999999999975432
Q ss_pred cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
....|..+-|.-|.|||.+.+. .|+...|+||+|||+.||++++..|......++.+ .+...+. ...+.+-|.+
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llG--tPte~iwpg~ 305 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLG--TPSEAIWPGY 305 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhC--CCccccCCCc
Confidence 2345666789999999988765 79999999999999999999987775433322222 2222221 1111111110
Q ss_pred hhc-------cCC------CCccch-HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEH-------RGH------SDAGTL-ASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~-------~~~------~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... +.. ...... ...+.-.+|....|.+||.+|-|+.|.++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 000 000000 03356778999999999999999998664
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.62 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=198.6
Q ss_pred ccCCCceEEEEEEEcC-CcEEEEEEeccCCh---hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||.||++...+ ++.+++|.++.... ...+.+.+|++++.+++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 89999999976533 4567889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc-------
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS------- 418 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~------- 418 (603)
.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997643 589999999999999999999998 999999999999999999999999999875332211
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......++..|++||.+.....+.++||||||++++||++|+.|+...... .. ...+..+....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~-------- 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EI-FQNILNGKIEW-------- 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCCcCC--------
Confidence 1223345788999999998888999999999999999999999998643211 11 11122221110
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.........+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 221 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 ------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0001125678899999999999999999777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.58 Aligned_cols=270 Identities=20% Similarity=0.247 Sum_probs=197.1
Q ss_pred CCCccCcccCCCceEEEEEEEcC---CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQI 334 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 334 (603)
.|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778889999999999999754 6899999998732 34446778999999999999999999999988 7899
Q ss_pred EEEeeCCCCCHHHHhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----CCcEEEeec
Q 007442 335 LVYEFMPNGTLCQHLQRERG---DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY----NFKSKVADF 407 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~---~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~----~~~~kl~DF 407 (603)
+||||+++ +|.+++..... ..+++...+.|+.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999974 77777754322 3589999999999999999999998 9999999999999999 899999999
Q ss_pred cCccccccccc--ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchh------hHHHH
Q 007442 408 GLSRLGMTEIS--HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV------NLAAL 478 (603)
Q Consensus 408 Gla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~------~l~~~ 478 (603)
|+++....... .......++..|+|||++.+. .++.++||||||++|+||++|+.||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986433221 112234678899999988764 5789999999999999999999998744332200 00001
Q ss_pred HHHHhhcCC---------cccccc---hhhhhccCCCCc----cc--hHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 479 AADRISKGR---------LDEIID---PLIIEHRGHSDA----GT--LASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 479 ~~~~~~~~~---------~~~~~d---~~l~~~~~~~~~----~~--~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+...+.... +.+..+ ..... ...... .. .....++.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK-TYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCC-CCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111110000 000000 00000 000000 00 023456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.88 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=205.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|+||.||++... ++..||+|++.... ....+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999985 57899999998653 35667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
+++++|.+++.... ...+++..++.++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998653 35699999999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......+++.|+|||.+....++.++||||||+++++|++|+.|+..... ...... +.......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~------- 222 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALK-ILKGQYPP------- 222 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHH-HhcCCCCC-------
Confidence 223334688899999999888899999999999999999999999864321 111111 11211111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++||++.|+++
T Consensus 223 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 --------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.37 Aligned_cols=268 Identities=21% Similarity=0.244 Sum_probs=196.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCc-----
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGE----- 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 332 (603)
++|+..+.||+|+||.||+|... +++.||||.++... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 58899999987542 223467889999999995 6999999999887665
Q ss_pred eEEEEeeCCCCCHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeecc
Q 007442 333 QILVYEFMPNGTLCQHLQRER---GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFG 408 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFG 408 (603)
.++||||+++ +|.+++.... ...+++...+.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8999987543 23589999999999999999999998 9999999999999998 8899999999
Q ss_pred CcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
+++..... ........+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ...+...+....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIP-VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCC-ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 98753221 111223356889999998865 4578999999999999999999988864322111 111111111100
Q ss_pred cc---cccchhh-hhccC----CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LD---EIIDPLI-IEHRG----HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~---~~~d~~l-~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.. ...+-.. ..... ...........++.+++.+||+.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000 00000 000001224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.92 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=194.3
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 444668999999999999875 57899999987543 345567899999999996 999999999999999999999998
Q ss_pred CCCCHHHHh---hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 341 PNGTLCQHL---QRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 341 ~~gsL~~~l---~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
. ++|.++. .......+++.....++.+++.||+|||+.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 6 4655543 3333456999999999999999999999742 89999999999999999999999999987533221
Q ss_pred cceeccCCCCCCCcCccccccC---CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQNF---HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......++..|+|||++... .++.++||||||+++|||++|+.||.... ....... ....+.. +
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~-~~~~~~~-----~ 229 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLT-QVVKGDP-----P 229 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHh-hhcCCCC-----C
Confidence 12334688999999998876 68999999999999999999999986322 1111111 1111111 1
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+.. ........++.+++.+||+.+|++|||+.||++.
T Consensus 230 ~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSN------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCC------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 1112345678999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.83 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=215.1
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcC--------CcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeee
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLG 325 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g 325 (603)
.++...+++...+.||+|.||.|++|.+.. ...||||.++.. +....+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455555666666799999999999998541 467999999865 345678899999999999 5999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhc------C--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRER------G--------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKS 391 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~ 391 (603)
+|.+.+..++|.||+..|+|.++|...+ . ..|+....+.++.|||.|++||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 2388999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEeeccCcccccccccceeccCCC--CCCCcCccccccCCCCcccccccHHHHHHHHHhCC-CccCCCC
Q 007442 392 SNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG--TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITAL-KVVDFSR 468 (603)
Q Consensus 392 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~-~p~~~~~ 468 (603)
+|||+.++..+||+|||+++...+...+......+ ...|||||.+....|+.|||||||||+||||+|.. .|+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-- 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-- 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--
Confidence 99999999999999999999755544444333333 45699999999999999999999999999999954 44421
Q ss_pred CcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 469 PPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 469 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
......+.+.+++|...+ .+..+..++.+|+..||+.+|++||++.|+.+.|+...
T Consensus 525 ----~~~~~~l~~~l~~G~r~~---------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 ----IPPTEELLEFLKEGNRME---------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ----CCcHHHHHHHHhcCCCCC---------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111222244666664322 23345778899999999999999999999999999853
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=299.31 Aligned_cols=250 Identities=25% Similarity=0.290 Sum_probs=203.1
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||.|.-|+||.+.+++ +..+|+|.+.+.. .....+...|-+||+.++||.|+.|++.+..++..+|||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4446689999999999999976 4899999997653 34455677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc----
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT---- 415 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~---- 415 (603)
|+||+|+.+++++.++.+++.....+|.+++.||+|||-. +||.|||||+||||.++|++.|+||.|+.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999999888899999999999999999999999 999999999999999999999999998743100
Q ss_pred -----------------------------c-c---------------------cceeccCCCCCCCcCccccccCCCCcc
Q 007442 416 -----------------------------E-I---------------------SHISTAPQGTPGYLDPQYHQNFHLSDK 444 (603)
Q Consensus 416 -----------------------------~-~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k 444 (603)
. . ...+...+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 011223468999999999999999999
Q ss_pred cccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhcc
Q 007442 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAF 524 (603)
Q Consensus 445 sDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 524 (603)
.|.|+|||+||||+.|+.||......+. +.. ++-..+. -....+.+..+.+||.+.|..
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~T--l~N-------------Iv~~~l~------Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKET--LRN-------------IVGQPLK------FPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhh--HHH-------------HhcCCCc------CCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999975433222 111 1111110 011224566788999999999
Q ss_pred CCCCCCC----HHHHHH
Q 007442 525 HRDMRPS----MTEVAT 537 (603)
Q Consensus 525 ~p~~RPs----m~eV~~ 537 (603)
||++|-. +.||.+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999987 666654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=291.87 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=202.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|...+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 578999999987644 4667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++... ..+++..++.++.+++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999999764 4599999999999999999999998 999999999999999999999999999986433221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......++..|+|||+..+..++.++|||+||++++||++|+.|+..... .. ..... ......
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~-~~~~~-~~~~~~---------- 217 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MA-ALFRI-VQDDHP---------- 217 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HH-HHHHH-hccCCC----------
Confidence 12334688999999999888889999999999999999999999863221 11 11111 111110
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.+++.
T Consensus 218 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111123457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.36 Aligned_cols=271 Identities=23% Similarity=0.268 Sum_probs=200.4
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC---
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG--- 331 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 331 (603)
+.+.++|+..+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999986 57899999997543 223356788999999999999999999987655
Q ss_pred -------ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 007442 332 -------EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404 (603)
Q Consensus 332 -------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl 404 (603)
..++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 787777654 34699999999999999999999998 9999999999999999999999
Q ss_pred eeccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 405 ADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 405 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
+|||++...............++..|+|||++.+ ..++.++||||||+++|||++|+.|+..... ......+.+..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Confidence 9999998644332222233356788999998865 4578999999999999999999988863221 11111111111
Q ss_pred hcCC---cccc--------cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 484 SKGR---LDEI--------IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 484 ~~~~---~~~~--------~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.... ..++ .++.-...+ .........+..+.+++.+||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhccccccccccccccccccccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 0000 000000000 000001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.02 Aligned_cols=241 Identities=24% Similarity=0.278 Sum_probs=192.1
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||+||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68899999986532 23345678899999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.......+++..++.++.|++.||.|||+. +++||||+|+|||+++++.+||+|||++..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 9999876555699999999999999999999998 999999999999999999999999999875332 11223346
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
++..|++||++.+..++.++||||||++++||++|+.||........ ........... ...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~----------------~~~ 216 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLEM----------------AVE 216 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhccccc----------------ccc
Confidence 78899999999888899999999999999999999999864332111 01111111000 001
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
........+.+++.+||+.+|++||+..|
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 11123557889999999999999995555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.38 Aligned_cols=271 Identities=19% Similarity=0.244 Sum_probs=194.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE------ 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 332 (603)
++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999875 57899999986542 2223456789999999999999999999876543
Q ss_pred --eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 333 --QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 333 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
.++||||+. ++|.+++... ...+++...+.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 499999996 5888888654 23589999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc---ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 411 RLGMTEIS---HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 411 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
........ .......++..|+|||++.+. .++.++||||||+++|||++|+.|+..................+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76432211 112234578899999988664 47889999999999999999998886433221111111110000000
Q ss_pred Ccccccchhhhhc---cCCC------CccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEH---RGHS------DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~---~~~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+...... .... ..........+.+++.+||+.+|++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000000 0000 0000012345678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=293.28 Aligned_cols=237 Identities=23% Similarity=0.253 Sum_probs=191.7
Q ss_pred ccCCCceEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||.|+||.||+++... ++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999864 7899999987542 23457799999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.+. ..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999764 3489999999999999999999998 99999999999999999999999999998643321 223346
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
++..|++||++....++.++|+||||+++|||++|+.|+...... ..... ..+..+... ..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~--------------~~ 214 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIY-NDILKGNGK--------------LE 214 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHH-HHHhccCCC--------------CC
Confidence 889999999998888999999999999999999999998643321 11111 111111100 01
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+......+.+++.+||+.+|++||++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCC
Confidence 111225578999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=302.53 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=196.1
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33455566666666655 6889999999754 44566789999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc------
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS------ 418 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~------ 418 (603)
|.+++.......+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999876556689999999999999999999998 999999999999999999999999998865322111
Q ss_pred ceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc----
Q 007442 419 HISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII---- 492 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 492 (603)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...+.+. +.....+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~-~~~~~~~~~~~ 235 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVR-GTVPCLLDKST 235 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-ccCccccccCc
Confidence 11123457788999999875 358899999999999999999999986432211 1111111 1111111
Q ss_pred ----------------chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 493 ----------------DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 493 ----------------d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
++.... ............++.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRD--SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhh--hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 111000 00111223445678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.63 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=193.4
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCceeeeeeeEeec--CceEEEEe
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIER--GEQILVYE 338 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 338 (603)
|...+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 455778999999999999875 57899999987642 222234567899999985 99999999999987 88999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++ |+|.+++.... ..++|..++.++.|++.||+|||+. +|+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 996 68888886542 4689999999999999999999998 9999999999999999 999999999997643221
Q ss_pred ceeccCCCCCCCcCccccc-cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh-----------hcC
Q 007442 419 HISTAPQGTPGYLDPQYHQ-NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI-----------SKG 486 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-----------~~~ 486 (603)
......++..|+|||++. +..++.++||||||+++|||++|+.||......+ ........+ ...
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence 122345788999999765 4567889999999999999999999886432211 111111111 000
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+..... .........+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGT--GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccc--cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 000001234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.13 Aligned_cols=273 Identities=21% Similarity=0.252 Sum_probs=189.9
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC--CcEEEEE------------------EeccCChhhHHHHHHHHHHHhccCCCc
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN--DLLVAIK------------------RIKHRDTDGIQQVVNEIKLISCVSHPN 319 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~--~~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~n 319 (603)
...+|...+.||+|+||+||++.++. +..+++| +++. .......+.+|+.+|.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987642 2222222 1111 2234467889999999999999
Q ss_pred eeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER---GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 320 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
||++++++...+..++|+|++ .++|.+++.... ...........|+.|++.||+|||+. +|+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999999999999999999998 468888875432 11234556778999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcch-hhH
Q 007442 397 DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE-VNL 475 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~-~~l 475 (603)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||+||||++|..++........ ..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999986443333333345799999999999999999999999999999999998764432221111 111
Q ss_pred HHHHHHHhh--cCCcc-------cccchhhhhccCCCC---ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 476 AALAADRIS--KGRLD-------EIIDPLIIEHRGHSD---AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 476 ~~~~~~~~~--~~~~~-------~~~d~~l~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.. ....+. ...+. +.++........... .........+.+++.+||+.||++|||+.|++..
T Consensus 381 ~~-~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LK-IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HH-HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 111110 00000 000000000000000 0001123456778999999999999999999863
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.63 Aligned_cols=247 Identities=23% Similarity=0.404 Sum_probs=203.3
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|+..+.||+|+||.||++... +++.+|+|.++.. ......++.+|++++++++|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999764 6789999998754 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
+++++|.+++.... ...+++..++.++.+++.||+|||+. +++|+||+|.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999997632 34589999999999999999999998 9999999999999999999999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......++..|++||++.+..++.++|+||||+++|||++|+.|+...... .....+..+....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~------- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYPP------- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCC-------
Confidence 222345888999999999889999999999999999999999998643211 1111222222111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......++.+++.+||+.+|++||++.|+++
T Consensus 221 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 --------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.44 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=196.8
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|...+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999986 478899999876432 22234567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
+|+|.+++.......++|..++.++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 89999999876545699999999999999999999998 99999999999999999999999999997533211 1
Q ss_pred eccCCCCCCCcCccccc-cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc--------C-Cccc
Q 007442 421 STAPQGTPGYLDPQYHQ-NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK--------G-RLDE 490 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--------~-~~~~ 490 (603)
.....++..|+|||++. ...++.++||||||++++||++|+.|+.......... .....+.. + .+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCCCChhhhhhHhhhhc
Confidence 23345788999999875 4468899999999999999999998885433221110 00000000 0 0000
Q ss_pred ccchhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IIDPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.++..+..... ............+.+++.+||+.+|++||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00100000000 000001112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=312.57 Aligned_cols=272 Identities=24% Similarity=0.297 Sum_probs=199.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 333 (603)
+++|...++||+|+||.||+|... +++.||||.++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68899999997532 334567889999999999999999999876543 57
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++|+||++ ++|.+++.. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 588887753 3599999999999999999999998 9999999999999999999999999998764
Q ss_pred cccccc--eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---
Q 007442 414 MTEISH--ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR--- 487 (603)
Q Consensus 414 ~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 487 (603)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHH
Confidence 322111 1123468899999998754 46889999999999999999999988542211 11111111111110
Q ss_pred cccccchhhhhc---cCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhh
Q 007442 488 LDEIIDPLIIEH---RGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHI 542 (603)
Q Consensus 488 ~~~~~d~~l~~~---~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i 542 (603)
+..+.+...... ...... .......++.+++.+||+.+|++|||+.|+++. |+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 011111100000 000000 011234568899999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.01 Aligned_cols=265 Identities=25% Similarity=0.291 Sum_probs=195.8
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh--hhHHHHHHHHHHHhcc---CCCceeeeeeeEeecCc-----
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT--DGIQQVVNEIKLISCV---SHPNLVRLLGCSIERGE----- 332 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 332 (603)
|...+.||+|+||.||+|+.+. ++.||+|+++.... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999864 88999999975422 2234566788777666 59999999999988776
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+++|||++ ++|.+++.......++|..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999997 5899999765445699999999999999999999998 999999999999999999999999999876
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc-CCcccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK-GRLDEI 491 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 491 (603)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.|+......+ .... +.+.... +.....
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhcC
Confidence 43221 1123357889999999999899999999999999999999988876422211 1111 1111110 000000
Q ss_pred cch-----hhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDP-----LIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~-----~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... ..... ..............+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000 00000111234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.47 Aligned_cols=256 Identities=24% Similarity=0.287 Sum_probs=201.5
Q ss_pred CCCccCcccCCCceEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCce
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD----TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 333 (603)
+|...+.||+|+||.||+++. .++..||||.++... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999875 356889999987532 22346788999999999 599999999999988999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++|+|.+++... ..+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999999753 3589999999999999999999998 9999999999999999999999999998764
Q ss_pred cccccceeccCCCCCCCcCccccccCC--CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
............++..|+|||.+.+.. .+.++||||||+++|||++|..|+....... ........+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~---- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSK---- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHccC----
Confidence 433222223346889999999987654 7889999999999999999999985322111 1111111111110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
+ .........+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 229 --~----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --P----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 01112334678899999999999999999998888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.74 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=190.6
Q ss_pred HHHHHhcCCCccCcc--cCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 256 EIEKATIGFSEKQRL--GTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 256 el~~at~~f~~~~~L--G~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
++....++|...+.+ |+|+||.||++..+ ++..+|+|.++....... |+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444445666666665 99999999999874 578899999875422211 22222222 6999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLS 410 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla 410 (603)
..++||||+++|+|.+++.... .++|..++.++.|++.||+|||+. +++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997653 699999999999999999999998 999999999999999998 9999999998
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
+..... ....++..|+|||++.+..++.++||||||++++||++|+.|+..... .......+.... ....
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~-- 227 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--QKKL-- 227 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--cccC--
Confidence 753221 234688999999999998999999999999999999999999873222 221222221111 1100
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-MTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eV~~ 537 (603)
.........+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 --------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111124457889999999999999996 587763
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.87 Aligned_cols=242 Identities=21% Similarity=0.270 Sum_probs=186.1
Q ss_pred cccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHh---ccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 269 RLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLIS---CVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~---~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 57899999886532 122233445544433 4479999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ..++|.....|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...... ..
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Cc
Confidence 99999998754 3599999999999999999999998 9999999999999999999999999998753221 12
Q ss_pred ccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....|+..|+|||.+.+ ..++.++||||||++++||++|+.||.......... ....... .+.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~------ 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNV------ 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCc------
Confidence 23468999999999864 458899999999999999999999996433221111 1111100 000
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
........++.+++.+||+.+|++|| +++|+++.
T Consensus 217 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01112345788999999999999999 58887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.06 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=200.5
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|...+.||+|++|.||++... +++.+++|+++.... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999875 688999999876533 34577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++ +|.+++.... ..+++..++.++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 8988887643 4699999999999999999999998 99999999999999999999999999987643322 12
Q ss_pred eccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---Ccccccc---
Q 007442 421 STAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---RLDEIID--- 493 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--- 493 (603)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+. .......+... ....+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2334578899999998876 789999999999999999999988854322111 11111111110 0000000
Q ss_pred h---hhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 P---LIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~---~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ..... .............++.+++.+||+.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000 00000111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.52 Aligned_cols=243 Identities=22% Similarity=0.342 Sum_probs=196.6
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
.+||+|+||.||++... ++..||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999884 68899999987665566678999999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCC
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~g 426 (603)
+++.. ..+++...+.++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... .......+
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 98753 2489999999999999999999998 99999999999999999999999999987533221 12233468
Q ss_pred CCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCcc
Q 007442 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAG 506 (603)
Q Consensus 427 t~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 506 (603)
++.|++||++.+..++.++||||||+++|||++|..|+....... . ...+..+. .+.+. .
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~----~~~~~~~~-----~~~~~--------~ 238 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRDNL-----PPKLK--------N 238 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhhC-----CcccC--------C
Confidence 899999999988889999999999999999999999986322111 1 11111110 00000 0
Q ss_pred chHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 507 TLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 507 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.+++.+||+.+|.+||++.+|++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0112346778999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.50 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=190.7
Q ss_pred CcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHH-HhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIKL-ISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||.||+|... +++.||||.++.... .....+..|..+ ....+|+||+++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999875 578999999875432 223344555544 4455899999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+|||+++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999999754 3588999999999999999999998 999999999999999999999999999875322 22
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...++..|++||.+.+..++.++||||||+++|||++|..|+...... .....+..+.... .
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~--~--------- 213 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRINW--P--------- 213 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccCC--C---------
Confidence 346888999999998888999999999999999999999998632211 1112222221110 0
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
..........+.+++.+||+.+|++||++.++.+.|.
T Consensus 214 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 214 -EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0011123567889999999999999998877766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.08 Aligned_cols=256 Identities=15% Similarity=0.192 Sum_probs=186.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCC----cEEEEEEeccCChhhH-----------HHHHHHHHHHhccCCCceeeeeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGI-----------QQVVNEIKLISCVSHPNLVRLLGC 326 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g~ 326 (603)
++|...++||+|+||+||+|...++ ..+|+|.......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788899999999999999997653 4566665433221110 122334455667789999999998
Q ss_pred EeecC----ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 327 SIERG----EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 327 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+.... ..++++|++. .++.+.+... ...++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 3467777764 3666666543 2367888999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhh--
Q 007442 403 KVADFGLSRLGMTEISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN-- 474 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~-- 474 (603)
||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||..........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999764322111 1123469999999999999999999999999999999999999997542222110
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
....+...+.++.+ ........+.+++..|++.+|++||++.++.+.|+
T Consensus 246 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHEGKI-----------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhhhhh-----------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00111222222211 01123467889999999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.46 Aligned_cols=251 Identities=25% Similarity=0.299 Sum_probs=195.1
Q ss_pred CCCccCcccCCCceEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCce
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD----TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 333 (603)
+|...+.||+|+||.||++.. .+|..||+|+++... ....+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 367899999997532 22346788999999999 599999999999988899
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++++|.+++... ..+++.....++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999999754 4588999999999999999999998 9999999999999999999999999998764
Q ss_pred cccccceeccCCCCCCCcCccccccC--CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
............|+..|+|||++... .++.++||||||+++|||++|+.|+....... ...... ..+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~-~~~~~~~---- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEIS-RRILKSE---- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHH-HHhhccC----
Confidence 33222222344688999999998753 46789999999999999999999986432211 111111 1111110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
..........+.+++.+||+.+|++|| ++.+++.
T Consensus 229 ------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001112345678999999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.91 Aligned_cols=267 Identities=24% Similarity=0.337 Sum_probs=199.2
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------ 330 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 330 (603)
..++|...+.||+|+||.||++... +++.||||.+... +....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999875 6889999998643 334456788999999999999999999988643
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
...++||||+. ++|.+++... +++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888888643 88999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH------------H-
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA------------A- 477 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~------------~- 477 (603)
+..... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||............ .
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 863221 1123346789999999999999999999999999999999999998643221110000 0
Q ss_pred ---HHHHHhhcCC------cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 478 ---LAADRISKGR------LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 478 ---~~~~~~~~~~------~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......... +.+.+...+.. .............+.+++.+||+.||++|||+.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFP--PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccC--cccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00010000000 00001122345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.91 Aligned_cols=272 Identities=19% Similarity=0.257 Sum_probs=199.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 333 (603)
..+|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888999999999999999875 58899999997542 2345678889999999999999999998763 3467
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++|+||+. |+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998654 3499999999999999999999998 9999999999999999999999999998764
Q ss_pred ccccc---ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH--------HHH
Q 007442 414 MTEIS---HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL--------AAD 481 (603)
Q Consensus 414 ~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~--------~~~ 481 (603)
..... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32211 11223468899999998865 4688999999999999999999999864322111100000 000
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+....+.+.++..-.................+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000111111110000000000000012246678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.13 Aligned_cols=261 Identities=16% Similarity=0.233 Sum_probs=196.8
Q ss_pred cccCC--CceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 269 RLGTG--AFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 269 ~LG~G--~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
.||+| +||+||++... +++.||||.++.. .....+.+.+|+.+++.++||||+++++++...+..++|+||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999874 6899999998754 3344578899999999999999999999999999999999999999
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc----
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH---- 419 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~---- 419 (603)
+|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999876555699999999999999999999998 9999999999999999999999999865432111100
Q ss_pred --eeccCCCCCCCcCccccccC--CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc-------
Q 007442 420 --ISTAPQGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL------- 488 (603)
Q Consensus 420 --~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 488 (603)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ....+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccccc
Confidence 01112356679999998763 578999999999999999999999864322110 0111100000
Q ss_pred -----------------------------ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH-
Q 007442 489 -----------------------------DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE- 538 (603)
Q Consensus 489 -----------------------------~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~- 538 (603)
....+..+ ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL------RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccc------cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00000000 011123456788999999999999999999999753
Q ss_pred -HHhhhh
Q 007442 539 -LEHIRT 544 (603)
Q Consensus 539 -L~~i~~ 544 (603)
++.++.
T Consensus 310 ~~~~~~~ 316 (328)
T cd08226 310 FFKQVKE 316 (328)
T ss_pred HHHHHHH
Confidence 455544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.20 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=195.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-------
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE------- 329 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------- 329 (603)
+-..+|++..+||+||||.|||++.+ ||+.+|||++... .......+.+|+..|++|+|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567888999999999999999986 8999999999876 34445678899999999999999998765400
Q ss_pred -----------------------------------------------------------------------c--------
Q 007442 330 -----------------------------------------------------------------------R-------- 330 (603)
Q Consensus 330 -----------------------------------------------------------------------~-------- 330 (603)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 007442 331 ---------------------------------GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377 (603)
Q Consensus 331 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH 377 (603)
-.+||-||||+.-+|.+++.++.... .-...|+++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 12468899999988888887653221 35677899999999999999
Q ss_pred hcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc------c-----------cccceeccCCCCCCCcCccccccC-
Q 007442 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM------T-----------EISHISTAPQGTPGYLDPQYHQNF- 439 (603)
Q Consensus 378 ~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~aPE~~~~~- 439 (603)
+. +||||||||.|||||++..+||+|||++.... . ......|...||.-|+|||.+.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999997511 0 011134566799999999998754
Q ss_pred --CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHH
Q 007442 440 --HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAEL 517 (603)
Q Consensus 440 --~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l 517 (603)
.|+.|+|+||+||||+||+.- |. +.. -...+...+++|.+..- + ....+....-+.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~yP---F~--TsM----ERa~iL~~LR~g~iP~~--~----------~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLYP---FG--TSM----ERASILTNLRKGSIPEP--A----------DFFDPEHPEEASL 850 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhcc---CC--chH----HHHHHHHhcccCCCCCC--c----------ccccccchHHHHH
Confidence 599999999999999999863 32 111 22334555666666543 1 1111223345689
Q ss_pred HHHHhccCCCCCCCHHHHHH
Q 007442 518 AFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 518 ~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.++++.||.+|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.85 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=196.5
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.|+..+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566778999999999999975 5788999998642 33445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+. |+|.+++... ...+++..++.++.+++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 996 6888887644 34589999999999999999999998 999999999999999999999999999875322
Q ss_pred ceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 419 HISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.....++..|+|||++. ...++.++||||||+++|||++|+.|+...... . ....+..+.....
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~~---- 234 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------S-ALYHIAQNESPAL---- 234 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------H-HHHHHhhcCCCCc----
Confidence 22346788999999974 356888999999999999999999987532111 0 1111111111110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
........+.+++.+||+.+|++||++.+|++....
T Consensus 235 ----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 235 ----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ----------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 011234568899999999999999999999876433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.80 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=195.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 557778899999999999999875 8899999997643 334566777888777775 9999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++ ++|.+++... ...+++..+..++.+++.||+|||+. ++|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 985 5777776553 34699999999999999999999973 289999999999999999999999999987533221
Q ss_pred ceeccCCCCCCCcCccccccCC----CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 419 HISTAPQGTPGYLDPQYHQNFH----LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||....... .. ...+..+....+
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~--- 239 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EV-LTKILQEEPPSL--- 239 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HH-HHHHhcCCCCCC---
Confidence 123345788999999987553 7889999999999999999999985321110 11 111111111110
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........++.+++.+||+.+|++||++.++++.
T Consensus 240 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 ----------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0011234578899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.62 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--Cce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 333 (603)
.+|...+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999874 5889999987532 234456889999999999999999999998764 457
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++|+||+++++|.+++... ..+++...++++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 8999999999999999754 3488999999999999999999998 9999999999999999999999999999753
Q ss_pred cccc--cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 414 MTEI--SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 414 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... ....+...++..|+|||++.+..++.++||||||++++||++|+.||...... ..+.+....+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~ 229 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP-TKPM 229 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC-CCCC
Confidence 2211 11122346889999999999888999999999999999999999998632111 1111111111 1111
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+......+.+++.+||+ +|.+||+..+++.
T Consensus 230 --------------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 --------------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 112234578899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.10 Aligned_cols=268 Identities=21% Similarity=0.233 Sum_probs=196.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 335 (603)
.++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999985 588999999975422 2234567899999999999999999998765 46899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+. ++|.+++.... ..++|..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58999887542 5699999999999999999999999 999999999999999999999999999976432
Q ss_pred cccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC--Cccccc
Q 007442 416 EISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG--RLDEII 492 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~ 492 (603)
.. ...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+...+... .....+
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhh
Confidence 21 12223346788999999865 457899999999999999999999986432211 111111111100 000000
Q ss_pred c------h-hhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 D------P-LIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d------~-~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+ . .+..... ............+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0 0000000 000000112556788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.16 Aligned_cols=273 Identities=23% Similarity=0.281 Sum_probs=201.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----Cc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-----GE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 332 (603)
.++|...+.||+|+||+||+|... +++.||||.++.. .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999874 5789999998753 233456778899999999999999999987654 34
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+. ++|.+++... ..+++...+.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899988653 4599999999999999999999998 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc---CCc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK---GRL 488 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 488 (603)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... ........+.. ..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDL 233 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHh
Confidence 43221 22233467889999998765 468999999999999999999999986432111 11111111100 000
Q ss_pred ccccchhhhh----c----cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 007442 489 DEIIDPLIIE----H----RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 489 ~~~~d~~l~~----~----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~ 543 (603)
..+.++.... . .............++.+++.+||+.+|++|||+.|+++. ++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0011110000 0 000000112345678899999999999999999999876 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.63 Aligned_cols=277 Identities=21% Similarity=0.271 Sum_probs=200.0
Q ss_pred ChHHHHHHh----cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeee
Q 007442 253 PYREIEKAT----IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 253 ~~~el~~at----~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
..+|+.+++ ++|...+.||+|+||.||+|... +++.||||+++.. .......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 344555543 78888999999999999999874 6889999998753 2223456889999999999999999999
Q ss_pred eEeecC------ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 007442 326 CSIERG------EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN 399 (603)
Q Consensus 326 ~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~ 399 (603)
++.... ..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~ 153 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNED 153 (342)
T ss_pred eecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 987543 45899999964 7776652 3589999999999999999999998 99999999999999999
Q ss_pred CcEEEeeccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 400 FKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 400 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
+.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 154 ~~~kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~ 226 (342)
T cd07879 154 CELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQ 226 (342)
T ss_pred CCEEEeeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 9999999999875321 1223457889999999876 4688999999999999999999999864321111 111
Q ss_pred HHHH-----------hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhh
Q 007442 479 AADR-----------ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIRT 544 (603)
Q Consensus 479 ~~~~-----------~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~~ 544 (603)
.... +........++....................+.+++.+||+.+|++||++.|++.. ++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1100 00000000000000000000000001234567899999999999999999999854 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=311.51 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=202.8
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
|.+...||.|+||+|||+..++ +...|-|.+.....+.+++|+-||+||+...||+||+|++.|+..+.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4445679999999999999875 455678888888888899999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|-++..+... +..|++.++.-++.+++.||.|||+. .|||||||+.|||++-+|.++|+|||.+.... .......
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRD 188 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhhc
Confidence 9998887655 45699999999999999999999999 99999999999999999999999999875421 2223345
Q ss_pred cCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 423 APQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
...||+.|||||+.. ..+|+.++||||||+.|.||..+..|... .+....++ .+.+.....++.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVll-KiaKSePPTLlq---- 257 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLL-KIAKSEPPTLLQ---- 257 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHH-HHhhcCCCcccC----
Confidence 678999999999864 45799999999999999999999877542 22222222 222222222221
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+..-...+.++..+||..||..||++.++++
T Consensus 258 ---------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ---------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2234557889999999999999999988764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=296.57 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=193.7
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||+|+||+||+|+.. ++..|++|++... .....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445667999999999999874 5789999998743 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+. |+|.+++... ..+++|..++.++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 95 6888888654 34699999999999999999999998 99999999999999999999999999986421
Q ss_pred eeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 420 ISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
......++..|+|||++. ...++.++||||||+++|||++|+.|+...... .... .+.........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~---- 241 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY-HIAQNDSPTLQ---- 241 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHHhcCCCCCC----
Confidence 122346889999999974 457888999999999999999999988532211 1111 11111111110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++.+||+.+|++||++.+++..
T Consensus 242 ----------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ----------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123457889999999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.44 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=206.7
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
-|+...+||+|+||.|||+.++ .|+.||||.+... ..++++++||.+|.+...|++|+++|.|.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3666788999999999999885 5899999998754 457899999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
-|++.+.+..+ +++|++.....|+...+.||+|||.. .-||||||..||||+-++.+||+|||.+-... +.-...
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT-DTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT-DTMAKR 186 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh-hhHHhh
Confidence 99999998654 57899999999999999999999999 89999999999999999999999999987533 333345
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
..+.||+-|||||+++.-.|..++||||+|+...||..|+.|+..-.+-.... .+......
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIPT~PPP------------ 247 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIPTKPPP------------ 247 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------eccCCCCC------------
Confidence 56789999999999999999999999999999999999999986433321110 01111100
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.-..+..-..++.+++..||-.+|++|-|+.++++
T Consensus 248 -TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 -TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 01113345678899999999999999999987765
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.88 Aligned_cols=194 Identities=28% Similarity=0.401 Sum_probs=169.2
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-C-----CceeeeeeeEeecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-H-----PNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 335 (603)
+|.+.+.||+|.||.|-|+... +++.||||+++... .-..+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788999999999999999864 58999999998753 33456678999999997 4 389999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC--cEEEeeccCcccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF--KSKVADFGLSRLG 413 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~--~~kl~DFGla~~~ 413 (603)
|+|.+ .-+|.++|+.++..+|+......|+.||+.||.+||+. +|||.||||+||||.+-. .+||+|||.|...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 55999999998888899999999999999999999998 999999999999996543 6999999999863
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccC
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
.. ... ....+.-|.|||++.+.+|+.+.||||||||+.||++|..-|.
T Consensus 342 ~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 342 SQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred CC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 21 111 4456788999999999999999999999999999999965554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=304.91 Aligned_cols=273 Identities=22% Similarity=0.278 Sum_probs=204.4
Q ss_pred CCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ceE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQI 334 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 334 (603)
+|...+.||+|+||.||+|+..+ +..||||++.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778899999999999999864 8899999997653 445578999999999999999999999988775 789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||++ ++|.+++... ..+++..++.++.+++.||+|||+. +|+||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 5899988654 3699999999999999999999998 99999999999999999999999999998643
Q ss_pred cccc--ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc------
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK------ 485 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------ 485 (603)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 3211 112334578899999999887 8999999999999999999999998643321111 111111000
Q ss_pred -----CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhhh
Q 007442 486 -----GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIRT 544 (603)
Q Consensus 486 -----~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~~ 544 (603)
....+.+.....................+.+++.+||+.+|++||++.+++.. ++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000000000000111245678899999999999999999999874 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.26 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=201.3
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 338 (603)
..|++.++||+||.+.|||+...+.+.+|+|++... +.+..+-|.+|+.+|.+|+ |.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 346778899999999999999988899999988643 6777899999999999996 9999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|= +-+|..+|.........| .+..+..|++.++.++|.+ +|||-||||.|+|+-. |.+||+|||+|.....+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 86 669999998776555667 7778999999999999999 9999999999999974 5899999999987655443
Q ss_pred c-eeccCCCCCCCcCccccccC-----------CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 419 H-ISTAPQGTPGYLDPQYHQNF-----------HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 419 ~-~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
. ......||+.||+||.+... +.+.+|||||+||+||+|+.|+.||..-.. .| .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~-------a 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI-------A 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH-------H
Confidence 3 34456799999999987522 256799999999999999999999852110 11 1
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
++..+.||.-.-.++. .....++++++..||+.||++||+..|+++.
T Consensus 581 Kl~aI~~P~~~Iefp~-----~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPD-----IPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccC-----CCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2233445522111101 1112238999999999999999999998863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=285.27 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=201.1
Q ss_pred HhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.+++|+..+.||+|.|+.||+... ..|+.+|+|.+... .....+++.+|+.|-..|+|||||+|...+.+.+..+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345677778899999999998876 46888898888643 334678889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCcccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSRLG 413 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~~~ 413 (603)
+|+|.+|+|..-|-.+ .-.++...-....||+++|.|.|.+ +|||||+||.|+||.. .--+||+|||++...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999998766543 2366777788999999999999999 9999999999999943 345899999999864
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
. .....-...||++|||||+++..+|+..+|||+.||+||-|+.|..||.... .....+.+.+|...- +
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------~~rlye~I~~g~yd~--~ 232 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYEQIKAGAYDY--P 232 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhccccCC--C
Confidence 4 3334456689999999999999999999999999999999999999996311 122334444443211 1
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
+ ..-....++..+|+.+||..||.+|-|+.|.+
T Consensus 233 ~----------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 S----------PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred C----------cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1 11123445677899999999999999998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.55 Aligned_cols=269 Identities=23% Similarity=0.271 Sum_probs=199.8
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cC
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RG 331 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 331 (603)
++..++++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++.+++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999865 6889999988643 23345678899999999999999999999875 55
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++|+||+ +++|.+++.. .++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 788999998 5689888863 3488888999999999999999998 99999999999999999999999999987
Q ss_pred cccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh-------
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI------- 483 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~------- 483 (603)
.... ......++..|+|||++.+ ..++.++||||||++++||+||+.||........ .....+.+
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 229 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ---FSIITDLLGTPPDDV 229 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 5321 1123457889999998766 5689999999999999999999998864322111 11111111
Q ss_pred ----hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 484 ----SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 484 ----~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+...+.+.....................+.+++.+||+.+|++||++.|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0010000000000000000000011234678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.39 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=194.2
Q ss_pred CCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccC-----ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR-----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+|...+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36777899999999999998753 344556655532 223345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 337 YEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||+++++|.+++... ....++|..++.++.|++.||+|||+. +++|+||||+||++++ ..+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999999753 235699999999999999999999998 9999999999999986 469999999987643
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. ........++..|+|||++.+..++.++||||||+++|+|++|+.|+.... ..... ..+..+...
T Consensus 157 ~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~-~~~~~~~~~----- 223 (260)
T cd08222 157 GS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVV-LRIVEGPTP----- 223 (260)
T ss_pred CC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcCCCC-----
Confidence 32 122234568899999999988888999999999999999999999885321 11111 111111111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.|+++
T Consensus 224 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ----------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112234557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=290.84 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=186.4
Q ss_pred cccCCCceEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHH---HHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 269 RLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIK---LISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.||+|+||.||++... +++.||+|.+..... .....+.+|.. +++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 578999999865421 12223444443 4445579999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CC
Confidence 99999998653 4599999999999999999999998 9999999999999999999999999998753221 12
Q ss_pred ccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....|+..|+|||++.++ .++.++||||||+++|||++|+.||.......... ........ ++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~------~~------ 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM------AV------ 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc------CC------
Confidence 234689999999998754 68999999999999999999999987532221110 11111100 00
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.........+.+++.+||..+|.+|| ++.|+++
T Consensus 217 ----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11112345788999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.85 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=199.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46778889999999999999985 6889999998753 2334567889999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++++|.+++... ..+++..++.|+.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999764 3599999999999999999999998 9999999999999999999999999998754322
Q ss_pred cc-------------------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHH
Q 007442 417 IS-------------------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477 (603)
Q Consensus 417 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~ 477 (603)
.. .......++..|++||.+....++.++||||||++++|+++|+.|+..... . .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~ 229 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---Y---L 229 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---H---H
Confidence 11 112233578899999999888899999999999999999999999864321 0 0
Q ss_pred HHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH----HHHH
Q 007442 478 LAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM----TEVA 536 (603)
Q Consensus 478 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm----~eV~ 536 (603)
. ...+..... .........+.+++.+||+.+|++||++ .+++
T Consensus 230 ~-~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 230 T-FQKILKLEY----------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred H-HHHHHhcCC----------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1 111111100 1111224578899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.50 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=198.6
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|+....||+|+||.||+|+..+ ++.||+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999864 8999999998653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
+ ++|.+++.... ..+++..++.++.+++.||+|||+. +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 59999998653 4599999999999999999999998 999999999999999999999999999876432211 2
Q ss_pred eccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---c---ccc--
Q 007442 421 STAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR---L---DEI-- 491 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~~-- 491 (603)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ............ . ..+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence 2233467789999998776 889999999999999999999888854322111 111111110000 0 000
Q ss_pred cchhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+........ ............+.+++.+||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000001122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.64 Aligned_cols=248 Identities=25% Similarity=0.284 Sum_probs=204.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
+.|..-++||+||||.||-...+ +|+.+|.|++.+. ...+..-.++|-.+|.+++.+.||.|--.|...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45778899999999999988765 5899999988644 2334455688999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
..|.+|+|.-||.+.....+++...+.+|.+|+.||++||.. +||.|||||+|||||+.|+++|+|+|||.......
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999888766799999999999999999999999 99999999999999999999999999998644332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....+||.||||||++++..|+...|.||+||+||||+.|+.||....... .. +-+|....
T Consensus 342 --~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~-------------eEvdrr~~ 403 (591)
T KOG0986|consen 342 --PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KR-------------EEVDRRTL 403 (591)
T ss_pred --ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hH-------------HHHHHHHh
Confidence 2344589999999999999999999999999999999999999996432211 11 11222222
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
. ...+++....++...|....|+.||++|..-+
T Consensus 404 ~---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 E---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred c---chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2 12234445667788899999999999997543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.20 Aligned_cols=272 Identities=21% Similarity=0.258 Sum_probs=201.0
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
....++..++++|...+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 44567778889999999999999999999986 468899999997542 233567889999999999999999999876
Q ss_pred ec------CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 329 ER------GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 329 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
.. ...+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 43 3467788876 7899888864 3489999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
||+|||+++.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ +.. ...
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~ 232 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKL-ILR 232 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHH
Confidence 9999999875321 2233467889999998866 5688899999999999999999998853222111 110 000
Q ss_pred HhhcCCcccc----cch---h-hhhccCC----CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 482 RISKGRLDEI----IDP---L-IIEHRGH----SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 482 ~~~~~~~~~~----~d~---~-l~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.. .....++ .+. . +...... ...........+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred Hh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000 000 0 0000000 000001134568899999999999999999988754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.62 Aligned_cols=269 Identities=22% Similarity=0.248 Sum_probs=194.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
.++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999975 578999999865422 22346788999999999999999999876543
Q ss_pred --ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 332 --EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 332 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
..++|+||+.. +|.+.+... ...+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999964 787777653 34599999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc----------ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 410 SRLGMTEIS----------HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 410 a~~~~~~~~----------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
++....... ...+...+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 975332111 111233568889999987654 58899999999999999999998886322211 1111
Q ss_pred HHHHhhcC---------Ccccccchhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 479 AADRISKG---------RLDEIIDPLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 479 ~~~~~~~~---------~~~~~~d~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......- .+....+...... ..............+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100 0000000000000 00000000112357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.17 Aligned_cols=269 Identities=20% Similarity=0.268 Sum_probs=197.4
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC--
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-- 331 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-- 331 (603)
+....++|...+.||+|+||.||++... ++..||||+++.. .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999864 6889999998643 2333467889999999999999999999987554
Q ss_pred ----ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 332 ----EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 332 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 7799888863 3589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH--------HHH
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL--------AAL 478 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l--------~~~ 478 (603)
|++..... ......+++.|+|||++.+ ..++.++||||||+++++|++|+.||........... ...
T Consensus 163 g~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99875322 1223467889999998876 4688999999999999999999999864322110000 000
Q ss_pred HHHHhhcCCcccccchhhhhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 479 AADRISKGRLDEIIDPLIIEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+...+........+.. +.... .............+.+++.+|++.+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011110000000000 00000 0000001123456889999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.73 Aligned_cols=267 Identities=19% Similarity=0.204 Sum_probs=195.2
Q ss_pred cCCCc-cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhh--------------HHHHHHHHHHHhccCCCceeeeee
Q 007442 262 IGFSE-KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDG--------------IQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 262 ~~f~~-~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
++|.. .+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34443 467999999999999875 58899999987543221 125778999999999999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
++...+..++||||+. |+|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6999998653 3489999999999999999999998 99999999999999999999999
Q ss_pred eccCccccccc-------------ccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcc
Q 007442 406 DFGLSRLGMTE-------------ISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471 (603)
Q Consensus 406 DFGla~~~~~~-------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~ 471 (603)
|||+++..... .........++..|+|||++.+. .++.++||||||+++|||++|+.|+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 99998753310 01111223468889999998764 4789999999999999999999988643321
Q ss_pred hhhHHHHHHHHhhcCCcccccc--------hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 472 EVNLAALAADRISKGRLDEIID--------PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d--------~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.....+...+.......+.+ +...................+.+++.+||+.+|++||++.|++.
T Consensus 241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 --DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11122222221111000000 00000000000001123457889999999999999999999885
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=305.56 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=197.7
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc---
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE--- 332 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 332 (603)
...++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678889999999999999999986 5789999998753 23344677889999999999999999998876654
Q ss_pred ---eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 333 ---QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 333 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799999864 3599999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH------
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR------ 482 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~------ 482 (603)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTPDE 237 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCCH
Confidence 8753221 233467889999998865 36789999999999999999999998643221110 000000
Q ss_pred -----hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 483 -----ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 483 -----~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+........+.....................+.+++.+||+.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000000000000000123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=292.05 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=204.4
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
|+..+.||+|.|..|-.+++ -.|..||||++.+. +......+.+|+.-|+.++|||||+|+.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55567899999999999986 47999999999765 3445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCcccccccccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla~~~~~~~~~ 419 (603)
.+|+|+|||.++ ...|.+....+++.||..|+.|.|+. .+|||||||+||.+-+. |-+||.|||++..+.+. .
T Consensus 100 D~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred CCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 999999999876 35699999999999999999999999 99999999999988654 68999999999765442 3
Q ss_pred eeccCCCCCCCcCccccccCCCCc-ccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSD-KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~-ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
..+...|...|-|||.+.+..|+. +.||||+|||||-|++|+.||+.....+. +.-|+|-..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY-- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY-- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc--
Confidence 345668999999999999988764 89999999999999999999975433221 112233211
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+.-...+..+||..||..||++|.+.+||+.
T Consensus 237 ------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 ------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 223345678899999999999999999998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=297.61 Aligned_cols=266 Identities=23% Similarity=0.252 Sum_probs=191.2
Q ss_pred CCCccCcccCCCceEEEEEEEcC---CcEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec----Cc
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN---DLLVAIKRIKHR--DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER----GE 332 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 332 (603)
+|...+.||+|+||.||++.... +..||||++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999753 678999998753 223356788999999999 599999999976433 35
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678888885 6999998643 4589999999999999999999998 999999999999999999999999999975
Q ss_pred cccccc---ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC--
Q 007442 413 GMTEIS---HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-- 486 (603)
Q Consensus 413 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 486 (603)
...... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 332111 11223468999999998765 468999999999999999999998886432111 111101000000
Q ss_pred -Ccccccchhh-------hhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 -RLDEIIDPLI-------IEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 -~~~~~~d~~l-------~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+..+.++.. .... .............+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0000 0000001112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.80 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=194.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec----------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER---------- 330 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 330 (603)
.+|...+.||.|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999875 5789999999877666678899999999999999999999876543
Q ss_pred ----CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEe
Q 007442 331 ----GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVA 405 (603)
Q Consensus 331 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~~kl~ 405 (603)
...++|+||++ ++|.+++.. ..+++...+.++.|++.||.|||+. +|+||||||+|||++ ++..+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 589888853 3489999999999999999999998 999999999999997 45678999
Q ss_pred eccCcccccccccc--eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 406 DFGLSRLGMTEISH--ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 406 DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....+..... .....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~~~ 234 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LILES 234 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHh
Confidence 99998753221111 1123357889999997654 568889999999999999999999996433211110 00000
Q ss_pred hhcC------Ccccccchhhhh-ccCCCC---ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 483 ISKG------RLDEIIDPLIIE-HRGHSD---AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 483 ~~~~------~~~~~~d~~l~~-~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.... .....+...+.. ...... ........++.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 000000000000 000000 001123457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.18 Aligned_cols=236 Identities=28% Similarity=0.330 Sum_probs=193.1
Q ss_pred ccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 270 LGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 270 LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999986 47899999987543 23567889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
.+++.... .+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99997643 589999999999999999999998 99999999999999999999999999987643221 1233456
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
++..|++||.+.+...+.++|+||||+++|||++|+.|+..... .. ....+.++.+ .
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~~----------------~ 211 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KE-IYEKILKDPL----------------R 211 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHhcCCC----------------C
Confidence 88999999999888899999999999999999999999863221 11 1111111111 0
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTE 534 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 534 (603)
........+.+++.+||..+|++||++++
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11112457789999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.36 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=201.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
...|.....||+|.|++|..|++. .+..||||.+.+. +....+.+.+|+++|..++|||||+|+.+......++|||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788889999999999999875 5789999999866 3444567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||..+|.|++||.++.. +.......++.|+..|++|+|++ .|+|||||++||||+.+.++||+|||++..+. .
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999999987643 55688888999999999999999 99999999999999999999999999998643 3
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........|++.|.|||++.+..| +++.|+||+|++||-|+.|..||+...-.+- .++...|++.
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~r------- 273 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKYR------- 273 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeeec-------
Confidence 445567789999999999988754 5699999999999999999999974322111 0111111110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. +.-...+.-+|+.+.|-.+|.+|+++.++.+
T Consensus 274 ------I---p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 ------I---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ------c---cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 0 0112234567899999999999999988764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=278.45 Aligned_cols=265 Identities=26% Similarity=0.338 Sum_probs=213.5
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeE
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 327 (603)
+||.....++....++-+|.||.||.|.+. +.+.|-||.++.. ..-+...++.|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 345555667888888999999999999664 3467888888765 444567889999999999999999999998
Q ss_pred eec-CceEEEEeeCCCCCHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 328 IER-GEQILVYEFMPNGTLCQHLQRER------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 328 ~~~-~~~~lV~E~~~~gsL~~~l~~~~------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
.++ ..++.+|.++.-|+|..||...+ .+.++-.+...+|.|++.|++|||.. ++||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 764 57899999999999999998432 23477888899999999999999999 999999999999999999
Q ss_pred cEEEeeccCcccccccccce-eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHH
Q 007442 401 KSKVADFGLSRLGMTEISHI-STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~ 478 (603)
++||+|=.++|-..+...+. .........||+||.+.+.+|+.++|||||||+||||+| |+.|+..-+|. .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------E 506 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------E 506 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------H
Confidence 99999999998654433332 233345678999999999999999999999999999998 66666432221 1
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
+...+++|. +-..+.+++.++..++.-||+..|++||++.+++.-|.+.-.
T Consensus 507 m~~ylkdGy---------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 507 MEHYLKDGY---------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHHHHhccc---------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 222333332 123356788999999999999999999999999998887643
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=270.31 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=193.5
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
...||.|..|.|+|.+.+ .|..+|||.+... +.+..+.++..+.++.+-+ .|.||+.+|||..+...++.||.|. -
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 346999999999999986 4889999999765 4566678888888777665 8999999999999999999999983 2
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceecc
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 423 (603)
-++.+|. ....++++...=++...+..||.||.++. +|+|||+||+|||||+.+++|++|||++-...+. ...+.
T Consensus 176 C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtr 250 (391)
T KOG0983|consen 176 CAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTR 250 (391)
T ss_pred HHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccccc
Confidence 3444444 33566888888899999999999999874 9999999999999999999999999999764443 23345
Q ss_pred CCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 424 PQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+.....+.+. ...+... .-|.|.+
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------ltkvln~-----ePP~L~~-- 317 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------LTKVLNE-----EPPLLPG-- 317 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------HHHHHhc-----CCCCCCc--
Confidence 678999999999863 46888999999999999999999999754333221 1111110 0122221
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++..||+.|+.+||...++++.
T Consensus 318 ------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 ------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22356789999999999999999999987753
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.78 Aligned_cols=275 Identities=25% Similarity=0.333 Sum_probs=201.7
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec------CceEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------GEQIL 335 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 335 (603)
|...+.||+|+||.||+|++ ..|+.||||.++... ....+...+|+++|++++|+|||++++.-.+. ..+++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999996 469999999998742 33446677899999999999999999985543 36789
Q ss_pred EEeeCCCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCC--cEEEeeccCc
Q 007442 336 VYEFMPNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD--YNF--KSKVADFGLS 410 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld--~~~--~~kl~DFGla 410 (603)
|||||++|+|+..|..-. ...|++.+.+.+..+++.||.|||+. +|+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999997542 35699999999999999999999998 999999999999993 334 4699999999
Q ss_pred ccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
+...++ ...+...||..|++||.+.. ..|+...|.|||||++||.+||..||.....+. ++....+..+.+..-.
T Consensus 172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCCc
Confidence 974433 35677899999999999884 789999999999999999999999997543332 1222222222221111
Q ss_pred ccc--chhhhh------ccCCCCccchHHHHHHHHHHHHHhccCCCCCC--CHHHHHHHHHhhhhc
Q 007442 490 EII--DPLIIE------HRGHSDAGTLASVHKVAELAFRCLAFHRDMRP--SMTEVATELEHIRTR 545 (603)
Q Consensus 490 ~~~--d~~l~~------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP--sm~eV~~~L~~i~~~ 545 (603)
-++ ++...+ ..+............+-.....+|..+|++|= ...+....+..|...
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111 110000 00001111223344555666677888888887 666666666666543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=326.49 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=200.1
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
+...+-++....+||.|.||.||-+.. .+|...|||-++..+ ........+|+.+|..|+|||+|+.+|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 345566778889999999999999875 568999999987653 33446678899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
+|.||||.+|+|.+.+... .-+++.....+..|++.|++|||+. +||||||||.|||||.++.+|++|||.|...
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999999643 3366777777889999999999999 9999999999999999999999999999864
Q ss_pred ccccc---ceeccCCCCCCCcCccccccCC---CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 414 MTEIS---HISTAPQGTPGYLDPQYHQNFH---LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 414 ~~~~~---~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
..... .......||+-|||||++.+.. -..+.||||+|||++||+||++||......... .-++..|.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------My~V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------MYHVAAGH 1458 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH------HhHHhccC
Confidence 43211 1123456999999999987543 455899999999999999999999643332211 11222232
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
. +..+.....+-.+++.+||+.||++|-++.|++
T Consensus 1459 ~---------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1459 K---------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred C---------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 2 122223556677899999999999996665443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=299.72 Aligned_cols=261 Identities=23% Similarity=0.244 Sum_probs=183.2
Q ss_pred HhcCCCccCcccCCCceEEEEEEE-----------------cCCcEEEEEEeccCChhhHHHHH--------------HH
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL-----------------QNDLLVAIKRIKHRDTDGIQQVV--------------NE 308 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~E 308 (603)
..++|...++||+|+||+||+|.+ .+++.||||+++.......++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23568999999765443334444 46
Q ss_pred HHHHhccCCCce-----eeeeeeEee--------cCceEEEEeeCCCCCHHHHhhhhcC---------------------
Q 007442 309 IKLISCVSHPNL-----VRLLGCSIE--------RGEQILVYEFMPNGTLCQHLQRERG--------------------- 354 (603)
Q Consensus 309 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 354 (603)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 678888753 3568999999999999999975311
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCc
Q 007442 355 -DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP 433 (603)
Q Consensus 355 -~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aP 433 (603)
..++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1357888999999999999999998 999999999999999999999999999975332222222223458899999
Q ss_pred cccccCC----------------------CCcccccccHHHHHHHHHhCCC-ccCCCCCcc-hh---hHHHHHHHHhhcC
Q 007442 434 QYHQNFH----------------------LSDKSDVYSFGVVLVEIITALK-VVDFSRPPN-EV---NLAALAADRISKG 486 (603)
Q Consensus 434 E~~~~~~----------------------~s~ksDVySfGvvL~elltg~~-p~~~~~~~~-~~---~l~~~~~~~~~~~ 486 (603)
|.+.... ...+.||||+||+|+||+++.. |+....... +. ......+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1235799999999999999875 543211100 00 0000111111111
Q ss_pred CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCC---CCCCCHHHHHH
Q 007442 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHR---DMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPsm~eV~~ 537 (603)
...-. ..........+|+.++|..+| .+|+|+.|+++
T Consensus 460 ~~~~~--------------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFS--------------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcc--------------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11100 011224567789999999766 68999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=311.79 Aligned_cols=145 Identities=29% Similarity=0.399 Sum_probs=131.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...++||+|+||+||+|... +++.||||+++.. .......+.+|+.++..++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999986 5789999999754 2344577889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
||+++++|.+++... ..+++...+.|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999754 3488999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=269.28 Aligned_cols=238 Identities=29% Similarity=0.350 Sum_probs=194.6
Q ss_pred CceEEEEEEEcC-CcEEEEEEeccCChhh-HHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhh
Q 007442 274 AFGTVYAGKLQN-DLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR 351 (603)
Q Consensus 274 ~~g~Vykg~~~~-~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 351 (603)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8899999998765444 68999999999999999999999999999999999999999999999976
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCc
Q 007442 352 ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431 (603)
Q Consensus 352 ~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 431 (603)
... +++..++.++.+++++|+|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 89999999999999999999998 99999999999999999999999999998643321 233456888999
Q ss_pred CccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHH
Q 007442 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASV 511 (603)
Q Consensus 432 aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 511 (603)
+||.+....++.++|||+||++++||++|..|+...... ....+.+..+..... .......
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~-------------~~~~~~~ 214 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFP-------------PPEWKIS 214 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCc-------------cccccCC
Confidence 999999888999999999999999999999988642111 111222222211110 0000034
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 512 HKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 512 ~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.++.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 57889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=268.31 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=209.4
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeec
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIER 330 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 330 (603)
+++|+-+.| .+.||+|+|+.|-... +.++..+|||++.+........+.+|++++.+.+ |+||++|+.+|.++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 477888877 4679999999999876 5789999999999887777889999999999996 99999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEeec
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KSKVADF 407 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~kl~DF 407 (603)
...|||||-|.+|.|..+|++++ .+++.+.-++..+||.||.|||.+ +|.||||||+|||-.... -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998764 489999999999999999999999 999999999999996654 3799999
Q ss_pred cCccccc--ccc----cceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcc-----
Q 007442 408 GLSRLGM--TEI----SHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN----- 471 (603)
Q Consensus 408 Gla~~~~--~~~----~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~----- 471 (603)
.|..-.. .+- ........|+..|||||+.. ...|+.+.|.||+|||||-|++|..||......+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9874311 111 12233567889999999764 2358889999999999999999999997543321
Q ss_pred ---hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 472 ---EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 472 ---~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
-..-.....+.+.+|... +-|. .-.....+..+++...|..++.+|-++.+|+.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYe-FPdk-----------dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYE-FPDK-----------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCc-CChh-----------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 011223445556666532 2222 11234556678888899999999999988876
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.00 Aligned_cols=247 Identities=26% Similarity=0.301 Sum_probs=200.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|+..++||+|.||+|...+-+ .++.+|+|++++. ..+....-+.|-.+|...+||.+..|.-.+...+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 67888999999999999998865 5899999999875 3445556678999999999999999998899999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||..+|.|.-||.+.+ .+++.....+-.+|..||.|||+. +||.||||.+|.|||.|+++||+||||++.... .
T Consensus 248 eyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-Y 321 (516)
T ss_pred EEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-c
Confidence 9999999999997653 478877788889999999999998 999999999999999999999999999986433 2
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++....|....|.|.+|||+|||++|+.||....... +-..+. .+.+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl----~ed~--------- 385 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL----MEDL--------- 385 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH----hhhc---------
Confidence 344566799999999999999999999999999999999999999997432221 111111 0000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
..+.....+...|....|..||.+|. .++||.+
T Consensus 386 -------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 -------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11223344566788899999999995 3455543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=272.91 Aligned_cols=222 Identities=19% Similarity=0.170 Sum_probs=177.3
Q ss_pred CCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhh
Q 007442 273 GAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR 351 (603)
Q Consensus 273 G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 351 (603)
|.||+||++... +++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 67899999997643 234555666667799999999999999999999999999999999975
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCc
Q 007442 352 ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431 (603)
Q Consensus 352 ~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 431 (603)
. ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++|||++..... ......++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED----SCDGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc----ccccCCcCcccc
Confidence 4 3499999999999999999999998 999999999999999999999999998764322 122334677899
Q ss_pred CccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHH
Q 007442 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASV 511 (603)
Q Consensus 432 aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 511 (603)
|||++....++.++||||+|++++||++|+.|+...... +... ..+ ..+....
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~--~~~-------------~~~~~~~ 202 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH--TTL-------------NIPEWVS 202 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc--ccc-------------CCcccCC
Confidence 999998888999999999999999999998776421110 0000 000 0011234
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHH
Q 007442 512 HKVAELAFRCLAFHRDMRPSMTEV 535 (603)
Q Consensus 512 ~~l~~l~~~Cl~~~p~~RPsm~eV 535 (603)
..+.+++.+||+.||++||++.+.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCcc
Confidence 567889999999999999998543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=271.91 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=201.2
Q ss_pred CCCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcc-CCCceeeee
Q 007442 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DGIQQVVNEIKLISCV-SHPNLVRLL 324 (603)
Q Consensus 248 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~ 324 (603)
.+..|+.++|+. ...||.|.||+|+|-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++
T Consensus 57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344566555554 456999999999998875 589999999987644 5567788888765554 699999999
Q ss_pred eeEeecCceEEEEeeCCCCCHHHHh---hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 325 GCSIERGEQILVYEFMPNGTLCQHL---QRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 325 g~~~~~~~~~lV~E~~~~gsL~~~l---~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
|.+..++..++.||.| .-||+.+. +.-....+++...-.|+.-+..||.||.... .||||||||+|||||..|.
T Consensus 130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCC
Confidence 9999999999999999 45665543 3333456999999999999999999998764 8999999999999999999
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccccC--CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~ 479 (603)
+||+|||++-.... +...+.-.|-..|||||.+... .|+.+|||||+|++|+|+.||+.|+..... ....
T Consensus 207 vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeq 278 (361)
T KOG1006|consen 207 VKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQ 278 (361)
T ss_pred EeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHH
Confidence 99999999864332 2333455788999999998643 488999999999999999999999863211 1122
Q ss_pred HHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...+..|....+.. +....+....+..++..||..|...||...++.+.
T Consensus 279 l~~Vv~gdpp~l~~----------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQVVIGDPPILLF----------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHcCCCCeecC----------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22333343322211 11223456778999999999999999999987754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.26 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=201.8
Q ss_pred hcCCCcc-CcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEee----cCce
Q 007442 261 TIGFSEK-QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE----RGEQ 333 (603)
Q Consensus 261 t~~f~~~-~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 333 (603)
|++|.+. ++||-|-.|+|-....+ .++.+|+|.+... ....+|+++--.. .|||||.++++|.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4445443 57999999999988765 6889999998764 4457788876666 49999999999764 3567
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLS 410 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla 410 (603)
++|||.|++|.|+..++.+....+++.+.-.|..||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999999998878899999999999999999999999 9999999999999954 456899999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
+.. .........+-|+.|.|||++...+|+...|+||+||++|-|+.|..||..... ..+.--...+++.|...
T Consensus 212 K~t--~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy~- 285 (400)
T KOG0604|consen 212 KET--QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQYE- 285 (400)
T ss_pred ccc--CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCcc-
Confidence 852 223445667889999999999999999999999999999999999999974322 11122233444444331
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+- ++.-.+.++...+++...|..+|.+|.|+.|++..
T Consensus 286 FP-----------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 FP-----------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CC-----------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 11223456777889999999999999999998753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=300.94 Aligned_cols=264 Identities=21% Similarity=0.217 Sum_probs=169.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC-----CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeee------Ee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC------SI 328 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 328 (603)
..++|...+.||+|+||.||+|++.+ +..||||+++..... +.+.+| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999854 689999998653221 111221 1222223333332222 24
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERGD------------------GLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIK 390 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik 390 (603)
+....+|||||+++++|.++++..... ...+.....|+.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999998753210 012234557999999999999998 99999999
Q ss_pred CCCeeecC-CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC----------------------CCCccccc
Q 007442 391 SSNILLDY-NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF----------------------HLSDKSDV 447 (603)
Q Consensus 391 ~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDV 447 (603)
|+||||++ ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986433333344556789999999965322 24456799
Q ss_pred ccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc-----ccccchhhhhccCCCCccchHHHHHHHHHHHHHh
Q 007442 448 YSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL-----DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCL 522 (603)
Q Consensus 448 ySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl 522 (603)
|||||+||||+++..+.+.. +.. +...+..... ...+++.....................+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999976553310 111 1111111000 0000000000000000000001223458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 007442 523 AFHRDMRPSMTEVATE 538 (603)
Q Consensus 523 ~~~p~~RPsm~eV~~~ 538 (603)
+.||++|||+.|+++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999998864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=273.13 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=199.1
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeE
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCS 327 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 327 (603)
+-.+..+++ +|+...+||+|+||+|..|.-+. .+.+|||++++. ..+..+--+.|-++|... +-|.+++|..|+
T Consensus 341 ~~~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 341 SKRDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred Ccccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 334444443 57888899999999999997654 578999999865 122333345677777766 478999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
..-+.+++||||+.+|+|-.+++.-. .+.++...-+|.+||-||-+||++ +||.||||..|||||.++++||+||
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 99999999999999999999998653 488889999999999999999999 9999999999999999999999999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
|+++...-+ ...+....||+.|+|||.+...+|+...|.|||||+||||+.|+.||+.... ..+ .+.+.+
T Consensus 495 GmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~el----F~aI~e-- 564 (683)
T KOG0696|consen 495 GMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DEL----FQAIME-- 564 (683)
T ss_pred ccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHH----HHHHHH--
Confidence 999863322 2334567899999999999999999999999999999999999999974322 111 112211
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 531 (603)
+.-.++...+.+...|....|...|.+|..
T Consensus 565 --------------hnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 --------------HNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------------ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 122344556677888999999999999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.09 Aligned_cols=240 Identities=23% Similarity=0.291 Sum_probs=194.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++..|.....+|.|+|+.|-+.... +++..+||++.... .+-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3556777778999999999988764 57889999997662 2234577666666 6999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCCCcEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL-DYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl-d~~~~~kl~DFGla~~~~~~ 416 (603)
|++.+|-|.+.+.... .....+..|+.+++.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++....+
T Consensus 396 e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999888886543 22267778999999999999998 99999999999999 58899999999999864433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.....-|..|.|||++....|++++|+||||++||||++|+.|+..+... ..+..++..++..
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc-------
Confidence 33446788999999999999999999999999999999999999754332 2233344433332
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+....+|+.+||+.+|.+||+|.++..
T Consensus 533 -----------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -----------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 234556788999999999999999999764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=299.66 Aligned_cols=258 Identities=22% Similarity=0.259 Sum_probs=208.0
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
.++..-.++|.+.++||+|+||.|..++++ .++.+|+|++++. ......-|..|-.+|.--+.+=|++|.-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455555678999999999999999999986 4789999999863 334456788999999998999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
.++|||||||+||+|-.+|.+.. ++++.....++.+|..||.-||+. |+|||||||.|||||..|++||+|||.+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999998754 688888889999999999999999 9999999999999999999999999998
Q ss_pred ccccccccceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
-.+..+..-.+...+|||-|++||+++. +.|+...|.||+||++|||+.|..||+. ..++......+..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~h 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMNH 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhch
Confidence 7655566666777899999999999862 5789999999999999999999999963 2334333333222
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS---MTEVAT 537 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~eV~~ 537 (603)
.....+. .....+++..+||.+.+. +|+.|.. ..++..
T Consensus 297 k~~l~FP-------------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 KESLSFP-------------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhcCCC-------------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111111 122355667778877665 6777776 666553
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=264.23 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=166.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-----CcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEee-cCce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 333 (603)
..|+....||+|.||.||||.-.+ ...+|||+++.... .-.....+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778889999999999996543 23799999986521 122456789999999999999999999988 7788
Q ss_pred EEEEeeCCCCCHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEee
Q 007442 334 ILVYEFMPNGTLCQHLQRER---GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN----FKSKVAD 406 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~----~~~kl~D 406 (603)
+|++||.+. +|.+.|+-++ ...++-.....|+.||+.|++|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 8888886543 23588889999999999999999999 79999999999999877 8999999
Q ss_pred ccCcccccccccc--eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccC
Q 007442 407 FGLSRLGMTEISH--ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 407 FGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
||++|++...... ....++-|+-|.|||.+.+. +||.+.|||+.||++.||+|-+.-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999986543222 23345678999999998765 79999999999999999999876664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.21 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=208.3
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEee-
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE- 329 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 329 (603)
.++-+...++-|.+.+.||+|.+|.|||++. ++++.+|||++... .+..+++..|.++|+.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444555677889999999999999999986 46889999988754 34446778899999988 59999999999863
Q ss_pred ----cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 330 ----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 330 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
++.++||||||.+||..|++++..+..+.|.....|+.++++||.|||.. .++|||||-.||||+.++.+|+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999999987778899999999999999999999999 99999999999999999999999
Q ss_pred eccCcccccccccceeccCCCCCCCcCccccccC-----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 406 DFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 406 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
|||.+... +..........||+.|||||++.-. .|+..+|+||+|++..||--|..|+-...+.. +.
T Consensus 166 DFGvSaQl-dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aL 237 (953)
T KOG0587|consen 166 DFGVSAQL-DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------AL 237 (953)
T ss_pred eeeeeeee-ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hh
Confidence 99998753 2233444566899999999998643 46779999999999999999988875322211 11
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
-.+.... -|.| ..+..-.+++.+++..||..|-++||++.++++
T Consensus 238 F~IpRNP-----PPkL--------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPRNP-----PPKL--------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCCCC-----Cccc--------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111 1111 113445778999999999999999999988764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.50 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=193.4
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
++.||.|-||+||-|+++ +|+.||||.+.+. ...+..++.+|+.||.++.||.||.|---|...+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 468999999999999974 6999999999754 2344578899999999999999999999999999999999999 55
Q ss_pred CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccCcccccccccce
Q 007442 344 TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 344 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGla~~~~~~~~~~ 420 (603)
+..+.|-......|++..-..++.||+.||.|||.+ +|+|.||||+||||... -.+||+|||+||+... ...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--hhh
Confidence 665655544455688888888999999999999999 99999999999999543 3689999999997433 334
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
...+.||+.|+|||++++..|...-|+||.||++|--++|..||..... .+ +.+... .++-
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---In------dQIQNA---aFMy------- 783 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---IN------DQIQNA---AFMY------- 783 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hh------HHhhcc---cccc-------
Confidence 5667899999999999999999999999999999999999999963211 11 111110 0000
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEV 535 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV 535 (603)
....-.+.....++|+...|+..-.+|-+...-
T Consensus 784 --Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 784 --PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred --CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 112223556678899999999999999887653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=269.07 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=190.6
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC---hh----hHHHHHHHHHHHhccCCCceeeeeeeEe-ecCceE
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TD----GIQQVVNEIKLISCVSHPNLVRLLGCSI-ERGEQI 334 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~---~~----~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~ 334 (603)
|-..++||+|||+.|||+.. ...+.||||+-.... .+ -.+...+|..|-+.|.||.||++++++. +.+..+
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 44467899999999999975 457889999764331 11 1233567999999999999999999986 556778
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~ 411 (603)
-|+||+++.+|+-||..++ .+++.....|+.||..||.||.+. .|+|||-||||.||||-+ .+.+||.||||++
T Consensus 545 TVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999998753 489999999999999999999986 789999999999999944 5789999999999
Q ss_pred ccccccc------ceeccCCCCCCCcCccccccC----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 412 LGMTEIS------HISTAPQGTPGYLDPQYHQNF----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 412 ~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
.+.++.. ..+....||.-|++||.+.-+ .++.|.||||.||++|..+.|++||.......+.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-------- 693 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-------- 693 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--------
Confidence 8654322 233456799999999977544 5788999999999999999999999743332211
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
+.++.+...-.- .-...+....+...++.+||++.-++|-...+++
T Consensus 694 -LqeNTIlkAtEV--------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 -LQENTILKATEV--------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -Hhhhchhcceec--------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111100000 0011122344667899999999999998766654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=256.91 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=202.0
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
.++|...++||+|+|.+|..++++ ..+.+|+|.+++. +.+.++-...|-.+..+- +||.+|-|..|+..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999985 4689999999864 344556666777777776 69999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|.||+++|+|--++++++ .|++.....+..+|..||.|||+. +||.||||..|+|||..+++||.|+|+++....
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999988887654 499999999999999999999999 999999999999999999999999999987443
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCc-chhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP-NEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
. ...+....||+.|+|||.+++..|....|.|++||+++||+.|+.||+..... .+.+...+..+.+.+.++.-
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---- 478 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---- 478 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc----
Confidence 3 33445678999999999999999999999999999999999999999864332 22344444444444333211
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP 530 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 530 (603)
+.....+...+...-|+.||.+|.
T Consensus 479 ------------prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 ------------PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------------cceeehhhHHHHHHhhcCCcHHhc
Confidence 112233456788889999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=261.85 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=201.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCC--C----ceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH--P----NLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~ 333 (603)
+++|.+..+||+|.||.|-+.... .+..||||+++..+.- .+.-+-|+++|.++.+ | -+|.+.+|+.-.+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999998764 3689999999865432 2444669999999942 2 388888999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---------------
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--------------- 398 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--------------- 398 (603)
+||+|.+ +-|+.++|..+.-.+++......|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 56999999987777899999999999999999999999 9999999999999831
Q ss_pred -----CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchh
Q 007442 399 -----NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473 (603)
Q Consensus 399 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~ 473 (603)
+..+||+|||.|+.... .+ ...+.|..|.|||++.+-.++..+||||+||||.||.||...|+.....+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e--~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE--HH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceecc--Cc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 33589999999986322 12 4557899999999999999999999999999999999999988765533322
Q ss_pred hHHHHHH--------------HHhhcCCccc-----------ccch-hhhhccCCCCccchHHHHHHHHHHHHHhccCCC
Q 007442 474 NLAALAA--------------DRISKGRLDE-----------IIDP-LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRD 527 (603)
Q Consensus 474 ~l~~~~~--------------~~~~~~~~~~-----------~~d~-~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~ 527 (603)
.+.+.+. +....|+++. ..++ .... ........+..++.+|+.++|.+||.
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~---~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLK---KYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHH---HHhccCcHHHhHHHHHHHHHHccCcc
Confidence 1111111 1111122110 0000 0000 00012335567799999999999999
Q ss_pred CCCCHHHHHH
Q 007442 528 MRPSMTEVAT 537 (603)
Q Consensus 528 ~RPsm~eV~~ 537 (603)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=241.33 Aligned_cols=207 Identities=25% Similarity=0.427 Sum_probs=169.9
Q ss_pred HHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
...+.......||+|++|.|-|-++ .+|+..|||+++.. +.+..++.++|+.+..+. .+|.+|.++|........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3334444466799999999988887 57899999999865 345556778888877665 69999999999999999999
Q ss_pred EEeeCCCCCHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 336 VYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
.||.| .-||..+-.. .++..+++...=+||..+..||.|||++. .+||||+||+||||+.++++||+|||++-..
T Consensus 123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999 4577766543 23566999999999999999999999985 8999999999999999999999999999764
Q ss_pred cccccceeccCCCCCCCcCcccccc----CCCCcccccccHHHHHHHHHhCCCccCCCCCc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQN----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~ 470 (603)
.+. -..+...|-..|||||.+.. ..|+-||||||+|+.+.||.+++.|++....+
T Consensus 200 ~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 200 VDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 332 22233468889999998763 36899999999999999999999999865544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=240.63 Aligned_cols=210 Identities=36% Similarity=0.555 Sum_probs=183.9
Q ss_pred ccCCCceEEEEEEEcC-CcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHH
Q 007442 270 LGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347 (603)
Q Consensus 270 LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 347 (603)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999876433 45789999999999999999999999999999999999999999999
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCcccccccccceeccCCC
Q 007442 348 HLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEISHISTAPQG 426 (603)
Q Consensus 348 ~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 426 (603)
++.... ..+++..++.++.+++++|+|||+. +++|+||+|.||+++. +..++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 997642 4589999999999999999999999 9999999999999999 89999999999876432211 2233567
Q ss_pred CCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCc
Q 007442 427 TPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDA 505 (603)
Q Consensus 427 t~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 505 (603)
...|++||.+... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999999
Q ss_pred cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 506 GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 506 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 146689999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=268.19 Aligned_cols=237 Identities=24% Similarity=0.247 Sum_probs=196.5
Q ss_pred cCcccCCCceEEEEEEEcCCc-EEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDL-LVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
...||-||||.|=.+..+... .+|+|.+++. +..+.+.+..|-.+|.+.+.|.||+|+..|.+....|+.||-|-+
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 456999999999998876543 4888888754 566678889999999999999999999999999999999999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|.|+..|.++ ..++......++..+.+|++|||++ +||.|||||+|.|||.++-+||.|||+|+... ....+.
T Consensus 505 GElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTw 577 (732)
T KOG0614|consen 505 GELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTW 577 (732)
T ss_pred chhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc--cCCcee
Confidence 9999999765 3488888888999999999999999 99999999999999999999999999998643 334456
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|.|||.+.+...+.+.|.||+|++++||++|..||....+....++ +.+| +|.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkG-----id~-------- 637 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKG-----IDK-------- 637 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhh-----hhh--------
Confidence 67999999999999999999999999999999999999999976544322221 1111 111
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCC
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPS 531 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 531 (603)
-+.+....+...+|+.+....+|.+|..
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1223344556778999999999999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=280.80 Aligned_cols=244 Identities=28% Similarity=0.373 Sum_probs=183.6
Q ss_pred CCCccCcccCCCceE-EEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGT-VYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~-Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
-|...+.+|.|.-|+ ||+|... ++.||||++-... .+-..+||..|..- +||||||+++.-.+....||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 356667899999876 7999984 5699999986432 23456899999888 4999999999888888999999999
Q ss_pred CCCCHHHHhhhhc-C-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----CCcEEEeeccCcccc
Q 007442 341 PNGTLCQHLQRER-G-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-----NFKSKVADFGLSRLG 413 (603)
Q Consensus 341 ~~gsL~~~l~~~~-~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-----~~~~kl~DFGla~~~ 413 (603)
..+|.+++.... . ....-...+.+..|++.||+|||+. +||||||||.||||+. ..+++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 569999998741 1 1122245677889999999999998 9999999999999965 257999999999875
Q ss_pred cccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 414 MTEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 414 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
..+... ......||-||+|||++....-+.+.||||+|||+|+.++| ..||..... .+.+ +..|...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~~N--------Il~~~~~- 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQAN--------ILTGNYT- 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-hhhh--------hhcCccc-
Confidence 443322 23456799999999999998888899999999999999997 667752111 0110 1111100
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
++. | ....++ +..+||.+|++.+|..||++.+|+
T Consensus 732 -L~~-L--------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 732 -LVH-L--------EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -eee-e--------ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 000 0 001111 678999999999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-31 Score=250.28 Aligned_cols=270 Identities=20% Similarity=0.258 Sum_probs=191.7
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeec--------Cc
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIER--------GE 332 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~~ 332 (603)
|....+||+|.||.||||+.++ ++.||+|++-..+. .--...++|+.+|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4445689999999999999865 67789987754221 1124457899999999999999999988632 24
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||.+++. +|...|... ...++...+.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7899999976 788888654 34588999999999999999999999 999999999999999999999999999986
Q ss_pred cccc---ccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 413 GMTE---ISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 413 ~~~~---~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+... .....+...-|.-|.+||.+.+. +|+++.|||.-|||+.||.||..-+..........+....-..+...-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 5432 22234555679999999988765 7999999999999999999997776643332222222111111111111
Q ss_pred ccccchhhhhcc-CC-CCc----cchHH------HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 DEIIDPLIIEHR-GH-SDA----GTLAS------VHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 ~~~~d~~l~~~~-~~-~~~----~~~~~------~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+...-.|...- .+ ... ...+. ..+.++|+..++..||.+|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110000000000 00 000 00111 2267789999999999999999887743
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=227.72 Aligned_cols=197 Identities=26% Similarity=0.369 Sum_probs=165.2
Q ss_pred CCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+|..-++||+|.||+||||+..+ ++.||+|+++..+. ..-....+||-+|+.++|+|||+++++...+..+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34556679999999999999764 68999999986533 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+. -+|..|..... ..++-.....++.|+++||.|.|+. ++.|||+||.|.||+.+++.|++|||+++.+.... .
T Consensus 83 cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred hh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 94 47877776553 4488888889999999999999999 99999999999999999999999999998754322 1
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccC
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
......-|.-|.+|.++.+. -|+...|+||-|+++.||.....|..
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 22344678899999998875 58889999999999999998666654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=239.28 Aligned_cols=199 Identities=32% Similarity=0.489 Sum_probs=173.3
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
|...+.||+|++|+||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 789999999876554 67889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+++|.+++..... .+++...+.++.+++.+|.|||.. +++|+||+|.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999976532 289999999999999999999998 999999999999999999999999999886443321122
Q ss_pred ccCCCCCCCcCcccc-ccCCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 422 TAPQGTPGYLDPQYH-QNFHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
....++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578889999998 666788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=257.11 Aligned_cols=215 Identities=26% Similarity=0.373 Sum_probs=177.6
Q ss_pred ChHHHHHHhc---CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhccCCCceeeeee
Q 007442 253 PYREIEKATI---GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 253 ~~~el~~at~---~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
.|--|++|.- -|...+.||-|+||+|..+.-. ....+|+|.|++.+. .....+..|-.||..-..+=||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 3445555543 4777889999999999998754 467899999987643 34456778999999999999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
.|.+.+.+|+||+|+++|++-.+|.+. .-+.+.....++.+++.|+++.|.. ++|||||||.|||||.+|++||.
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 999999999999999999999999765 2367777777888999999999999 99999999999999999999999
Q ss_pred eccCccccc---c-----cccce---------------------------------eccCCCCCCCcCccccccCCCCcc
Q 007442 406 DFGLSRLGM---T-----EISHI---------------------------------STAPQGTPGYLDPQYHQNFHLSDK 444 (603)
Q Consensus 406 DFGla~~~~---~-----~~~~~---------------------------------~~~~~gt~~Y~aPE~~~~~~~s~k 444 (603)
||||+.-+. + ...|. ....+||+.|+|||++....++.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999984210 0 00000 002359999999999999999999
Q ss_pred cccccHHHHHHHHHhCCCccCCCCCcch
Q 007442 445 SDVYSFGVVLVEIITALKVVDFSRPPNE 472 (603)
Q Consensus 445 sDVySfGvvL~elltg~~p~~~~~~~~~ 472 (603)
.|.||.||||+||+.|+.||-...+.+.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999987666543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-29 Score=240.97 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=193.6
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-----ceEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-----EQIL 335 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~l 335 (603)
...++.||-|+||.||..+. ++|+.||.|++... +....+.+.+|+++|.-++|.|++..++...... +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34578899999999999986 57899999998654 3345578899999999999999999988765332 4577
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+|.|. .+|+..|-. ...|+-....-+..||++||.|||+. +|.||||||.|.|++.|-..||+|||++|....
T Consensus 135 ~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 888883 466666643 34578778888899999999999999 999999999999999999999999999997555
Q ss_pred cccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH-----Hh---hcC
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD-----RI---SKG 486 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~-----~~---~~~ 486 (603)
+.....+...-|..|.|||.+.+. +|+.+.||||.|+++.||+.++..|....+.....+...... .+ -+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555666789999999998865 799999999999999999999888876655444333221110 00 011
Q ss_pred Ccccccch-----hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 487 RLDEIIDP-----LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 487 ~~~~~~d~-----~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
.-.-++.. .+........ ....-.+...+...++.++|++|-+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS--~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIAS--PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecC--CcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 10000000 0000000000 001122345677788999999999988877553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=226.49 Aligned_cols=260 Identities=19% Similarity=0.265 Sum_probs=195.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeec--CceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIER--GEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 337 (603)
++|...+++|+|.|+.||.|.. .+++.++||.++.. ..+.+.+|+.||..|. ||||++|++...+. ..+.||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 5677788999999999999985 56789999999864 3467889999999998 99999999998754 4678999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~ 416 (603)
||+.|.+...+.. .|+.........+++.||.|.|+. +|.|||+||.|++||... .++|+|+|||.+....
T Consensus 115 E~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999987766553 377778888999999999999999 999999999999999764 6899999999886543
Q ss_pred ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHH--------HHHHHhhcCC
Q 007442 417 ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA--------LAADRISKGR 487 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~--------~~~~~~~~~~ 487 (603)
.. ......+..|--||.+-. ..|+..-|+||||++|.+|+..+.||..+....+. ++. .+...+.+-.
T Consensus 187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHHHHHc
Confidence 22 223456777889998764 46788899999999999999999999865543321 111 1111222222
Q ss_pred cccccchhhhhccC----------CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDEIIDPLIIEHRG----------HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~~~d~~l~~~~~----------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+ .+||......+ ...+...-...+.++++.+.|..|-++|||++|.+.
T Consensus 264 i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 I--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred c--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2 14443322000 001111122467889999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=239.16 Aligned_cols=131 Identities=26% Similarity=0.357 Sum_probs=113.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-----C---CceeeeeeeEeec--
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-----H---PNLVRLLGCSIER-- 330 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~~-- 330 (603)
.+|...++||-|.|++||.+.. .+.+.||+|+++.. ..-.+.-+.||++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5677889999999999999986 45689999999864 233456678999999994 3 3699999999754
Q ss_pred --CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 331 --GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 331 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
.+.++|+|++ +-+|..+|....-+.++.....+|+.||+.||.|||..| +|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4789999999 779999998877777999999999999999999999998 99999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=228.27 Aligned_cols=255 Identities=19% Similarity=0.250 Sum_probs=192.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeee-EeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGC-SIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~~~~~~lV~ 337 (603)
.+.|++.+.||+|.||.+-.+.++. ++.+++|.+... .....+|.+|...--.|. |.||+.-++. +...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568889999999999999999864 678999988765 345688999998766664 9999988776 45566778999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cC-CCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL-DY-NFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl-d~-~~~~kl~DFGla~~~~~ 415 (603)
||+|.|+|.+-+.. ..+.+..-.+++.|++.||.|||++ ++||||||.+|||| +. ..++||+|||+++....
T Consensus 102 E~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999998865 3488888899999999999999999 99999999999999 33 45899999999875211
Q ss_pred cccceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 416 EISHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
......-+..|.+||.... ....+.+|||.||++++.++||+.|++.....+ ...|-+..+.++....
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPA 248 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCcc
Confidence 1122235667999997643 245678999999999999999999997432222 2334444444443332
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.-+. .....+.+..+..+-|..++++|--..++.++-..
T Consensus 249 ~P~~------------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 249 LPKK------------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred Cchh------------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 2111 12234567778888999999999777777766543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=252.67 Aligned_cols=195 Identities=24% Similarity=0.324 Sum_probs=165.6
Q ss_pred CCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCCh--------hhHHHHHHHHHHHhccC---CCceeeeeeeEeec
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDT--------DGIQQVVNEIKLISCVS---HPNLVRLLGCSIER 330 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 330 (603)
+|+..+.||.|+||.|+.+.++. ...|+||.+.+..- ...-.+-.||.||..++ |+||+|++++|++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47778999999999999999864 57799998875421 11123456999999998 99999999999999
Q ss_pred CceEEEEeeC-CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 331 GEQILVYEFM-PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 331 ~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
+..+|+||-. ++-+|+++|..+ ..+++.....|+.|++.|+++||+. +|||||||-+||.+|.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 9999999976 466899999765 3499999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCC-cccccccHHHHHHHHHhCCCccC
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS-DKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvL~elltg~~p~~ 465 (603)
+.+... ......+||.+|.|||++.+..|- ..-|||++|++||-++....|+.
T Consensus 717 aa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876322 223456899999999999988764 46899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=254.46 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=201.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.+|.|.||.|||++.. .+...|||.++....+...-+.+|+-+++..+|||||.++|-+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 356777899999999999999974 5789999999988777778888999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+.+|+|.+.-+.. .+|++.+......+..+||+|||+. +-+|||||-.|||+++.+.+|++|||.+-.... .-.
T Consensus 94 cgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIA 167 (829)
T ss_pred cCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hhh
Confidence 9999999987653 4699999999999999999999999 899999999999999999999999998764222 223
Q ss_pred eeccCCCCCCCcCcccc---ccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch-h
Q 007442 420 ISTAPQGTPGYLDPQYH---QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP-L 495 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~ 495 (603)
......||+.|||||+. +.+.|..++|||+.|+...||---+.|...-.+. ...+ .+.+- .++| .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-----r~l~--LmTkS----~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-----RALF--LMTKS----GFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-----HHHH--Hhhcc----CCCCCc
Confidence 34566899999999976 4667899999999999999998776665321111 1111 11110 1111 1
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
+ .....-...+.++++.|+-.+|++||+++.++
T Consensus 237 l--------kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 L--------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred c--------cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1 11233456788999999999999999997654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=230.53 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=190.9
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------Cc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------GE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 332 (603)
.+|.....+|.|.. .|--+.. -.++.||+|++... +....+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 4444433 35789999998654 334456678899999999999999999998643 35
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||| ..+|...++.. ++......|..|+..|+.|||+. +|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 78999999 67999988733 77888889999999999999999 999999999999999999999999999985
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH----------------H
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL----------------A 476 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l----------------~ 476 (603)
... .-..+....|..|.|||++.+..+.+..||||.||++.||++|+.-|.....-+.... .
T Consensus 168 e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 322 2355667889999999999988899999999999999999999887752211111100 0
Q ss_pred HHHHHHhh---c---CCccccc-chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 477 ALAADRIS---K---GRLDEII-DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 477 ~~~~~~~~---~---~~~~~~~-d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+....+ + -...+.+ |.... ...+...-......+++.+||-.+|++|-+..++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~----~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFP----VVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCccccc----ccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000 0 0000000 10000 0111222334457789999999999999999987753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=270.17 Aligned_cols=195 Identities=20% Similarity=0.246 Sum_probs=139.4
Q ss_pred ccCC-CceeeeeeeE-------eecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007442 314 CVSH-PNLVRLLGCS-------IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385 (603)
Q Consensus 314 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iv 385 (603)
.++| +||+++++++ .+.+..++++||+ .++|.++|... ...+++..++.|+.||++||+|||+. +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4556 5888888887 3334667888987 66999999753 34599999999999999999999998 999
Q ss_pred ecCCCCCCeeecC-------------------CCcEEEeeccCcccccccc---------------cceeccCCCCCCCc
Q 007442 386 HRDIKSSNILLDY-------------------NFKSKVADFGLSRLGMTEI---------------SHISTAPQGTPGYL 431 (603)
Q Consensus 386 H~Dik~~NILld~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~Y~ 431 (603)
||||||+||||+. ++.+||+|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456667777765311000 00011235788999
Q ss_pred CccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHH
Q 007442 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASV 511 (603)
Q Consensus 432 aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 511 (603)
|||++.+..++.++|||||||+||||++|..|+... . . ....+... .+.+.. ....
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----~----~-~~~~~~~~----~~~~~~-----------~~~~ 238 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----S----R-TMSSLRHR----VLPPQI-----------LLNW 238 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----H----H-HHHHHHHh----hcChhh-----------hhcC
Confidence 999999999999999999999999999987765311 0 0 01111111 111110 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 512 HKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 512 ~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.....++.+||+.+|.+||+|.||++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh
Confidence 34567889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=211.46 Aligned_cols=169 Identities=20% Similarity=0.241 Sum_probs=127.2
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceec
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|||.+++... +..++|.+++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 7999999754 45699999999999999999999998 4 999999999999999 9998763321
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|||||++.+..++.++||||||+++|||+||+.|+........ .+..+ .......... +.
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~-~~~~~~~~~~---~~-------- 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEIL-LNGMPADDPR---DR-------- 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHH-HHHhccCCcc---cc--------
Confidence 12689999999999999999999999999999999999999853222111 11111 1111110000 00
Q ss_pred CCccchHHH--HHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 503 SDAGTLASV--HKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 503 ~~~~~~~~~--~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
....... .++.+++.+||+.+|++||++.|+++.+..+..
T Consensus 130 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 --SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0011122 268999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=227.12 Aligned_cols=271 Identities=21% Similarity=0.319 Sum_probs=196.6
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecC
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERG 331 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 331 (603)
+....+.|...++||+|.|++||++.+.. .+.||+|.+.... ....+.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44455678889999999999999998643 5789999997643 3356889999999996 999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLS 410 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla 410 (603)
...+|+||+++..-.+++.. ++......++..+..||+|+|.. +||||||||+|+|.+.. .+-.|.||||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888853 67888899999999999999999 99999999999999764 56799999998
Q ss_pred ccccc-------cc--------------------------cc----------eeccCCCCCCCcCcccccc-CCCCcccc
Q 007442 411 RLGMT-------EI--------------------------SH----------ISTAPQGTPGYLDPQYHQN-FHLSDKSD 446 (603)
Q Consensus 411 ~~~~~-------~~--------------------------~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~ksD 446 (603)
..... .. .+ .....+||+||.|||++.. ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 61000 00 00 0112359999999998864 46788999
Q ss_pred cccHHHHHHHHHhCCCccCCCCCcch--hhHHHHHHH-H-----hhcCC--ccc--c--cchhhh--------hc-cC--
Q 007442 447 VYSFGVVLVEIITALKVVDFSRPPNE--VNLAALAAD-R-----ISKGR--LDE--I--IDPLII--------EH-RG-- 501 (603)
Q Consensus 447 VySfGvvL~elltg~~p~~~~~~~~~--~~l~~~~~~-~-----~~~~~--~~~--~--~d~~l~--------~~-~~-- 501 (603)
|||-|||++-+++++.||......-+ ..++..+.. . ...|+ +.+ . ..+.+. +. ..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999974332211 111111111 1 11133 111 0 000000 00 00
Q ss_pred ----CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 502 ----HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 502 ----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+.......+.++..+|+..||.+|-|++|.++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011111222347889999999999999999999764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=232.37 Aligned_cols=272 Identities=20% Similarity=0.203 Sum_probs=204.3
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccC------CCceeeeeeeEee
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVS------HPNLVRLLGCSIE 329 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~ 329 (603)
-+....+|......|+|-|++|..|.... |..||||+++... -..+.=+.|+++|++|+ -.|.++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 45556778888889999999999998753 6799999998653 22344568999999996 3589999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeec
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADF 407 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DF 407 (603)
.++++||||-+ ..+|.+.|..... ..|.......++.|+..||..|..- +|+|.||||.|||+++. ..+||+||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 99999999988 5699999987643 3588899999999999999999987 99999999999999886 46799999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH-----HHH
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA-----ADR 482 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~-----~~~ 482 (603)
|.|...... ..+...-+.-|.|||.+.+..|+...|+||.||.||||.||+..|...+...-..+...+ ...
T Consensus 582 GSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 582 GSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 998653221 122233455699999999999999999999999999999999988755443322222111 122
Q ss_pred hhcCCcc-cccchh--------------------------------hhhccCCCCccchHHHHHHHHHHHHHhccCCCCC
Q 007442 483 ISKGRLD-EIIDPL--------------------------------IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529 (603)
Q Consensus 483 ~~~~~~~-~~~d~~--------------------------------l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 529 (603)
+++|.+. .-+|.. |.. ........+..+..+.+|...||..||++|
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~-~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA-VQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc-cCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 3333221 111111 100 001223355677889999999999999999
Q ss_pred CCHHHHHH
Q 007442 530 PSMTEVAT 537 (603)
Q Consensus 530 Psm~eV~~ 537 (603)
-|..+.+.
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=224.01 Aligned_cols=169 Identities=20% Similarity=0.155 Sum_probs=131.2
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEc--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ--NDLLVAIKRIKHR-----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
.+.....+|...+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++++|+|+++.+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34455678999999999999999999875 5778899987532 22345678999999999999999853322
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCcEEEeec
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDI-KSSNILLDYNFKSKVADF 407 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Di-k~~NILld~~~~~kl~DF 407 (603)
.+..+|||||+++++|.. +.. .. ...++.++++||+|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 256899999999999973 211 11 146788999999999998 9999999 999999999999999999
Q ss_pred cCccccccccc-------ceeccCCCCCCCcCccccccC
Q 007442 408 GLSRLGMTEIS-------HISTAPQGTPGYLDPQYHQNF 439 (603)
Q Consensus 408 Gla~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~ 439 (603)
|+++....... ..-+...+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99986433211 011355688899999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=210.49 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=189.6
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
.+|.+...|..|+|+++.+ .+++|+++.. .....++|..|.-.|+-+.||||+.++|.|.....+.++..|||.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3588899999999999765 4556766543 344457899999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe--eccCcccccccccceecc
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA--DFGLSRLGMTEISHISTA 423 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~--DFGla~~~~~~~~~~~~~ 423 (603)
+..||....-.++-.+..++|.++|+|++|||+. +|-|----|.+..++||++.+++|+ |--++.. ...
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------e~g 345 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EVG 345 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------ccc
Confidence 9999987666688899999999999999999997 3334455799999999999998885 3222211 111
Q ss_pred CCCCCCCcCccccccCCCC---cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 424 PQGTPGYLDPQYHQNFHLS---DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 424 ~~gt~~Y~aPE~~~~~~~s---~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
..-.+.||+||.++..+.+ .+.|+|||.++||||.|+..||....+.+-.. ++.-.-+..-
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------kialeglrv~--------- 409 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------KIALEGLRVH--------- 409 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------hhhhcccccc---------
Confidence 2346789999999876544 37899999999999999999997544432111 1111111111
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.++.....+.+|+.-|++.||.+||.+..|+-.||+++
T Consensus 410 -----ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 -----IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12344567889999999999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=208.96 Aligned_cols=261 Identities=18% Similarity=0.199 Sum_probs=197.1
Q ss_pred CCCccCcccCCCceEEEEEEEcCC--cEEEEEEeccCChhhHHHHHHHHHHHhccCC----CceeeeeeeE-eecCceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQND--LLVAIKRIKHRDTDGIQQVVNEIKLISCVSH----PNLVRLLGCS-IERGEQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 335 (603)
+|...+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999997653 4788888776533322367788888888873 5888898888 47778899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----CcEEEeeccCc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-----FKSKVADFGLS 410 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-----~~~kl~DFGla 410 (603)
||+.+ +-+|.++........++-.+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999988665556799999999999999999999999 99999999999999765 46899999999
Q ss_pred c--ccccccc----ce---eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 411 R--LGMTEIS----HI---STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 411 ~--~~~~~~~----~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
+ ....... .. .....||..|.++..+.+...+.+.|+||++.++.|++.|..|+......... ..+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHH
Confidence 8 3222211 11 12345999999999999999999999999999999999999998543322221 11111
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..... .... .....+.++.++...+-..+...+|....+...|+.....
T Consensus 252 ~~~~~----~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRKL----LTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred Hhhhh----cccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11100 0000 0112234566666666778999999999999998877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-21 Score=198.15 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=197.0
Q ss_pred CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChh---hHHHHHHHHHHHhccCCC-ceeeeeeeEeecCceEEEEee
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD---GIQQVVNEIKLISCVSHP-NLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 339 (603)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +|+++..++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999987 78999999765332 467899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~~ 417 (603)
+.+++|.+++..... ..+.......++.+++.++.|+|+. +++||||||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977754421 2588899999999999999999999 899999999999999998 79999999997533322
Q ss_pred cc-----eeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 418 SH-----ISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 418 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
.. ......|+..|++||.+.. ..++...|+|++|++++++++|..|+...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 21 2456679999999999987 57889999999999999999999996533221 0111112222111111
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
....... ..........+.+++.+++..+|..|.++.+....
T Consensus 234 -~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLS------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccC------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001223567889999999999999999887764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=204.90 Aligned_cols=218 Identities=26% Similarity=0.388 Sum_probs=166.4
Q ss_pred HhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCC
Q 007442 312 ISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI-YHRDIK 390 (603)
Q Consensus 312 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i-vH~Dik 390 (603)
|+++.|.|+.+++|.+.+....+.|.+|+..|+|.|.+... ...++|.....+..+++.||+|||.. +| +|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 45789999999999999999999999999999999999863 45699999999999999999999987 55 999999
Q ss_pred CCCeeecCCCcEEEeeccCcccccc-cccceeccCCCCCCCcCccccccC-------CCCcccccccHHHHHHHHHhCCC
Q 007442 391 SSNILLDYNFKSKVADFGLSRLGMT-EISHISTAPQGTPGYLDPQYHQNF-------HLSDKSDVYSFGVVLVEIITALK 462 (603)
Q Consensus 391 ~~NILld~~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVySfGvvL~elltg~~ 462 (603)
++|.++|....+||+|||+..+... ..........-..-|.|||.+... ..+.+.||||||++++|+++++.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999876432 011111112234569999998763 25778999999999999999999
Q ss_pred ccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 463 VVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 463 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
||+........ ......+++ .....+-|.+.. ..+...++..++.+||..+|++||+++.|-..++.+
T Consensus 157 ~~~~~~~~~~~---~eii~~~~~-~~~~~~rP~i~~--------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDP---DEIILRVKK-GGSNPFRPSIEL--------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCCh---HHHHHHHHh-cCCCCcCcchhh--------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99864433322 122222333 111222222211 013444789999999999999999999999988877
Q ss_pred hhc
Q 007442 543 RTR 545 (603)
Q Consensus 543 ~~~ 545 (603)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=184.23 Aligned_cols=138 Identities=18% Similarity=0.130 Sum_probs=108.6
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChh--h-------HHH-----------------HHHHHHHHhccCCCce
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD--G-------IQQ-----------------VVNEIKLISCVSHPNL 320 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~ni 320 (603)
...||+|+||.||+|...+|+.||||+++..... . ... ..+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 0 112 2349999999988776
Q ss_pred eeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeeecCC
Q 007442 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL-HSAINPPIYHRDIKSSNILLDYN 399 (603)
Q Consensus 321 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~ivH~Dik~~NILld~~ 399 (603)
.....+. ....+|||||+++++|...+.. ..++++...+.++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 4433322 2234899999999887665432 24588999999999999999999 677 999999999999998 4
Q ss_pred CcEEEeeccCccc
Q 007442 400 FKSKVADFGLSRL 412 (603)
Q Consensus 400 ~~~kl~DFGla~~ 412 (603)
+.++|+|||++..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 7899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=185.21 Aligned_cols=173 Identities=14% Similarity=0.069 Sum_probs=134.1
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhH---HH------HHHHHHHHhccCCCceeeeeeeEee
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI---QQ------VVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~---~~------~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
...++|...++||.|+||.||.... ++..+|||.++....... +. +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3567899999999999999999655 566899999975532222 22 6899999999999999999988664
Q ss_pred c--------CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 330 R--------GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 330 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
. +..+|||||+++.+|.++.. ++. ....+++.+|..||.. +++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 3 35789999999999988742 222 3456899999999999 999999999999999988
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt 459 (603)
++|+|||.......+... ..+.....+..++|+|+||+.+.-+..
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999987643211110 113344456679999999998877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=214.10 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=186.8
Q ss_pred ccCcccCCCceEEEEEEEc-CCcEEEEEEec----cC-Chhh-HHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 266 EKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIK----HR-DTDG-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 266 ~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~----~~-~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
..+++|.|++|.|+..... .....+.|..+ .. .... ...+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999977766543 33334444332 11 1111 1225668888888999999988888777766666699
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++ +|..++... ..++-..+-.++.|+..|+.|||+. +|.|||||++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999999764 3478888889999999999999999 999999999999999999999999999977543222
Q ss_pred ---ceeccCCCCCCCcCccccccCCCCc-ccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 419 ---HISTAPQGTPGYLDPQYHQNFHLSD-KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 419 ---~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.......|+..|+|||++....|.+ ..||||.|+++..|++|+.||......+... ......+.......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~- 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEG- 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccC-
Confidence 4556678999999999999988887 5899999999999999999997554433221 00000000000000
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+...++.++|+.+|.+|-||.+|++.
T Consensus 550 --------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 --------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred --------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011123456677889999999999999999998863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=177.24 Aligned_cols=138 Identities=16% Similarity=0.138 Sum_probs=110.6
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHhccCCCce
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD--------------------------GIQQVVNEIKLISCVSHPNL 320 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~ni 320 (603)
...||+|+||.||+|...+|+.||||.++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999999888999999999864211 01223578999999999987
Q ss_pred eeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCC
Q 007442 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYN 399 (603)
Q Consensus 321 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~ 399 (603)
.....+... ..+|||||++++++...+... ..++.....+++.+++.+|.+||+ . +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554444332 348999999988665442222 347788899999999999999999 7 999999999999999 7
Q ss_pred CcEEEeeccCccc
Q 007442 400 FKSKVADFGLSRL 412 (603)
Q Consensus 400 ~~~kl~DFGla~~ 412 (603)
+.++|+|||++..
T Consensus 154 ~~~~liDFG~a~~ 166 (190)
T cd05145 154 GKPYIIDVSQAVE 166 (190)
T ss_pred CCEEEEEccccee
Confidence 8999999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.6e-20 Score=179.24 Aligned_cols=262 Identities=18% Similarity=0.211 Sum_probs=199.1
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
-+|...++||+|.||..+.|+. -+++.||||.-.... ..-++..|....+.|. .+.|...+-+-.+...-+||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4688899999999999999984 578999999754432 2345667888888775 78999998888888889999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----CcEEEeeccCccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-----FKSKVADFGLSRLGM 414 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-----~~~kl~DFGla~~~~ 414 (603)
+ +-+|+|++.-. +..++..+.+.||.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+...
T Consensus 106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 77999988654 45699999999999999999999999 99999999999999543 358999999998754
Q ss_pred cccc--c----eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 415 TEIS--H----ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 415 ~~~~--~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+... | ......||.+||+--.+.+...+.+.|.-|+|-|+...|-|..||..-..+... .-.+.|.+.+-
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK----~kYeKIGe~Kr 256 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK----EKYEKIGETKR 256 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----HHHHHhccccc
Confidence 4222 1 223456999999999999999999999999999999999999999864443221 11223333222
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..-++.. ....+.+++.-+.-.-..+-++-|...-+...+..+..+
T Consensus 257 ~T~i~~L-----------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 257 STPIEVL-----------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cCCHHHH-----------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 2222211 122455666666666677788889998888777776544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=170.52 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=199.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC-CceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..|...++||.|+||.+|.|.. .+|..||||.-.... .-.++.-|..+...++| ..|..+.-+..+...-.|||+.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4688889999999999999985 679999999865432 22456778999999975 5777888888889999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccCccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGLSRLGMTE 416 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGla~~~~~~ 416 (603)
+ +-||.+++.-. ...++..+.+-+|-|++.-++|+|.. ++|||||||+|.|..-+ ..+.++|||||+...+.
T Consensus 93 L-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 93 L-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred c-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 8 77999988644 34488999999999999999999999 99999999999999654 46899999999864432
Q ss_pred cc--c----eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 417 IS--H----ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 417 ~~--~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.. | ......||.+|.+--.+.+-..+.+.|+-|+|.+|..+.-|..||+.-.+..... ..+.+.+.++.-
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----KyEkI~EkK~s~ 243 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----KYEKISEKKMST 243 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH----HHHHHHHhhcCC
Confidence 11 1 2234569999999887777778889999999999999999999998654432221 223333333322
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.+... ....+.++...+.-|-...-++-|...-+.+.+.-+..
T Consensus 244 ~ie~L-----------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PIEVL-----------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CHHHH-----------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 22221 22345678888889999999999998877776655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=173.09 Aligned_cols=137 Identities=22% Similarity=0.241 Sum_probs=108.2
Q ss_pred CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-----CCCceeeeeeeEeecC---c-eE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-----SHPNLVRLLGCSIERG---E-QI 334 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 334 (603)
.+..++||+|+||.||. +.+....+||++........+++.+|+.++.++ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45577899999999996 433333479988765555567899999999999 5799999999998763 3 33
Q ss_pred EEEee--CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeecC----CCcEEEeec
Q 007442 335 LVYEF--MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI-AHLHSAINPPIYHRDIKSSNILLDY----NFKSKVADF 407 (603)
Q Consensus 335 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L-~yLH~~~~~~ivH~Dik~~NILld~----~~~~kl~DF 407 (603)
+|+|| .++|+|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 6689999999653 25555 35677888777 999999 9999999999999973 348999995
Q ss_pred cCc
Q 007442 408 GLS 410 (603)
Q Consensus 408 Gla 410 (603)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=169.27 Aligned_cols=184 Identities=17% Similarity=0.174 Sum_probs=139.0
Q ss_pred CccCcccCCCceEEEEEEEcCCcEEEEEEeccCChh----hHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEee
Q 007442 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD----GIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.....|++|+||+||.+.- ++..++.+.+.....- ....|.+|+++|.++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4467899999999997665 6778888888765321 1225789999999995 5889999886 456999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCcEEEeeccCccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDI-KSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Di-k~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
+.+.+|.+.+.. ....++.+++.+|+++|+. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998765421 1135778999999999999 9999999 79999999999999999999975332111
Q ss_pred -----------ce-eccCCCCCCCcCccccccC-CCC-cccccccHHHHHHHHHhCCCccC
Q 007442 419 -----------HI-STAPQGTPGYLDPQYHQNF-HLS-DKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 419 -----------~~-~~~~~gt~~Y~aPE~~~~~-~~s-~ksDVySfGvvL~elltg~~p~~ 465 (603)
+. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 0112368889999864432 223 45688899999999999988764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=206.14 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=179.0
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC-hhhHHHHHHHHHH--HhccCCCceeeeeeeEeecCceEEEEee
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD-TDGIQQVVNEIKL--ISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++...+.||.+.|=+|.+++.+.|. |+||.+-..+ .-..+.|.++++- ...++|||.+++..+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999999996 8899886554 3344555544433 4556899999999887777788999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc--cccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG--MTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~--~~~~ 417 (603)
+.+ +|+|.|..+. -|...+..-|+.|++.||...|.. +|.|||||.+||||+.-.-+.|+||..-+.. ..+.
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 854 8999886532 277788888999999999999999 9999999999999999999999999865531 1111
Q ss_pred ----cceeccCCCCCCCcCccccccC-----------CCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHH
Q 007442 418 ----SHISTAPQGTPGYLDPQYHQNF-----------HLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 418 ----~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~ 481 (603)
.........-..|+|||.+... .++++.||||.|||+.||++- +.+|. +...+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHhH
Confidence 1112222344579999976431 277899999999999999984 55664 2222221
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+.|. .......|.. -+...+.+++..|++.||++|-++.+.++.
T Consensus 248 --r~~~-~~~~e~~Le~----------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 --RSGN-ADDPEQLLEK----------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --hccC-ccCHHHHHHh----------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1221 1111111111 011246789999999999999999999887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-20 Score=193.77 Aligned_cols=225 Identities=26% Similarity=0.279 Sum_probs=175.7
Q ss_pred cccCCCceEEEEEE----EcCCcEEEEEEeccCChh--hHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeCC
Q 007442 269 RLGTGAFGTVYAGK----LQNDLLVAIKRIKHRDTD--GIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 269 ~LG~G~~g~Vykg~----~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.+|+|.||.|+... .+.+..+|+|.+++.... .......|..++..++ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999543 345678899988765221 1114456788888887 9999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|.|..++... ...+..........+|-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++........
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99999998754 2366666667778899999999999 9999999999999999999999999999875443222
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
.||..|||||++. .....+|-||||++.+||+||..||.. + . ...+.+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~-----~-~~~Il~---------------- 201 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----D-----T-MKRILK---------------- 201 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----H-----H-HHHHhh----------------
Confidence 7999999999998 457799999999999999999998863 1 1 111111
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.....+.+.......++.+++..+|.+|--.
T Consensus 202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 0112233445566778888899999999755
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=172.10 Aligned_cols=231 Identities=19% Similarity=0.214 Sum_probs=150.8
Q ss_pred CCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCC----------CceeeeeeeEe-
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSH----------PNLVRLLGCSI- 328 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~- 328 (603)
+...+.||.|+++.||.+++.. ++.+|||.+.... ...++++.+|.-....+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456789999999999999864 8999999886442 3456777777766655433 11222112111
Q ss_pred -------ecC---------ceEEEEeeCCCCCHHHHhhh---hcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007442 329 -------ERG---------EQILVYEFMPNGTLCQHLQR---ERG--DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387 (603)
Q Consensus 329 -------~~~---------~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~ 387 (603)
+.. ..+++|+-+ .++|.+++.. ... ..+....|+.+..|+.+.+++||+. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 235677777 6788887642 211 1255677888889999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCcccccc--------CCCCcccccccHHHHHHHHHh
Q 007442 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN--------FHLSDKSDVYSFGVVLVEIIT 459 (603)
Q Consensus 388 Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDVySfGvvL~ellt 459 (603)
||||+|+|++.+|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|++|++||.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987653211 1111 345688999997643 257889999999999999999
Q ss_pred CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCC
Q 007442 460 ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529 (603)
Q Consensus 460 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 529 (603)
++.|++...+...... .. ..+. +.++.+..|+..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f-------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF-------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG-------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc-------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999975433222111 11 1233 667889999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=165.35 Aligned_cols=134 Identities=22% Similarity=0.306 Sum_probs=114.6
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT--------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
+.||+|++|.||+|.. ++..|+||....... .....+.+|+.++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 666899998654321 1124678899999999999998888888788889999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+++++|.+++... .+ .+..++.+++.+|++||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 22 8889999999999999998 999999999999999 78999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-18 Score=195.80 Aligned_cols=202 Identities=20% Similarity=0.245 Sum_probs=160.8
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCceeeeeeeEee
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPNLVRLLGCSIE 329 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 329 (603)
+..+++.-...|.+.+.||+|+||+||+|...+|+.||+|.-+....-. |.-=.+++.+|+ -+-|..+..++.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3445666667788999999999999999999999999999987764321 111123333443 3445556666667
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-------CCCcE
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-------YNFKS 402 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-------~~~~~ 402 (603)
.+.-+||+||.+.|||.+++.. .+.++|...+.++.++++-+++||.. +|||+||||+|.||. +..-+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 7788999999999999999983 45599999999999999999999999 999999999999993 23458
Q ss_pred EEeeccCcccccc-cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCC
Q 007442 403 KVADFGLSRLGMT-EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALK 462 (603)
Q Consensus 403 kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~ 462 (603)
+|+|||-+--+.- ..........+|-++--+|...+..++...|.|.|..+++-||.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999998853221 12234456678999999999999999999999999999999999954
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.8e-18 Score=187.26 Aligned_cols=139 Identities=19% Similarity=0.266 Sum_probs=113.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC-C------hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR-D------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~-~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
....|...++||+|+||+||+|.+.+...++.+++... . ....+.+.+|++++.+++|++++....++.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34455678899999999999998865543333323221 1 1123568899999999999999998888888788
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++++|.+++. .+..++.+++++|.|||+. +|+||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 3567899999999999998 99999999999999 577999999999975
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=161.14 Aligned_cols=142 Identities=18% Similarity=0.127 Sum_probs=111.9
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh----------------------hhHHHHHHHHHHHh
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT----------------------DGIQQVVNEIKLIS 313 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~ 313 (603)
++.+....|...+.||+|+||.||++...+|+.||||+++.... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444444777889999999999999988899999998764321 01123667899999
Q ss_pred ccCCCc--eeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007442 314 CVSHPN--LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKS 391 (603)
Q Consensus 314 ~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~ 391 (603)
.+.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 998874 444444 2456899999999999776431 23467889999999999998 999999999
Q ss_pred CCeeecCCCcEEEeeccCccc
Q 007442 392 SNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 392 ~NILld~~~~~kl~DFGla~~ 412 (603)
+||++++++.++|+|||++..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred ccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.9e-18 Score=166.76 Aligned_cols=140 Identities=15% Similarity=0.096 Sum_probs=110.4
Q ss_pred CCCccCcccCCCceEEEEEE--EcCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHhccC
Q 007442 263 GFSEKQRLGTGAFGTVYAGK--LQNDLLVAIKRIKHRDTD------------------------GIQQVVNEIKLISCVS 316 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 316 (603)
.|...+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35667889999999999998 568999999999754210 1123568999999997
Q ss_pred CC--ceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCC
Q 007442 317 HP--NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP-IYHRDIKSSN 393 (603)
Q Consensus 317 H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-ivH~Dik~~N 393 (603)
+. .+.+++++ ...+|||||+++++|..++... ..+.......++.+++.+|++||+. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34444443 2358999999998987765332 2355666789999999999999999 8 9999999999
Q ss_pred eeecCCCcEEEeeccCccc
Q 007442 394 ILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~ 412 (603)
|+++ +++++|+|||.+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=160.59 Aligned_cols=130 Identities=22% Similarity=0.346 Sum_probs=107.9
Q ss_pred cccCCCceEEEEEEEcCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 269 RLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT--------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 567899998654311 12356788999999999887666666666677789999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
++++|.+++..... .++.+++.+|.+||+. +++|||++|.|||++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998854311 7899999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=182.58 Aligned_cols=174 Identities=25% Similarity=0.360 Sum_probs=132.1
Q ss_pred ceEEEEeeCCCCCHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 332 EQILVYEFMPNGTLCQHLQRE-RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
.+++.|+++...+|.+||.+. .....+|...+.++.|++.|++| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999744 34568999999999999999999 5 8999999999999999999999999998
Q ss_pred ccccccc-----cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhC-CCccCCCCCcchhhHHHHHHHHhh
Q 007442 411 RLGMTEI-----SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITA-LKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 411 ~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg-~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
....... ....+...||..||+||.+.+.+|+.|+||||+|++|+||+.- ..+++ .......++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence 7543322 2344667899999999999999999999999999999999972 11111 112223334
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
.|.+. |.... .-..=..+..+++...|.+||++.++.
T Consensus 474 ~g~ip----~~~~~-----------d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 474 DGIIP----PEFLQ-----------DYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred cCCCC----hHHhh-----------cCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 44333 11111 011234688899999999999555543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=156.63 Aligned_cols=197 Identities=24% Similarity=0.251 Sum_probs=136.2
Q ss_pred CCCceeeeeeeEee---------------------------cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHH
Q 007442 316 SHPNLVRLLGCSIE---------------------------RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368 (603)
Q Consensus 316 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ 368 (603)
+|||||+++++|.+ ...+||||.-.+ -+|.+||..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999988642 224578888774 48999997543 555667778899
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCCeee--cCCC--cEEEeeccCcccccc---cccce--eccCCCCCCCcCccccccC
Q 007442 369 TAQAIAHLHSAINPPIYHRDIKSSNILL--DYNF--KSKVADFGLSRLGMT---EISHI--STAPQGTPGYLDPQYHQNF 439 (603)
Q Consensus 369 ia~~L~yLH~~~~~~ivH~Dik~~NILl--d~~~--~~kl~DFGla~~~~~---~~~~~--~~~~~gt~~Y~aPE~~~~~ 439 (603)
+++|+.|||.+ +|.|||+|+.|||| |+|. ...|+|||.+-.... ..... .-...|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 5554 468899998743111 00111 1223477788999987543
Q ss_pred C------CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHH
Q 007442 440 H------LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHK 513 (603)
Q Consensus 440 ~------~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~ 513 (603)
+ --.|+|.|+.|.+.||+++...||+.. .+....... +.+.++ ...+..++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~-----Yqe~qL---------------Palp~~vpp~ 485 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRT-----YQESQL---------------PALPSRVPPV 485 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhh-----hhhhhC---------------CCCcccCChH
Confidence 2 124899999999999999999999741 111111111 111111 1223345567
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 514 VAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 514 l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
+.+|+...|+.||.+||+..-....|.
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 889999999999999998765555443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-16 Score=140.91 Aligned_cols=134 Identities=19% Similarity=0.197 Sum_probs=115.8
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC--CceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH--PNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.+.||+|.++.||++...+ ..++||..+.... ...+.+|+.++..++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999865 6899999876543 5678999999999976 599999998888888999999999877
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+..+ ++.....++.+++++|++||.....+++|+|++|.|||+++++.+++.|||+++.
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7654 5567788899999999999987555799999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.8e-16 Score=146.90 Aligned_cols=134 Identities=20% Similarity=0.208 Sum_probs=98.0
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChh--hHHHH----------------------HHHHHHHhccCCC--ce
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD--GIQQV----------------------VNEIKLISCVSHP--NL 320 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~--ni 320 (603)
.+.||+|+||+||+|...+++.||||.++..... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754211 11111 3456666666443 24
Q ss_pred eeeeeeEeecCceEEEEeeCCCCCHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecC
Q 007442 321 VRLLGCSIERGEQILVYEFMPNGTLCQH-LQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDY 398 (603)
Q Consensus 321 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~ 398 (603)
.+.+++ ...+|||||++++++... +.... .. .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 346899999999654322 21111 11 5677899999999999998 6 999999999999999
Q ss_pred CCcEEEeeccCccc
Q 007442 399 NFKSKVADFGLSRL 412 (603)
Q Consensus 399 ~~~~kl~DFGla~~ 412 (603)
++.++|+|||.+..
T Consensus 150 ~~~~~liDfg~a~~ 163 (187)
T cd05119 150 DGKVYIIDVPQAVE 163 (187)
T ss_pred CCcEEEEECccccc
Confidence 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=176.10 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=143.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..+|+.+++|..|+||.||..+++. .+.+|+| +++.+ .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 4678999999999999999999874 5678884 33221 01100 22222233222
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc---
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE--- 416 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~--- 416 (603)
|+-...+..... ++- +++.+++|||+. +|+|||+||.|.||+.=+++|+.|||+++.....
T Consensus 136 ---gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 555555544322 221 227899999999 9999999999999999999999999998753210
Q ss_pred ---cc------c--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 417 ---IS------H--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 417 ---~~------~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
.. + ....+.||+.|+|||++....|..-.|.|++|+++||.+-|..||+..++++-. ...+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhh
Confidence 00 0 112347999999999999999999999999999999999999999876654322 111111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP 530 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 530 (603)
.- + -.+.......+..+++.+.|+.+|..|-
T Consensus 274 ~i--~------------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 DI--E------------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hc--c------------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00 0 0011223345788899999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-15 Score=146.58 Aligned_cols=135 Identities=23% Similarity=0.274 Sum_probs=106.2
Q ss_pred cCccc-CCCceEEEEEEEcCCcEEEEEEeccCC-------------hhhHHHHHHHHHHHhccCCCce--eeeeeeEeec
Q 007442 267 KQRLG-TGAFGTVYAGKLQNDLLVAIKRIKHRD-------------TDGIQQVVNEIKLISCVSHPNL--VRLLGCSIER 330 (603)
Q Consensus 267 ~~~LG-~G~~g~Vykg~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 330 (603)
...|| .||.|+||+.... +..++||+++... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999885 5678999885421 1223567889999999998875 7777775443
Q ss_pred C----ceEEEEeeCCC-CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 331 G----EQILVYEFMPN-GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 331 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
. ..+||+||+++ .+|.+++... +++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988542 34443 356899999999999 99999999999999998899999
Q ss_pred eccCccc
Q 007442 406 DFGLSRL 412 (603)
Q Consensus 406 DFGla~~ 412 (603)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.9e-14 Score=151.55 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=102.5
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhH----------------------------------------HHHH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI----------------------------------------QQVV 306 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 306 (603)
.+.||.|++|.||+|++++|+.||||..+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999876421111 0245
Q ss_pred HHHHHHhccC----CCceeeeeeeEe-ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 007442 307 NEIKLISCVS----HPNLVRLLGCSI-ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ-AIAHLHSAI 380 (603)
Q Consensus 307 ~Ei~~l~~l~----H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~-~L~yLH~~~ 380 (603)
+|+..+.++. |.+-+.+-.++. .....+|||||+++++|.+++..... .+ .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5666565552 333333333333 34567999999999999988754321 12 34567777766 46788887
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
+++|+|+||.||++++++++++.|||++...
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-15 Score=170.02 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=187.5
Q ss_pred cCCCccCcccCCCceEEEEEEEcC--CcEEEEEEeccCC--hhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN--DLLVAIKRIKHRD--TDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 336 (603)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667779999999998876633 4567777776553 333344455788878887 99999999999999999999
Q ss_pred EeeCCCCCHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeecCCC-cEEEeeccCcccc
Q 007442 337 YEFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIAHLH-SAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLG 413 (603)
Q Consensus 337 ~E~~~~gsL~~~l-~~~~~~~l~~~~~~~ia~~ia~~L~yLH-~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~ 413 (603)
.||..+|++.+-+ +.. ....+....-.++.|+..++.|+| .. ++.||||||+|.+++..+ ..|++|||+|...
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999999988 433 224566677788999999999999 66 999999999999999999 9999999999875
Q ss_pred cc--cccceeccCCC-CCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 414 MT--EISHISTAPQG-TPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 414 ~~--~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|.... +...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~~~ 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GRFT 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---cccc
Confidence 44 22333345567 9999999998873 5567899999999999999999999865443311 11111100 0000
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.............+..+++..+|..|.+.+++..
T Consensus 252 --------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 --------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001122334566778888899999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.51 Aligned_cols=153 Identities=22% Similarity=0.335 Sum_probs=117.9
Q ss_pred HHHHhccCCCceeeeeeeEeecC-----ceEEEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 007442 309 IKLISCVSHPNLVRLLGCSIERG-----EQILVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAIN 381 (603)
Q Consensus 309 i~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~ 381 (603)
..-|-++.|.|||++..|+.+.. ...++.|||..|+|..+|++.+ ...+......+|+-||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455677999999999987543 4689999999999999998653 3447777778999999999999998 58
Q ss_pred CCeEecCCCCCCeeecCCCcEEEeeccCcccccc---cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHH
Q 007442 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT---EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEII 458 (603)
Q Consensus 382 ~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ell 458 (603)
|+|+|+++.-+-|++..++-+||+---....... -.........+-++|.+||+=...+.+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999998888752211111000 0011112335788999999887778888999999999999998
Q ss_pred hCCC
Q 007442 459 TALK 462 (603)
Q Consensus 459 tg~~ 462 (603)
-+..
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 7754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=140.14 Aligned_cols=247 Identities=19% Similarity=0.207 Sum_probs=175.6
Q ss_pred CCCccCcccC--CCceEEEEEEE---cCCcEEEEEEeccCCh--hhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceE
Q 007442 263 GFSEKQRLGT--GAFGTVYAGKL---QNDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 263 ~f~~~~~LG~--G~~g~Vykg~~---~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 334 (603)
.|.....+|. |.+|.||++.. .+...+|+|+-+..-. .....=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555678999 99999999987 3578899998654422 22222245666666775 999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccC
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ----AIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGL 409 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~----~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGl 409 (603)
+-+|++. .+|.++.+... ..++....+.+..+... ||.++|+. .|+|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 9999984 78888887542 23555666666666666 99999998 99999999999999999 8899999999
Q ss_pred cccccccc----cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 410 SRLGMTEI----SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 410 a~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
........ ........|...|++||..++ -++.++|+|++|.+.+|..++..+...+... . |..++.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~--W~~~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------S--WSQLRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------C--cccccc
Confidence 87644322 122223357888999998754 6788999999999999999987665432110 0 111111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.+ -+ +....-..++...+..+++.+|-.|++..++..
T Consensus 341 ~~i---p~-----------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 GYI---PL-----------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccC---ch-----------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 01 111112234445888999999999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.7e-12 Score=118.88 Aligned_cols=131 Identities=16% Similarity=0.157 Sum_probs=97.3
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCcee-eeeeeEeecCceEEEEeeCCCCCH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLV-RLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
.+.|+.|.++.||++... +..|++|....... ....+.+|+.++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999875 66899998765432 223567899999998765544 455443 3345899999999887
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI--NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6530 1 11345678999999999973 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.3e-12 Score=136.63 Aligned_cols=144 Identities=15% Similarity=0.212 Sum_probs=95.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChh------------------------------hHH-------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTD------------------------------GIQ------- 303 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~------------------------------~~~------- 303 (603)
..|+. +.||.|++|.||+|++++ |+.||||.++..-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999987 999999999754211 011
Q ss_pred ---HHHHHHHHHhccC----CCceeeeeeeEee-cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHH-HH
Q 007442 304 ---QVVNEIKLISCVS----HPNLVRLLGCSIE-RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQA-IA 374 (603)
Q Consensus 304 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~-L~ 374 (603)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++++.|.++-.-. ....+ +..++...+.. +.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d---~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTD---MKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCC---HHHHHHHHHHHHHH
Confidence 2344555555552 4444444444433 45678999999999998753211 11122 12223222222 22
Q ss_pred HHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeccCcccc
Q 007442 375 HLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFGLSRLG 413 (603)
Q Consensus 375 yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFGla~~~ 413 (603)
.++.. +++|+|+||.||+++.++ ++++.|||+....
T Consensus 275 Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 33444 999999999999999988 9999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-10 Score=126.30 Aligned_cols=166 Identities=14% Similarity=0.140 Sum_probs=127.0
Q ss_pred EcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHH
Q 007442 283 LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR 362 (603)
Q Consensus 283 ~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 362 (603)
..++.+|.|+..+.......+...+-++.|+.++||||++++..+.+.+..|||+|-+. -|..+|.... ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 34678888888887766555667888999999999999999999999999999999874 4667776532 4455
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCC
Q 007442 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442 (603)
Q Consensus 363 ~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 442 (603)
.-.+.||+.||.|||..+ +++|++|.-..|++++.|..||++|.++....... .......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~-~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN-APAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC-cccccchhhhcccChhhcCccc--
Confidence 567899999999999775 89999999999999999999999998875421111 0011111223467777554322
Q ss_pred cccccccHHHHHHHHHhC
Q 007442 443 DKSDVYSFGVVLVEIITA 460 (603)
Q Consensus 443 ~ksDVySfGvvL~elltg 460 (603)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.4e-11 Score=115.56 Aligned_cols=142 Identities=21% Similarity=0.245 Sum_probs=112.1
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCCh-hhHHHHHHHHHHHhccCC--CceeeeeeeEeecC---ceEEEEeeCC
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSH--PNLVRLLGCSIERG---EQILVYEFMP 341 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 341 (603)
+.|+.|..+.||++...+|..+++|....... ....++.+|++++..+.+ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899999865432 234678899999999975 44677787766542 5689999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI----------------------------------------- 380 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~----------------------------------------- 380 (603)
+.+|.+.+.. ..++...+..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988776532 24777788888899999999998531
Q ss_pred ------------CCCeEecCCCCCCeeecC--CCcEEEeeccCccc
Q 007442 381 ------------NPPIYHRDIKSSNILLDY--NFKSKVADFGLSRL 412 (603)
Q Consensus 381 ------------~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~ 412 (603)
...++|+|+++.|||+++ +..+.|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-11 Score=130.75 Aligned_cols=261 Identities=20% Similarity=0.217 Sum_probs=184.8
Q ss_pred CCCCChHH-HHHHhcCCCccCcccCCCceEEEEEEE--cCCcEEEEEEeccCChhhHHHH--HHHHHHHhccC-CCceee
Q 007442 249 IPIYPYRE-IEKATIGFSEKQRLGTGAFGTVYAGKL--QNDLLVAIKRIKHRDTDGIQQV--VNEIKLISCVS-HPNLVR 322 (603)
Q Consensus 249 ~~~~~~~e-l~~at~~f~~~~~LG~G~~g~Vykg~~--~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~ 322 (603)
.++|.-.+ ...-+.+|.....||.|.|+.|++... .++..+++|.+........+++ ..|+.+...+. |.++++
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34455555 444566788899999999999998764 3578999999876643332222 45666666664 999999
Q ss_pred eeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-Cc
Q 007442 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FK 401 (603)
Q Consensus 323 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~ 401 (603)
....+.+....++--||++++++...+.- ...++...++++..+++.++.++|+. .++|+|+||+||++..+ +.
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence 88888888888899999999998877622 23477888999999999999999988 99999999999999886 78
Q ss_pred EEEeeccCcccccccccceeccCCCCCCC-cCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGY-LDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
-+++|||...... .........+..| .+|+......+-.+.|+||||.-+.|.+++..-..... . +
T Consensus 406 ~~~~~~~~~t~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~--~ 472 (524)
T KOG0601|consen 406 SKLGDFGCWTRLA---FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q--S 472 (524)
T ss_pred hhccccccccccc---eecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c--c
Confidence 8999999886311 1111122233334 35555566678889999999999999999854322100 0 1
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
..+..|.... .......+..++..+...++..||.+.++....+.++
T Consensus 473 ~~i~~~~~p~----------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 LTIRSGDTPN----------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred eeeecccccC----------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1112221111 1112256677888899999999999988776655543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-10 Score=108.59 Aligned_cols=134 Identities=16% Similarity=0.102 Sum_probs=98.2
Q ss_pred CcccCCCceEEEEEEEcC-------CcEEEEEEeccCC----------------------hhhHHHHH----HHHHHHhc
Q 007442 268 QRLGTGAFGTVYAGKLQN-------DLLVAIKRIKHRD----------------------TDGIQQVV----NEIKLISC 314 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~ 314 (603)
..||.|.-+.||.|.-.+ +..+|||..+... ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999886320 01122333 79999999
Q ss_pred cC--CCceeeeeeeEeecCceEEEEeeCCCCCHHH-HhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCC
Q 007442 315 VS--HPNLVRLLGCSIERGEQILVYEFMPNGTLCQ-HLQRERGDGLSWPIRLTVAMETAQAIAHL-HSAINPPIYHRDIK 390 (603)
Q Consensus 315 l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~ivH~Dik 390 (603)
+. .-++.+++++ ..-+|||||+.+..+.. .|.. ..++......+..+++.+|..| |.. +|+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 85 3466667764 56789999997654432 2221 1244455677889999999999 777 99999999
Q ss_pred CCCeeecCCCcEEEeeccCccc
Q 007442 391 SSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 391 ~~NILld~~~~~kl~DFGla~~ 412 (603)
+.|||+++ +.+.|+|||.+-.
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEEC-CcEEEEECCCcee
Confidence 99999974 6899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=100.64 Aligned_cols=143 Identities=22% Similarity=0.231 Sum_probs=105.4
Q ss_pred ccCcccCCCceEEEEEEEcCCcEEEEE-EeccC----C---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 266 EKQRLGTGAFGTVYAGKLQNDLLVAIK-RIKHR----D---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 266 ~~~~LG~G~~g~Vykg~~~~~~~vavK-~~~~~----~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
...+|-+|+-+.|+++.+... ...|| ++.+. . .-..+.-.+|+.+|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCc-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999998654 44444 33322 1 112355678999999887545544444556667778999
Q ss_pred eeCCC-CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEeeccCccc
Q 007442 338 EFMPN-GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KSKVADFGLSRL 412 (603)
Q Consensus 338 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~kl~DFGla~~ 412 (603)
||+++ -++.+++................+..|-+.+.-||.. +|+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 4889998876544444444478889999999999999 999999999999996554 458999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-09 Score=101.20 Aligned_cols=130 Identities=20% Similarity=0.317 Sum_probs=99.1
Q ss_pred cccCCCceEEEEEEEcCCcEEEEEEe-ccC--Chh-----hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 269 RLGTGAFGTVYAGKLQNDLLVAIKRI-KHR--DTD-----GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~~~~vavK~~-~~~--~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.+++|+-..+|.+.+.+.. +++|.- ++. .++ ..+.-.+|+.+|.+++--.|.-..=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775543 455533 222 111 1234567999999987555544444556778889999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
++-.|.+.|... +..++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998654 356778888888999999 999999999999998775 99999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=107.28 Aligned_cols=168 Identities=14% Similarity=0.209 Sum_probs=128.3
Q ss_pred ceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEe----ecCceEEEEeeCCC-CCHHHH
Q 007442 275 FGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI----ERGEQILVYEFMPN-GTLCQH 348 (603)
Q Consensus 275 ~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 348 (603)
-.+.||+.. .||..|++||++.........-..-++.++++.|+|+|+|..++. .+..++|||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899986 488999999994332222333345688999999999999998876 34567899999985 578776
Q ss_pred hhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 349 LQRER-------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 349 l~~~~-------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
-.... +..+++...|.++.|++.||.++|+. ++.-+-|.+.+||++.+.+++|+..|...+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 12378899999999999999999999 999999999999999999999999988766433
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCc
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p 463 (603)
+.. |-+.. -.+-|.=.||.+|+.|.||...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 1257888999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-08 Score=101.45 Aligned_cols=139 Identities=13% Similarity=0.068 Sum_probs=100.0
Q ss_pred ccCCCceEEEEEEEcCCcEEEEEEeccCChh-hHH----------HHHHHHHHHhccCC--CceeeeeeeEee-----cC
Q 007442 270 LGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD-GIQ----------QVVNEIKLISCVSH--PNLVRLLGCSIE-----RG 331 (603)
Q Consensus 270 LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~-~~~----------~~~~Ei~~l~~l~H--~niv~l~g~~~~-----~~ 331 (603)
+-.-....|++..+ +|+.+.||+....... ..+ .+.+|...+.++.. -...+++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667766 5678999977543311 111 37789988888853 334445555543 23
Q ss_pred ceEEEEeeCCCC-CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-------CCcEE
Q 007442 332 EQILVYEFMPNG-TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-------NFKSK 403 (603)
Q Consensus 332 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-------~~~~k 403 (603)
..+||+|++++- +|.+++......+.+...+..++.+++..+.-||.. +|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence 478999999886 899998643233456677789999999999999999 9999999999999975 46899
Q ss_pred EeeccCccc
Q 007442 404 VADFGLSRL 412 (603)
Q Consensus 404 l~DFGla~~ 412 (603)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5e-08 Score=100.26 Aligned_cols=266 Identities=15% Similarity=0.152 Sum_probs=162.2
Q ss_pred ccCcccCCCceEEEEE-EEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeE------ee-cCceEEE
Q 007442 266 EKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCS------IE-RGEQILV 336 (603)
Q Consensus 266 ~~~~LG~G~~g~Vykg-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~------~~-~~~~~lV 336 (603)
..+.||+|+-+.+|.- ...| -+-|+..........+- +..|... .||-+-.-+.+= -+ ....-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4677999999999953 3222 23465555443332322 3334344 465443312220 11 2224567
Q ss_pred EeeCCCC-CHHHHhhhh-cC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 337 YEFMPNG-TLCQHLQRE-RG---DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 337 ~E~~~~g-sL~~~l~~~-~~---~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
|..+++- -+..++... +. ....|...++.+..+|.+.+-||.. +.+-+|++++|+|+.++..+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 7776654 233333211 11 2378999999999999999999999 99999999999999999999998755433
Q ss_pred cccccccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhC-CCccCCCCC--cchhhHHHHHHHHh
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITA-LKVVDFSRP--PNEVNLAALAADRI 483 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg-~~p~~~~~~--~~~~~l~~~~~~~~ 483 (603)
+. ..........|...|.+||.-. +..-+..+|.|.+||++++|+.| +.|+..... .....+. ..|
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~I 239 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDI 239 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhh
Confidence 21 2233445567899999999644 44567789999999999999887 888864211 0000000 012
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccC--CCCCCCHHHHHHHHHhhhhcc
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFH--RDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~--p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..|.+...-|.............-......+..|..+|+... +.-|||++..+..|..++...
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 223322222221111000111111223456777888898654 568999999999988887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.6e-10 Score=127.07 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=166.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.-+.|...+-+-+|.++.++-+.-. .+...++|..+..+ ....+....+-.++-..+||-+++..--+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456667777888999999876532 23333444333221 1122222333333333455777766655556778899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc-ccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGM 414 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~-~~~ 414 (603)
|++|..+++|...|+... .++..........+..+++|||+. .+.|+|++|.|+|+..++..+++|||+.. ...
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998653 234333344455677889999997 79999999999999999999999998432 110
Q ss_pred c----cc-------------------------cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccC
Q 007442 415 T----EI-------------------------SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 415 ~----~~-------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
. +. ........+|+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 001123458999999999999999999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 466 FSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 466 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
...+.... +.+..+.+ .......+...+...++.+.+..+|.+|-.|.
T Consensus 1037 a~tpq~~f-------~ni~~~~~-------------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-------ENILNRDI-------------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhh-------hccccCCC-------------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 65543221 11111111 11122334455677888899999999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.4e-08 Score=96.74 Aligned_cols=124 Identities=21% Similarity=0.199 Sum_probs=82.4
Q ss_pred EEEEEEEcCCcEEEEEEeccCC-------------h-------------hhHHHHHHHHHHHhccCCC--ceeeeeeeEe
Q 007442 277 TVYAGKLQNDLLVAIKRIKHRD-------------T-------------DGIQQVVNEIKLISCVSHP--NLVRLLGCSI 328 (603)
Q Consensus 277 ~Vykg~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 328 (603)
.||.|...++..+|||..+... . .......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999999999999886421 0 0112456799999999755 56666654
Q ss_pred ecCceEEEEeeCC--CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 329 ERGEQILVYEFMP--NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL-HSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 329 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
..-.|||||++ +..+..+.... ++......++.+++..+..+ |.. +|+|+||.+.|||++++ .+.|+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 24579999998 54444433221 22344566777888866664 676 99999999999999988 99999
Q ss_pred eccCccc
Q 007442 406 DFGLSRL 412 (603)
Q Consensus 406 DFGla~~ 412 (603)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.7e-07 Score=87.74 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=105.5
Q ss_pred ccCCCceEEEEEEEcCCcEEEEEEeccC------ChhhHHHHHHHHHHHhccCC--CceeeeeeeEeecC----ceEEEE
Q 007442 270 LGTGAFGTVYAGKLQNDLLVAIKRIKHR------DTDGIQQVVNEIKLISCVSH--PNLVRLLGCSIERG----EQILVY 337 (603)
Q Consensus 270 LG~G~~g~Vykg~~~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~ 337 (603)
-|+||-+.|++-.+.+. .+-+|+-... -+.....|.+|+..|.++.. -.+.+.+.+..... ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 57799999999877555 6888887521 13356789999999999963 33555552222211 367999
Q ss_pred eeCCC-CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeccCccc
Q 007442 338 EFMPN-GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK--SKVADFGLSRL 412 (603)
Q Consensus 338 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~--~kl~DFGla~~ 412 (603)
|-+++ -+|.+++....-.+.+...+..++.+++..++-||.. ++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5899998665444567888899999999999999999 9999999999999986666 99999987654
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.6e-08 Score=83.31 Aligned_cols=64 Identities=11% Similarity=0.195 Sum_probs=45.8
Q ss_pred CCCCeeecccCCC--cceeeec-------ccccccceeEEeecccccccchhhcccccccccceeEEEEEEeCCc
Q 007442 73 SSISCYSEEKNDR--EFIDYEN-------ATKQQCKFLLSAISSELFNTSAASINISAASLDVKVLEVGWWLNGH 138 (603)
Q Consensus 73 ~~~~C~~~~~~~~--~~~~~~~-------~~~~~C~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~W~~~~~ 138 (603)
+|.+|||++||.+ +++.... ....+|++||+....+...++ .+|+...+.+++||+|+|.|+..
T Consensus 5 sG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~--t~p~~~~~~~y~pv~L~W~i~t~ 77 (103)
T PF08488_consen 5 SGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNI--TDPEDFHAMGYVPVVLDWFIDTS 77 (103)
T ss_pred CCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccC--CChHHhccCCeeEEEEEEEEecC
Confidence 5999999999963 4555431 134799999988765332221 26667788899999999999654
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.9e-07 Score=101.99 Aligned_cols=158 Identities=17% Similarity=0.221 Sum_probs=103.9
Q ss_pred CCCCCChHHHH------------HHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhh--------------
Q 007442 248 NIPIYPYREIE------------KATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDG-------------- 301 (603)
Q Consensus 248 ~~~~~~~~el~------------~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~-------------- 301 (603)
.++.|++++.+ ..-..|+. +.|+.++-|.||+|++++|+.||||+.+..-...
T Consensus 100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~ 178 (517)
T COG0661 100 RVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL 178 (517)
T ss_pred CCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence 45667766543 22233443 5799999999999999999999999987542111
Q ss_pred ----------------HH----------HHHHHHHHHhccC-----CCceeeeeeeEeecCceEEEEeeCCCCCHHHHhh
Q 007442 302 ----------------IQ----------QVVNEIKLISCVS-----HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQ 350 (603)
Q Consensus 302 ----------------~~----------~~~~Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 350 (603)
.+ ++.+|..-+.+++ .+++.--.=|+.-....+|+|||++|-.+.+...
T Consensus 179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~ 258 (517)
T COG0661 179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA 258 (517)
T ss_pred HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence 11 2344555555552 2333322223334678899999999999988853
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 351 RERGDGLSWPIRLTVAMETAQAI-AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 351 ~~~~~~l~~~~~~~ia~~ia~~L-~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
-.. ..++ +..|+..++++. ..+-.. +++|.|.+|.||+++.++++.+.|||+....
T Consensus 259 l~~-~g~d---~k~ia~~~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 259 LKS-AGID---RKELAELLVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHh-cCCC---HHHHHHHHHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 222 2244 334444444432 222223 8999999999999999999999999998653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3e-07 Score=89.45 Aligned_cols=105 Identities=26% Similarity=0.281 Sum_probs=84.0
Q ss_pred HHHHHHHHHHhccC--CCceeeeeeeEeecC----ceEEEEeeCCCC-CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 007442 303 QQVVNEIKLISCVS--HPNLVRLLGCSIERG----EQILVYEFMPNG-TLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375 (603)
Q Consensus 303 ~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~y 375 (603)
....+|...+..+. .-...+.+++..... ..+||+|++++- +|.+++..... ++...+..++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45677888877775 334566677665532 348999999884 89999976332 5666788999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeeecCCC---cEEEeeccCccc
Q 007442 376 LHSAINPPIYHRDIKSSNILLDYNF---KSKVADFGLSRL 412 (603)
Q Consensus 376 LH~~~~~~ivH~Dik~~NILld~~~---~~kl~DFGla~~ 412 (603)
||.. +|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 999999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-08 Score=109.85 Aligned_cols=150 Identities=19% Similarity=0.192 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc--------ceeccCCCCCCCcCcccccc
Q 007442 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS--------HISTAPQGTPGYLDPQYHQN 438 (603)
Q Consensus 367 ~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~ 438 (603)
.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+-....... ......+....|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44559999999874 999999999999999999999999998754222110 11112245668999999999
Q ss_pred CCCCcccccccHHHHHHHHHhCCCccCCCCC-cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHH
Q 007442 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRP-PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAEL 517 (603)
Q Consensus 439 ~~~s~ksDVySfGvvL~elltg~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l 517 (603)
...+.++|+||+|++++-+..|.++.-.... ...... ... .+ +. .......+.+.++.+=
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-----~~~-~~------~~-------~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-----SRN-LL------NA-------GAFGYSNNLPSELRES 244 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-----hhc-cc------cc-------ccccccccCcHHHHHH
Confidence 8899999999999999999966555432211 111000 000 00 00 0111224556778888
Q ss_pred HHHHhccCCCCCCCHHHHHH
Q 007442 518 AFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 518 ~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.+.+..++..||++.++..
T Consensus 245 l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHhcCCcccCcchhhhhc
Confidence 89999999999998877553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-06 Score=86.48 Aligned_cols=132 Identities=15% Similarity=0.125 Sum_probs=91.8
Q ss_pred CccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh----------------------hhHHHHHHHHHHHhccCCC--ce
Q 007442 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT----------------------DGIQQVVNEIKLISCVSHP--NL 320 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~H~--ni 320 (603)
....+||.|.-+.||.|..++|.++|||.=+.... -......+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996543210 0112345799999998744 66
Q ss_pred eeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 321 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
.+.+++ +.-.+||||+++--|...-- +-...-.|+..|++-+.-+-.. +|||+|+.+-|||+++|+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 666654 45679999998855544321 1111223333344433333344 899999999999999999
Q ss_pred cEEEeeccCc
Q 007442 401 KSKVADFGLS 410 (603)
Q Consensus 401 ~~kl~DFGla 410 (603)
.+.|+||--+
T Consensus 240 ~~~vIDwPQ~ 249 (304)
T COG0478 240 DIVVIDWPQA 249 (304)
T ss_pred CEEEEeCccc
Confidence 9999999654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.5e-06 Score=82.36 Aligned_cols=139 Identities=14% Similarity=0.114 Sum_probs=86.3
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc--eeeeeeeEeecCceEEEEeeCCCCC-
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN--LVRLLGCSIERGEQILVYEFMPNGT- 344 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 344 (603)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24457788876533 2345688999999886433 4667777777777789999998863
Q ss_pred HHHH---------------------hhhhcCCCCCHHHHHHHHH-----------HHH-HHHHHHHhcC-CCCeEecCCC
Q 007442 345 LCQH---------------------LQRERGDGLSWPIRLTVAM-----------ETA-QAIAHLHSAI-NPPIYHRDIK 390 (603)
Q Consensus 345 L~~~---------------------l~~~~~~~l~~~~~~~ia~-----------~ia-~~L~yLH~~~-~~~ivH~Dik 390 (603)
+... ||...........+..-.. .+. ....+|.... .+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1111001111111111000 011 1123333221 3457899999
Q ss_pred CCCeeecCCCcEEEeeccCccc
Q 007442 391 SSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 391 ~~NILld~~~~~kl~DFGla~~ 412 (603)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=92.33 Aligned_cols=160 Identities=18% Similarity=0.186 Sum_probs=103.3
Q ss_pred CCCCCCChHHHHHH------------hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhH------------
Q 007442 247 SNIPIYPYREIEKA------------TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI------------ 302 (603)
Q Consensus 247 ~~~~~~~~~el~~a------------t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~------------ 302 (603)
...|.++++|+.+. -..|+ .+.||.-+.|.||+|++++|+.||||.-+..-....
T Consensus 135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~ 213 (538)
T KOG1235|consen 135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAK 213 (538)
T ss_pred ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHH
Confidence 35677888875432 22343 358999999999999999999999998875422110
Q ss_pred -------------------------HHHHHHHHHHhcc----CCCc---eeeeeeeEe-ecCceEEEEeeCCCCCHHHHh
Q 007442 303 -------------------------QQVVNEIKLISCV----SHPN---LVRLLGCSI-ERGEQILVYEFMPNGTLCQHL 349 (603)
Q Consensus 303 -------------------------~~~~~Ei~~l~~l----~H~n---iv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l 349 (603)
=+|.+|++-..+. .|-+ =|++=.++. -.....|+||||+|..+.|..
T Consensus 214 ~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~ 293 (538)
T KOG1235|consen 214 VLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLD 293 (538)
T ss_pred HHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHH
Confidence 0244555443333 3555 122222222 345789999999999887654
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----CCcEEEeeccCcccc
Q 007442 350 QRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY----NFKSKVADFGLSRLG 413 (603)
Q Consensus 350 ~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~----~~~~kl~DFGla~~~ 413 (603)
.-. ...++-. .|+..+.++ |++.....+++|.|-+|.||+++. ++.+.+-|||+....
T Consensus 294 ~i~-~~gi~~~---~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 294 AID-KRGISPH---DILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHH-HcCCCHH---HHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 221 1224433 444444443 444444458999999999999983 678999999998753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.6e-06 Score=80.46 Aligned_cols=103 Identities=18% Similarity=0.234 Sum_probs=82.8
Q ss_pred HHHHHHHhccCC-CceeeeeeeEeecCceEEEEeeCCCCCHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007442 306 VNEIKLISCVSH-PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR-ERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383 (603)
Q Consensus 306 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ 383 (603)
.+|.-+|..+++ +++.+++|.| ..++|.||.+.+++...-.. ..-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888976 6999999999 34789999988766432000 00123689999999999999999999965556
Q ss_pred eEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 384 ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+.-.|++++|+-+++++++|+.|....-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=79.85 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=86.5
Q ss_pred ccCCCc-eEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeCCCCCHHH
Q 007442 270 LGTGAF-GTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347 (603)
Q Consensus 270 LG~G~~-g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 347 (603)
|-.|.. ..||+....+ ..+.||+..... ..++.+|++++..+. +--+.+++++....+..++|||++++.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 7899997654 678888876543 345677898888884 4446677887766667899999999887764
Q ss_pred Hh-------------------hhhcCC--CCC--HHHHHHHHHH--------------------HHHHHHHHHhc----C
Q 007442 348 HL-------------------QRERGD--GLS--WPIRLTVAME--------------------TAQAIAHLHSA----I 380 (603)
Q Consensus 348 ~l-------------------~~~~~~--~l~--~~~~~~ia~~--------------------ia~~L~yLH~~----~ 380 (603)
.. |..... +.. +..++..... +...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 111000 111 0011110000 11112222111 2
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35689999999999999987789999987754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=7.1e-06 Score=80.59 Aligned_cols=142 Identities=18% Similarity=0.230 Sum_probs=86.5
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC--ceeeeeeeEee---cCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP--NLVRLLGCSIE---RGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~E~~~~ 342 (603)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999888 58999987654 4557778899998888533 35667764432 2346899999999
Q ss_pred CCHHH----------------Hh---hhhc--CCCCCHHHH---------HHH------------HHHHHH-HHHHHHhc
Q 007442 343 GTLCQ----------------HL---QRER--GDGLSWPIR---------LTV------------AMETAQ-AIAHLHSA 379 (603)
Q Consensus 343 gsL~~----------------~l---~~~~--~~~l~~~~~---------~~i------------a~~ia~-~L~yLH~~ 379 (603)
..+.. .| +... ..++.+... ... ...+.+ .++.++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 1111 111111110 000 112222 33444432
Q ss_pred ----CCCCeEecCCCCCCeeec-CCCcEEEeeccCccc
Q 007442 380 ----INPPIYHRDIKSSNILLD-YNFKSKVADFGLSRL 412 (603)
Q Consensus 380 ----~~~~ivH~Dik~~NILld-~~~~~kl~DFGla~~ 412 (603)
....++|+|+.|.|||++ +++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 245699999999999999 666668999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.7e-05 Score=75.32 Aligned_cols=137 Identities=14% Similarity=0.123 Sum_probs=89.9
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHH---------HHHHHHhccCC---CceeeeeeeE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVV---------NEIKLISCVSH---PNLVRLLGCS 327 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~---------~Ei~~l~~l~H---~niv~l~g~~ 327 (603)
...+|...+++-......|.+-.. ++..+++|..+.......+.|. +++..+.+++. ..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 345666666676666666666555 4568899988776544333322 34444444432 2233322222
Q ss_pred -----eecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 328 -----IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 328 -----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
......+|||||++|..|.++.. ++. .++..+++++.-||.. +++|+|.+|.|++++++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cE
Confidence 22345679999999988876642 222 3556677889999999 99999999999999965 59
Q ss_pred EEeeccCcc
Q 007442 403 KVADFGLSR 411 (603)
Q Consensus 403 kl~DFGla~ 411 (603)
++.||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-07 Score=99.34 Aligned_cols=181 Identities=20% Similarity=0.172 Sum_probs=130.3
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc-eeeeeeeEeecCceEEEEeeCCCC-CH
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN-LVRLLGCSIERGEQILVYEFMPNG-TL 345 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL 345 (603)
+-+++|+++++||.+-.-.+...++.+... ....-++++|.+++||| .++.++-+..+...+++++++..| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 458899999999987544334445555433 34456899999999999 777777777788889999999877 22
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCC
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 425 (603)
..-... ....+...+...+...-+++|+|||+. .=+|+| |||..+ ...|..||+......... ......
T Consensus 323 ~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 323 ALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred cccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 111110 011133444455667778899999987 568998 888776 578999999887543322 345567
Q ss_pred CCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCcc
Q 007442 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 426 gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
+++.++|||+...+.+..+-|+|+.|+--.++--|-.|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 999999999999999999999999998766766665543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-05 Score=75.75 Aligned_cols=151 Identities=15% Similarity=0.156 Sum_probs=98.1
Q ss_pred CChHHHHHHhcCCCccCc---ccCCCceEEEEEEEcCCcEEEEEEeccCChhhH-------------------H-----H
Q 007442 252 YPYREIEKATIGFSEKQR---LGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI-------------------Q-----Q 304 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~---LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~-------------------~-----~ 304 (603)
.+.+.|.....+...... |..|.-..||+|.-.++..+|||+.+....... + -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345556666666555554 456777789999988899999999975421110 0 1
Q ss_pred HHHHHHHHhccC--CCceeeeeeeEeecCceEEEEeeCCCCCH-HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 007442 305 VVNEIKLISCVS--HPNLVRLLGCSIERGEQILVYEFMPNGTL-CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381 (603)
Q Consensus 305 ~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~ 381 (603)
..+|+.-|.++. +-.+.+-+++. .-.|||||+....+ .-.|.. -++.......+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 134666666663 34444444443 34799999965411 111111 11223346667778888888777633
Q ss_pred CCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 382 ~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
++||+||..-|||+. ++.+.|+|||-|..
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccc
Confidence 999999999999999 88999999998753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.4e-05 Score=89.62 Aligned_cols=147 Identities=14% Similarity=0.256 Sum_probs=93.3
Q ss_pred cCcccCCCceEEEEEEEcCC---cEEEEEEeccCC-hhhHHHHHHHHHHHhccC-CCce--eeeeeeEeec---CceEEE
Q 007442 267 KQRLGTGAFGTVYAGKLQND---LLVAIKRIKHRD-TDGIQQVVNEIKLISCVS-HPNL--VRLLGCSIER---GEQILV 336 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 336 (603)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999877654 367777765432 123357889999999995 6665 7888887664 468999
Q ss_pred EeeCCCCCHHH--------------------H---hhhhcC---------CCCCH--------HHHHHH---------HH
Q 007442 337 YEFMPNGTLCQ--------------------H---LQRERG---------DGLSW--------PIRLTV---------AM 367 (603)
Q Consensus 337 ~E~~~~gsL~~--------------------~---l~~~~~---------~~l~~--------~~~~~i---------a~ 367 (603)
|||+++..+.+ . ||.... .+..+ ...+.- .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 121100 01111 111110 01
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCCCeeecCC-Cc-EEEeeccCcccc
Q 007442 368 ETAQAIAHLHSAIN--------PPIYHRDIKSSNILLDYN-FK-SKVADFGLSRLG 413 (603)
Q Consensus 368 ~ia~~L~yLH~~~~--------~~ivH~Dik~~NILld~~-~~-~kl~DFGla~~~ 413 (603)
.+...+++|..+.. +.++|+|+++.|||++.+ .+ .-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667755432 359999999999999853 33 579999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=70.60 Aligned_cols=134 Identities=22% Similarity=0.231 Sum_probs=94.1
Q ss_pred CccCcccCCCceEEEEEEEcCCcEEEEEEeccCC----------------hhhHHHHHHHHHHHhccC------CCceee
Q 007442 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD----------------TDGIQQVVNEIKLISCVS------HPNLVR 322 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~ 322 (603)
+....||+|+.=.||. ++++....||..+... ....+++.+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 4466899999999996 4555667888887654 223456667776666655 889999
Q ss_pred eeeeEeecCceEEEEeeCCC--C----CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 323 LLGCSIERGEQILVYEFMPN--G----TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 323 l~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
++|+...+..+-+|+|.+.+ | ||.+++... .++. ...+ .+-+-..||-.. .|+.+||+|.||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 99999999999999998753 2 688888433 2554 3223 333444567666 89999999999999
Q ss_pred cCC---C-cEEEee-ccCc
Q 007442 397 DYN---F-KSKVAD-FGLS 410 (603)
Q Consensus 397 d~~---~-~~kl~D-FGla 410 (603)
... . .+.|.| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 533 2 567776 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00017 Score=74.29 Aligned_cols=76 Identities=9% Similarity=0.064 Sum_probs=57.0
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC---CceeeeeeeEee---cCceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH---PNLVRLLGCSIE---RGEQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~---~~~~~lV~E~~ 340 (603)
.+.||.|..+.||+-...+++ +.+|..+.. .....|.+|.+.|+.+.- -.+.++++++.. .+..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 457999999999998876664 666765431 122578899999998853 367888888754 36689999999
Q ss_pred CCCCH
Q 007442 341 PNGTL 345 (603)
Q Consensus 341 ~~gsL 345 (603)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00015 Score=72.04 Aligned_cols=139 Identities=17% Similarity=0.193 Sum_probs=77.2
Q ss_pred CcccCCCce-EEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC---ceeeeeeeEeec---CceEEEEeeC
Q 007442 268 QRLGTGAFG-TVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP---NLVRLLGCSIER---GEQILVYEFM 340 (603)
Q Consensus 268 ~~LG~G~~g-~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~E~~ 340 (603)
+.|+.|+.. .||+. +..+++|..+.. ....++.+|+++|..+... -+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 58875 224667765542 2345788899999887532 344444443322 2358899999
Q ss_pred CCCCHHHH------------------hhhhcCCC--C-------------CHHHHH--HHH-------HHHHHH-HHH-H
Q 007442 341 PNGTLCQH------------------LQRERGDG--L-------------SWPIRL--TVA-------METAQA-IAH-L 376 (603)
Q Consensus 341 ~~gsL~~~------------------l~~~~~~~--l-------------~~~~~~--~ia-------~~ia~~-L~y-L 376 (603)
++.++.+. ||...... . .|.... .+. .+.+.. ++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98766321 12111000 0 121111 010 011111 111 1
Q ss_pred Hhc--CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 377 HSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 377 H~~--~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+.. ..+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 111 234589999999999999776667999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0007 Score=72.12 Aligned_cols=75 Identities=11% Similarity=0.129 Sum_probs=54.5
Q ss_pred CcccCCCceEEEEEEEcCC-cEEEEEEeccC-----C--hhhHHHHHHHHHHHhccC---CCceeeeeeeEeecCceEEE
Q 007442 268 QRLGTGAFGTVYAGKLQND-LLVAIKRIKHR-----D--TDGIQQVVNEIKLISCVS---HPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 336 (603)
+.||.|.+..||++...+| +.|+||.-... . +...+.+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999999887 58999985421 1 123456677888887763 3456777776 44567899
Q ss_pred EeeCCCCC
Q 007442 337 YEFMPNGT 344 (603)
Q Consensus 337 ~E~~~~gs 344 (603)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00029 Score=67.40 Aligned_cols=134 Identities=19% Similarity=0.295 Sum_probs=95.6
Q ss_pred CCCCCChHHHHHHhcCCCccCcccCCCc-eEEEEEEEcCCcEEEEEEeccC---Ch------------------hhHHHH
Q 007442 248 NIPIYPYREIEKATIGFSEKQRLGTGAF-GTVYAGKLQNDLLVAIKRIKHR---DT------------------DGIQQV 305 (603)
Q Consensus 248 ~~~~~~~~el~~at~~f~~~~~LG~G~~-g~Vykg~~~~~~~vavK~~~~~---~~------------------~~~~~~ 305 (603)
.+..|+. -+.+++..+.||.|.- |.|||+++. |+.+|+|.++.- .. .....|
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 4555665 2267888899999999 999999985 559999994321 00 122468
Q ss_pred HHHHHHHhccC---CCce--eeeeeeEeecC------------------ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHH
Q 007442 306 VNEIKLISCVS---HPNL--VRLLGCSIERG------------------EQILVYEFMPNGTLCQHLQRERGDGLSWPIR 362 (603)
Q Consensus 306 ~~Ei~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 362 (603)
..|.....+|+ +.++ |+.+||..-.. ...||.||++... ...
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~ 166 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQ 166 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccc
Confidence 88998888885 4566 99999874221 2357888876543 112
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 363 ~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
.+-+.++.+-|..+|.. +|+-+|+|+.|.. .-||.|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 23456677788899998 9999999999986 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00023 Score=70.47 Aligned_cols=140 Identities=19% Similarity=0.228 Sum_probs=81.5
Q ss_pred CcccCCCceEEEEEEEcC--CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc-eeeeeeeEeecCceEEEEeeCCCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN--DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN-LVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
+.|..|-...+|+....+ +..|++|........ .-+..+|+.++..+.... ..++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 678889977643222 223357888888885333 344444332 248999999876
Q ss_pred HHHH-----------------hhhhcCC---------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 007442 345 LCQH-----------------LQRERGD---------GL-SWPIRLTVAM----------------------ETAQAIAH 375 (603)
Q Consensus 345 L~~~-----------------l~~~~~~---------~l-~~~~~~~ia~----------------------~ia~~L~y 375 (603)
+... ||..... .. .|.....+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5311 1111100 01 1222111111 11111122
Q ss_pred H----Hhc-CCCCeEecCCCCCCeeecC-CCcEEEeeccCccc
Q 007442 376 L----HSA-INPPIYHRDIKSSNILLDY-NFKSKVADFGLSRL 412 (603)
Q Consensus 376 L----H~~-~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~ 412 (603)
| ... ....++|+|+.+.|||+++ +..+.|.||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346899999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00022 Score=71.68 Aligned_cols=138 Identities=15% Similarity=0.134 Sum_probs=79.1
Q ss_pred cccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEEeeCCCCCHHH
Q 007442 269 RLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVYEFMPNGTLCQ 347 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 347 (603)
.+..|-...+|+... ++..+++|........-.-+..+|..+++.+....+ .++++.. ...+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355677889998874 566788887654322211235778888888864333 3344432 2368999999876532
Q ss_pred --------------H---hhhhc--CCCCCHHHHH-HHHH---------HHHHHHHHHHhc-----CCCCeEecCCCCCC
Q 007442 348 --------------H---LQRER--GDGLSWPIRL-TVAM---------ETAQAIAHLHSA-----INPPIYHRDIKSSN 393 (603)
Q Consensus 348 --------------~---l~~~~--~~~l~~~~~~-~ia~---------~ia~~L~yLH~~-----~~~~ivH~Dik~~N 393 (603)
. ||... ..+++...++ .... .+...+..+-.. ..+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12111 1112222211 1111 111122222221 12358999999999
Q ss_pred eeecCCCcEEEeeccCccc
Q 007442 394 ILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~ 412 (603)
|++++++ +.|.||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0019 Score=67.21 Aligned_cols=141 Identities=14% Similarity=0.152 Sum_probs=77.6
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC--ceeeeeee------EeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP--NLVRLLGC------SIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E~ 339 (603)
+.|+.|....+|+....+| .+++|+....... +...|+.++..|... .+.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999887666 6888887622222 333344544444211 23333321 1234567899999
Q ss_pred CCCCCHH-----------HH---hhhhcC---------CCCCH-HHHHHHH-------------HHHHHHHHHHHhc---
Q 007442 340 MPNGTLC-----------QH---LQRERG---------DGLSW-PIRLTVA-------------METAQAIAHLHSA--- 379 (603)
Q Consensus 340 ~~~gsL~-----------~~---l~~~~~---------~~l~~-~~~~~ia-------------~~ia~~L~yLH~~--- 379 (603)
+++..+. +. ||.... ..+.| ...+.-. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9887431 11 221110 01223 2211111 1111222333211
Q ss_pred -CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 380 -INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 380 -~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
...+++|+|+++.|||++++...-|.||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245799999999999999776668999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00055 Score=63.58 Aligned_cols=128 Identities=16% Similarity=0.206 Sum_probs=85.6
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLC 346 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 346 (603)
.+.|++|.+|.||+|.+.++ .+|+|.-+..+ ....+..|+++|..+.-.++-+=+-.+ +.-++.|||+.+-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcchh
Confidence 56799999999999998766 78888776543 346788899999988866655433222 2334559999887887
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeeecCCCcEEEeeccCccc
Q 007442 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIK-SSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 347 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik-~~NILld~~~~~kl~DFGla~~ 412 (603)
++-... +-.+. ..+++.---|... +|-|+.|. |..++|-.+..+.|+||..|+.
T Consensus 101 ~~~~~~-----~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG-----DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc-----cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 765421 11222 2333332223334 88888886 4555555555999999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00068 Score=69.64 Aligned_cols=142 Identities=18% Similarity=0.222 Sum_probs=86.9
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC--ceeeeeee------EeecCceEEEEe
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP--NLVRLLGC------SIERGEQILVYE 338 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 338 (603)
.+.|..|....+|+....++ .+++|+.... ..++...|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677787789999876555 6888887652 234566678777777533 24454442 122345689999
Q ss_pred eCCCCCHHH--------------Hhhhhc-C--------CCCCHHHHHH----------HHHHHHHHHHHHHh----cCC
Q 007442 339 FMPNGTLCQ--------------HLQRER-G--------DGLSWPIRLT----------VAMETAQAIAHLHS----AIN 381 (603)
Q Consensus 339 ~~~~gsL~~--------------~l~~~~-~--------~~l~~~~~~~----------ia~~ia~~L~yLH~----~~~ 381 (603)
|+++..+.. .||... . ....|..... ....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876421 112110 0 1123433221 11223344555553 123
Q ss_pred CCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 382 ~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987779999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00092 Score=68.93 Aligned_cols=140 Identities=21% Similarity=0.224 Sum_probs=83.2
Q ss_pred CcccCCCceEEEEEEEcC-------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQN-------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 339 (603)
+.|..|-...+|+....+ +..+++|...... ....+..+|.+++..+....+ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345556677899988765 4788899876543 233455778888888853333 34555543 2368999
Q ss_pred CCCCCHHHH-----------------hhhhcCC-------C--CCHHHHHHH--------------------------HH
Q 007442 340 MPNGTLCQH-----------------LQRERGD-------G--LSWPIRLTV--------------------------AM 367 (603)
Q Consensus 340 ~~~gsL~~~-----------------l~~~~~~-------~--l~~~~~~~i--------------------------a~ 367 (603)
++|.++... ||..... . .-|...-++ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 1111111 0 011111110 11
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCCeeecCC----CcEEEeeccCccc
Q 007442 368 ETAQAIAHLHS------AINPPIYHRDIKSSNILLDYN----FKSKVADFGLSRL 412 (603)
Q Consensus 368 ~ia~~L~yLH~------~~~~~ivH~Dik~~NILld~~----~~~kl~DFGla~~ 412 (603)
.+..-+.+|.. .....++|+|+.+.|||++++ ..++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 12222334432 234578999999999999985 7899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0035 Score=64.85 Aligned_cols=143 Identities=13% Similarity=0.164 Sum_probs=83.0
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC--ceeeeeeeE------eecCceEEEEe
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP--NLVRLLGCS------IERGEQILVYE 338 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E 338 (603)
.+.++.|-...+|+....++ .+++|+.+... ..++...|++++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34577777789999876656 57788775432 123445566777666422 234444321 12456789999
Q ss_pred eCCCCCHH-----------H---HhhhhcCC----------CCCHHHHHH------------HHHHHHHHHHHHHh----
Q 007442 339 FMPNGTLC-----------Q---HLQRERGD----------GLSWPIRLT------------VAMETAQAIAHLHS---- 378 (603)
Q Consensus 339 ~~~~gsL~-----------~---~l~~~~~~----------~l~~~~~~~------------ia~~ia~~L~yLH~---- 378 (603)
|+++..+. . .||..... .-.|..... ....+...+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 12221110 012221111 01123345555543
Q ss_pred cCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 379 ~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
....+++|+|+++.||+++++....|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2345899999999999999987778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00069 Score=78.59 Aligned_cols=198 Identities=18% Similarity=0.154 Sum_probs=134.7
Q ss_pred HHHHHHHHHHhccCCCceeeeeeeEeecCceE----EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007442 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378 (603)
Q Consensus 303 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~ 378 (603)
..-.-|.+.+.++.|+|++.++.|-.+....- +..|++..-++.+.++.. ..++....+.+..++..||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 33455777888889999999999987654332 445788888888888754 347777888889999999999999
Q ss_pred cCCCCeEecCCCCC---CeeecCCCcEEEe--eccCcccccccccceeccCCCCCCCcCccccccCCCCc--ccccccHH
Q 007442 379 AINPPIYHRDIKSS---NILLDYNFKSKVA--DFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD--KSDVYSFG 451 (603)
Q Consensus 379 ~~~~~ivH~Dik~~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDVySfG 451 (603)
. ...|.-+..+ +--.+.++...++ ||+.++...+... .....-+..|.+||......++. ..|+|.+|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 8 5555555544 5555666777777 9988775433221 11223455678888776655544 47999999
Q ss_pred HHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC
Q 007442 452 VVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531 (603)
Q Consensus 452 vvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 531 (603)
..+..+..|..+....... ..+++. .....+.....+|+..++++|++
T Consensus 380 ll~~~~~~~~~i~~~~~~~------------------~~~l~~--------------~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAVP------------------VSLLDV--------------LSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHhhhhhcCcccccccch------------------hhhhcc--------------ccchhhhhhhhhhcchhhhhccc
Confidence 9999999885443211100 000010 01114567788999999999999
Q ss_pred HHHHHHHH
Q 007442 532 MTEVATEL 539 (603)
Q Consensus 532 m~eV~~~L 539 (603)
..+++...
T Consensus 428 ~~~ll~~~ 435 (1351)
T KOG1035|consen 428 ALELLTHP 435 (1351)
T ss_pred hhhhhhch
Confidence 99987653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0029 Score=64.63 Aligned_cols=138 Identities=19% Similarity=0.256 Sum_probs=74.5
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
.+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999987 6677899998762 23356788888888773 446778899887777889999999877
Q ss_pred C--------HHH---Hhhh-hcCCC-------------------CCHHH-----HHHHHHHHHH-----------HHHHH
Q 007442 344 T--------LCQ---HLQR-ERGDG-------------------LSWPI-----RLTVAMETAQ-----------AIAHL 376 (603)
Q Consensus 344 s--------L~~---~l~~-~~~~~-------------------l~~~~-----~~~ia~~ia~-----------~L~yL 376 (603)
. |-. .||. ..... -+|.. |+.-..+.+. .++-+
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 1 111 2333 11110 23432 2222221111 12222
Q ss_pred Hhc-----CCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 377 HSA-----INPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 377 H~~-----~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
.+. ..|.++|+||.+.|++.+.++.+.|.|=.
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 222 25679999999999999999889998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.01 Score=61.27 Aligned_cols=129 Identities=17% Similarity=0.225 Sum_probs=78.3
Q ss_pred CcEEEEEEec-cCChhhHHHHHHHHHHHhccCC--CceeeeeeeEeecC--ceEEEEeeCCCCCHHH-------------
Q 007442 286 DLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSH--PNLVRLLGCSIERG--EQILVYEFMPNGTLCQ------------- 347 (603)
Q Consensus 286 ~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~------------- 347 (603)
++.+++.+-. ........+..+|..+|+.+.- --..+.+++|.+.. .++.||+|+++..+.+
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6677777221 1233445666778888888753 34455677777665 7799999998743222
Q ss_pred -----HhhhhcC-----C------------C-CCHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeEecCCCC
Q 007442 348 -----HLQRERG-----D------------G-LSWPIRLTVA--------METAQAIAHLHSAI-----NPPIYHRDIKS 391 (603)
Q Consensus 348 -----~l~~~~~-----~------------~-l~~~~~~~ia--------~~ia~~L~yLH~~~-----~~~ivH~Dik~ 391 (603)
.|..-.. . + -.|...++.+ -....-..||+... .+.++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 2211000 0 0 1222222111 11223345565543 35799999999
Q ss_pred CCeeecCCCcEEEeeccCccccc
Q 007442 392 SNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 392 ~NILld~~~~~kl~DFGla~~~~ 414 (603)
.||+++.+.-+-|.||+++.+..
T Consensus 208 gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCEEEeCCCeeEEEeccccccCC
Confidence 99999998889999999998743
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0079 Score=61.25 Aligned_cols=31 Identities=19% Similarity=0.452 Sum_probs=26.2
Q ss_pred CCeEecCCCCCCeeecCCCc-EEEeeccCccc
Q 007442 382 PPIYHRDIKSSNILLDYNFK-SKVADFGLSRL 412 (603)
Q Consensus 382 ~~ivH~Dik~~NILld~~~~-~kl~DFGla~~ 412 (603)
+.++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.009 Score=62.89 Aligned_cols=139 Identities=21% Similarity=0.218 Sum_probs=80.8
Q ss_pred cccCCCceEEEEEEEcC-----CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCcee-eeeeeEeecCceEEEEeeCCC
Q 007442 269 RLGTGAFGTVYAGKLQN-----DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLV-RLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 342 (603)
.|-.|-.-.+|+....+ ++.|++|.........++ -.+|..++..+...++. ++++.+.. + .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 45457778899987543 367889987665432222 36788888888644433 45565432 2 58999987
Q ss_pred CCHHHH-----------------hhhhc--CC--CCCHHHHHHHHH-----------------HHHHHHHHHHh-----c
Q 007442 343 GTLCQH-----------------LQRER--GD--GLSWPIRLTVAM-----------------ETAQAIAHLHS-----A 379 (603)
Q Consensus 343 gsL~~~-----------------l~~~~--~~--~l~~~~~~~ia~-----------------~ia~~L~yLH~-----~ 379 (603)
.+|... ||... .. ...|....++.. .+...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 12111 00 112322222221 11122222322 1
Q ss_pred CCCCeEecCCCCCCeeecC-CCcEEEeeccCccc
Q 007442 380 INPPIYHRDIKSSNILLDY-NFKSKVADFGLSRL 412 (603)
Q Consensus 380 ~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~ 412 (603)
....++|+|+++.|||+++ +..+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 46799999988764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.11 Score=53.61 Aligned_cols=31 Identities=29% Similarity=0.322 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
..+++|+|+++.|||++. ..+.|.||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 357999999999999998 5789999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.0058 Score=62.15 Aligned_cols=144 Identities=17% Similarity=0.173 Sum_probs=92.2
Q ss_pred CChHHHHHHhcC---CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC-----------------hhhH-----HHHH
Q 007442 252 YPYREIEKATIG---FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD-----------------TDGI-----QQVV 306 (603)
Q Consensus 252 ~~~~el~~at~~---f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~-----------------~~~~-----~~~~ 306 (603)
+.|-.|+..+++ ++..+.||-|.-+.||.+...+|++.++|.-+... ...+ -...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 344444443332 46678999999999999999999999888543220 0011 1234
Q ss_pred HHHHHHhccC-CC-ceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007442 307 NEIKLISCVS-HP-NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384 (603)
Q Consensus 307 ~Ei~~l~~l~-H~-niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i 384 (603)
+|+..|+.|. |. -+.+.+++ +..++|||++.+-.|...-+-. +-++...- +..-+--|-.. ++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~---lm~~Iv~la~~---Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYDD---LMGLIVRLANH---GL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHHH---HHHHHHHHHHc---Cc
Confidence 6888888885 32 34444544 3557899999887766543221 12222222 22223334444 99
Q ss_pred EecCCCCCCeeecCCCcEEEeeccCc
Q 007442 385 YHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 385 vH~Dik~~NILld~~~~~kl~DFGla 410 (603)
||+|..--||+++++..++++||--.
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred eecccchheeEEecCCCEEEeechHh
Confidence 99999999999999999999999643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.00077 Score=79.86 Aligned_cols=175 Identities=11% Similarity=0.027 Sum_probs=119.2
Q ss_pred EEEEEeccCChhhHHHH-----HHHHHHHhccCCCceeeeeeeEe--ecCceEEEEeeCCCCCHHHHhhhhcC--CCCCH
Q 007442 289 VAIKRIKHRDTDGIQQV-----VNEIKLISCVSHPNLVRLLGCSI--ERGEQILVYEFMPNGTLCQHLQRERG--DGLSW 359 (603)
Q Consensus 289 vavK~~~~~~~~~~~~~-----~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~ 359 (603)
+-+|+.+..+.+..-+- ..|...++...|++++....-.. +..+.+.+++|+..|.+++.|.+... .+++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45566665554443333 33444555668998887655443 33466889999999999999865322 23444
Q ss_pred HHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccc
Q 007442 360 PIRLTVAMETAQAIAHLHSAI--NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437 (603)
Q Consensus 360 ~~~~~ia~~ia~~L~yLH~~~--~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 437 (603)
......-.+...+..-.|+.. ..--+|+++|+-|.+|+.+.++|++++|+.+...+. ........+++.|+.|+...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHH
Confidence 333333333345555555543 234789999999999999999999999999842222 12223345778899999988
Q ss_pred cCCCCcccccccHHHHHHHHHhCCCcc
Q 007442 438 NFHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 438 ~~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
.-.++.++|+|..|.-++++--|..++
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 888999999999999999988775554
|
|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.0024 Score=43.15 Aligned_cols=29 Identities=41% Similarity=1.043 Sum_probs=22.2
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYP 173 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gnpy~ 173 (603)
.|+.|+.|.+. .+.|.|.|+.||.|||+.
T Consensus 7 ~C~~nA~C~~~-----~~~~~C~C~~Gy~GdG~~ 35 (36)
T PF12947_consen 7 GCHPNATCTNT-----GGSYTCTCKPGYEGDGFF 35 (36)
T ss_dssp GS-TTCEEEE------TTSEEEEE-CEEECCSTC
T ss_pred CCCCCcEeecC-----CCCEEeECCCCCccCCcC
Confidence 68999999875 238999999999999873
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.074 Score=55.04 Aligned_cols=32 Identities=16% Similarity=0.210 Sum_probs=28.7
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
..+++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44799999999999999999999999988865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.16 Score=54.28 Aligned_cols=73 Identities=10% Similarity=0.035 Sum_probs=49.2
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCCh-------hhHHHHHHHHHHHhccC---CCceeeeeeeEeecCceEEE
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT-------DGIQQVVNEIKLISCVS---HPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 336 (603)
.+.||.|....||+.... +..++||+-..... .....-..|...|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999998864 45688997752211 12233344566665553 357888888876 456789
Q ss_pred EeeCCC
Q 007442 337 YEFMPN 342 (603)
Q Consensus 337 ~E~~~~ 342 (603)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.04 Score=53.23 Aligned_cols=153 Identities=14% Similarity=0.086 Sum_probs=95.8
Q ss_pred CCceEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhh
Q 007442 273 GAFGTVYAGKLQNDLLVAIKRIKHRDTD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR 351 (603)
Q Consensus 273 G~~g~Vykg~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 351 (603)
++-.+.-+|+-+-| ...+|++....-. ...-|.++..+++++. .|++|.-- ..-..-++.|++-.-.
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 34455555554444 4566777654333 4466788999999886 57777621 2334558888873210
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCc
Q 007442 352 ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431 (603)
Q Consensus 352 ~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 431 (603)
-+. ..++.-=..+|.-.|+. .++.+|+|-.|+||+-|..|.+||.|-+.--. .+..|.
T Consensus 141 ----i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~v 198 (308)
T PF07387_consen 141 ----INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMV 198 (308)
T ss_pred ----cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEE
Confidence 000 11121124667888965 56899999999999999999999999874321 111233
Q ss_pred CccccccCCCCcccccccHHHHHHHHHhCCC
Q 007442 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALK 462 (603)
Q Consensus 432 aPE~~~~~~~s~ksDVySfGvvL~elltg~~ 462 (603)
--| ....|.++.+=+|=.-+++++....
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 312 2345778888888888888887543
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.074 Score=55.63 Aligned_cols=139 Identities=18% Similarity=0.263 Sum_probs=78.7
Q ss_pred cccCCCceEEEEEEEcC----CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEEeeCCCC
Q 007442 269 RLGTGAFGTVYAGKLQN----DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~g 343 (603)
.|..|=...+|+....+ +..|++|........ .-+-.+|..++..+..-++ .++++++ ..+ +|.+|+++-
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcCC
Confidence 45446677899887643 237888887654332 2233578888888865444 3556555 222 589999776
Q ss_pred CHHH--------------H---hhhhcC--C--CCCHHHHHHHHHHH----------------------HHHHHHHHhc-
Q 007442 344 TLCQ--------------H---LQRERG--D--GLSWPIRLTVAMET----------------------AQAIAHLHSA- 379 (603)
Q Consensus 344 sL~~--------------~---l~~~~~--~--~l~~~~~~~ia~~i----------------------a~~L~yLH~~- 379 (603)
+|.. . ||.... . +--|....++..++ ..-+..+...
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 1 121110 0 11233322222111 1112222211
Q ss_pred ----CCCCeEecCCCCCCeeecC-CCcEEEeeccCccc
Q 007442 380 ----INPPIYHRDIKSSNILLDY-NFKSKVADFGLSRL 412 (603)
Q Consensus 380 ----~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~ 412 (603)
...-+.|+|+.+.|||+++ +..++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1224789999999999975 56899999988754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.16 Score=61.17 Aligned_cols=142 Identities=18% Similarity=0.283 Sum_probs=79.2
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-------CCCceeeee-ee----Eee-cC--c
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-------SHPNLVRLL-GC----SIE-RG--E 332 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-------~H~niv~l~-g~----~~~-~~--~ 332 (603)
+.|+ |..-.+|+....++..+++|+.+..... .....|...|..| .-|.+++-. |- ... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 4567889998888888999999865322 2333344455433 233444322 11 111 22 3
Q ss_pred eEEEEeeCCCCCHHHH-----------------hhhh------c--CCCCCHHHH-----------------HHHHHHHH
Q 007442 333 QILVYEFMPNGTLCQH-----------------LQRE------R--GDGLSWPIR-----------------LTVAMETA 370 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~-----------------l~~~------~--~~~l~~~~~-----------------~~ia~~ia 370 (603)
.+-+++|+++..|.+. |+.. . ...+.|..+ ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5668999999877651 1110 0 012444321 12222222
Q ss_pred HHHHH----HHhcCCCCeEecCCCCCCeeecCCC--cEE-EeeccCccc
Q 007442 371 QAIAH----LHSAINPPIYHRDIKSSNILLDYNF--KSK-VADFGLSRL 412 (603)
Q Consensus 371 ~~L~y----LH~~~~~~ivH~Dik~~NILld~~~--~~k-l~DFGla~~ 412 (603)
..+.- ........+||+|+++.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22211 1112345799999999999999875 454 999998754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.18 Score=52.47 Aligned_cols=136 Identities=20% Similarity=0.288 Sum_probs=80.4
Q ss_pred CceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCc---eeeeeeeEe--ecC--ceEEEEeeCCCC
Q 007442 274 AFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPN---LVRLLGCSI--ERG--EQILVYEFMPNG 343 (603)
Q Consensus 274 ~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~n---iv~l~g~~~--~~~--~~~lV~E~~~~g 343 (603)
.-..+|+....+|+. ++|..... ....++..|+..|..+. .+= |..+=|-.. -.. ..+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789998888876 78877765 23345555666666653 222 222222111 122 677899999988
Q ss_pred CHHH---------------Hhhhh-------cC---CCCCHHH-------------HHHHHHHHHHHHHHHHhcC----C
Q 007442 344 TLCQ---------------HLQRE-------RG---DGLSWPI-------------RLTVAMETAQAIAHLHSAI----N 381 (603)
Q Consensus 344 sL~~---------------~l~~~-------~~---~~l~~~~-------------~~~ia~~ia~~L~yLH~~~----~ 381 (603)
.+.. .||.. +. ..+.|.. ......++...++.+.+.. .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 11211 00 1144541 0112334444455554432 2
Q ss_pred CC---eEecCCCCCCeeecCCCc-EEEeeccCccc
Q 007442 382 PP---IYHRDIKSSNILLDYNFK-SKVADFGLSRL 412 (603)
Q Consensus 382 ~~---ivH~Dik~~NILld~~~~-~kl~DFGla~~ 412 (603)
.. +||+|+.|.|||+|++.. ..+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999999885 89999998763
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.18 Score=52.94 Aligned_cols=73 Identities=14% Similarity=0.100 Sum_probs=47.5
Q ss_pred cccCCCceEEEEEEEcCC-cEEEEEEeccC-------ChhhHHHHHHHHHHHhccC--CC-ceeeeeeeEeecCceEEEE
Q 007442 269 RLGTGAFGTVYAGKLQND-LLVAIKRIKHR-------DTDGIQQVVNEIKLISCVS--HP-NLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~~-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 337 (603)
.||-|....||++...++ +.|+||.-... -+-..++-.-|.+.|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998765 57999975421 1222344455667776553 34 34445443 556667999
Q ss_pred eeCCCC
Q 007442 338 EFMPNG 343 (603)
Q Consensus 338 E~~~~g 343 (603)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.056 Score=56.77 Aligned_cols=62 Identities=15% Similarity=0.231 Sum_probs=46.0
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY 398 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~ 398 (603)
...|+=+|+++-++..++.... .++..+.+++.-.+.||--+--. -+++|.|++|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 3457778898999999987543 45567777887777776554433 27999999999999953
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.028 Score=54.69 Aligned_cols=122 Identities=16% Similarity=0.121 Sum_probs=60.2
Q ss_pred CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc-eeeeeeeEeecCceEEEEeeCCCCCHHH-------H---------
Q 007442 286 DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN-LVRLLGCSIERGEQILVYEFMPNGTLCQ-------H--------- 348 (603)
Q Consensus 286 ~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gsL~~-------~--------- 348 (603)
.+.|+|+..... ....-.-.+|..+++.+.... -.++++++.+ .+|+||+++.+|.. .
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 356888887766 333455577888888886433 3556665433 26779996655421 1
Q ss_pred -hhhhcC-----CCCCHHHHHHH----------------------HHHHHHHHHHHHh---cC--CCCeEecCCCCCCee
Q 007442 349 -LQRERG-----DGLSWPIRLTV----------------------AMETAQAIAHLHS---AI--NPPIYHRDIKSSNIL 395 (603)
Q Consensus 349 -l~~~~~-----~~l~~~~~~~i----------------------a~~ia~~L~yLH~---~~--~~~ivH~Dik~~NIL 395 (603)
||.... ..--|.....+ ...+..-+..+.. .. ...+.|+|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111111 00112222222 1112222222222 11 125779999999999
Q ss_pred e-cCCCcEEEeeccCccc
Q 007442 396 L-DYNFKSKVADFGLSRL 412 (603)
Q Consensus 396 l-d~~~~~kl~DFGla~~ 412 (603)
+ +.++.++++||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.19 Score=52.31 Aligned_cols=137 Identities=19% Similarity=0.189 Sum_probs=90.9
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccC-----Chh-------------------h--HHHHHHHHHHHhccCCCce
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR-----DTD-------------------G--IQQVVNEIKLISCVSHPNL 320 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~-----~~~-------------------~--~~~~~~Ei~~l~~l~H~ni 320 (603)
...|..|.-.-||.+.-.+|..+|||+.+.. +.+ . .--...|+.-|.+|+.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3468888899999999999999999998642 110 0 0112356777777754433
Q ss_pred eeeeeeEeecCceEEEEeeCCCCC-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 007442 321 VRLLGCSIERGEQILVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN 399 (603)
Q Consensus 321 v~l~g~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~ 399 (603)
.-.--... ..-+|||+|+.... -.-.|. ...|+.......-.+++.-+.-|-+.| ++||.||.--|+|+-+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-
Confidence 21111111 23468999985321 111121 223666677777888888888888887 9999999999998864
Q ss_pred CcEEEeeccCcc
Q 007442 400 FKSKVADFGLSR 411 (603)
Q Consensus 400 ~~~kl~DFGla~ 411 (603)
+.+.|+|-+-+-
T Consensus 301 G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 GKLYIIDVSQSV 312 (520)
T ss_pred CEEEEEEccccc
Confidence 589999988764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.5 Score=49.28 Aligned_cols=71 Identities=14% Similarity=0.047 Sum_probs=43.8
Q ss_pred CCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC--Cceeeee---e--eEeecCceEEEEeeCCCCC
Q 007442 273 GAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH--PNLVRLL---G--CSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 273 G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~---g--~~~~~~~~~lV~E~~~~gs 344 (603)
+.-..||+....++..+++|..+... ....++..|++.+..+.. -.++..+ | +...++..+.|+++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 45568999988888889999876432 234556667777766631 1122211 2 1222456788999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.14 Score=54.46 Aligned_cols=75 Identities=12% Similarity=0.122 Sum_probs=49.1
Q ss_pred cCcccCCCceEEEEEEEcC-CcEEEEEEeccC------ChhhHHHHHHHHHHHhccC--CC-ceeeeeeeEeecCceEEE
Q 007442 267 KQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR------DTDGIQQVVNEIKLISCVS--HP-NLVRLLGCSIERGEQILV 336 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~--H~-niv~l~g~~~~~~~~~lV 336 (603)
.+.||-|.-.-||++.+.+ +..|+||.-... -+-..++-.-|.+.|+... -| .+.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3468999999999999853 567999865321 1223445556777777653 34 45556544 55566789
Q ss_pred EeeCCCC
Q 007442 337 YEFMPNG 343 (603)
Q Consensus 337 ~E~~~~g 343 (603)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.28 Score=49.16 Aligned_cols=79 Identities=14% Similarity=0.116 Sum_probs=54.8
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC-CCCCH
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM-PNGTL 345 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~-~~gsL 345 (603)
...+-.|..+.|++++..+|..+++|......... .+. .....|...+-...|++++.- .+.-.|++|.+ ++-+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence 34566788999999999999999999987543211 111 122458888888889999863 34566788888 45566
Q ss_pred HHHh
Q 007442 346 CQHL 349 (603)
Q Consensus 346 ~~~l 349 (603)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 5544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.39 Score=51.26 Aligned_cols=73 Identities=15% Similarity=0.227 Sum_probs=44.2
Q ss_pred cccCCCceEEEEEEEcCC--c-----EEEEEEeccCChhhHHHHHHHHHHHhccCCCcee-eeeeeEeecCceEEEEeeC
Q 007442 269 RLGTGAFGTVYAGKLQND--L-----LVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLV-RLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~~~--~-----~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~ 340 (603)
.|..|-...+|+....++ . .|.++...... ...-+-.+|+++++.+...++- ++++.+. -.+|+||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 455577889999876543 1 24444332221 1112235689999999755544 4555543 25999999
Q ss_pred CCCCHH
Q 007442 341 PNGTLC 346 (603)
Q Consensus 341 ~~gsL~ 346 (603)
++-+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 603 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-124
Identities = 116/294 (39%), Positives = 169/294 (57%), Gaps = 12/294 (4%)
Query: 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKL 311
P ++E+AT F K +G G FG VY G L++ VA+KR + GI++ EI+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 312 ISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--LSWPIRLTVAMET 369
+S HP+LV L+G ER E IL+Y++M NG L +HL +SW RL + +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-EISHISTAPQGTP 428
A+ + +LH I HRD+KS NILLD NF K+ DFG+S+ G + +H+ST +GT
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
GY+DP+Y L++KSDVYSFGVVL E++ A + S P VNLA A + + G+L
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
++I+DP + S+ K + A +CLA + RPSM +V +LE+
Sbjct: 266 EQIVDPNL---ADKIR---PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-108
Identities = 107/299 (35%), Positives = 174/299 (58%), Gaps = 13/299 (4%)
Query: 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQ-QVV 306
+ + RE++ A+ FS K LG G FG VY G+L + LVA+KR+K T G + Q
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG---LSWPIRL 363
E+++IS H NL+RL G + E++LVY +M NG++ L RER + L WP R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-RERPESQPPLDWPKRQ 134
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
+A+ +A+ +A+LH +P I HRD+K++NILLD F++ V DFGL++L + +H++TA
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE--VNLAALAAD 481
+GT G++ P+Y S+K+DV+ +GV+L+E+IT + D +R N+ V L
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
+ + +L+ ++D + +G+ V ++ ++A C RP M+EV LE
Sbjct: 255 LLKEKKLEALVDVDL---QGNYKD---EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 27/309 (8%)
Query: 247 SNIPIYPYREIEKATIGFSEKQ------RLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD 300
+ + + E++ T F E+ ++G G FG VY G + N+ VA+K++
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68
Query: 301 ----GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG 356
QQ EIK+++ H NLV LLG S + + LVY +MPNG+L L G
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 357 -LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG-M 414
LSW +R +A A I LH HRDIKS+NILLD F +K++DFGL+R
Sbjct: 129 PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474
+ +++ GT Y+ P+ + ++ KSD+YSFGVVL+EIIT L VD R
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQL 242
Query: 475 LAALAADRIS-KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
L + + + +++ ID + + SV + +A +CL ++ RP +
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDA-------DSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 534 EVATELEHI 542
+V L+ +
Sbjct: 296 KVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-72
Identities = 68/311 (21%), Positives = 117/311 (37%), Gaps = 30/311 (9%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
+ ++ + G FG V+ +L N+ VA+K +D Q E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 313 SCVSHPNLVRLLGCSIE----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
+ H N+++ +G + L+ F G+L L+ +SW +A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAET 129
Query: 369 TAQAIAHLHSAI-------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421
A+ +A+LH I P I HRDIKS N+LL N + +ADFGL+ S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 422 TAPQ-GTPGYLDPQY-----HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475
T Q GT Y+ P+ + + D+Y+ G+VL E+ + D +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 476 AALAADRISKGRLDEIIDP----LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531
S + E++ ++ AG + + E C + R S
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG----MAMLCETIEECWDHDAEARLS 305
Query: 532 MTEVATELEHI 542
V + +
Sbjct: 306 AGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 83/328 (25%), Positives = 151/328 (46%), Gaps = 39/328 (11%)
Query: 233 RKSTKRCLKEARGISNIPIYPYREIEKATIGFSE---KQRLGTGAFGTVYAGKLQNDLLV 289
+ + + +++ I + + K+++G G+FGTV+ + + V
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMD---IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 290 AIKRIKHRDTDG--IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347
A+K + +D + + + E+ ++ + HPN+V +G + +V E++ G+L +
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 348 HLQR-ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406
L + + L RL++A + A+ + +LH+ NPPI HR++KS N+L+D + KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDF 466
FGLSRL S + GTP ++ P+ ++ ++KSDVYSFGV+L E+ T
Sbjct: 183 FGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL------ 235
Query: 467 SRPPNEVNLAALAADRISKG-RLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLA 523
+P +N A + A K RL+ ++P +VA + C
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP------------------QVAAIIEGCWT 277
Query: 524 FHRDMRPSMTEVATELEHIRTRTMEDIN 551
RPS + L + + N
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 3e-60
Identities = 55/301 (18%), Positives = 113/301 (37%), Gaps = 45/301 (14%)
Query: 258 EKATIGFSE---KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDG--IQQVVNEIKLI 312
+ + I F + +L G ++ G+ Q + + +K +K RD + E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 313 SCVSHPNLVRLLGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA 370
SHPN++ +LG + +MP G+L L + + A++ A
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
+ +A LH+ + P I + S ++++D + ++++ + S S P +
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAW 174
Query: 431 LDP---QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG- 486
+ P Q +D++SF V+L E++T P +++ + +G
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTR------EVPFADLSNMEIGMKVALEGL 228
Query: 487 RLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
R I P V++L C+ RP + LE ++
Sbjct: 229 RPTIPPGISP------------------HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
Query: 545 R 545
+
Sbjct: 271 K 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 7e-60
Identities = 79/309 (25%), Positives = 135/309 (43%), Gaps = 35/309 (11%)
Query: 244 RGISNIPIYPYREIEKATIGFSE---KQRLGTGAFGTVYAGKLQNDLLVAIKRIK--HRD 298
+G + + I + QR+G+G+FGTVY GK D VA+K +
Sbjct: 3 KGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPT 60
Query: 299 TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGL 357
+Q NE+ ++ H N++ +G S Q+ +V ++ +L HL
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHA-SETKF 117
Query: 358 SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL-GMTE 416
+ +A +TA+ + +LH+ I HRD+KS+NI L + K+ DFGL+
Sbjct: 118 EMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 417 ISHISTAPQGTPGYLDP---QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
SH G+ ++ P + + S +SDVY+FG+VL E++T P + +
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG------QLPYSNI 228
Query: 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
N + + +G L P + + R + ++ L CL RD RPS
Sbjct: 229 NNRDQIIEMVGRGSL----SPDLSKVRSNCPK-------RMKRLMAECLKKKRDERPSFP 277
Query: 534 EVATELEHI 542
+ E+E +
Sbjct: 278 RILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-59
Identities = 79/320 (24%), Positives = 137/320 (42%), Gaps = 54/320 (16%)
Query: 243 ARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDG 301
A G S P + I + ++ +G G FG V+ G+L + +VAIK + D++G
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59
Query: 302 -------IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG 354
Q+ E+ ++S ++HPN+V+L G +V EF+P G L L +
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD-KA 116
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-----YNFKSKVADFGL 409
+ W ++L + ++ A I ++ + NPPI HRD++S NI L +KVADFGL
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 410 SRLGMTEISHISTAPQGTPGYLDPQ--YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFS 467
S+ + H + G ++ P+ + ++K+D YSF ++L I+T
Sbjct: 176 SQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG------E 225
Query: 468 RPPNEVNL--AALAADRISKG-RLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCL 522
P +E + +G R E P ++ + C
Sbjct: 226 GPFDEYSYGKIKFINMIREEGLRPTIPEDCPP------------------RLRNVIELCW 267
Query: 523 AFHRDMRPSMTEVATELEHI 542
+ RP + + EL +
Sbjct: 268 SGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-59
Identities = 64/321 (19%), Positives = 114/321 (35%), Gaps = 46/321 (14%)
Query: 240 LKEARGISNIPIYPYREIEKATIGFSE---KQRLGTGAFGTVYAGKLQNDLLVAIKRIK- 295
L AR +++ I F + + +G G FG VY G+ + VAI+ I
Sbjct: 8 LLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDI 65
Query: 296 -HRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG 354
+ D ++ E+ H N+V +G + ++ TL + R+
Sbjct: 66 ERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAK 124
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL-- 412
L +A E + + +LH+ I H+D+KS N+ D N K + DFGL +
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 413 --GMTEISHISTAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIITAL 461
G +L P S SDV++ G + E+
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR- 239
Query: 462 KVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRC 521
P A ++ G P + + + ++++ C
Sbjct: 240 -----EWPFKTQPAEA-IIWQMGTGMK-----PNLSQIGMGKE---------ISDILLFC 279
Query: 522 LAFHRDMRPSMTEVATELEHI 542
AF ++ RP+ T++ LE +
Sbjct: 280 WAFEQEERPTFTKLMDMLEKL 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-59
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 42/294 (14%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
Y+EIE ++ +G GAFG V K VAIK+I+ + + E++ +
Sbjct: 6 DYKEIE-------VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQL 55
Query: 313 SCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQ-RERGDGLSWPIRLTVAMETAQ 371
S V+HPN+V+L G + LV E+ G+L L E + ++ ++ +Q
Sbjct: 56 SRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKS-KVADFGLSRLGMTEISHISTAPQGTPGY 430
+A+LHS + HRD+K N+LL K+ DFG + +I T +G+ +
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAW 169
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA-DRISKGRLD 489
+ P+ + + S+K DV+S+G++L E+IT +P +E+ A + G
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITR------RKPFDEIGGPAFRIMWAVHNGTRP 223
Query: 490 EIIDPLIIEHRGHSDAGTLASVHK-VAELAFRCLAFHRDMRPSMTEVATELEHI 542
+I ++ K + L RC + RPSM E+ + H+
Sbjct: 224 PLIK----------------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-56
Identities = 80/301 (26%), Positives = 124/301 (41%), Gaps = 46/301 (15%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD----TDGIQQVVNEIKL 311
EI+ A + E +G G FG VY VA+K +H + I+ V E KL
Sbjct: 3 EIDFAELTLEEI--IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 312 ISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ + HPN++ L G ++ LV EF G L + L +R + I + A++ A+
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKS--------KVADFGLSRLGMTEISHISTA 423
+ +LH PI HRD+KSSNIL+ ++ K+ DFGL+R +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMS 173
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483
G ++ P+ + S SDV+S+GV+L E++T P ++ A+A
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVA 227
Query: 484 SKGRLDEIID--PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
I P A+L C RPS T + +L
Sbjct: 228 MNKLALPIPSTCP-----------------EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
Query: 542 I 542
I
Sbjct: 271 I 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-55
Identities = 58/322 (18%), Positives = 108/322 (33%), Gaps = 41/322 (12%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLI 312
E + +G G +G VY G L VA+K + I +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSFANRQNFINEK-NIYRV 61
Query: 313 SCVSHPNLVRLLGCSIE-----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+ H N+ R + R E +LV E+ PNG+L ++L W +A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 368 ETAQAIAHLHSAI------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL-------GM 414
+ +A+LH+ + P I HRD+ S N+L+ + ++DFGLS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 415 TEISHISTAPQGTPGYLDP-------QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFS 467
E + + + GT Y+ P + D+Y+ G++ EI +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 468 RPPNEVNLAALAADRISKGRLDEIIDP-------LIIEHRGHSDAGTLASVHKVAELAFR 520
E + A + + +++ ++ + + E
Sbjct: 239 ESVPEYQM-AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR---SLKETIED 294
Query: 521 CLAFHRDMRPSMTEVATELEHI 542
C + R + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAEL 316
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 40/320 (12%)
Query: 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIK 310
P+R + + E LG G FG + ++ +K + D + + + E+K
Sbjct: 2 MPHRIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 311 LISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA 370
++ C+ HPN+++ +G + + E++ GTL ++ W R++ A + A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIA 118
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL-------------GMTEI 417
+A+LHS I HRD+ S N L+ N VADFGL+RL
Sbjct: 119 SGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477
G P ++ P+ +K DV+SFG+VL EII + P+ +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTM 230
Query: 478 LAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537
+ + S + RC + RPS ++
Sbjct: 231 DFGLNVRGFL------------DRYCPPNCPPSFF---PITVRCCDLDPEKRPSFVKLEH 275
Query: 538 ELEHIRTRTMEDINCTASLE 557
LE +R + LE
Sbjct: 276 WLETLRMHLAGHLPLGPQLE 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-53
Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 44/303 (14%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
+ +G G +G V+ G Q + VA+K RD + E+ + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQGEN-VAVKIFSSRDEKSWFRET-ELYNTVMLRHENILGFIASD 71
Query: 328 IERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI--- 380
+ L+ + G+L +LQ L L + + A +AHLH I
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 381 --NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQGTPGYLDP-- 433
P I HRD+KS NIL+ N + +AD GL+ + ++ + GT Y+ P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 434 ----QYHQNFHLSDKSDVYSFGVVLVEIIT---ALKVVDFSRPP--NEVNLAALAADRIS 484
F + D+++FG+VL E+ + +V+ +PP + V D
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 485 -----KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
+ R + I + +A+L C + R + + L
Sbjct: 249 VVCVDQQRPN--IPNRWFSDPTLT---------SLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 540 EHI 542
I
Sbjct: 298 TKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 63/297 (21%), Positives = 120/297 (40%), Gaps = 32/297 (10%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
+++G G +G V+ GK + + VA+K + + EI + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEASWFRET-EIYQTVLMRHENILGFIAAD 100
Query: 328 IERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI--- 380
I+ L+ ++ NG+L +L+ L L +A + + HLH+ I
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 381 --NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQGTPGYLDP-- 433
P I HRD+KS NIL+ N +AD GL+ E+ GT Y+ P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 434 ----QYHQNFHLSDKSDVYSFGVVLVEIIT----ALKVVDFSRPPNEVNLAALAADRISK 485
+F +D+YSFG++L E+ V ++ P +++ + + + + +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+ + P + + ++ +L C A + R + V L +
Sbjct: 278 IVCIKKLRPSFPNRWSSDEC-----LRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-52
Identities = 75/320 (23%), Positives = 133/320 (41%), Gaps = 35/320 (10%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVV 306
S +P+ R I + TI E +G G FG V+ GK + + VA+K R+ +
Sbjct: 30 SGLPLLVQRTIAR-TIVLQES--IGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREA 85
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIR 362
EI + H N++ + + LV ++ +G+L +L R ++
Sbjct: 86 -EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGM 141
Query: 363 LTVAMETAQAIAHLHSAI-----NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417
+ +A+ TA +AHLH I P I HRD+KS NIL+ N +AD GL+ +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 418 SHISTAP---QGTPGYLDP------QYHQNFHLSDKSDVYSFGVVLVEIIT----ALKVV 464
I AP GT Y+ P ++F ++D+Y+ G+V EI
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 465 DFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAF 524
D+ P ++ + + + + K ++ + P I +A + +A++ C
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA-----LRVMAKIMRECWYA 316
Query: 525 HRDMRPSMTEVATELEHIRT 544
+ R + + L +
Sbjct: 317 NGAARLTALRIKKTLSQLSQ 336
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 60/251 (23%), Positives = 111/251 (44%), Gaps = 25/251 (9%)
Query: 250 PIYPYREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK---HRDTDGIQQV 305
P Y + F ++++G G F VY L + + VA+K+++ D
Sbjct: 24 PDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79
Query: 306 VNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR--L 363
+ EI L+ ++HPN+++ IE E +V E G L + ++ + P R
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
++ A+ H+HS + HRDIK +N+ + K+ D GL R ++ + +
Sbjct: 140 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP---NEVNLAALAA 480
GTP Y+ P+ + KSD++S G +L E+ + P +++NL +L
Sbjct: 197 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------LQSPFYGDKMNLYSLCK 248
Query: 481 DRISKGRLDEI 491
+I + +
Sbjct: 249 -KIEQCDYPPL 258
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 18/248 (7%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQ 303
++ +EK + Q++G G+FG K ++ IK I + +
Sbjct: 13 LGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 304 QVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL 363
+ E+ +++ + HPN+V+ E G +V ++ G L + + ++G L
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
++ A+ H+H I HRDIKS NI L + ++ DFG++R+ + +
Sbjct: 129 DWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483
GTP YL P+ +N ++KSD+++ G VL E+ T ++ L +I
Sbjct: 186 -IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT------LKHAFEAGSMKNLVL-KI 237
Query: 484 SKGRLDEI 491
G +
Sbjct: 238 ISGSFPPV 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 59/298 (19%), Positives = 112/298 (37%), Gaps = 41/298 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ Q+LG G F V + L + A+KRI + ++ E + +HPN++R
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 323 LLGCSIERGEQ----ILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHL 376
L+ + L+ F GTL ++R ++G+ L+ L + + + + +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--------GTP 428
H+ HRD+K +NILL + + D G + A T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 429 GYLDP---QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485
Y P + + +++DV+S G VL ++ P + V + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF------GEGPYDMVFQKGDSVALAVQ 261
Query: 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
+L P HS A + +L + RP + + ++LE ++
Sbjct: 262 NQLSIPQSP------RHSSA--------LWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 17/237 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-LLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNL 320
+ +GTG++G + ++D ++ K + Q +V+E+ L+ + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 321 VRLLGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDGLSWPIR--LTVAMETAQAIAHL 376
VR I+R L V E+ G L + + + L V + A+
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 377 HS--AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
H + HRD+K +N+ LD K+ DFGL+R+ + S T GTP Y+ P+
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPE 186
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491
++KSD++S G +L E+ P + L A +I +G+ I
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCA------LMPPFTAFSQKEL-AGKIREGKFRRI 236
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 54/305 (17%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDG-IQQVVNEIKLIS 313
+ + E+ +G G FG V++G+L+ ++ LVA+K + + + E +++
Sbjct: 110 VLNHEDLVLGEQ--IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
SHPN+VRL+G ++ +V E + G L R G L L + + A +
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGM 226
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG------T 427
+L S HRD+ + N L+ K++DFG+SR + + ++ T
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWT 282
Query: 428 PGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVNLAALAAD 481
P+ S +SDV+SFG++L E + P + +
Sbjct: 283 A----PEALNYGRYSSESDVWSFGILLWETFS------LGASPYPNLSNQQT------RE 326
Query: 482 RISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540
+ KG RL P +V L +C A+ RPS + + EL+
Sbjct: 327 FVEKGGRLPC---P----------ELCPDAVF---RLMEQCWAYEPGQRPSFSTIYQELQ 370
Query: 541 HIRTR 545
IR R
Sbjct: 371 SIRKR 375
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 50/289 (17%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRL 323
+G G+F TVY G + + VA ++ R Q+ E +++ + HPN+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 324 LGCSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+ +LV E M +GTL +L+R + + + + + + + LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR 148
Query: 380 INPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
PPI HRD+K NI + K+ D GL+ L S GTP ++ P+ ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAV-IGTPEFMAPEMYEE 204
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAAL---AADRISKGRLDEIID 493
+ + DVY+FG+ ++E+ T S P N A + + D++
Sbjct: 205 KY-DESVDVYAFGMCMLEMAT-------SEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL-EH 541
P V E+ C+ ++D R S +L H
Sbjct: 257 PE------------------VKEIIEGCIRQNKDERYS----IKDLLNH 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 58/304 (19%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F E + +G+G FG V+ K + IKR+K+ + ++ E+K ++ + H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 323 LLGCSIERGEQI----------------LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
GC + EF GTL Q +++ RG+ L + L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
+ + + ++HS + +RD+K SNI L + K+ DFGL + + G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--G 183
Query: 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486
T Y+ P+ + + D+Y+ G++L E++ + G
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFT----DLRDG 234
Query: 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH--IRT 544
+ +I D K L + L+ + RP+ +E+ L +
Sbjct: 235 IISDIFDK------------------KEKTLLQKLLSKKPEDRPNTSEI---LRTLTVWK 273
Query: 545 RTME 548
++ E
Sbjct: 274 KSPE 277
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-36
Identities = 81/303 (26%), Positives = 130/303 (42%), Gaps = 34/303 (11%)
Query: 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVV 306
P Y E+E+ I K LG G +G VY G + L VA+K +K + +++ +
Sbjct: 208 VSPNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 264
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
E ++ + HPNLV+LLG ++ EFM G L +L+ +S + L +A
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 367 METAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAP 424
+ + A+ +L I HR++ + N L+ N KVADFGLSRL +
Sbjct: 325 TQISSAMEYLEKKNFI-----HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 425 QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484
+ + P+ S KSDV++FGV+L EI T + P + + +
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLE 433
Query: 485 KG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
K R++ P G V+ EL C ++ RPS E+ E +
Sbjct: 434 KDYRMER---P----------EGCPEKVY---ELMRACWQWNPSDRPSFAEIHQAFETMF 477
Query: 544 TRT 546
+
Sbjct: 478 QES 480
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 86/314 (27%), Positives = 134/314 (42%), Gaps = 60/314 (19%)
Query: 250 PIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNE 308
P Y E+E+ I K LG G +G VY G + L VA+K +K + +++ + E
Sbjct: 3 PNYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
++ + HPNLV+LLG ++ EFM G L +L+ +S + L +A +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS------- 421
+ A+ +L N HRD+ + N L+ N KVADFGLSRL +
Sbjct: 120 ISSAMEYL-EKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 422 --TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEV 473
TAP+ + F S KSDV++FGV+L EI T + P ++V
Sbjct: 177 KWTAPESL-------AYNKF--SIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQV 221
Query: 474 NLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532
+ + K R++ P G V+ EL C ++ RPS
Sbjct: 222 ------YELLEKDYRMER---P----------EGCPEKVY---ELMRACWQWNPSDRPSF 259
Query: 533 TEVATELEHIRTRT 546
E+ E + +
Sbjct: 260 AEIHQAFETMFQES 273
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 83/343 (24%), Positives = 141/343 (41%), Gaps = 54/343 (15%)
Query: 228 SYYRARKSTKRCLKE--------ARGISNIPIYPYREIEKATIGFSEK------------ 267
+Y ++ L++ A G+ + + T G ++
Sbjct: 130 GFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLE 189
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
+LG G FG V+ G VAIK +K + + E +++ + H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA--INPPIY 385
E I V E+M G+L L+ E G L P + +A + A +A++ +
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----- 302
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYLDPQYHQNFHLSDK 444
HRD++++NIL+ N KVADFGL+RL + + + + P + P+ + K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLDEIIDPLIIEHRGHS 503
SDV+SFG++L E+ T +V EV D++ +G R+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPC---P--------- 403
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546
S+H +L +C + RP+ + LE T T
Sbjct: 404 -PECPESLH---DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 69/312 (22%), Positives = 138/312 (44%), Gaps = 43/312 (13%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEI 309
+ E+ + F ++ LG G FG+V + +VA+K+++H + ++ EI
Sbjct: 36 TQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 93
Query: 310 KLISCVSHPNLVRLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+++ + H N+V+ G G + L+ E++P G+L +LQ+ + + L
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTS 152
Query: 368 ETAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS---- 421
+ + + +L + I HRD+ + NIL++ + K+ DFGL+++ + +
Sbjct: 153 QICKGMEYLGTKRYI-----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 422 -------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474
AP+ F S SDV+SFGVVL E+ T ++ S+ P
Sbjct: 208 GESPIFWYAPESL-------TESKF--SVASDVWSFGVVLYELFT---YIEKSKSPPAEF 255
Query: 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTE 534
+ + D+ + + +I+ L R G ++ + C + + RPS +
Sbjct: 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY---MIMTECWNNNVNQRPSFRD 312
Query: 535 VATELEHIRTRT 546
+A ++ IR +
Sbjct: 313 LALRVDQIRDQM 324
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 12/203 (5%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCV-SHPN 319
F RLG G++G V+ ++ L A+KR R + + E+ V HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
VRL E G L E +L QH + G L +T A+AHLHS
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ H D+K +NI L + K+ DFGL + +G P Y+ P+ Q
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE-LGTAGAGEVQ-EGDPRYMAPELLQGS 231
Query: 440 HLSDKSDVYSFGVVLVEIITALK 462
+ +DV+S G+ ++E+ ++
Sbjct: 232 Y-GTAADVFSLGLTILEVACNME 253
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 69/309 (22%), Positives = 137/309 (44%), Gaps = 37/309 (11%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEI 309
+ E+ + F ++ LG G FG+V + +VA+K+++H + ++ EI
Sbjct: 5 TQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 62
Query: 310 KLISCVSHPNLVRLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+++ + H N+V+ G G + L+ E++P G+L +LQ+ + + L
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTS 121
Query: 368 ETAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
+ + + +L + I HRD+ + NIL++ + K+ DFGL+++ + + +
Sbjct: 122 QICKGMEYLGTKRYI-----HRDLATRNILVENENRVKIGDFGLTKV-LPQDKEFFKVKE 175
Query: 426 GT--------PGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477
P L F S SDV+SFGVVL E+ T ++ S+ P +
Sbjct: 176 PGESPIFWYAPESL---TESKF--SVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRM 227
Query: 478 LAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537
+ D+ + + +I+ L R G ++ + C + + RPS ++A
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY---MIMTECWNNNVNQRPSFRDLAL 284
Query: 538 ELEHIRTRT 546
++ IR
Sbjct: 285 RVDQIRDNM 293
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
E+ + T+ E+ LG G FG V+ G VA+K +K + E L+ +
Sbjct: 9 EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
H LVRL + I + E+M NG+L L+ G L+ L +A + A+ +A
Sbjct: 66 QHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQ 425
+ N HRD++++NIL+ K+ADFGL+RL + + + + TAP+
Sbjct: 125 I-EERN--YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ F + KSDV+SFG++L EI+T
Sbjct: 181 AI-------NYGTF--TIKSDVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLIS 313
+ E+++ I ++ LG+G FG V GK + VA+K IK + E + +
Sbjct: 2 HMELKREEITLLKE--LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMM 58
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
+SHP LV+ G + +V E++ NG L +L R G GL L + + + +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGM 117
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TA 423
A L + HRD+ + N L+D + KV+DFG++R + + ++S +A
Sbjct: 118 AFL-ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSA 173
Query: 424 PQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ ++ + S KSDV++FG+++ E+ +
Sbjct: 174 PEVF-------HYFKY--SSKSDVWAFGILMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 48/314 (15%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEI 309
E+ + + + LG G FG+V + LVA+K+++H D + EI
Sbjct: 18 TIFEERHLKYISQ--LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 310 KLISCVSHPNLVRLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+++ + +V+ G S G Q LV E++P+G L LQR R L L +
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSS 134
Query: 368 ETAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS---- 421
+ + + +L S + HRD+ + NIL++ K+ADFGL++L + +
Sbjct: 135 QICKGMEYLGSRRCV-----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 422 -------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474
AP+ F S +SDV+SFGVVL E+ T + +
Sbjct: 190 GQSPIFWYAPESL-------SDNIF--SRQSDVWSFGVVLYELFT------YCDKSCSPS 234
Query: 475 LAALAADRISKGRLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532
L + +++ L R + A VH EL C A RPS
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH---ELMKLCWAPSPQDRPSF 291
Query: 533 TEVATELEHIRTRT 546
+ + +L+ + + +
Sbjct: 292 SALGPQLDMLWSGS 305
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 8e-35
Identities = 84/306 (27%), Positives = 136/306 (44%), Gaps = 66/306 (21%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
+ + + +G G FG V G + + VA+K IK+ T Q + E +++ +
Sbjct: 17 ALNMKELKLLQT--IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQL 71
Query: 316 SHPNLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
H NLV+LLG E+G +V E+M G+L +L+ L L +++ +A+
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS---------TAPQ 425
+L N HRD+ + N+L+ + +KV+DFGL++ E S TAP+
Sbjct: 132 YL-EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPE 184
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVNLAALA 479
+ F S KSDV+SFG++L EI + F R P +V
Sbjct: 185 AL-------REKKF--STKSDVWSFGILLWEIYS------FGRVPYPRIPLKDV------ 223
Query: 480 ADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538
R+ KG ++D P G +V+ E+ C MRPS ++ +
Sbjct: 224 VPRVEKGYKMDA---P----------DGCPPAVY---EVMKNCWHLDAAMRPSFLQLREQ 267
Query: 539 LEHIRT 544
LEHI+T
Sbjct: 268 LEHIKT 273
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 36/296 (12%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC 314
EI + ++ K LG G FG V+ G VAIK +K + + E +++
Sbjct: 262 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKK 318
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
+ H LV+L E I V E+M G+L L+ E G L P + +A + A +A
Sbjct: 319 LRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 375 HLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP-GYL 431
++ + HRD++++NIL+ N KVADFGL+RL + + + + P +
Sbjct: 378 YVERMNYV-----HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWT 431
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLDE 490
P+ + KSDV+SFG++L E+ T +V EV D++ +G R+
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPC 485
Query: 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546
P S+H +L +C + RP+ + LE T T
Sbjct: 486 ---P----------PECPESLH---DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 78/307 (25%), Positives = 133/307 (43%), Gaps = 66/307 (21%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
+ + + +G G FG V G + + VA+K IK+ T Q + E +++ +
Sbjct: 189 ALNMKELKLLQT--IGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQL 243
Query: 316 SHPNLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
H NLV+LLG E+G +V E+M G+L +L+ L L +++ +A+
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 375 HLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG------ 426
+L + HRD+ + N+L+ + +KV+DFGL++ S+
Sbjct: 304 YLEGNNFV-----HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVK 351
Query: 427 -TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVNLAALA 479
T P+ + S KSDV+SFG++L EI + F R P +V
Sbjct: 352 WTA----PEALREKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDV------ 395
Query: 480 ADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538
R+ KG ++D P G +V+ ++ C RP+ ++ +
Sbjct: 396 VPRVEKGYKMDA---P----------DGCPPAVY---DVMKNCWHLDAATRPTFLQLREQ 439
Query: 539 LEHIRTR 545
LEHIRT
Sbjct: 440 LEHIRTH 446
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 60/214 (28%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
I+ + + F ++ +G+G FG V+ G N VAIK I+ + + E +++ +
Sbjct: 4 VIDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKL 60
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
SHP LV+L G +E+ LV EFM +G L +L+ +RG + L + ++ + +A+
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAY 119
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQ 425
L + HRD+ + N L+ N KV+DFG++R + + + S +P+
Sbjct: 120 L-EEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPE 175
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ S KSDV+SFGV++ E+ +
Sbjct: 176 VF-------SFSRY--SSKSDVWSFGVLMWEVFS 200
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 56/254 (22%), Positives = 97/254 (38%), Gaps = 38/254 (14%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLV 321
F Q LG G FG V+ K +D AIKRI+ ++V+ E+K ++ + HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 322 RLLGCSIERGE---------QILVY---EFMPNGTLCQHLQRERGDG-LSWPIRLTVAME 368
R +E+ ++ +Y + L + + L + ++
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--- 425
A+A+ LHS + HRD+K SNI + KV DFGL + +
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 426 --------GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477
GT Y+ P+ S K D++S G++L E++ P +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQMERV 234
Query: 478 LAADRISKGRLDEI 491
+ + +
Sbjct: 235 RTLTDVRNLKFPPL 248
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F E LG GAFG V + + AIK+I+H + + +++E+ L++ ++H +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 323 LLGCSIERGEQI-------------LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
+ER + + E+ NGTL + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQI 125
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---- 425
+A++++HS I HRD+K NI +D + K+ DFGL++ + + Q
Sbjct: 126 LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 426 ---------GTPGYLDP-QYHQNFHLSDKSDVYSFGVVLVE 456
GT Y+ H ++K D+YS G++ E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 43/292 (14%)
Query: 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNL 320
I F K LG GA GT+ + ++ VA+KRI + E++ L HPN+
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+R +R Q + E TL +++++ + +T+ +T +AHLHS
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 381 NPPIYHRDIKSSNILL-----DYNFKSKVADFGLSRL---GMTEISHISTAPQGTPGYLD 432
I HRD+K NIL+ K+ ++DFGL + G S S GT G++
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV-PGTEGWIA 194
Query: 433 P---QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
P + + D++S G V +I+ P +L A + LD
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE------GSHPFGKSLQRQANILLGACSLD 248
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ + A L + +A RPS V L+H
Sbjct: 249 CLHPEKHED----VIARELIE---------KMIAMDPQKRPSAKHV---LKH 284
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 72/316 (22%), Positives = 129/316 (40%), Gaps = 62/316 (19%)
Query: 248 NIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVN 307
EI + ++ +K LG G FG V+ VA+K +K + +
Sbjct: 176 KPWEKDAWEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLA 232
Query: 308 EIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
E ++ + H LV+L + I + EFM G+L L+ + G P + +
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS------ 421
+ A+ +A + N HRD++++NIL+ + K+ADFGL+R+ + + + +
Sbjct: 292 QIAEGMAFI-EQRN--YIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKF 347
Query: 422 ----TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------N 471
TAP+ +F + KSDV+SFG++L+EI+T + R P
Sbjct: 348 PIKWTAPEAI-------NFGSF--TIKSDVWSFGILLMEIVT------YGRIPYPGMSNP 392
Query: 472 EVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP 530
EV + +G R+ P ++ + RC + RP
Sbjct: 393 EV------IRALERGYRMPR---P----------ENCPEELY---NIMMRCWKNRPEERP 430
Query: 531 SMTEVATELEHIRTRT 546
+ + + L+ T T
Sbjct: 431 TFEYIQSVLDDFYTAT 446
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/315 (21%), Positives = 114/315 (36%), Gaps = 51/315 (16%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIK-HRDTDGIQQVVNE 308
K + LG G FG V +VA+K +K E
Sbjct: 26 TVFHKRYLKKIRD--LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQE 83
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
I ++ + H ++++ GC + G LV E++P G+L +L R + L A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFA 140
Query: 367 METAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS--- 421
+ + +A+LH+ I HRD+ + N+LLD + K+ DFGL++ +
Sbjct: 141 QQICEGMAYLHAQHYI-----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 422 --------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
AP+ F SDV+SFGV L E++T
Sbjct: 196 DGDSPVFWYAPECL-------KEYKF--YYASDVWSFGVTLYELLT------HCDSSQSP 240
Query: 474 NLAALAADRISKGRLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531
L I++G++ + + L R A V+ L C RP+
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY---HLMKNCWETEASFRPT 297
Query: 532 MTEVATELEHIRTRT 546
+ L+ + +
Sbjct: 298 FENLIPILKTVHEKY 312
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV 315
EI+ + F ++ LGTG FG V GK + VAIK IK + + E K++ +
Sbjct: 20 EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNL 76
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
SH LV+L G ++ ++ E+M NG L +L+ R L + + +A+ +
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEY 135
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQ 425
L + HRD+ + N L++ KV+DFGLSR + + + S + P+
Sbjct: 136 L-ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPE 191
Query: 426 GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ F S KSD+++FGV++ EI +
Sbjct: 192 VL-------MYSKF--SSKSDIWAFGVLMWEIYS 216
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 64/320 (20%), Positives = 116/320 (36%), Gaps = 75/320 (23%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTDGIQQV 305
+ +I + F+E LG G F ++ G + + V +K + + +
Sbjct: 2 FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 306 VNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV 365
++S +SH +LV G + E ILV EF+ G+L +L++ + ++ +L V
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEV 118
Query: 366 AMETAQAIAHL--HSAINPPIYHRDIKSSNILLDYNFKS--------KVADFGLSR-LGM 414
A + A A+ L ++ I H ++ + NILL K++D G+S +
Sbjct: 119 AKQLAAAMHFLEENTLI-----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 415 TEISHIS---TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP- 470
+I P+ + +N + +D +SFG L EI + P
Sbjct: 174 KDILQERIPWVPPECI------ENPKNL--NLATDKWSFGTTLWEICS------GGDKPL 219
Query: 471 -----NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAF 524
+L P E +A L C+ +
Sbjct: 220 SALDSQRK------LQFYEDRHQLPA---PKAAE---------------LANLINNCMDY 255
Query: 525 HRDMRPSMTEVATELEHIRT 544
D RPS + +L + T
Sbjct: 256 EPDHRPSFRAIIRDLNSLFT 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 41/239 (17%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTD 300
+++ + E+ + I S + LG G+FG VY G + + VAIK + +
Sbjct: 12 ADVYVPDEWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 301 G-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSW 359
+ +NE ++ + ++VRLLG + +++ E M G L +L+ R +
Sbjct: 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 360 PIR--------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
P+ + +A E A +A+L++ HRD+ + N ++ +F K+ DFG++R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 412 LGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+I +G G L D + + SDV+SFGVVL EI T
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVF------TTYSDVWSFGVVLWEIAT 235
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 69/300 (23%)
Query: 268 QRLGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLV 321
+ LG+GAFGTVY G + + VAIK ++ + +++++E +++ V +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA-- 379
RLLG + Q+ + + MP G L ++ RE D + L ++ A+ + +L
Sbjct: 81 RLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQGTPG 429
+ HRD+ + N+L+ K+ DFGL++L E A +
Sbjct: 139 V-----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-- 191
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVNLAALAADRI 483
H+ + + +SDV+S+GV + E++T F P +E+ + +
Sbjct: 192 -----LHRIY--THQSDVWSYGVTVWELMT------FGSKPYDGIPASEI------SSIL 232
Query: 484 SKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
KG RL + P V+ + +C D RP E+ E +
Sbjct: 233 EKGERLPQ---P----------PICTIDVY---MIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTD-GIQQVVNE 308
EK + LG G FG V + VA+K +K I + E
Sbjct: 16 THFEKRFLKRIRD--LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 309 IKLISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
I+++ + H N+V+ G C+ + G I L+ EF+P+G+L ++L + + ++ +L A
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYA 132
Query: 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----- 421
++ + + +L S HRD+ + N+L++ + K+ DFGL++ T+ + +
Sbjct: 133 VQICKGMDYLGS-RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 422 ------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
AP+ F SDV+SFGV L E++T
Sbjct: 190 DSPVFWYAPECL-------MQSKF--YIASDVWSFGVTLHELLT 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQVVNE 308
I++ I + LG GAFG V+ + N +LVA+K +K Q E
Sbjct: 36 HHIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 93
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR------ 362
+L++ + H ++VR G E ++V+E+M +G L + L+ D
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 363 -------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415
L VA + A + +L + ++ HRD+ + N L+ K+ DFG+SR
Sbjct: 154 PLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR---- 206
Query: 416 EISHISTAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
+I G L P Y + F + +SDV+SFGVVL EI T
Sbjct: 207 DIYSTDYYRVGGRTML-PIRWMPPESILYRK-F--TTESDVWSFGVVLWEIFT 255
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHRDTDGIQQV-VNE 308
EI + + + +G G FG VY G L+ ++ VAIK +K T+ + + E
Sbjct: 39 TEIHPSCVTRQKV--IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 309 IKLISCVSHPNLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
++ SH N++RL G S + I + E+M NG L + L+ + G+ S + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMI-ITEYMENGALDKFLREKDGE-FSVLQLVGMLR 154
Query: 368 ETAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
A + +L + +N Y HRD+ + NIL++ N KV+DFGLSR+ + + + G
Sbjct: 155 GIAAGMKYL-ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEATYTTSG 209
Query: 427 -------TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
T P+ + SDV+SFG+V+ E++T
Sbjct: 210 GKIPIRWTA----PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 72/361 (19%), Positives = 135/361 (37%), Gaps = 81/361 (22%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTD-GIQQVVNE 308
R ++ + + LG+G FGTV+ G + + V IK I+ + Q V +
Sbjct: 8 RIFKETELRKLKV--LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
+ I + H ++VRLLG Q+ V +++P G+L H+ R+ L + L ++
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQ 123
Query: 369 TAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----- 421
A+ + +L + HR++ + N+LL + +VADFG++ L + +
Sbjct: 124 IAKGMYYLEEHGMV-----HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 422 -----TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------ 470
A + + + + +SDV+S+GV + E++T F P
Sbjct: 179 TPIKWMALESI-------HFGKY--THQSDVWSYGVTVWELMT------FGAEPYAGLRL 223
Query: 471 NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529
EV D + KG RL + P V+ + +C ++R
Sbjct: 224 AEV------PDLLEKGERLAQ---P----------QICTIDVY---MVMVKCWMIDENIR 261
Query: 530 PSMTEVATELEHIRTRTMEDINCTASLEASLCSSSYNASERMKDNSPPSVQDSWSSEQSS 589
P+ E+A E + + + P + + E
Sbjct: 262 PTFKELANEFTRMARDPPRYLVIKRESGPGIAPGP----------EPHGLTNKKLEEVEL 311
Query: 590 S 590
Sbjct: 312 E 312
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 83/329 (25%), Positives = 140/329 (42%), Gaps = 75/329 (22%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQV-VNEI 309
REIE + I + +G+G G V G+L+ D+ VAIK +K T+ ++ ++E
Sbjct: 44 REIEASRIHIEKI--IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 310 KLISCVSHPNLVRLLG-CSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
++ HPN++RL G + RG + V E+M NG+L L R + + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLR 158
Query: 368 ETAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS---- 421
+ +L + HRD+ + N+L+D N KV+DFGLSR+ +
Sbjct: 159 GVGAGMRYLSDLGYV-----HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213
Query: 422 -------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP---- 470
TAP+ + F S SDV+SFGVV+ E++ + P
Sbjct: 214 GKIPIRWTAPEAI-------AFRTF--SSASDVWSFGVVMWEVLA------YGERPYWNM 258
Query: 471 --NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRD 527
+V + +G RL P G ++H +L C R
Sbjct: 259 TNRDV------ISSVEEGYRLPA---P----------MGCPHALH---QLMLDCWHKDRA 296
Query: 528 MRPSMTEVATELEHIRTRTMEDINCTASL 556
RP +++ + L+ + R+ E + TA++
Sbjct: 297 QRPRFSQIVSVLDAL-IRSPESLRATATV 324
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 71/316 (22%), Positives = 134/316 (42%), Gaps = 60/316 (18%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRDTDG-IQQVVNEIK 310
I + + +G G FG VY G+ QN + AIK + ++ + E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 311 LISCVSHPNLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
L+ ++HPN++ L+G G ++ +M +G L Q ++ + + + ++ ++
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQV 133
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPG 429
A+ + +L + HRD+ + N +LD +F KVADFGL+R + + Q
Sbjct: 134 ARGMEYL-AEQK--FVHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQHRH 187
Query: 430 YLDP---------QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVN 474
P Q ++ F + KSDV+SFGV+L E++T PP ++
Sbjct: 188 ARLPVKWTALESLQTYR-F--TTKSDVWSFGVLLWELLT------RGAPPYRHIDPFDL- 237
Query: 475 LAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
+++G RL + P S++ ++ +C +RP+
Sbjct: 238 -----THFLAQGRRLPQ---P----------EYCPDSLY---QVMQQCWEADPAVRPTFR 276
Query: 534 EVATELEHIRTRTMED 549
+ E+E I + + D
Sbjct: 277 VLVGEVEQIVSALLGD 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
++ L G F VY + + + A+KR+ + + + ++ E+ + HPN+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 325 GCSIERGEQ-------ILVYEFMPNGTLCQHLQRERGDG-LSWPIRLTVAMETAQAIAHL 376
+ E+ L+ + G L + L++ G LS L + +T +A+ H+
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ----------- 425
H PPI HRD+K N+LL K+ DFG + + +A +
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 426 GTPGYLDP---QYHQNFHLSDKSDVYSFGVVL 454
TP Y P + NF + +K D+++ G +L
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 74/315 (23%), Positives = 124/315 (39%), Gaps = 71/315 (22%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGIQQV-VNEIK 310
I + + + LG G FG VY G N + VA+K K T ++ ++E
Sbjct: 8 GIAREDVVLNRI--LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 311 LISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
++ + HP++V+L+G E ++ E P G L +L+R + L + +++
Sbjct: 66 IMKNLDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQ 121
Query: 369 TAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS------ 421
+A+A+L +IN HRDI NIL+ K+ DFGLSR E + +
Sbjct: 122 ICKAMAYL-ESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 422 ---TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NE 472
+P+ + F + SDV+ F V + EI++ F + P +
Sbjct: 178 IKWMSPESI-------NFRRF--TTASDVWMFAVCMWEILS------FGKQPFFWLENKD 222
Query: 473 VNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531
V + KG RL + P ++ L RC + RP
Sbjct: 223 V------IGVLEKGDRLPK---P----------DLCPPVLY---TLMTRCWDYDPSDRPR 260
Query: 532 MTEVATELEHIRTRT 546
TE+ L +
Sbjct: 261 FTELVCSLSDVYQME 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 42/227 (18%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQVVN--- 307
I + + EK LG G+FG V G+ + VA+K +K + + +
Sbjct: 13 CLIGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 308 EIKLISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTV 365
E+ + + H NL+RL G + +V E P G+L L R+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRY 126
Query: 366 AMETAQAIAHLHSA--INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--------GMT 415
A++ A+ + +L S I HRD+ + N+LL K+ DFGL R M
Sbjct: 127 AVQVAEGMGYLESKRFI-----HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 416 EISHIS---TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
E + AP+ + F S SD + FGV L E+ T
Sbjct: 182 EHRKVPFAWCAPESL-------KTRTF--SHASDTWMFGVTLWEMFT 219
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 72/311 (23%), Positives = 129/311 (41%), Gaps = 52/311 (16%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRDTDG-IQQVVNEIK 310
+ F+E +G G FG VY G L + A+K + G + Q + E
Sbjct: 21 GPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 311 LISCVSHPNLVRLLGCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
++ SHPN++ LLG + L V +M +G L ++ E + + + ++
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST-APQGTP 428
A+ + +L ++ HRD+ + N +LD F KVADFGL+R ++ +
Sbjct: 138 AKGMKYL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKT 190
Query: 429 GYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479
G P Q + F + KSDV+SFGV+L E++T ++
Sbjct: 191 GAKLPVKWMALESLQTQK-F--TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 241
Query: 480 ADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538
+ +G RL + P ++ E+ +C +MRPS +E+ +
Sbjct: 242 TVYLLQGRRLLQ---P----------EYCPDPLY---EVMLKCWHPKAEMRPSFSELVSR 285
Query: 539 LEHIRTRTMED 549
+ I + + +
Sbjct: 286 ISAIFSTFIGE 296
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 71/322 (22%), Positives = 131/322 (40%), Gaps = 73/322 (22%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQND---LLVAIKRIKHRDTDGIQQV--VNEIK 310
+++ + +K+ LG+G FGTV G Q VA+K +K+ D + + E
Sbjct: 12 YLDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70
Query: 311 LISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
++ + +P +VR++G C E LV E G L ++LQ+ + + + +
Sbjct: 71 VMQQLDNPYIVRMIGICE---AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQ 125
Query: 369 TAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS------ 421
+ + +L N + HRD+ + N+LL +K++DFGLS+ + ++
Sbjct: 126 VSMGMKYL-EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 422 -----TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------ 470
AP+ + F S KSDV+SFGV++ E + + + P
Sbjct: 182 WPVKWYAPECI-------NYYKF--SSKSDVWSFGVLMWEAFS------YGQKPYRGMKG 226
Query: 471 NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529
+EV + KG R+ P AG ++ +L C + + R
Sbjct: 227 SEV------TAMLEKGERMGC---P----------AGCPREMY---DLMNLCWTYDVENR 264
Query: 530 PSMTEVATELEHIRTRTMEDIN 551
P V L + + + +
Sbjct: 265 PGFAAVELRLRNYYYDVVNEGH 286
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 76/317 (23%), Positives = 126/317 (39%), Gaps = 73/317 (23%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGIQQV-VNEI 309
EI++ I +G G FG V+ G + L VAIK K+ +D +++ + E
Sbjct: 10 YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 310 KLISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+ HP++V+L+G + + ++ E G L LQ + L + A
Sbjct: 68 LTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAY 123
Query: 368 ETAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----- 421
+ + A+A+L + + HRDI + N+L+ N K+ DFGLSR M + ++
Sbjct: 124 QLSTALAYL-ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178
Query: 422 -----TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------ 470
AP+ + + F + SDV+ FGV + EI+ P
Sbjct: 179 LPIKWMAPESI------NFRR-F--TSASDVWMFGVCMWEILM------HGVKPFQGVKN 223
Query: 471 NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529
N+V RI G RL P +++ L +C A+ R
Sbjct: 224 NDV------IGRIENGERLPM---P----------PNCPPTLY---SLMTKCWAYDPSRR 261
Query: 530 PSMTEVATELEHIRTRT 546
P TE+ +L I
Sbjct: 262 PRFTELKAQLSTILEEE 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQVVNEI 309
I++ I + LG GAFG V+ + N +LVA+K +K + E
Sbjct: 11 HIKRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68
Query: 310 KLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR------- 362
+L++ + H ++V+ G + I+V+E+M +G L + L+ D +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 363 -------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415
L +A + A + +L ++ + HRD+ + N L+ N K+ DFG+SR
Sbjct: 129 ELGLSQMLHIASQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR---- 181
Query: 416 EISHISTAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
++ G L P Y + F + +SDV+SFGV+L EI T
Sbjct: 182 DVYSTDYYRVGGHTML-PIRWMPPESIMYRK-F--TTESDVWSFGVILWEIFT 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIK--HRDTDGIQQVVNEI 309
I + LG G FG+V +L+ + + VA+K +K + I++ + E
Sbjct: 19 LIPEQQFTLGRM--LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 310 KLISCVSHPNLVRLLGCSIERGEQI------LVYEFMPNGTLCQHLQRER----GDGLSW 359
+ HP++ +L+G S+ + ++ FM +G L L R L
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419
+ ++ A + +L S+ N HRD+ + N +L + VADFGLSR +I
Sbjct: 137 QTLVRFMVDIACGMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR----KIYS 189
Query: 420 ISTAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
QG L P + + + SDV++FGV + EI+T
Sbjct: 190 GDYYRQGCASKL-PVKWLALESLADNL-Y--TVHSDVWAFGVTMWEIMT 234
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGIQQV--VNEI 309
I++ + + LG G FG+V G L+ + L VA+K +K ++ + ++E
Sbjct: 30 VIDRNLLILGKI--LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 310 KLISCVSHPNLVRLLGCSIERGEQI-----LVYEFMPNGTLCQHLQRERGDGLSWPIR-- 362
+ SHPN++RLLG IE Q ++ FM G L +L R + I
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 363 --LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
L ++ A + +L S N HRD+ + N +L + VADFGLS+ +I
Sbjct: 148 TLLKFMVDIALGMEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSG 200
Query: 421 STAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
QG + P + + KSDV++FGV + EI T
Sbjct: 201 DYYRQGRIAKM-PVKWIAIESLADRV-Y--TSKSDVWAFGVTMWEIAT 244
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 63/319 (19%), Positives = 121/319 (37%), Gaps = 73/319 (22%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGIQQV-VNEIKL 311
+++ + LG G FG+V G + + VAIK +K + + E ++
Sbjct: 5 FLKRDNLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 312 ISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
+ + +P +VRL+G C E + LV E G L + L + + + + +
Sbjct: 64 MHQLDNPYIVRLIGVCQ---AEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQV 119
Query: 370 AQAIAHL--HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS------ 421
+ + +L + + HRD+ + N+LL +K++DFGLS+ + S+ +
Sbjct: 120 SMGMKYLEEKNFV-----HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 422 -----TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------ 470
AP+ + + F S +SDV+S+GV + E ++ + + P
Sbjct: 175 WPLKWYAPECI------NFRK-F--SSRSDVWSYGVTMWEALS------YGQKPYKKMKG 219
Query: 471 NEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR 529
EV I +G R++ P ++ L C + + R
Sbjct: 220 PEV------MAFIEQGKRMEC---P----------PECPPELY---ALMSDCWIYKWEDR 257
Query: 530 PSMTEVATELEHIRTRTME 548
P V +
Sbjct: 258 PDFLTVEQRMRACYYSLAS 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
LG G +G VYAG+ L N + +AIK I RD+ Q + EI L + H N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT---VAMETAQ---AIAHLHSAINP 382
E G + E +P G+L L+ + G P++ + T Q + +LH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 383 PIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ--YHQNF 439
I HRDIK N+L++ Y+ K++DFG S+ + I+ + GT Y+ P+
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470
+D++S G ++E+ T +PP
Sbjct: 201 GYGKAADIWSLGCTIIEMATG-------KPP 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQND---LLVAIKRIKHRDTDG-IQQVVNEI 309
Y ++ I F + +G G FG V +++ D + AIKR+K + + E+
Sbjct: 19 YPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 76
Query: 310 KLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER--------------G 354
+++ + HPN++ LLG RG L E+ P+G L L++ R
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414
LS L A + A+ + +L S HRD+ + NIL+ N+ +K+ADFGLSR
Sbjct: 137 STLSSQQLLHFAADVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQE 193
Query: 415 TEISHIS-------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ A + Y + SDV+S+GV+L EI++
Sbjct: 194 VYVKKTMGRLPVRWMAIE---SLNYSVY------TTNSDVWSYGVLLWEIVS 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 74/350 (21%), Positives = 134/350 (38%), Gaps = 85/350 (24%)
Query: 268 QRLGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLV 321
+ LG+GAFGTVY G + + VAIK ++ + +++++E +++ V +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA-- 379
RLLG + Q+ + + MP G L ++ RE D + L ++ A+ + +L
Sbjct: 81 RLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQGTPG 429
+ HRD+ + N+L+ K+ DFGL++L E A +
Sbjct: 139 V-----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-- 191
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEVNLAALAADRI 483
H+ + + +SDV+S+GV + E++T F P +E+ + +
Sbjct: 192 -----LHRIY--THQSDVWSYGVTVWELMT------FGSKPYDGIPASEI------SSIL 232
Query: 484 SKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
KG RL + P V+ + +C D RP E+ E +
Sbjct: 233 EKGERLPQ---P----------PICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKM 276
Query: 543 RTRTMEDINCTASLEASLCSSSYNASERMKDNSPPSVQDSWSSEQSSSSP 592
Y + + PS DS
Sbjct: 277 AR----------------DPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 50/254 (19%), Positives = 93/254 (36%), Gaps = 44/254 (17%)
Query: 264 FSEKQRLGTGAFGTVYAG-KLQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVS-HPN 319
F E +++G+G FG+V+ K + + AIKR K + Q + E+ + + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--LSWPIRLTVAMETAQAIAHLH 377
+VR E ++ E+ G+L + + ++ + + ++H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 378 SAINPPIYHRDIKSSNILLDYN-------------------FKSKVADFGLSRLGMTEIS 418
S + H DIK SNI + K+ D G T IS
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----TRIS 185
Query: 419 HISTAPQGTPGYLDPQ-YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477
+G +L + +N+ K+D+++ + +V A P +
Sbjct: 186 SPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------PLPRNGDQWH 238
Query: 478 LAADRISKGRLDEI 491
I +GRL I
Sbjct: 239 ----EIRQGRLPRI 248
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQV-VNEI 309
+E++ I + +G G FG V +G+L+ ++ VAIK +K T+ ++ + E
Sbjct: 40 KELDATNISIDKV--VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 310 KLISCVSHPNLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
++ HPN++RL G + + I V E+M NG+L L++ + + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRG 155
Query: 369 TAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG- 426
A + +L S + Y HRD+ + NIL++ N KV+DFGL R+ + + + +G
Sbjct: 156 IASGMKYL-SDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV-LEDDPEAAYTTRGG 210
Query: 427 ------TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
T P+ + SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 56/244 (22%), Positives = 106/244 (43%), Gaps = 55/244 (22%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDG-IQQVVNE 308
E + + + LG G FG V VA+K +K + ++ +++E
Sbjct: 19 EFPRKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER--------------- 353
++ V+HP++++L G + G +L+ E+ G+L L+ R
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 354 -------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406
L+ ++ A + +Q + +L + + + HRD+ + NIL+ K K++D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISD 193
Query: 407 FGLSRLGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLV 455
FGLSR ++ + + + G + D Y + +SDV+SFGV+L
Sbjct: 194 FGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLW 243
Query: 456 EIIT 459
EI+T
Sbjct: 244 EIVT 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQ-VV 306
+EI + + F E+ LG FG VY G L VAIK +K + +++
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG---------- 356
+E L + + HPN+V LLG + +++ + +G L + L
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 357 ----LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
L P + + + A + +L S+ + + H+D+ + N+L+ K++D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR- 176
Query: 413 GMTEISHISTAPQGTPGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
E+ L P Y + F S SD++S+GVVL E+ +
Sbjct: 177 ---EVYAADYYKLLGNSLL-PIRWMAPEAIMYGK-F--SIDSDIWSYGVVLWEVFS 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 12/194 (6%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRI---KHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG VY A + Q+ ++A+K + + Q+ E+++ S + HPN++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ L+ E+ P GT+ + LQ+ T E A A+++ HS +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVI 131
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRDIK N+LL + K+ADFG S + GT YL P+ + +K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKV 188
Query: 446 DVYSFGVVLVEIIT 459
D++S GV+ E +
Sbjct: 189 DLWSLGVLCYEFLV 202
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDG-IQQVVNE 308
E+ + I LG GAFG VY G++ L VA+K + ++ + E
Sbjct: 26 EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-----LSWPIRL 363
+IS +H N+VR +G S++ + ++ E M G L L+ R L+ L
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSRLGMTEISHI 420
VA + A +L + HRDI + N LL +K+ DFG++R +I
Sbjct: 144 HVARDIACGCQYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRA 196
Query: 421 STAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
S +G L + + + K+D +SFGV+L EI +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIF------TSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 50/239 (20%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL--------QNDLLVAIKRIKHRDTDG-IQQVV 306
E + + + LG GAFG V + + + VA+K +K T+ + +V
Sbjct: 31 EFPRDKLTL--GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88
Query: 307 NEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--------- 356
+E++++ + H N++ LLG + G ++ E+ G L ++L+ R G
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 357 -----LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+++ ++ + A+ + +L ++ HRD+ + N+L+ N K+ADFGL+R
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 412 LGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+I++I + T G L D Y + +SDV+SFGV++ EI T
Sbjct: 206 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVLMWEIFT 254
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRDTDG-IQQVVNE 308
+ F+E +G G FG VY G L + A+K + G + Q + E
Sbjct: 83 VIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQIL-VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
++ SHPN++ LLG + L V +M +G L ++ E + + + +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGL 199
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGT 427
+ A+ + L ++ HRD+ + N +LD F KVADFGL+R M + S T
Sbjct: 200 QVAKGMKFL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVH-NKT 254
Query: 428 PGYLDP---------QYHQNFHLSDKSDVYSFGVVLVEIIT 459
L P Q + F + KSDV+SFGV+L E++T
Sbjct: 255 GAKL-PVKWMALESLQTQK-F--TTKSDVWSFGVLLWELMT 291
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDG-IQQVVNE 308
E + + + LG GAFG V VA+K +K T + +++E
Sbjct: 23 EFPRDRLKL--GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 309 IKLISCV-SHPNLVRLLGCSIERGEQILV-YEFMPNGTLCQHLQRERGDGLSWPIR---- 362
+K++ + H N+V LLG + G ++V EF G L +L+ +R + + + +
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 363 ----------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
+ + + A+ + L ++ HRD+ + NILL K+ DFGL+R
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLAR- 196
Query: 413 GMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+I + L D Y + +SDV+SFGV+L EI +
Sbjct: 197 ---DIYKDPDYVRKGDARLPLKWMAPETIFDRVY------TIQSDVWSFGVLLWEIFS 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 59/255 (23%), Positives = 97/255 (38%), Gaps = 55/255 (21%)
Query: 245 GISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD 298
+ P E + I + +G GAFG V+ + +VA+K +K
Sbjct: 32 PLLLNPKLLSLEYPRNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 89
Query: 299 TDGIQQ-VVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL 357
+ +Q E L++ +PN+V+LLG L++E+M G L + L+ +
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 149
Query: 358 SWPIR----------------------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395
L +A + A +A+L S HRD+ + N L
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCL 206
Query: 396 LDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDK 444
+ N K+ADFGLSR I + +Y + +
Sbjct: 207 VGENMVVKIADFGLSR----NIYSADYYKADGNDAIPIRWMPPESIFYNRY------TTE 256
Query: 445 SDVYSFGVVLVEIIT 459
SDV+++GVVL EI +
Sbjct: 257 SDVWAYGVVLWEIFS 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 46/248 (18%), Positives = 99/248 (39%), Gaps = 45/248 (18%)
Query: 270 LGTGAFGTVYAGKLQNDLLVAIK-----------------RIKHRDTDGIQQVVNEIKLI 312
L G F + + +++ A+K K NE+++I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 313 SCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT------V 365
+ + + + G I +++ ++YE+M N ++ + + ++ + +
Sbjct: 98 TDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
+ +++H+ N I HRD+K SNIL+D N + K++DFG S I + +
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGS-R 211
Query: 426 GTPGYLDP---QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAALAA 480
GT ++ P +++ K D++S G+ L + P +++L L
Sbjct: 212 GTYEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFYN-------VVPFSLKISLVEL-F 262
Query: 481 DRISKGRL 488
+ I +
Sbjct: 263 NNIRTKNI 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 50/246 (20%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTD 300
+P P E+ + + + LG GAFG V + VA+K +K T+
Sbjct: 58 LPEDPRWELPRDRLVL--GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 115
Query: 301 G-IQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLS 358
+ +++E++++ + H N++ LLG + G ++ E+ G L ++LQ R GL
Sbjct: 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 359 WPIR--------------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404
+ ++ A + A+ + +L ++ HRD+ + N+L+ + K+
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKI 232
Query: 405 ADFGLSRLGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVV 453
ADFGL+R +I HI + T G L D Y + +SDV+SFGV+
Sbjct: 233 ADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIY------THQSDVWSFGVL 282
Query: 454 LVEIIT 459
L EI T
Sbjct: 283 LWEIFT 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 41/230 (17%), Positives = 73/230 (31%), Gaps = 24/230 (10%)
Query: 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGK------LQNDLLVAIKRIKHRDTDGIQQ 304
I P E + + LG GAF VY +N +K K +
Sbjct: 54 IKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI 113
Query: 305 VVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER---GDGLSWPI 361
++ + ++ + + +LV E GTL + + + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 362 RLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS-----------KVADFGLS 410
++ AM I +H I H DIK N +L F + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 411 R-LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ + I TA T G+ + N + + D + + ++
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 52/211 (24%), Positives = 79/211 (37%), Gaps = 24/211 (11%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
LG GA V+ G+ + L AIK + + E +++ ++H N+V+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 325 GCSIERGEQILVY---EFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
E EF P G+L L + GL L V + + HL
Sbjct: 74 AI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 381 NPPIYHRDIKSSNILL----DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
I HR+IK NI+ D K+ DFG +R + + + GT YL P +
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSL-YGTEEYLHPDMY 187
Query: 437 QNFHLSD--------KSDVYSFGVVLVEIIT 459
+ L D++S GV T
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 41/239 (17%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTD 300
I +E+ + I LG GAFG VY G++ L VA+K + ++
Sbjct: 58 KTSSISDLKEVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 115
Query: 301 G-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--- 356
+ E +IS +H N+VR +G S++ + ++ E M G L L+ R
Sbjct: 116 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 357 --LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSR 411
L+ L VA + A +L + HRDI + N LL +K+ DFG++R
Sbjct: 176 SSLAMLDLLHVARDIACGCQYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 412 LGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+I +G L + + + K+D +SFGV+L EI +
Sbjct: 233 ----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF------TSKTDTWSFGVLLWEIFS 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 55/273 (20%)
Query: 228 SYYRARK----STKRCLKEARGISNIPIYPYR-------EIEKATIGFSEKQRLGTGAFG 276
Y +K + ++ G S I P + E + + F + LG GAFG
Sbjct: 3 DYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGAFG 60
Query: 277 TVYAGKL------QNDLLVAIKRIKHRDTDGIQQ-VVNEIKLISCV-SHPNLVRLLGCSI 328
V L VA+K +K ++ +++E+K++S + H N+V LLG
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR------------LTVAMETAQAIAHL 376
G +++ E+ G L L+R+ + P L + + AQ +A L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS----------TAPQG 426
++ N HRD+ + N+LL +K+ DFGL+R M + ++I AP+
Sbjct: 181 -ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE- 236
Query: 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
D Y + +SDV+S+G++L EI +
Sbjct: 237 --SIFDCVY------TVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/246 (24%), Positives = 113/246 (45%), Gaps = 50/246 (20%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKL--------QNDLLVAIKRIKHRDTD 300
+P P E + + + LG G FG V + + + VA+K +K T+
Sbjct: 70 LPEDPKWEFPRDKLTL--GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 301 G-IQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG-- 356
+ +V+E++++ + H N++ LLG + G ++ E+ G L ++L+ R G
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 357 ------------LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404
+++ ++ + A+ + +L ++ HRD+ + N+L+ N K+
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKI 244
Query: 405 ADFGLSRLGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVV 453
ADFGL+R +I++I + T G L D Y + +SDV+SFGV+
Sbjct: 245 ADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVY------THQSDVWSFGVL 294
Query: 454 LVEIIT 459
+ EI T
Sbjct: 295 MWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 57/238 (23%), Positives = 107/238 (44%), Gaps = 48/238 (20%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDGIQQ-VVNE 308
E + + F + LG GAFG V + VA+K +K ++ +++E
Sbjct: 19 EFPRNRLSF--GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 309 IKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR----- 362
+K++S + +H N+V LLG G +++ E+ G L L+R+R +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 363 -----------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
L+ + + A+ +A L ++ N HRD+ + NILL + +K+ DFGL+R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 412 LGMTEISHIS----------TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ +++ AP+ + Y + +SDV+S+G+ L E+ +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPE---SIFNCVY------TFESDVWSYGIFLWELFS 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG VY A + QN ++A+K + Q+ EI++ S + HPN++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL------TVAMETAQAIAHLHSA 379
+R L+ EF P G L + LQ+ R T E A A+ + H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHG--------RFDEQRSATFMEELADALHYCHER 133
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ HRDIK N+L+ Y + K+ADFG S + GT YL P+ +
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGK 187
Query: 440 HLSDKSDVYSFGVVLVEIIT 459
+K D++ GV+ E +
Sbjct: 188 THDEKVDLWCAGVLCYEFLV 207
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 52/211 (24%), Positives = 79/211 (37%), Gaps = 24/211 (11%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
LG GA V+ G+ + L AIK + + E +++ ++H N+V+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 325 GCSIERGEQILVY---EFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
E EF P G+L L + GL L V + + HL
Sbjct: 74 AI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 381 NPPIYHRDIKSSNILL----DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
I HR+IK NI+ D K+ DFG +R + + + GT YL P +
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSL-YGTEEYLHPDMY 187
Query: 437 QNFHLSD--------KSDVYSFGVVLVEIIT 459
+ L D++S GV T
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 59/245 (24%), Positives = 97/245 (39%), Gaps = 24/245 (9%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
K+RLGTG FG V VAIK+ + ++ EI+++ ++HPN+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 325 ------GCSIERGEQILVYEFMPNGTLCQHL-QRERGDGLSWPIRLTVAMETAQAIAHLH 377
+L E+ G L ++L Q E GL T+ + + A+ +LH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 378 SAINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
I HRD+K NI+L + K+ D G ++ + + + GT YL P+
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEF-VGTLQYLAPE 193
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494
+ + D +SFG + E IT P N + + + +E I
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG-------FRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 495 LIIEH 499
Sbjct: 247 YDDLT 251
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 72/303 (23%)
Query: 268 QRLGTGAFGTVYAGKLQNDLL----VAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNL 320
+LG G TVY + D + VAIK I + +++ E+ S +SH N+
Sbjct: 17 DKLGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V ++ E LV E++ TL +++ G LS + + I H H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP-LSVDTAINFTNQILDGIKHAHDM- 130
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL----GMTEISHISTAPQGTPGYLDPQYH 436
I HRDIK NIL+D N K+ DFG+++ +T+ +H+ GT Y P+
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV----LGTVQYFSPEQA 184
Query: 437 QNFHLSDKSDVYSFGVVLVEIIT-------------ALKVV--DFSRPPNEVNLAALAAD 481
+ + +D+YS G+VL E++ A+K + +V
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR------K 238
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELE 540
I + L +I R + R ++ E+ +L
Sbjct: 239 DIPQS-LSNVI--------------------------LRATEKDKANRYKTIQEMKDDLS 271
Query: 541 HIR 543
+
Sbjct: 272 SVL 274
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 55/244 (22%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGIQQ-VVNE 308
E + + F + LG+GAFG V + VA+K +K + ++ +++E
Sbjct: 41 EFPRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 309 IKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIR----- 362
+K+++ + SH N+V LLG G L++E+ G L +L+ +R I
Sbjct: 99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 363 ----------------LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406
L A + A+ + L + HRD+ + N+L+ + K+ D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICD 215
Query: 407 FGLSRLGMTEISHISTAPQGTPGYL-----------DPQYHQNFHLSDKSDVYSFGVVLV 455
FGL+R +I S L + Y + KSDV+S+G++L
Sbjct: 216 FGLAR----DIMSDSNYVVRGNARLPVKWMAPESLFEGIY------TIKSDVWSYGILLW 265
Query: 456 EIIT 459
EI +
Sbjct: 266 EIFS 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLV 321
+ ++ +G+GA V A VAIKRI + + +++ EI+ +S HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL------TVAMETAQAIAH 375
+ + E LV + + G++ ++ G L T+ E + + +
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-----GTPGY 430
LH N I HRD+K+ NILL + ++ADFG+S + I+ GTP +
Sbjct: 137 LHK--NGQI-HRDVKAGNILLGEDGSVQIADFGVSAF-LATGGDITRNKVRKTFVGTPCW 192
Query: 431 LDPQYHQNFHLSD-KSDVYSFGVVLVEIIT 459
+ P+ + D K+D++SFG+ +E+ T
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELAT 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 75/314 (23%), Positives = 128/314 (40%), Gaps = 55/314 (17%)
Query: 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGIQQ 304
+P EI++ I +G G FG V+ G + + VAIK K+ +D +++
Sbjct: 379 MPSTRDYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 305 V-VNEIKLISCVSHPNLVRLLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPI 361
+ E + HP++V+L+G + + ++ E G L L + R L
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFL-QVRKFSLDLAS 492
Query: 362 RLTVAMETAQAIAHLHSAINPPIY-HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+ A + + A+A+L + + HRDI + N+L+ N K+ DFGLSR M + ++
Sbjct: 493 LILYAYQLSTALAYL-ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYY 547
Query: 421 STAPQGTP-GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP------NEV 473
+ P ++ P+ + SDV+ FGV + EI+ P N+V
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNNDV 601
Query: 474 NLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532
RI G RL P +++ L +C A+ RP
Sbjct: 602 ------IGRIENGERLPM---P----------PNCPPTLY---SLMTKCWAYDPSRRPRF 639
Query: 533 TEVATELEHIRTRT 546
TE+ +L I
Sbjct: 640 TELKAQLSTILEEE 653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 267 KQRLGTGAFGTVYAGKLQND---LLVAIKRIKHRDTDGIQQV-VNEIKLISCVSHPNLVR 322
LG G FG+V G + + VAIK +K + + E +++ + +P +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 323 LLG-CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
L+G C E + LV E G L + L + + + + + + + +L
Sbjct: 401 LIGVCQ---AEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL-EEK 455
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS-----------TAPQGTPG 429
N HR++ + N+LL +K++DFGLS+ + S+ + AP+
Sbjct: 456 N--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 511
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ F S +SDV+S+GV + E ++
Sbjct: 512 -----NFRKF--SSRSDVWSYGVTMWEALS 534
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 46/288 (15%), Positives = 97/288 (33%), Gaps = 60/288 (20%)
Query: 269 RLGTGAFGTVYAGKLQNDLL-----VAIKRIKH-RDTDGIQQVVNEIKLISCVSHPNLVR 322
+ G G +Y D V +K + H D + + E + ++ V HP++V+
Sbjct: 87 CIAHGGLGWIYLAL---DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 323 LL--GCSIERGEQILVY---EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
+ +R + Y E++ +L + ++ L + +E A+++LH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH 199
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-QYH 436
S + + D+K NI+L + K+ D G + ++ GTPG+ P
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPEIVR 250
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
+ +D+Y+ G L + P + + + L+
Sbjct: 251 T--GPTVATDIYTVGRTLAALTLD-------LPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIR 543
R + R + E++ +L +
Sbjct: 302 R----------------------RAIDPDPRQRFTTAEEMSAQLTGVL 327
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++ +++G GA GTVY + VAI+++ + + ++NEI ++ +PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + E +V E++ G+L + + V E QA+ LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQYHQNF 439
+ HRDIKS NILL + K+ DFG +I+ + GTP ++ P+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 440 HLSDKSDVYSFGVVLVEII 458
K D++S G++ +E+I
Sbjct: 192 AYGPKVDIWSLGIMAIEMI 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 21/195 (10%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G+F VY + + L VAIK + +Q+V NE+K+ + HP+++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
E + LV E NG + ++L+ R S + + +LHS I
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GI 133
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-----QYHQNF 439
HRD+ SN+LL N K+ADFGL+ T GTP Y+ P H
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAH--- 189
Query: 440 HLSDKSDVYSFGVVL 454
+SDV+S G +
Sbjct: 190 --GLESDVWSLGCMF 202
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 40/200 (20%), Positives = 76/200 (38%), Gaps = 14/200 (7%)
Query: 271 GTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
G TV + V ++RI + + + E+ + +HPN+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387
I E +V FM G+ + DG++ + +A+ ++H + HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYV-HR 152
Query: 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ------GTPGYLDPQ-YHQNFH 440
+K+S+IL+ + K ++ + ++ +L P+ QN
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 441 LSD-KSDVYSFGVVLVEIIT 459
D KSD+YS G+ E+
Sbjct: 213 GYDAKSDIYSVGITACELAN 232
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++G G+ G V + + VA+K + R + + NE+ ++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
+ + E ++ EF+ G L + + R L+ TV QA+A+LH+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHA---Q 160
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-----GTPGYLDPQYHQ 437
+ HRDIKS +ILL + + K++DFG +IS P+ GTP ++ P+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISK--DVPKRKSLVGTPYWMAPEVIS 214
Query: 438 NFHLSDKSDVYSFGVVLVEII 458
+ + D++S G++++E++
Sbjct: 215 RSLYATEVDIWSLGIMVIEMV 235
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 44/223 (19%), Positives = 87/223 (39%), Gaps = 25/223 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ + R+G G+FG V+ K Q A+K+++ V E+ + +S P +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L G E + E + G+L Q +++ L L + + + +LH+
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 383 PIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEISHISTAP----QGTPGYLDPQYHQ 437
I H D+K+ N+LL + ++ + DFG + + S GT ++ P+
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 438 NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAAL 478
K D++S +++ ++ P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLN-------GCHPWTQYFRGPLC 265
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ LG GAFG VY K + L A K I+ + + ++ + EI++++ HP +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
LLG G+ ++ EF P G + E GL+ P V + +A+ LHS
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGA-VDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDP-----Q 434
I HRD+K+ N+L+ ++ADFG+S + GTP ++ P +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 435 YHQNFHLSDKSDVYSFGVVLVEII 458
++ K+D++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMA 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLV 321
F + LG G G V+ + L++A K I Q++ E++++ + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
G GE + E M G+L Q L++ + I V++ + + +L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I HRD+K SNIL++ + K+ DFG+S G S ++ GT Y+ P+ Q H
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF-VGTRSYMSPERLQGTHY 207
Query: 442 SDKSDVYSFGVVLVEIIT 459
S +SD++S G+ LVE+
Sbjct: 208 SVQSDIWSMGLSLVEMAV 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH-RDTDGIQQVVNEIK-LISCVSHPNL 320
+G+G G V+ + + ++A+K+++ + + ++++ ++ ++ P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+ G I + + E M GT + L++ + I + + +A+ +L
Sbjct: 87 VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY-----LDPQY 435
+ HRD+K SNILLD + K+ DFG+S G G Y +DP
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 436 HQNFHLSDKSDVYSFGVVLVEIIT 459
++DV+S G+ LVE+ T
Sbjct: 201 PTKPDYDIRADVWSLGISLVELAT 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 65/354 (18%), Positives = 121/354 (34%), Gaps = 54/354 (15%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNL--VRL 323
+++G+G V+ + + AIK + + D + NEI ++ + + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
I +V E N L L++++ + R + +A+ +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQ-------- 434
I H D+K +N L+ + K+ DFG++ + S + + GT Y+ P+
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 435 ---YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP---NEVNLAALAADRISKGRL 488
+S KSDV+S G +L + + P ++ L A I
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTY-------GKTPFQQIINQISKLHA--IIDPN- 237
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH--IRTRT 546
EI P I E + ++ CL R S+ E+ L H ++ +T
Sbjct: 238 HEIEFPDIPE-------------KDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQIQT 281
Query: 547 MEDINCTASLEASLCSSSYNASERMKDNSPPSVQDSWSSEQSSSSPLSNSLLSN 600
+ NS + S ++S
Sbjct: 282 HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKT 335
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 44/206 (21%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 270 LGTGAFGTVYAGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNL--VRLLG 325
+G+G V+ + + AIK + + D + NEI ++ + + +RL
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
I +V E N L L++++ + R + +A+ +H I
Sbjct: 96 YEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIV 149
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQ---------- 434
H D+K +N L+ + K+ DFG++ + S + + GT Y+ P+
Sbjct: 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 435 -YHQNFHLSDKSDVYSFGVVLVEIIT 459
+S KSDV+S G +L +
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTY 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 60/244 (24%), Positives = 95/244 (38%), Gaps = 42/244 (17%)
Query: 246 ISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQV 305
I+NIP + + ++ ++ LG G+ GTV VA+KR+ D
Sbjct: 3 IANIPNFE-QSLKNL---VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL-- 56
Query: 306 VNEIK-LISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQR-----ERGDGLS 358
EIK L HPN++R CS + + E N L ++ E
Sbjct: 57 -MEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113
Query: 359 WPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-------------YNFKSKVA 405
+++ + A +AHLHS + I HRD+K NIL+ N + ++
Sbjct: 114 EYNPISLLRQIASGVAHLHS-LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 406 DFGLSRL---GMTEISHISTAPQGTPGYLDP-------QYHQNFHLSDKSDVYSFGVVLV 455
DFGL + G + P GT G+ P L+ D++S G V
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 456 EIIT 459
I++
Sbjct: 231 YILS 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 53/199 (26%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIKLISCVSHPNLV 321
F++ +++G G+FG V+ G + +VAIK I D I+ + EI ++S P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+ G ++ + ++ E++ G+ L L T+ E + + +LHS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP--LDETQIATILREILKGLDYLHSE-- 138
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLS-RLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
HRDIK++N+LL + + K+ADFG++ +L T+I + GTP ++ P+ +
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSA 195
Query: 441 LSDKSDVYSFGVVLVEIIT 459
K+D++S G+ +E+
Sbjct: 196 YDSKADIWSLGITAIELAR 214
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 43/214 (20%), Positives = 82/214 (38%), Gaps = 25/214 (11%)
Query: 253 PYREIEKATIGFSEKQR-LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVN 307
P ++ + + R LG G F + + A K + +++
Sbjct: 5 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM 64
Query: 308 EIKLISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
EI + ++H ++V G E + + +V E +L + +R + LT
Sbjct: 65 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK--------ALTEP 115
Query: 367 ------METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+ +LH + HRD+K N+ L+ + + K+ DFGL+ +
Sbjct: 116 EARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172
Query: 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVL 454
GTP Y+ P+ S + DV+S G ++
Sbjct: 173 KVLC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIK-LISCVSHPNL 320
+ +G GA+G+V + ++A+KRI+ D +Q++ ++ ++ P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 321 VRLLGCSIERGEQILVYEFMPNG--TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
V+ G G+ + E M +++ D + I + + T +A+ HL
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----Q 434
+ I HRDIK SNILLD + K+ DFG+S + I+ A G Y+ P
Sbjct: 144 NLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDP 199
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIIT 459
+SDV+S G+ L E+ T
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELAT 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 49/201 (24%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
LG GA+G V + + + ++A+KRI+ ++ ++++ ++ + V P V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
G G+ + E M + +L + ++ ++G + I +A+ +A+ HLHS ++
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----QYHQN 438
+ HRD+K SN+L++ + K+ DFG+S + +++ A G Y+ P
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPELNQ 187
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
S KSD++S G+ ++E+
Sbjct: 188 KGYSVKSDIWSLGITMIELAI 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 35/219 (15%)
Query: 253 PYREIEKATIGFSEKQR-LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVN 307
P ++ + + R LG G F + + A K + +++
Sbjct: 31 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM 90
Query: 308 EIKLISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVA 366
EI + ++H ++V G E + + +V E +L + +R + LT
Sbjct: 91 EISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK--------ALTEP 141
Query: 367 ------METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+ +LH + HRD+K N+ L+ + + K+ DFGL+ +
Sbjct: 142 EARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 421 STAPQGTPGYLDP-----QYHQNFHLSDKSDVYSFGVVL 454
GTP Y+ P + H S + DV+S G ++
Sbjct: 199 KVLC-GTPNYIAPEVLSKKGH-----SFEVDVWSIGCIM 231
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 31/311 (9%), Positives = 69/311 (22%), Gaps = 64/311 (20%)
Query: 269 RLGTGAFGTVY-AGKLQNDLLVAIKRI---KHRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
L G V+ ++ A+K ++++ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 325 GC--------------------------SIERGEQILVYEFM-----PNGTLCQHLQRER 353
+L+ + + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 354 GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413
GD + + + A+L S + H N+ + + + + D
Sbjct: 189 GD-EGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 414 MTEISHISTAPQGTPGYLDPQY--HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
++ A Y ++ + + + G+ + + P
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-------FLPF 293
Query: 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGH-SDAGTLASVHKVAELAFRCLAFHRDMRP 530
+ + D L D V L R L F R R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF--------VKTLIGRFLNFDRRRRL 345
Query: 531 SMTEVATELEH 541
E +E
Sbjct: 346 LPLEA---MET 353
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 51/296 (17%)
Query: 268 QRLGTGAFGTVYAGKLQNDLL----VAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNL 320
+ LG G V+ + DL VA+K ++ RD + E + + ++HP +
Sbjct: 18 EILGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 321 VRLL--GCSIERGEQI--LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
V + G + + +V E++ TL + E ++ + V + QA+
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFS 132
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDP 433
H I HRD+K +NI++ KV DFG++R + + + T GT YL P
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYLSP 188
Query: 434 QYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP----NEVNLAALAADRISKGRLD 489
+ + + +SDVYS G VL E++T PP + V++ A +
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTG-------EPPFTGDSPVSV-AYQ-------HVR 233
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIRT 544
E P H G S + + + LA + + R + E+ +L +
Sbjct: 234 EDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 23/208 (11%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNL--VRL 323
+++G+G V+ + + AIK + + D + NEI ++ + + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
I +V E N L L++++ + R + +A+ +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-GTPGYLDPQ-------- 434
I H D+K +N L+ + K+ DFG++ + + + Q G Y+ P+
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 435 ---YHQNFHLSDKSDVYSFGVVLVEIIT 459
+S KSDV+S G +L +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTY 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 54/212 (25%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
F ++LG G++G+VY + +VAIK++ +Q+++ EI ++ P++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
G + + +V E+ G+ + R R L+ T+ T + + +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGS-VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM--- 144
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQYHQNF 439
HRDIK+ NILL+ +K+ADFG++ +++ GTP ++ P+ Q
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
+ +D++S G ITA+++ + +PP
Sbjct: 201 GYNCVADIWSLG------ITAIEMAE-GKPPY 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
FS+ + +G G+FG VY + ++N +VAIK++ + + Q ++ E++ + + HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++ GC + LV E+ L L V Q +A+LHS
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP---QYH 436
+ HRD+K+ NILL K+ DFG + + ++ ++ GTP ++ P
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSF-VGTPYWMAPEVILAM 225
Query: 437 QNFHLSDKSDVYSFGVVLVEIIT 459
K DV+S G+ +E+
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAE 248
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLIS-CVSHPNLV 321
F + +G G +G VY G+ ++ L AIK + D +++ EI ++ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 322 RLLGCSIERGEQI------LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAH 375
G I++ LV EF G++ ++ +G+ L + E + ++H
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 376 LHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY 435
LH + HRDIK N+LL N + K+ DFG+S + +T GTP ++ P+
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEV 200
Query: 436 HQNFHLSD-----KSDVYSFGVVLVEIIT 459
D KSD++S G+ +E+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAE 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 53/291 (18%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 268 QRLGTGAFGTVYAGKLQNDLL----VAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNL 320
+ +G G G VY + D + VA+K + D ++ E + + P++
Sbjct: 40 RLVGRGGMGDVYEAE---DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V + G+ + + L L R +G L+ P + + + A+ H+A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQG-PLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQYHQNF 439
HRD+K NIL+ + + + DFG++ +++ + GT Y+ P+
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSES 210
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
H + ++D+Y+ VL E +T PP + + ++ +++ I
Sbjct: 211 HATYRADIYALTCVLYECLTG-------SPPYQGDQLSVMG-----AHINQAIPRPSTVR 258
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMR-PSMTEVATELEHIRTRTMED 549
G A + R +A + + R + +++ +D
Sbjct: 259 PGIPVA--------FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 264 FSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
S+ + LG G FG V+ + L +A K IK R ++V NEI +++ + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
L + + +LV E++ G L R + L+ + + + I H+H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 381 NPPIYHRDIKSSNILLDYNFKS--KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
I H D+K NIL K+ DFGL+R + GTP +L P+
Sbjct: 208 ---ILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVN-FGTPEFLAPEVVNY 262
Query: 439 FHLSDKSDVYSFGVVL 454
+S +D++S GV+
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLL 324
++G G++G V+ + +VAIK+ D I + + EI+++ + HPNLV LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ LV+E+ + T+ L R G+ + ++ +T QA+ H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKH---NC 123
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K NIL+ + K+ DFG +R
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 45/151 (29%), Positives = 81/151 (53%), Gaps = 7/151 (4%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNL 320
F + +++G G +G VY + +VA+K+I+ +T+G+ + EI L+ ++HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LL + LV+EF+ L + + G+ P+ + + Q +A HS
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ HRD+K N+L++ K+ADFGL+R
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 8/149 (5%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLVRLLG 325
++LG G + TVY G + VA+K +K +G + EI L+ + H N+VRL
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 326 CSIERGEQILVYEFMPN---GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
+ LV+EFM N + GL + + Q +A H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I HRD+K N+L++ + K+ DFGL+R
Sbjct: 129 -ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G+F TV A +L AIK ++ R + + V E ++S + HP V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHSA 379
+ + + NG L +++++ E A+ +LH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIG--------SFDETCTRFYTAEIVSALEYLHG- 148
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ-GTPGYLDPQYHQN 438
I HRD+K NILL+ + ++ DFG +++ E GT Y+ P+
Sbjct: 149 KG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL--- 203
Query: 439 FHLSDK-----SDVYSFGVVLVEIIT 459
L++K SD+++ G ++ +++
Sbjct: 204 --LTEKSACKSSDLWALGCIIYQLVA 227
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGIQQV----VNEIKL---ISC 314
+ +G GA+GTVY + + VA+K ++ G + V E+ L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 315 VSHPNLVRLL----GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
HPN+VRL+ +R ++ LV+E + L +L + GL + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ + LH+ I HRD+K NIL+ K+ADFGL+R
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 52/233 (22%)
Query: 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRI------KHRDTDGIQQVV 306
+ E+ I ++ + +G G+FG V+ KL VAIK++ K+R
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--------- 81
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQI------LVYEFMPNGTLCQHLQRERGDGLSWP 360
E++++ V HPN+V L G++ LV E++P T+ + + + P
Sbjct: 82 -ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139
Query: 361 IRLTVAMETAQ---AIAHLHSAINPPIYHRDIKSSNILLDYNFKS-KVADFGLSRL---G 413
+ L + + Q ++A++HS I HRDIK N+LLD K+ DFG +++ G
Sbjct: 140 M-LLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 414 MTEISHIST----APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+S+I + AP+ G Y + D++S G V+ E++
Sbjct: 196 EPNVSYICSRYYRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQ 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 2e-22
Identities = 24/231 (10%), Positives = 56/231 (24%), Gaps = 43/231 (18%)
Query: 269 RLGTGAFGTVY-AGKLQNDLLVAIKRI-------------------------KHRDTDGI 302
LG A + + ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM----PNGTLCQHLQRERGDG-- 356
+ + I V P +++ ++ + ++ F L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 357 ---LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413
L RL + ++ + +A LH + H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 414 MTEISHISTAPQGTPGYLDP-----QYHQNFHLSDKSDVYSFGVVLVEIIT 459
P H ++ D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 56/277 (20%), Positives = 100/277 (36%), Gaps = 31/277 (11%)
Query: 233 RKSTKRCLKEARGISNIPIYPYREIEKATIGFSEK----QRLGTGAFGTVY-AGKLQNDL 287
K T + Y + +E + + LGTGAFG V+ +
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 288 LVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347
A K + + V EI+ +S + HP LV L + E +++YEFM G L +
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 348 HLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS--KVA 405
+ E +S + + + + H+H H D+K NI+ + K+
Sbjct: 244 KVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLI 299
Query: 406 DFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVL----------- 454
DFGL+ + + GT + P+ + + +D++S GV+
Sbjct: 300 DFGLTAH-LDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357
Query: 455 ----VEIITALK--VVDFSRPPNEVNLAALAADRISK 485
E + +K + ++ D I K
Sbjct: 358 GENDDETLRNVKSCDWNMDDSAFS-GISEDGKDFIRK 393
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 13/193 (6%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+ LG+GAFG V+ + + K I V NEI +++ + HP L+ L
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
++ E +L+ EF+ G L R +S + + + + H+H
Sbjct: 116 AFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---S 169
Query: 384 IYHRDIKSSNILLDYNFKS--KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I H DIK NI+ + S K+ DFGL+ + + T + P+ +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVT-TATAEFAAPEIVDREPV 227
Query: 442 SDKSDVYSFGVVL 454
+D+++ GV+
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLL 324
+G G++G V + +VAIK+ D + + + EIKL+ + H NLV LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
++ LV+EF+ + T+ L+ +GL + + + I HS I
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSH---NI 145
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSR 411
HRDIK NIL+ + K+ DFG +R
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLLG 325
+++G G +G VY K +VA+KRI+ + +GI + EI L+ + HPN+V L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
LV+EFM L + L E GL + + +AH H I
Sbjct: 87 VIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ + K+ADFGL+R
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 243 ARGISNIPIYPYREIEKATIGFSEK----QRLGTGAFGTVYAGK-LQNDLLVAIKRI--- 294
+ ++ P ++ +T FS++ + LG G+FG V K A+K I
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 295 KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG 354
+ + + ++ E++L+ + HPN+++L ++G LV E G L + R
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRK 121
Query: 355 DGLSWPIRLT------VAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVA 405
R + + + I ++H I HRD+K N+LL + ++
Sbjct: 122 -------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171
Query: 406 DFGLSRLGMTEISHISTAPQGTPGYLDPQ-YHQNFHLSDKSDVYSFGVVL 454
DFGLS E S GT Y+ P+ H + +K DV+S GV+L
Sbjct: 172 DFGLST--HFEASKKMKDKIGTAYYIAPEVLHGTY--DEKCDVWSTGVIL 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLLG 325
+++G G +G VY + A+K+I+ ++ +GI + EI ++ + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ +LV+E + L + L G S + + IA+ H +
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQ-LLNGIAYCHDR---RVL 122
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ + K+ADFGL+R
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLL 324
+++G G +GTV+ K + +VA+KR++ D +G+ + EI L+ + H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ LV+EF L ++ L I + + + + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSR 411
HRD+K N+L++ N + K+A+FGL+R
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 47/202 (23%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIK----HRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
LG G++G V + A+K +K R +G V EI+L+ + H N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 325 G-CSIERGEQI-LVYEFMPNGT--LCQHLQRERGDGLSWPIRLTVAMETAQ----AIAHL 376
E +++ +V E+ G + + +R + A + +L
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------FPVCQAHGYFCQLIDGLEYL 125
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDPQ 434
HS I H+DIK N+LL K++ G++ T+ QG+P + P+
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPE 181
Query: 435 YHQNFHLSD--KSDVYSFGVVL 454
K D++S GV L
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTL 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V + A+K +K D + + E +++ HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV--AMETAQAIAHLHSAINPP 383
V E+ G L HL RER + E A+ +LHS N
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN-- 269
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ-YHQNFHLS 442
+ +RD+K N++LD + K+ DFGL + G+ + + + T GTP YL P+ N +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDY-- 326
Query: 443 DKS-DVYSFGVVLVEIIT 459
++ D + GVV+ E++
Sbjct: 327 GRAVDWWGLGVVMYEMMC 344
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 57/204 (27%), Positives = 83/204 (40%), Gaps = 36/204 (17%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+ LG+GAF V+ + L A+K IK + NEI ++ + H N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAMETAQAIAHLH 377
LV + + G L R ERG T V + A+ +LH
Sbjct: 74 IYESTTHYYLVMQLVSGGEL---FDRILERG-------VYTEKDASLVIQQVLSAVKYLH 123
Query: 378 SAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLG----MTEISHISTAPQGTPGY 430
I HRD+K N+L + N K + DFGLS++ M+ GTPGY
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-------GTPGY 173
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVL 454
+ P+ S D +S GV+
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRL 323
++LG+GA+G V + + AIK I+ T +++ E+ ++ + HPN+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLH 377
++ LV E G L + R + + + + +LH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEII-HRM-------KFNEVDAAVIIKQVLSGVTYLH 153
Query: 378 SAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
I HRD+K N+LL + + K+ DFGLS + E GT Y+ P+
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA--VFENQKKMKERLGTAYYIAPE 208
Query: 435 -YHQNFHLSDKSDVYSFGVVL 454
+ + +K DV+S GV+L
Sbjct: 209 VLRKKY--DEKCDVWSIGVIL 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLV 321
+ + +LG G + TVY GK D LVA+K I+ +G + E+ L+ + H N+V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
L LV+E++ L Q+L + G+ ++ + + +A+ H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ HRD+K N+L++ + K+ADFGL+R
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 37/203 (18%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
LG GA+G V + VA+K + R D + + EI + ++H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ--------AIAHLHSA 379
E Q L E+ G L ++ + AQ + +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDI-------GMP--EPDAQRFFHQLMAGVVYLHGI 124
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDP---- 433
I HRDIK N+LLD K++DFGL+ + ++ GT Y+ P
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 434 --QYHQNFHLSDKSDVYSFGVVL 454
++H ++ DV+S G+VL
Sbjct: 181 RREFH-----AEPVDVWSCGIVL 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 51/225 (22%)
Query: 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRI------KHRDTDGIQQVVNEIKLIS 313
+ +++ + +G G+FG VY KL + LVAIK++ K+R E++++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----------ELQIMR 102
Query: 314 CVSHPNLVRLLGCSIERGEQI------LVYEFMPNGTLCQHLQRERGDGLSWPIRLT--V 365
+ H N+VRL GE+ LV +++P T+ + + + P+
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 161
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS-KVADFGLSRL---GMTEISHIS 421
+ +++A++HS I HRDIK N+LLD + K+ DFG ++ G +S+I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 422 T----APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ AP+ G Y + DV+S G VL E++
Sbjct: 219 SRYYRAPELIFGATDY-----------TSSIDVWSAGCVLAELLL 252
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 14/152 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKLISCVSHPNLVRLL 324
+LG G +G VY + VAIKRI+ + +G+ + E+ L+ + H N++ L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
L++E+ N L +++ ++ +S + + + + HS
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRC 153
Query: 385 YHRDIKSSNILLDYNFKS-----KVADFGLSR 411
HRD+K N+LL + S K+ DFGL+R
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 35/364 (9%), Positives = 93/364 (25%), Gaps = 88/364 (24%)
Query: 226 RRSYYRARKSTKRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGK-LQ 284
R + + + + + + P E+ + LG +
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQE 96
Query: 285 NDLLVAIK------RIKHRDTDGIQQVVNEIKLISCVS---------------------- 316
+ R +++ V ++L+ +
Sbjct: 97 TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156
Query: 317 HPNLVRLLGCSIERGEQILVYEFM-PNGTLCQHLQ-----RERGDGLSWPIRLTVAMETA 370
++R+ + + + L + L RL + ++
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
+ +A LH + H ++ +I+LD + F + G+
Sbjct: 217 RLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGF 268
Query: 431 LDPQY-----------HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479
P+ + ++ D ++ G+V+ I A P + A
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-------DLPITKDAALGG 321
Query: 480 ADRISKGRLD--EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537
++ I + + + + L+ L + ++ R +
Sbjct: 322 SEWIFRSCKNIPQPVRALLE----------------------GFLRYPKEDRLLPLQA-- 357
Query: 538 ELEH 541
+E
Sbjct: 358 -MET 360
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGK--LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKL---ISCVS 316
+ +G GA+G V+ + VA+KR++ +G+ + E+ + +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 317 HPNLVRLL----GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
HPN+VRL +R ++ LV+E + L +L + G+ + + +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ LHS + HRD+K NIL+ + + K+ADFGL+R
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 36/202 (17%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V G+ VA+K R K R D + ++ EI+ + HP++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETAQ----AIAHLHS 378
I +V E++ G L ++ + G R+ A Q A+ + H
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYIC-KHG-------RVEEMEARRLFQQILSAVDYCHR 129
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
+ HRD+K N+LLD + +K+ADFGLS + M++ + T+ G+P Y P
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISG 184
Query: 434 -QYHQNFHLSDKSDVYSFGVVL 454
Y + D++S GV+L
Sbjct: 185 RLYA-----GPEVDIWSCGVIL 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 48/200 (24%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+G G+FG V K + A+K + + + + ++ V E++++ + HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWP---IRLTVAMETAQAIAHLHSAINP 382
+ + +V + + G L HLQ+ + ++L + E A+ +L +
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVKLFIC-ELVMALDYLQNQ--- 134
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ--YHQNFH 440
I HRD+K NILLD + + DF ++ + E + A GT Y+ P+ +
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGA 192
Query: 441 LSDKS-DVYSFGVVLVEIIT 459
+ D +S GV E++
Sbjct: 193 GYSFAVDWWSLGVTAYELLR 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-21
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 39/211 (18%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIK--------HRDTDGIQQVVNEIKLISCVSH 317
+ LG+GA G V A + + VAI+ I R+ D V EI+++ ++H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAMET 369
P ++++ + + +V E M G L + RL +
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEGGEL---FDKVVGNK-------RLKEATCKLYFYQM 248
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQG 426
A+ +LH I HRD+K N+LL + + K+ DFG S++ + E S + T G
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTL-CG 303
Query: 427 TPGYLDP---QYHQNFHLSDKSDVYSFGVVL 454
TP YL P + D +S GV+L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-21
Identities = 50/205 (24%), Positives = 75/205 (36%), Gaps = 25/205 (12%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
+G GAFG V D + A+K + + E ++ + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAIAHLHSA 379
+ LV ++ G L L + RL M E AI +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFED-------RLPEEMARFYLAEMVIAIDSVHQL 194
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
HRDIK NIL+D N ++ADFG M + + S+ GTP Y+ P+ Q
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 440 HLSDKS-----DVYSFGVVLVEIIT 459
D +S GV + E++
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 233 RKSTKRCLKEARGISNIPIYPYREIEKATIG-FSEKQRLGTGAFGTVY-AGKLQNDLLVA 290
++S K L +A+ + + A + F + LGTG+FG V ++ A
Sbjct: 12 QESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 291 IKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQ 347
+K + + I+ +NE +++ V+ P LV+L + +V E++ G +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 348 HLQRERGDGLSWPIRLTV------AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401
HL+R R + A + +LHS + +RD+K N+L+D
Sbjct: 131 HLRRIG--------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKS-DVYSFGVVLVEIIT 459
+V DFG ++ + + GTP L P+ + + +K+ D ++ GV++ E+
Sbjct: 180 IQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAA 233
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 28/197 (14%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
+G G++G V + A K+I + + + EI+++ + HPN++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 329 ERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAMETAQAIAHLHSAI 380
+ + LV E G L +R + + + A+A+ H
Sbjct: 77 DNTDIYLVMELCTGGEL---FERVVHKR-------VFRESDAARIMKDVLSAVAYCHKL- 125
Query: 381 NPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
+ HRD+K N L + K+ DFGL+ + T GTP Y+ PQ +
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTK-VGTPYYVSPQVLE 181
Query: 438 NFHLSDKSDVYSFGVVL 454
+ + D +S GV++
Sbjct: 182 GLY-GPECDEWSAGVMM 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 44/190 (23%), Positives = 83/190 (43%), Gaps = 14/190 (7%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328
LG G FG V+ + + K +K + TD V EI +++ H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 329 ERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
E ++++EF+ + +R L+ ++ + +A+ LHS I H
Sbjct: 72 SMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 387 RDIKSSNILL--DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
DI+ NI+ + K+ +FG +R + + P Y P+ HQ+ +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLL-FTAPEYYAPEVHQHDVVSTA 183
Query: 445 SDVYSFGVVL 454
+D++S G ++
Sbjct: 184 TDMWSLGTLV 193
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 48/202 (23%), Positives = 74/202 (36%), Gaps = 17/202 (8%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLG 325
+G GAF V Q + A+K + D + E ++ + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ + + LV E+ G L L + G+ + + E AI +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GY 183
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
HRDIK NILLD ++ADFG + + S GTP YL P+ Q
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 445 SDVY-------SFGVVLVEIIT 459
+ Y + GV E+
Sbjct: 244 TGSYGPECDWWALGVFAYEMFY 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK----HRDTDGI-QQVVNEIKLISCVSHPNLV 321
LG G F TVY + + +VAIK+IK DGI + + EIKL+ +SHPN++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
LL + LV++FM L + ++ L+ + T Q + +LH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I HRD+K +N+LLD N K+ADFGL++
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 39/211 (18%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIK--------HRDTDGIQQVVNEIKLISCVSH 317
+ LG+GA G V A + + VAIK I R+ D V EI+++ ++H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAMET 369
P ++++ + + +V E M G L + RL +
Sbjct: 75 PCIIKIKN-FFDAEDYYIVLELMEGGEL---FDKVVGNK-------RLKEATCKLYFYQM 123
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQG 426
A+ +LH I HRD+K N+LL + + K+ DFG S++ + E S + T G
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTL-CG 178
Query: 427 TPGYLDP---QYHQNFHLSDKSDVYSFGVVL 454
TP YL P + D +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 37/203 (18%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
LG GA+G V + VA+K + R D + + EI + ++H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ--------AIAHLHSA 379
E Q L E+ G L ++ + AQ + +LH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDI-------GMP--EPDAQRFFHQLMAGVVYLHGI 124
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDP---- 433
I HRDIK N+LLD K++DFGL+ + ++ GT Y+ P
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 434 --QYHQNFHLSDKSDVYSFGVVL 454
++H ++ DV+S G+VL
Sbjct: 181 RREFH-----AEPVDVWSCGIVL 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIK-----RIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G FG V A +++ + A K RIK R G +NE +++ V+ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVSL 249
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+ LV M G L H+ G + A E + LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---R 306
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--GTPGYLDPQYHQNFHL 441
I +RD+K NILLD + +++D GL+ + T GT GY+ P+ +N
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 442 SDKSDVYSFGVVLVEIITAL 461
+ D ++ G +L E+I
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 54/239 (22%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRI-----KHRDTDGIQQVVNEIKLISCVSHPNL 320
K +G G++G V Q + AIK + + + ++++ E++L+ + HPN+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETA---------- 370
RL + LV E G L L D V +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 371 ----------------------------QAIAHLHSAINPPIYHRDIKSSNILL--DYNF 400
A+ +LH+ I HRDIK N L + +F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QG--ICHRDIKPENFLFSTNKSF 207
Query: 401 KSKVADFGLSRL---GMTEISHISTAPQGTPGYLDPQ--YHQNFHLSDKSDVYSFGVVL 454
+ K+ DFGLS+ + T GTP ++ P+ N K D +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
LG G+FG V K A+K I ++ E++L+ + HPN+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHSAI 380
+ +V E G L + +R R + + + I ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEII-KRK-------RFSEHDAARIIKQVFSGITYMHKH- 140
Query: 381 NPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ-YH 436
I HRD+K NILL + + K+ DFGLS + + + GT Y+ P+
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRI-GTAYYIAPEVLR 196
Query: 437 QNFHLSDKSDVYSFGVVL 454
+ +K DV+S GV+L
Sbjct: 197 GTY--DEKCDVWSAGVIL 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 47/198 (23%), Positives = 75/198 (37%), Gaps = 14/198 (7%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSHPNLVRLLG 325
+G GAFG V + A+K + + E +++ + P +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ +V E+MP G L + + E A+ +HS
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFI 190
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP---QYHQNFHLS 442
HRD+K N+LLD + K+ADFG E GTP Y+ P +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 443 DKS-DVYSFGVVLVEIIT 459
+ D +S GV L E++
Sbjct: 251 GRECDWWSVGVFLYEMLV 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 25/198 (12%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS 327
LG+GAFG V+ + + L IK I K R ++Q+ EI+++ + HPN++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 328 IERGEQI-LVYEFMPNGTLCQH-LQRERGDGLSWPIRLT------VAMETAQAIAHLHSA 379
E + +V E G L + + + L+ + + A+A+ HS
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ 143
Query: 380 INPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
+ H+D+K NIL + K+ DFGL+ L H + A GT Y+ P+
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNA-AGTALYMAPEVF 198
Query: 437 QNFHLSDKSDVYSFGVVL 454
+ ++ K D++S GVV+
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 258 EKATIGFSEKQR-LGTGAFGTVYAGK-LQNDLLVAIKRI-KHR-DTDGIQQVVNEIKLIS 313
E+ IG + +G G F V + + VAIK I K + + +Q++ E++++
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 314 CVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETA 370
++HPN+V+L IE + + L+ E+ G + +L G R+ A
Sbjct: 70 ILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLV-AHG-------RMKEKEARSKF 120
Query: 371 Q----AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
+ A+ + H I HRD+K+ N+LLD + K+ADFG S T + G
Sbjct: 121 RQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAFC-G 175
Query: 427 TPGY------LDPQYHQNFHLSDKSDVYSFGVVL 454
P Y +Y + DV+S GV+L
Sbjct: 176 APPYAAPELFQGKKYD-----GPEVDVWSLGVIL 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 43/203 (21%), Positives = 77/203 (37%), Gaps = 23/203 (11%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-----HRDTDGIQQVVNEIKLISCVSHPNL 320
+ +G G F V + A+K + + + E + + HP++
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIA 374
V LL G +V+EFM LC + +R + + +A+
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIV-KRA---DAGFVYSEAVASHYMRQILEALR 144
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYL 431
+ H I HRD+K +LL S K+ FG++ + E ++ GTP ++
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGLVAGGRVGTPHFM 200
Query: 432 DPQYHQNFHLSDKSDVYSFGVVL 454
P+ + DV+ GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 44/209 (21%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI------KHRDTDGIQQVVNEIKLISCVSH--PNL 320
LG+G FG+VY+G + ++L VAIK + + +V E+ L+ VS +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 321 VRLLGCSIERGEQI-LVYEF-MPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQA 372
+RLL ER + L+ E P L + ERG L + +A
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI-TERG-------ALQEELARSFFWQVLEA 161
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKS-KVADFGLSRLGMTEISHISTAPQGTPGYL 431
+ H H+ + HRDIK NIL+D N K+ DFG L + + + GT Y
Sbjct: 162 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDF-DGTRVYS 215
Query: 432 DP------QYHQNFHLSDKSDVYSFGVVL 454
P +YH + V+S G++L
Sbjct: 216 PPEWIRYHRYH-----GRSAAVWSLGILL 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 32/203 (15%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G+FG V K A+K I ++ E++L+ + HPN+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAMETAQAIAH 375
+ +V E G L +R R + + + I +
Sbjct: 87 FEILEDSSSFYIVGELYTGGEL---FDEIIKRK-------RFSEHDAARIIKQVFSGITY 136
Query: 376 LHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
+H I HRD+K NILL + + K+ DFGLS + + + GT Y+
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDR-IGTAYYIA 191
Query: 433 PQ-YHQNFHLSDKSDVYSFGVVL 454
P+ + +K DV+S GV+L
Sbjct: 192 PEVLRGTY--DEKCDVWSAGVIL 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 51/226 (22%), Positives = 86/226 (38%), Gaps = 57/226 (25%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIK--------------------------RIKHRDTDGI 302
+G G++G V ++ A+K + I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 303 QQVVNEIKLISCVSHPNLVRLLGCSIE------RGEQILVYEFMPNGTLCQHLQRERGDG 356
+QV EI ++ + HPN+V+L +E +V+E + G + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133
Query: 357 LSWPIRLTVAMETAQ----AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412
+ A Q I +LH I HRDIK SN+L+ + K+ADFG+S
Sbjct: 134 ----LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 413 GMTEISHISTAPQGTPGYLDP----QYHQNFHLSDKSDVYSFGVVL 454
+ +S GTP ++ P + + F DV++ GV L
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTL 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 270 LGTGAFGTVYAGKLQN-DLLVAIK-----RIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G FG V+A +++ L A K R+K R G Q + E K+++ V +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKVHSRFIVSL 250
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV--AMETAQAIAHLHSAIN 381
+ + LV M G + H+ D + + + + HLH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL 441
I +RD+K N+LLD + +++D GL+ + GTPG++ P+
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 442 SDKSDVYSFGVVLVEIITAL 461
D ++ GV L E+I A
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 53/230 (23%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 258 EKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRI------KHRDTDGIQQVVNEIK 310
K F ++ G G FGTV GK + VAIK++ ++R+ + ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-------LQIMQ 71
Query: 311 LISCVSHPNLVRLLGCSIERGEQ-------ILVYEFMPNGTLCQHLQRERGDGLSWPIRL 363
++ + HPN+V+L GE+ +V E++P+ TL + + ++ P L
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 364 TVAMETAQ---AIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRL---GMTE 416
+ + Q +I LH + + HRDIK N+L++ + K+ DFG ++
Sbjct: 131 -IKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 417 ISHIST----APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+++I + AP+ G Y + D++S G + E++
Sbjct: 189 VAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMML 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V + A+K ++ D + V E +++ HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHSA 379
V E+ G L HL RER T E A+ +LHS
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRER--------VFTEERARFYGAEIVSALEYLHSR 124
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-----Q 434
+ +RDIK N++LD + K+ DFGL + G+++ + + T GTP YL P
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 435 YHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ ++ D + GVV+ E++
Sbjct: 181 DY------GRAVDWWGLGVVMYEMMC 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 43/242 (17%)
Query: 241 KEARGISNIPIYPYREIEKATIGFSEK----QRLGTGAFGTVYAGK-LQNDLLVAIKRIK 295
+E I I P + K E ++LG+GA+G V K AIK IK
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 296 -------------HRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342
+++ NEI L+ + HPN+++L ++ LV EF
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 343 GTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396
G L + + R + + + I +LH I HRDIK NILL
Sbjct: 131 GELFEQII-NRH-------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179
Query: 397 ---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ-YHQNFHLSDKSDVYSFGV 452
+ K+ DFGLS + GT Y+ P+ + + ++K DV+S GV
Sbjct: 180 ENKNSLLNIKIVDFGLSS--FFSKDYKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGV 235
Query: 453 VL 454
++
Sbjct: 236 IM 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 37/276 (13%), Positives = 75/276 (27%), Gaps = 61/276 (22%)
Query: 268 QRLGTGAFGTVYAGKLQNDLL----VAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNL 320
G + D VA+ + D +Q+ ++ +S + P +
Sbjct: 37 IFHGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
R+L R ++V E++ G+L + S + A A H A
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
+ S + + + +A T P P
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDANP------------ 181
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500
+ D+ G L ++ R P + + I+P I+
Sbjct: 182 ---QDDIRGIGASLYALLVN-------RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231
Query: 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536
++ +A R + +R + T +
Sbjct: 232 IPFQ---------ISAVAARSVQGDGGIRSASTLLN 258
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 25/200 (12%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRL 323
K+ LG GAF V L A K I + Q++ E ++ + HPN+VRL
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLH 377
E LV++ + G L + + R + + ++IA+ H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIV-ARE-------FYSEADASHCIQQILESIAYCH 122
Query: 378 SAINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
S I HR++K N+LL K K+ADFGL+ + + GTPGYL P+
Sbjct: 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF-AGTPGYLSPE 177
Query: 435 YHQNFHLSDKSDVYSFGVVL 454
+ S D+++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 29/202 (14%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLG 325
LGTG+FG V+ N A+K +K ++ +E ++S V+HP ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAIAHLHSA 379
+ + ++ +++ G L L++ + R + E A+ +LHS
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEVCLALEYLHSK 125
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ-YHQN 438
I +RD+K NILLD N K+ DFG ++ + ++ GTP Y+ P+
Sbjct: 126 ---DIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 439 FHLSDKS-DVYSFGVVLVEIIT 459
+ +KS D +SFG+++ E++
Sbjct: 179 PY--NKSIDWWSFGILIYEMLA 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 270 LGTGAFGTVYAGKLQ-NDLLVAIK-----RIKHRDTDGIQQVVNE---IKLISCVSHPNL 320
+G G FG VY + + A+K RIK + G +NE + L+S P +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFI 254
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V + + + + M G L HL + S A E + H+H+
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR- 311
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
+ +RD+K +NILLD + +++D GL+ + H S GT GY+ P+ Q
Sbjct: 312 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 366
Query: 441 LSDKS-DVYSFGVVLVEIITAL 461
D S D +S G +L +++
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGH 388
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDG--IQQVVNEIKLISCVSHPNLVRL 323
K+ LG GAF V L A K I + Q++ E ++ + HPN+VRL
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLH 377
E LV++ + G L + + R + + ++IA+ H
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIV-ARE-------FYSEADASHCIQQILESIAYCH 145
Query: 378 SAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
S I HR++K N+LL K+ADFGL+ + + GTPGYL P+
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF-AGTPGYLSPE 200
Query: 435 YHQNFHLSDKSDVYSFGVVL 454
+ S D+++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 26/201 (12%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRI--KHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ LG GAF V K+ A I K Q++ E ++ + HPN+VRL
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLH 377
E G L+++ + G L + + R + + +A+ H H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIV-ARE-------YYSEADASHCIQQILEAVLHCH 127
Query: 378 SAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
+ HR++K N+LL K+ADFGL+ E GTPGYL P+
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPE 183
Query: 435 -YHQNFHLSDKSDVYSFGVVL 454
++ + D+++ GV+L
Sbjct: 184 VLRKDPY-GKPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 33/210 (15%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
+ LG GA V L A+K I+ + +V E++ L C H N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHS 378
E LV+E M G++ H+ +R V + A A+ LH+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIH-KRR-------HFNELEASVVVQDVASALDFLHN 129
Query: 379 AINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQ------GTPG 429
I HRD+K NIL ++ + K+ DF L + G+
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 430 Y-----LDPQYHQNFHLSDKSDVYSFGVVL 454
Y ++ + + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ + +G+GA G V A + VAIK++ ++ ++ E+ L+ CV+H N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 321 VRLL-----GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ--- 371
+ LL S+E + + +V E M LCQ +Q E E
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDH------------ERMSYLL 133
Query: 372 -----AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
I HLHSA I HRD+K SNI++ + K+ DFGL+R S + T
Sbjct: 134 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 188
Query: 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
T Y P+ + D++S G ++ E+I
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 48/228 (21%), Positives = 85/228 (37%), Gaps = 16/228 (7%)
Query: 235 STKRCLKEARGISNIPIYPYREIEKA-TIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIK 292
G N+ + + LG G F V A K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYIL---TSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 293 RIK--HRDTDGIQQVVNEIKLISCVSH-PNLVRLLGCSIERGEQILVYEFMPNGTLCQHL 349
+K R D ++++EI ++ P ++ L E IL+ E+ G +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 350 QRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVAD 406
E + +S + + + + + +LH N I H D+K NILL K+ D
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQ-NN--IVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVL 454
FG+SR + + GTP YL P+ ++ +D+++ G++
Sbjct: 178 FGMSRK-IGHACELREI-MGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+ LG GA VY + A+K +K + V EI ++ +SHPN+++L
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHSA 379
E LV E + G L + E+G + + +A+A+LH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV-EKG-------YYSERDAADAVKQILEAVAYLHEN 167
Query: 380 INPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
I HRD+K N+L + K+ADFGLS++ + + T GTPGY P+
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTV-CGTPGYCAPEIL 222
Query: 437 QNFHLSDKSDVYSFGVVL 454
+ + D++S G++
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/210 (29%), Positives = 80/210 (38%), Gaps = 44/210 (20%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRI------KHRDTDGIQQVVNEI----KLISCVSHP 318
LG G FGTV+AG L + L VAIK I E+ K+ + HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 319 NLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQ 371
++RLL E E LV E E+G L +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG-------PLGEGPSRCFFGQVVA 150
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEISHISTAPQGTPGY 430
AI H HS + HRDIK NIL+D +K+ DFG L + GT Y
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDF-DGTRVY 204
Query: 431 LDP------QYHQNFHLSDKSDVYSFGVVL 454
P QYH + + V+S G++L
Sbjct: 205 SPPEWISRHQYH-----ALPATVWSLGILL 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHR------DTDGIQQVVNEIKLISCVSHPN 319
+ LG+G F V + L A K IK R +++ E+ ++ V H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++ L R + +L+ E + G L L ++ + LS + + + +LH+
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK 134
Query: 380 INPPIYHRDIKSSNILL-DYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYLDPQY 435
I H D+K NI+L D N K+ DFGL+ + + GTP ++ P+
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNI-FGTPEFVAPEI 189
Query: 436 HQNFHLSDKSDVYSFGVVL 454
L ++D++S GV+
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 39/172 (22%), Positives = 74/172 (43%), Gaps = 28/172 (16%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK-HRDTDGI-QQVVNEIKL 311
E+ K + + ++G G FG V+ + + VA+K++ + +G + EIK+
Sbjct: 14 DEVSK----YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI 69
Query: 312 ISCVSHPNLVRLLGCSIERGEQI--------LVYEFMPNGTLCQH----LQRERGDGLSW 359
+ + H N+V L+ + LV++F +H L +
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTL 123
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
V + ++H I HRD+K++N+L+ + K+ADFGL+R
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 41/213 (19%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRI--------KHRDTDGIQQVVNEIKLISCVS- 316
K +G G V A+K + + + + E ++ V+
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 317 HPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VAM 367
HP+++ L+ S E + LV++ M G L E+ L+ +
Sbjct: 159 HPHIITLID-SYESSSFMFLVFDLMRKGEL---FDYLTEKV-------ALSEKETRSIMR 207
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGT 427
+A++ LH+ I HRD+K NILLD N + +++DFG S + + GT
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGEKLREL-CGT 262
Query: 428 PGYLDP------QYHQNFHLSDKSDVYSFGVVL 454
PGYL P + + D+++ GV+L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG V GK VA+K R K R D + ++ EI+ + HP++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 326 CSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAMETAQ----AIAHLHS 378
I I +V E++ G L ++ + G RL + Q + + H
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYIC-KNG-------RLDEKESRRLFQQILSGVDYCHR 134
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
+ + HRD+K N+LLD + +K+ADFGLS + M++ + T+ G+P Y P
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISG 189
Query: 434 -QYHQNFHLSDKSDVYSFGVVL 454
Y + D++S GV+L
Sbjct: 190 RLYA-----GPEVDIWSSGVIL 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/214 (23%), Positives = 79/214 (36%), Gaps = 42/214 (19%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGI---------QQVVNEIKLISCVS 316
K+ LG G V A+K I + + E+ ++ VS
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 317 -HPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT------VA 366
HPN+++L + E LV++ M G L E+ L+ +
Sbjct: 82 GHPNIIQLKD-TYETNTFFFLVFDLMKKGEL---FDYLTEKV-------TLSEKETRKIM 130
Query: 367 METAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
+ I LH I HRD+K NILLD + K+ DFG S + + G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV-CG 185
Query: 427 TPGYLDP------QYHQNFHLSDKSDVYSFGVVL 454
TP YL P + + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 30/202 (14%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIK--------HRDTDGIQQVVNEIKLISCVSHPNL 320
LG+GAFG V+ + + V +K IK + + +V EI ++S V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 321 VRLLGCSIERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
+++L E LV E +G L + +R L P+ + + A+ +L
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I HRDIK NI++ +F K+ DFG + + T GT Y P
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-GTIEYCAPEVLMG 203
Query: 434 -QYHQNFHLSDKSDVYSFGVVL 454
Y + +++S GV L
Sbjct: 204 NPYR-----GPELEMWSLGVTL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 30/205 (14%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHR------DTDGIQQVVNEIKLISCVSHPN 319
+ LG+G F V + L A K IK R +++ E+ ++ V HPN
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAI 373
++ L R + +L+ E + G L L ++ L+ + +
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFL-AQKE-------SLSEEEATSFIKQILDGV 128
Query: 374 AHLHSAINPPIYHRDIKSSNILL-DYNFKS---KVADFGLSRLGMTEISHISTAPQGTPG 429
+LH+ I H D+K NI+L D N K+ DFGL+ + + GTP
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNI-FGTPE 183
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVL 454
++ P+ L ++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 30/202 (14%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDG------IQQVVNEIKLISCVSHPNLVR 322
LG+G F V + A K IK R +++ E+ ++ + HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHL 376
L + + +L+ E + G L L E+ LT + + +L
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA-EKE-------SLTEDEATQFLKQILDGVHYL 124
Query: 377 HSAINPPIYHRDIKSSNILL-DYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYLD 432
HS I H D+K NI+L D N + K+ DFG++ + + GTP ++
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNI-FGTPEFVA 179
Query: 433 PQYHQNFHLSDKSDVYSFGVVL 454
P+ L ++D++S GV+
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 256 EIEKATIGFSEKQR-LGTGAFGTVYAGK-LQNDLLVAIK---RIKHRDTDGIQQVVNEIK 310
I K IG + LG G+FG V + VA+K R + +D +V EI
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 311 LISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLT--VAM 367
+ + HP++++L I I +V E+ G L ++ E+ R+T
Sbjct: 62 YLKLLRHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIV-EKK-------RMTEDEGR 111
Query: 368 ETAQ----AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTA 423
Q AI + H I HRD+K N+LLD N K+ADFGLS + MT+ + + T+
Sbjct: 112 RFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS 167
Query: 424 PQGTPGYLDP------QYHQNFHLSDKSDVYSFGVVL 454
G+P Y P Y + DV+S G+VL
Sbjct: 168 C-GSPNYAAPEVINGKLYA-----GPEVDVWSCGIVL 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 40/211 (18%)
Query: 270 LGTGAFGTVY-----AGKLQNDLLVAIKRIK----HRDTDGIQQVVNEIKLISCVSHPNL 320
LG G +G V+ G + A+K +K R+ E ++ V HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAIA 374
V L+ G+ L+ E++ G L L+RE E + A+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--------IFMEDTACFYLAEISMALG 135
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP- 433
HLH I +RD+K NI+L++ K+ DFGL + + + + T GT Y+ P
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191
Query: 434 ----QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
H +++ D +S G ++ +++T
Sbjct: 192 ILMRSGH------NRAVDWWSLGALMYDMLT 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 35/207 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHPNLVRLL 324
+G G+FG V A ++ A+K ++ + + +++E L+ V HP LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
+ V +++ G L HLQRER A E A A+ +LHS
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRER--------CFLEPRARFYAAEIASALGYLHS 157
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I +RD+K NILLD + DFGL + + S ST GTP YL P
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
Q + D++ D + G VL E++
Sbjct: 214 QPY------DRTVDWWCLGAVLYEMLY 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHPNLVRLL 324
+G G++ V + D + A+K +K D + I V E +HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
C V E++ G L H+QR+R +L + E + A+ +LH
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQR--------KLPEEHARFYSAEISLALNYLHE 128
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I +RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 184
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ + S D ++ GV++ E++
Sbjct: 185 EDY------GFSVDWWALGVLMFEMMA 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 30/201 (14%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
+ LG G+F +++ A+K I R Q EI L C HPN+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLH 72
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIAHLHS 378
++ LV E + G L + ++ ++ + + + A++H+H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIK-KKK-------HFSETEASYIMRKLVSAVSHMHD 124
Query: 379 AINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ- 434
+ HRD+K N+L + N + K+ DFG +RL + + T P T Y P+
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPEL 180
Query: 435 YHQNFHLSDKS-DVYSFGVVL 454
+QN + D+S D++S GV+L
Sbjct: 181 LNQNGY--DESCDLWSLGVIL 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIK------HRDTDGIQQVVNEIKLISCVSHPNLVR 322
LG+G F V + L A K IK R + + E+ ++ + HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLT---VAMETAQ---AIA 374
L + + IL+ E + G L E+ LT Q +
Sbjct: 79 LHEVYENKTDVILILELVAGGEL---FDFLAEKE-------SLTEEEATEFLKQILNGVY 128
Query: 375 HLHSAINPPIYHRDIKSSNILL-DYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGY 430
+LHS I H D+K NI+L D N K+ DFGL+ + + GTP +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNI-FGTPEF 183
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVL 454
+ P+ L ++D++S GV+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 37/225 (16%)
Query: 247 SNIPIYPYREIEKATIGFSEKQR-LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQ 304
+ + P + + +G+G FG + LVA+K I+ R +
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDEN 62
Query: 305 VVNEIKLISCVSHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRL 363
V EI + HPN+VR I + ++ E+ G L + + R
Sbjct: 63 VQREIINHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAG--------RF 113
Query: 364 T--VAMETAQ----AIAHLHSAINPPIYHRDIKSSNILLDYNFKS--KVADFGLSRLGMT 415
+ A Q +++ HS I HRD+K N LLD + K+ DFG S+
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SV 169
Query: 416 EISHISTAPQGTPGYLDP------QYHQNFHLSDKSDVYSFGVVL 454
S + GTP Y+ P +Y +DV+S GV L
Sbjct: 170 LHSQPKSTV-GTPAYIAPEVLLRQEYD-----GKIADVWSCGVTL 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIK-LISCVSHPNLVRLL 324
LG G+FG V+ A + + AIK +K D ++ + E + L HP L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
+ V E++ G L H+Q + + A E + LHS
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--------KFDLSRATFYAAEIILGLQFLHS 136
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
+Y RD+K NILLD + K+ADFG+ + M + +T GTP Y+ P+
Sbjct: 137 --KGIVY-RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 192
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+ D +SFGV+L E++
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLI 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHPNLVRLL 324
LG G+FG V A + L A+K +K D ++ + E + L +HP L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
C V EF+ G L H+Q+ R R A E A+ LH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSR--------RFDEARARFYAAEIISALMFLHD 142
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I +RD+K N+LLD+ K+ADFG+ + G+ +T GTP Y+ P
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQE 198
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ + D ++ GV+L E++
Sbjct: 199 MLY------GPAVDWWAMGVLLYEMLC 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHR---DTDGIQQVVNEIK-LISCVSHPNLVRLL 324
+G G++ V + D + A++ +K D + I V E +HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
C V E++ G L H+QR+R +L + E + A+ +LH
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQR--------KLPEEHARFYSAEISLALNYLHE 171
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I +RD+K N+LLD K+ D+G+ + G+ ST GTP Y+ P
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 227
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ + S D ++ GV++ E++
Sbjct: 228 EDY------GFSVDWWALGVLMFEMMA 248
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 32/203 (15%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
KQ LG G G V + A+K + + E+ P++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 325 G----CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIA 374
+ +++ E M G L +Q ERGD T + + AI
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQ-----AFTEREAAEIMRDIGTAIQ 142
Query: 375 HLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
LHS N I HRD+K N+L + + K+ DFG ++ T + + T P TP Y+
Sbjct: 143 FLHS-HN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQT-PCYTPYYV 196
Query: 432 DPQYHQNFHLSDKSDVYSFGVVL 454
P+ D++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 44/222 (19%)
Query: 255 REIEKATIGFSE----KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEI 309
+++ + +I F++ K+ +G G++ ++ A+K I D +++ EI
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EI 68
Query: 310 KLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT----- 364
L+ HPN++ L + +V E M G L + + +
Sbjct: 69 -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQK-------FFSEREAS 119
Query: 365 -VAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKS-KVADFGLSRLGMTEISH 419
V + + +LH+ + HRD+K SNIL N +S ++ DFG ++ E
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 420 ISTAPQGTPGYLDPQ------YHQNFHLSDKS-DVYSFGVVL 454
+ T P T ++ P+ Y D + D++S GV+L
Sbjct: 177 LMT-PCYTANFVAPEVLERQGY-------DAACDIWSLGVLL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 15/168 (8%)
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHL-QRERGDGLSWPIRLTV 365
+I+ + S N V L S + + + L + +R + + L +
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169
Query: 366 AMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ 425
++ A+A+ LHS + HRD+K SNI + KV DFGL + +
Sbjct: 170 FIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 426 -----------GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALK 462
GT Y+ P+ + S K D++S G++L E++ +
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 23/81 (28%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLV 321
F Q +G G FG V+ K +D AIKRI+ + + ++V+ E+K ++ + HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 322 RLLGCSIERGEQILVYEFMPN 342
R +E + E
Sbjct: 68 RYFNAWLETPPEKWQEEMDEI 88
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 270 LGTGAFGTVY-----AGKLQNDLLVAIKRIK----HRDTDGIQQVVNEIKLISCVSH-PN 319
LGTGA+G V+ +G L A+K +K + + E +++ + P
Sbjct: 62 LGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAI 373
LV L + L+ +++ G L HL + R T E A+
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--------RFTEHEVQIYVGEIVLAL 172
Query: 374 AHLHSA-INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
HLH I IY RDIK NILLD N + DFGLS+ + + + + GT Y+
Sbjct: 173 EHLHKLGI---IY-RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 433 P---QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
P + + H DK+ D +S GV++ E++T
Sbjct: 229 PDIVRGGDSGH--DKAVDWWSLGVLMYELLT 257
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 42/211 (19%)
Query: 270 LGTGAFGTVY----AGKLQNDLLVAIK-----RIKHRDTDGIQQVVNEIKLISCVSHPNL 320
LG G+FG V+ L A+K +K RD + E ++ V+HP +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILVEVNHPFI 88
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAIA 374
V+L G+ L+ +F+ G L L +E T E A A+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALALD 140
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP- 433
HLHS I +RD+K NILLD K+ DFGLS+ + + GT Y+ P
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 196
Query: 434 ----QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
+ H +S D +SFGV++ E++T
Sbjct: 197 VVNRRGH------TQSADWWSFGVLMFEMLT 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ + +G+GA G V A D VAIK++ ++ ++ E+ L+ CV+H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 321 VRLL-----GCSIERGEQI-LVYEFMP---NGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ LL ++E + + LV E M + L ER L + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM--------LC 175
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
I HLHSA I HRD+K SNI++ + K+ DFGL+R T + T T Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYR 230
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ + D++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 266 EKQRLGTGAFGTVYAGK---LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLV 321
E ++G G +G VY K ++D A+K+I+ GI EI L+ + HPN++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVI 81
Query: 322 RLLGCSIERGEQI--LVYEFMPNGTLCQHLQRER-GDGLSWPIRLTVAM------ETAQA 372
L + ++ L++++ + L ++ R P++L M +
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKS----KVADFGLSRL 412
I +LH+ + HRD+K +NIL+ K+AD G +RL
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 53/261 (20%), Positives = 103/261 (39%), Gaps = 85/261 (32%)
Query: 258 EKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRI------KHRDTDGIQQVVNEIK 310
E ++ +S + LGTG+FG V +++ A+K++ K+R E+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----------ELD 52
Query: 311 LISCVSHPNLVRLLGCSIERGEQI------------------------------------ 334
++ + H N+++L+ G++
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 335 --LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ---AIAHLHSAINPPIYHRDI 389
++ E++P+ TL + L+ G S P+ +++ Q A+ +HS I HRDI
Sbjct: 113 LNVIMEYVPD-TLHKVLKSFIRSGRSIPM-NLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 390 KSSNILLDYN-FKSKVADFGLSRL---GMTEISHIST----APQ---GTPGYLDPQYHQN 438
K N+L++ K+ DFG ++ +++I + AP+ G Y
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY-------- 219
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+ D++S G V E+I
Sbjct: 220 ---TPSIDLWSIGCVFGELIL 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGI-----------QQVVNEIKLI 312
++ ++ + +G++G V AG + VAIKR+ + +DG ++V+ EI+L+
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 313 SCVSHPNLVRLLGC----SIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM 367
+ HPN++ L ++ LV E M T + ++ +S P + M
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVIS-PQHIQYFM 140
Query: 368 -ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG-----MTE 416
+ LH A + HRD+ NILL N + DF L+R T
Sbjct: 141 YHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 35/207 (16%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIK-LISCVSHPNLVRLL 324
LG G+FG V + + D L A+K +K D ++ + E + L P L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV------AMETAQAIAHLHS 378
C V E++ G L H+Q+ R A E A + L S
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--------RFKEPHAVFYAAEIAIGLFFLQS 139
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP----- 433
I +RD+K N++LD K+ADFG+ + + + T GTP Y+ P
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 195
Query: 434 QYHQNFHLSDKS-DVYSFGVVLVEIIT 459
Q + KS D ++FGV+L E++
Sbjct: 196 QPY------GKSVDWWAFGVLLYEMLA 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 49/213 (23%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLG 325
++LG G + V+ + N+ V +K +K I++ EIK++ + PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 326 C--SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM------ETAQAIAHLH 377
LV+E + N Q Q LT E +A+ + H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDIRFYMYEILKALDYCH 147
Query: 378 SAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLG-----MTEISHIST----APQGT 427
S I HRD+K N+++D+ + K ++ D+GL+ +++ P+
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELL 202
Query: 428 PGYLDPQYHQNFHLSDKS-DVYSFGVVLVEIIT 459
Y Y D S D++S G +L +I
Sbjct: 203 VDY--QMY-------DYSLDMWSLGCMLASMIF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 47/218 (21%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ +G+GA+G+V + ++ VAIK++ + ++ E+ L+ + H N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 321 VRLL-----GCSIERGEQI-LVYEFMP---NGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ LL S+ LV FM + E+ L + + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------LK 137
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHIST----AP 424
+ ++HSA + HRD+K N+ ++ + + K+ DFGL+R MT ++ T AP
Sbjct: 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVVTRWYRAP 192
Query: 425 Q---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ Y + D++S G ++ E++T
Sbjct: 193 EVILSWMHY-----------NQTVDIWSVGCIMAEMLT 219
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 25/202 (12%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRD---TDGIQQVVNEIK-LISCVSHPNLVRLL 324
LG G+FG V + + D L A+K +K D ++ + E + L P L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTV--AMETAQAIAHLHSAINP 382
C V E++ G L H+Q+ + V A E A + L S
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK--- 461
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
I +RD+K N++LD K+ADFG+ + + + T GTP Y+ P+ ++
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI-----IA 515
Query: 443 DKS-----DVYSFGVVLVEIIT 459
+ D ++FGV+L E++
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLA 537
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 41/199 (20%), Positives = 82/199 (41%), Gaps = 35/199 (17%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
+ K +G G++G VY + VAIK++ D ++++ EI +++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC-KRILREITILNRLKSDY 86
Query: 320 LVRLLGC----SIERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAMETAQ-- 371
++RL + + +++ +V E + L + + PI LT E +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKT--------PIFLT--EEHIKTI 134
Query: 372 ------AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAP 424
+H + I HRD+K +N LL+ + KV DFGL+R + + ++I
Sbjct: 135 LYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 425 QGTPGYLDPQYHQNFHLSD 443
+ + L+
Sbjct: 192 EENEEPGPHNKNLKKQLTS 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 45/210 (21%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
Q LG G G V + A+K ++ + E++ P++VR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121
Query: 325 G----CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLT------VAMETAQAIA 374
R ++V E + G L +Q +RGD T + +AI
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQ-----AFTEREASEIMKSIGEAIQ 175
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKS---KVADFGLSRLGMTEISHISTAPQGTPGYL 431
+LHS IN I HRD+K N+L + K+ DFG ++ T + T P TP Y+
Sbjct: 176 YLHS-IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYV 230
Query: 432 DPQ------YHQNFHLSDKS-DVYSFGVVL 454
P+ Y DKS D++S GV++
Sbjct: 231 APEVLGPEKY-------DKSCDMWSLGVIM 253
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 50/216 (23%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ + Q +G+GA+G V + + VAIK++ + ++ E++L+ + H N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 321 VRLL-----GCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAM-ETAQAI 373
+ LL +++ LV FM L + ++ E+ L R+ + + + +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LG-EDRIQFLVYQMLKGL 141
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHIST----APQ- 425
++H+A I HRD+K N+ ++ + + K+ DFGL+R MT ++ T AP+
Sbjct: 142 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVVTRWYRAPEV 196
Query: 426 --GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
Y + D++S G ++ E+IT
Sbjct: 197 ILNWMRY-----------TQTVDIWSVGCIMAEMIT 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 42/201 (20%), Positives = 87/201 (43%), Gaps = 31/201 (15%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
+ + +GTG++G V +VAIK+I D ++++ EI +++ ++H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC-KRILREIAILNRLNHDH 113
Query: 320 LVRLL----GCSIERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAM------ 367
+V++L +E+ +++ +V E + + + P+ LT
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRT--------PVYLTELHIKTLLY 163
Query: 368 ETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGT 427
+ ++HSA I HRD+K +N L++ + KV DFGL+R + + ++ +
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR-TVDYPENGNSQLPIS 219
Query: 428 PGYLDPQYHQNFHLSDKSDVY 448
P D H +
Sbjct: 220 PREDDMNLVTFPHTKNLKRQL 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 27/174 (15%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
+ + + LG G G V++ D VAIK+I D ++ + EIK+I + H N+V+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 323 LL-------------GCSIERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAM 367
+ S+ + +V E+M T L L++ L + M
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGP---LL-EEHARLFM 126
Query: 368 -ETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISH 419
+ + + ++HSA + HRD+K +N+ ++ + K+ DFGL+R+ SH
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNL 320
F K LG GA+G V + +VAIK+I+ + + + EIK++ H N+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLREIKILKHFKHENI 71
Query: 321 VRLLGC----SIERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAMETAQ--- 371
+ + S E ++ ++ E M T L + + + L+ + Q
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQM---------LSD--DHIQYFI 118
Query: 372 -----AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQG 426
A+ LH + + HRD+K SN+L++ N KV DFGL+R + E + ++ P G
Sbjct: 119 YQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR-IIDESAADNSEPTG 174
Query: 427 TPGYL 431
+
Sbjct: 175 QQSGM 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVS-HP 318
+ ++LG GA+G V+ + +VA+K+I TD Q+ EI +++ +S H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFREIMILTELSGHE 69
Query: 319 NLVRLLGCSI-ERGEQI-LVYEFMPNGT-LCQHLQRERGDGLSWPIRLTVAM-ETAQAIA 374
N+V LL + + LV+++M T L + R + L P+ + + + I
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVI---RANILE-PVHKQYVVYQLIKVIK 123
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
+LHS + HRD+K SNILL+ KVADFGLSR + + P +
Sbjct: 124 YLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 435 YHQNFHLSD 443
L+D
Sbjct: 181 DDDQPILTD 189
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH--RDTDGIQQVVNEIKLISCVSHPNL 320
+ +G+GA+G+V A + L VA+K++ + ++ E++L+ + H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 321 VRLL-----GCSIERGEQI-LVYEFMP----NGTLCQHLQRERGDGLSWPIRLTVAMETA 370
+ LL S+E + LV M N CQ L + L + I
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI--------L 142
Query: 371 QAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG---MTEISHIST----A 423
+ + ++HSA I HRD+K SN+ ++ + + K+ DFGL+R MT +++T A
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG--YVATRWYRA 197
Query: 424 PQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ Y + D++S G ++ E++T
Sbjct: 198 PEIMLNWMHY-----------NQTVDIWSVGCIMAELLT 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNL 320
++ +G GA+G V + N + VAIK+I T Q+ + EIK++ H N+
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLREIKILLRFRHENI 87
Query: 321 VRLLGC----SIERGEQI-LVYEFMP----NGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ + +IE+ + + +V + M QHL + + I +
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--------LR 139
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419
+ ++HSA + HRD+K SN+LL+ K+ DFGL+R+ + H
Sbjct: 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 45/218 (20%), Positives = 88/218 (40%), Gaps = 42/218 (19%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-----------H 317
LG G F TV+ A + N+ VA+K ++ + +EIKL+ V+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 318 PNLVRLLGCSIERGEQI----LVYEFM-PNGTLCQHLQRERGDGLSWPIRLTVAMETAQA 372
++++LL +G +V+E + N L +++ G+ ++ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKS------KVADFGLSRLGMTEIS-HIST--- 422
+ ++H I H DIK N+L++ K+AD G + + I T
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 201
Query: 423 -APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+P+ G + +D++S ++ E+IT
Sbjct: 202 RSPEVLLGA---PW------GCGADIWSTACLIFELIT 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-12
Identities = 31/212 (14%), Positives = 59/212 (27%), Gaps = 63/212 (29%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDG----- 301
+P + EK +G G FG V+ + VAIK I D
Sbjct: 15 HCLPTEKLQRCEK----------IGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSH 63
Query: 302 ------------IQQVVNEIKLISCVSHPNLVRLLGCSIERGE----------------- 332
I + ++ + C + L +G
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 333 -------------QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V EF G + ++ + S ++ + ++A ++
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL---SSLATAKSILHQLTASLAVAEAS 180
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
+ HRD+ N+LL K+ +
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 33/160 (20%)
Query: 267 KQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
Q LG G G V + A+K + + E++ P++VR++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 77
Query: 325 G----CSIERGEQILVYEFMPNGTLCQHLQR--ERGDGL------SWPIRLTVAMETAQA 372
R ++V E + G L R +RGD S ++ +A
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-----SIGEA 129
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKS---KVADFGL 409
I +LHS I HRD+K N+L + K+ DFG
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 36/208 (17%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH------PNLVR 322
+G G+FG V A + VA+K +++ +Q EI+++ + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-HRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 323 LLGCSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+L R + +E + N L + +++ + G S P+ A Q + LH
Sbjct: 164 MLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-- 219
Query: 382 PPIYHRDIKSSNILLDYNFKS--KVADFGLS-RLGMTEISHIST----APQ---GTPGYL 431
I H D+K NILL +S KV DFG S ++I + AP+ G Y
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGAR-Y- 276
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
D++S G +L E++T
Sbjct: 277 ----------GMPIDMWSLGCILAELLT 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 267 KQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRDTDG-IQQVVNEIKLISCV-SHP 318
+ LG GAFG V VA+K +K T + +++E+K++ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 319 NLVRLLG-CSIERGEQILVYEFMPNGTLCQHLQRERGD 355
N+V LLG C+ G +++ EF G L +L+ +R +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 347 QHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406
+ + D L+ + + + A+ + L S HRD+ + NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 236
Query: 407 FGLSRLGMTEISHISTAPQGTPG-YLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
FGL+R + ++ P ++ P+ + + +SDV+SFGV+L EI +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 20/202 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLG 325
+R+G G+FG ++ G L N+ VAIK + R +D Q+ +E + ++ + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
E +LV + + G + L G S A + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 128
Query: 386 HRDIKSSNILLDYNFKSK-----VADFGLSRLGMTEIS--HI----STAPQGTPGYLDPQ 434
+RDIK N L+ V DFG+ + ++ HI GT Y+
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188
Query: 435 YHQNFHLSDKSDVYSFGVVLVE 456
H S + D+ + G V +
Sbjct: 189 THLGREQSRRDDLEALGHVFMY 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 18/200 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLG 325
+++G+G+FG +Y G + VAIK + T Q+ E K+ + + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH-PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
C E ++V E + G + L S L +A + I ++HS
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 127
Query: 386 HRDIKSSNILLDYNFKSK---VADFGLSRLGMTEIS--HI----STAPQGTPGYLDPQYH 436
HRD+K N L+ K + DFGL++ + HI + GT Y H
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 437 QNFHLSDKSDVYSFGVVLVE 456
S + D+ S G VL+
Sbjct: 188 LGIEQSRRDDLESLGYVLMY 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 40/229 (17%)
Query: 252 YPYREIEKATIGFSEKQRLGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIK 310
Y + EK + +G G+FG V A VAIK IK++ + Q E++
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVR 102
Query: 311 LISCVSHP------NLVRLLGCSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWPIRL 363
L+ ++ +V L + R LV+E + N L L+ G+S +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTR 160
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS--KVADFGLSRLGMTEISHIS 421
A + A+ L + I H D+K NILL +S K+ DFG S I
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIY 216
Query: 422 T--------APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+P+ G P Y D++S G +LVE+ T
Sbjct: 217 QYIQSRFYRSPEVLLGMP-Y-----------DLAIDMWSLGCILVEMHT 253
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 41/203 (20%), Positives = 78/203 (38%), Gaps = 22/203 (10%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLG 325
+++G G FG + GK L + VAIK ++ + Q+ E + + + ++
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA-PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 326 CSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+V E + P+ L + L S TV M Q I+ + + +
Sbjct: 73 FGPCGKYNAMVLELLGPS--L-EDLFDLCDRTFSLK---TVLMIAIQLISRMEYVHSKNL 126
Query: 385 YHRDIKSSNILLDYNFKSK-----VADFGLSRLGMTEIS--HI----STAPQGTPGYLDP 433
+RD+K N L+ + DF L++ + + HI + GT Y+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 434 QYHQNFHLSDKSDVYSFGVVLVE 456
H S + D+ + G + +
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMY 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 37/249 (14%), Positives = 75/249 (30%), Gaps = 38/249 (15%)
Query: 240 LKEARGISNIPIYPYREIEKATIG--FSEKQRLGTGAFGTVYAGK---------LQNDLL 288
L +++ P + G + K G +Y
Sbjct: 18 LYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQK 77
Query: 289 VAIKRIKHRDTDG------------IQQVVNEIKLISCVSHPNLVRLLGCSIERGE-QIL 335
++K + +D QV KL S + +G + + + + L
Sbjct: 78 FSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFL 135
Query: 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395
V + G Q R +V + + L H ++ + NI
Sbjct: 136 VLPSL--GRSLQSALDVSPKH-VLSER-SVLQVACRLLDALEFLHENEYVHGNVTAENIF 191
Query: 396 LDYNFKSKV--ADFGLSRLGMTEISHISTAPQ------GTPGYLDPQYHQNFHLSDKSDV 447
+D +S+V A +G + H++ G ++ H+ S +SD+
Sbjct: 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251
Query: 448 YSFGVVLVE 456
S G +++
Sbjct: 252 QSLGYCMLK 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 38/223 (17%), Positives = 71/223 (31%), Gaps = 44/223 (19%)
Query: 268 QRLGTGAFGTVYAG------KLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLV 321
+G G FG +Y + +D +K + + E+K + P +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQI 96
Query: 322 ---------------RLLGCSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIR 362
+ G + ++ + G+ Q + S R
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFS---R 151
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV--ADFGLS---RLGMTEI 417
TV + + + L H DIK+SN+LL+Y +V D+GL+
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 418 SHISTAP----QGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVE 456
+ P GT + H S + D+ G +++
Sbjct: 212 -AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 18/200 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLG 325
+++G+G+FG +Y G +Q + VAIK + Q++ E K+ + + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+E +LV + + G + L LS TV M Q I + +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK---TVLMLADQMINRVEFVHSKSFL 125
Query: 386 HRDIKSSNILLDYNFKSK---VADFGLSRLGMTEIS--HI----STAPQGTPGYLDPQYH 436
HRDIK N L+ ++ + DFGL++ + HI + GT Y H
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185
Query: 437 QNFHLSDKSDVYSFGVVLVE 456
S + D+ S G VL+
Sbjct: 186 LGIEQSRRDDLESLGYVLMY 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 46/253 (18%), Positives = 86/253 (33%), Gaps = 37/253 (14%)
Query: 234 KSTKRCLKEARGISNIPIYPYREIEKATIG--FSEKQRLGTGAFGTVYAGK-LQNDLLVA 290
S+ L +P ++ G + +++G+G FG +Y A
Sbjct: 7 HSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDA 66
Query: 291 IKRIKHRDTDGIQQVVNEIKLISCVSHPNLV---------------RLLGCSIERGEQ-- 333
+K + + +E+K V+ + + G + +
Sbjct: 67 RHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 334 --ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKS 391
+V E + G Q + + G L + + + ++H H DIK+
Sbjct: 126 YRFMVMERL--GIDLQKISGQNGT-FKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKA 179
Query: 392 SNILLDYNFKSKV--ADFGLSRLGMTEISHI------STAPQGTPGYLDPQYHQNFHLSD 443
+N+LL Y +V AD+GLS +H GT + H+ LS
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR 239
Query: 444 KSDVYSFGVVLVE 456
+SDV G ++
Sbjct: 240 RSDVEILGYCMLR 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 52/255 (20%), Positives = 86/255 (33%), Gaps = 72/255 (28%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-----SHPN-- 319
++LG G F TV+ +Q VA+K + + ++EI+L+ V + PN
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 320 -LVRLLGCSIERGE----QILVYEFMPNG-TLCQHLQRERGDGLSWPIRLTVAMETAQAI 373
+V+LL G +V+E + G L + + + GL P + + Q +
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYN---------------------------------- 399
+LH+ I H DIK NILL N
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 400 ---------------FKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
K K+AD G + T T Y + +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 445 SDVYSFGVVLVEIIT 459
+D++S + E+ T
Sbjct: 274 ADIWSTACMAFELAT 288
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 59/413 (14%), Positives = 120/413 (29%), Gaps = 116/413 (28%)
Query: 223 LMRRRSYYRARKST--KRCLKEARGISNIPIYPYREIEKATIGFSEKQRLGTGAFG-TVY 279
+ + + R + ++ L E R N+ I G G T
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLID------------------GVLGSGKTWV 166
Query: 280 AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339
A + +++ + I + L +C S ++ +L Q L+Y+
Sbjct: 167 ALDVCLS-----YKVQCKMDFKIFW----LNLKNCNSPETVLEML--------QKLLYQI 209
Query: 340 MPNGT-LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY 398
PN T H + S L +++ + + + + +++++ +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP---YENCLL---VL-LNVQNAKAWNAF 262
Query: 399 NFKSK---------VADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS---D 446
N K V DF LS T IS + TP + + + +
Sbjct: 263 NLSCKILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 447 VYSFGVVLVEIITALKVVDFSRPPN--EVNLAALAADRISKGRLDEIIDPLIIEHRGHSD 504
V + + II + N VN L I + L+ ++P E+R
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL--TTIIESSLNV-LEPA--EYRKM-- 374
Query: 505 AGTLASVHKVAELAFRCLA-FHRDMR-PSMT-----------EVATELEHIRTRTM---- 547
F L+ F P++ +V + + ++
Sbjct: 375 --------------FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 548 ------------EDINCTASLEASL---CSSSYNASERMKDN--SPPSVQDSW 583
++ E +L YN + + PP + +
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 6e-05
Identities = 68/493 (13%), Positives = 130/493 (26%), Gaps = 154/493 (31%)
Query: 27 QNYAPTSR--NGIL---LSSCNSSKVTACKIPLIDVRTQFNSIKCDSSSNSSSI--SCYS 79
+Y + I L +CNS + L + Q + S +SS+I +S
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPE--TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 80 EEKNDREFI---DYENATKQQCKFLLSAISSELFNTSAASI--NISAASLDVKVLEVGWW 134
+ R + YEN LL + N+ + K
Sbjct: 230 IQAELRRLLKSKPYENC-------LL--------------VLLNVQ----NAKAWNA--- 261
Query: 135 LNGHCHC---SQNANCTPVLTPHGRSGFRCG-CNKGFEGDGYPAGSGCRKASCNAAKYIS 190
N C ++ T L+ + + D + KY+
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD---------EVKSLLLKYLD 312
Query: 191 GQCGGKTRIAVLIIGGSTAGASLIISMRLLCCLMR----RRSYYRARKSTKRCLKEARGI 246
+ R + +S+ + +R ++ K L
Sbjct: 313 CRPQDLPREVLTT-------NPRRLSI--IAESIRDGLATWDNWKHVNCDK--LTTIIES 361
Query: 247 S--NIPIYPYREI-EKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIK----HRDT 299
S + YR++ ++ ++ F + +
Sbjct: 362 SLNVLEPAEYRKMFDRLSV-FPP-------------------SAHIPTILLSLIWFDVIK 401
Query: 300 DGIQQVVNEIKLISCV---SHPNLVRLLGCSIERGEQI---------LVYEFMPNGTLCQ 347
+ VVN++ S V + + + +E ++ +V + T
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
Query: 348 -HLQRERGDGLSWPIRLTVAMETAQAIA-HLHSAINPPIYHRDIKSSNILLDYNF-KSKV 404
L D + I HL + + R + LD+ F + K
Sbjct: 462 DDLIPPYLDQYFY-----------SHIGHHLKNIEH---PERMTLFRMVFLDFRFLEQK- 506
Query: 405 ADFGLSRLGMTEISHISTAPQGTPGYLD-----PQYHQNFHLSDKSDVYSFGVVLVEIIT 459
I H STA + L+ Y ++ D Y ++
Sbjct: 507 ------------IRHDSTAWNASGSILNTLQQLKFYKP--YICDNDPKYE------RLVN 546
Query: 460 ALKVVDFSRPPNE 472
A+ DF E
Sbjct: 547 AIL--DFLPKIEE 557
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 15/135 (11%)
Query: 270 LGTGAFGTVY-AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-----PNLVRL 323
+G G FG V + N A+K +++ + E ++ + + N+V+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-TRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 324 LGCSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWP-IRLTVAMETAQAIAHLHSAIN 381
G + L++E + P+ L + + R +G I+ +E +A+ +L
Sbjct: 102 HGKFMYYDHMCLIFEPLGPS--LYEIITRNNYNGFHIEDIK-LYCIEILKALNYLRKM-- 156
Query: 382 PPIYHRDIKSSNILL 396
+ H D+K NILL
Sbjct: 157 -SLTHTDLKPENILL 170
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 42/229 (18%), Positives = 71/229 (31%), Gaps = 60/229 (26%)
Query: 270 LGTGAFGTVY--AGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP------NLV 321
LG G FG V + VA+K I++ + EI ++ + V
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-REAARLEINVLKKIKEKDKENKFLCV 85
Query: 322 RLLGCSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+ G + +E + N + L+ P +A + A+ LH
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN- 142
Query: 381 NPPIYHRDIKSSNILLDYNFKS-------------------KVADFGLSRLGMTEISHIS 421
+ H D+K NIL + +VADFG + + H +
Sbjct: 143 --QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHT 197
Query: 422 T--------APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
T P+ + + DV+S G +L E
Sbjct: 198 TIVATRHYRPPEVILELG-W-----------AQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 56/227 (24%)
Query: 270 LGTGAFGTVYAGK--LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP------NLV 321
LG GAFG V VA+K +K+ D + +EI+++ ++ V
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-CEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 322 RLLGCSIERGEQILVYEFM-PNGTLCQHLQRERGDGLSWP-IRLTVAMETAQAIAHLHSA 379
++L G +V+E + + ++ IR +A + +++ LHS
Sbjct: 81 QMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIR-KMAYQICKSVNFLHSN 137
Query: 380 INPPIYHRDIKSSNILLDYNFKS-------------------KVADFGLS-RLGMTEISH 419
+ H D+K NIL + + KV DFG + +
Sbjct: 138 ---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 420 IST----APQ---GTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
+ST AP+ + S DV+S G +L+E
Sbjct: 195 VSTRHYRAPEVILALG------W------SQPCDVWSIGCILIEYYL 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.45 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.5 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.54 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.68 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.7 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.76 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.82 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 85.91 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 84.97 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 81.9 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=465.61 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=211.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999875 478899999998887888999999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 336 VYEFMPNGTLCQHLQRER-------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
||||+++|+|.++|+... ..+++|.++++|+.|||.||+|||+. +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997642 23599999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccccc-ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTE-ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++..... .....+...||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 99999999864332 2233445679999999999999999999999999999999999 8999863221 1122
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+.++...+ .+..++.++.+|+.+||+.||++||||.||++.|+.+...
T Consensus 271 ~~i~~g~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGRELE---------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTCCCC---------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCCCC---------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 3333332111 1223456788999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-57 Score=460.86 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=216.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777889999999999999874 468899999998877788899999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 007442 336 VYEFMPNGTLCQHLQRER-----------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl 404 (603)
||||+++|+|.++|+... ...|+|.++++|+.|||.||+|||+. +||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 34699999999999999999999998 9999999999999999999999
Q ss_pred eeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHH
Q 007442 405 ADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 405 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
+|||+|+........ ......||+.|||||++.+..++.|+|||||||+||||+| |+.||..... ..+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence 999999864333222 2233468999999999999999999999999999999999 8999864221 122333
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+.++...+ .+..++.++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 243 i~~~~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVLQ---------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCC---------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 44443211 1223456788999999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=450.47 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=207.8
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...++||+|+||+||+|++++ .||||.++.. +.+..++|.+|+.+|++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 566778899999999999998754 5999999754 45567889999999999999999999999865 568999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc-ccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-EIS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~-~~~ 418 (603)
+++|+|.++|+.. ...++|.++++|+.|||.||+|||+. +||||||||+||||++++.+||+|||+|+.... ...
T Consensus 113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999765 34699999999999999999999998 999999999999999999999999999986433 222
Q ss_pred ceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 419 HISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
...+...||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... ..+...+..+... |.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~----p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS----PD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----CC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----CC
Confidence 33455689999999999864 46899999999999999999999999643221 1222223332211 11
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+ ......++..+.+|+.+||+.+|++||||.||++.|+.++..
T Consensus 259 ~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 259 L-------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp S-------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred c-------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1 111234566789999999999999999999999999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=456.72 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=210.9
Q ss_pred CCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
+...++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 334678999999999999873 46789999997653 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
|||+++|+|.++|+... ...|+|..+++|+.|||.||+|||+. +||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999997542 13599999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHH
Q 007442 403 KVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 403 kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~ 480 (603)
||+|||+++...... ....+...||++|||||++.++.++.++|||||||+||||+| |+.||..... ..+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~~ 257 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDVV 257 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence 999999998644322 233445679999999999999999999999999999999999 8888863221 1223
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
..+..+.... .+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 258 ~~i~~~~~~~---------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIRNRQVLP---------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCCC---------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 3344443221 12234567899999999999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=439.67 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=204.2
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC----ceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG----EQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 338 (603)
++...+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456678999999999999998 5789999999754322 223345666677899999999999998764 5799999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA-----INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~-----~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
|+++|+|.++|+.. +++|..+++|+.|+|.||+|||+. ..++||||||||+|||||+++++||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999753 499999999999999999999986 2568999999999999999999999999999864
Q ss_pred cccccc---eeccCCCCCCCcCccccccC------CCCcccccccHHHHHHHHHhCCCccCCCCCcc----h----hhHH
Q 007442 414 MTEISH---ISTAPQGTPGYLDPQYHQNF------HLSDKSDVYSFGVVLVEIITALKVVDFSRPPN----E----VNLA 476 (603)
Q Consensus 414 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvL~elltg~~p~~~~~~~~----~----~~l~ 476 (603)
...... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+....... . ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 332221 22345799999999998754 46789999999999999999988765322111 0 0111
Q ss_pred HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+..+.+...+... ....+.+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 239 ~~~~~~~~~~~~rp~~p~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNR---------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGG---------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCCcc---------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 2222233232222111111 11235677899999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=445.94 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=205.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+|+.. +|+.||||+++.. +....+.|.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 6899999999754 44556789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++|+|.++|...+...+++...+.|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999876666789999999999999999999999 9999999999999999999999999999864322 1
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
...+...||+.|||||++.+..|+.++|||||||+||||+||+.||.... .... ...+..+....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~-~~~i~~~~~~~-------- 244 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNL-VLKIISGSFPP-------- 244 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHH-HHHHHHTCCCC--------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHH-HHHHHcCCCCC--------
Confidence 22344579999999999999999999999999999999999999996321 1112 22233332211
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 245 -------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223457889999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=446.34 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=221.0
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCC-Cceeee
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSH-PNLVRL 323 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H-~niv~l 323 (603)
+...+++...++|...+.||+|+||+||+|.+.. ++.||||+++... ....++|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445666677889999999999999999998753 3689999998653 4456789999999999975 899999
Q ss_pred eeeEeec-CceEEEEeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007442 324 LGCSIER-GEQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388 (603)
Q Consensus 324 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~D 388 (603)
+|+|.+. +..+||||||++|+|.++|+... ...|+|..++.|+.|||.||+|||+. +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999775 56899999999999999997642 23489999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCC
Q 007442 389 IKSSNILLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDF 466 (603)
Q Consensus 389 ik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~ 466 (603)
|||+||||++++.+||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999875443332 3345578999999999999999999999999999999998 8999864
Q ss_pred CCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 467 SRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 467 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..... .+...+.++.... .+..++.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 291 ~~~~~------~~~~~i~~g~~~~---------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTRMR---------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSH------HHHHHHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCCCC---------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 33221 2233333332211 1122355788999999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=419.19 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=198.6
Q ss_pred CccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCceEEEE
Q 007442 265 SEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQILVY 337 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 337 (603)
...++||+|+||+||+|... ++..||||++... .....+.|.+|+++|++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999985 5789999999654 44556789999999999999999999999875 34579999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~~~~~ 416 (603)
||+++|+|.++|.+. ..+++..+..|+.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999765 4599999999999999999999997 223999999999999984 78999999999986322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ...+...+..+.....++
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~--- 252 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD--- 252 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG---
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCC---
Confidence 22345689999999998865 699999999999999999999999963322 122233333332211111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+.++.+|+.+||+.||++|||+.|+++
T Consensus 253 -----------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 -----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112346889999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=429.13 Aligned_cols=254 Identities=19% Similarity=0.184 Sum_probs=206.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+.|...++||+|+||+||+|+.. +|+.||||+++.... +.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777788999999999999985 589999999976422 247999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCcccccccccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~~~~ 419 (603)
++|+|.++|... ..+++...+.|+.|++.||+|||++ +||||||||+||||+.++ ++||+|||+|+....+...
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999765 3599999999999999999999998 999999999999999987 6999999999865432211
Q ss_pred ----eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 420 ----ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 420 ----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
......||+.|||||++.+..|+.++|||||||+||||+||+.||........ . ..+..+...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~----~~i~~~~~~------ 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C----LKIASEPPP------ 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H----HHHHHSCCG------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H----HHHHcCCCC------
Confidence 12335799999999999999999999999999999999999999974333221 1 111111110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+. .........+.+++.+||+.||++|||+.|+++.|......
T Consensus 275 ~~-------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 275 IR-------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GG-------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ch-------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00 11123456788999999999999999999999999877643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=430.80 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=208.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
..|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999985 68999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.. ..+++.....|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+..... ...
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCc
Confidence 99999999975 3499999999999999999999999 9999999999999999999999999999864332 223
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.+...||+.|||||++.+..|+.++|||||||+||||++|+.||..... . .....+..+.....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~----~~~~~i~~~~~~~~--------- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---L----KAMKMIRDNLPPRL--------- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H----HHHHHHHHSSCCCC---------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---H----HHHHHHHcCCCCCC---------
Confidence 4556899999999999999999999999999999999999999963211 1 11222222211110
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........++.+|+.+||+.||++|||+.|+++
T Consensus 291 ----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 ----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234567889999999999999999998765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=429.29 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=208.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
..|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999985 58999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++... .+++.....|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..... ...
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-Ccc
Confidence 999999999643 499999999999999999999999 9999999999999999999999999999864332 223
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||..... . .....+..+.... +
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~----~~~~~i~~~~~~~-----~---- 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---L----KAMKMIRDNLPPR-----L---- 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H----HHHHHHHHSCCCC-----C----
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---H----HHHHHHHcCCCCC-----C----
Confidence 4556899999999999999999999999999999999999999963211 1 1122222221111 0
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........++.+|+.+||+.||++|||+.|+++
T Consensus 368 ----~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 ----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223457889999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=419.22 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=207.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.. +++.||||.++.. +....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999975 6899999999753 2344678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.++|... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999765 3599999999999999999999999 99999999999999999999999999998754322
Q ss_pred -cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 -SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 -~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|||||++.+..|+.++||||+||+||||+||+.||..... ......+..+.+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~------- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLEYD------- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC-------
Confidence 2234556899999999999999999999999999999999999999963211 1122233333221
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
.+.....++.+|+.+||+.||++|||+.|++
T Consensus 253 ---------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ---------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0112345678999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=405.31 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=191.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999974 6899999999754 2334567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+ +|+|.++|... ..+++.....++.|++.||+|||++ +|+||||||+||||++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 999 78999999764 4599999999999999999999999 999999999999999999999999999986432
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|||||++.+..+ +.++||||+||+||||+||+.||.... .. ...+.+..+...
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~-~~~~~i~~~~~~------- 230 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IP-VLFKNISNGVYT------- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH-HHHHHHHHTCCC-------
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HH-HHHHHHHcCCCC-------
Confidence 222345679999999999988776 579999999999999999999996321 11 122233333211
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+.....++.+|+.+||+.||++|||+.|+++
T Consensus 231 ---------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ---------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01123456789999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=414.66 Aligned_cols=242 Identities=26% Similarity=0.294 Sum_probs=194.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||+|+.. .++.||||.++... ......+.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 46899999997542 2233568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.++|... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999865 3599999999999999999999999 999999999999999999999999999986332
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........||+.|||||++.+..|+.++|||||||+||||+||+.||..... .. ....+.++.+.
T Consensus 179 ~-~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~-~~~~i~~~~~~------ 244 (304)
T 3ubd_A 179 H-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KE-TMTMILKAKLG------ 244 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC------
T ss_pred C-CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HH-HHHHHHcCCCC------
Confidence 2 2233456899999999999999999999999999999999999999963211 11 12223232211
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+...+.++.+|+.+||+.||++|||+
T Consensus 245 ----------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 ----------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111234578899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=403.17 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=190.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc-------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE------- 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------- 332 (603)
++|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999975 68999999997654 3455789999999999999999999999876553
Q ss_pred -----eEEEEeeCCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 007442 333 -----QILVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406 (603)
Q Consensus 333 -----~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~D 406 (603)
.+|||||+++|+|.+++..... ...++...+.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999976532 2367788899999999999999999 999999999999999999999999
Q ss_pred ccCccccccccc-----------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH
Q 007442 407 FGLSRLGMTEIS-----------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475 (603)
Q Consensus 407 FGla~~~~~~~~-----------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l 475 (603)
||+|+....... ...+...||+.|||||++.+..|+.++|||||||+||||++ ||.. ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~- 232 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QME- 232 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHH-
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccH-
Confidence 999986433211 11234579999999999999999999999999999999996 5531 111
Q ss_pred HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 476 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+....... ........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~p~---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDVRNLKFPP---------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHTTCCCH---------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhcCCCCC---------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122222222211 11123345678999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=402.63 Aligned_cols=286 Identities=41% Similarity=0.652 Sum_probs=248.9
Q ss_pred CCChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 251 ~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
.+++.+++.++++|...+.||+|+||+||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45666778889999999999999999999999888999999999887777788999999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERG--DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
+..++||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976532 3599999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccc-cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 409 LSRLGMT-EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 409 la~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9976332 222223445689999999999989999999999999999999999999987666666667777777777777
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+..++++.+.. ....+....+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 265 ~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLAD------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTT------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhcc------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 77777775432 34567888999999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=399.19 Aligned_cols=291 Identities=35% Similarity=0.586 Sum_probs=246.7
Q ss_pred CCCCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh-hhHHHHHHHHHHHhccCCCceeeeee
Q 007442 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT-DGIQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 247 ~~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
...+.|++++++.++++|...+.||+|+||+||+|...+++.||||+++.... .....|.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 45678999999999999999999999999999999988899999999976532 22346899999999999999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRERG--DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSK 403 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~k 403 (603)
++.+.+..++||||+++|+|.+++..... ..++|..++.|+.|++.||+|||+...++|+||||||+|||+++++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999986532 3599999999999999999999998777999999999999999999999
Q ss_pred EeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC--CcchhhHHHHHHH
Q 007442 404 VADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR--PPNEVNLAALAAD 481 (603)
Q Consensus 404 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~--~~~~~~l~~~~~~ 481 (603)
|+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+... .........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998754444444556679999999999998899999999999999999999999996321 1223345556555
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.+....+..+.+..+.. .........+.+++.+||+.+|++|||+.||++.|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQG------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTT------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhcc------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55666666666665432 345677889999999999999999999999999998743
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=398.35 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=201.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee------cCc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE------RGE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 332 (603)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57888999999999999999975 6899999999754 33455778999999999999999999998764 357
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||++ |+|.++|... ..+++.....|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999754 4699999999999999999999999 999999999999999999999999999986
Q ss_pred cccc---ccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 413 GMTE---ISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 413 ~~~~---~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.... .....+...||+.|||||++.+. .++.++||||+||+||||++|+.||..... ......+........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p~- 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTPS- 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCC-
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCC-
Confidence 4322 12234456899999999998775 569999999999999999999999964321 111111111111100
Q ss_pred ccccc--------hhhhhccCCCCcc-----chHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEIID--------PLIIEHRGHSDAG-----TLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~~d--------~~l~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+... ..+.. ....... ......++.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00000 0000000 0122457889999999999999999999775
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=388.36 Aligned_cols=201 Identities=19% Similarity=0.341 Sum_probs=171.7
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
....+.|...++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999863 46789999987643 345688999999998 69999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCcc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSR 411 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla~ 411 (603)
.+|||||+++|+|.+++. .+++.....++.|++.||+|||+. +|+||||||+||||+.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999984 389999999999999999999999 99999999999999887 799999999997
Q ss_pred ccccccc---------------------------ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCc
Q 007442 412 LGMTEIS---------------------------HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKV 463 (603)
Q Consensus 412 ~~~~~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p 463 (603)
....... ...+...||+.|||||++.+. .++.++||||+||+||||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5322110 112334699999999998775 589999999999999999999999
Q ss_pred cCCCC
Q 007442 464 VDFSR 468 (603)
Q Consensus 464 ~~~~~ 468 (603)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=369.31 Aligned_cols=282 Identities=35% Similarity=0.587 Sum_probs=230.4
Q ss_pred CCCCCChHHHHHHhcCCCcc------CcccCCCceEEEEEEEcCCcEEEEEEeccC----ChhhHHHHHHHHHHHhccCC
Q 007442 248 NIPIYPYREIEKATIGFSEK------QRLGTGAFGTVYAGKLQNDLLVAIKRIKHR----DTDGIQQVVNEIKLISCVSH 317 (603)
Q Consensus 248 ~~~~~~~~el~~at~~f~~~------~~LG~G~~g~Vykg~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H 317 (603)
..+.|++.++++++++|... +.||+|+||+||+|.. +++.||||++... .....+.|.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 46789999999999999988 8899999999999987 5779999999753 23456789999999999999
Q ss_pred CceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 318 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
|||+++++++.+.+..++||||+++|+|.+++.... ...++|..++.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999997543 34699999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH
Q 007442 397 DYNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l 475 (603)
++++.+||+|||+++...... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-- 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence 999999999999997643322 222334578999999998865 5889999999999999999999999754433221
Q ss_pred HHHHHHHhhc--CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 476 AALAADRISK--GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 476 ~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..+ ...+.. ..+.+.+++.+ ..........+.+++.+||+.+|++|||+.||++.|+++..
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDI-KEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THH-HHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHH-HHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111 111111 12233333322 22345677889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.65 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=214.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||+||+|... +++.||+|++...+....+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56778899999999999999985 58999999998877888899999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc-
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH- 419 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~- 419 (603)
++|+|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999764 34699999999999999999999999 9999999999999999999999999999864332111
Q ss_pred ------------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 420 ------------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 420 ------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
......||+.|+|||++.+..++.++||||||++||||++|..|+....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------------ 233 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------------ 233 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------------
Confidence 11145799999999999999999999999999999999999988864333221100
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......+.. ......+..+.+|+.+||+.||++|||+.||++.|+.++...
T Consensus 234 --~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 234 --LNVRGFLDR------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --BCHHHHHHH------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --hhhhccccc------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000000000 001122346788999999999999999999999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=407.30 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=210.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+++.+ +|+.||||.++.......+.+.+|+.+|++++|||||+|++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999985 6899999999887777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN--FKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~--~~~kl~DFGla~~~~~~~ 417 (603)
+++|+|.++|... ...+++.....++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999754 34599999999999999999999999 99999999999999854 79999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..+... +.+
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~~---- 377 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWN-MDD---- 377 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCC-CCS----
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHhCCCC-CCc----
Confidence 223445799999999999999999999999999999999999999963221 1112233332211 001
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........++.+|+.+||+.||++|||+.|+++
T Consensus 378 -------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 -------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457889999999999999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=380.54 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=213.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeec
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIER 330 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 330 (603)
.++|...+.||+|+||+||+|... ++..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999863 34679999998653 44567899999999999 899999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
+..++||||+++|+|.++|..... ..+++..++.++.|++.||+|||+. +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986532 3489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~ 474 (603)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++||||+| |+.||...... +
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~-- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-E-- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-G--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-H--
Confidence 9999999999999985433221 22334467889999999999999999999999999999999 88888643221 1
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
....+..+... .........+.+++.+||+.+|++||++.||++.|+++...
T Consensus 314 ----~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 ----LFKLLKEGHRM---------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ----HHHHHHTTCCC---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11222222111 11223455788999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=370.46 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=217.2
Q ss_pred CCCChHHHHHHhcC----------CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC
Q 007442 250 PIYPYREIEKATIG----------FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP 318 (603)
Q Consensus 250 ~~~~~~el~~at~~----------f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ 318 (603)
+.|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 56889999998875 666778999999999999986 6899999999877666778899999999999999
Q ss_pred ceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 007442 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY 398 (603)
Q Consensus 319 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~ 398 (603)
||+++++++...+..++||||+++|+|.+++.. ..++|..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 999999999999999999999999999999864 3599999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 399 NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 399 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-------~ 248 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-------Q 248 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H
T ss_pred CCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H
Confidence 9999999999987643322 2234557999999999999999999999999999999999999998642211 1
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
....+........ .........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AMKRLRDSPPPKL-------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHSSCCCC-------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCCCCc-------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122222211111 0112234578899999999999999999998763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.50 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=206.3
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
+++....+|...+.||+|+||+||+|+. +++.||||++.... ....++|.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3444456788899999999999999987 57789999997653 45567899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 334 ILVYEFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPP--IYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999976421 2399999999999999999999998 7 999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
+.... .........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 187 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~-- 257 (309)
T 3p86_A 187 RLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKR-- 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCC--
T ss_pred ccccc-cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC--
Confidence 75322 122234457999999999999999999999999999999999999998632211 111111111110
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..........+.+|+.+||+.+|++|||+.||++.|+.+....
T Consensus 258 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 -------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0111233457889999999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=399.39 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=199.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC------ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR------DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...++||+|+||+||+++.. +|+.||||+++.. ..........++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56888999999999999999985 5899999999643 1122223344567788889999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.++|... ..+++.....++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999865 3599999999999999999999999 99999999999999999999999999998643
Q ss_pred ccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ......||+.|||||++.. ..|+.++|||||||+||||++|+.||........ . .+...+....+
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~-~i~~~i~~~~~----- 411 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---H-EIDRMTLTMAV----- 411 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---H-HHHHHHHHCCC-----
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---H-HHHHhhcCCCC-----
Confidence 32 2344689999999999975 5799999999999999999999999964332221 1 11122222111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
..+.....++.+|+.+||+.||++|++ +.||++
T Consensus 412 -----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111223457889999999999999998 566654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=395.82 Aligned_cols=266 Identities=22% Similarity=0.350 Sum_probs=219.8
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
...+++...++|...+.||+|+||+||+|.+.++..||||+++... ...++|.+|+.+|++++|||||++++++. .+.
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 3445566677888999999999999999999888999999998654 34688999999999999999999999986 667
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++|+|.++|.......+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 89999999999999999866545689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.............+++.|+|||++....++.++||||||++||||+| |+.||..... . .+...+..+...
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~-~~~~~i~~~~~~-- 404 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------P-EVIRALERGYRM-- 404 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------H-HHHHHHHHTCCC--
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------H-HHHHHHHcCCCC--
Confidence 44332222334457889999999999999999999999999999999 9988863221 1 112222222110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+..++..+.+|+.+||+.+|++||||.+|++.|+.+...
T Consensus 405 -------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 -------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11123456788999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=373.25 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=210.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.+|...+.||+|+||+||+|.+. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..+||
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 35666789999999999999984 3457999999865 445567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999999999754 34599999999999999999999999 9999999999999999999999999999864332
Q ss_pred cc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 IS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. .......+|+.|+|||++.+..++.++||||||++||||++ |+.||..... ......+..+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~~~~---- 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVEEGYRL---- 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCC----
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCCC----
Confidence 21 22233456788999999998899999999999999999999 9998853221 1112222222110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.........+.+|+.+||+.+|++|||+.||++.|+.+....
T Consensus 274 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 -----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 112234567889999999999999999999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=366.45 Aligned_cols=265 Identities=22% Similarity=0.365 Sum_probs=210.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 334 (603)
++|...+.||+|+||+||++++ .+++.||||+++.......+.|.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5678889999999999999985 35789999999988777788999999999999999999999998654 4589
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999997653 3599999999999999999999998 99999999999999999999999999998643
Q ss_pred cccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC---------CcchhhHHHHHHHHh
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR---------PPNEVNLAALAADRI 483 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~---------~~~~~~l~~~~~~~~ 483 (603)
.... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.... ..............+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 3221 22234457778999999999999999999999999999999988875211 000011111112222
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+. ........+.++.+|+.+||+.+|++|||+.||++.|++++..
T Consensus 246 ~~~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 246 KNNG---------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HTTC---------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hccC---------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 2111 1111234456789999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=362.12 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=214.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||+||+|...++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56788899999999999999998889999999986543 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999764 34599999999999999999999999 999999999999999999999999999986444333333
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~~~----------- 226 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRL----------- 226 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-----------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCccC-----------
Confidence 44567888999999999999999999999999999999 8888863221 1112222222110
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 01112345688999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=380.84 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=202.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.+|...+.||+|+||+||+|++. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999875 4678999999865 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999754 34699999999999999999999998 9999999999999999999999999999864332
Q ss_pred ccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 ISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... ......+++.|+|||++.+..++.++||||||++||||++ |+.||..... ......+..+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~~~~---- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEGYRL---- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTTEEC----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC----
Confidence 211 1222345788999999999999999999999999999998 9999853221 1112222222100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......+..+.+|+.+||+.+|++||+|.||++.|+.+....
T Consensus 270 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 270 -----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111234567889999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=377.69 Aligned_cols=271 Identities=23% Similarity=0.317 Sum_probs=211.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc----eEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE----QILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~lV 336 (603)
.++|...++||+|+||+||+|+.. ++.||||+++.... ....+..|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367888999999999999999876 68999999976533 34556779999999999999999999987553 6999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-------NPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-------~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
|||+++|+|.+++... .++|..++.|+.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999999753 4999999999999999999999752 34899999999999999999999999999
Q ss_pred ccccccccc-ceeccCCCCCCCcCccccccC-----CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH-------
Q 007442 410 SRLGMTEIS-HISTAPQGTPGYLDPQYHQNF-----HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA------- 476 (603)
Q Consensus 410 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~------- 476 (603)
++....... .......||+.|+|||++.+. .++.++||||||+++|||+||+.||............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 976433222 223345799999999998863 4566899999999999999999999754332221111
Q ss_pred --HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 477 --ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 477 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+........+.... .......++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYW---------QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGG---------GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccc---------cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111222222211111111 1234567799999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=359.97 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=214.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.++|...+.||+|+||+||+|...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999999888999999986543 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999765 34599999999999999999999999 99999999999999999999999999998654433333
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... . ....+..+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~---------- 224 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------E-VVLKVSQGHRL---------- 224 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHHTTCCC----------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------H-HHHHHHcCCCC----------
Confidence 344567788999999998899999999999999999999 98888632211 1 11122222110
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+++.+||+.+|++|||+.||++.|+.++.+
T Consensus 225 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 -----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00112245688999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.55 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=208.0
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999986 46899999999876556667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-c
Confidence 9999999999754 489999999999999999999999 99999999999999999999999999987643322 2
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .........+.. ..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~-------- 236 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL-------- 236 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC--------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CC--------
Confidence 234557999999999999999999999999999999999999998632211 111111111111 00
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112234557889999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=380.55 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=212.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
...++|...+.||+|+||+||+|.+. +++.||||.++.. .....++|.+|+.+|++++||||+++++++.+.+..+||
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34467888899999999999999986 6899999999865 334556789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999999764 34599999999999999999999999 9999999999999999999999999999853322
Q ss_pred cccee-ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 417 ISHIS-TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 417 ~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
..... ....+++.|+|||.+....++.++||||||++||||+| |+.|+..... ......+..+...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~----- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGGRL----- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTCCC-----
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-----
Confidence 11111 12235678999999998899999999999999999999 8888853221 1122222222111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+..+.+|+.+||+.+|++|||+.||++.|+.++.+
T Consensus 335 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11122355788999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=391.69 Aligned_cols=262 Identities=28% Similarity=0.383 Sum_probs=217.6
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++....+|...+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++|||||+++++|.+.+..+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 33445678888999999999999999875 7899999998653 346789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.++|.......+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999876556799999999999999999999999 999999999999999999999999999987543
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
..........+++.|+|||++....++.++||||||++||||+| |+.|+....... +.+.+..+...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~----- 438 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRM----- 438 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCC-----
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 33233334456789999999999999999999999999999999 888886432211 11222222110
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.....++..+.+|+.+||+.+|++||||.||++.|+.+..
T Consensus 439 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1122345678899999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=382.33 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=210.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC-ceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG-EQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|.+. ++.||||.++... ..+.|.+|+.+|++++||||+++++++.+.+ ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456778899999999999999985 6799999998653 4578999999999999999999999988765 78999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.++|.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 341 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc----
Confidence 9999999999876555589999999999999999999999 999999999999999999999999999985321
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......+++.|+|||.+.+..++.++||||||++||||+| |+.||......+ +...+..+...
T Consensus 342 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~--------- 405 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM--------- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTCCC---------
T ss_pred cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence 1223367899999999999999999999999999999999 999986433221 11222232111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+..++..+.+|+.+||+.+|++|||+.||++.|+.+...
T Consensus 406 ------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 ------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223456788999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=384.96 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=211.2
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++...++|...+.||+|+||+||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..+||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 444556788889999999999999999888889999998654 335789999999999999999999999876 678999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.++|.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999865556699999999999999999999999 9999999999999999999999999999864433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.........+++.|+|||.+....++.++||||||++||||+| |+.|+..... ..+...+..+...
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~------ 400 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRM------ 400 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCC------
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC------
Confidence 2222334457889999999999999999999999999999999 8888853221 1122223332111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+..++..+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11223456788999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=358.24 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=201.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--cCCCceeeeeeeEeec----CceE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC--VSHPNLVRLLGCSIER----GEQI 334 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~ 334 (603)
.++|...+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999988 6889999999754 33556667777666 7999999999997653 4578
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeeecCCCcEEEee
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH--------SAINPPIYHRDIKSSNILLDYNFKSKVAD 406 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH--------~~~~~~ivH~Dik~~NILld~~~~~kl~D 406 (603)
+||||+++|+|.+++.. ..+++..++.|+.|++.||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999954 35999999999999999999999 66 999999999999999999999999
Q ss_pred ccCcccccccccce---eccCCCCCCCcCccccccC------CCCcccccccHHHHHHHHHhC----------CCccCCC
Q 007442 407 FGLSRLGMTEISHI---STAPQGTPGYLDPQYHQNF------HLSDKSDVYSFGVVLVEIITA----------LKVVDFS 467 (603)
Q Consensus 407 FGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvL~elltg----------~~p~~~~ 467 (603)
||+++......... .....||+.|+|||++.+. .++.++||||||+++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997643322211 2334799999999999876 455799999999999999999 6676543
Q ss_pred CCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 468 RPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 468 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
.+.... ... ....+........+.+ ..........+.+|+.+||+.||++|||+.||++.|++|
T Consensus 237 ~~~~~~-~~~-~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FED-MRKVVCVDQQRPNIPN---------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHH-HHHHHTTSCCCCCCCG---------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhh-hhHHHhccCCCCCCCh---------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332211 111 1111111111111111 011234678899999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=374.85 Aligned_cols=271 Identities=24% Similarity=0.309 Sum_probs=219.1
Q ss_pred CCChHHHHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceee
Q 007442 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVR 322 (603)
Q Consensus 251 ~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~ 322 (603)
.+...+++...++|...+.||+|+||.||+|++. +++.||||+++.. .....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556677778899999999999999999999742 3578999999865 344557899999999999 7999999
Q ss_pred eeeeEeecCc-eEEEEeeCCCCCHHHHhhhhcC-----------------------------------------------
Q 007442 323 LLGCSIERGE-QILVYEFMPNGTLCQHLQRERG----------------------------------------------- 354 (603)
Q Consensus 323 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 354 (603)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999976532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc-
Q 007442 355 -----------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE- 416 (603)
Q Consensus 355 -----------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~- 416 (603)
..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1289999999999999999999999 9999999999999999999999999999864332
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.........||+.|+|||++.+..++.++||||||+++|||+| |+.||....... .+...+..+....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~----- 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR----- 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCC-----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCC-----
Confidence 2223344568899999999999999999999999999999999 999986433221 1122222221111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.......++.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1112345688999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=357.22 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=211.3
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..++|...+.||+|+||+||++...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3467888899999999999999999888999999986543 347799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999997642 3599999999999999999999999 9999999999999999999999999999864443333
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+..+...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~~--------- 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRL--------- 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCC---------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhcccCC---------
Confidence 3344557888999999999999999999999999999998 9888863221 1112222222110
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.........+.+|+.+||+.+|++|||+.|+++.|+.+..
T Consensus 241 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 241 ------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0011224578899999999999999999999999998865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=368.26 Aligned_cols=266 Identities=25% Similarity=0.325 Sum_probs=216.3
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
+++...++|...+.||+|+||.||+|+..+ ++.||||.++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344456789999999999999999999853 478999999865 3445678999999999999999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRER----------------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH 386 (603)
+.+..++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 9999999999999999999997642 14699999999999999999999999 9999
Q ss_pred cCCCCCCeeecCCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCcc
Q 007442 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVV 464 (603)
Q Consensus 387 ~Dik~~NILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~ 464 (603)
|||||+|||++.++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999997543221 122334567899999999999999999999999999999999 88888
Q ss_pred CCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 465 DFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 465 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..... ......+.++..... ....+..+.+|+.+||+.+|++||++.||++.|+++..
T Consensus 278 ~~~~~-------~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMAH-------EEVIYYVRDGNILAC---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSCH-------HHHHHHHHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCh-------HHHHHHHhCCCcCCC---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 63211 112233333332111 11234578899999999999999999999999999876
Q ss_pred cc
Q 007442 545 RT 546 (603)
Q Consensus 545 ~~ 546 (603)
..
T Consensus 336 ~~ 337 (343)
T 1luf_A 336 RA 337 (343)
T ss_dssp --
T ss_pred hh
Confidence 54
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=364.75 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=206.8
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..+|...+.||+|+||.||+|.. .+++.||||++... +....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788899999999999999998 57899999999754 4456678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999765 3499999999999999999999999 9999999999999999999999999999754322
Q ss_pred cceeccCCCCCCCcCccccccCCCC-cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLS-DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|+|||++.+..++ .++||||||++||||++|+.||..... ......+..+...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~------- 232 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRGKYR------- 232 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC-------
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC-------
Confidence 223456799999999999888765 799999999999999999999964211 1122222222211
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ---------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ---------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01123456789999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.32 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=209.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||.||++... +++.||||.+... .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999975 5789999998643 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... .++++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999765 3599999999999999999999999 9999999999999999999999999999864433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.........||+.|+|||.+.+..++.++||||||+++|||+||+.||..... .......+... ..... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~~-~-- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNVT-T-- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCHH-H--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCcc-h--
Confidence 32333445799999999999999999999999999999999999999964221 11122222221 11100 0
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhhc
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIRTR 545 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eV~~~L~~i~~~ 545 (603)
......+..+.+++.+||+.+|++|| ++.++.+.|+.+...
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 235 --------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp --------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred --------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 01123456788999999999999998 999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=374.67 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=216.8
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeE
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCS 327 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 327 (603)
+...++|...+.||+|+||+||+|... .+..||||+++.. .....+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578888999999999999999863 2367999999765 345567899999999999 899999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
.+.+..++||||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999986542 3599999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
|||++++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||++||||++ |+.|+.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998643321 123344567889999999999999999999999999999999 8888853211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......+..+.... .......++.+|+.+||+.+|++|||+.||++.|+++....
T Consensus 300 -----~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 -----EELFKLLKEGHRMD---------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -----HHHHHHHHTTCCCC---------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHHcCCCCC---------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11223333322111 11223457889999999999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.00 Aligned_cols=263 Identities=16% Similarity=0.157 Sum_probs=211.4
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 338 (603)
..+|...+.||+|+||+||+|+. .+++.||||.+..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999997 5689999999875432 24688999999999 89999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----EEEeeccCcccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK-----SKVADFGLSRLG 413 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~-----~kl~DFGla~~~ 413 (603)
|+ +|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999865 35699999999999999999999999 9999999999999998887 999999999864
Q ss_pred cccccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 414 MTEISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 414 ~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
...... ......||+.|+|||++.+..++.++||||||++||||++|+.||..............+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-- 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-- 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH--
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc--
Confidence 332211 124567999999999999999999999999999999999999999754333221111111111000
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
... ..+ ....+ ++.+++.+||+.+|.+||++.+|.+.|+.+..+.
T Consensus 239 --~~~-~~~----------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 --TPI-EVL----------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp --SCH-HHH----------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --CCH-HHH----------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 000 01123 7899999999999999999999999999887653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=366.27 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||+|++. +++ .||+|.++.. .....++|.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56888899999999999999964 333 4689988654 334567899999999999999999999999875 4789
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999765 34699999999999999999999999 999999999999999999999999999986433
Q ss_pred cc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ........+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... + ...+..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~---- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL---- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCC----
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHHHHcCCCC----
Confidence 22 222334457889999999999999999999999999999999 999986432211 1 1122222110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+|+.+||+.+|++||+|.||++.|+.+...
T Consensus 239 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 -----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11223455788999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=363.59 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=215.1
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
+...++|...+.||+|+||.||+|... ++..||||.++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 334577888899999999999999862 3478999999865 345668899999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERG----------------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~D 388 (603)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999986432 2389999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCC
Q 007442 389 IKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDF 466 (603)
Q Consensus 389 ik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~ 466 (603)
|||+|||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986433222 12234457889999999998889999999999999999999 9888864
Q ss_pred CCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 467 SRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 467 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..... ....+..+... .........+.+++.+||+.||++||++.||++.|+++..+
T Consensus 256 ~~~~~-------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 256 IPPER-------LFNLLKTGHRM---------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCGGG-------HHHHHHTTCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHH-------HHHHhhcCCcC---------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32211 11222222111 11123455788999999999999999999999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=352.86 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=213.5
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||.||++...++..||||.++.... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56778889999999999999998889999999987543 34789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999764 34689999999999999999999999 999999999999999999999999999986443322233
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~~----------- 224 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRL----------- 224 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-----------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCcC-----------
Confidence 44567889999999998899999999999999999999 8888763221 1112222222110
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00112345788999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.57 Aligned_cols=264 Identities=28% Similarity=0.391 Sum_probs=219.7
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
+++...++|...+.||+|+||+||+|.... +..||||.++.. ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 334456788889999999999999999865 788999999764 345678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++.......+++..++.++.+++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999876666799999999999999999999999 99999999999999999999999999998754
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ...+..+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~----~~~~~~~~~----- 230 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKDYR----- 230 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTTCC-----
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhccCC-----
Confidence 433333444567889999999999999999999999999999999 888886432211 1 111111110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.......+..+.+|+.+||+.+|++|||+.||++.|+.+...
T Consensus 231 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 ----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 011123456788999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=355.65 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
..++|...+.||+|+||+||+|.... +..||||.++.. .....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678888999999999999998753 457999998764 3445678999999999999999999999984 56789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999754 34699999999999999999999998 99999999999999999999999999998644
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
...........+|+.|+|||.+....++.++||||||+++|||++ |+.||......+ . ...+..+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~----~~~i~~~~~~---- 236 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGERL---- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCC----
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---H----HHHHHcCCCC----
Confidence 333233344457889999999998999999999999999999997 888886432221 1 1122222111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+..+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 237 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 -----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11123455788999999999999999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=357.57 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=214.9
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++...++|...+.||+|+||.||+|...++..||||.++... ...+.|.+|++++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 334456788899999999999999999888899999997653 34578999999999999999999999986 4568999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999765444699999999999999999999999 9999999999999999999999999999865433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+..+...
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~------ 229 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-------EVIQNLERGYRM------ 229 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCC------
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-------HHHHHHhcccCC------
Confidence 3333344567889999999998889999999999999999999 88888532211 112222222110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 230 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 ---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11122345788999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=372.62 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=211.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...+.||+|+||+||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999853 4578999999754 4455678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEee
Q 007442 335 LVYEFMPNGTLCQHLQRERG-----DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KSKVAD 406 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~kl~D 406 (603)
+||||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999987542 3499999999999999999999999 999999999999999544 599999
Q ss_pred ccCccccccc-ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhh
Q 007442 407 FGLSRLGMTE-ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 407 FGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
||+++..... .........+|+.|+|||++.+..++.++||||||++||||+| |+.||..... ......+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 9999753221 1122233467899999999999999999999999999999998 8888863211 11222222
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+.... ........+.+|+.+||+.+|++||++.||++.|+.+...
T Consensus 301 ~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMD---------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCC---------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 222111 1123345788999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=352.38 Aligned_cols=264 Identities=17% Similarity=0.217 Sum_probs=213.1
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|.. .+++.||||.++... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35788899999999999999997 568999999987543 235678899999999 79999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----EEEeeccCcccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK-----SKVADFGLSRLG 413 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~-----~kl~DFGla~~~ 413 (603)
|+ +++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999764 34599999999999999999999998 9999999999999987766 999999999864
Q ss_pred ccccc------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 414 MTEIS------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 414 ~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 33221 123445799999999999999999999999999999999999999976443332222221111111111
Q ss_pred cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 488 ~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..+ .....+..+.+++.+||+.+|++||++.+|++.|+++....
T Consensus 242 ~~~---------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 242 LRE---------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHH---------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH---------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 01123457889999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.15 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=208.7
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee---------
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--------- 329 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 329 (603)
...+|...+.||+|+||.||+|... +++.||||+++... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467888999999999999999986 68999999998654 356789999999999999999999864
Q ss_pred -------cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 330 -------RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 330 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 44579999999999999999876666799999999999999999999999 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.. .......
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTD 230 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHH
Confidence 999999997643321 23345699999999999999999999999999999999999887631 1112222
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhccc
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTM 547 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~~ 547 (603)
+..+.+... ....+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 231 ~~~~~~~~~------------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LRDGIISDI------------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHTTCCCTT------------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hhccccccc------------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 333322211 23357789999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.62 Aligned_cols=264 Identities=21% Similarity=0.244 Sum_probs=211.1
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
.+++++..+++|...++||+|+||+||+|++.+ ++.||||+++... ....+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455667778899999999999999999999865 7899999997531 122234889999999999999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
+.+..+|||||+++|+|.++|... ...+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999764 34599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
+++..............||+.|+|||++. ...++.++||||||++||||++|+.||...... .....+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~ 297 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHK 297 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcc
Confidence 99765444444445568999999999987 557899999999999999999999999642211 1111111000
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
..-.+. .........+.+|+.+||..+|++ ||++.|+++.
T Consensus 298 ~~~~~p---------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFP---------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCC---------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCC---------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000000 111123456888999999888888 9999998763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=360.01 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=197.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +||||+++++++.+.+..+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367899999999999999999986 6899999998754 233445566677666666 899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+ +|+|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~- 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT- 209 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence 9999 78999999765 35699999999999999999999998 999999999999999999999999999876332
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||++|+|||++.+ .++.++||||||++||||++|..++... . ....+..+... +.+
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~-----~~~~~~~~~~~----~~~ 273 (311)
T 3p1a_A 210 -AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----E-----GWQQLRQGYLP----PEF 273 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----H-----HHHHHTTTCCC----HHH
T ss_pred -CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----c-----HHHHHhccCCC----ccc
Confidence 223345569999999999876 7999999999999999999997766421 1 12222222221 111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......++.+++.+||+.||++|||+.|+++
T Consensus 274 ----------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 ----------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123457889999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=388.96 Aligned_cols=264 Identities=26% Similarity=0.341 Sum_probs=217.3
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
.+++...++|...+.||+|+||+||+|.+.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 33444566788889999999999999999888889999998654 335789999999999999999999999876 6789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.++|.......+++..++.|+.|++.||+|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999865555699999999999999999999999 99999999999999999999999999998644
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
...........++..|+|||.+....++.++||||||++||||+| |+.||..... ..+...+..+...
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~~---- 483 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRM---- 483 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCCC----
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC----
Confidence 322222334457789999999999999999999999999999999 8888853211 1122233332111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.....+...+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 484 -----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11123456788999999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.98 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=207.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.. ++.||||+++.. .....+.|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56788899999999999999985 788999999865 345567899999999999999999999999877 7889999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP--IYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++|+|.+++.......+++..++.|+.|++.||+|||+. + |+||||||+|||++.++.++|.|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999876555699999999999999999999997 6 9999999999999999999999999875421
Q ss_pred cccceeccCCCCCCCcCccccccCCCCc---ccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSD---KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ..........+...
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 230 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRP--- 230 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCC---
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCC---
Confidence 22346899999999998755444 89999999999999999999863221 11112222221111
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.........+.+++.+||+.+|++|||+.||++.|+++..
T Consensus 231 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 ------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112234578899999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.97 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=204.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778889999999999999975 343 38888886442 333466788999999999999999999985 567899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999764 24599999999999999999999999 999999999999999999999999999987543
Q ss_pred cc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ........+|..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA--- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTTCBCC---
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCCC---
Confidence 22 223345568889999999999999999999999999999999 999987433221 112222221111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
........+.+++.+||+.+|++||++.||++.|+.+...+
T Consensus 238 ------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 238 ------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 01112335778999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.93 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=208.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec--Cce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 333 (603)
..|...+.||+|+||.||++++ .+++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577788999999999999984 36789999999854 334567899999999999999999999999876 668
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999765 34599999999999999999999999 9999999999999999999999999999864
Q ss_pred ccccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC--------CcchhhHHHHHHHHh
Q 007442 414 MTEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR--------PPNEVNLAALAADRI 483 (603)
Q Consensus 414 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~--------~~~~~~l~~~~~~~~ 483 (603)
..... .......+|..|+|||.+.+..++.++||||||+++|||+||+.|+.... +.............+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 43222 22344568888999999999899999999999999999999988864210 111111111112222
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
..+.. ..........+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 257 ~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKR---------------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCC---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCC---------------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22111 1112234567899999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=363.72 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=199.7
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcCC----cEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
+....++|...+.||+|+||+||+|..... ..||||.++.. .....+.|.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 334456899999999999999999987543 27999999765 345578899999999999999999999999877
Q ss_pred Cce------EEEEeeCCCCCHHHHhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 331 GEQ------ILVYEFMPNGTLCQHLQRERG----DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 331 ~~~------~lV~E~~~~gsL~~~l~~~~~----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
... ++||||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+++++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 999999999999999975432 2599999999999999999999999 999999999999999999
Q ss_pred cEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHH
Q 007442 401 KSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~ 478 (603)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~--- 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I--- 248 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H---
Confidence 999999999976433221 22234457889999999999999999999999999999999 888886432211 1
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
...+..+... .........+.+|+.+||+.||++|||+.|+++.|+++...+
T Consensus 249 -~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 -YNYLIGGNRL---------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHHHTTCCC---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHHhcCCCC---------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111110 112234457889999999999999999999999999997653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.73 Aligned_cols=270 Identities=14% Similarity=0.185 Sum_probs=209.7
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCChhhH-----------HHHHHHHHHHhccCCCceee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRDTDGI-----------QQVVNEIKLISCVSHPNLVR 322 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~ 322 (603)
..++|...+.||+|+||+||+|.+.+ ++.||||.+........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44689999999999999999999865 37899999876543211 23445667788889999999
Q ss_pred eeeeEeec----CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-
Q 007442 323 LLGCSIER----GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD- 397 (603)
Q Consensus 323 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld- 397 (603)
+++++... ...+|||||+ +|+|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99998875 4489999999 99999999764 35699999999999999999999999 999999999999999
Q ss_pred -CCCcEEEeeccCcccccccccce------eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCc
Q 007442 398 -YNFKSKVADFGLSRLGMTEISHI------STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP 470 (603)
Q Consensus 398 -~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~ 470 (603)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++||||||++||||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999997644322111 12345999999999999999999999999999999999999999743222
Q ss_pred chhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 471 NEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 471 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.. ......... ...+.+++++.+.. ...+.++.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 268 ~~--~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PK--YVRDSKIRY-RENIASLMDKCFPA---------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HH--HHHHHHHHH-HHCHHHHHHHHSCT---------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH--HHHHHHHHh-hhhHHHHHHHhccc---------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11 111111111 11233333333211 123567889999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.58 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=215.3
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEee
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE 329 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 329 (603)
+...++|...+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 33456788899999999999999985 246789999998653 34567899999999999 89999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERG----------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999986532 2489999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999864433222 2234457889999999999999999999999999999999 888886432211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
. ....+..+.. . .........+.+|+.+||+.+|++|||+.||++.|+++....
T Consensus 256 ~------~~~~~~~~~~-~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 K------FYKMIKEGFR-M--------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H------HHHHHHHTCC-C--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H------HHHHhccCCC-C--------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 1111211110 0 011123457889999999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=361.76 Aligned_cols=265 Identities=27% Similarity=0.367 Sum_probs=212.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEe--ecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI--ERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 334 (603)
++|...+.||+|+||.||++++ .+++.||||+++.......+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678889999999999999984 357899999999887777888999999999999999999999987 455688
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999998653 3599999999999999999999998 99999999999999999999999999998643
Q ss_pred cccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcc--------hhhHHHHHHHHhh
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN--------EVNLAALAADRIS 484 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~--------~~~l~~~~~~~~~ 484 (603)
.... .......+|+.|+|||++.+..++.++||||||+++|||++|+.|+....... ...........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 3222 12334568888999999999889999999999999999999999985311100 0000111111111
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+. ...........+.+|+.+||+.+|++|||+.||++.|+.+...
T Consensus 259 ~~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 259 EGQ---------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp TTC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ccc---------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111 1112234556789999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=356.80 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=199.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE------ 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 332 (603)
.++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888999999999999999986 78999999997543 3456789999999999999999999999876543
Q ss_pred ---------------------------------------------------eEEEEeeCCCCCHHHHhhhhcC-CCCCHH
Q 007442 333 ---------------------------------------------------QILVYEFMPNGTLCQHLQRERG-DGLSWP 360 (603)
Q Consensus 333 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 360 (603)
.++||||+++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 7899999999999999986533 236788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc-----------ceeccCCCCCC
Q 007442 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-----------HISTAPQGTPG 429 (603)
Q Consensus 361 ~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 429 (603)
.++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999998 999999999999999999999999999986433211 12234569999
Q ss_pred CcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchH
Q 007442 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLA 509 (603)
Q Consensus 430 Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 509 (603)
|+|||++.+..++.++||||||+++|||++|..|+. ........+..+.... ....
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~~~~~~~~~~~~---------------~~~~ 297 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFPL---------------LFTQ 297 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHHHHHHHTTCCCH---------------HHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHHHHHhhccCCCc---------------cccc
Confidence 999999999999999999999999999999865532 1111122222221111 1123
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 510 SVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 510 ~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+.+++.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3456789999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.45 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=203.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|+..+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997542 2335778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|++ |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp CCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred CCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 997 5888888754 34599999999999999999999999 9999999999999999999999999999864322 2
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc---cch
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI---IDP 494 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d~ 494 (603)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .......+......+. .+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhcc
Confidence 22344578999999999876 5689999999999999999999999975443322 1122222211111100 000
Q ss_pred hhhhcc--CCCC-----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHR--GHSD-----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~--~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...... .... ........++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 0000 001123457889999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.42 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=205.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999986 5899999999753 2334577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999765 3589999999999999999999999 9999999999999999999999999999853222
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+..+.+.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~-~~~~i~~~~~~-------- 223 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ER-LFELILMEEIR-------- 223 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC--------
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HH-HHHHHHcCCCC--------
Confidence 2223455799999999999999999999999999999999999999863211 11 11222222110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
.+.....++.+|+.+||+.||++|| ++.||++.
T Consensus 224 --------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112345788999999999999999 88888753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.72 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=211.9
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEe
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSI 328 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 328 (603)
++...++|...+.||+|+||+||+|... ++..||||.++.. .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678888999999999999999962 4568999999754 234457899999999999 8999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERG---------------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHR 387 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~ 387 (603)
..+..+|||||+++|+|.+++..... ..++|..++.++.|++.||+|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 99999999999999999999976532 2389999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccC
Q 007442 388 DIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVD 465 (603)
Q Consensus 388 Dik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~ 465 (603)
||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||++||||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986433222 22334457889999999999999999999999999999998 998986
Q ss_pred CCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 466 FSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 466 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
...... .+...+..+... .........+.+|+.+||+.+|++|||+.||++.|+.+...
T Consensus 277 ~~~~~~------~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDA------NFYKLIQNGFKM---------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSH------HHHHHHHTTCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHH------HHHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 433221 111222222110 11122345788999999999999999999999999998765
Q ss_pred c
Q 007442 546 T 546 (603)
Q Consensus 546 ~ 546 (603)
.
T Consensus 336 ~ 336 (344)
T 1rjb_A 336 A 336 (344)
T ss_dssp -
T ss_pred H
Confidence 4
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.34 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=200.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
..+|...+.||+|+||+||+|+..+ .||||.++.. .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4678889999999999999998644 5999999754 345568899999999999999999999965 5567899999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc-cc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT-EI 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~-~~ 417 (603)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999754 34599999999999999999999999 999999999999999999999999999975332 11
Q ss_pred cceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ......+..+.....+.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~- 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLS- 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTT-
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchh-
Confidence 22233456999999999986 567888999999999999999999999643321 12223333333222111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
......+..+.+|+.+||+.+|++|||+.||+++|+++.+
T Consensus 249 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 ----------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ----------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1122345678999999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=363.94 Aligned_cols=266 Identities=25% Similarity=0.352 Sum_probs=215.1
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeE
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCS 327 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 327 (603)
+++...++|...+.||+|+||+||+|.... ...||||.++... ....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455566789999999999999999999743 2489999997653 44567899999999999 899999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRER------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 99999999999999999999997642 24589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchh
Q 007442 396 LDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEV 473 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~ 473 (603)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999864332222 2233457889999999999999999999999999999999 8888864322211
Q ss_pred hHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 474 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
....+..+... .........+.+|+.+||+.+|++|||+.||++.|+++...
T Consensus 276 -----~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 -----FYKLVKDGYQM---------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----HHHHHHHTCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCC---------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11122111100 01112345788999999999999999999999999988653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=361.87 Aligned_cols=272 Identities=25% Similarity=0.328 Sum_probs=220.9
Q ss_pred CCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCcee
Q 007442 249 IPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLV 321 (603)
Q Consensus 249 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv 321 (603)
...+..++++...++|...+.||+|+||.||+|... +++.||||.++... ......|.+|+.++++++||||+
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 345666677778889999999999999999999865 36789999997653 34556799999999999999999
Q ss_pred eeeeeEeecCceEEEEeeCCCCCHHHHhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 007442 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERG--------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSN 393 (603)
Q Consensus 322 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~N 393 (603)
++++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~N 168 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 168 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGG
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccce
Confidence 999999999999999999999999999976421 4579999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 394 ILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 394 ILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 246 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-- 246 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--
Confidence 9999999999999999986433221 12233456889999999999999999999999999999999 7777753211
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+..+.... ........+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 247 -----~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 -----EQVLRFVMEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -----HHHHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -----HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11222222322211 1123345788999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=349.31 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=203.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhh-------HHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDG-------IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
++|...+.||+|+||+||+|+.. +++.||||++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67888999999999999999984 68899999997543211 167899999999999999999999986554
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCc-----EEEee
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP--IYHRDIKSSNILLDYNFK-----SKVAD 406 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--ivH~Dik~~NILld~~~~-----~kl~D 406 (603)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999999764 34699999999999999999999998 7 999999999999988776 99999
Q ss_pred ccCcccccccccceeccCCCCCCCcCccccc--cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQ--NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 407 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ .. ...+.
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~-~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF-INMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH-HHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH-HHHHh
Confidence 999975322 234457999999999984 45678899999999999999999999974333211 11 11111
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
...... .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 244 ~~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRP--------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCC--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCC--------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 11123355788999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.76 Aligned_cols=275 Identities=22% Similarity=0.251 Sum_probs=213.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC--ceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG--EQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 337 (603)
++|...++||+|+||+||+|.... ++.||||+++... ....+.+.+|++++++++||||+++++++.+.. ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 568888999999999999999864 8899999997543 334677889999999999999999999988765 779999
Q ss_pred eeCCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeccCccc
Q 007442 338 EFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVADFGLSRL 412 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl----d~~~~~kl~DFGla~~ 412 (603)
||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986543 3499999999999999999999999 99999999999999 7888899999999986
Q ss_pred ccccccceeccCCCCCCCcCccccc--------cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQ--------NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
..... ......||+.|+|||++. +..++.++||||||+++|||+||+.||......... .......+.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhc
Confidence 43322 223456999999999886 568899999999999999999999999743332221 111122211
Q ss_pred c---CCcccccch---hhh--hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 485 K---GRLDEIIDP---LII--EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 485 ~---~~~~~~~d~---~l~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
. ..+..+.+. .+. ................+.+++.+||+.||++|||+.|+++......
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1 111110000 000 0000112334567788999999999999999999999999887653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.11 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=208.0
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
..++|...+.||+|+||+||+|...+ +..||||.++.. .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998653 246999999865 44566889999999999999999999999764 5678
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999999765 34599999999999999999999998 99999999999999999999999999998644
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
...........+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... .. ..+..+....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~----~~~~~~~~~~--- 234 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI----GVLEKGDRLP--- 234 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH----HHHHHTCCCC---
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH----HHHhcCCCCC---
Confidence 333333344567889999999998999999999999999999998 999986432221 11 1122211100
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
........+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 235 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1112345688999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.07 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=201.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||+||+|+.. ++.||||+++.. ...+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46777889999999999999985 678999999754 34578999999999999999999999886 45899999999
Q ss_pred CCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-EEEeeccCcccccccccc
Q 007442 342 NGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK-SKVADFGLSRLGMTEISH 419 (603)
Q Consensus 342 ~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~-~kl~DFGla~~~~~~~~~ 419 (603)
+|+|.+++..... ..+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999986532 24789999999999999999999943238999999999999998886 79999999975322
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... ....+....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~-~~~~~~~~~--------- 224 (307)
T 2eva_A 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW-AVHNGTRPP--------- 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH-HHHTTCCCC---------
T ss_pred ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH-HHhcCCCCC---------
Confidence 1233469999999999999999999999999999999999999986432211 11111 111221111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.....+..+.+|+.+||+.+|++|||+.||++.|+.+....
T Consensus 225 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 ------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223457889999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=346.74 Aligned_cols=253 Identities=29% Similarity=0.396 Sum_probs=195.3
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh----hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT----DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||+||+|... +..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999975 78999999975432 33578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--------CCcEEEeeccC
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--------NFKSKVADFGL 409 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--------~~~~kl~DFGl 409 (603)
||+++++|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999963 35999999999999999999999982223999999999999986 67899999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .+..+...
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~ 232 (271)
T 3dtc_A 163 AREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAY-GVAMNKLA 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHH-HHHTSCCC
T ss_pred ccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-hhhcCCCC
Confidence 9753322 12244689999999999999999999999999999999999999863211 11111 11111111
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
. .........+.+++.+||+.+|++|||+.||++.|++|
T Consensus 233 ~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 L--------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 11123345788999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=358.96 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=213.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc--------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ--------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE 329 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 329 (603)
..++|...+.||+|+||+||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478888999999999999999873 4678999999865 345567899999999999 89999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999986532 2489999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchh
Q 007442 396 LDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEV 473 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~ 473 (603)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999986433221 22334467889999999998889999999999999999999 8888863211
Q ss_pred hHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 474 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......+..+.... ........+.+++.+||+.+|++||++.||++.|+++....
T Consensus 266 ---~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 ---EELFKLLKEGHRMD---------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ---HHHHHHHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHhcCCCCC---------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11122222221111 11233457889999999999999999999999999997653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.96 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=204.0
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||.||+|.. .+++.||||+++.. +....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688899999999999999997 46899999999753 3456678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++|+|.+++... ....+++..++.++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999753 245699999999999999999999999 999999999999999999999999999876432
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. .....+..+......
T Consensus 189 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~~~~~--- 259 (310)
T 2wqm_A 189 K-TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIEQCDYPPLP--- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HH-HHHHHHHTTCSCCCC---
T ss_pred C-CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HH-HHHHHhhcccCCCCc---
Confidence 2 12223446899999999999999999999999999999999999998642221 11 112223332221111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......++.+|+.+||+.||++|||+.||++.|+++....
T Consensus 260 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 -----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1123457889999999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.06 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=202.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999986 68999999997543 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc-c
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE-I 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~-~ 417 (603)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999754 3499999999999999999999998 9999999999999999999999999999764322 2
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||++.+..+ +.++||||||++||||++|+.||......... . ......... .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~----~~~~~~~~~---~---- 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y----SDWKEKKTY---L---- 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H----HHHHTTCTT---S----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H----HHHhccccc---C----
Confidence 222345679999999999987765 77999999999999999999999753332111 1 111111100 0
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+|+.+||+.||++|||+.|+++.
T Consensus 229 --------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 --------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0012234567899999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.49 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=204.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-C-------cEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-D-------LLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
++|...+.||+|+||+||+|.... + ..||+|.++.......+.|.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 567888999999999999998753 3 57999999877667778999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--------EEEe
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK--------SKVA 405 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~--------~kl~ 405 (603)
++||||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999764 23499999999999999999999999 9999999999999998887 9999
Q ss_pred eccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 406 DFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 406 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+....... .. .....
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~-~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RK-LQFYE 232 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH-HHHHH
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HH-HHHhh
Confidence 99998753221 22347889999999987 679999999999999999999766554222111 11 11111
Q ss_pred c-CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 485 K-GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 485 ~-~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
. ..+. .....++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 233 ~~~~~~------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 DRHQLP------------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TTCCCC------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ccCCCC------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1 1111 11123577899999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=356.47 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=204.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD------GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.++|...+.||+|+||+||++... +++.||||.++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999986 5889999999764321 357899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeccC
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFGL 409 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFGl 409 (603)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999753 4599999999999999999999998 999999999999998887 899999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+......
T Consensus 165 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~-~~~~~~~~~~~ 235 (326)
T 2y0a_A 165 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------E-TLANVSAVNYE 235 (326)
T ss_dssp CEECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------H-HHHHHHHTCCC
T ss_pred CeECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------H-HHHHHHhcCCC
Confidence 9864322 2233457999999999999899999999999999999999999998632111 1 11112111110
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..++ . .......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~-~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 -FEDE-Y----------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCHH-H----------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCcc-c----------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011 0 1123456889999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.90 Aligned_cols=252 Identities=19% Similarity=0.234 Sum_probs=206.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||++... +++.||+|.++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999986 57899999997653 4456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--NFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~~~~~~ 417 (603)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999754 34599999999999999999999999 9999999999999987 789999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... . .....+..+.... ++.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~-~~~~~i~~~~~~~--~~~-- 225 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------Q-QIIENIMNAEYTF--DEE-- 225 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------H-HHHHHHHHTCCCC--CHH--
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------H-HHHHHHHcCCCCC--Chh--
Confidence 223345689999999999988899999999999999999999999864221 1 1122222222110 110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......++.+++.+||+.||++|||+.|+++.
T Consensus 226 --------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 --------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011234578899999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=361.73 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=206.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD------GIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
..+.|...+.||+|+||+||++... +++.||||.++..... ..+.+.+|+.+|.+++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467888999999999999999986 5899999999765321 35789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeecc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFG 408 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFG 408 (603)
.+|||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999653 4599999999999999999999999 999999999999998876 79999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 165 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVSY 235 (361)
T ss_dssp SCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCC
T ss_pred CceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCC
Confidence 99864332 223445799999999999998999999999999999999999999963211 111222322221
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. +++.. .......+.+++.+||..||++|||+.|+++
T Consensus 236 ~--~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D--FDEEF----------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCchh----------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 11111 1123456889999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=353.03 Aligned_cols=262 Identities=22% Similarity=0.350 Sum_probs=209.1
Q ss_pred CCccCcccCCCceEEEEEEEc-----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--CceEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-----NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER--GEQIL 335 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 335 (603)
|...+.||+|+||+||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477889999999999998753 57899999998653 45567899999999999999999999999874 56789
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999754 399999999999999999999999 999999999999999999999999999986433
Q ss_pred ccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCc--------chhhHHHHHHHHhhc
Q 007442 416 EIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPP--------NEVNLAALAADRISK 485 (603)
Q Consensus 416 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~--------~~~~l~~~~~~~~~~ 485 (603)
... .......+|..|+|||++.+..++.++||||||+++|||+||+.|+...... ............+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 221 2233456888899999999989999999999999999999999998632110 000001111111211
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
+. ...........+.+|+.+||+.+|++|||+.||++.|+.+....
T Consensus 267 ~~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 GE---------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc---------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11 11112334567899999999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=354.49 Aligned_cols=265 Identities=22% Similarity=0.367 Sum_probs=212.0
Q ss_pred cCCCccCcccCCCceEEEEEEE-----cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC--ceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-----QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG--EQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~ 334 (603)
.+|...+.||+|+||.||++++ .+++.||||+++.......+.|.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577888999999999999984 367899999998877777889999999999999999999999987654 689
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 999999999999999765 34599999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC---------CcchhhHHHHHHHHh
Q 007442 415 TEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR---------PPNEVNLAALAADRI 483 (603)
Q Consensus 415 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~---------~~~~~~l~~~~~~~~ 483 (603)
..... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.... ............+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 32221 1233457788999999998889999999999999999999998875210 000000111111122
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+. ........+.++.+|+.+||+.+|++|||+.||++.|+.++..
T Consensus 277 ~~~~---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNG---------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTC---------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCC---------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 0111223456789999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.43 Aligned_cols=276 Identities=22% Similarity=0.335 Sum_probs=209.3
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc--CCCceeeeeeeEee
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV--SHPNLVRLLGCSIE 329 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~ 329 (603)
.+...-....++|...+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344444556678999999999999999999986 7899999996532 34455566666554 89999999999988
Q ss_pred c----CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCC
Q 007442 330 R----GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-----NPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 330 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~ivH~Dik~~NILld~~~ 400 (603)
. ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7 6789999999999999999653 4999999999999999999999752 34899999999999999999
Q ss_pred cEEEeeccCcccccccccc---eeccCCCCCCCcCccccccCCCCcc------cccccHHHHHHHHHhC----------C
Q 007442 401 KSKVADFGLSRLGMTEISH---ISTAPQGTPGYLDPQYHQNFHLSDK------SDVYSFGVVLVEIITA----------L 461 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~s~k------sDVySfGvvL~elltg----------~ 461 (603)
.+||+|||+++........ ......||+.|+|||++.+...+.+ +||||||+++|||+|| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999754332221 1224579999999999987766665 9999999999999999 4
Q ss_pred CccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 462 KVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 462 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
.|+....+.... .......+........+.... ....+..++.+|+.+||+.||++|||+.||++.|+.
T Consensus 260 ~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 260 LPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNRW---------SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGG---------GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccHhhhcCCCCc--hhhhHHHHhhhccCccccccc---------hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 555432222111 111122222222211111111 123567889999999999999999999999999999
Q ss_pred hhhc
Q 007442 542 IRTR 545 (603)
Q Consensus 542 i~~~ 545 (603)
+...
T Consensus 329 l~~~ 332 (337)
T 3mdy_A 329 MSES 332 (337)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 8764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=357.41 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
++|...+.||+|+||+||+|... +++ .||+|.++.. .....+.+.+|+.++++++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence 56888999999999999999974 343 4688888644 344568899999999999999999999999865 4889
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|+||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999999765 34599999999999999999999999 999999999999999999999999999986432
Q ss_pred cc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... + ...+..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~---- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL---- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCCC----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCC----
Confidence 21 122233457889999999999999999999999999999999 999986432211 1 1122222111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.........+.+|+.+||+.+|++||++.||++.|+++...+
T Consensus 239 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 239 -----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111223457889999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=384.51 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=203.6
Q ss_pred cccCCCceEEEEEEEc---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 269 RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 269 ~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..+|||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 45679999998653 3457889999999999999999999999875 56899999999999
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc--eec
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--IST 422 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~--~~~ 422 (603)
|.++|... ...+++..++.|+.|++.||+|||+. +|+||||||+||||++++.+||+|||+++........ ...
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999754 45699999999999999999999999 9999999999999999999999999999864332221 122
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
...+++.|+|||++.+..++.++||||||++||||+| |+.||......+ +...+..+...
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~------------ 558 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM------------ 558 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC------------
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC------------
Confidence 3346789999999999999999999999999999998 999986433211 22333333211
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.....++..+.+|+.+||+.+|++||++.+|++.|+.+....
T Consensus 559 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 559 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112234567889999999999999999999999999987554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=355.96 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=204.3
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...+.||+|+||+||+|.... +..||||.++.. .......|.+|+.++++++||||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 345557899999999999998753 246999999865 34456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999764 34699999999999999999999999 999999999999999999999999999986433
Q ss_pred ccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 416 EIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 416 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~--- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL--- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC---
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCcC---
Confidence 211 11223346788999999999999999999999999999999 9998853221 1122223222110
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+|+.+||+.+|++||++.||++.|+++...
T Consensus 270 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 ------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11123355788999999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=351.99 Aligned_cols=274 Identities=22% Similarity=0.307 Sum_probs=214.6
Q ss_pred CCChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--cCCCceeeeeeeEe
Q 007442 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISC--VSHPNLVRLLGCSI 328 (603)
Q Consensus 251 ~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~ 328 (603)
..+..--....++|...+.||+|+||+||+|+. +++.||||+++.. ..+.+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 445555566678899999999999999999998 5889999999643 34677889998887 78999999999998
Q ss_pred ecC----ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeee
Q 007442 329 ERG----EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH--------SAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 329 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH--------~~~~~~ivH~Dik~~NILl 396 (603)
... ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 876 789999999999999999753 4999999999999999999999 66 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccc---eeccCCCCCCCcCccccccCC------CCcccccccHHHHHHHHHhC-------
Q 007442 397 DYNFKSKVADFGLSRLGMTEISH---ISTAPQGTPGYLDPQYHQNFH------LSDKSDVYSFGVVLVEIITA------- 460 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVySfGvvL~elltg------- 460 (603)
+.++.+||+|||+++........ ......||+.|+|||.+.+.. ++.++||||||++||||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999764332211 234457999999999987652 33689999999999999999
Q ss_pred ---CCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 461 ---LKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 461 ---~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.||........ .. ......+..+.+...+.... ...+....+.+|+.+||+.+|++|||+.||++
T Consensus 261 ~~~~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SV-EEMRKVVCEQKLRPNIPNRW---------QSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CCCCCTTTTTSCSSC-CH-HHHHHHHTTSCCCCCCCGGG---------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCccccCcCcc-cH-HHHHHHHHHHHhCCCCcccc---------cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 566654322211 11 11222222222221111110 12356778999999999999999999999999
Q ss_pred HHHhhhhc
Q 007442 538 ELEHIRTR 545 (603)
Q Consensus 538 ~L~~i~~~ 545 (603)
.|+++...
T Consensus 330 ~L~~i~~~ 337 (342)
T 1b6c_B 330 TLSQLSQQ 337 (342)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=349.69 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--------------------------hhHHHHHHHHHHHhc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--------------------------DGIQQVVNEIKLISC 314 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~ 314 (603)
++|...+.||+|+||+||+|... +++.||||.++.... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999975 578999999975421 123578999999999
Q ss_pred cCCCceeeeeeeEee--cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007442 315 VSHPNLVRLLGCSIE--RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSS 392 (603)
Q Consensus 315 l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~ 392 (603)
++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 999999999999986 5678999999999999887642 4599999999999999999999999 9999999999
Q ss_pred CeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCC---CCcccccccHHHHHHHHHhCCCccCCCCC
Q 007442 393 NILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH---LSDKSDVYSFGVVLVEIITALKVVDFSRP 469 (603)
Q Consensus 393 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvL~elltg~~p~~~~~~ 469 (603)
|||++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS-SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccc-cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999864322 22234557999999999997765 37789999999999999999999863211
Q ss_pred cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .....+..+.... .........+.+|+.+||+.||++|||+.|+++
T Consensus 246 ------~-~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ------M-CLHSKIKSQALEF--------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------H-HHHHHHHHCCCCC--------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------H-HHHHHHhcccCCC--------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1122222221110 001123457889999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=360.45 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=207.7
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
...++|...+.||+|+||.||++... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999999999999985 5889999999754 34456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccCccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGLSRL 412 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGla~~ 412 (603)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999999754 4589999999999999999999999 99999999999999765 4599999999986
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.... .
T Consensus 181 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~-~ 250 (362)
T 2bdw_A 181 VNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDY-P 250 (362)
T ss_dssp CTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC-C
T ss_pred ecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCC-C
Confidence 4322 223345799999999999998999999999999999999999999863211 11222333332211 0
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
. ........++.+|+.+||+.||++||++.|+++.
T Consensus 251 ~-----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 S-----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp T-----------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c-----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0112235578899999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=364.20 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=201.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...++||+|+||+||+++.. +++.||||+++.. .....+.+.+|..++.++ +|||||++++++.+.+..+||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57888999999999999999986 4789999999754 233345688899999887 899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999865 3599999999999999999999999 999999999999999999999999999985322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcch--hhHHHHHHHHhhcCCcccccch
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE--VNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.........||+.|+|||++.+..++.++||||||++||||++|+.||........ ........+.+..+.+
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 22234456799999999999999999999999999999999999999974332211 1112222333333221
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
..+.....++.+|+.+||+.||++||++
T Consensus 280 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112234578899999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=362.97 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=198.3
Q ss_pred ccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 266 EKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 266 ~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
..+.||+|+||.||+|... +++.||||+++.......++|.+|+.++.+++||||+++++++.+.+..+|||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3567999999999999875 689999999988776777899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--cCCCcEEEeeccCcccccccccceec
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL--DYNFKSKVADFGLSRLGMTEISHIST 422 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~ 422 (603)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++..... ....
T Consensus 173 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~~ 246 (373)
T 2x4f_A 173 LFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLK 246 (373)
T ss_dssp EHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBCC
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cccc
Confidence 99999754 24599999999999999999999999 99999999999999 56789999999999864332 2233
Q ss_pred cCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCC
Q 007442 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502 (603)
Q Consensus 423 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 502 (603)
...||+.|+|||++....++.++||||||++||||++|+.||..... ... ...+...... ..+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~-~~~i~~~~~~-~~~--------- 309 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AET-LNNILACRWD-LED--------- 309 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHHTCCC-SCS---------
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhccCC-CCh---------
Confidence 45699999999999988999999999999999999999999863221 111 1122121111 000
Q ss_pred CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 503 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........++.+|+.+||+.+|++|||+.|+++
T Consensus 310 --~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 --EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011123457889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=361.08 Aligned_cols=253 Identities=20% Similarity=0.266 Sum_probs=204.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
.+.|...+.||+|+||+||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999875 58999999986421 224578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeccC
Q 007442 335 LVYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK---SKVADFGL 409 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~---~kl~DFGl 409 (603)
|||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999999886543 34589999999999999999999999 9999999999999987654 99999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
++..... ........||+.|+|||++.+..++.++||||||++||||++|+.||... . ......+..+...
T Consensus 180 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~----~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----K----ERLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----H----HHHHHHHHHTCCC
T ss_pred eeEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----H----HHHHHHHHcCCCC
Confidence 9764332 22234457999999999999999999999999999999999999999642 1 1122222222221
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ++.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~--~~~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 M--NPRQ----------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CHHH----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--Cccc----------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1100 0123457889999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=363.88 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=197.8
Q ss_pred CCCccCcccCCCceEEEEEEEcC--C--cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cCceEEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN--D--LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~--~--~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV 336 (603)
.|...+.||+|+||+||+|.+.+ + ..||||.++.. +....++|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35556789999999999998742 2 46899999754 44567889999999999999999999999765 4578999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999754 34589999999999999999999999 9999999999999999999999999999864322
Q ss_pred cc---ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 417 IS---HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 417 ~~---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.. .......+|+.|+|||.+.+..++.++||||||++||||+| |..|+......+ .. ..+..+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~----~~~~~~~~~--- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT----VYLLQGRRL--- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HH----HHHHTTCCC---
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HH----HHHHcCCCC---
Confidence 11 12234457889999999999999999999999999999999 455554322211 11 112222111
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhccc
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTM 547 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~~ 547 (603)
..+...+..+.+++.+||+.+|++||++.||++.|+.+.....
T Consensus 316 ------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 ------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0112234578899999999999999999999999999986543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=345.71 Aligned_cols=265 Identities=18% Similarity=0.195 Sum_probs=206.6
Q ss_pred HhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeE-eecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS-IERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 337 (603)
..++|...+.||+|+||+||+|+. .+++.||||.+..... .+++.+|+.++.+++|++++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 5688999998765432 24578899999999988877777666 5667789999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~ 414 (603)
||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 99999999754 34599999999999999999999999 99999999999999 789999999999998643
Q ss_pred cccc------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 415 TEIS------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 415 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 3221 1223457999999999999999999999999999999999999999764443322222211111111000
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
. . .....+..+.+|+.+||+.+|++|||+.||++.|+++....
T Consensus 240 ----~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 240 ----E-V----------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----H-H----------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----h-h----------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0 0 00122457889999999999999999999999999987653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.02 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999986 5789999999754 344567788999999988 899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999765 3599999999999999999999999 9999999999999999999999999999853222
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcch--hhHHHHHHHHhhcCCcccccch
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNE--VNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
........||+.|+|||++.+..++.++||||||++||||++|+.||........ ..........+..+.+.
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 237 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 237 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence 2233456799999999999999999999999999999999999999974322211 11122222333322211
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+......+.+|+.+||+.||++||++
T Consensus 238 -----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -----------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111234568899999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.33 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=206.4
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
...++|...+.||+|+||+||++... +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34567889999999999999999874 68899999997653 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeccCccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD---YNFKSKVADFGLSRL 412 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld---~~~~~kl~DFGla~~ 412 (603)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999999764 4599999999999999999999999 999999999999998 467899999999976
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.... ........||+.|+|||++.+..++.++||||||++||||++|+.||.... .......+..+.... .
T Consensus 163 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~-~ 233 (444)
T 3soa_A 163 VEGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAYDF-P 233 (444)
T ss_dssp CCTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCC-C
T ss_pred ecCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCC-C
Confidence 4332 222345679999999999999899999999999999999999999985321 111223333332211 0
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+ ........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~-----------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SP-----------EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TT-----------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cc-----------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 01123457889999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.19 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=210.5
Q ss_pred cCCCccC-cccCCCceEEEEEEEc---CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQ-RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~-~LG~G~~g~Vykg~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|.... .||+|+||.||+|... ++..||||.++.. .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3454555 8999999999999864 5788999999875 345678899999999999999999999999 56679999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999754 34599999999999999999999999 9999999999999999999999999999864332
Q ss_pred ccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 ISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+..+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~---- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC----
Confidence 221 1233457889999999998889999999999999999999 999986432211 11222222211
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
......+..+.+++.+||+.+|++||++.||++.|+.+....
T Consensus 233 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 -----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111234567889999999999999999999999999997654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.16 Aligned_cols=264 Identities=19% Similarity=0.207 Sum_probs=209.5
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeE-eecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCS-IERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|+. .+++.||||++..... .+++.+|+.++.+++|++++..+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999997 5789999999876532 24688999999999998877766665 55667799999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCcccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~~ 415 (603)
|+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 99999999754 34699999999999999999999999 99999999999999 5889999999999986433
Q ss_pred cccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 416 EISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 416 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
.... ......||+.|+|||.+.+..++.++||||||++||||++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 2221 124457999999999999999999999999999999999999999764433322222211111111000
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
+.+ ....+..+.+++.+||+.+|++|||+.||++.|+++....
T Consensus 240 ----~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ----EVL----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----HHH----------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHH----------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000 1123457889999999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.27 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=208.2
Q ss_pred CCCccCcccCCCceEEEEEEEcC-C---cEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce-EEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQN-D---LLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ-ILV 336 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 336 (603)
.|...++||+|+||+||+|.+.+ + ..||+|.++... ....+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45556889999999999998643 2 379999998643 45568899999999999999999999999876655 999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
+||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999764 35689999999999999999999999 9999999999999999999999999999764332
Q ss_pred c---cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 I---SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~---~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
. ........+++.|+|||.+.+..++.++||||||+++|||++|..|+........ . ...+..+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~----~~~~~~~~~~---- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--L----THFLAQGRRL---- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--H----HHHHHTTCCC----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--H----HHHhhcCCCC----
Confidence 1 1222345678899999999999999999999999999999997777643322221 1 1112222110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 248 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 -----------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 111223457889999999999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=347.98 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=202.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-CceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-GEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|... ++.||||.++... ..+.|.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357888899999999999999875 7899999997643 457899999999999999999999997655 478999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999999865444589999999999999999999999 9999999999999999999999999998753221
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.|+....... ....+..+...
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 233 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKM--------- 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTTCCC---------
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC---------
Confidence 223367889999999999999999999999999999998 988886432211 11222222111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+..+.+++.+||+.+|++||++.|+++.|+.++..
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 ------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11123356788999999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.95 Aligned_cols=270 Identities=24% Similarity=0.320 Sum_probs=217.6
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeee
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRL 323 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l 323 (603)
+...+++...++|...+.||+|+||+||+|.. .+++.||||.++... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556666778899999999999999999985 245899999998653 34557899999999999 69999999
Q ss_pred eeeEeecC-ceEEEEeeCCCCCHHHHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007442 324 LGCSIERG-EQILVYEFMPNGTLCQHLQRERG--------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRD 388 (603)
Q Consensus 324 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~D 388 (603)
++++.+.+ ..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988755 48999999999999999976532 1288999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCC
Q 007442 389 IKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDF 466 (603)
Q Consensus 389 ik~~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~ 466 (603)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986433222 22334457889999999999999999999999999999998 9888864
Q ss_pred CCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 467 SRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 467 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..... .+...+..+.... ........+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 254 ~~~~~------~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGTRMR---------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSH------HHHHHHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccCccCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 33221 1122222221111 1112345688999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.23 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=183.7
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.+.||+|+||+||++... +++.||||++... ....+.+|+.++.++. ||||+++++++.+....+|||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999985 5899999999753 3467788999999997 9999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEeeccCccccccccccee
Q 007442 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 345 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~kl~DFGla~~~~~~~~~~~ 421 (603)
|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcc
Confidence 99999764 4599999999999999999999999 999999999999997665 8999999999864322 2223
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+.....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~---------- 236 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE---------- 236 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC----------
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC----------
Confidence 4456899999999999999999999999999999999999999754332222222333444444432110
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........++.+|+.+||+.||++|||+.|+++
T Consensus 237 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 --GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0111224567889999999999999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.72 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=205.4
Q ss_pred cCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-cCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-RGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 335 (603)
.+|...+.||+|+||+||+|.+.+ ...||||.++.. .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778899999999999998743 236899999864 34556789999999999999999999998654 557899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999754 35589999999999999999999999 999999999999999999999999999986433
Q ss_pred ccc---ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 416 EIS---HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 416 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+.......+. . ..+..+...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~----~~~~~~~~~--- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--T----VYLLQGRRL--- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--H----HHHHTTCCC---
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--H----HHHhcCCCC---
Confidence 221 2233446788999999999999999999999999999999966554332222111 1 111111110
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.........+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 252 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 ------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011123457889999999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.18 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=197.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
.++|...+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.++..+ +||||+++++++.+.+..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999986 5789999999754 233456788999999998 69999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999765 3499999999999999999999999 999999999999999999999999999985322
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... . .....+..+...
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~-~~~~~i~~~~~~------ 242 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------D-DLFEAILNDEVV------ 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------H-HHHHHHHHCCCC------
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------H-HHHHHHHcCCCC------
Confidence 2 2233455799999999999988999999999999999999999999963221 1 112222222211
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+......+.+|+.+||+.+|++||++
T Consensus 243 ----------~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 243 ----------YPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ----------CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 111234567889999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=354.01 Aligned_cols=265 Identities=24% Similarity=0.341 Sum_probs=202.4
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
++....++|...+.||+|+||+||+|.... +..||||.++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334455678888999999999999998743 458999999754 34556789999999999999999999999987
Q ss_pred cCc-----eEEEEeeCCCCCHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 007442 330 RGE-----QILVYEFMPNGTLCQHLQRE----RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF 400 (603)
Q Consensus 330 ~~~-----~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~ 400 (603)
.+. .++||||+++|+|.+++... ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 653 49999999999999999543 234699999999999999999999998 999999999999999999
Q ss_pred cEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHH
Q 007442 401 KSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~ 478 (603)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~--- 258 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M--- 258 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---
Confidence 999999999976433221 22234457889999999999999999999999999999999 877876432211 1
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
...+..+... .........+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 259 -~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 -YDYLLHGHRL---------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp -HHHHHTTCCC---------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHcCCCC---------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1112122111 11123445788999999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=356.59 Aligned_cols=273 Identities=22% Similarity=0.324 Sum_probs=202.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHH--HhccCCCceeeeeeeEee-----cCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKL--ISCVSHPNLVRLLGCSIE-----RGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~~ 334 (603)
++|...+.||+|+||+||+|+. +++.||||+++... .+.+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999987 67899999997543 3344445444 456899999999986543 22568
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI------NPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~------~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
|||||+++|+|.+++... .++|..++.|+.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999999654 3689999999999999999999863 3389999999999999999999999999
Q ss_pred Ccccccccc-------cceeccCCCCCCCcCcccccc-------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhh
Q 007442 409 LSRLGMTEI-------SHISTAPQGTPGYLDPQYHQN-------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474 (603)
Q Consensus 409 la~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~ 474 (603)
+++...... ........||+.|+|||++.+ ..++.++||||||++||||++|+.|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 997643211 112234569999999999876 456679999999999999999988875433322110
Q ss_pred --H---------HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 475 --L---------AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 475 --l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
. .......+........+.. ...........+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--------AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--------TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc--------ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 0011111111111111111 11112346778999999999999999999999999999998
Q ss_pred hccccc
Q 007442 544 TRTMED 549 (603)
Q Consensus 544 ~~~~~~ 549 (603)
.....+
T Consensus 318 ~~~~~~ 323 (336)
T 3g2f_A 318 MIWERN 323 (336)
T ss_dssp HCCCC-
T ss_pred HHHHhc
Confidence 765443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.77 Aligned_cols=262 Identities=21% Similarity=0.225 Sum_probs=208.1
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
.+++++...++|...+.||+|+||+||+++.+ +++.||||+++... ....+.+.+|+.++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566667789999999999999999999985 68999999997532 223345889999999999999999999999
Q ss_pred ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 329 ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
+.+..+|||||+++|+|.++|... +..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 999999999999999999999765 34699999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccc-------cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQ-------NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...... ....
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~- 280 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYG- 280 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHH-
Confidence 99865443333344568999999999987 357899999999999999999999999642211 1111
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCC---CCHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR---PSMTEVAT 537 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~eV~~ 537 (603)
.+..... .. ...........++.+|+.+||. +|++| |++.||++
T Consensus 281 ~i~~~~~-~~----------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYKE-HL----------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHHH-HC----------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhccc-Cc----------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111000 00 0000011234578899999999 99998 58888764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=344.69 Aligned_cols=267 Identities=19% Similarity=0.241 Sum_probs=200.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||+|+..+++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999998899999999976532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VR 155 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc-cc
Confidence 975 999998754 34599999999999999999999999 9999999999999999999999999999753221 12
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc--------
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE-------- 490 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-------- 490 (603)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..........+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhccc
Confidence 23345689999999998764 589999999999999999999999864321 111111122111111000
Q ss_pred ccchhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IIDPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..++.+..... ............+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100000 000011224567889999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.30 Aligned_cols=264 Identities=16% Similarity=0.196 Sum_probs=209.0
Q ss_pred cCCCccCcccCCCceEEEEEEEcC---------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceee----------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN---------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR---------- 322 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~---------- 322 (603)
++|...+.||+|+||+||+|+... ++.||||.++.. +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999864 789999999754 46789999999999999998
Q ss_pred -----eeeeEee-cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 323 -----LLGCSIE-RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 323 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
+++++.. .+..+|||||+ +|+|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6777766 67889999999 99999999876446699999999999999999999999 99999999999999
Q ss_pred cCCC--cEEEeeccCcccccccccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC
Q 007442 397 DYNF--KSKVADFGLSRLGMTEISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR 468 (603)
Q Consensus 397 d~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~ 468 (603)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999864432211 1233479999999999999999999999999999999999999997543
Q ss_pred CcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 469 PPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 469 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
..... .... ...+. .....+.++.. ........+.+|+.+||+.+|++||++.||++.|+++....
T Consensus 273 ~~~~~-~~~~-~~~~~-~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 273 PNTED-IMKQ-KQKFV-DKPGPFVGPCG---------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TCHHH-HHHH-HHHHH-HSCCCEECTTS---------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCHHH-HHHH-HHhcc-CChhhhhhhcc---------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 22211 1111 11111 11111211110 01123467889999999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=346.54 Aligned_cols=261 Identities=18% Similarity=0.239 Sum_probs=202.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
-++|...+.||+|+||.||+|... +++.||||.++.. +....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367889999999999999999985 6889999999754 233457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999865 3599999999999999999999999 9999999999999999999999999999764433
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...... +.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~----~~- 255 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPR----PS- 255 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCC----GG-
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCC----cc-
Confidence 22233445689999999999999999999999999999999999999863211 1222222221110 00
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhhcc
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIRTRT 546 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eV~~~L~~i~~~~ 546 (603)
......+..+.+++.+||+.+|++|| ++.++++.|+.+....
T Consensus 256 --------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 --------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 01122344688999999999999999 9999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.65 Aligned_cols=260 Identities=20% Similarity=0.255 Sum_probs=208.1
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
+++++...++|...+.||+|+||+||+++.. +++.||||+++... ....+.+.+|+.+++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4456667788999999999999999999986 47899999996521 1223457899999999999999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
.+..+|||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999753 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCC----CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFH----LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
++..............||+.|+|||++.+.. ++.++||||||++||||++|+.||..... .... ..+..
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~-~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTY-SKIMN 287 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-HHHHT
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHH-HHHHh
Confidence 9864443333344668999999999998665 78899999999999999999999963221 1111 11111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM--RPSMTEVATE 538 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eV~~~ 538 (603)
+... + ..........++.+|+.+||+.+|++ ||++.||++.
T Consensus 288 ~~~~------~------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNS------L------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHH------C------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccc------c------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1000 0 00001123457889999999999988 9999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.28 Aligned_cols=212 Identities=22% Similarity=0.299 Sum_probs=187.7
Q ss_pred CCCCCCCChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-----CCc
Q 007442 246 ISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-----HPN 319 (603)
Q Consensus 246 ~~~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~n 319 (603)
......|++++.....++|...++||+|+||+||+|+.. +++.||||+++.. ....+.+..|+.++.+++ |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 345667788888888899999999999999999999984 6789999999753 444567788999999996 999
Q ss_pred eeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-
Q 007442 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY- 398 (603)
Q Consensus 320 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~- 398 (603)
|+++++++...+..+|||||+ +++|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||||+.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 999999999999999999999 99999999877656799999999999999999999998 9999999999999975
Q ss_pred ------------------------CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHH
Q 007442 399 ------------------------NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVL 454 (603)
Q Consensus 399 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL 454 (603)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||++|
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 78999999999975322 22345789999999999999999999999999999
Q ss_pred HHHHhCCCccCC
Q 007442 455 VEIITALKVVDF 466 (603)
Q Consensus 455 ~elltg~~p~~~ 466 (603)
|||++|+.||..
T Consensus 250 ~ell~g~~pf~~ 261 (360)
T 3llt_A 250 AELYTGSLLFRT 261 (360)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.40 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=207.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|... +++.||+|.+..........+.+|+.+|++++||||+++++++.+.+..+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467889999999999999999985 5789999999877666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--NFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~~~~~~ 417 (603)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999754 34599999999999999999999999 9999999999999974 4789999999998643322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|+|||++.+..++.++||||||++||||++|+.||..... . . ....+...... .++
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~---~-~~~~i~~~~~~--~~~--- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---L---E-TLQNVKRCDWE--FDE--- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---H---H-HHHHHHHCCCC--CCS---
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---H---H-HHHHHHhCCCC--CCc---
Confidence 22334699999999999999999999999999999999999999863211 1 1 11222222111 000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........++.+++.+||+.||++|||+.|+++.
T Consensus 272 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 -------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111235578899999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.09 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=193.9
Q ss_pred hcCCCccCcccCCCceEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD----TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
.++|...+.||+|+||+||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999997 468999999998642 2344668899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999765 3489999999999999999999999 999999999999999999999999999975
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+..+...
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~i~~~~~~--- 239 (327)
T 3a62_A 171 SIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KK-TIDKILKCKLN--- 239 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHTCCC---
T ss_pred cccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHhCCCC---
Confidence 3222 2223445799999999999999999999999999999999999999863211 11 11222222110
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.+......+.+++.+||+.+|++|| ++.|+++
T Consensus 240 -------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 -------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0112345788999999999999999 5666654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.39 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=197.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCC--CceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSH--PNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||+||++...+++.||||+++.. .....+.+.+|+.+|.+++| |||+++++++.+.+..+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568889999999999999999988999999999754 44556889999999999986 9999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|| +.+|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5689999999764 4599999999999999999999999 999999999999997 578999999999864332
Q ss_pred cc-ceeccCCCCCCCcCcccccc-----------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 417 IS-HISTAPQGTPGYLDPQYHQN-----------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 417 ~~-~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
.. .......||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ........+.
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~ 235 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 235 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhc
Confidence 22 22345579999999999865 6789999999999999999999999863221 1111111111
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.. .. ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~-~~--------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 PN-HE--------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TT-SC--------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC-cc--------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 00 01111223468899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.53 Aligned_cols=273 Identities=18% Similarity=0.228 Sum_probs=208.3
Q ss_pred hcCCCccCcccCC--CceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTG--AFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G--~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
..+|...++||+| +||+||+++.. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 99999999986 6899999999754 34556788899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876556799999999999999999999999 999999999999999999999999999865322
Q ss_pred cc------cceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC
Q 007442 416 EI------SHISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487 (603)
Q Consensus 416 ~~------~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 487 (603)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .... .+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~ 253 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGT 253 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHh-----cCC
Confidence 11 111223468999999999987 57999999999999999999999999753332211 0000 000
Q ss_pred cccccchh-----------------------hh-------hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDEIIDPL-----------------------II-------EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~~~d~~-----------------------l~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+++.. +. ................+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000000 00 0000000112234567899999999999999999999985
Q ss_pred H--HHhhh
Q 007442 538 E--LEHIR 543 (603)
Q Consensus 538 ~--L~~i~ 543 (603)
. ++.+.
T Consensus 334 hp~f~~~~ 341 (389)
T 3gni_B 334 HSFFKQIK 341 (389)
T ss_dssp SGGGGGC-
T ss_pred CHHHHHHh
Confidence 4 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.40 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=207.2
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 335 (603)
.++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36788899999999999999998 5689999999987777778899999999999999999999999873 347889
Q ss_pred EEeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 336 VYEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999764 235699999999999999999999999 9999999999999999999999999998753
Q ss_pred cccccc--------eeccCCCCCCCcCccccccCC---CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 414 MTEISH--------ISTAPQGTPGYLDPQYHQNFH---LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 414 ~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
...... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ ... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA----LA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH----HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh----HH
Confidence 221100 112235799999999987543 68899999999999999999999852110000 000 01
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+.. ... ..........+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 260 ~~~-~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 VQN-QLS--------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHC-C----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhc-cCC--------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 111 000 001122345788999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=356.85 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=202.5
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-----DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
++....++|...+.||+|+||+||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45677788999999999999999999984 5789999998643 34556789999999999999999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhc--------------------------------------CCCCCHHHHHHHHHHHHH
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRER--------------------------------------GDGLSWPIRLTVAMETAQ 371 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~ia~~ia~ 371 (603)
.+..+|||||+++|+|.+++.... ...+++..++.|+.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999995211 112457778899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeeecCCC--cEEEeeccCccccccc---ccceeccCCCCCCCcCcccccc--CCCCcc
Q 007442 372 AIAHLHSAINPPIYHRDIKSSNILLDYNF--KSKVADFGLSRLGMTE---ISHISTAPQGTPGYLDPQYHQN--FHLSDK 444 (603)
Q Consensus 372 ~L~yLH~~~~~~ivH~Dik~~NILld~~~--~~kl~DFGla~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~--~~~s~k 444 (603)
||+|||+. +|+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 8999999999854321 1112345579999999999875 678999
Q ss_pred cccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhcc
Q 007442 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAF 524 (603)
Q Consensus 445 sDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 524 (603)
+||||||++||||++|+.||..... .......+ .+... ... .........+.+|+.+||+.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~-~~~~~-~~~-----------~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVL-NKKLC-FEN-----------PNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCCC-TTS-----------GGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHH-hcccc-cCC-----------cccccCCHHHHHHHHHHcCC
Confidence 9999999999999999999863221 11111222 11111 001 11112355788999999999
Q ss_pred CCCCCCCHHHHHH
Q 007442 525 HRDMRPSMTEVAT 537 (603)
Q Consensus 525 ~p~~RPsm~eV~~ 537 (603)
+|++||++.|+++
T Consensus 318 ~p~~Rps~~~~l~ 330 (345)
T 3hko_A 318 NVDERFDAMRALQ 330 (345)
T ss_dssp CTTTSCCHHHHHH
T ss_pred ChhHCCCHHHHhc
Confidence 9999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=356.17 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=201.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||+||+|.. .+++.||||++.... .+..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999997 568899999986431 122357889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+ +|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 78999999765 3599999999999999999999999 9999999999999999999999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|+|||.+.+..+ +.++||||||++||||++|+.||+........ ..+..
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~-- 222 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS-- 222 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS--
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc--
Confidence 22344579999999999987765 78999999999999999999999743221110 00000
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 223 -----~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 -----CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0001112234578899999999999999999998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=355.07 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=201.2
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
+.|...+.||+|+||+||+|+. .+++.||||+++... ....+++.+|++++++++||||+++++++.+.+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999997 568999999997542 334578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+. |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9997 7899988654 35699999999999999999999999 999999999999999999999999999976432
Q ss_pred cceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.....||+.|+|||++. ...++.++||||||++||||++|+.||..... ...... +..+......
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~~-- 274 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPALQ-- 274 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCCC--
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH-HHhcCCCCCC--
Confidence 23457999999999984 56789999999999999999999999853211 111111 1122111110
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 275 ------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11234568899999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=342.13 Aligned_cols=268 Identities=21% Similarity=0.231 Sum_probs=203.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999985 58899999997543 3445788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-C
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-c
Confidence 9975 666666543 34599999999999999999999999 9999999999999999999999999999864322 2
Q ss_pred ceeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc---c--
Q 007442 419 HISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI---I-- 492 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~-- 492 (603)
.......||+.|+|||++.+.. ++.++||||||+++|||++|..|+....... .................. .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccc
Confidence 2234457899999999997765 8999999999999999999999875332211 111122222111100000 0
Q ss_pred -chh---hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 -DPL---IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 -d~~---l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.. ..................+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000001112234567889999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.36 Aligned_cols=265 Identities=17% Similarity=0.204 Sum_probs=201.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccCChhh-----------HHHHHHHHHHHhccCCCceeeeeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHRDTDG-----------IQQVVNEIKLISCVSHPNLVRLLGC 326 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g~ 326 (603)
++|...+.||+|+||+||+|... ++..||||++....... ...+.+|+.++..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999986 56889999997653221 1346788999999999999999999
Q ss_pred Eee----cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC--
Q 007442 327 SIE----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-- 400 (603)
Q Consensus 327 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-- 400 (603)
+.+ ....+|||||+ +++|.+++.... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 67889999999 999999997654 699999999999999999999999 999999999999999887
Q ss_pred cEEEeeccCcccccccccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhh
Q 007442 401 KSKVADFGLSRLGMTEISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~ 474 (603)
.+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-- 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--
Confidence 9999999999764332111 12445799999999999999999999999999999999999999963222111
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
........... .+.+.+... ......+.++.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 269 ~~~~~~~~~~~-----~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLD-----ELPQSVLKW-----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHH-----TTTHHHHHH-----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcc-----cccHHHHhh-----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111 111111100 0001245578999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=352.50 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=199.6
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc----
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE---- 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 332 (603)
.++|...+.||+|+||+||+++. .+++.||||+++.. +....+.|.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999997 56889999999764 33445688999999999999999999999876654
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 39999999999999999765 3599999999999999999999999 999999999999999999999999999976
Q ss_pred cccccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 413 GMTEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 413 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......+......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~- 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP- 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC-
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC-
Confidence 433211 122344689999999999999999999999999999999999999863221 12222222222111
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHH-HHHHHHhhh
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTE-VATELEHIR 543 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e-V~~~L~~i~ 543 (603)
+.. ........+.+|+.+||+.||++||++.+ +...|.++.
T Consensus 239 ---~~~---------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 ---PSA---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---HHH---------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---ccc---------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 100 01123457889999999999999996655 445565554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.10 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=207.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcE--EEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLL--VAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||.||+|+.. ++.. ||||.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999875 4554 599998754 334557789999999999 899999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997642 24699999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~ 481 (603)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||+| |+.||..... .....
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence 9999999874221 122234467889999999998889999999999999999998 9999863221 11222
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.+..+... .........+.+|+.+||+.+|++|||+.|+++.|+.+....
T Consensus 253 ~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 KLPQGYRL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HGGGTCCC---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhhcCCCC---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 33222110 111233457889999999999999999999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=357.90 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=204.0
Q ss_pred HHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 258 EKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 258 ~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
....++|...+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999986 57899999997542 23456788899999887 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999765 3499999999999999999999999 999999999999999999999999999985
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 168 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~---- 235 (345)
T 1xjd_A 168 NMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP---- 235 (345)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC----
T ss_pred cccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCC----
Confidence 3221 2223456799999999999999999999999999999999999999863221 111222222211
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT-EVA 536 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eV~ 536 (603)
..+.....++.+|+.+||+.+|++||++. ||+
T Consensus 236 ------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01112345688999999999999999997 554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.76 Aligned_cols=269 Identities=23% Similarity=0.268 Sum_probs=200.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcc---CCCceeeeeeeEeec
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD-----TDGIQQVVNEIKLISCV---SHPNLVRLLGCSIER 330 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~ 330 (603)
.+++|...+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999997 468899999997432 11224566777777666 499999999999876
Q ss_pred C-----ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 331 G-----EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 331 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
. ..++||||+. |+|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 6999999876656699999999999999999999999 99999999999999999999999
Q ss_pred eccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 406 DFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 406 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
|||+++.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...+..
T Consensus 163 Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (308)
T 3g33_A 163 DFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGL 237 (308)
T ss_dssp SCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred eCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 9999986432 2223445789999999999999999999999999999999999999864222 1112222222211
Q ss_pred CCccccc------chhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 486 GRLDEII------DPLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 486 ~~~~~~~------d~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....... ....... .........+....+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1100000 0000000 00000011234567889999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.62 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=190.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
..+|...+.||+|+||+||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999875 58899999997553 2344678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 339 FMPNGTLCQHLQRER----GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999997643 23589999999999999999999998 99999999999999999999999999997643
Q ss_pred ccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC--c-cc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR--L-DE 490 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--~-~~ 490 (603)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+........ . ..
T Consensus 160 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IP-VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SC-CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred CC-cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 22 122334578999999999876 46899999999999999999999998643221 11111222111100 0 00
Q ss_pred -----ccchhhhhccCC------CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 -----IIDPLIIEHRGH------SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 -----~~d~~l~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..++.+...... ...........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000000 00001123457889999999999999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.42 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=203.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||.++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999985 68999999997542 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999764 3599999999999999999999998 999999999999999999999999999986322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ...+..+.+.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-~~~i~~~~~~-------- 221 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKT-YEKILNAELR-------- 221 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHHCCCC--------
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCCC--------
Confidence 22345799999999999999999999999999999999999999863211 111 1222222110
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.+.....++.+++.+||+.+|++|| ++.||++
T Consensus 222 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 --------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0112345688999999999999999 7888764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=354.44 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=191.8
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
...++|...+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 35678999999999999999999986 47899999998643 3467889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~~~~ 414 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999754 4599999999999999999999999 9999999999999975 8899999999998633
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
. ........||+.|+|||++.+..++.++||||||++||||++|+.||...... ......+..+... ...+
T Consensus 203 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~ 273 (349)
T 2w4o_A 203 H--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT
T ss_pred c--ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc
Confidence 2 12233457899999999999999999999999999999999999998643221 1112222222211 1111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+|+.+||+.||++|||+.|+++
T Consensus 274 -----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -----------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11233457889999999999999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=370.08 Aligned_cols=248 Identities=24% Similarity=0.278 Sum_probs=194.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||.||++... +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999975 5889999999753 334456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ . +|+||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999765 359999999999999999999998 7 899999999999999999999999999986332
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........||+.|+|||++.+..++.++||||||++||||++|+.||..... .. ....+..+...
T Consensus 302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~-~~~~i~~~~~~------ 367 (446)
T 4ejn_A 302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EK-LFELILMEEIR------ 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC------
T ss_pred C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HH-HHHHHHhCCCC------
Confidence 2 2233456799999999999999999999999999999999999999963211 11 11112111110
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.+.....++.+|+.+||+.||++|| ++.|+++
T Consensus 368 ----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 ----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1112345788999999999999999 9988875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.57 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=206.5
Q ss_pred hcCCCccC-cccCCCceEEEEEEEc---CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 261 TIGFSEKQ-RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 261 t~~f~~~~-~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
..+|...+ .||+|+||+||+|.+. +++.||||.++... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35666666 8999999999999653 35789999997653 33467899999999999999999999999 667889
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999999764 4599999999999999999999999 99999999999999999999999999998643
Q ss_pred ccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 415 TEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 415 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~- 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMG- 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC-
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCC-
Confidence 32221 1233456789999999998889999999999999999999 9999864221 11222232322111
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
........+.+++.+||+.+|++||++.||++.|+++...
T Consensus 241 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 241 --------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1123456788999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=353.86 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=195.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999986 688999999976532 236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK--SKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~--~kl~DFGla~~~~~~~ 417 (603)
+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999997643 499999999999999999999998 9999999999999987765 99999999974222
Q ss_pred cceeccCCCCCCCcCccccccCCCCcc-cccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDK-SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||++.+..++.+ +||||||++||||++|+.||........ .... ...+.......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~------ 241 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKT-IQRILSVKYSI------ 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHH-HHHHHTTCCCC------
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHH-HHHHhcCCCCC------
Confidence 122234569999999999988877665 8999999999999999999974333222 1111 11221111100
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+|+.+||+.+|++|||+.|+++.
T Consensus 242 --------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 --------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011234578899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=357.87 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=203.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.+|.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 4789999999653 2334578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999764 4599999999999999999999999 9999999999999999999999999999864322
Q ss_pred cceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.......||+.|+|||++.. ..++.++||||||++||||++|+.||.......... ....+.....
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~~~~~~~~~~------ 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IVHTFETTVV------ 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----HHHHHHHCCC------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----HHHHHhhccc------
Confidence 23345679999999999864 458999999999999999999999997543322211 1111111111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-MTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eV~~ 537 (603)
..+......+.+|+.+||+.+|++||+ +.+|.+
T Consensus 238 ----------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111223457889999999999999998 666553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.58 Aligned_cols=260 Identities=18% Similarity=0.187 Sum_probs=210.7
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEE------EcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCceeee
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGK------LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPNLVRL 323 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l 323 (603)
+..+++...++|...+.||+|+||+||+|. ..+++.||||+++... ..++..|++++.+++ |+||+++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 334455566789999999999999999994 4567899999998654 356777888887776 9999999
Q ss_pred eeeEeecCceEEEEeeCCCCCHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--
Q 007442 324 LGCSIERGEQILVYEFMPNGTLCQHLQRER---GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-- 398 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-- 398 (603)
++++...+..+|||||+++|+|.+++.... ...++|..++.|+.|++.||+|||+. +|+||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence 999999999999999999999999997542 34699999999999999999999998 9999999999999998
Q ss_pred ---------CCcEEEeeccCcccccc-cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCC
Q 007442 399 ---------NFKSKVADFGLSRLGMT-EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSR 468 (603)
Q Consensus 399 ---------~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~ 468 (603)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||++||||+||+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999975321 22334456679999999999999999999999999999999999999985321
Q ss_pred CcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhhhhc
Q 007442 469 PPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMR-PSMTEVATELEHIRTR 545 (603)
Q Consensus 469 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Psm~eV~~~L~~i~~~ 545 (603)
... ..++..+.. ....+.+.+++..||+.+|.+| |++.++.+.|+.+...
T Consensus 290 ~~~------------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 290 GGE------------------CKPEGLFRR---------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TTE------------------EEECSCCTT---------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCc------------------eeechhccc---------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 110 001111100 0124567789999999999999 7899999999988754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=358.35 Aligned_cols=277 Identities=22% Similarity=0.247 Sum_probs=215.8
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC--ceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG--EQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 337 (603)
++|...++||+|+||+||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 568888999999999999999864 8999999997543 334577889999999999999999999998765 679999
Q ss_pred eeCCCCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeccCccc
Q 007442 338 EFMPNGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVADFGLSRL 412 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl----d~~~~~kl~DFGla~~ 412 (603)
||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976532 3499999999999999999999999 99999999999999 7788899999999986
Q ss_pred ccccccceeccCCCCCCCcCcccccc--------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQN--------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
..... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ...... +.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~-~~ 240 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK-II 240 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH-HH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH-Hh
Confidence 43322 2234579999999999865 56778999999999999999999999743332221 112222 22
Q ss_pred cCCcccccch-------hhhh--ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 485 KGRLDEIIDP-------LIIE--HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 485 ~~~~~~~~d~-------~l~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
.+.....+.. .+.. ...............+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 2221111100 0000 000111234567788999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=340.39 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=206.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468889999999999999999975 5789999999654 3455678899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK---SKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~---~kl~DFGla~~~~ 414 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999765 3599999999999999999999999 9999999999999987655 9999999997543
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+.... ..
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~-~~- 228 (284)
T 3kk8_A 160 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDY-PS- 228 (284)
T ss_dssp SS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC-CT-
T ss_pred cC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhccccC-Cc-
Confidence 22 222345799999999999999999999999999999999999999853211 11122222222111 00
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 ----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011234578899999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.64 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 48999999986553 3345778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-S 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-c
Confidence 99999999988654 4599999999999999999999999 9999999999999999999999999999864322 2
Q ss_pred ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh-----------cC
Q 007442 419 HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS-----------KG 486 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~~ 486 (603)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ......+. ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHTC
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccccccccccc
Confidence 22334578999999999876 67899999999999999999999998643222111 11111110 00
Q ss_pred Ccc---cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 487 RLD---EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 487 ~~~---~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
... .+.++.-.. ............+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDME---PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCC---CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccc---hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000000000 0000012345568899999999999999999998853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.39 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=183.1
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688889999999999999997 468999999996532 223477899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999754 35699999999999999999999999 99999999999999999999999999997643211
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~---------- 228 (278)
T 3cok_A 167 -EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLAD---------- 228 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSC----------
T ss_pred -CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhcc----------
Confidence 1223456899999999999889999999999999999999999998743322110 0000000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+.....++.+++.+||+.||++|||+.||++
T Consensus 229 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 ------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0011123457889999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=341.30 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=205.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
..++|...+.||+|+||+||+|.... +..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34578889999999999999999864 67899999987655667889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCcccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~~ 415 (603)
|+++++|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999765 3489999999999999999999999 99999999999999 7889999999999975432
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+..+..... ..
T Consensus 162 ~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~- 229 (277)
T 3f3z_A 162 G--KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SEVMLKIREGTFTFP-EK- 229 (277)
T ss_dssp T--SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCC-HH-
T ss_pred c--cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCC-ch-
Confidence 2 22344579999999998865 489999999999999999999999863221 112222222221110 00
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++|||+.|+++
T Consensus 230 ----------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 ----------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123457889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=380.47 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=201.0
Q ss_pred CcccCCCceEEEEEEEc---CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQ---NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
+.||+|+||+||+|.+. .++.||||+++.. +....++|.+|+++|.+++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999763 4578999999864 3345688999999999999999999999985 4568899999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc--ce
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS--HI 420 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~--~~ 420 (603)
|+|.++|... ..+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999753 4599999999999999999999999 999999999999999999999999999986433221 22
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.+...+|+.|+|||++.+..++.++||||||++||||++ |+.||..... ..+...+..+....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~~~~--------- 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMG--------- 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC---------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCC---------
Confidence 334457889999999999999999999999999999999 9999864221 11223333332111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
....++.++.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 593 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122345678999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=340.96 Aligned_cols=248 Identities=28% Similarity=0.372 Sum_probs=201.4
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
+.++|...+.||+|+||+||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999876 46799999986532 2234678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999765 3499999999999999999999998 999999999999999999999999999864322
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------- 224 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRVEF------- 224 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC-------
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHhCCC-------
Confidence 1223457899999999999999999999999999999999999998632111 11112211111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..+......+.+|+.+||+.+|++|||+.||++.
T Consensus 225 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 ---------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111234567899999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.53 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=204.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||.++... ....+.+.+|+.++.+++||||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 58999999997542 234577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999865 3499999999999999999999999 9999999999999999999999999999864321
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.....||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+..+.+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~-------- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVR-------- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCCCC--------
Confidence 2345789999999999999999999999999999999999999863211 1122233333221
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
.+......+.+|+.+||+.||++||+ +.||++
T Consensus 257 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01123456889999999999999998 777654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.11 Aligned_cols=259 Identities=21% Similarity=0.243 Sum_probs=200.7
Q ss_pred cCCCc-cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSE-KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~-~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 338 (603)
+.|.. .+.||+|+||+||+|... +++.||||+++.......+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45665 368999999999999864 6899999999876666678899999999985 79999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeccCcccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK---SKVADFGLSRLGMT 415 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~---~kl~DFGla~~~~~ 415 (603)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999865 3589999999999999999999999 9999999999999988766 99999999875322
Q ss_pred cc------cceeccCCCCCCCcCcccccc-----CCCCcccccccHHHHHHHHHhCCCccCCCCCcchh--------hHH
Q 007442 416 EI------SHISTAPQGTPGYLDPQYHQN-----FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV--------NLA 476 (603)
Q Consensus 416 ~~------~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~--------~l~ 476 (603)
.. ........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 111223459999999999875 56889999999999999999999999754332110 011
Q ss_pred HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+..+... ..++. .......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~i~~~~~~-~~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYE-FPDKD-----------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCC-CCHHH-----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcc-cCchh-----------cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1222333333221 00000 0123457889999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.38 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=207.1
Q ss_pred hcCCCccCcccCCCceEEEEEEE------cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.++|...+.||+|+||.||+|+. .++..||||.+... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999984 24678999999754 345567899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEe
Q 007442 334 ILVYEFMPNGTLCQHLQRERG-----DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD---YNFKSKVA 405 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld---~~~~~kl~ 405 (603)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ ++..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 3489999999999999999999999 999999999999998 45569999
Q ss_pred eccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHh
Q 007442 406 DFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 406 DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHHH
Confidence 999987532211 112233457899999999999999999999999999999998 8888753211 1122222
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+.... ........+.+|+.+||+.+|++||++.||++.|+.+...
T Consensus 259 ~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TSGGRMD---------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCCCC---------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2222111 1122345788999999999999999999999999988754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.88 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=200.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
.++|...+.||+|+||+||+++... ++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678899999999999999999864 789999999754 223456788999999988 79999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999998653 499999999999999999999999 999999999999999999999999999985322
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+..+.+.
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~-~~~~i~~~~~~------ 239 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DE-LFQSIMEHNVA------ 239 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC------
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HH-HHHHHHhCCCC------
Confidence 1 2233456799999999999999999999999999999999999999863211 11 12222222211
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
.+.....++.+|+.+||+.+|++||++
T Consensus 240 ----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 ----------YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ----------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111234578899999999999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.81 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=193.2
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEe------
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSI------ 328 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~------ 328 (603)
++....+|...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3344567888999999999999999975 68899999998777777788999999999996 999999999984
Q ss_pred --ecCceEEEEeeCCCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEE
Q 007442 329 --ERGEQILVYEFMPNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPP--IYHRDIKSSNILLDYNFKSK 403 (603)
Q Consensus 329 --~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--ivH~Dik~~NILld~~~~~k 403 (603)
.....++|+||+. |+|.+++.... ...+++..++.|+.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3335789999995 89999997632 34699999999999999999999998 7 99999999999999999999
Q ss_pred EeeccCcccccccccc-----------eeccCCCCCCCcCcccc---ccCCCCcccccccHHHHHHHHHhCCCccCCCCC
Q 007442 404 VADFGLSRLGMTEISH-----------ISTAPQGTPGYLDPQYH---QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRP 469 (603)
Q Consensus 404 l~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~ 469 (603)
|+|||+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999864332111 11134589999999998 566789999999999999999999999863211
Q ss_pred cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.. +..+.... .........+.+|+.+||+.+|++|||+.|+++.|+.+...
T Consensus 259 ~~-----------~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 259 LR-----------IVNGKYSI--------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------------CCC--------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-----------hhcCcccC--------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 10 00111000 00011123477899999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.46 Aligned_cols=253 Identities=25% Similarity=0.303 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD----TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
++|...+.||+|+||+||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999998 368999999997532 22345677899999999 69999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999765 3599999999999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.............||+.|+|||++.+ ..++.++||||||++||||++|+.||........ .... ...+....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~-~~~~~~~~--- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEI-SRRILKSE--- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHH-HHHHHHCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHH-HHHHhccC---
Confidence 44433333445579999999999985 3578999999999999999999999974332221 1111 11111111
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVATE 538 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~~ 538 (603)
..........+.+|+.+||+.||++|| ++.|+++.
T Consensus 283 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 011223345688999999999999999 88888764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.94 Aligned_cols=250 Identities=20% Similarity=0.243 Sum_probs=198.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccC--CCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVS--HPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||+||++...+++.||||+++.. +....+.+.+|+.+|.+++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999999754 4456688999999999996 599999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
| +.+|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 5789999999764 3689999999999999999999998 999999999999996 5799999999998643322
Q ss_pred c-ceeccCCCCCCCcCcccccc-----------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 418 S-HISTAPQGTPGYLDPQYHQN-----------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 418 ~-~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
. .......||+.|+|||++.+ ..++.++||||||++||||++|+.||...... ...+.. +..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~-~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA-IID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHH-HHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHH-HhC
Confidence 2 22345579999999999865 46899999999999999999999999632211 111111 111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+.... ..+......+.+|+.+||+.||++|||+.||++.
T Consensus 283 ~~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEI--------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCC--------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccC--------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11100 0011123568899999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=357.84 Aligned_cols=252 Identities=22% Similarity=0.251 Sum_probs=192.7
Q ss_pred cCCCcc-CcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhc-cCCCceeeeeeeEee----cCceE
Q 007442 262 IGFSEK-QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISC-VSHPNLVRLLGCSIE----RGEQI 334 (603)
Q Consensus 262 ~~f~~~-~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~ 334 (603)
++|... +.||+|+||+||++... +++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999985 5789999999743 456788888754 489999999999875 56789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~ 411 (603)
|||||+++|+|.++|.......+++..++.|+.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876555699999999999999999999998 9999999999999998 7899999999998
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
..... .......||+.|+|||++.+..++.++||||||++||||++|+.||........... ....+..+....
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~~- 286 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEF- 286 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCCC-
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcccC-
Confidence 63321 223455789999999999999999999999999999999999999975433221100 111222222110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.. ........++.+|+.+||+.||++|||+.||++.
T Consensus 287 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 PN-----------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CT-----------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC-----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011235578899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.50 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=199.0
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
.|....+||+|+||.||+|... +++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455668999999999999974 578999999988766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeccCcccccccccc
Q 007442 342 NGTLCQHLQRERG-DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 342 ~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-NP 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC-CC
Confidence 9999999976532 3577999999999999999999999 9999999999999987 899999999999764321 12
Q ss_pred eeccCCCCCCCcCccccccCC--CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 420 ISTAPQGTPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ ....... ...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~-~~~---------- 243 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGM-FKV---------- 243 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHH-HCC----------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcc-ccc----------
Confidence 233457899999999987653 88999999999999999999999863221111 1111000 000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..........++.+++.+||+.+|++||++.|+++
T Consensus 244 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 -----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111233457889999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.58 Aligned_cols=251 Identities=21% Similarity=0.247 Sum_probs=205.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD------GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.++|...+.||+|+||.||++... +++.||||.++..... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999986 5889999999764321 367899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeccC
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFGL 409 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFGl 409 (603)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999753 4589999999999999999999999 999999999999999887 799999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . .....+.....
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~i~~~~~- 235 (321)
T 2a2a_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------Q-ETLANITSVSY- 235 (321)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------H-HHHHHHHTTCC-
T ss_pred ceecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------H-HHHHHHHhccc-
Confidence 9764322 222345699999999999999999999999999999999999999863211 1 11122222211
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..++.+ .......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DFDEEF----------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCHHH----------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -ccChhh----------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111 1123456889999999999999999999886
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.03 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=209.4
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC-CceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...++||+|+||.||+|+. .+++.||||+++..... +++.+|++++..++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46789999999999999999997 56899999988754322 457899999999986 566666667778888999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCcccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~~ 415 (603)
|+ +++|.+++... ...++|..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999754 34699999999999999999999999 99999999999999 6889999999999986443
Q ss_pred cccc------eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 416 EISH------ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 416 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
.... ......||+.|+|||++.+..++.++||||||++||||++|+.||..............+.... +.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----~~ 234 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----VA 234 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH----HH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc----cc
Confidence 2211 1235579999999999999999999999999999999999999997644433222222111111 11
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..++.. ....+.++.+|+.+||+.+|++||++.+|++.|+.+...
T Consensus 235 ~~~~~l-----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 235 TSIEAL-----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp SCHHHH-----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHHH-----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 112345789999999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=343.67 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=205.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 335 (603)
.++|...+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999985 6899999999754 34556789999999999999999999998854 567899
Q ss_pred EEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCeeecCCCcEEEeecc
Q 007442 336 VYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPP-----IYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-----ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997643 34599999999999999999999998 6 9999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKF 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhccc
Confidence 987633221 112234689999999999998999999999999999999999999864211 112233333332
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~ 541 (603)
..+ .......+.+++.+||+.+|++||++.||++.+..
T Consensus 234 ~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 RRI---------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCC---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccC---------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 211 11234578899999999999999999999886543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.43 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=197.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888899999999999999985 57899999997642 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCccccc
Q 007442 340 MPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 340 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~ 414 (603)
+++|+|.+++... ....+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999654 345699999999999999999999999 99999999999999 456789999999997643
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......||+.|+|||.+. ..++.++||||||+++|||++|+.||..... ... ............
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~-~~~~~~~~~~~~--- 245 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEV-QQKATYKEPNYA--- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCCCCC---
T ss_pred Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHH-HhhhccCCcccc---
Confidence 22 2234457899999999875 5789999999999999999999999863221 111 111111111000
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+|+.+||+.||++|||+.||++
T Consensus 246 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 ----------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000112456789999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=370.75 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=207.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.+|.+++|||||++++++.+.+..+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999985 6899999999653 123456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.......+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876555699999999999999999999999 9999999999999999999999999999864322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ..+...+.....
T Consensus 340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~-------- 406 (576)
T 2acx_A 340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE-------- 406 (576)
T ss_dssp --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC--------
T ss_pred --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc--------
Confidence 2233457999999999999989999999999999999999999999754322111 111122221111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.........+.+|+.+||+.||++|| ++.||++
T Consensus 407 --------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11122345788999999999999999 6778764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=338.88 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=206.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...+.||+|+||+||++... +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999986 589999999975422 13678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeccCc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFGLS 410 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFGla 410 (603)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999764 3599999999999999999999999 999999999999998877 8999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
...... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+......
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~- 229 (283)
T 3bhy_A 160 HKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNYD- 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCC-
T ss_pred eeccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcccC-
Confidence 764322 122345689999999999999999999999999999999999999864221 1111222222111
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhhhhc
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT--ELEHIRTR 545 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~--~L~~i~~~ 545 (603)
.++.. .......+.+++.+||+.+|++||++.|+++ .++.++.+
T Consensus 230 -~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 230 -FDEEY----------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp -CCHHH----------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred -Ccchh----------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 11111 1123456889999999999999999999997 46666544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=335.14 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=197.8
Q ss_pred CCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCceEEE
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQILV 336 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV 336 (603)
|...+.||+|+||+||+|... ++..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556678999999999999875 5789999999754 45566789999999999999999999999875 3458999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeec-CCCcEEEeeccCcccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP--IYHRDIKSSNILLD-YNFKSKVADFGLSRLG 413 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--ivH~Dik~~NILld-~~~~~kl~DFGla~~~ 413 (603)
|||+++|+|.+++... ..+++..++.|+.|++.||+|||+. + |+||||||+|||++ +++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999764 3589999999999999999999998 6 99999999999997 7899999999999753
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...... ......+..+.....++
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG
T ss_pred ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccccC
Confidence 221 223456999999999886 46999999999999999999999998643221 11222222222111111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+.+|+.+||+.+|++|||+.||++
T Consensus 253 --------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 --------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 122346889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.02 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=205.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||++... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..+|||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999986 6789999999865 445567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++.... .+++..+..|+.+++.||+|||+.. +|+||||||+|||++.++.+||+|||++..... .
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---H
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc---c
Confidence 99999999997653 4999999999999999999999831 799999999999999999999999999875322 1
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh----------------
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI---------------- 483 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~---------------- 483 (603)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE---LELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH---HHHHHC-------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccCCCCCCCcccCCC
Confidence 2234579999999999999999999999999999999999999996432111 000000000
Q ss_pred ----------hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 484 ----------SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 484 ----------~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
......+.++...... ...........++.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000011111111110 0001112235578999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=338.81 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=200.7
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 335 (603)
.+++|...+.||+|+||+||+|... +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567888999999999999999986 6899999999864 344567889999999999 89999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---------------
Q 007442 336 VYEFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--------------- 398 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--------------- 398 (603)
||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997653 25699999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchh
Q 007442 399 ----NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473 (603)
Q Consensus 399 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~ 473 (603)
...+||+|||++...... ....||+.|+|||.+.+. .++.++||||||+++|||++|+.++... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 447999999999764321 233589999999999765 6678999999999999999998765321 1
Q ss_pred hHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 474 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
....+..+....+ .......+.+++.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----QWHEIRQGRLPRI---------------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHHTTCCCCC---------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHcCCCCCC---------------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1122233322111 1123457889999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.34 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=205.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999986 4789999998654 345567889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999998764 3599999999999999999999999 9999999999999999999999999999764322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ...+..+...
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~------- 233 (294)
T 2rku_A 169 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KET-YLRIKKNEYS------- 233 (294)
T ss_dssp -TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHTTCCC-------
T ss_pred -ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHhhccCC-------
Confidence 2223445789999999999988999999999999999999999999864221 111 1122222110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 ---------IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011223468889999999999999999998864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.38 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888899999999999999986 4889999999877667778999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 98 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQ 172 (302)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-HHH
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc-ccc
Confidence 9999999998764 34599999999999999999999999 999999999999999999999999999764211 111
Q ss_pred eeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 420 ISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......||+.|+|||++. ...++.++||||||+++|||++|+.|+..... ...... +..+......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~-- 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK-IAKSDPPTLL-- 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCCS--
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHH-HhccCCcccC--
Confidence 223456899999999983 66789999999999999999999999863221 111111 1121111111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++|||+.|+++
T Consensus 244 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -----------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11223457889999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.72 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=194.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHH-HhccCCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKL-ISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.++|...+.||+|+||+||+++.+ +++.||||+++... ....+.+.+|..+ ++.++||||+++++++.+.+..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888999999999999999986 47899999997542 2334566777776 577899999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999765 3489999999999999999999999 999999999999999999999999999985322
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+..+.+.
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~-~~~~i~~~~~~------ 257 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AE-MYDNILNKPLQ------ 257 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HH-HHHHHHHSCCC------
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HH-HHHHHHhcccC------
Confidence 1 2233456799999999999999999999999999999999999999863211 11 12222222111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
........+.+|+.+||+.||++||++.+.++++
T Consensus 258 ----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 ----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 0112345688999999999999999986544333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.39 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=205.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
..+|...+.||+|+||.||++...+ ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578889999999999999999864 789999998754 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998764 3599999999999999999999999 9999999999999999999999999999864322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||++.+..++.++||||||++||||++|+.||..... ... ...+..+...
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-~~~~~~~~~~------- 259 (335)
T 2owb_A 195 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KET-YLRIKKNEYS------- 259 (335)
T ss_dssp -TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHHTCCC-------
T ss_pred -cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHH-HHHHhcCCCC-------
Confidence 2223445799999999999998999999999999999999999999863221 111 1112221110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+|+.+||+.||++||++.|+++
T Consensus 260 ---------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 ---------IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122346788999999999999999999886
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=340.71 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=198.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc--CC--cEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ--ND--LLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~--~~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...+.||+|+||+||+|++. ++ ..||||.++.. .....+.+.+|+.++.+++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999864 23 36999998754 3455688999999999999999999999987654 88
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999997653 4589999999999999999999999 99999999999999999999999999998643
Q ss_pred ccccc--eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 415 TEISH--ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 415 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ...+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~~~- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQI-LHKIDKEGERL- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-HHHHHTSCCCC-
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHH-HHHHHccCCCC-
Confidence 32221 2234467889999999998889999999999999999999 9998863221 111 12222111100
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
......+..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus 245 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 -------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11123456788999999999999999999999999988654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.55 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=202.9
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+++.. +++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999985 6899999999876555557789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~~~~ 416 (603)
+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999999765 3589999999999999999999999 99999999999999 78899999999999753221
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.++.... ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~-~~--- 228 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGYYEF-ES--- 228 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCCCCC-CT---
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC-Cc---
Confidence 12233589999999999999999999999999999999999999863211 11222333332110 00
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 --------PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111123457889999999999999999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.91 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=196.2
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhh-HHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||+|... +++.||||+++...... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999986 68899999997553222 22456799999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
++ |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TK 155 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-cc
Confidence 97 6999999765 34699999999999999999999999 9999999999999999999999999999753322 22
Q ss_pred eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---Ccccccchh
Q 007442 420 ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---RLDEIIDPL 495 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~~ 495 (603)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+...+... .+....+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcch
Confidence 2334568999999999876 56899999999999999999999999643221 1112222221111 111111100
Q ss_pred -hhhc-cCC-CC----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 -IIEH-RGH-SD----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 -l~~~-~~~-~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.... ... .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000 00 001123457889999999999999999999886
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=351.11 Aligned_cols=243 Identities=24% Similarity=0.305 Sum_probs=201.4
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--------DGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
..++|...+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567889999999999999999874 678999999976521 1334678899999999999999999999999
Q ss_pred CceEEEEeeCCCC-CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 331 GEQILVYEFMPNG-TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 331 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
+..++||||+.+| +|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999877 999999754 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------------------- 234 (335)
T 3dls_A 177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-------------------- 234 (335)
T ss_dssp CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG--------------------
T ss_pred ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH--------------------
Confidence 98643322 2233569999999999988776 789999999999999999999985310
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+.+...+ ........++.+|+.+||+.+|++|||+.|+++.
T Consensus 235 -~~~~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 235 -ETVEAAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GGTTTCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HHHhhcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0011234578899999999999999999998874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.99 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=197.0
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
.++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+|+.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999875 5889999999754 4455678899999999999999999999996543
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..+|||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 56999999975 57776643 389999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC-----
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG----- 486 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----- 486 (603)
.... ....+...||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....+.+.+...
T Consensus 213 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHH
T ss_pred ecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHH
Confidence 6432 223345679999999999999999999999999999999999999996432111 111111111100
Q ss_pred -Cc--------------ccccchhhhhc--cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 487 -RL--------------DEIIDPLIIEH--RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 487 -~~--------------~~~~d~~l~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+ ....-+.+... .............++.+|+.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000000 000011112235678999999999999999999998863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=346.87 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=202.2
Q ss_pred CCCChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeE
Q 007442 250 PIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCS 327 (603)
Q Consensus 250 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 327 (603)
+.+.+.++....++|...+.||+|+||.||+|+.. +++.||||.+.... ...+.+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 33445556667788999999999999999999984 68899999997553 3347789999999999 799999999999
Q ss_pred ee------cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 328 IE------RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 328 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
.. .+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 87 46789999999999999999876556799999999999999999999999 9999999999999999999
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~ 476 (603)
+||+|||++...... ........||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 168 ~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 240 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred EEEeeCcCceecCcC-ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------
Confidence 999999998763321 11223456899999999987 567899999999999999999999998532211
Q ss_pred HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... ..+..+...... .......+.+++.+||+.+|++||++.|+++
T Consensus 241 ~~~-~~~~~~~~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 RAL-FLIPRNPAPRLK--------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH-HHHHHSCCCCCS--------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH-HHhhcCccccCC--------------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 111111111111 1123457889999999999999999999886
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.83 Aligned_cols=248 Identities=14% Similarity=0.138 Sum_probs=194.2
Q ss_pred HhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHH---HHHhccCCCceeeee-------e
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEI---KLISCVSHPNLVRLL-------G 325 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g 325 (603)
..++|...+.||+|+||+||+|+. .+++.||||+++.. .....+.|.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788889999999999999996 56899999999743 445668899999 556666899999998 5
Q ss_pred eEeecC-----------------ceEEEEeeCCCCCHHHHhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 007442 326 CSIERG-----------------EQILVYEFMPNGTLCQHLQRERG-----DGLSWPIRLTVAMETAQAIAHLHSAINPP 383 (603)
Q Consensus 326 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ 383 (603)
++.+.+ ..+|||||+ +|+|.+++..... ..++|..++.|+.|++.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 554443 278999999 6899999986432 1245689999999999999999999 9
Q ss_pred eEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC-----------CCCcccccccHHH
Q 007442 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-----------HLSDKSDVYSFGV 452 (603)
Q Consensus 384 ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGv 452 (603)
|+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.++||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999998522 22344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 453 VLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 453 vL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
+||||++|+.||........ ...+.. . .......+.+|+.+||+.||++|||+
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~----~--------~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFR----S--------CKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGS----S--------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhh----h--------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 99999999999863222111 001100 0 01234578899999999999999999
Q ss_pred HHHHH--HHHhhh
Q 007442 533 TEVAT--ELEHIR 543 (603)
Q Consensus 533 ~eV~~--~L~~i~ 543 (603)
.|+++ .++.+.
T Consensus 355 ~e~l~hp~f~~~~ 367 (377)
T 3byv_A 355 LQAMETPEYEQLR 367 (377)
T ss_dssp HHHHTSHHHHHHH
T ss_pred HHHhhChHHHHHH
Confidence 99986 344443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.59 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=204.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456888999999999999999986 6889999999754 33456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc-
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI- 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~- 417 (603)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999653 4599999999999999999999998 99999999999999999999999999997643221
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. ..+...... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~~--~---- 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKTY--L---- 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCTT--S----
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhcccc--c----
Confidence 122344578999999999987665 7799999999999999999999975332211 11 111111100 0
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001123456889999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.40 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=204.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+|...+.||+|+||+||+|+.. +|+.||||+++... .+..+.+.+|+.+++.++||||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56788899999999999999986 68999999997542 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999753 4599999999999999999999998 9999999999999999999999999999864322
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|+|||++.+..+ +.++||||||++||||++|+.||+..... . ....+..+...
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~~------- 234 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------T-LFKKICDGIFY------- 234 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------H-HHHHHHTTCCC-------
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCcC-------
Confidence 22344579999999999988765 68999999999999999999999643221 1 12223232211
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01112346889999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.96 Aligned_cols=264 Identities=20% Similarity=0.236 Sum_probs=208.1
Q ss_pred CCCChHHHHHHhcCCCcc-CcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccC-CCceeeee
Q 007442 250 PIYPYREIEKATIGFSEK-QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVS-HPNLVRLL 324 (603)
Q Consensus 250 ~~~~~~el~~at~~f~~~-~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~ 324 (603)
+...++..+...+.|... +.||+|+||+||+|... +++.||||+++.. .......+.+|+.++.++. ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 334455556666777776 78999999999999986 5899999999754 2344678999999999995 69999999
Q ss_pred eeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCc
Q 007442 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFK 401 (603)
Q Consensus 325 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~ 401 (603)
+++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999999766556799999999999999999999999 9999999999999988 789
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
+||+|||+++..... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... .. ..
T Consensus 173 ~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~-~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ET-YL 243 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HH
T ss_pred EEEeeCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HH-HH
Confidence 999999999864322 1223457999999999999999999999999999999999999998642211 11 11
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+....... ...........+.+++.+||+.+|++|||+.|+++
T Consensus 244 ~i~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 244 NISQVNVDY------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHTCCCC------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhccccc------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111100 00111234557889999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.53 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=208.3
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcc-CCCceee
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--------DGIQQVVNEIKLISCV-SHPNLVR 322 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~ 322 (603)
..........+|...+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+.++.++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455666788999999999999999999986 689999999875431 2245678999999999 7999999
Q ss_pred eeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 323 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
+++++...+..+|||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999999764 3599999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCcccccc------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~ 476 (603)
||+|||++...... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||.....
T Consensus 240 kl~DfG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------- 310 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------- 310 (365)
T ss_dssp EECCCTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred EEEecCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------
Confidence 99999998764322 22344579999999999863 3588899999999999999999999863211
Q ss_pred HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+..+.... ..+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 311 ~~~~~~i~~~~~~~-~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ILMLRMIMEGQYQF-SSPEW-----------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHHTCCCC-CHHHH-----------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCC-CCccc-----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122222222111 01100 122456889999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=364.17 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=203.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+++.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..+|||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888889999999999999985 58999999997542 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRER--GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||+++|+|.++|.... ...+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997653 34699999999999999999999999 999999999999999999999999999986432
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ... ....+..+..
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~i~~~~~------- 410 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRVLEQAV------- 410 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHHHHHCCC-------
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHHHhhccc-------
Confidence 22 223345799999999999999999999999999999999999999975332111 111 1222222211
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 533 (603)
..+......+.+|+.+||+.||++||++.
T Consensus 411 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ---------TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ---------CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 11122345788999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=347.42 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=199.6
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999986 48899999986543 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-G 178 (331)
T ss_dssp CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC-c
Confidence 99999999887543 3599999999999999999999999 9999999999999999999999999999763322 2
Q ss_pred ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh-----------hcC
Q 007442 419 HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI-----------SKG 486 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~-----------~~~ 486 (603)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ........ ...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHHC
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHhhhc
Confidence 223445789999999998875 789999999999999999999999864322111 11111100 000
Q ss_pred C-cccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 R-LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~-~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ......+.+.. ..............+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000000 00000011234567899999999999999999999885
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.10 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=206.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.+.|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999875 68899999997553 4456889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-Q 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-B
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc-c
Confidence 9999999999964 3599999999999999999999999 9999999999999999999999999999764322 1
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .....+..+....
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~-------- 238 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPT-------- 238 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCC--------
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhcCCCCC--------
Confidence 2234457899999999999999999999999999999999999998632211 1111122221111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L 539 (603)
........+.+|+.+||+.+|++|||+.||++..
T Consensus 239 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 -------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 1112345688999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.80 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=193.5
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--------hhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
...++|...+.||+|+||+||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999875 57899999987531 122335889999999999999999999974
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEee
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVAD 406 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~D 406 (603)
.+..++||||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.+ ..+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 55689999999999999998754 4599999999999999999999999 99999999999999654 4599999
Q ss_pred ccCcccccccccceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 407 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
||+++.... ........||+.|+|||++.+ ..++.++||||||++||||++|+.||........ + ...+
T Consensus 286 FG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~i 357 (419)
T 3i6u_A 286 FGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQI 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHHH
T ss_pred cccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHHH
Confidence 999986432 222344579999999999853 5788899999999999999999999974333221 1 1122
Q ss_pred hcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 484 SKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 484 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+..... +.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 358 ~~~~~~~~--~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGKYNFI--PEV----------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTCCCCC--HHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCCC--chh----------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22221110 100 1123557889999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.13 Aligned_cols=201 Identities=29% Similarity=0.383 Sum_probs=164.1
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecC--c
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERG--E 332 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 332 (603)
...++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999874 6899999999643 3455677889999999997 999999999997544 6
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6999999753 599999999999999999999999 999999999999999999999999999975
Q ss_pred cccc--------------------ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 413 GMTE--------------------ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 413 ~~~~--------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
.... .....+...||+.|+|||++.+ ..++.++||||||++||||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 3220 1122344579999999999876 6789999999999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.60 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=202.6
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..++|...+.||+|+||+||++... +++.||||.++.... .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567888999999999999999986 578999999976532 245688888888 7999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEeeccCcccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN----FKSKVADFGLSRLG 413 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~----~~~kl~DFGla~~~ 413 (603)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999754 4599999999999999999999999 99999999999998443 35999999999864
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||....... .......+..+.....
T Consensus 171 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~~~-- 243 (342)
T 2qr7_A 171 RAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT----PEEILARIGSGKFSLS-- 243 (342)
T ss_dssp BCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC----HHHHHHHHHHCCCCCC--
T ss_pred cCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC----HHHHHHHHccCCcccC--
Confidence 3322 23345578999999999988888999999999999999999999997432211 1222333434332210
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
..........+.+|+.+||+.||++||++.|+++.
T Consensus 244 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 ----------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00112235578899999999999999999998863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.76 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=195.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|... +++.||||.++... .+..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999986 68999999997542 234568899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 999999999999765 3489999999999999999999999 9999999999999999999999999999764322
Q ss_pred cceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ......+..+...
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~------- 229 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVFY------- 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC-------
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCccc-------
Confidence 22234468999999999987765 6899999999999999999999863211 1112222222110
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.+|++|||+.||++.
T Consensus 230 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011223468899999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.94 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=200.6
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
...++|...+.||+|+||.||+|... +++.||||.++... ..+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567899999999999999999986 48999999997643 3467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ...+++..++.++.+++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp ECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 999999999999743 45699999999999999999999999 9999999999999999999999999999764322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+..+.....
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~------ 245 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAI-FMIPTNPPPTF------ 245 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSCCCCC------
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHH-HHHhcCCCccc------
Confidence 22234457899999999999999999999999999999999999998632211 111 11111111111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 246 -------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011223457889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.12 Aligned_cols=273 Identities=23% Similarity=0.260 Sum_probs=198.3
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD-----GIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
+....++|...+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3444578999999999999999999985 5899999999754221 124688999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
+..++||||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999999975 899988754 34689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
+..... ........+|+.|+|||++.+. .++.++||||||+++|||++|..|+..... ......+..........
T Consensus 160 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE 235 (346)
T ss_dssp STTTSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred eeccCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence 864322 2233456789999999998754 589999999999999999999888753221 11111122221111111
Q ss_pred cccchh-hhhc--cCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 490 EIIDPL-IIEH--RGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 490 ~~~d~~-l~~~--~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...+.. +... ...... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 0000 000000 012234678999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=376.32 Aligned_cols=263 Identities=25% Similarity=0.322 Sum_probs=209.3
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
.+.+...++|...+.||+|+||+||+|.+.. +..||||+++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3444455678888899999999999998743 467999998764 3445578999999999999999999999985
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccC
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGL 409 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGl 409 (603)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 46789999999999999999754 34599999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
++..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..+..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~ 610 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGER 610 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCC
Confidence 98754433333344567889999999999999999999999999999997 88888632211 11222222211
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.. .....+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 611 ~~---------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 LP---------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11 112344678899999999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=346.61 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=205.0
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG 331 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 331 (603)
.++++...++|...+.||+|+||.||+|...+ .||||.++.. .....+.|.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445556788999999999999999999865 4999998754 2333466788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999764 34699999999999999999999999 999999999999998 6799999999987
Q ss_pred ccccc----ccceeccCCCCCCCcCcccccc---------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH
Q 007442 412 LGMTE----ISHISTAPQGTPGYLDPQYHQN---------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478 (603)
Q Consensus 412 ~~~~~----~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~ 478 (603)
..... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||..... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~ 250 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EA 250 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH
Confidence 53211 1122234458999999999864 4578899999999999999999999864221 11
Q ss_pred HHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhcc
Q 007442 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546 (603)
Q Consensus 479 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~~ 546 (603)
....+..+....... .....++.+|+.+||+.+|++|||+.||+++|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~--------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 IIWQMGTGMKPNLSQ--------------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHTTCCCCCCC--------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHhccCCCCCCCc--------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 112222222111111 112345889999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=335.71 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999986 57889999996532 223467899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 9999999999997653 489999999999999999999998 999999999999999999999999999865322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ....+.....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~-~~~~~~~~~~--------- 229 (284)
T 2vgo_A 167 -LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TE-THRRIVNVDL--------- 229 (284)
T ss_dssp -SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHTTCC---------
T ss_pred -cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hH-HHHHHhcccc---------
Confidence 122345789999999999999999999999999999999999999863221 11 1112222111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.+|++||++.|+++
T Consensus 230 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 011123456889999999999999999999886
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.51 Aligned_cols=269 Identities=18% Similarity=0.188 Sum_probs=193.3
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT--DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
...++|...+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34567999999999999999999875 688999999975532 234678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-----cCCCcEEEeeccCc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL-----DYNFKSKVADFGLS 410 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl-----d~~~~~kl~DFGla 410 (603)
||||++ |+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999997 5999999764 3499999999999999999999999 99999999999999 45556999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
+..... ........+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... .........+......
T Consensus 185 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred cccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchh
Confidence 763322 1223445689999999999874 5899999999999999999999998643221 1111111111110000
Q ss_pred cc--cch--hhhhccCC-CC-----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EI--IDP--LIIEHRGH-SD-----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~--~d~--~l~~~~~~-~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.. ... ........ .. ........++.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000 00000000 00 001113467889999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.42 Aligned_cols=274 Identities=21% Similarity=0.240 Sum_probs=201.6
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC-----------hhhHHHHHHHHHHHhccCCCceee
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD-----------TDGIQQVVNEIKLISCVSHPNLVR 322 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~niv~ 322 (603)
.+++....++|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 567888899999999999999999999999889999999996432 223478999999999999999999
Q ss_pred eeeeEeec-----CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 007442 323 LLGCSIER-----GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD 397 (603)
Q Consensus 323 l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld 397 (603)
+++++... ...++||||++ |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 99998543 35799999997 7999988754 34699999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCcccccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH
Q 007442 398 YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA 476 (603)
Q Consensus 398 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~ 476 (603)
.++.+||+|||+++.... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 243 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL 243 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred CCCCEEEEecCccccccc--ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 999999999999975322 222344578999999999876 67999999999999999999999999643221 111
Q ss_pred HHHHHHhhcCCcccc-----------cchhhhhccC-CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 477 ALAADRISKGRLDEI-----------IDPLIIEHRG-HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~-----------~d~~l~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.............+. +...+..... ............+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111111110000 0000000000 000011123456889999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.15 Aligned_cols=194 Identities=25% Similarity=0.348 Sum_probs=155.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----Cc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-----GE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 332 (603)
.++|...+.||+|+||+||+|... +++.||||++... +....+.+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999875 6889999999754 344567899999999999999999999998543 56
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+ +|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 57999999653 4599999999999999999999999 999999999999999999999999999986
Q ss_pred cccccc--------------------------ceeccCCCCCCCcCcccc-ccCCCCcccccccHHHHHHHHHhC
Q 007442 413 GMTEIS--------------------------HISTAPQGTPGYLDPQYH-QNFHLSDKSDVYSFGVVLVEIITA 460 (603)
Q Consensus 413 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvL~elltg 460 (603)
...... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 432110 123445789999999976 456799999999999999999995
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.21 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=201.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC----hhhHHHHHHHHHHHhccCCCceeeeeeeEe--ecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD----TDGIQQVVNEIKLISCVSHPNLVRLLGCSI--ERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~ 333 (603)
.++|...+.||+|+||.||++... +++.||||.++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 57899999997542 244678999999999999999999999984 45578
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||++++ |.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 88888766566799999999999999999999999 9999999999999999999999999999764
Q ss_pred ccc-ccceeccCCCCCCCcCccccccCC--CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 414 MTE-ISHISTAPQGTPGYLDPQYHQNFH--LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 414 ~~~-~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ......+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~- 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGSYA- 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCC-
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCCCC-
Confidence 321 222334557999999999987644 37799999999999999999999863211 1122223222211
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
........+.+++.+||+.||++|||+.|+++.
T Consensus 232 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ---------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011234568899999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=345.58 Aligned_cols=264 Identities=17% Similarity=0.263 Sum_probs=207.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChh-----------------hHHHHHHHHHHHhccCCCceeee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTD-----------------GIQQVVNEIKLISCVSHPNLVRL 323 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~l 323 (603)
.++|...+.||+|+||.||+|.. +++.||||.+...... ..+.|.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788899999999999999999 8999999999753211 12789999999999999999999
Q ss_pred eeeEeecCceEEEEeeCCCCCHHHH------hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeee
Q 007442 324 LGCSIERGEQILVYEFMPNGTLCQH------LQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILL 396 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILl 396 (603)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+|||+ . +|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 655435679999999999999999999999 7 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC-CCCc-ccccccHHHHHHHHHhCCCccCCCCCcchhh
Q 007442 397 DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSD-KSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDVySfGvvL~elltg~~p~~~~~~~~~~~ 474 (603)
+.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999764322 34456799999999999877 6666 999999999999999999999743331
Q ss_pred HHHHHHHHhhcCCcccccch--hhhhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 475 LAALAADRISKGRLDEIIDP--LIIEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~--~l~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+..+......+. ...... .............+.+|+.+||+.||++|||+.|+++
T Consensus 259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112223333322111100 000000 0000011234567889999999999999999999886
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=343.36 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=199.4
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeec--------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-------- 330 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 330 (603)
.+|...+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999998 468999999986543 22346788999999999999999999999873
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
+..+|||||++ |+|.+.+.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46899999997 58888886542 4599999999999999999999999 9999999999999999999999999999
Q ss_pred cccccc---ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 411 RLGMTE---ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 411 ~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
+..... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .......... +
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~--~ 246 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC--G 246 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH--C
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh--C
Confidence 764321 1222344578999999998876 45899999999999999999999998643221 1111111111 1
Q ss_pred Ccccccchhh-----hhccC---CCCccchH------HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEIIDPLI-----IEHRG---HSDAGTLA------SVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~d~~l-----~~~~~---~~~~~~~~------~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......-+.. ..... ........ ....+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111000000 00000 00000000 1345889999999999999999999876
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.57 Aligned_cols=253 Identities=24% Similarity=0.271 Sum_probs=204.5
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHhccC-CCceeeeeeeE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---------TDGIQQVVNEIKLISCVS-HPNLVRLLGCS 327 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 327 (603)
...++|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578889999999999999999985 57899999997543 123467889999999996 99999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999999764 3599999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccc------cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHH
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQ------NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~ 481 (603)
|++...... .......+++.|+|||++. ...++.++||||||+++|||++|+.|+..... .....
T Consensus 169 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~ 239 (298)
T 1phk_A 169 GFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLR 239 (298)
T ss_dssp TTCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred cchhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHH
Confidence 999764322 2233456899999999885 45688999999999999999999999863211 11122
Q ss_pred HhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 482 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+..+..... . .........+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~-~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFG-S-----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCC-T-----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccC-c-----------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2222221110 0 111234567889999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=359.23 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=199.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.+.|...+.||+|+||+||+|+.. ++..||||.++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999986 67899999997542 334578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGla~~~~ 414 (603)
||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999999765 3499999999999999999999999 99999999999999764 459999999998643
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......||+.|+|||++. ..++.++||||||+++|||++|+.||..... ......+..+.... ..+
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~-~~~ 259 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYTF-DSP 259 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC-CSG
T ss_pred CC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC-Cch
Confidence 32 2234457999999999886 5799999999999999999999999864221 12223333332211 011
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+|+.+||+.+|++|||+.|+++
T Consensus 260 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 -----------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01123457889999999999999999999885
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.99 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=195.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999984 6899999999653 3344578899999999999999999999997653
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 8899999975 3599999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.... ..+...+|+.|+|||++.+ ..++.++||||||++++||++|+.||...... .....+...... ...+
T Consensus 177 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~-~~~~ 248 (367)
T 1cm8_A 177 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGT-PPAE 248 (367)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCC-CCHH
T ss_pred cccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC-CCHH
Confidence 6322 2344578999999999887 68999999999999999999999998643221 111111111100 0000
Q ss_pred ccc--------hhhhhcc----CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IID--------PLIIEHR----GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d--------~~l~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+. ..+.... .............+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000000 0000011223567889999999999999999999886
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.62 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=187.2
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
...++|...+.||+|+||+||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 67899999987543 34457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 337 YEFMPNGTLCQHLQRE------RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999999742 234599999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc----cceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhc
Q 007442 411 RLGMTEI----SHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK 485 (603)
Q Consensus 411 ~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 485 (603)
....... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ ....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~- 241 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQ- 241 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHT-
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhc-
Confidence 7533211 112234568999999999876 5689999999999999999999999864332211 111111
Q ss_pred CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 486 GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 486 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+.......... ...........+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQ------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccc------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111100000 00111123457889999999999999999999876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=372.94 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 334 (603)
...+|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467899999999999999999986 5789999999753 233456788999999988 6999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.++|.... .+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998653 499999999999999999999999 99999999999999999999999999998532
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. ........||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+..+.+
T Consensus 494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~------ 559 (674)
T 3pfq_A 494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNV------ 559 (674)
T ss_dssp CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHSSCC------
T ss_pred cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCCC------
Confidence 22 2234456799999999999999999999999999999999999999964211 112222322221
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
..+.....++.+|+.+||+.||++||++
T Consensus 560 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1112345578899999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.44 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=203.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.++|...+.||+|+||+||++... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999985 6889999998643 2234578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD---YNFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld---~~~~~kl~DFGla~~~~ 414 (603)
||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999765 3599999999999999999999999 999999999999995 45679999999998643
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.. .......||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ......+..+......
T Consensus 176 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~-- 243 (486)
T 3mwu_A 176 QN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDL-- 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCS--
T ss_pred CC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCC--
Confidence 22 22344579999999999875 699999999999999999999999863211 1122333333221111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........+.+++.+||+.+|++|||+.|+++.
T Consensus 244 ----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 ----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112335578899999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.43 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=188.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hh-hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TD-GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.++|...+.||+|+||+||++... +++.||||+++... .. ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 68899999997652 22 2334455556688889999999999999999999999
Q ss_pred eeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 338 EFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||++ |+|.+++... ....+++..++.|+.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 6998888653 3456999999999999999999999852 899999999999999999999999999976432
Q ss_pred cccceeccCCCCCCCcCcccc----ccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 416 EISHISTAPQGTPGYLDPQYH----QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
. .......||+.|+|||++ ....++.++||||||+++|||++|+.||...... .......+..... ..
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~ 234 (290)
T 3fme_A 163 D--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP-QL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC-CC
T ss_pred c--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC-Cc
Confidence 2 222334699999999996 5667899999999999999999999998642221 1111122222111 10
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.+++.+||+.+|++|||+.|+++
T Consensus 235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01123457889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.17 Aligned_cols=269 Identities=21% Similarity=0.237 Sum_probs=205.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC--------CCceeeeeeeEe---
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS--------HPNLVRLLGCSI--- 328 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 328 (603)
.++|...++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467899999999999999999874 5789999999754 445678899999999996 788999999987
Q ss_pred -ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-------
Q 007442 329 -ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF------- 400 (603)
Q Consensus 329 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~------- 400 (603)
+....+|||||+ +|+|.+++.......+++..++.|+.|++.||+|||+.+ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 456789999999 778888877655567999999999999999999999853 799999999999998775
Q ss_pred ------------------------------------------cEEEeeccCcccccccccceeccCCCCCCCcCcccccc
Q 007442 401 ------------------------------------------KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438 (603)
Q Consensus 401 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 438 (603)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999764321 334578999999999999
Q ss_pred CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhh---HHHHHHHHhhc--------CCc-ccccchh--hhhc-----
Q 007442 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN---LAALAADRISK--------GRL-DEIIDPL--IIEH----- 499 (603)
Q Consensus 439 ~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~---l~~~~~~~~~~--------~~~-~~~~d~~--l~~~----- 499 (603)
..++.++||||||++||||+||+.||.......... ........+.. +.. .+.++.. +...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999999999997544332211 11111111110 100 0000000 0000
Q ss_pred ------cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 ------RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..............+.+|+.+||+.||++|||+.||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011234566788999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=352.80 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=173.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcc------CCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCV------SHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~ 333 (603)
..+|...+.||+|+||+||+|... +++.||||+++.. ....+++.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457888999999999999999875 4789999999764 34456778888888887 577999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeccCcc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK--SKVADFGLSR 411 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~--~kl~DFGla~ 411 (603)
++||||+. |+|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 7999999877666799999999999999999999999 9999999999999999887 9999999997
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
.... ......||+.|+|||++.+..++.++|||||||+||||+||+.||..
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 5322 22345789999999999999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.47 Aligned_cols=254 Identities=11% Similarity=0.037 Sum_probs=183.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcc--CCCceeeee-------eeE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIKLISCV--SHPNLVRLL-------GCS 327 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~ 327 (603)
..+|...+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 455888899999999999999975 689999999987542 3456677885444444 699988755 444
Q ss_pred eec-----------------CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 007442 328 IER-----------------GEQILVYEFMPNGTLCQHLQRERGDGLSWPIR------LTVAMETAQAIAHLHSAINPPI 384 (603)
Q Consensus 328 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~ia~~ia~~L~yLH~~~~~~i 384 (603)
... ...+|||||++ |+|.+++.... ..+.+..+ +.++.|++.||+|||+. +|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 332 23799999998 99999998653 23577777 88999999999999999 99
Q ss_pred EecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCC
Q 007442 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALK 462 (603)
Q Consensus 385 vH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~ 462 (603)
+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||++||||+||+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986322 1113457799999999987 679999999999999999999999
Q ss_pred ccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 463 VVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 463 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
||....+..... +............+ ...........+.+|+.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS--------WKRPSLRVPGTDSL------AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC--------CCBCCTTSCCCCSC------CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc--------hhhhhhhhcccccc------chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 997543321110 00000000000000 00111234567889999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.05 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=202.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHhccCCCceeeeee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-------------DGIQQVVNEIKLISCVSHPNLVRLLG 325 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g 325 (603)
..++|...++||+|+||+||+|... +++.||||.++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999986 478999999975421 23577899999999999999999999
Q ss_pred eEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cE
Q 007442 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF---KS 402 (603)
Q Consensus 326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~---~~ 402 (603)
++.+.+..+|||||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999999765 3599999999999999999999999 999999999999998775 69
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
||+|||+++..... .......||+.|+|||++. ..++.++||||||+++|||++|+.||..... ......
T Consensus 189 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKK 258 (504)
T ss_dssp EECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred EEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 99999999864332 2234457999999999987 4689999999999999999999999864221 122333
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+..+........ ......++.+|+.+||+.+|.+|||+.|+++
T Consensus 259 i~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFND------------WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHHH------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccc------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 333332111000 0123457889999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=338.41 Aligned_cols=270 Identities=21% Similarity=0.295 Sum_probs=203.5
Q ss_pred HHhcCCCccCcccCCCceEEEEEEE--cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcc---CCCceeeeeeeEe---
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKL--QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCV---SHPNLVRLLGCSI--- 328 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 328 (603)
.+.++|...+.||+|+||+||+|.. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999998 367899999997432 22223566777777666 8999999999987
Q ss_pred --ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 007442 329 --ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406 (603)
Q Consensus 329 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~D 406 (603)
.....++||||++ |+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999997 7999999876556699999999999999999999999 999999999999999999999999
Q ss_pred ccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 407 FGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 407 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...+...
T Consensus 164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCC
Confidence 9999864322 223445789999999999999999999999999999999999999864322 11112222221111
Q ss_pred Cccccc------chhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 RLDEII------DPLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 ~~~~~~------d~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...... ....... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000000 00000111234567889999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.54 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=200.5
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEee--cCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIE--RGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|.. .+++.||||.++... .+.+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999987 468999999997543 467889999999997 9999999999987 66789999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~ 416 (603)
||+++++|.+++.. +++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999853 88999999999999999999999 999999999999999776 8999999999864322
Q ss_pred ccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHH--------HHHHhhcCC
Q 007442 417 ISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL--------AADRISKGR 487 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~--------~~~~~~~~~ 487 (603)
.......+|..|+|||.+.+ ..++.++||||||++||||++|+.||.......+. +... ....+....
T Consensus 185 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred --CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhc
Confidence 22344578999999999877 67899999999999999999999999643332111 1110 011111111
Q ss_pred cccccchhhhhccC----------CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 488 LDEIIDPLIIEHRG----------HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 488 ~~~~~d~~l~~~~~----------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .+++....... ...........++.+|+.+||+.||++|||+.|+++
T Consensus 262 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 I--ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp C--CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c--ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01111000000 001112224678899999999999999999999886
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.51 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=204.9
Q ss_pred hcCCCccCcccCCCceEEEEEEE--cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc------eeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL--QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN------LVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 332 (603)
.++|...+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.++..++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788899999999999999987 36789999999754 344577889999999987654 9999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--------------
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-------------- 398 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-------------- 398 (603)
.++||||+ +++|.+++......++++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 89999999876556799999999999999999999999 9999999999999987
Q ss_pred -----CCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchh
Q 007442 399 -----NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473 (603)
Q Consensus 399 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~ 473 (603)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 66899999999975322 22345789999999999999999999999999999999999999964322111
Q ss_pred hHHHHHHHHhh--------cCCcccccch-h------------hhhcc---CCCCccchHHHHHHHHHHHHHhccCCCCC
Q 007442 474 NLAALAADRIS--------KGRLDEIIDP-L------------IIEHR---GHSDAGTLASVHKVAELAFRCLAFHRDMR 529 (603)
Q Consensus 474 ~l~~~~~~~~~--------~~~~~~~~d~-~------------l~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 529 (603)
......... .......... . +.... .............+.+|+.+||+.||++|
T Consensus 243 --~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 243 --LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp --HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred --HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 111111110 0000000000 0 00000 00001123456789999999999999999
Q ss_pred CCHHHHHHH
Q 007442 530 PSMTEVATE 538 (603)
Q Consensus 530 Psm~eV~~~ 538 (603)
||+.||++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.82 Aligned_cols=198 Identities=24% Similarity=0.327 Sum_probs=167.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----Cc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-----GE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 332 (603)
.++|...+.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467899999999999999999975 5789999999754 344567899999999999999999999998776 57
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+. |+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 6999999753 4599999999999999999999999 999999999999999999999999999986
Q ss_pred cccccc---------------------ceeccCCCCCCCcCcccc-ccCCCCcccccccHHHHHHHHHhCCCcc
Q 007442 413 GMTEIS---------------------HISTAPQGTPGYLDPQYH-QNFHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 413 ~~~~~~---------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
...... ...+...||+.|+|||++ ....++.++||||||++||||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 432211 123556799999999986 5667999999999999999999865554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.39 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=194.1
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee---------
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--------- 329 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 329 (603)
..++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467888999999999999999975 6899999999753 4556789999999999999999999999865
Q ss_pred ----cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 007442 330 ----RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVA 405 (603)
Q Consensus 330 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~ 405 (603)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 35678999999999999999754 34588899999999999999999999 99999999999999999999999
Q ss_pred eccCcccccccc-------------cceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcc
Q 007442 406 DFGLSRLGMTEI-------------SHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471 (603)
Q Consensus 406 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~ 471 (603)
|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++ |+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----- 230 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----- 230 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence 999997643211 1122345689999999998754 78999999999999999998 3321
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... .......+...... + ...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~-~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 GME-RVNILKKLRSVSIE--F----------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHH-HHHHHHHHHSTTCC--C----------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chh-HHHHHHhccccccc--c----------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111 11122222222110 0 01112234556889999999999999999999886
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.60 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=201.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----Cce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-----GEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 333 (603)
..+|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999875 67899999997543 44557899999999999999999999998754 368
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++|+||+. |+|.+++... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 6999999653 499999999999999999999999 9999999999999999999999999999864
Q ss_pred cccccce--eccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc--
Q 007442 414 MTEISHI--STAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL-- 488 (603)
Q Consensus 414 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 488 (603)
....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ...+...+.....
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHH
Confidence 4322211 2345799999999987654 589999999999999999999999964433221 1111111111000
Q ss_pred -ccccchh---hhhccCCCC-----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 -DEIIDPL---IIEHRGHSD-----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 -~~~~d~~---l~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+.+.. ......... .........+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000000000 001123457889999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.40 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=205.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
.++|...+.||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456888999999999999999986 68999999996542 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeccCcccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---DYNFKSKVADFGLSRLG 413 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---d~~~~~kl~DFGla~~~ 413 (603)
|||+.+|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999754 4599999999999999999999999 99999999999999 56789999999999754
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... .......||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ......+..+......
T Consensus 180 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~- 248 (484)
T 3nyv_A 180 EAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTFEL- 248 (484)
T ss_dssp CCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCS-
T ss_pred ccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCC-
Confidence 322 12234469999999999876 799999999999999999999999864221 1122333333322111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+|+.+||+.+|++|||+.|+++
T Consensus 249 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 -----------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 111234567889999999999999999999885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.90 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=193.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
.++|...+.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999875 5889999999753 3455678899999999999999999999997665
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 588888853 389999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH---------
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR--------- 482 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~--------- 482 (603)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+...
T Consensus 176 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHH
T ss_pred cccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 6322 122334578999999999999999999999999999999999999986432111 10000000
Q ss_pred ----------hhcC-Cc-----ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 483 ----------ISKG-RL-----DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 483 ----------~~~~-~~-----~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+... .. ...+...+. .............+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLF---PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGS---CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccC---cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 00 000000000 00011122346789999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.59 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=197.0
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC--------hhhHHHHHHHHHHHhccCCCceeeeeeeEeec
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD--------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER 330 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 330 (603)
..++|...+.||+|+||.||+|... +++.||||.++... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467889999999999999999985 57899999997542 12234688999999999999999999998655
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeec
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK---SKVADF 407 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~---~kl~DF 407 (603)
..++||||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -ceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 489999999999999999754 4599999999999999999999999 9999999999999987654 999999
Q ss_pred cCcccccccccceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 408 GLSRLGMTEISHISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 408 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
|+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +. ..+.
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~ 233 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQIT 233 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHH
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHH
Confidence 999864321 1122346899999999874 56789999999999999999999999975433221 11 1122
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+.... .+.. .......+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~--~~~~----------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNF--IPEV----------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCC--CHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccc--Cchh----------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 222110 0111 1123457889999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=337.06 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=195.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEe------------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSI------------ 328 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~------------ 328 (603)
.+|...+.||+|+||.||+|.... ++.||||++...+....+++.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578888999999999999999864 8999999998877777889999999999999999999999873
Q ss_pred --ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEe
Q 007442 329 --ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVA 405 (603)
Q Consensus 329 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~~kl~ 405 (603)
+....++||||++ |+|.+++.. .++++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 799999964 4589999999999999999999999 999999999999997 56799999
Q ss_pred eccCccccccccc--ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 406 DFGLSRLGMTEIS--HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 406 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||....... ........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHh
Confidence 9999986432211 12233457999999998865 678999999999999999999999986432211 11111111
Q ss_pred hhc----------CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 483 ISK----------GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 483 ~~~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... ..+...+....................++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 0000000000000000000011224567899999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.60 Aligned_cols=273 Identities=21% Similarity=0.291 Sum_probs=198.5
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC----
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG---- 331 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 331 (603)
++...++|...+.||+|+||+||+|.. .+++.||||++..... ...+|+++++.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678899999999999999999987 4689999999975432 2347999999999999999999985432
Q ss_pred ----------------------------------ceEEEEeeCCCCCHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHH
Q 007442 332 ----------------------------------EQILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAH 375 (603)
Q Consensus 332 ----------------------------------~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~y 375 (603)
..++||||++ |+|.+.+.. .....+++..++.++.|++.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3789999998 698888864 234569999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeeec-CCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHH
Q 007442 376 LHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVV 453 (603)
Q Consensus 376 LH~~~~~~ivH~Dik~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvv 453 (603)
||+. +|+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999998 6889999999999864332 223445789999999998765 58999999999999
Q ss_pred HHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc----------ccccchhhhhccCCCCccchHHHHHHHHHHHHHhc
Q 007442 454 LVEIITALKVVDFSRPPNEVNLAALAADRISKGRL----------DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLA 523 (603)
Q Consensus 454 L~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 523 (603)
+|||++|+.||......+ ........+..... .+..-+.+.. ..............+.+|+.+||+
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA-KDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCc-ccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999986432211 11111111111100 0000000000 000000111235578899999999
Q ss_pred cCCCCCCCHHHHHHH--HHhhh
Q 007442 524 FHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 524 ~~p~~RPsm~eV~~~--L~~i~ 543 (603)
.+|++|||+.|+++. ++.++
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999853 44444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.44 Aligned_cols=260 Identities=19% Similarity=0.234 Sum_probs=201.0
Q ss_pred CChHHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccC--CCceeeeeeeE
Q 007442 252 YPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVS--HPNLVRLLGCS 327 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~ 327 (603)
+.++.+....++|...+.||+|+||.||++...+++.||||.++.. .....+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4444455556789999999999999999999988999999999754 4456688999999999997 59999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeec
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADF 407 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DF 407 (603)
.+.+..++||| +.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++ +.+||+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence 99999999999 6689999999764 4589999999999999999999999 9999999999999975 79999999
Q ss_pred cCccccccccc-ceeccCCCCCCCcCcccccc-----------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH
Q 007442 408 GLSRLGMTEIS-HISTAPQGTPGYLDPQYHQN-----------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL 475 (603)
Q Consensus 408 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l 475 (603)
|+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----- 245 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----- 245 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----
Confidence 99986433221 12234568999999999875 47888999999999999999999998643221
Q ss_pred HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 476 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.......+... ... .........+.+++.+||+.+|++||++.|+++.
T Consensus 246 ~~~~~~~~~~~-~~~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ISKLHAIIDPN-HEI--------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHCTT-SCC--------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcc-ccc--------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111111111 100 0111123568899999999999999999998864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.68 Aligned_cols=273 Identities=21% Similarity=0.278 Sum_probs=192.4
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE 332 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 332 (603)
..+.....++|...+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++.+..++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456777889999999999999999999985 58999999986543 233566788999999999999999999976544
Q ss_pred -------eEEEEeeCCCCCHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeeecC-CC
Q 007442 333 -------QILVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLH--SAINPPIYHRDIKSSNILLDY-NF 400 (603)
Q Consensus 333 -------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH--~~~~~~ivH~Dik~~NILld~-~~ 400 (603)
.++||||+++ +|.+.+.. .....+++..++.++.|++.||+||| +. +|+||||||+||||+. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999975 66555543 22456899999999999999999999 77 9999999999999997 89
Q ss_pred cEEEeeccCcccccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHH
Q 007442 401 KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~ 479 (603)
.+||+|||+++..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .....
T Consensus 170 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred cEEEeeCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence 9999999999864332 223345689999999998655 48999999999999999999999996432211 11111
Q ss_pred HHHhhcCCccccc---ch-----hhhhccC-----CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 480 ADRISKGRLDEII---DP-----LIIEHRG-----HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 480 ~~~~~~~~~~~~~---d~-----~l~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+... ..+.+ ++ ....... ............+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111000 00000 00 0000000 001112234678999999999999999999999885
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.19 Aligned_cols=198 Identities=23% Similarity=0.361 Sum_probs=155.1
Q ss_pred CCc-cCcccCCCceEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEEE
Q 007442 264 FSE-KQRLGTGAFGTVYAGKLQ---NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILVY 337 (603)
Q Consensus 264 f~~-~~~LG~G~~g~Vykg~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 337 (603)
|.. .++||+|+||+||+|+.. +++.||||+++.... .+.+.+|+.+|++++||||+++++++.. ....+|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999976 468899999976432 2568899999999999999999999964 66789999
Q ss_pred eeCCCCCHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEee
Q 007442 338 EFMPNGTLCQHLQRER-------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL----DYNFKSKVAD 406 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl----d~~~~~kl~D 406 (603)
||+. |+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 68888886432 12499999999999999999999999 99999999999999 7788999999
Q ss_pred ccCccccccccc--ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCC
Q 007442 407 FGLSRLGMTEIS--HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFS 467 (603)
Q Consensus 407 FGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~ 467 (603)
||+++....... .......||+.|+|||++.+. .++.++||||||++||||++|+.||...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999986432211 223345789999999998874 5899999999999999999999999643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.37 Aligned_cols=267 Identities=25% Similarity=0.268 Sum_probs=200.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeec-----Cce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-----GEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~ 333 (603)
.++|...+.||+|+||+||+|... +++.||||+++... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999986 58899999997543 34557788999999999999999999998754 678
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 699999875 3599999999999999999999999 9999999999999999999999999999864
Q ss_pred cccccc---------eeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHh
Q 007442 414 MTEISH---------ISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRI 483 (603)
Q Consensus 414 ~~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~ 483 (603)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHh
Confidence 321111 1223468999999998764 67899999999999999999999998643211 1111111111
Q ss_pred hcCC----cccccchhhhhc----cCCC----CccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 484 SKGR----LDEIIDPLIIEH----RGHS----DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 484 ~~~~----~~~~~d~~l~~~----~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.... ...+.++..... .... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1100 000001000000 0000 0001234567889999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.78 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=195.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------ceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------EQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~ 334 (603)
.+|...+.||+|+||+||+|++. +++.||||++.... +.+.+|+++|++++|||||++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999985 58999999997542 22347999999999999999999986432 367
Q ss_pred EEEeeCCCCCHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQR--ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla~ 411 (603)
|||||+++ +|.+.+.. .....+++..++.++.|++.||+|||+. +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 67776653 2345699999999999999999999998 99999999999999965 578999999998
Q ss_pred cccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC----
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG---- 486 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---- 486 (603)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+. .+...+...
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~-~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLV-EIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-HHHHHHCSCCHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCCCCHHH
Confidence 643222 22345789999999998764 79999999999999999999999986432111 111 111111110
Q ss_pred ------CcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 007442 487 ------RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 487 ------~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~ 543 (603)
...+..-+.+.... -..........++.+|+.+||+.||++|||+.|+++. ++.+.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHP-WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCC-HHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCC-HHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 01111001000000 0000011234678999999999999999999999853 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.59 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=184.5
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------C
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------G 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 331 (603)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367888999999999999999864 6889999999754 344567889999999999999999999998654 5
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899999864 3599999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR--- 487 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 487 (603)
.... ..+...||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+...+....
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHH
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 6322 1344579999999999876 6899999999999999999999999864322 111111111111100
Q ss_pred cccccchhh---hhccCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 488 LDEIIDPLI---IEHRGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 488 ~~~~~d~~l---~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
+..+..... ......... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 000000000 001224568899999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.20 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=197.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce----
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ---- 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 333 (603)
.++|...+.||+|+||+||+|... +++.||||+++.. .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888899999999999999875 5899999999764 334467889999999999999999999999877655
Q ss_pred --EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 334 --ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 334 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
++||||+. |+|.+++. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 68888874 3499999999999999999999999 99999999999999999999999999997
Q ss_pred cccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||......+ ........... ...+
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~-~~~~ 264 (371)
T 4exu_A 193 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGV-PGTE 264 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-CCHH
T ss_pred cccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC-CcHH
Confidence 5322 2344578999999999887 689999999999999999999999996432111 11111111100 0000
Q ss_pred cc----c----hhhhhccCC-CC---ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 491 II----D----PLIIEHRGH-SD---AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 491 ~~----d----~~l~~~~~~-~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.. + ..+...... .. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0 000000000 00 0011235678999999999999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.95 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=201.3
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-----------CCceeeeeeeEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-----------HPNLVRLLGCSIE 329 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 329 (603)
.+|...+.||+|+||+||+|+. .+++.||||.++.. ....+.+.+|+.++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999997 46889999999753 345577889999999886 8999999999886
Q ss_pred cC----ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec------CC
Q 007442 330 RG----EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD------YN 399 (603)
Q Consensus 330 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld------~~ 399 (603)
.+ ..++||||+ +++|.+++.......+++..++.|+.|++.||+|||+.. +|+||||||+||||+ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 689999999 999999998766667999999999999999999999853 799999999999994 44
Q ss_pred CcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchh---hHH
Q 007442 400 FKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV---NLA 476 (603)
Q Consensus 400 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~---~l~ 476 (603)
+.+||+|||+++.... ......||+.|+|||++.+..++.++||||||++||||+||+.||......... ...
T Consensus 175 ~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 5899999999976432 223457899999999999999999999999999999999999999754322111 111
Q ss_pred HHHHHHhhcCCccc-----------cc-----------------chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCC
Q 007442 477 ALAADRISKGRLDE-----------II-----------------DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDM 528 (603)
Q Consensus 477 ~~~~~~~~~~~~~~-----------~~-----------------d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~ 528 (603)
..+...+ +.+.. .+ ...+.. ...........+.+|+.+||+.||++
T Consensus 251 ~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 251 AQIIELL--GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE----KYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp HHHHHHH--CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH----TTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred HHHHHhc--CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh----cccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111 11000 00 000000 11234567788999999999999999
Q ss_pred CCCHHHHHH
Q 007442 529 RPSMTEVAT 537 (603)
Q Consensus 529 RPsm~eV~~ 537 (603)
|||+.||++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=328.18 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=203.2
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
...++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34467888999999999999999986 6889999998654 23456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeccCccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN---FKSKVADFGLSRL 412 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~---~~~kl~DFGla~~ 412 (603)
|+||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999999997653 599999999999999999999999 99999999999999754 4799999999976
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
..... ......+|+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+..+......
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDL 243 (287)
T ss_dssp BCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCS
T ss_pred ecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCc
Confidence 43221 1222347889999998865 589999999999999999999999863211 1122333333221111
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ........+.+++.+||+.+|++|||+.|+++
T Consensus 244 ~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 P------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp G------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 01123457889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.20 Aligned_cols=206 Identities=25% Similarity=0.274 Sum_probs=176.5
Q ss_pred hHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CC-----ceeeeeee
Q 007442 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HP-----NLVRLLGC 326 (603)
Q Consensus 254 ~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~ 326 (603)
..+.+...++|...+.||+|+||+||+|... +++.||||+++.. ....+++..|+.++..++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444556788999999999999999999976 5789999999754 344577888999998885 55 49999999
Q ss_pred EeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCcEEE
Q 007442 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD--YNFKSKV 404 (603)
Q Consensus 327 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld--~~~~~kl 404 (603)
+...+..+|||||++ |+|.+++.......+++..++.++.|++.||+|||+. ..+|+||||||+||||+ .++.+||
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999995 6999999876556799999999999999999999952 23899999999999994 5788999
Q ss_pred eeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCC
Q 007442 405 ADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDF 466 (603)
Q Consensus 405 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~ 466 (603)
+|||+++.... ......||+.|+|||++.+..++.++||||||++||||+||+.||..
T Consensus 203 ~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 203 VDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCCTTCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeccCceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999976422 22345789999999999999999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.53 Aligned_cols=270 Identities=21% Similarity=0.313 Sum_probs=196.1
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc------eEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE------QIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l 335 (603)
.+|...+.||+|+||+||+|++.++..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999998777799999865432 12369999999999999999999976543 789
Q ss_pred EEeeCCCCCHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeccCcccc
Q 007442 336 VYEFMPNGTLCQHLQR-ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLG 413 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~~kl~DFGla~~~ 413 (603)
||||++++.+...... .....+++..++.++.|++.||+|||+. +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987544443332 2245699999999999999999999999 999999999999999 7999999999999864
Q ss_pred cccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc--
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE-- 490 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-- 490 (603)
... .......+|+.|+|||++.+. .++.++||||||++||||++|+.||......+ ....+...+.......
T Consensus 193 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHH
T ss_pred cCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 332 223345789999999998764 58999999999999999999999996432211 1111111111100000
Q ss_pred ccchhhhhcc-CC--CC----ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 007442 491 IIDPLIIEHR-GH--SD----AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 491 ~~d~~l~~~~-~~--~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~ 543 (603)
..++...... .. .. ........++.+|+.+||+.||++|||+.|+++. ++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0000000000 00 00 0111245678999999999999999999999864 44443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=334.94 Aligned_cols=252 Identities=19% Similarity=0.236 Sum_probs=174.0
Q ss_pred hcCCCcc-CcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCceE
Q 007442 261 TIGFSEK-QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQI 334 (603)
Q Consensus 261 t~~f~~~-~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 334 (603)
.++|... ++||+|+||+||+|... +++.||||++.... .. ..+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678874 46999999999999986 68999999997542 11 1222334566789999999999876 44589
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~ 411 (603)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999876556799999999999999999999999 9999999999999976 4559999999997
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... .......+|+.|+|||++....++.++||||||+++|||++|+.||........ .......+..+...
T Consensus 180 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~-- 251 (336)
T 3fhr_A 180 ETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQYG-- 251 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C--
T ss_pred eccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhccccc--
Confidence 5332 122345689999999999888899999999999999999999999864322111 00001111111000
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
............+.+|+.+||+.||++|||+.|+++
T Consensus 252 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 ----------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000111234567889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=334.68 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=202.7
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CC-cEEEEEEeccCChhhHHHHHHHHHHHhccCCCc------eeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-ND-LLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN------LVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 332 (603)
.++|...+.||+|+||+||+|... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467889999999999999999975 34 78999999754 345577889999999998766 9999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----------------
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL---------------- 396 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl---------------- 396 (603)
.+|||||+ +++|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 77888888776556799999999999999999999998 99999999999999
Q ss_pred ---cCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchh
Q 007442 397 ---DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473 (603)
Q Consensus 397 ---d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~ 473 (603)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||++||||++|+.||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 6788999999999975322 2234579999999999999999999999999999999999999996432211
Q ss_pred hHHHHHHHHhhcCCcccc---------c-c------h-----h-hhhccC---CCCccchHHHHHHHHHHHHHhccCCCC
Q 007442 474 NLAALAADRISKGRLDEI---------I-D------P-----L-IIEHRG---HSDAGTLASVHKVAELAFRCLAFHRDM 528 (603)
Q Consensus 474 ~l~~~~~~~~~~~~~~~~---------~-d------~-----~-l~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~~p~~ 528 (603)
....+.... ......+ . + . . +..... ............+.+|+.+||+.||++
T Consensus 247 -~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 -HLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp -HHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111111111 0000000 0 0 0 0 000000 000112344668999999999999999
Q ss_pred CCCHHHHHH
Q 007442 529 RPSMTEVAT 537 (603)
Q Consensus 529 RPsm~eV~~ 537 (603)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.83 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=180.3
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHH-HHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIK-LISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.++|...+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999985 68899999997653 344456666666 777889999999999999999999999
Q ss_pred eeCCCCCHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRE---RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
||++ |+|.+++... ....+++..++.++.+++.||+|||+.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9997 4888887642 2456999999999999999999999852 79999999999999999999999999997643
Q ss_pred ccccceeccCCCCCCCcCcccc----ccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYH----QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.. .......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......+ . ...+..+....
T Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~-~~~~~~~~~~~ 249 (327)
T 3aln_A 178 DS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q-LTQVVKGDPPQ 249 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCC
T ss_pred cc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H-HHHHhcCCCCC
Confidence 22 122334699999999998 456789999999999999999999999864221100 0 00000111000
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+ ...........+.+|+.+||+.||++||++.||++
T Consensus 250 -----~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 -----L------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -----C------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----C------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 00111234567889999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=336.05 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=196.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc------
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE------ 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 332 (603)
++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888899999999999999985 5899999999754 33445788999999999999999999999987654
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+. |+|.+++.. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 688887742 499999999999999999999999 999999999999999999999999999976
Q ss_pred ccccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCC---c
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR---L 488 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~ 488 (603)
... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .............. .
T Consensus 176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHH
T ss_pred CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence 322 1234578999999999877 68899999999999999999999999743221 11111111110000 0
Q ss_pred ccccch----hhhh---c-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEIIDP----LIIE---H-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~~d~----~l~~---~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+.+. .+.. . ..............+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000 0 00001112234667899999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.25 Aligned_cols=251 Identities=18% Similarity=0.304 Sum_probs=180.2
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-hh-HHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-DG-IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
.++|...+.||+|+||.||+|... +++.||||+++.... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999999999999985 689999999976532 22 234445556788889999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
||+ ++.+..++. .....+++..++.++.+++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 445544443 334569999999999999999999998 5 8999999999999999999999999999753322
Q ss_pred ccceeccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 417 ISHISTAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.......+|+.|+|||++. ...++.++||||||+++|||++|+.||...... ..... .+..+.....
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~~~~~ 250 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLT-KVLQEEPPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH-HHHHSCCCCC
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHH-HHhccCCCCC
Confidence 2223456899999999984 557889999999999999999999998642221 11111 1111111110
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+++.+||+.||.+||++.||++
T Consensus 251 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 -------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001123457889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.89 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=185.9
Q ss_pred CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+.+..+|||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4446789999999998776778999999998753 345678999999987 89999999999999999999999995
Q ss_pred CCHHHHhhhhcCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-------------CcEEE
Q 007442 343 GTLCQHLQRERGDG-----LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-------------FKSKV 404 (603)
Q Consensus 343 gsL~~~l~~~~~~~-----l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-------------~~~kl 404 (603)
|+|.+++....... .++..++.|+.|++.||+|||+. +|+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 79999997653211 23445678999999999999999 99999999999999754 58999
Q ss_pred eeccCcccccccccc---eeccCCCCCCCcCcccccc-------CCCCcccccccHHHHHHHHHh-CCCccCCCCCcchh
Q 007442 405 ADFGLSRLGMTEISH---ISTAPQGTPGYLDPQYHQN-------FHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEV 473 (603)
Q Consensus 405 ~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~ 473 (603)
+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||+| |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999864332211 1234579999999999875 678999999999999999999 888885322111
Q ss_pred hHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 474 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .+..+.... +. ...........++.+|+.+||+.||++|||+.||++
T Consensus 248 --~-----~i~~~~~~~--~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --S-----NIIRGIFSL--DE-------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --H-----HHHHTCCCC--CC-------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --H-----HHhcCCCCc--cc-------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 111111100 00 001112345678999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.67 Aligned_cols=246 Identities=28% Similarity=0.347 Sum_probs=190.9
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcc----CCCceeee
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD------GIQQVVNEIKLISCV----SHPNLVRL 323 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l 323 (603)
.+.+...++|...+.||+|+||.||+|... +++.||||+++..... ....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345666788999999999999999999874 6789999999765321 233456799999999 89999999
Q ss_pred eeeEeecCceEEEEee-CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCc
Q 007442 324 LGCSIERGEQILVYEF-MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFK 401 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~ 401 (603)
++++.+.+..++|+|| +.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 9999999999999999 7899999999864 3599999999999999999999999 999999999999999 8899
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccccCCCC-cccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS-DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
+||+|||+++..... ......||..|+|||++.+..+. .++||||||+++|||++|+.||... .
T Consensus 179 ~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~---- 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------Q---- 243 (312)
T ss_dssp EEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H----
T ss_pred EEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--------H----
Confidence 999999999864322 23345689999999998877664 4899999999999999999998521 0
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+..... .........+.+++.+||+.+|++|||+.|+++
T Consensus 244 -~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -EILEAEL----------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHHTCC----------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHhhhcc----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111110 011123456889999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=333.10 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=199.0
Q ss_pred ChHHHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhccC--CCceeee
Q 007442 253 PYREIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT------DGIQQVVNEIKLISCVS--HPNLVRL 323 (603)
Q Consensus 253 ~~~el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l 323 (603)
+.++.+...++|...+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+.++++++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 34445556678999999999999999999874 688999999975421 12245678999999996 5999999
Q ss_pred eeeEeecCceEEEEeeCCC-CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCc
Q 007442 324 LGCSIERGEQILVYEFMPN-GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFK 401 (603)
Q Consensus 324 ~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~ 401 (603)
++++.+.+..++|+||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999999976 8999999764 3599999999999999999999998 999999999999999 7889
Q ss_pred EEEeeccCcccccccccceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 402 SKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||... .
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~---- 253 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------E---- 253 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------H----
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh--------h----
Confidence 999999999864321 2234569999999999987765 67899999999999999999998521 0
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+..+... .......++.+|+.+||+.+|++|||+.||++
T Consensus 254 -~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -EIIRGQVF----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHHHCCCC----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hhhccccc----------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111110 01123457889999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.45 Aligned_cols=249 Identities=26% Similarity=0.312 Sum_probs=187.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..+|...++||+|+||+||.....+++.||||++..... +.+.+|+.+|+++ +|||||++++++.+.+..+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456888899999999997665566889999999975432 2356799999999 799999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-----CCCcEEEeeccCccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-----YNFKSKVADFGLSRLGM 414 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-----~~~~~kl~DFGla~~~~ 414 (603)
+. |+|.+++.... ..+.+..++.++.|++.||+|||+. +|+||||||+||||+ ....+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 69999997653 3355666789999999999999999 999999999999994 33468899999998643
Q ss_pred cccc--ceeccCCCCCCCcCccccc---cCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQ---NFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.... .......||+.|+|||++. ...++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCCc
Confidence 2211 2234457999999999997 4577889999999999999999 88887532111 01111111111
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
... .........+.+|+.+||+.||++|||+.||++
T Consensus 248 -~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 -DCL------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TTS------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccc------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 111234556789999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.40 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=195.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc--CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc-----e
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ--NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE-----Q 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~--~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~ 333 (603)
++|...+.||+|+||+||+|.+. +++.||||++... +....+.|.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67888999999999999999985 5899999998754 34556788999999999999999999999988766 7
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
+|||||+++++|.+++.. .++|..++.|+.|++.||+|||+. +|+||||||+||||+.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999998754 599999999999999999999999 99999999999999986 9999999999863
Q ss_pred cccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... ....||++|+|||++.+.. +.++||||||++||||++|..|+...... .+. .
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~---~ 286 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLP---E 286 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCC---T
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------ccc---c
Confidence 321 3457999999999987654 89999999999999999998877521100 000 0
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhhh
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIRT 544 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eV~~~L~~i~~ 544 (603)
..........+.+|+.+||+.||++|| ++.++.+.|..+..
T Consensus 287 ----------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 ----------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 001122345788999999999999999 56777777777653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.32 Aligned_cols=232 Identities=14% Similarity=0.101 Sum_probs=185.5
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||.||+|.... ++.||||.++... ....+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 568889999999999999999864 8999999998652 345578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++++|.+++... ......++|+.|++.||+|||+. +|+||||||+||||+.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999532 45557889999999999999999 99999999999999999999998543
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
|++| ++.++||||||++||||+||+.||............ ..........+.
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~-- 226 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPA-- 226 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHH--
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChh--
Confidence 3333 688999999999999999999999754332111000 000000000000
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+|+.+||+.||++| |+.|+++.|+++...
T Consensus 227 -------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 -------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0112345678899999999999999 999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=350.02 Aligned_cols=274 Identities=23% Similarity=0.256 Sum_probs=206.3
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee------cCce
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE------RGEQ 333 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~~ 333 (603)
.+|...+.||+|+||+||+|... +++.||||+++.. .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 5889999999764 45556789999999999999999999999765 6678
Q ss_pred EEEEeeCCCCCHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeccC
Q 007442 334 ILVYEFMPNGTLCQHLQRER-GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK---SKVADFGL 409 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~---~kl~DFGl 409 (603)
++||||+++|+|.+++.... ...+++..++.|+.+++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 23599999999999999999999998 9999999999999997654 99999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC---
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG--- 486 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 486 (603)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|.......+
T Consensus 171 a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 9864322 2234457999999999999999999999999999999999999999642111 11000000000
Q ss_pred -Ccccccchhhh--hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHHhhhhc
Q 007442 487 -RLDEIIDPLII--EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTE-----VATELEHIRTR 545 (603)
Q Consensus 487 -~~~~~~d~~l~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e-----V~~~L~~i~~~ 545 (603)
...+.....+. ................+.+++.+||+.||++|||+.| ..+.++.+...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000110000 0000112233456788999999999999999999988 56777777654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=336.75 Aligned_cols=243 Identities=14% Similarity=0.108 Sum_probs=182.0
Q ss_pred HHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhccCC-Cceeeee---------
Q 007442 259 KATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---DGIQQVVNEIKLISCVSH-PNLVRLL--------- 324 (603)
Q Consensus 259 ~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~niv~l~--------- 324 (603)
..+.+|...++||+|+||+||+|+.. +++.||||+++.... ...+.|.+|+.++..++| +|...+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456777889999999999999964 689999999984432 235789999999999987 3221111
Q ss_pred ------------eeEee-----cCceEEEEeeCCCCCHHHHhhh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 007442 325 ------------GCSIE-----RGEQILVYEFMPNGTLCQHLQR-----ERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382 (603)
Q Consensus 325 ------------g~~~~-----~~~~~lV~E~~~~gsL~~~l~~-----~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~ 382 (603)
.+... ....+++|+++ +++|.+++.. .....++|..++.|+.|++.||+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 11111 12345666654 7899999852 2233488999999999999999999999
Q ss_pred CeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCcccc----------ccCCCCcccccccHHH
Q 007442 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH----------QNFHLSDKSDVYSFGV 452 (603)
Q Consensus 383 ~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDVySfGv 452 (603)
+|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999998753222 344567 999999998 5556888999999999
Q ss_pred HHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCH
Q 007442 453 VLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM 532 (603)
Q Consensus 453 vL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 532 (603)
+||||+||+.||....... ..+..+.. ....+..+.+|+.+||+.+|++||++
T Consensus 306 il~elltg~~Pf~~~~~~~-------------------~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALG-------------------GSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGS-------------------CSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHCCCCCCCcchhh-------------------hHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCH
Confidence 9999999999996432111 11111111 01224578899999999999999998
Q ss_pred HHHHH
Q 007442 533 TEVAT 537 (603)
Q Consensus 533 ~eV~~ 537 (603)
.|+++
T Consensus 359 ~~~l~ 363 (413)
T 3dzo_A 359 LQAME 363 (413)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 88764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.90 Aligned_cols=231 Identities=21% Similarity=0.239 Sum_probs=179.5
Q ss_pred cCCCcc-CcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHH-hccCCCceeeeeeeEee----cCceE
Q 007442 262 IGFSEK-QRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLI-SCVSHPNLVRLLGCSIE----RGEQI 334 (603)
Q Consensus 262 ~~f~~~-~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~~ 334 (603)
++|... +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 77999999999999984 6889999999753 4567888888 55689999999999887 67789
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCcc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLSR 411 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla~ 411 (603)
+||||+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999876556799999999999999999999999 9999999999999998 7899999999986
Q ss_pred cccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
... +..++.++||||||++||||++|+.||........ .......+
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~ 214 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRI 214 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSS
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHH
Confidence 421 13467799999999999999999999863222110 00000000
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
...... ...........++.+++.+||+.||++|||+.|+++.
T Consensus 215 ~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 215 RMGQYE----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CTTCCS----SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccc----CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0000002245678999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.67 Aligned_cols=240 Identities=18% Similarity=0.190 Sum_probs=182.5
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhccC---------CCceeeee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD--------TDGIQQVVNEIKLISCVS---------HPNLVRLL 324 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l~ 324 (603)
++|...+.||+|+||+||+|+. +++.||||+++... ....+.+.+|+.++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577788999999999999998 67999999998652 233478899999999886 77777666
Q ss_pred eeE-----------------ee-------------cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 007442 325 GCS-----------------IE-------------RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374 (603)
Q Consensus 325 g~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~ 374 (603)
+++ .+ .+..+|||||+++|+|.+.+.+ ..+++..++.|+.|++.||+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence 654 22 6789999999999987777743 45899999999999999999
Q ss_pred HHH-hcCCCCeEecCCCCCCeeecCCC--------------------cEEEeeccCcccccccccceeccCCCCCCCcCc
Q 007442 375 HLH-SAINPPIYHRDIKSSNILLDYNF--------------------KSKVADFGLSRLGMTEISHISTAPQGTPGYLDP 433 (603)
Q Consensus 375 yLH-~~~~~~ivH~Dik~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aP 433 (603)
||| +. +|+||||||+||||+.++ .+||+|||+++.... ....||+.|+||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccCh
Confidence 999 88 999999999999999887 899999999986432 123699999999
Q ss_pred cccccCCCCcccccccHHHH-HHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC-CcccccchhhhhccCCCCccchHHH
Q 007442 434 QYHQNFHLSDKSDVYSFGVV-LVEIITALKVVDFSRPPNEVNLAALAADRISKG-RLDEIIDPLIIEHRGHSDAGTLASV 511 (603)
Q Consensus 434 E~~~~~~~s~ksDVySfGvv-L~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~ 511 (603)
|++.+.. +.++||||||.+ .+++++|..|+.. ........+.+... ..... ..........
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~s 309 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFKTK----------CNTPAMKQIK 309 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCSSC----------CCSHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccCcc----------cchhhhhhcC
Confidence 9998665 889999998776 7778889887731 10001111121111 11100 0111233567
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHH
Q 007442 512 HKVAELAFRCLAFHRDMRPSMTEVA 536 (603)
Q Consensus 512 ~~l~~l~~~Cl~~~p~~RPsm~eV~ 536 (603)
.++.+|+.+||+.+ |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 78999999999966 888877
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=290.02 Aligned_cols=185 Identities=15% Similarity=0.056 Sum_probs=130.3
Q ss_pred cccCCCceEEEEEE-EcCCcEEEEEEeccCC----------hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 269 RLGTGAFGTVYAGK-LQNDLLVAIKRIKHRD----------TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 269 ~LG~G~~g~Vykg~-~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
.++.|+.|.+.+++ .--|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 2347889999996531 23456799999999999 699999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||++||+|.++|... .+++.. +|+.||+.||+|||++ +||||||||+||||++++++||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999999764 346543 5899999999999999 9999999999999999999999999999864332
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCc
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p 463 (603)
. ...+...||++|||||++.+ ++..++|+||+|++++++.++..+
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 22334569999999999875 567889999999999888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=263.69 Aligned_cols=184 Identities=14% Similarity=0.182 Sum_probs=145.8
Q ss_pred CccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT--------DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
...++||+|+||+||+|.. .+..+++|+...... ...+.|.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 567888988654321 1235689999999999999999777777788888999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.. ++.|+.|++.||+|||+. +|+||||||+|||+++ ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999975 568999999999999999 9999999999999999 9999999999875432
Q ss_pred ccc------eeccCCCCCCCcCcccccc--CCCCcccccccHHHHHHHHHhCCCcc
Q 007442 417 ISH------ISTAPQGTPGYLDPQYHQN--FHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 417 ~~~------~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
... ......||+.|||||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 1234579999999999986 56888999999999999988876654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=217.57 Aligned_cols=151 Identities=14% Similarity=0.058 Sum_probs=122.4
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhccCCC
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT------------------DGIQQVVNEIKLISCVSHP 318 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~ 318 (603)
+......|...+.||+|+||.||+|...+++.||||.++.... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444455666789999999999999997799999999975321 13567899999999999
Q ss_pred ceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 007442 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY 398 (603)
Q Consensus 319 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~ 398 (603)
| +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS- 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence 5 67777553 456799999999999988 521 22457999999999999998 999999999999999
Q ss_pred CCcEEEeeccCcccccccccceeccCCCCCCCcCcccccc
Q 007442 399 NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438 (603)
Q Consensus 399 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 438 (603)
++.+||+|||+++. +..|+|||++..
T Consensus 228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999999863 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=181.84 Aligned_cols=135 Identities=16% Similarity=0.136 Sum_probs=106.8
Q ss_pred CCccCcccCCCceEEEEEEE-cCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHhccC
Q 007442 264 FSEKQRLGTGAFGTVYAGKL-QNDLL--VAIKRIKHRDTD------------------------GIQQVVNEIKLISCVS 316 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 316 (603)
|...+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999998 68888 999987643111 1236789999999998
Q ss_pred CCce--eeeeeeEeecCceEEEEeeCCC-C----CHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecC
Q 007442 317 HPNL--VRLLGCSIERGEQILVYEFMPN-G----TLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH-SAINPPIYHRD 388 (603)
Q Consensus 317 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH-~~~~~~ivH~D 388 (603)
|+++ ..++++ +..+|||||+.+ | +|.+++.. .++.....++.|++.||.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8764 334432 367899999942 4 77776543 235567889999999999999 87 999999
Q ss_pred CCCCCeeecCCCcEEEeeccCccc
Q 007442 389 IKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 389 ik~~NILld~~~~~kl~DFGla~~ 412 (603)
|||+|||+++ .++|+|||++..
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEE
T ss_pred CCHHHEEEcC--cEEEEECccccc
Confidence 9999999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4.2e-17 Score=170.76 Aligned_cols=138 Identities=13% Similarity=0.102 Sum_probs=96.5
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh--------------hhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT--------------DGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
-|.....||+|+||.||+|...+|+.||||.++.... ........++++.....|+||+++.....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3788899999999999999999999999998764210 01112222333333333444433322211
Q ss_pred ------ecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC--
Q 007442 329 ------ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-- 400 (603)
Q Consensus 329 ------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-- 400 (603)
.....+|||||+++++|.++.. . .....++.|++.+|.|||+. +||||||||.||||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 1122369999999988866532 1 12356889999999999998 999999999999998776
Q ss_pred --------cEEEeeccCcc
Q 007442 401 --------KSKVADFGLSR 411 (603)
Q Consensus 401 --------~~kl~DFGla~ 411 (603)
.+.|+||+-+-
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3e-12 Score=127.63 Aligned_cols=148 Identities=16% Similarity=0.063 Sum_probs=115.8
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEE
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~l 335 (603)
+.....+|.....++.|+.+.||+.... +..+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4444567877778888999999999754 5789999987532122346888999999885 6778899999988889999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI----------------------------------- 380 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~----------------------------------- 380 (603)
||||+++.+|.+.+. +......++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999987642 11234578899999999999820
Q ss_pred ---------------------CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 ---------------------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ---------------------~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.5e-11 Score=121.84 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=101.1
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc--eeeeeeeEeecCceEEEEeeC
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN--LVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~ 340 (603)
++....+.+.|..+.||+....+|..+++|..... ....+.+|+.++..+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333455669999998877888999997654 2245778999999886544 556888888778899999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI---------------------------------------- 380 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~---------------------------------------- 380 (603)
++.+|. ... .+ ...++.++++.|+.||+..
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998884 211 11 2356777888888888642
Q ss_pred ---------------CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 ---------------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ---------------~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|++|.|||++++..++|.||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.4e-10 Score=119.37 Aligned_cols=142 Identities=16% Similarity=0.242 Sum_probs=107.9
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEec--cCC-hhhHHHHHHHHHHHhccC--CCceeeeeeeEeec---CceEEEEe
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIK--HRD-TDGIQQVVNEIKLISCVS--HPNLVRLLGCSIER---GEQILVYE 338 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E 338 (603)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998765 478888776 322 123357788999999997 45688899988776 45899999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-------------------------------------- 380 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-------------------------------------- 380 (603)
|+++.+|.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99998875422 123778889999999999999999831
Q ss_pred -----------------CCCeEecCCCCCCeeecCCCc--EEEeeccCcccc
Q 007442 381 -----------------NPPIYHRDIKSSNILLDYNFK--SKVADFGLSRLG 413 (603)
Q Consensus 381 -----------------~~~ivH~Dik~~NILld~~~~--~kl~DFGla~~~ 413 (603)
.+.++|+|+++.|||++.+.. +.|.||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.95 E-value=2.6e-10 Score=116.29 Aligned_cols=186 Identities=17% Similarity=0.173 Sum_probs=123.1
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCc--eeeeeeeEeecC---ceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPN--LVRLLGCSIERG---EQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~E~~ 340 (603)
.+.++.|....||+.. ..+++|.... ......+.+|+.+|..+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3468999999999863 4588888653 244577899999998884 332 344555443332 358899999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI---------------------------------------- 380 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~---------------------------------------- 380 (603)
++.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888764432 3677888889999999999999611
Q ss_pred ---------------CCCeEecCCCCCCeeecC--CCcEEEeeccCcccccccccceeccCCCCCCCcCcccccc-----
Q 007442 381 ---------------NPPIYHRDIKSSNILLDY--NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN----- 438 (603)
Q Consensus 381 ---------------~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----- 438 (603)
.+.++|+|+++.|||+++ +..+.|.||+.+........ ........ .-..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDD-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTT-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhc-cccCHHHHHHHHHHc
Confidence 145899999999999998 45678999999875322110 00000000 0023332111
Q ss_pred CCC---------CcccccccHHHHHHHHHhCCCcc
Q 007442 439 FHL---------SDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 439 ~~~---------s~ksDVySfGvvL~elltg~~p~ 464 (603)
+.. ....+.|+++.++|++.+|..++
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11368999999999999997654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=8.3e-07 Score=90.37 Aligned_cols=136 Identities=17% Similarity=0.209 Sum_probs=95.1
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCC---ceeeeeeeEe-ecCceEEEEeeCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHP---NLVRLLGCSI-ERGEQILVYEFMPN 342 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 342 (603)
.+.++.|....||+. +..++||.-. .......+.+|+.+|..+.+. .+.+.+.+.. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 345788888999987 4567888753 234457889999999999753 3566666664 45568899999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA------------------------------------------- 379 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~------------------------------------------- 379 (603)
.+|.+.... .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 134445555555555555555542
Q ss_pred --------------CCCCeEecCCCCCCeeecC---CCc-EEEeeccCccc
Q 007442 380 --------------INPPIYHRDIKSSNILLDY---NFK-SKVADFGLSRL 412 (603)
Q Consensus 380 --------------~~~~ivH~Dik~~NILld~---~~~-~kl~DFGla~~ 412 (603)
..+.++|+|+++.|||+++ ++. ..|.||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.6e-06 Score=83.59 Aligned_cols=135 Identities=19% Similarity=0.152 Sum_probs=98.5
Q ss_pred cccCCCce-EEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 269 RLGTGAFG-TVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 269 ~LG~G~~g-~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
.+..|..| .||+.... ++..+++|+-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 68987765 456788888653 23467888999998885 44477889999889999999999999888
Q ss_pred HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 007442 346 CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI--------------------------------------------- 380 (603)
Q Consensus 346 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------------------- 380 (603)
.+..... ...+..++.+++..|+-||...
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765421 1233456667777777777531
Q ss_pred ----------CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 ----------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ----------~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|+++.|||++++..+-|.||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.1e-07 Score=93.17 Aligned_cols=80 Identities=8% Similarity=0.039 Sum_probs=55.4
Q ss_pred cCcc-cCCCceEEEEEEEc-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccC-C--CceeeeeeeEeec--
Q 007442 267 KQRL-GTGAFGTVYAGKLQ-------NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVS-H--PNLVRLLGCSIER-- 330 (603)
Q Consensus 267 ~~~L-G~G~~g~Vykg~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~-- 330 (603)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.++..+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988765 25678888765422 001245678888888874 3 3567788877655
Q ss_pred -CceEEEEeeCCCCCHH
Q 007442 331 -GEQILVYEFMPNGTLC 346 (603)
Q Consensus 331 -~~~~lV~E~~~~gsL~ 346 (603)
+..++||||+++.+|.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=2e-05 Score=80.65 Aligned_cols=140 Identities=17% Similarity=0.215 Sum_probs=81.5
Q ss_pred CcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC--CCceeeeee------eEeecCceEEEEee
Q 007442 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS--HPNLVRLLG------CSIERGEQILVYEF 339 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g------~~~~~~~~~lV~E~ 339 (603)
+.|+.|..+.||+....++ .+++|+.... . .++..|+.++..+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987665 4889988752 2 23334455554442 112333433 12245678899999
Q ss_pred CCCCCHH--------------HHhhhhcC-C--C---------CCHHHHHH-----------------------------
Q 007442 340 MPNGTLC--------------QHLQRERG-D--G---------LSWPIRLT----------------------------- 364 (603)
Q Consensus 340 ~~~gsL~--------------~~l~~~~~-~--~---------l~~~~~~~----------------------------- 364 (603)
+++.++. ..||.... . + -.|...+.
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 12232111 0 0 23432110
Q ss_pred --HHHHHHHHHHHHHh----------cCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 365 --VAMETAQAIAHLHS----------AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 365 --ia~~ia~~L~yLH~----------~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+...+..++++|+. ...+.++|+|+++.|||++.+..+.|.||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11123346677763 1245899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-05 Score=84.52 Aligned_cols=75 Identities=19% Similarity=0.159 Sum_probs=49.8
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHhccCC--Cc-eeeeeeeEeecCceEE
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT-------DGIQQVVNEIKLISCVSH--PN-LVRLLGCSIERGEQIL 335 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-iv~l~g~~~~~~~~~l 335 (603)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++|..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 467899998653211 123456778888887742 33 3455543 3455789
Q ss_pred EEeeCCCC
Q 007442 336 VYEFMPNG 343 (603)
Q Consensus 336 V~E~~~~g 343 (603)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.2e-05 Score=77.70 Aligned_cols=78 Identities=10% Similarity=0.093 Sum_probs=57.2
Q ss_pred CCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC---CceeeeeeeEeecCceEEEEeeC
Q 007442 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH---PNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 264 f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
....+.+|.|..+.||+.++.||+.|+||+...........|..|+..|+.|.- --+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 344567899999999999999999999998765443334567889999988842 234455554 2357899999
Q ss_pred CCCCH
Q 007442 341 PNGTL 345 (603)
Q Consensus 341 ~~gsL 345 (603)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00018 Score=73.15 Aligned_cols=137 Identities=16% Similarity=0.201 Sum_probs=92.4
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCceeeeeeeEeecCceEEEEeeCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPNLVRLLGCSIERGEQILVYEFMPNG 343 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 343 (603)
.+.|+.|....+|+... ++..+++|+.... ....|..|+..|+.|. ...+.+++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999886 4567888887543 3567888999888884 357888998888788899999999987
Q ss_pred CHH--------H---HhhhhcC-C-------------------CCCHHHHH---HHH--HHH-----------HHHH---
Q 007442 344 TLC--------Q---HLQRERG-D-------------------GLSWPIRL---TVA--MET-----------AQAI--- 373 (603)
Q Consensus 344 sL~--------~---~l~~~~~-~-------------------~l~~~~~~---~ia--~~i-----------a~~L--- 373 (603)
.+. + .||.... . .-+|...+ ++. .+. .+.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 642 1 2333211 0 02454322 111 111 1112
Q ss_pred -HHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 374 -AHLHS-AINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 374 -~yLH~-~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
..|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2356899999999999999887 8899983
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00015 Score=76.90 Aligned_cols=79 Identities=10% Similarity=0.056 Sum_probs=47.7
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccC---CCCcccccccHHHHHHHH
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF---HLSDKSDVYSFGVVLVEI 457 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvL~el 457 (603)
.+.++|+|+++.|||++++. ++|.||+.+........-......-...|.+|++.... ......+++.....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45799999999999998876 99999999876432111000000001235566554311 111234556778888887
Q ss_pred HhC
Q 007442 458 ITA 460 (603)
Q Consensus 458 ltg 460 (603)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0014 Score=66.34 Aligned_cols=159 Identities=13% Similarity=0.087 Sum_probs=91.3
Q ss_pred CCChHHHHHHhcCCCc-----cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc--eeee
Q 007442 251 IYPYREIEKATIGFSE-----KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN--LVRL 323 (603)
Q Consensus 251 ~~~~~el~~at~~f~~-----~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l 323 (603)
.++.+++......|.. .+.|+.|....+|+....++ .+++|...... ..+++..|+.++..+.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3556667666666654 23466788899999988766 57889887521 1234456777776664212 3333
Q ss_pred eee------EeecCceEEEEeeCCCCCHHH--------------Hhhhhc-C--CC-------CCHHHHHHH--------
Q 007442 324 LGC------SIERGEQILVYEFMPNGTLCQ--------------HLQRER-G--DG-------LSWPIRLTV-------- 365 (603)
Q Consensus 324 ~g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~--~~-------l~~~~~~~i-------- 365 (603)
+.. ....+..++++||+++..+.. .||... . .+ ..|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999998765311 123211 0 00 124332111
Q ss_pred ----HHHHHHHHHHHHhcC----CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 366 ----AMETAQAIAHLHSAI----NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 366 ----a~~ia~~L~yLH~~~----~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
...+...+++|+... ...++|+|+++.|||++++..+.|.||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 112445566666432 34699999999999999876568999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00068 Score=69.25 Aligned_cols=141 Identities=14% Similarity=0.125 Sum_probs=73.9
Q ss_pred CcccCCCceE-EEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-C-CceeeeeeeEeecCceEEEEeeCCCCC
Q 007442 268 QRLGTGAFGT-VYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-H-PNLVRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 268 ~~LG~G~~g~-Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-~niv~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
+.|+.|.... +|+....++..+++|....... +++..|+.++..+. + -.+.+++.+..+.+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565554 6677654466777776543321 23345666666553 2 23556676643333 78999998777
Q ss_pred HHHHhhhhc---------------------CCCCC-H--HHHH-------H-------------HHHHHHHHHHHHHh--
Q 007442 345 LCQHLQRER---------------------GDGLS-W--PIRL-------T-------------VAMETAQAIAHLHS-- 378 (603)
Q Consensus 345 L~~~l~~~~---------------------~~~l~-~--~~~~-------~-------------ia~~ia~~L~yLH~-- 378 (603)
+.+++.... ...++ | .... . ....+...++.|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 765543210 00111 1 1000 0 00111222333321
Q ss_pred -cCCCCeEecCCCCCCeeecCC----CcEEEeeccCcccc
Q 007442 379 -AINPPIYHRDIKSSNILLDYN----FKSKVADFGLSRLG 413 (603)
Q Consensus 379 -~~~~~ivH~Dik~~NILld~~----~~~kl~DFGla~~~ 413 (603)
...+.++|||+.+.|||++.+ ..+.|.||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999875 67999999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0023 Score=64.97 Aligned_cols=158 Identities=13% Similarity=0.073 Sum_probs=90.1
Q ss_pred CCChHHHHHHhcCCCc-----cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC--Cceeee
Q 007442 251 IYPYREIEKATIGFSE-----KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH--PNLVRL 323 (603)
Q Consensus 251 ~~~~~el~~at~~f~~-----~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l 323 (603)
..+.+++..+...|.. ...|+ |....||+....+|+.+++|...... ...+.+..|..++..+.. -.+.++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 3444555544444422 23466 88889999887777789999986431 123456678887777742 224445
Q ss_pred eee-----EeecCceEEEEeeCCCCCHH-----H---------HhhhhcC-------CCCCHHHH----HHH--------
Q 007442 324 LGC-----SIERGEQILVYEFMPNGTLC-----Q---------HLQRERG-------DGLSWPIR----LTV-------- 365 (603)
Q Consensus 324 ~g~-----~~~~~~~~lV~E~~~~gsL~-----~---------~l~~~~~-------~~l~~~~~----~~i-------- 365 (603)
+.. ....+..++||||+++.++. . .||.... ..+++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 443 12245567899999875431 1 1222110 11222211 001
Q ss_pred -------HHHHHHHHHHHHhc----CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 366 -------AMETAQAIAHLHSA----INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 366 -------a~~ia~~L~yLH~~----~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
...+...++.+... ....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11112223444332 234588999999999999 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00046 Score=73.46 Aligned_cols=73 Identities=19% Similarity=0.256 Sum_probs=49.7
Q ss_pred cCcccCCCceEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEE
Q 007442 267 KQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVY 337 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 337 (603)
.+.|+.|-...+|+....+ +..+++|+...... .+.+.+|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3467888889999998763 46888998744211 2456679988888853333 567776532 3899
Q ss_pred eeCCCCCH
Q 007442 338 EFMPNGTL 345 (603)
Q Consensus 338 E~~~~gsL 345 (603)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00031 Score=70.78 Aligned_cols=137 Identities=12% Similarity=0.111 Sum_probs=74.7
Q ss_pred cCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEEeeC-CCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVYEFM-PNGT 344 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 344 (603)
.+.|+.|....+|+. ..+++|+....... ..+..+|+.++..+....+ .+++++ ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 45888887653211 1123467777776642222 455554 333457899999 5544
Q ss_pred HHH------------------HhhhhcCC---CCCHHHHH-HHHH--------------HHHHHHH----HHHh-cCCCC
Q 007442 345 LCQ------------------HLQRERGD---GLSWPIRL-TVAM--------------ETAQAIA----HLHS-AINPP 383 (603)
Q Consensus 345 L~~------------------~l~~~~~~---~l~~~~~~-~ia~--------------~ia~~L~----yLH~-~~~~~ 383 (603)
|.. .||..... ......++ .+.. .+...+. .|.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 01111100 01111111 1100 0111111 1211 12345
Q ss_pred eEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 384 ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
++|+|+.+.||| ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5666889999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0016 Score=69.71 Aligned_cols=74 Identities=15% Similarity=0.045 Sum_probs=47.6
Q ss_pred cCcccCCCceEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce-eeeeeeEeecCceEEEEeeCCCCC
Q 007442 267 KQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL-VRLLGCSIERGEQILVYEFMPNGT 344 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 344 (603)
.+.|+.|-...+|+....+ +..+++|+........ -+..+|..++..+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998876 4678888775432111 112578888888865444 56777662 2 35999998754
Q ss_pred H
Q 007442 345 L 345 (603)
Q Consensus 345 L 345 (603)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0021 Score=67.04 Aligned_cols=140 Identities=16% Similarity=0.164 Sum_probs=82.7
Q ss_pred CcccCCCceEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEe
Q 007442 268 QRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 338 (603)
+.|..|-...+|+....+ +..+++|+.... ......+.+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356667788899988752 468889886432 223466678999988885 3333567766543 29999
Q ss_pred eCCCCCHHH--------------H---hhhhc---CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 007442 339 FMPNGTLCQ--------------H---LQRER---GDGLS--WPIRLTVAMETA-------------------QAIAHLH 377 (603)
Q Consensus 339 ~~~~gsL~~--------------~---l~~~~---~~~l~--~~~~~~ia~~ia-------------------~~L~yLH 377 (603)
|+++.+|.. . ||... ..... |.+..++..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765531 1 12111 11122 344444443332 2233333
Q ss_pred h----c-CCCCeEecCCCCCCeeecCC----CcEEEeeccCccc
Q 007442 378 S----A-INPPIYHRDIKSSNILLDYN----FKSKVADFGLSRL 412 (603)
Q Consensus 378 ~----~-~~~~ivH~Dik~~NILld~~----~~~kl~DFGla~~ 412 (603)
. . ....++|+|+.+.|||++++ ..+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 12368999999999999876 6899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0014 Score=67.95 Aligned_cols=139 Identities=14% Similarity=0.182 Sum_probs=76.1
Q ss_pred CcccCCCceEEEEEEEcC---------CcEEEEEEeccCChhhHHHHHHHHHHHhccCCCc-eeeeeeeEeecCceEEEE
Q 007442 268 QRLGTGAFGTVYAGKLQN---------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPN-LVRLLGCSIERGEQILVY 337 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 337 (603)
..|+.|....+|+....+ +..+++|+..... ....+...|..++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998764 2578888765432 22223356888887775333 34666543 2 36899
Q ss_pred eeCCCCCHH--------------HH---hhhhc-----CCCCC-----HHHHHHHH--------------------HHHH
Q 007442 338 EFMPNGTLC--------------QH---LQRER-----GDGLS-----WPIRLTVA--------------------META 370 (603)
Q Consensus 338 E~~~~gsL~--------------~~---l~~~~-----~~~l~-----~~~~~~ia--------------------~~ia 370 (603)
||+++.+|. .. ||... ...+. |.....+. ..+.
T Consensus 114 e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (369)
T 3c5i_A 114 EWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKESD 193 (369)
T ss_dssp ECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHHH
T ss_pred EEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHHH
Confidence 999875431 11 12110 01111 11111111 1112
Q ss_pred HHHHHHHh-------cCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 371 QAIAHLHS-------AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 371 ~~L~yLH~-------~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
..+++|.. .....++|+|+++.|||++++. +.|+||..+..
T Consensus 194 ~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 194 KFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp HHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred HHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 23344542 1134689999999999998664 89999988764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.011 Score=60.64 Aligned_cols=135 Identities=13% Similarity=0.145 Sum_probs=77.7
Q ss_pred cCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC---CCceeeeeee------EeecCceEEEEeeCC
Q 007442 271 GTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS---HPNLVRLLGC------SIERGEQILVYEFMP 341 (603)
Q Consensus 271 G~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~------~~~~~~~~lV~E~~~ 341 (603)
|.|....||+....+| .+++|+...... ..|+.++..|. -|.+.+.+.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344689999988777 899998765432 34555555442 2224555432 233467789999999
Q ss_pred CCCHH-------------HH---hhhhcC----------C--CCCHHHHHH-HH--------------------------
Q 007442 342 NGTLC-------------QH---LQRERG----------D--GLSWPIRLT-VA-------------------------- 366 (603)
Q Consensus 342 ~gsL~-------------~~---l~~~~~----------~--~l~~~~~~~-ia-------------------------- 366 (603)
+..+. .. ||.... . ...|...+. +.
T Consensus 105 G~~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (339)
T 3i1a_A 105 APNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAA 184 (339)
T ss_dssp CCBTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHHH
T ss_pred CCcCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHHH
Confidence 87651 11 222110 0 011221111 00
Q ss_pred -HHHHHHHHHHHhc-----CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 367 -METAQAIAHLHSA-----INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 367 -~~ia~~L~yLH~~-----~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
..+...+..+... ....++|+|+.+.|||+++++.+.|.||+.+..
T Consensus 185 l~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 185 IHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp HHHHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred HHHHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 1111122222211 134699999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.12 E-value=0.033 Score=52.83 Aligned_cols=103 Identities=12% Similarity=0.075 Sum_probs=67.1
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
.-||.+.|... +.+|++.+.|.++.|.+.+|.-+-....+ ..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 34899999765 57899999999999999998766221111 1233446889999999887764 1111
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALK 462 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~ 462 (603)
.....+.+||... ...+.+.=|||+|++||.-+--..
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888763 345678899999999999886433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.056 Score=57.03 Aligned_cols=139 Identities=12% Similarity=0.148 Sum_probs=82.7
Q ss_pred CcccCCCceEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEe
Q 007442 268 QRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 338 (603)
+.|..|-...+|+....+ +..+++|+...... ..-+..+|..+++.+. +.-..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 457678888999998763 57888888654321 1122356888887774 32234555533 2 378999
Q ss_pred eCCCCCHHH--------------H---hhhhc----------C-CCCCHHHHHHHHHH-------------------HHH
Q 007442 339 FMPNGTLCQ--------------H---LQRER----------G-DGLSWPIRLTVAME-------------------TAQ 371 (603)
Q Consensus 339 ~~~~gsL~~--------------~---l~~~~----------~-~~l~~~~~~~ia~~-------------------ia~ 371 (603)
|+++.+|.. . ||... . .+.-|.+..++..+ +..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999866421 1 12110 0 11124333333222 122
Q ss_pred HHHHHHhc---------------------CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 372 AIAHLHSA---------------------INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 372 ~L~yLH~~---------------------~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.+|... ....++|+|+.+.||+ +++..+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 33444321 1235899999999999 8888999999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.54 E-value=0.082 Score=36.31 Aligned_cols=26 Identities=31% Similarity=0.465 Sum_probs=12.3
Q ss_pred eeehHHHHHHHHHHHHHH-HHHHhhhh
Q 007442 202 LIIGGSTAGASLIISMRL-LCCLMRRR 227 (603)
Q Consensus 202 ~i~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (603)
.|+++++.++++++++++ +++++|||
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 345666665555444333 33334444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.93 E-value=0.075 Score=36.44 Aligned_cols=27 Identities=30% Similarity=0.565 Sum_probs=12.3
Q ss_pred eeehHHHHHHHHHHHHHH-HHHHhhhhh
Q 007442 202 LIIGGSTAGASLIISMRL-LCCLMRRRS 228 (603)
Q Consensus 202 ~i~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (603)
.|+++++.++++++++++ +++++|||+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 345666655554433333 333444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.68 E-value=0.82 Score=47.59 Aligned_cols=29 Identities=34% Similarity=0.437 Sum_probs=24.9
Q ss_pred eEecCCCCCCeee------cCCCcEEEeeccCccc
Q 007442 384 IYHRDIKSSNILL------DYNFKSKVADFGLSRL 412 (603)
Q Consensus 384 ivH~Dik~~NILl------d~~~~~kl~DFGla~~ 412 (603)
++|+|+.+.|||+ +++..++|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4566799999998865
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.70 E-value=0.69 Score=43.77 Aligned_cols=84 Identities=10% Similarity=0.107 Sum_probs=62.0
Q ss_pred CCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCCe
Q 007442 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA-HLHSAINPPIYHRDIKSSNI 394 (603)
Q Consensus 316 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~-yLH~~~~~~ivH~Dik~~NI 394 (603)
.||++ -...-.+.+...+.|+.-+++.=+..+. .++...|++++..++.... +++ .-+|--|.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57777 3333456667777777665554444442 2788999999999988776 555 458889999999
Q ss_pred eecCCCcEEEeeccCcc
Q 007442 395 LLDYNFKSKVADFGLSR 411 (603)
Q Consensus 395 Lld~~~~~kl~DFGla~ 411 (603)
++|.++.++|.-.|+-.
T Consensus 116 ~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EECTTCCEEESCCEETT
T ss_pred EEeCCCcEEEEEcCCcc
Confidence 99999999999888654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.76 E-value=0.48 Score=44.72 Aligned_cols=116 Identities=11% Similarity=0.144 Sum_probs=77.0
Q ss_pred CCCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 316 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
.||+++.. .+-.+.+...+.|+.-+++.=+..+. .++...+++++..++....+++. -+|--|.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 57888866 45455565556565543322222232 27889999999999998866664 488899999999
Q ss_pred ecCCCcEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccC
Q 007442 396 LDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVD 465 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~ 465 (603)
+|.++.+++.-.|+.... +|. ..+...=.-.+=+++..+++++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999988865431 221 01111112246678888999877764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.82 E-value=0.09 Score=56.19 Aligned_cols=59 Identities=10% Similarity=0.167 Sum_probs=17.2
Q ss_pred cCcccCCCceEEEEEEEcC-CcEEEE------EEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEe
Q 007442 267 KQRLGTGAFGTVYAGKLQN-DLLVAI------KRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSI 328 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~-~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 328 (603)
.+.|| ||.||+|.+.. ..+||| |..+.. ..+....|.+|..++.+++|||+++..++-.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 44576 99999999865 367899 777653 2344567889999999999999999988754
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=85.91 E-value=0.2 Score=49.20 Aligned_cols=32 Identities=34% Similarity=0.897 Sum_probs=26.6
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCCCCCCCCCCcC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGYPAGSGCRK 180 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gnpy~~g~gC~~ 180 (603)
.|+.++.|.+. .++|.|.|+.||.||+. .|.+
T Consensus 14 ~C~~~a~C~Nt-----~Gsy~C~C~~Gy~GnG~----~C~d 45 (285)
T 1gl4_A 14 QCSVHAECRDY-----ATGFCCRCVANYTGNGR----QCVA 45 (285)
T ss_dssp GSCTTEEEEEC-----SSCEEEEECTTEEECSS----SEEE
T ss_pred CCCCCCEeEcC-----CCCeEEEcCCCCCCCCC----cCCC
Confidence 68889999874 47899999999999875 4766
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=84.97 E-value=0.45 Score=31.45 Aligned_cols=26 Identities=31% Similarity=0.798 Sum_probs=20.2
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. .++|+|.|..||.|.
T Consensus 10 pC~ngg~C~~~-----~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 10 PCLNGGSCKDD-----INSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTCEEEEE-----TTEEEEECCTTCCST
T ss_pred CCCCCCEeEcC-----CCceEeECCCCCcCC
Confidence 47777888753 467999999999763
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.90 E-value=0.54 Score=34.02 Aligned_cols=31 Identities=29% Similarity=0.660 Sum_probs=21.4
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
-|.+++.|..........+|+|.|..||.|.
T Consensus 15 pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~ 45 (55)
T 3u7u_G 15 FCVNGGECFMVKDLSNPSRYLCKCPNEFTGD 45 (55)
T ss_dssp TSCTTCEEEEECCC--CCCEEEEECTTEEST
T ss_pred CCCCCCCcCCCCccCCCCCEeEeCCCCCcCC
Confidence 5788899964321124578999999999763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 603 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-19 | |
| d1gl4a2 | 40 | g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-65
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ QR+G+G+FGTVY GK D+ V + + +Q NE+ ++ H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+G S + +V ++ +L HL + +A +TAQ + +LH
Sbjct: 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL-GMTEISHISTAPQGTPGYLDPQY---HQNF 439
I HRD+KS+NI L + K+ DFGL+ + SH G+ ++ P+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
S +SDVY+FG+VL E++T P + +N + +G L + +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN- 237
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
+ L CL RD RP ++ +E +
Sbjct: 238 ----------CPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-64
Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 26/283 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+RLG G FG V+ G VA+K +K + + + E L+ + H LVRL
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+ ++ E+M NG+L L+ G L+ L +A + A+ +A +
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
HRD++++NIL+ K+ADFGL+RL + + P+ +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
KSDV+SFG++L EI+T R P + +G D E
Sbjct: 190 KSDVWSFGILLTEIVT------HGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE----- 238
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546
+ +L C + RP+ + + LE T T
Sbjct: 239 ----------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-62
Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 32/282 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
Q +G G FG V G + + VA+K IK+ T Q + E +++ + H NLV+L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQL 65
Query: 324 LGCSIERGEQI-LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
LG +E + +V E+M G+L +L+ L L +++ +A+ +L
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
HRD+ + N+L+ + +KV+DFGL++ E S + + P+ + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
KSDV+SFG++L EI + F R P R+ KG + D
Sbjct: 179 TKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA---- 228
Query: 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
V E+ C MRPS ++ +LEHI+T
Sbjct: 229 -----------VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-60
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 26/280 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ Q +G+G FG V+ G N VAIK I+ + + E +++ +SHP LV+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
G +E+ LV+EFM +G L R + + L + ++ + +A+L
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---AC 121
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
+ HRD+ + N L+ N KV+DFG++R + + ST + + P+ S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
KSDV+SFGV++ E+ + K+ +R +EV + IS G + P +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTGF--RLYKPRLASTH--- 230
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
V ++ C + RP+ + + +L I
Sbjct: 231 ----------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 70/306 (22%), Positives = 129/306 (42%), Gaps = 34/306 (11%)
Query: 267 KQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
++ +G G FG V+ GK + + VA+K R+ + EI + H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKWRGEE-VAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 65
Query: 327 SIERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-- 380
+ LV ++ +G+L +L R ++ + +A+ TA +AHLH I
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 381 ---NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ---GTPGYLDPQ 434
P I HRD+KS NIL+ N +AD GL+ + I AP GT Y+ P+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 435 Y------HQNFHLSDKSDVYSFGVVLVEIITALKV----VDFSRPPNEVNLAALAADRIS 484
++F ++D+Y+ G+V EI + D+ P ++ + + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544
K ++ + P I +A + +A++ C + R + + L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEA-----LRVMAKIMRECWYANGAARLTALRIKKTLSQL-- 295
Query: 545 RTMEDI 550
E I
Sbjct: 296 SQQEGI 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-60
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 26/283 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ +LG G FG V+ G VAIK +K T + + E +++ + H LV+L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
+ +V E+M G+L L+ E G L P + +A + A +A++
Sbjct: 78 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
HRD++++NIL+ N KVADFGL+RL + + P+ +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
KSDV+SFG++L E+ T R P + D++ +G
Sbjct: 194 KSDVWSFGILLTELTT------KGRVPYPGMVNREVLDQVERGYRMPCPPEC-------- 239
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546
+ +L +C + RP+ + LE T T
Sbjct: 240 -------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-59
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 26/279 (9%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ + LGTG FG V GK + VAIK IK + + + E K++ +SH LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
G ++ ++ E+M NG L +L+ R L + + +A+ +L +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
HRD+ + N L++ KV+DFGLSR + + S + + P+ S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
KSD+++FGV++ EI + + P E + A+ I++G + P +
Sbjct: 181 KSDIWAFGVLMWEIYS------LGKMPYERFTNSETAEHIAQGL--RLYRPHLAS----- 227
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
KV + + C D RP+ + + + +
Sbjct: 228 --------EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 5e-59
Identities = 81/294 (27%), Positives = 127/294 (43%), Gaps = 28/294 (9%)
Query: 250 PIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQN-DLLVAIKRIKHRDTDGIQQVVNE 308
P Y E+E+ + K +LG G +G VY G + L VA+K +K DT +++ + E
Sbjct: 7 PNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 309 IKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAME 368
++ + HPNLV+LLG ++ EFM G L +L+ +S + L +A +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTP 428
+ A+ +L HRD+ + N L+ N KVADFGLSRL + +
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 429 GYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488
+ P+ S KSDV++FGV+L EI T + P + + + K
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYR 234
Query: 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
E + KV EL C ++ RPS E+ E +
Sbjct: 235 MERPEGC---------------PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 2e-57
Identities = 65/309 (21%), Positives = 126/309 (40%), Gaps = 43/309 (13%)
Query: 252 YPYREIEKATIGFSEK---------QRLGTGAFGTVYAGKL----QNDLLVAIKRIKHRD 298
+ + + +A F+++ Q +G G FG V +G L + ++ VAIK +K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 299 T-DGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGL 357
T + ++E ++ HPN++ L G + +++ EFM NG+L L++ G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 358 SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417
+ + + A + +L + HRD+ + NIL++ N KV+DFGLSR +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 418 SHI----STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
S + + + P+ Q + SDV+S+G+V+ E+++ + P
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWD 236
Query: 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
+ I + + +L C R+ RP
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDC---------------PSALHQLMLDCWQKDRNHRPKFG 281
Query: 534 EVATELEHI 542
++ L+ +
Sbjct: 282 QIVNTLDKM 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-56
Identities = 63/293 (21%), Positives = 120/293 (40%), Gaps = 35/293 (11%)
Query: 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQN---DLLVAIKRIKHRDTDG--IQQVVNEIKL 311
+++ + +K+ LG+G FGTV G Q VA+K +K+ D +++ E +
Sbjct: 3 LDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 312 ISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ + +P +VR++G E +LV E G L ++LQ+ R + + + + +
Sbjct: 62 MQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSM 118
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--GTPG 429
+ +L HRD+ + N+LL +K++DFGLS+ + ++
Sbjct: 119 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 430 YLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
+ P+ + S KSDV+SFGV++ E + + + P + + KG
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFS------YGQKPYRGMKGSEVTAMLEKGERM 229
Query: 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
E + +L C + + RP V L +
Sbjct: 230 GCPAGCPRE---------------MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 69/320 (21%), Positives = 127/320 (39%), Gaps = 35/320 (10%)
Query: 257 IEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI-QQVVNEIKLISC 314
+E F + LG G G V+ + L++A K I I Q++ E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 315 VSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
+ P +V G GE + E M G+L Q L++ + I V++ + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
+L I HRD+K SNIL++ + K+ DFG+S I ++ + GT Y+ P+
Sbjct: 119 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFVGTRSYMSPE 173
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIIT-------------------ALKVVDFSRPPNEVNL 475
Q H S +SD++S G+ LVE+ ++ PP
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 476 AALAADRISKGRLDEIIDPLI--IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
+ R I L+ I + + + + +CL + R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 534 EVATELEH--IRTRTMEDIN 551
++ + H I+ E+++
Sbjct: 294 QL---MVHAFIKRSDAEEVD 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 2e-56
Identities = 68/319 (21%), Positives = 116/319 (36%), Gaps = 54/319 (16%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGKLQNDL------LVAIKRIK-HRDTDGIQQVV 306
+E + +G GAFG V+ + L +VA+K +K D
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 307 NEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG---------- 356
E L++ +PN+V+LLG L++E+M G L + L+
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 357 ------------LSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404
LS +L +A + A +A+L HRD+ + N L+ N K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 405 ADFGLSR-LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKV 463
ADFGLSR + + ++ P+ + +SDV+++GVVL EI +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 464 VDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLA 523
+ EV + G + + +E + L C +
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPLE---------------LYNLMRLCWS 280
Query: 524 FHRDMRPSMTEVATELEHI 542
RPS + L+ +
Sbjct: 281 KLPADRPSFCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-56
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 32/279 (11%)
Query: 270 LGTGAFGTVYAGKLQ---NDLLVAIKRIKH-RDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
LG G FG+V G + + VAIK +K + ++++ E +++ + +P +VRL+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ +LV E G L + L +R + + + + + + +L
Sbjct: 77 V-CQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDPQYHQNFHLSD 443
HRD+ + N+LL +K++DFGLS+ +A + + P+ S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 444 KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHS 503
+SDV+S+GV + E ++ + + P + I +G+ E E
Sbjct: 192 RSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE----- 240
Query: 504 DAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+ L C + + RP V +
Sbjct: 241 ----------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-55
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 35/287 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNL 320
+ +GTG++G + + ++ K + + Q +V+E+ L+ + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 321 VRLLGCSIERGEQIL--VYEFMPNGTLCQHLQRERGDG--LSWPIRLTVAMETAQAIAHL 376
VR I+R L V E+ G L + + + L L V + A+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 377 H--SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQ 434
H S + HRD+K +N+ LD K+ DFGL+R+ + + + A GTP Y+ P+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPE 184
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494
++KSD++S G +L E+ PP A +I +G+ I
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCAL-------MPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
E + E+ R L RPS+ E+ LE+
Sbjct: 238 YSDE---------------LNEIITRMLNLKDYHRPSVEEI---LEN 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 36/303 (11%)
Query: 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQND----LLVAIKRIKH-RDTDGIQQVVNEIK 310
+ F+E +G G FG VY G L ++ + A+K + D + Q + E
Sbjct: 23 GPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 311 LISCVSHPNLVRLLGCSIER-GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMET 369
++ SHPN++ LLG + G ++V +M +G L ++ R + + ++
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQV 139
Query: 370 AQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL---GMTEISHISTAPQG 426
A+ + L + HRD+ + N +LD F KVADFGL+R + H T +
Sbjct: 140 AKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 427 TPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486
++ + Q + KSDV+SFGV+L E++T PP + +G
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQG 250
Query: 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRT 546
R L E+ + E+ +C +MRPS +E+ + + I +
Sbjct: 251 R-----RLLQPEY----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 547 MED 549
+ +
Sbjct: 296 IGE 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-55
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 38/283 (13%)
Query: 267 KQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRL 323
+G G+F TVY G + + VA ++ R Q+ E +++ + HPN+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 324 LGCSIERGEQ----ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+ +LV E M +GTL +L+R + + + + + + + LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR 131
Query: 380 INPPIYHRDIKSSNILL-DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
PPI HRD+K NI + K+ D GL+ L + + A GTP ++ P+ ++
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE 187
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498
+ DVY+FG+ ++E+ T+ P +E AA R++ G D + I
Sbjct: 188 -KYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+V E+ C+ ++D R S+ ++ L H
Sbjct: 241 --------------EVKEIIEGCIRQNKDERYSIKDL---LNH 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-54
Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIKHRDTDG-IQQVVNEIKLISCVSH 317
+ ++ +G G FG VY G L+ + VAIK +K T+ + E ++ SH
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
N++RL G + +++ E+M NG RE+ S + + A + +L
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL--GMTEISHISTAPQGTPGYLDPQY 435
N HRD+ + NIL++ N KV+DFGLSR+ E ++ ++ + + P+
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 436 HQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495
+ SDV+SFG+V+ E++T + + +EV I+ G
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------MKAINDGFRLPTPMDC 238
Query: 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+ +L +C R RP ++ + L+ +
Sbjct: 239 ---------------PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-53
Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 34/280 (12%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
LG GAFG VY + + +L A K I + + ++ + EI +++ HPN+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
++ EF G + + L+ V +T A+ +LH I H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 387 RDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSD--- 443
RD+K+ NIL + K+ADFG+S I + GTP ++ P+ D
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPY 192
Query: 444 --KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501
K+DV+S G+ L+E+ PP+ +I+K + P
Sbjct: 193 DYKADVWSLGITLIEMAEI-------EPPHHELNPMRVLLKIAKSEPPTLAQPSRW---- 241
Query: 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
S + +CL + D R + +++ L+H
Sbjct: 242 -SSN--------FKDFLKKCLEKNVDARWTTSQL---LQH 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-53
Identities = 74/322 (22%), Positives = 124/322 (38%), Gaps = 49/322 (15%)
Query: 251 IYPYREIEKATIGFSEKQRLGTGAFGTVYAGKLQND---LLVAIKRIK-HRDTDGIQQVV 306
IYP + + +G G FG V +++ D + AIKR+K + D +
Sbjct: 3 IYPVLDWND----IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 307 NEIKLIS-CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQR-------------- 351
E++++ HPN++ LLG RG L E+ P+G L L++
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 352 ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
LS L A + A+ + +L HRD+ + NIL+ N+ +K+ADFGLSR
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 412 LGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPN 471
+ ++ + + SDV+S+GV+L EI++ P
Sbjct: 176 GQEVYVKKTMGR--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPY 227
Query: 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS 531
A +++ +G E E V +L +C RPS
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDE---------------VYDLMRQCWREKPYERPS 272
Query: 532 MTEVATELEHIRTRTMEDINCT 553
++ L + +N T
Sbjct: 273 FAQILVSLNRMLEERKTYVNTT 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 3e-53
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 41/285 (14%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPN 319
FS+ + +G G+FG VY + ++N +VAIK++ + + + Q ++ E++ + + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++ GC + LV E+ ++ L V Q +A+LHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH 134
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQY---H 436
+ HRD+K+ NILL K+ DFG + + S + GTP ++ P+
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 186
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
K DV+S G+ +E+ +PP A A I++ +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAE-------RKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
E CL RP+ + L+H
Sbjct: 240 SE--------------YFRNFVDSCLQKIPQDRPTSEVL---LKH 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 59/289 (20%), Positives = 108/289 (37%), Gaps = 34/289 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVS 316
++LG G+FG V G+ + VA+K +K + + + E+ + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 317 HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
H NL+RL G + +V E P G+L L++ +G A++ A+ + +L
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL 127
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--ISTAPQGTPGYLDPQ 434
S HRD+ + N+LL K+ DFGL R H + + + P+
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494
+ S SD + FGV L E+ T + +++ +I K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERLPRPE 238
Query: 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543
+ + + +C A + RP+ + L +
Sbjct: 239 DCPQ--------------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-52
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 38/282 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIK---HRDTDGIQQVVNEIKLISCVSHPN 319
F + LG G FG VY + Q+ ++A+K + Q+ E+++ S + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++RL G + L+ E+ P GT+ + LQ+ T E A A+++ HS
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK 125
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ HRDIK N+LL + K+ADFG S + GT YL P+ +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGR 179
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
+K D++S GV+ E + +PP E N RIS+ + E
Sbjct: 180 MHDEKVDLWSLGVLCYEFLV-------GKPPFEANTYQETYKRISRVEFT--FPDFVTEG 230
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+L R L + RP + EV LEH
Sbjct: 231 --------------ARDLISRLLKHNPSQRPMLREV---LEH 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-51
Identities = 64/321 (19%), Positives = 125/321 (38%), Gaps = 50/321 (15%)
Query: 247 SNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGKL------QNDLLVAIKRIKH-RDT 299
+ +P E + + F + LG GAFG V + VA+K +K
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 300 DGIQQVVNEIKLIS-CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGD--- 355
+ +++E+K++S +H N+V LLG G +++ E+ G L L+R+R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 356 -------------GLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402
L L+ + + A+ +A L S HRD+ + NILL + +
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184
Query: 403 KVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITAL 461
K+ DFGL+R + ++ + + ++ P+ N + +SDV+S+G+ L E+ +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 462 KVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRC 521
P + ++ K + ++ ++ C
Sbjct: 245 SSPYPGMPVDSK------FYKMIKEGFRMLSPEHAPA--------------EMYDIMKTC 284
Query: 522 LAFHRDMRPSMTEVATELEHI 542
RP+ ++ +E
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-51
Identities = 64/286 (22%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSH 317
F + + LG+GAFGTVY G + + VAIK ++ +++++E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
P++ RLLG + L+ + MP G L +++ + + L ++ A+ + +L
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQYH 436
+ + HRD+ + N+L+ K+ DFGL++ LG E + + + ++ +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
+ + +SDV+S+GV + E++T F P + A+ + + KG
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMT------FGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
I+ V + +C D RP E+ E +
Sbjct: 240 ID---------------VYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-51
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 268 QRLGTGAFGTVYAGKLQND----LLVAIKRIKHRDTDGI-QQVVNEIKLISCVSHPNLVR 322
+ +G G FG V+ G + L VAIK K+ +D + ++ + E + HP++V+
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L+G I ++ E G L LQ + L + A + + A+A+L S
Sbjct: 73 LIGV-ITENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---K 127
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
HRDI + N+L+ N K+ DFGLSR + ++ + ++ P+ +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
SDV+ FGV + EI+ P + RI G +
Sbjct: 188 SASDVWMFGVCMWEILM------HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT---- 237
Query: 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542
+ L +C A+ RP TE+ +L I
Sbjct: 238 -----------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-51
Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 53/307 (17%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQND------LLVAIKRIKHR-DTDGIQQVVNEIKLIS-CV 315
+ LG+GAFG V + VA+K +K + D+ + +++E+K+++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 316 SHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERG--------------------- 354
SH N+V LLG G L++E+ G L +L+ +R
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 355 DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414
+ L++ L A + A+ + L HRD+ + N+L+ + K+ DFGL+R M
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 415 TEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEV 473
++ ++ + + ++ P+ + KSDV+S+G++L EI + P +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPGI 270
Query: 474 NLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT 533
+ A I G + E + + C AF RPS
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEE---------------IYIIMQSCWAFDSRKRPSFP 315
Query: 534 EVATELE 540
+ + L
Sbjct: 316 NLTSFLG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-51
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 31/279 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVR 322
++ +++G GA GTVY + VAI+++ + + ++NEI ++ +PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 323 LLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINP 382
L + E +V E++ G+L + D V E QA+ LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSN--- 135
Query: 383 PIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLS 442
+ HRDIKS NILL + K+ DFG +T + GTP ++ P+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
K D++S G++ +E+I PP A I+ E+ +P +
Sbjct: 195 PKVDIWSLGIMAIEMIEG-------EPPYLNENPLRALYLIATNGTPELQNPEKLS---- 243
Query: 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ RCL + R S E+ L+H
Sbjct: 244 ---------AIFRDFLNRCLDMDVEKRGSAKEL---LQH 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-50
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 32/282 (11%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRI-KHRDTDGIQQVVNEIKLISCVSHPNLV 321
+ Q LG GA+G V + VA+K + R D + + EI + ++H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 322 RLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAIN 381
+ G E Q L E+ G L ++ + G+ P + + +LH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI-- 122
Query: 382 PPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGTPGYLDPQYHQNFH 440
I HRDIK N+LLD K++DFGL+ + GT Y+ P+ +
Sbjct: 123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 441 LSD-KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
DV+S G+VL ++ D + +D K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKIDSA- 235
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
L + L + R ++ ++ +
Sbjct: 236 --------------PLALLHKILVENPSARITIPDI---KKD 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 67/304 (22%), Positives = 124/304 (40%), Gaps = 40/304 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDL------LVAIKRIKHR-DTDGIQQVVNEIKLISCVS 316
+ + LG G+FG VY G + + VAIK + + +NE ++ +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 317 HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--------LSWPIRLTVAME 368
++VRLLG + +++ E M G L +L+ R S + +A E
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 369 TAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR-LGMTEISHISTAPQGT 427
A +A+L++ HRD+ + N ++ +F K+ DFG++R + T+
Sbjct: 142 IADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 428 PGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGR 487
++ P+ ++ + SDV+SFGVVL EI T + P + + +G
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNEQVLRFVMEGG 252
Query: 488 LDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTM 547
L + D + EL C ++ MRPS E+ + ++
Sbjct: 253 LLDKPDNC---------------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 548 EDIN 551
+++
Sbjct: 298 REVS 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 3e-47
Identities = 62/326 (19%), Positives = 116/326 (35%), Gaps = 31/326 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+ LGTGAFG V+ A K + + V EI+ +S + HP LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
+ E +++YEFM G L + + E +S + + + + H+H H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147
Query: 387 RDIKSSNILL--DYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
D+K NI+ + + K+ DFGL+ + S T GT + P+ + +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 205
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSD 504
+D++S GV+ +++ P + + G S+
Sbjct: 206 TDMWSVGVLSYILLSG-------LSPFGGENDDETLRNVKSCDW----NMDDSAFSGISE 254
Query: 505 AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTMEDINCTASLEASLCSSS 564
+ + L + R ++ + LEH + + +S +
Sbjct: 255 D--------GKDFIRKLLLADPNTRMTIHQA---LEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 565 YNASERMKDNSPPSVQDSWSSEQSSS 590
++ + D P + SS
Sbjct: 304 RDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 49/304 (16%)
Query: 264 FSEKQRLGTGAFGTVYAGKL--------QNDLLVAIKRIKHRDTD-GIQQVVNEIKLIS- 313
+ LG GAFG V + VA+K +K T+ + +++E++++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 314 CVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDG--------------LSW 359
H N++ LLG + G ++ E+ G L ++LQ R G LS
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 360 PIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419
++ A + A+ + +L S HRD+ + N+L+ + K+ADFGL+R +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 420 IST-APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAAL 478
T + ++ P+ + + +SDV+SFGV+L EI T P E+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----- 246
Query: 479 AADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538
+ +G + E + + C RP+ ++ +
Sbjct: 247 -FKLLKEGHRMDKPSNCTNE---------------LYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 539 LEHI 542
L+ I
Sbjct: 291 LDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-45
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 37/295 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPN 319
F + LG G+F TV + L AIK ++ R + + V E ++S + HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
V+L + + + NG L +++++ E A+ +LH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG- 126
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQN 438
I HRD+K NILL+ + ++ DFG +++ E + + GT Y+ P+
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 439 FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD--EIIDPLI 496
SD+++ G ++ +++ PP L +I K D E P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAG-------LPPFRAGNEYLIFQKIIKLEYDFPEKFFP-- 235
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTMEDIN 551
K +L + L R E+ E +
Sbjct: 236 ----------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 47/303 (15%)
Query: 264 FSEKQRLGTGAFGTVYAGKLQNDL------LVAIKRIKHRDTDG-IQQVVNEIK-LISCV 315
+ LG GAFG V VA+K +K T + +++E+K LI
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 316 SHPNLVRLLGCSIERGEQI-LVYEFMPNGTLCQHLQRERG--------------DGLSWP 360
H N+V LLG + G + ++ EF G L +L+ +R D L+
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 361 IRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420
+ + + A+ + L S HRD+ + NILL K+ DFGL+R + ++
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 421 -STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479
+ ++ P+ + + +SDV+SFGV+L EI + + P V +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDEEF 246
Query: 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
R+ +G D E + + C RP+ +E+ L
Sbjct: 247 CRRLKEGTRMRAPDYTTPE---------------MYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 540 EHI 542
++
Sbjct: 292 GNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 58/328 (17%), Positives = 111/328 (33%), Gaps = 32/328 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+ LG G FG V+ + K +K + TD V EI +++ H N++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
E ++++EF+ + + + L+ ++ + +A+ LHS I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 387 RDIKSSNILLDY--NFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
DI+ NI+ + K+ +FG +R + P Y P+ HQ+ +S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSD 504
+D++S G ++ +++ P + I + S
Sbjct: 184 TDMWSLGTLVYVLLSG-------INPFLAETNQQIIENIMNAE----YTFDEEAFKEISI 232
Query: 505 AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTRTMEDINCTASLEASLCSSS 564
+ R L R R + +E L+H + + T +
Sbjct: 233 E--------AMDFVDRLLVKERKSRMTASEA---LQHPWLKQKIERVSTKVIRTLKHRRY 281
Query: 565 YNASERMKDNSPPSVQDSWSSEQSSSSP 592
Y+ + N S S
Sbjct: 282 YHTLIKKDLNMVVSAARISCGGAIRSQK 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 5e-44
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 28/290 (9%)
Query: 254 YREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQ-VVNEIKL 311
+++ E + + LGTGAF V + + LVAIK I + +G + + NEI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 312 ISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQ 371
+ + HPN+V L G L+ + + G L + + + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 372 AIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL 431
A+ +LH + LD + K ++DFGLS++ + + GTPGY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYV 176
Query: 432 DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491
P+ S D +S GV+ ++ PP A ++I K
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLC-------GYPPFYDENDAKLFEQILKAE---- 225
Query: 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ SD+ + + + R + + L+H
Sbjct: 226 YEFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA---LQH 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 6e-44
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKH---RDTDGIQQVVNEIKLISCVSHPNLVRL 323
+ LG G V+ + L+ VA+K ++ RD + E + + ++HP +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 324 LGCSIERGEQI----LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
+V E++ TL + E ++ + V + QA+ H
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 130
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI--STAPQGTPGYLDPQYHQ 437
I HRD+K +NI++ KV DFG++R + + + A GT YL P+ +
Sbjct: 131 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 438 NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497
+ +SDVYS G VL E++T PP + A + + P
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTG-------EPPFTGDSPVSVAYQHVRED----PIPPSA 236
Query: 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIR 543
H G S + + + LA + + R + E+ +L +
Sbjct: 237 RHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 2e-43
Identities = 56/279 (20%), Positives = 99/279 (35%), Gaps = 35/279 (12%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
+ LG+GAFG V+ + K I V NEI +++ + HP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYH 386
++ E +L+ EF+ G L + +S + + + + H+H I H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 387 RDIKSSNILLDYNFKS--KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
DIK NI+ + S K+ DFGL+ I T + P+ +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPP--NEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
+D+++ GV+ +++ P E +L L + DE +
Sbjct: 209 TDMWAIGVLGYVLLS-------GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE--- 258
Query: 503 SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ L R ++ + LEH
Sbjct: 259 -----------AKDFIKNLLQKEPRKRLTVHDA---LEH 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 1e-42
Identities = 67/295 (22%), Positives = 101/295 (34%), Gaps = 46/295 (15%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGI---------QQVVNEIKLIS 313
+ K+ LG G V A+K I + + E+ ++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 314 CVS-HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQA 372
VS HPN+++L LV++ M G L +L + LS + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
I LH I HRD+K NILLD + K+ DFG S + GTP YL
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLA 177
Query: 433 PQYHQ------NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486
P+ + + + D++S GV++ ++ PP L I G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------SPPFWHRKQMLMLRMIMSG 230
Query: 487 RLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
E +SD V +L R L R + E L H
Sbjct: 231 N----YQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA---LAH 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 23/289 (7%)
Query: 268 QRLGTGAFGTVYAGK--LQNDLLVAIKRIKHRDTDG-----IQQVVNEIKLISCVSHPNL 320
+G GA+G V+ + VA+KR++ + + + V ++ + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLC----QHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
VRL + + +L + G+ + + + + L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYH 436
HS + HRD+K NIL+ + + K+ADFGL+R+ +++ S T Y P+
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
+ D++S G + E+ + S +++ + +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 497 IEHRGHSDAGTLASVHKVAELAF----RCLAFHRDMRPSMTEVATELEH 541
S V + EL +CL F+ R S L H
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSH 293
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 9e-40
Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 16/282 (5%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNLVRLLG 325
+++G G +G VY + A+K+I+ D + EI ++ + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
+ +LV+E + E G L + ++ IA+ H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKS 445
HRD+K N+L++ + K+ADFGL+R + + + S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 446 DVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII-----DPLIIEHR 500
D++S G + E++ + +++ + + DP +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 501 GHSDAGTLASVHKVA-ELAFRCLAFHRDMRPSMTEVATELEH 541
L + + +L + L + R + + LEH
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA---LEH 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-39
Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 30/294 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNL 320
F + +++G G +G VY + +VA+K+I+ + EI L+ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 321 VRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
V+LL + LV+EF+ L + + G+ P+ + + Q +A HS
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-- 120
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFH 440
+ HRD+K N+L++ K+ADFGL+R + + +
Sbjct: 121 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 441 LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISK--GRLDEIIDPLIIE 498
S D++S G + E++T R + RI + G DE++ P +
Sbjct: 180 YSTAVDIWSLGCIFAEMVT-------RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 499 HRGHSDAGTLASVHKVAE-----------LAFRCLAFHRDMRPSMTEVATELEH 541
+ + + ++ L + L + + R S L H
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAH 283
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 3e-39
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 38/284 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPN 319
F + LGTG+FG V+ + N A+K +K ++ +E ++S V+HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
++R+ G + + ++ +++ G L L++ + A+ L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA-----AEVCLALEYL 120
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ I +RD+K NILLD N K+ DFG ++ + ++ GTP Y+ P+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTK 176
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499
+ D +SFG+++ E++ P + ++I L P E
Sbjct: 177 PYNKSIDWWSFGILIYEMLA-------GYTPFYDSNTMKTYEKILNAELR--FPPFFNE- 226
Query: 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEH 541
V +L R + R + TE H
Sbjct: 227 -------------DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 6e-39
Identities = 54/289 (18%), Positives = 97/289 (33%), Gaps = 33/289 (11%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLG- 325
+++G+G+FG +Y G + VAIK + Q+ E K+ + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
C E ++V E + R S L +A + I ++HS
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 386 HRDIKSSNIL---LDYNFKSKVADFGLSRL------GMTEISHISTAPQGTPGYLDPQYH 436
HRD+K N L + DFGL++ + GT Y H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 437 QNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
S + D+ S G VL+ P + AA + + ++ P+
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLG-------SLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545
+ +G+ A C + D +P + + ++ R
Sbjct: 239 VLCKGYPSE--------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR---DTDGIQQVVNEIKLIS-CVSHP 318
F + LG G+FG V+ + + + AIK +K D ++ + E +++S HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
L + + V E++ G L H+Q A E + LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS 121
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
I +RD+K NILLD + K+ADFG+ + M + +T GTP Y+ P+
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+ D +SFGV+L E++
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLI 198
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 37/284 (13%)
Query: 267 KQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIK-LISCVSHPNLVRLL 324
Q LG G G V + A+K ++ + E++ P++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 325 GC----SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
R ++V E + G L +Q + + +AI +LHS
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 381 NPPIYHRDIKSSNILLD---YNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
I HRD+K N+L N K+ DFG ++ + S + TP Y+ P+
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 438 NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497
D++S GV++ ++ PP N + + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLC-------GYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
E S+ V L L R ++TE + H
Sbjct: 240 EWSEVSEE--------VKMLIRNLLKTEPTQRMTITEF---MNH 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-38
Identities = 63/284 (22%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 270 LGTGAFGTVYAGK-LQNDLLVAIKRIK-----HRDTDGIQQVVNEIKLISCVSHPNLVRL 323
LG G F TVY + + +VAIK+IK + + EIKL+ +SHPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 324 LGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPP 383
L + LV++FM + ++ L+ + T Q + +LH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HW 120
Query: 384 IYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDP-QYHQNFHLS 442
I HRD+K +N+LLD N K+ADFGL++ + T T Y P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMYG 179
Query: 443 DKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGH 502
D+++ G +L E++ + + +++ ++ + ++
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 503 SDAGTLASVHKVA-----ELAFRCLAFHRDMRPSMTEVATELEH 541
L + A +L F+ R + T+ L+
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-38
Identities = 60/297 (20%), Positives = 119/297 (40%), Gaps = 30/297 (10%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDG-IQQVVNEIKLISCVSHPNLV 321
++ +G GA+G V + N + VAIK+I + Q+ + EIK++ H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 322 RLLGCSIERGEQILVYEFMPNGTL-CQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI 380
+ + + ++ + + + LS + + + ++HSA
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 128
Query: 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQ--GTPGYLDPQYHQN 438
+ HRD+K SN+LL+ K+ DFGL+R+ + H + T Y P+ N
Sbjct: 129 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 439 FHLSDKS-DVYSFGVVLVEIIT-------------ALKVVDFSRPPNEVNLAALAADRIS 484
KS D++S G +L E+++ ++ P++ +L + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
L + +R +A + A +L + L F+ R + + L H
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKA-----LDLLDKMLTFNPHKRIEVEQA---LAH 295
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 6e-38
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 16/204 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQV------VNEIKLISCVS 316
FS + +G G FG VY + + A+K + + Q + L+S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 317 HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
P +V + + + + M G L HL + S A E + H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHM 123
Query: 377 HSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL-DPQY 435
H+ + +RD+K +NILLD + +++D GL+ + H S GT GY+
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 177
Query: 436 HQNFHLSDKSDVYSFGVVLVEIIT 459
+ +D +S G +L +++
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLR 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (350), Expect = 1e-37
Identities = 48/291 (16%), Positives = 89/291 (30%), Gaps = 35/291 (12%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLG 325
+R+G G+FG ++ G L N+ VAIK R Q+ +E + ++ + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 326 CSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385
E +LV + + G + L G S A + + +H +
Sbjct: 69 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 386 HRDIKSSNILLD-----YNFKSKVADFGLSRLGMTEISHISTAPQ------GTPGYLDPQ 434
+RDIK N L+ V DFG+ + ++ + GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 435 YHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494
H S + D+ + G V + + + ++ L E+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545
E + D P + + R
Sbjct: 244 FPEE---------------FYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 17/230 (7%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPN 319
F + LG G FG V + A+K ++ D + V E +++ HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 320 LVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSA 379
L L V E+ G L HL RER + E A+ +LHS
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS- 123
Query: 380 INPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNF 439
+ +RDIK N++LD + K+ DFGL + G+++ + GTP YL P+ ++
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDN 180
Query: 440 HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489
D + GVV+ E++ R P + I +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-------GRLPFYNQDHERLFELILMEEIR 223
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-37
Identities = 69/285 (24%), Positives = 112/285 (39%), Gaps = 50/285 (17%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK------HRDTDGIQQVVNEIKLISCVS--HP 318
LG+G FG+VY+G + ++L VAIK ++ + +V E+ L+ VS
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 319 NLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
++RLL +L+ E ERG L + + + +A+ H H+
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN 128
Query: 379 AINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQ 437
+ HRDIK NIL+D N + K+ DFG L + T GT Y P++ +
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFDGTRVYSPPEWIR 182
Query: 438 NFHLSDKS-DVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496
+S V+S G++L +++ P E + +EII +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVC-------GDIPFEHD--------------EEIIRGQV 221
Query: 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
+ S L CLA RP+ E+ H
Sbjct: 222 FFRQRVSSE--------CQHLIRWCLALRPSDRPTFEEI---QNH 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 18/284 (6%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+++G G +GTV+ K + +VA+KR++ D + EI L+ + H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 325 GCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPI 384
+ LV+EF I + + + + H + +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 385 YHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDK 444
HRD+K N+L++ N + K+A+FGL+R + S S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 445 SDVYSFGVVLVEIITALKVVDFSRPPNEV------NLAALAADRISKGRLDEIIDPLIIE 498
D++S G + E+ A + + ++ L ++ P +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 499 HRGHSDAGTLASVHKVA-ELAFRCLAFHRDMRPSMTEVATELEH 541
S + ++ +L L + R S E L+H
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 55/289 (19%), Positives = 101/289 (34%), Gaps = 40/289 (13%)
Query: 264 FSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK------HRDTDGIQQVVNEIKLISCVS 316
+ + LG+G F V + L A K IK R + + E+ ++ +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 317 HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHL 376
HPN++ L + + IL+ E + G L L + L+ + + +L
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYL 129
Query: 377 HSAINPPIYHRDIKSSNILLDYN----FKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
HS I H D+K NI+L + K+ DFGL+ + + GTP ++
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVA 184
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492
P+ L ++D++S GV+ +++ E A + +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEH 541
L + R L R ++ + L+H
Sbjct: 244 SALAK------------------DFIRRLLVKDPKKRMTIQDS---LQH 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 59/302 (19%), Positives = 108/302 (35%), Gaps = 40/302 (13%)
Query: 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL 320
+ +++ + +G G+FG VY KL + LVAIK++ + E++++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 321 VRLLGCSIERGEQ------ILVYEFMPNGTLCQHLQRERGDG-LSWPIRLTVAMETAQAI 373
VRL GE+ LV +++P R L + +++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 374 AHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGMTEISHISTAPQGTPGYLD 432
A++HS I HRDIK N+LLD + K+ DFG ++ + +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIIT-------------ALKVVDFSRPPNEVNLAALA 479
+ DV+S G VL E++ ++++ P + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 480 ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATEL 539
+ P R + + L R L + R + E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAI-------ALCSRLLEYTPTARLTPLEA---C 301
Query: 540 EH 541
H
Sbjct: 302 AH 303
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-36
Identities = 58/311 (18%), Positives = 113/311 (36%), Gaps = 36/311 (11%)
Query: 255 REIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKL 311
E+ K + + ++G G FG V+ + + VA+K++ + + EIK+
Sbjct: 7 DEVSK----YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI 62
Query: 312 ISCVSHPNLVRLLGC--------SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRL 363
+ + H N+V L+ + +G LV++F + LS R+
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR---LGMTEISHI 420
+ L+ I HRD+K++N+L+ + K+ADFGL+R L +
Sbjct: 123 M-----QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 421 STAPQGTPGYL-DPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALA 479
T T Y D++ G ++ E+ T ++ + +++ L +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 480 --------ADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVA-ELAFRCLAFHRDMRP 530
+ L E ++ + + R D A +L + L R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 531 SMTEVATELEH 541
+ L H
Sbjct: 298 DSDDA---LNH 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 6e-34
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 21/235 (8%)
Query: 233 RKSTKRCLKEARG----ISNIPIYPYREIEKATIGFSEKQRLGTGAFGTVYAGK-LQNDL 287
++S K L +A+ P ++++ F + LGTG+FG V K ++
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 288 LVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGT 344
A+K + + I+ +NE +++ V+ P LV+L + +V E++ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 345 LCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKV 404
+ HL+R S P A + +LHS + +RD+K N+L+D +V
Sbjct: 128 MFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182
Query: 405 ADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
DFG ++ + GTP L P+ + + D ++ GV++ E+
Sbjct: 183 TDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-33
Identities = 53/314 (16%), Positives = 109/314 (34%), Gaps = 40/314 (12%)
Query: 252 YPYREIEKATIGFSEK----QRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQ 304
+ +E+ K Q +G+GA+G V + + VAIK++ + ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 305 VVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRE--RGDGLSWPIR 362
E++L+ + H N++ LL +F + + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 363 LTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIST 422
+ + + + ++H+ I HRD+K N+ ++ + + K+ DFGL+R S ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177
Query: 423 APQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482
+ D++S G ++ E+IT + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-------KTLFKGSDHLDQLKE 230
Query: 483 ISKG----------RLDEIIDPLIIEHRGHSDAGTLASVHKVA-----ELAFRCLAFHRD 527
I K RL ++ + AS+ A L + L +
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 528 MRPSMTEVATELEH 541
R + E L H
Sbjct: 291 QRVTAGEA---LAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 1e-31
Identities = 59/317 (18%), Positives = 115/317 (36%), Gaps = 47/317 (14%)
Query: 254 YREIEKATIGFSEKQR------LGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVV 306
Y + E + + + LG G + V+ + N+ V +K +K +++
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 77
Query: 307 NEIKLISCVS-HPNLVRLLGCSIERGEQ--ILVYEFMPNGTLCQHLQRERGDGLSWPIRL 363
EIK++ + PN++ L + + LV+E + N Q Q L+
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIR 132
Query: 364 TVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-NFKSKVADFGLSRLGMTEISHIST 422
E +A+ + HS I HRD+K N+++D+ + K ++ D+GL+
Sbjct: 133 FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYN 187
Query: 423 APQGTPGYLDPQYHQNFHLSD-KSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAAD 481
+ + P+ ++ + D D++S G +L +I + F + + A
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAK 245
Query: 482 RISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAF-----------------RCLAF 524
+ L + ID IE + K E + L +
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 525 HRDMRPSMTEVATELEH 541
R + E +EH
Sbjct: 306 DHQSRLTAREA---MEH 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 8e-31
Identities = 54/319 (16%), Positives = 117/319 (36%), Gaps = 46/319 (14%)
Query: 250 PIYPYREIEKATIGFSEK----QRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGI 302
P + +E+ K E+ +G+GA+G+V A + L VA+K++ +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 303 QQVVNEIKLISCVSHPNLVRLLGC-----SIERGEQILVYEFMPNGTLCQHLQRERGDGL 357
++ E++L+ + H N++ LL S+E + + + G ++ + + L
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK--L 118
Query: 358 SWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417
+ + + + + ++HS I HRD+K SN+ ++ + + K+ DFGL+
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTD 172
Query: 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAA 477
++ H + D++S G ++ E++T R
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-------RTLFPGTDHI 225
Query: 478 LAADRISKG--------------RLDEIIDPLIIEHRGHSDAGTLASVHKVA-ELAFRCL 522
I + + + + A + +A +L + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 523 AFHRDMRPSMTEVATELEH 541
D R + + L H
Sbjct: 286 VLDSDKRITAAQA---LAH 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 19/201 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIK--HRDTDGIQQVVNEIKLISCVSHPNLVRLL 324
+ +G+GA G V A D VAIK++ ++ ++ E+ L+ CV+H N++ LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 325 GCSI------ERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHS 378
E + LV E M + + I HLHS
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 379 AINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQN 438
I HRD+K SNI++ + K+ DFGL+R T S + T T Y P+
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 192
Query: 439 FHLSDKSDVYSFGVVLVEIIT 459
+ D++S G ++ E++
Sbjct: 193 MGYKENVDIWSVGCIMGEMVR 213
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-28
Identities = 67/291 (23%), Positives = 107/291 (36%), Gaps = 37/291 (12%)
Query: 264 FSEKQRLGTGAFGTVYAGKL----QNDLLVAIKRIKH----RDTDGIQQVVNEIKLISCV 315
F + LGTGA+G V+ + L A+K +K + + E +++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 316 SH-PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIA 374
P LV L + L+ +++ G L HL + + E A+
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALE 143
Query: 375 HLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHISTAPQGTPGYL--D 432
HLH I +RDIK NILLD N + DFGLS+ + + + + GT Y+ D
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 433 PQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492
+ D +S GV++ E++T P V+ + IS+ I+
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLT-------GASPFTVDGEKNSQAEISRR----IL 249
Query: 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSM-TEVATE-LEH 541
+ S +L R L R A E EH
Sbjct: 250 KSEPPYPQEMSAL--------AKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 8e-25
Identities = 41/209 (19%), Positives = 81/209 (38%), Gaps = 20/209 (9%)
Query: 268 QRLGTGAFGTVYAGK-LQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGC 326
++LG G F TV+ K + N+ VA+K ++ D + +EIKL+ V+ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 327 SIERGEQILVY--EFMPNGTLC------------QHLQRERGDGLSWPIRLTVAMETAQA 372
++L + PNG +++ G+ ++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 373 IAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLSRLGM-TEISHISTAPQGTPGY 430
+ ++H I H DIK N+L++ + ++ LG T T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 431 LDPQYHQNFHLSDKSDVYSFGVVLVEIIT 459
P+ +D++S ++ E+IT
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 6e-19
Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 19/154 (12%)
Query: 268 QRLGTGAFGTVYAGKLQNDLLVAIK----------RIKHRDTDGIQQVVNEIKLISCVSH 317
+ +G G V+ + +K ++K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 318 PNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLH 377
L +L G ++ + VY + N L + + + + V + +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 378 SAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411
I H D+ N+L+ + DF S
Sbjct: 121 H---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.6 bits (82), Expect = 5e-04
Identities = 11/32 (34%), Positives = 14/32 (43%), Gaps = 5/32 (15%)
Query: 141 CSQNANCTPVLTPHGRSGFRCGCNKGFEGDGY 172
CS +A C T GF C C + G+G
Sbjct: 9 CSVHAECRDYAT-----GFCCRCVANYTGNGR 35
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 96.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.97 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.11 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 89.16 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.06 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 88.87 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.66 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.86 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.46 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 87.41 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.49 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 84.74 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 83.65 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 83.65 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.45 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 81.55 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.78 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.6 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.06 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=431.06 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=204.6
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|...+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677888999999999999999999899999998643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++... ...++|..++.|+.|+|.||+|||+. +|+||||||+|||||+++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999999765 34599999999999999999999998 999999999999999999999999999987544433444
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccC
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRG 501 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 501 (603)
....||+.|+|||++.+..++.++|||||||+||||+|+..|+...... ..+...+..+...
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~------------ 221 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFRL------------ 221 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHHTCCC------------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHHhcCCC------------
Confidence 4567999999999999999999999999999999999976665432221 1122223332111
Q ss_pred CCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 502 HSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 502 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..+..+..++.+|+.+||+.||++||||+||++.|++|++
T Consensus 222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1112234578899999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-54 Score=433.27 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=216.1
Q ss_pred HhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
..++|...+.||+|+||+||+|.+++++.||||+++... ...++|.+|+++|++++|||||+++|++.+ +..+|||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 346788889999999999999999988999999997653 345789999999999999999999998854 567999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+++|+|.+++......+++|..+++|+.|||+||+|||+. +|+||||||+||||++++.+||+|||+|+........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999998776656799999999999999999999998 9999999999999999999999999999875544444
Q ss_pred eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 420 ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
......||+.|||||++.+..++.++|||||||+||||+||..|+...... ..+...+..+....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~------~~~~~~i~~~~~~~--------- 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGYRMV--------- 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCC---------
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCC---------
Confidence 455667999999999999999999999999999999999987766532221 11223333331111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.+...+.++.+|+.+||+.+|++||||.||++.|+.+-.
T Consensus 231 ------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 ------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 112344578899999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=436.02 Aligned_cols=269 Identities=23% Similarity=0.373 Sum_probs=209.4
Q ss_pred CCChHHHHHHhcCCC---------ccCcccCCCceEEEEEEEcC-C---cEEEEEEeccC-ChhhHHHHHHHHHHHhccC
Q 007442 251 IYPYREIEKATIGFS---------EKQRLGTGAFGTVYAGKLQN-D---LLVAIKRIKHR-DTDGIQQVVNEIKLISCVS 316 (603)
Q Consensus 251 ~~~~~el~~at~~f~---------~~~~LG~G~~g~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~ 316 (603)
.++|++++.++.+|. ..++||+|+||+||+|.++. + ..||||++... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 356777777776664 34689999999999999853 2 36999998764 4556678999999999999
Q ss_pred CCceeeeeeeEeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 007442 317 HPNLVRLLGCSIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILL 396 (603)
Q Consensus 317 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILl 396 (603)
|||||+++|+|.+.+..++||||+++|+|.+++... ...++|.+++.|+.|+|.||+|||+. +|+||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999998764 34599999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeccCcccccccccc----eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcc
Q 007442 397 DYNFKSKVADFGLSRLGMTEISH----ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPN 471 (603)
Q Consensus 397 d~~~~~kl~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~ 471 (603)
+.++++||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999864432221 1223457899999999999999999999999999999998 7888853221
Q ss_pred hhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 472 EVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 472 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+..+.. ...+...+..+.+|+.+||+.+|++||||.||++.|+++.+.
T Consensus 240 -----~~~~~~i~~~~~---------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 -----QDVINAIEQDYR---------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----HHHHHHHHTTCC---------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHHcCCC---------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 112223333211 111233456788999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=429.79 Aligned_cols=261 Identities=27% Similarity=0.385 Sum_probs=208.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
.++|...+.||+|+||+||+|++++ .||||+++.. +....+.|.+|+.+|++++|||||+++|++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678889999999999999998653 5999999754 45667899999999999999999999999864 56899999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc-c
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE-I 417 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~-~ 417 (603)
|+++|+|.++|+.. ...++|..++.|+.|+|.||+|||+. +||||||||+||||+.++.+||+|||+|+..... .
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999764 34599999999999999999999998 9999999999999999999999999999864332 2
Q ss_pred cceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .+...+..+.....+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLS- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCGG-
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcch-
Confidence 233455679999999999864 358999999999999999999999986433221 2222233332211111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.....++.++.+|+.+||+.+|++||||.||++.|+.+++.
T Consensus 233 ----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 ----------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ----------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11223456788999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-53 Score=432.52 Aligned_cols=264 Identities=28% Similarity=0.364 Sum_probs=221.2
Q ss_pred HHHHHhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 256 EIEKATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 256 el~~at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...++|...+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34444567888899999999999999986 58899999997653 34578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.++|.......++|..++.|+.|+|.||+|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999999876667799999999999999999999998 99999999999999999999999999998755
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
...........|++.|+|||++.+..++.|+|||||||+||||++|..|+....... .+.+.+..+...
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~~----- 235 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRM----- 235 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCC-----
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCCCC-----
Confidence 444444455568999999999999999999999999999999999888765332211 122233322111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
......+.++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 236 ----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112345678899999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=413.65 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=214.9
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMP 341 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 341 (603)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999999899999999986543 34789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccccee
Q 007442 342 NGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHIS 421 (603)
Q Consensus 342 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 421 (603)
+|+|.+++.... ..++|..+++|+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999987653 4589999999999999999999998 999999999999999999999999999986544444444
Q ss_pred ccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 422 TAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 422 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
....+|+.|+|||.+....++.|+||||||+++|||+| |+.||..... ..+...+.++.... .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~--~------- 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLY--R------- 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCCCC--C-------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCCCC--C-------
Confidence 55679999999999999999999999999999999998 7878753221 11223333332111 1
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
+...+.++.+|+.+||+.+|++|||+.||++.|.+|
T Consensus 223 ------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 ------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112345788999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=418.56 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=207.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcCC-----cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQND-----LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
..|+..++||+|+||+||+|.+++. ..||||+++.. .....++|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999997642 47999999754 34455689999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+.+|+|.+++... ...++|..+++|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999988654 35699999999999999999999998 999999999999999999999999999987433
Q ss_pred cc--cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EI--SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ........||+.|||||++.+..++.++|||||||+||||+|+..|+....... .+...+.++...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~~---- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFRL---- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHhccCCC----
Confidence 22 222334568999999999999999999999999999999999877765433221 122333333211
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+.++.+|+.+||+.+|++||||.||++.|+++.+.
T Consensus 233 -----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 -----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11223456789999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=417.62 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=209.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.++|...+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788899999999999999999988899999997553 345789999999999999999999999854 5689999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++.......++|.+++.|+.|||.||+|||+. +|+||||||+|||||.++++||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999999876656799999999999999999999998 99999999999999999999999999998754433344
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....||+.|+|||++....++.++||||||++||||+||..|+....... .....+..+...
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~~~~~i~~~~~~----------- 233 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRM----------- 233 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCC-----------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCC-----------
Confidence 455679999999999999999999999999999999999877765433221 112223322111
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+.....++++.+|+.+||+.||++||+|.+|+++|+.....
T Consensus 234 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11223456788999999999999999999999999987643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=417.09 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=209.5
Q ss_pred cCCCccC-cccCCCceEEEEEEEc---CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQ-RLGTGAFGTVYAGKLQ---NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~-~LG~G~~g~Vykg~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|++. .+..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEEE
Confidence 3455555 4999999999999864 3567999999765 4556788999999999999999999999986 4568999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++... ...++|..+++|+.|+|.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999998654 34699999999999999999999998 9999999999999999999999999999865432
Q ss_pred cc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 417 IS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 417 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. .......||+.|+|||++....++.++|||||||+||||+| |+.||...... .+...+.++...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~--- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRME--- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCCCC---
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---
Confidence 22 22334568999999999999999999999999999999998 89998643221 1223344433221
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.+...+.++.+|+.+||+.+|++||||.+|++.|+.+..
T Consensus 233 ------------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 ------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122345678899999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=412.29 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=201.3
Q ss_pred CcccCCCceEEEEEEEcC---CcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeCCC
Q 007442 268 QRLGTGAFGTVYAGKLQN---DLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFMPN 342 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 342 (603)
++||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998753 468999999754 3345678999999999999999999999985 4567899999999
Q ss_pred CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc--e
Q 007442 343 GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH--I 420 (603)
Q Consensus 343 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~--~ 420 (603)
|+|.+++... ..++|..+++|+.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999754 4599999999999999999999998 9999999999999999999999999999864433222 2
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....||+.|||||.+.+..++.++|||||||+||||+| |+.||..... ..+...+.++...+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~~~--------- 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGERMG--------- 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCC---------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCCCC---------
Confidence 334578999999999999999999999999999999998 8888863211 11223333332111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
.+...+.++.+|+.+||+.||++||||.||++.|+..-
T Consensus 231 ------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 12234567889999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=409.50 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=208.0
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688899999999999999987 468999999998765556688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++... .+++.....|+.|++.||+|||+. +|+||||||+||||+.++++||+|||+++..... ...
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc-ccc
Confidence 999999988643 499999999999999999999999 9999999999999999999999999999864332 223
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhcc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHR 500 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 500 (603)
.....||+.|+|||++.+..++.++|||||||+||||+||+.||..... ..........+... +
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~-~--------- 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE-L--------- 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC-C---------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC-C---------
Confidence 3456799999999999999999999999999999999999999853221 11112222222111 0
Q ss_pred CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 501 GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 501 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 237 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 ----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234567889999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-51 Score=417.21 Aligned_cols=265 Identities=24% Similarity=0.314 Sum_probs=216.3
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeE
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCS 327 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 327 (603)
.++|...++|+..+.||+|+||+||+|+++ +++.||||+++... .+..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 455556788999999999999999999874 35789999997653 44567899999999999999999999999
Q ss_pred eecCceEEEEeeCCCCCHHHHhhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007442 328 IERGEQILVYEFMPNGTLCQHLQRER----------------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIY 385 (603)
Q Consensus 328 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iv 385 (603)
.+.+..++||||+++|+|.++|+... ...++|..++.|+.|+|.||+|||+. +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999997532 12489999999999999999999998 999
Q ss_pred ecCCCCCCeeecCCCcEEEeeccCccccccc-ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCcc
Q 007442 386 HRDIKSSNILLDYNFKSKVADFGLSRLGMTE-ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVV 464 (603)
Q Consensus 386 H~Dik~~NILld~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~ 464 (603)
||||||+|||||.++.+||+|||+++..... .....+...+|+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999999864332 223334567899999999999999999999999999999999997543
Q ss_pred CCCCCcchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhh
Q 007442 465 DFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIR 543 (603)
Q Consensus 465 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~ 543 (603)
....... .+...+.++...++ +...+.++.+|+.+||+.+|++||||.||+++|++|.
T Consensus 243 ~~~~~~~------e~~~~v~~~~~~~~---------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHE------EVIYYVRDGNILAC---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHH------HHHHHHHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHH------HHHHHHHcCCCCCC---------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3222211 12233444433221 1223457889999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=410.78 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=196.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee--cCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--RGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 336 (603)
++|+..+.||+|+||+||+|+.. +|+.||||.++.. +....+.|.+|+++|++++|||||++++++.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999975 6899999999765 34556789999999999999999999999875 4568999
Q ss_pred EeeCCCCCHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 337 YEFMPNGTLCQHLQRE--RGDGLSWPIRLTVAMETAQAIAHLHSAI--NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999753 3456999999999999999999999872 12499999999999999999999999999987
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEII 492 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 492 (603)
.... ........||+.|||||++.+..++.++|||||||+||||+||+.||..... ......+..+....+
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~~- 234 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRRI- 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCC-
T ss_pred cccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCC-
Confidence 4332 2233456899999999999999999999999999999999999999863211 112233334433221
Q ss_pred chhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 493 DPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 493 d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 --------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --------------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1123457889999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=408.94 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=202.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|+..+.||+|+||+||+|+.. +++.||||+++... .+..+.|.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999985 68999999997553 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc-cc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE-IS 418 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~-~~ 418 (603)
+++|+|.++|... ..+++..++.|+.|++.||+|||+. +|+||||||+||||++++.+||+|||+|+..... ..
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999653 4599999999999999999999999 9999999999999999999999999999864332 22
Q ss_pred ceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
...+...||+.|||||++.+..+ +.++|||||||+||||+||+.||......... .. .+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~-~~~~~~~~~------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YS-DWKEKKTYL------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HH-HHHTTCTTS-------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HH-HHhcCCCCC-------
Confidence 33455689999999999988776 57899999999999999999999743322111 01 111111100
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........++.+|+.+||+.||++|||+.|+++
T Consensus 227 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011223456788999999999999999999854
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=409.08 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=208.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
+.|+..+.||+|+||+||+|+.. +++.||||+++.......+.|.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788889999999999999985 68899999998777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 999999998754 35699999999999999999999999 9999999999999999999999999999753322 122
Q ss_pred eccCCCCCCCcCccccc-----cCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchh
Q 007442 421 STAPQGTPGYLDPQYHQ-----NFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPL 495 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 495 (603)
.....||+.|+|||++. ...++.++|||||||+||||+||+.||....+.+. ...+..+....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~~~~~---- 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPTL---- 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSCCCCC----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCCC----
Confidence 34567999999999984 45689999999999999999999999864322211 112222221111
Q ss_pred hhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 496 IIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 496 l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ---------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234567889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=405.64 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=205.8
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.+ +++.||||+++.. +....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999985 5889999998643 2234577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.++|... ..+++...+.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999999865 3599999999999999999999999 9999999999999999999999999999764322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|||||++.+..++.++|||||||+||||++|+.||..... ......+.++...
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~-------- 222 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFT-------- 222 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCC--------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCC--------
Confidence 23345799999999999999999999999999999999999999863211 1122233332211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+...+.++.+|+.+||+.||++|||+.||++
T Consensus 223 --------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 --------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11123457889999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=417.68 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=206.4
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC-C-----cEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN-D-----LLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~-~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 332 (603)
.++|...++||+|+||+||+|++.. + ..||||.+... +....+.|.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578888999999999999998753 2 36999998654 334456899999999998 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007442 333 QILVYEFMPNGTLCQHLQRERG---------------------DGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKS 391 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~ 391 (603)
.+|||||+++|+|.++|+..+. ..++|..++.|+.|++.||+|||+. +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999976432 2489999999999999999999998 999999999
Q ss_pred CCeeecCCCcEEEeeccCcccccccccc-eeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCC
Q 007442 392 SNILLDYNFKSKVADFGLSRLGMTEISH-ISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRP 469 (603)
Q Consensus 392 ~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~ 469 (603)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999864433222 2334568999999999999999999999999999999998 8888864322
Q ss_pred cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 007442 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELE 540 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~ 540 (603)
.. .+...+..+... ..+...+.++.+|+.+||+.+|++||||+||++.|.
T Consensus 273 ~~------~~~~~~~~~~~~---------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA------NFYKLIQNGFKM---------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH------HHHHHHHTTCCC---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------HHHHHHhcCCCC---------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 112222222110 112234567889999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=405.43 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=200.8
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-CceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-GEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 340 (603)
++|...+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677889999999999999985 678999999754 3457899999999999999999999999764 5679999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
++|+|.++|.......++|..+++|+.|||.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----C
Confidence 999999999876555699999999999999999999998 999999999999999999999999999986322 2
Q ss_pred eccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.|+... ...+ +...+..+...+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~------~~~~i~~~~~~~--------- 220 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKD------VVPRVEKGYKMD--------- 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGG------HHHHHTTTCCCC---------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHH------HHHHHHcCCCCC---------
Confidence 233468899999999999999999999999999999999 55555432 2111 122233322111
Q ss_pred cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 500 RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 500 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
.......++.+|+.+||+.||++||||.||+++|++++.
T Consensus 221 ------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 122334578899999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=399.03 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=197.9
Q ss_pred CccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee----cCceEEEE
Q 007442 265 SEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE----RGEQILVY 337 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 337 (603)
...++||+|+||+||+|+.. +++.||||+++.. .....+.|.+|+++|++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999985 5789999998754 45556789999999999999999999999875 34578999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD-YNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld-~~~~~kl~DFGla~~~~~~ 416 (603)
||+++|+|.+++... ..+++..++.|+.|++.||+|||++ .++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999999999999765 3599999999999999999999997 12399999999999996 578999999999986322
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
.......||+.|||||++.+ .++.++|||||||+||||++|+.||...... ......+..+.....++
T Consensus 168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~--- 235 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD--- 235 (270)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG---
T ss_pred --CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC---
Confidence 22335679999999998865 6999999999999999999999998633221 12233333332211111
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.....++.+|+.+||+.||++|||+.|+++
T Consensus 236 -----------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 -----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 122346889999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=406.08 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=201.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQN----DLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.++|...+.||+|+||+||+|++.. +..||||.++.. .....+.|.+|+.+|++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998753 357999999754 3445678999999999999999999999985 467899
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
||||+++|+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999988754 35699999999999999999999999 999999999999999999999999999987544
Q ss_pred cccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 416 EISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 416 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
......+...||+.|+|||++.+..++.++|||||||+||||+| |+.|+......+ +...+..+....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~~~---- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLP---- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC----
Confidence 44444556678999999999999999999999999999999998 777776433211 122233332111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 230 -----------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 -----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1223456788999999999999999999999999988653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=413.18 Aligned_cols=274 Identities=22% Similarity=0.311 Sum_probs=208.8
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 6899999999765 3444578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.. +|+||||||+||||++++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 999999999999865 34999999999999999999999731 799999999999999999999999999986432
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhH-HHHHHHHh-------------
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNL-AALAADRI------------- 483 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l-~~~~~~~~------------- 483 (603)
...+...||+.|+|||++.+..++.++|||||||+||||++|+.||........... ........
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 223445899999999999999999999999999999999999999975332211000 00000000
Q ss_pred -h----c----CCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhh
Q 007442 484 -S----K----GRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT--ELEHI 542 (603)
Q Consensus 484 -~----~----~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~--~L~~i 542 (603)
. . ....+..+...... ...........++.+|+.+||+.||++|||+.|+++ .|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 0 00000000000000 000011123457889999999999999999999987 35443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=404.30 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=206.8
Q ss_pred cCcccCCCceEEEEEEEcCC----cEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec-CceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKLQND----LLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER-GEQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 340 (603)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++|||||+++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999998542 36999999753 556678899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc--
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS-- 418 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~-- 418 (603)
++|+|.+++... ...++|..+++++.|+|.||.|||+. +|+||||||+|||||+++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999998764 34588999999999999999999999 999999999999999999999999999986443222
Q ss_pred -ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 419 -HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 419 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|+|||++..+.++.++||||||++||||+||+.|+.......+ ....+..|....
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~~~------- 254 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLL------- 254 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCC-------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC-------
Confidence 223345789999999999999999999999999999999999888764322111 112222332111
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+.....++.+|+.+||+.||++||+|.||++.|+.+...
T Consensus 255 --------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 --------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122345788999999999999999999999999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=404.45 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=207.2
Q ss_pred cCCCccCcccCCCceEEEEEEEcC-Cc--EEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN-DL--LVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...++||+|+||+||+|++++ +. .||||+++.. ..+..++|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567778899999999999999864 43 5888988654 444567899999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 007442 337 YEFMPNGTLCQHLQRE--------------RGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKS 402 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~ 402 (603)
|||+++|+|.++|+.. ....|+|..+++++.|||.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 235699999999999999999999999 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHH
Q 007442 403 KVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADR 482 (603)
Q Consensus 403 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~ 482 (603)
||+|||+++..... .......||..|+|||.+....++.++||||||++||||++|..|+..... ...+...
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH
Confidence 99999999863321 222344689999999999999999999999999999999998765432222 1122333
Q ss_pred hhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 483 ISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 483 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
+.++... +.....+.++.+|+.+||+.||++||||.||++.|+++...
T Consensus 239 i~~~~~~---------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYRL---------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCCC---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCCC---------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 3333211 11223456789999999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-49 Score=404.38 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=201.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..|+..+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888999999999999999974 68899999997543 344577999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|..++... .++++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998766543 4699999999999999999999999 999999999999999999999999999986332
Q ss_pred cceeccCCCCCCCcCcccccc---CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 418 SHISTAPQGTPGYLDPQYHQN---FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
.....||+.|||||++.+ ..|+.++|||||||+||||++|+.||..... ... ...+..+......+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~-~~~i~~~~~~~~~~- 236 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA-LYHIAQNESPALQS- 236 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH-HHHHHHSCCCCCSC-
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHH-HHHHHhCCCCCCCC-
Confidence 234579999999999864 4689999999999999999999999863211 111 12222222211111
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 -------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 -------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 123457889999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=406.49 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDL----LVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQIL 335 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 335 (603)
.+|...++||+|+||+||+|.+. +|+ .||||+++.. +....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999875 343 6999998754 345568899999999999999999999999764 6778
Q ss_pred EEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccc
Q 007442 336 VYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMT 415 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~ 415 (603)
++||+.+|+|.+++... ...++|..+++|+.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999998765 45699999999999999999999998 999999999999999999999999999987543
Q ss_pred ccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 416 EIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 416 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
... .......||+.|+|||++.++.++.++|||||||+||||+| |+.|++.... .+ +...+..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~------~~~~i~~~~~~---- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE------ISSILEKGERL---- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GG------HHHHHHHTCCC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HH------HHHHHHcCCCC----
Confidence 222 23344568999999999999999999999999999999999 6777653221 11 11222222111
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+..++..+.+|+.+||+.+|++||||.||++.|+.+...
T Consensus 233 -----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 -----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11223456788999999999999999999999999988653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=403.79 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=204.8
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeee
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGC 326 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 326 (603)
.+++...++|...++||+|+||+||+|... +++.||||+++.. .....+.+.+|+.++.++ +|+|||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444567888999999999999999864 2468999999754 345567788999988887 58999999999
Q ss_pred EeecC-ceEEEEeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007442 327 SIERG-EQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKS 391 (603)
Q Consensus 327 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~ 391 (603)
+.+.+ ..++||||+++|+|.++|+... ...++|..++.++.|+|.||+|||+. +|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 87654 6899999999999999997543 23489999999999999999999998 999999999
Q ss_pred CCeeecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCC-ccCCCCC
Q 007442 392 SNILLDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALK-VVDFSRP 469 (603)
Q Consensus 392 ~NILld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~-p~~~~~~ 469 (603)
+||||++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||.. ||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986443222 23345679999999999999999999999999999999999865 4542222
Q ss_pred cchhhHHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 470 PNEVNLAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 470 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
. ..+...+.++...+. +...+.++.+|+.+||+.||++||||.||++.|+++.+
T Consensus 243 ~------~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 243 D------EEFCRRLKEGTRMRA---------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp S------HHHHHHHHHTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHHHhcCCCCCC---------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 122333333322211 11234578899999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=401.19 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=204.5
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999985 6899999999743 2334578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998765 3599999999999999999999999 99999999999999999999999999998654322
Q ss_pred -cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 418 -SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 418 -~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
........||+.|+|||++.+..++.++|||||||+||||+||+.||..... ......+..+.+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~------- 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD------- 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC-------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCCCC-------
Confidence 2233456799999999999999999999999999999999999999963211 1122233333221
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+.....++.+|+.+||+.||++|||++|++.
T Consensus 229 ---------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 ---------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01123456889999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-49 Score=403.90 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=191.6
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
..+.|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3466888999999999999999985 58899999997543 233466889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeccCccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD---YNFKSKVADFGLSRLGM 414 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld---~~~~~kl~DFGla~~~~ 414 (603)
||+++|+|.++|... ..+++.....++.|++.||+|||+. +|+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999753 4599999999999999999999999 999999999999994 57899999999998633
Q ss_pred ccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccch
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDP 494 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 494 (603)
. ........||+.|||||++.+..++.++|||||||+||||++|+.||..... . .....+..+.... +
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~-~~~~~i~~~~~~~--~- 229 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------A-KLFEQILKAEYEF--D- 229 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------H-HHHHHHHTTCCCC--C-
T ss_pred C--CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------H-HHHHHHhccCCCC--C-
Confidence 2 2223445799999999999999999999999999999999999999963211 1 1222232322110 0
Q ss_pred hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 495 LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 495 ~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 230 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 ---------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111234557889999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=400.70 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=202.4
Q ss_pred CCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC----ceEEEEe
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG----EQILVYE 338 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~E 338 (603)
.|...+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+ ..+||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 456678899999999999997 578999999975422 1222334555667889999999999998765 5789999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEEeeccCcccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI-----NPPIYHRDIKSSNILLDYNFKSKVADFGLSRLG 413 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~ 413 (603)
|+++|+|.++|++. +++|..+++++.++|.||+|||+.. .++|+||||||+||||++++.+||+|||+++..
T Consensus 82 y~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999753 4999999999999999999999742 359999999999999999999999999999874
Q ss_pred cccccc---eeccCCCCCCCcCccccccCC------CCcccccccHHHHHHHHHhCCCccCCCCCcc----h----hhHH
Q 007442 414 MTEISH---ISTAPQGTPGYLDPQYHQNFH------LSDKSDVYSFGVVLVEIITALKVVDFSRPPN----E----VNLA 476 (603)
Q Consensus 414 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~s~ksDVySfGvvL~elltg~~p~~~~~~~~----~----~~l~ 476 (603)
...... ......||++|+|||++.... ++.|+|||||||+||||+||..|+....... . ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 332221 234567999999999987542 6779999999999999999988775322111 0 0111
Q ss_pred HHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 477 ALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 477 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.........+.+..-+.. .....+....+.+|+.+||+.||++||||.||++.|+++...
T Consensus 239 ~~~~~~~~~~~~~p~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPN---------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCG---------GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCc---------ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 222222222222111111 111335667899999999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=397.17 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=197.4
Q ss_pred cCCCccCcccCCCceEEEEEEEcC--C--cEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN--D--LLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|+..+.||+|+||+||+|++.. + ..||||+++.. ..+..++|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457888899999999999998642 2 47999998754 34556789999999999999999999999965 5678
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
+||||+++|+|.+++.... ..++|..+++++.|+|.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999987653 4599999999999999999999998 99999999999999999999999999998753
Q ss_pred cccc--ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
.... .......|+..|+|||++.+..++.++||||||+++|||+| |+.||... +...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~~-- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERL-- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCC--
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCCC--
Confidence 3222 22334568889999999999999999999999999999998 78887522 1112222222222111
Q ss_pred cchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 007442 492 IDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHI 542 (603)
Q Consensus 492 ~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i 542 (603)
+.....+..+.+|+.+||+.||++||||.||.+.|++.
T Consensus 235 -------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-48 Score=407.50 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=209.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
-++|...+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 6899999999887777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--NFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~~~~~~ 417 (603)
+++|+|.++|... ...+++..++.|+.||+.||+|||+. +|+||||||+||||+. ++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999654 34599999999999999999999999 9999999999999954 678999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|||||++.+..++.++|||||||+||||+||+.||..... . .....+..+.... +
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~-~~~~~i~~~~~~~--~---- 245 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------D-ETLRNVKSCDWNM--D---- 245 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------H-HHHHHHHHTCCCS--C----
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------H-HHHHHHHhCCCCC--C----
Confidence 223445799999999999999999999999999999999999999863211 1 1122222222110 0
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.........++.+|+.+||+.||++|||+.|+++.
T Consensus 246 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 ------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112334578899999999999999999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=402.08 Aligned_cols=264 Identities=25% Similarity=0.323 Sum_probs=214.2
Q ss_pred HHHHhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhccCCCceeeeeeeEee
Q 007442 257 IEKATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE 329 (603)
Q Consensus 257 l~~at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 329 (603)
++..-++|...+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||+++|+|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3344467888899999999999999874 3578999999754 44455679999999999999999999999999
Q ss_pred cCceEEEEeeCCCCCHHHHhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 007442 330 RGEQILVYEFMPNGTLCQHLQRER--------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFK 401 (603)
Q Consensus 330 ~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~ 401 (603)
.+..++||||+++|+|.+++.... ...++|..+++++.|+|+||+|||+. +|+||||||+|||||++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999987542 13479999999999999999999998 9999999999999999999
Q ss_pred EEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 402 SKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 402 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
+||+|||+++....... .......||+.|+|||.+.+..++.++||||||++||||+||+.|+..... .... .
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----~~~~-~ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----NEQV-L 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----HHHH-H
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----HHHH-H
Confidence 99999999986443222 223444689999999999999999999999999999999999654432211 1122 2
Q ss_pred HHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 481 DRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
..+.++...++ +...+..+.+|+.+||+.+|++||||.||+++|++...
T Consensus 246 ~~i~~~~~~~~---------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFVMEGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHhCCCCCC---------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 23333332221 12234579999999999999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=396.48 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=207.7
Q ss_pred cCCCccCcccCCCceEEEEEEEcC--------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQN--------DLLVAIKRIKHRD-TDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
++|...+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567778899999999999998632 2579999997653 45568899999999998 7999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 007442 332 EQILVYEFMPNGTLCQHLQRER--------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD 397 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld 397 (603)
..++||||+++|+|.++|.... ...++|.++++++.|+|.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997553 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccCcccccccc-cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHh-CCCccCCCCCcchhhH
Q 007442 398 YNFKSKVADFGLSRLGMTEI-SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIIT-ALKVVDFSRPPNEVNL 475 (603)
Q Consensus 398 ~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~ellt-g~~p~~~~~~~~~~~l 475 (603)
.++.+||+|||+++...... ........+|+.|+|||.+.++.++.++||||||++||||++ |+.|+... ..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~~----- 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PV----- 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CH-----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-CH-----
Confidence 99999999999998654322 223445678999999999999999999999999999999998 56666421 11
Q ss_pred HHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 476 AALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 476 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
..+...+..+...+ .+...+.++.+|+.+||+.+|++||||.||++.|++|...
T Consensus 244 -~~~~~~i~~~~~~~---------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 -EELFKLLKEGHRMD---------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHHHHHHTTCCCC---------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCC---------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 12233333332211 1122345789999999999999999999999999998653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=397.78 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=214.2
Q ss_pred HhcCCCccCcccCCCceEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcc-CCCceeeeeeeEeecC
Q 007442 260 ATIGFSEKQRLGTGAFGTVYAGKLQ------NDLLVAIKRIKHR-DTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIERG 331 (603)
Q Consensus 260 at~~f~~~~~LG~G~~g~Vykg~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 331 (603)
..++|...++||+|+||.||+|++. +++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3467888899999999999999863 3578999999864 345567899999999999 6999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 007442 332 EQILVYEFMPNGTLCQHLQRER----------------GDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNIL 395 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NIL 395 (603)
..+|||||+++|+|.++|+... ...++|..++.++.|||.||+|||+. +|+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 9999999999999999997643 12589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEeeccCccccccccc-ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhh
Q 007442 396 LDYNFKSKVADFGLSRLGMTEIS-HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVN 474 (603)
Q Consensus 396 ld~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~ 474 (603)
++.++.+||+|||+++....... .......||+.|+|||++....++.++||||||++||||+|+..|+.......+.
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987544322 3344567899999999999999999999999999999999976665543332221
Q ss_pred HHHHHHHHhhcCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 475 LAALAADRISKGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 475 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
+...+..+... ..+...+..+.+|+.+||+.||++||||.||+++|+++..
T Consensus 257 ----~~~~i~~~~~~---------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 ----FYKMIKEGFRM---------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----HHHHHHHTCCC---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCC---------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 12222222111 1112234578899999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=395.24 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=206.1
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC------hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCce
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD------TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 333 (603)
.+.|...+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367899999999999999999984 68999999996432 22467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeccC
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF----KSKVADFGL 409 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~----~~kl~DFGl 409 (603)
+|||||+++|+|.++|... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999765 3599999999999999999999999 999999999999998776 599999999
Q ss_pred cccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 410 SRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 410 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
++.... ........||+.|+|||++.+..++.++|||||||+||||+||+.||..... ......+..+...
T Consensus 164 a~~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYE 234 (293)
T ss_dssp CEECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCC
T ss_pred hhhcCC--CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCC
Confidence 986432 2233455799999999999999999999999999999999999999863211 1112223332211
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .+ ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~--~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 F--ED----------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CH----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--Cc----------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 001123457889999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-48 Score=391.37 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=205.6
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCc----
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGE---- 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 332 (603)
.++|...+.||+|+||+||+|+. .+++.||||.++.. +....+.|.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46788999999999999999997 46899999999754 34456789999999999999999999999886543
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+|||||+++|+|.+++... ..+++.+.+.|+.|++.||+|||+. +|+||||||+||||+.++..+|+|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999998765 3599999999999999999999998 999999999999999999999999999875
Q ss_pred cccc--ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 413 GMTE--ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 413 ~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.... .........||+.|+|||++.+..++.++|||||||+||||+||+.||.... ........+..+....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPP 234 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCG
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCC
Confidence 3322 2223345579999999999999999999999999999999999999986322 1222333333322211
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhh
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-SMTEVATELEHIR 543 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eV~~~L~~i~ 543 (603)
. ......+.++.+++.+||+.||++|| |+.|+++.|.+++
T Consensus 235 ----~---------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ----S---------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----G---------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----c---------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 01112345788999999999999999 8999999998875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-48 Score=404.30 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=209.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
++|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56889999999999999999974 68999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCcEEEeeccCccccccccc
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD--YNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld--~~~~~kl~DFGla~~~~~~~~ 418 (603)
++|+|.+++... ..++++...+.|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999999988654 34699999999999999999999998 999999999999998 5789999999999864332
Q ss_pred ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIE 498 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 498 (603)
.......||+.|+|||++.+..++.++|||||||+||||+||+.||..... . .....+..+....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~-~~~~~i~~~~~~~-------- 247 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------L-ETLQNVKRCDWEF-------- 247 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------H-HHHHHHHHCCCCC--------
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------H-HHHHHHHhCCCCC--------
Confidence 233445799999999999999999999999999999999999999963211 1 1122232222110
Q ss_pred ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 499 HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 499 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
........+.++.+|+.+||+.||++|||+.|+++
T Consensus 248 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 ----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234557889999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=393.94 Aligned_cols=247 Identities=24% Similarity=0.297 Sum_probs=206.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57889999999999999999974 6899999999753 2345678899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||||++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 9999999999998753 489999999999999999999999 9999999999999999999999999999864332
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
........||+.|+|||++.+..++.++|||||||+||||++|+.||..... . .....+..+.+.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~-~~~~~i~~~~~~-------- 223 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------E-RLFELILMEEIR-------- 223 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------H-HHHHHHHHCCCC--------
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------H-HHHHHHhcCCCC--------
Confidence 2233456799999999999999999999999999999999999999864221 1 112223232211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
.+.....++.+|+.+||+.||++||+ +.|+++
T Consensus 224 --------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 --------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11223456789999999999999995 667664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-47 Score=390.51 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=204.1
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999984 6899999999743 2334678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999998764 4488999999999999999999999 999999999999999999999999999986432
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|||||++.+..++.++|||||||+||||+||+.||..... . .....+..+...
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~-~~~~~i~~~~~~-------- 219 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------M-KTYEKILNAELR-------- 219 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------H-HHHHHHHHCCCC--------
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------H-HHHHHHHcCCCC--------
Confidence 23346899999999999999999999999999999999999999963211 1 112222222210
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.+.....++.+++.+||+.||.+|| |++|+++
T Consensus 220 --------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 --------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112345688999999999999996 8888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-47 Score=381.04 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=204.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh---------hhHHHHHHHHHHHhccC-CCceeeeeeeEeec
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT---------DGIQQVVNEIKLISCVS-HPNLVRLLGCSIER 330 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 330 (603)
++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999974 689999999975421 12346889999999997 99999999999999
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
+..+|||||+++|+|.++|... .++++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999765 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccCCCCCCCcCcccccc------CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQN------FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS 484 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 484 (603)
+..... ...+...||+.|+|||++.+ ..++.++||||+||+|+||+||+.||..... ......+.
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i~ 228 (277)
T d1phka_ 158 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIM 228 (277)
T ss_dssp EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH
T ss_pred eEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHHH
Confidence 864332 23345679999999999863 3468899999999999999999999963221 11223333
Q ss_pred cCCcccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 485 KGRLDEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 485 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.+...- .. ......++++.+|+.+||+.+|++|||+.||++
T Consensus 229 ~~~~~~-~~-----------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQF-GS-----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCCC-CT-----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCCC-CC-----------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 332211 00 111234567889999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=389.11 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=199.3
Q ss_pred hcCCCccC-cccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcc-CCCceeeeeeeEee----cCce
Q 007442 261 TIGFSEKQ-RLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCV-SHPNLVRLLGCSIE----RGEQ 333 (603)
Q Consensus 261 t~~f~~~~-~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 333 (603)
.++|.... .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787654 699999999999997 46899999999753 4577899987655 79999999999865 4568
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeccCc
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY---NFKSKVADFGLS 410 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~---~~~~kl~DFGla 410 (603)
+|||||+++|+|.++|.......+++.+...|+.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876556799999999999999999999999 9999999999999975 457999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
+..... .......||+.|||||++.+..++.++|||||||+||||+||+.||........ .......+..+...
T Consensus 162 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~~- 235 (335)
T d2ozaa1 162 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYE- 235 (335)
T ss_dssp EECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS-
T ss_pred eeccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCCC-
Confidence 864332 223456799999999999999999999999999999999999999964322211 11111111111110
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~-----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 F-----------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp C-----------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-----------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00111234567899999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=388.24 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=203.7
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHh-ccCCCceeeeeeeEeecCceEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLIS-CVSHPNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 336 (603)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|+.++. .++|||||++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999985 5899999999743 2334566777887765 68999999999999999999999
Q ss_pred EeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccc
Q 007442 337 YEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~ 416 (603)
|||+++|+|.+++.... .+++...+.++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997653 489999999999999999999999 9999999999999999999999999999864332
Q ss_pred ccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI 496 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 496 (603)
....+...||+.|+|||++.+..++.++|||||||+||||+||+.||..... ..+...+..+..
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~-------- 220 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP-------- 220 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--------
T ss_pred -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--------
Confidence 2334456799999999999999999999999999999999999999963221 122233333221
Q ss_pred hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 007442 497 IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMT-EVAT 537 (603)
Q Consensus 497 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eV~~ 537 (603)
..+...+.++.+|+.+||+.||++||++. ||++
T Consensus 221 --------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112345688999999999999999996 6653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-46 Score=388.98 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=198.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCC---hhh---HHHHHHHHHHHhccCCCceeeeeeeEeecCceE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRD---TDG---IQQVVNEIKLISCVSHPNLVRLLGCSIERGEQI 334 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~---~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 334 (603)
++|...+.||+|+||+||+|+.. +|+.||||++.... ... .....+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999985 68999999986431 111 223344577888889999999999999999999
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
|||||+++|+|.++|... ..+++...+.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999765 3589999999999999999999999 99999999999999999999999999998643
Q ss_pred ccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc
Q 007442 415 TEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID 493 (603)
Q Consensus 415 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 493 (603)
.. ......||+.|+|||++.. ..++.++|||||||+||||+||+.||......... ...........
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~~~~----- 226 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV----- 226 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSSSCCC-----
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcccCCC-----
Confidence 32 2344579999999999875 46899999999999999999999999754332211 11111111110
Q ss_pred hhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 494 PLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 494 ~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
........++.+|+.+||+.||++||| +.|+++
T Consensus 227 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111123457889999999999999999 466654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=386.67 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=205.6
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
.++|...+.||+|+||+||+|... +++.||||.++....+ ...+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 357888999999999999999985 6889999999876433 46688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeccCcccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY--NFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~--~~~~kl~DFGla~~~~~~~ 417 (603)
+++|+|.++|... +..+++.+.+.|+.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999754 34599999999999999999999998 9999999999999985 458999999999864322
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......+|+.|+|||.+.+..++.++|||||||+||||++|+.||..... ..+...+..+... ++...
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~--~~~~~- 226 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYT--FDEEA- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCC--CCHHH-
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CChhh-
Confidence 223345689999999999999999999999999999999999999864221 1122223222211 11100
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
......++.+|+.+||+.||++|||+.|+++
T Consensus 227 ---------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 ---------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123456889999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-46 Score=390.03 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=204.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR---DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 337 (603)
++|...+.||+|+||+||+|+.+ +|+.||||+++.. +....+.+.+|+.+|++++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999985 6899999998643 2344578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEI 417 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~ 417 (603)
||+.+|+|.+++.... .+++...+.|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 9999999999997653 599999999999999999999999 999999999999999999999999999986432
Q ss_pred cceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 418 SHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 418 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
......||+.|||||++.+..++.++|||||||+||||+||+.||..... ......+..+...
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~-------- 256 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVR-------- 256 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--------
T ss_pred --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCCCC--------
Confidence 22345799999999999999999999999999999999999999963211 1122223332211
Q ss_pred hccCCCCccchHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 007442 498 EHRGHSDAGTLASVHKVAELAFRCLAFHRDMRP-----SMTEVAT 537 (603)
Q Consensus 498 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eV~~ 537 (603)
.......++.+|+.+||+.||.+|+ |+.|+++
T Consensus 257 --------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112345788999999999999994 8888875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=379.90 Aligned_cols=262 Identities=24% Similarity=0.249 Sum_probs=194.3
Q ss_pred cCcccCCCceEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEeeC
Q 007442 267 KQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTD-----GIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEFM 340 (603)
Q Consensus 267 ~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 340 (603)
.++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 5899999999754322 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccce
Q 007442 341 PNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISHI 420 (603)
Q Consensus 341 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 420 (603)
.++++..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRA 156 (299)
T ss_dssp SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCC
T ss_pred cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC-ccc
Confidence 98877766543 34599999999999999999999999 9999999999999999999999999999864332 222
Q ss_pred eccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhhhc
Q 007442 421 STAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLIIEH 499 (603)
Q Consensus 421 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 499 (603)
.....||+.|+|||++... .++.++|||||||++|||+||+.||..... ......+.+.+.........+..-...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhccch
Confidence 3345799999999998654 679999999999999999999988863322 111111222211111111100000000
Q ss_pred ---cCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 500 ---RGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 500 ---~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
...... .......++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 01123467889999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=376.72 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=202.0
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 568999999997543 2335789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
|+. |++.+++.......+++..++.++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.... ..
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~-~~ 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PV 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-CS
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC-Cc
Confidence 996 5566666555556799999999999999999999999 999999999999999999999999999986432 22
Q ss_pred ceeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhhh
Q 007442 419 HISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLII 497 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 497 (603)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... .......... +...+..-+...
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~--~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTL--GTPDEVVWPGVT 231 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH--CCCCTTTSTTGG
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhc--CCCchhhccccc
Confidence 3344557999999999876654 578999999999999999999999643211 1111111111 111111111100
Q ss_pred hccC--------CCC---ccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 498 EHRG--------HSD---AGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 498 ~~~~--------~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.... ... ........++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000 0011234678899999999999999999998763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-45 Score=371.64 Aligned_cols=267 Identities=18% Similarity=0.218 Sum_probs=200.4
Q ss_pred cCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRD--TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...++||+|+||+||+|+.++++.||||+++... ....+.|.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999997653 23357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcccccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEISH 419 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~~ 419 (603)
+.++.+..+.... ..+++.....|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||++...... ..
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VR 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC-cc
Confidence 9877766665433 5599999999999999999999998 9999999999999999999999999999764322 22
Q ss_pred eeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccc-----
Q 007442 420 ISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIID----- 493 (603)
Q Consensus 420 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 493 (603)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .........+.........+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhh
Confidence 23444689999999998754 5789999999999999999999999642211 11111111111111111000
Q ss_pred ---hhhhh-ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 494 ---PLIIE-HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 494 ---~~l~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..... ...............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000000111223467889999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=372.66 Aligned_cols=268 Identities=21% Similarity=0.264 Sum_probs=196.8
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-C-CcEEEEEEeccC--ChhhHHHHHHHHHHHhcc---CCCceeeeeeeEee----
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-N-DLLVAIKRIKHR--DTDGIQQVVNEIKLISCV---SHPNLVRLLGCSIE---- 329 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~---- 329 (603)
.++|...+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 678999998643 222233456777776655 79999999999863
Q ss_pred -cCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeecc
Q 007442 330 -RGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFG 408 (603)
Q Consensus 330 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFG 408 (603)
....++++||+.+|.+..... .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 346789999998877655443 3345699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 409 LSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 409 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
+++.... ........||+.|+|||++.+..++.++||||+||+||||+||+.||......+ ........+.....
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE 236 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCG
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCch
Confidence 9986332 233455689999999999999999999999999999999999999996432211 11111111111000
Q ss_pred ccc------cchhhhhc-cCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DEI------IDPLIIEH-RGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~~------~d~~l~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
..+ ........ ..............+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000 00000111233557889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=370.41 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=195.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhccC--CCceeeeeeeEeecCc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDT------DGIQQVVNEIKLISCVS--HPNLVRLLGCSIERGE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 332 (603)
++|...++||+|+||+||+|+.. +++.||||+++.... ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999975 689999999974311 12234678999999997 8999999999999999
Q ss_pred eEEEEeeCCC-CCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeccCc
Q 007442 333 QILVYEFMPN-GTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYN-FKSKVADFGLS 410 (603)
Q Consensus 333 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~-~~~kl~DFGla 410 (603)
.++||||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 6888888654 3599999999999999999999998 99999999999999854 79999999999
Q ss_pred ccccccccceeccCCCCCCCcCccccccCCC-CcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc
Q 007442 411 RLGMTEISHISTAPQGTPGYLDPQYHQNFHL-SDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD 489 (603)
Q Consensus 411 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 489 (603)
+.... ...+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||... +.+..+...
T Consensus 159 ~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------------~~i~~~~~~ 222 (273)
T d1xwsa_ 159 ALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------------EEIIRGQVF 222 (273)
T ss_dssp EECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------------HHHHHCCCC
T ss_pred eeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------------hHHhhcccC
Confidence 86322 22345679999999999987765 56789999999999999999998521 011111110
Q ss_pred cccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 490 EIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 490 ~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 223 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 ----------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01123457889999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-43 Score=361.01 Aligned_cols=261 Identities=18% Similarity=0.190 Sum_probs=198.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeee-eeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRL-LGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||+|+.. +++.||||.++.... .+++..|++++++++|+|++.+ .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46888999999999999999974 689999999876532 2467889999999987765555 5555677788899999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeccCccccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLD---YNFKSKVADFGLSRLGMTE 416 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld---~~~~~kl~DFGla~~~~~~ 416 (603)
+ +|+|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 56777766543 35699999999999999999999999 999999999999874 4567999999999875432
Q ss_pred cc------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 417 IS------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 417 ~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.. .......||+.|||||.+.+..++.++||||||+++|||+||+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence 21 1234457999999999999999999999999999999999999999754332222111111111000000
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhh
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRT 544 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~ 544 (603)
+ ......+.++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 238 ---~----------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 ---E----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---H----------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---h----------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 0011234678899999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-43 Score=356.28 Aligned_cols=262 Identities=18% Similarity=0.230 Sum_probs=208.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCC-CceeeeeeeEeecCceEEEEee
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-PNLVRLLGCSIERGEQILVYEF 339 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~ 339 (603)
++|...+.||+|+||+||+|+.. +++.||||.++.... .+++.+|++++..++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57888999999999999999975 688999999865432 2456788999999975 8999999999999999999999
Q ss_pred CCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----CCcEEEeeccCccccc
Q 007442 340 MPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDY-----NFKSKVADFGLSRLGM 414 (603)
Q Consensus 340 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~-----~~~~kl~DFGla~~~~ 414 (603)
+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 8 78999998654 45699999999999999999999999 9999999999999974 5689999999998743
Q ss_pred cccc------ceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCc
Q 007442 415 TEIS------HISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRL 488 (603)
Q Consensus 415 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 488 (603)
.... .......||+.|||||.+.+..++.++||||||+++|||+||+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 3211 1223457999999999999999999999999999999999999999754443332211111111111110
Q ss_pred ccccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhhhc
Q 007442 489 DEIIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATELEHIRTR 545 (603)
Q Consensus 489 ~~~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~L~~i~~~ 545 (603)
.+ + ....++++.+++..|++.+|++||++..+.+.|+++..+
T Consensus 238 ~~-----l----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 238 RE-----L----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HH-----H----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH-----h----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 00 0 112345788999999999999999999999999887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=362.08 Aligned_cols=268 Identities=18% Similarity=0.210 Sum_probs=193.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee--------c
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE--------R 330 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------~ 330 (603)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999974 7899999998644 23345778999999999999999999999865 3
Q ss_pred CceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCc
Q 007442 331 GEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLS 410 (603)
Q Consensus 331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla 410 (603)
+..++||||+.++.+..+... ...++......|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 457899999988777655443 34588999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccc---ceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcC
Q 007442 411 RLGMTEIS---HISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKG 486 (603)
Q Consensus 411 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 486 (603)
+....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... .............-
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 75432211 122334699999999998765 689999999999999999999999863221 11111111111110
Q ss_pred --C-cccccchhhhhc---cCCCCccc------hHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 487 --R-LDEIIDPLIIEH---RGHSDAGT------LASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 487 --~-~~~~~d~~l~~~---~~~~~~~~------~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .....+...... ........ ......+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 000000000000 00000000 111345678999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=367.68 Aligned_cols=268 Identities=21% Similarity=0.278 Sum_probs=196.5
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhccCCCceeeeeeeEeecC----ceE
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRD-TDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG----EQI 334 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 334 (603)
+.+|...++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999987 478999999997543 445678999999999999999999999987653 235
Q ss_pred EEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccc
Q 007442 335 LVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGM 414 (603)
Q Consensus 335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~ 414 (603)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 556677899999999653 499999999999999999999999 99999999999999999999999999998643
Q ss_pred cccc--ceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcc--
Q 007442 415 TEIS--HISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLD-- 489 (603)
Q Consensus 415 ~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 489 (603)
.... .......||+.|+|||.+.. ..++.++||||+|++++||++|+.||......+. ..............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDL 237 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhh
Confidence 3222 12344569999999999854 4678899999999999999999999864322111 11111111000000
Q ss_pred -cccc----hhhhhccCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 490 -EIID----PLIIEHRGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 490 -~~~d----~~l~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.... ..... ...... .......++.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLS-LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHT-SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccccc-CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 000000 011223468899999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-43 Score=354.70 Aligned_cols=267 Identities=21% Similarity=0.219 Sum_probs=205.4
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecCceEEEEe
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 338 (603)
++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999974 6889999999654 33456889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccccccccc
Q 007442 339 FMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRLGMTEIS 418 (603)
Q Consensus 339 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~~~~~~~ 418 (603)
++.+++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||.++..... .
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-C
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC-C
Confidence 99999998887653 4589999999999999999999999 9999999999999999999999999999864332 2
Q ss_pred ceeccCCCCCCCcCccccccCC-CCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccccchhh-
Q 007442 419 HISTAPQGTPGYLDPQYHQNFH-LSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEIIDPLI- 496 (603)
Q Consensus 419 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l- 496 (603)
.......+++.|+|||.+.... ++.++|||||||++|||++|+.|+.......+ ....+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~ 232 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGT-PTEEQWPSMTK 232 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCC-CCTTTCTTGGG
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCC-CChhhhhhhhh
Confidence 2334456788999999887654 68999999999999999999999864333221 11111111111 1000000000
Q ss_pred ---------hhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 497 ---------IEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 497 ---------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.................+.+|+.+||+.||++|||++||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111122334567889999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=365.48 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=193.0
Q ss_pred hcCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------ 331 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 331 (603)
.++|...++||+|+||+||+|... +|+.||||+++.. +....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467888999999999999999975 6899999999754 3445678899999999999999999999998655
Q ss_pred ceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCcc
Q 007442 332 EQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSR 411 (603)
Q Consensus 332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~ 411 (603)
..+|||||+ +.+|..+++. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 469999999 5677777653 3499999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 412 LGMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 412 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.... ..+...||+.|+|||.+.+. .++.++||||+||+||||++|+.||........ +.. ..... .....+
T Consensus 170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~-~~~~~-~~~~~~ 241 (346)
T d1cm8a_ 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKE-IMKVT-GTPPAE 241 (346)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHH-CCCCHH
T ss_pred ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHH-HHhcc-CCCcHH
Confidence 6322 23456799999999998764 578999999999999999999999864321111 110 00000 000000
Q ss_pred cc--------c---hhhhhcc-CCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 491 II--------D---PLIIEHR-GHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 491 ~~--------d---~~l~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
++ . ..+.... .............+.+|+.+||..||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 0000000 00000111234567899999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=361.01 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=201.9
Q ss_pred cCCCccCcccCCCceEEEEEEEc----CCcEEEEEEeccC----ChhhHHHHHHHHHHHhccCC-CceeeeeeeEeecCc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ----NDLLVAIKRIKHR----DTDGIQQVVNEIKLISCVSH-PNLVRLLGCSIERGE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~----~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 332 (603)
++|...+.||+|+||+||+|+.. +|+.||||.++.. +....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999862 4789999998643 22334678899999999976 899999999999999
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++|+||+.+|+|.+++.... .++....+.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999998764 477888999999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccCCCCCCCcCccccccC--CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNF--HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDE 490 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 490 (603)
.............|++.|++||.+.+. .++.++|||||||+||||+||+.||......... ..+.........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~-- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP-- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCC--
Confidence 544434444556799999999998754 4788999999999999999999999754332221 111111111111
Q ss_pred ccchhhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 007442 491 IIDPLIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPS-----MTEVAT 537 (603)
Q Consensus 491 ~~d~~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eV~~ 537 (603)
..+.....++.+++.+||+.||++||| ++|+++
T Consensus 254 --------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 --------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112234567889999999999999995 677764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=363.06 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=194.1
Q ss_pred CCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCceeeeeeeEeecC------ceEE
Q 007442 263 GFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNLVRLLGCSIERG------EQIL 335 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 335 (603)
.|...++||+|+||+||+|+.. +++.||||+++.... .+.+|+++|++++|||||++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778889999999999999985 589999999976532 2347999999999999999999986432 4689
Q ss_pred EEeeCCCCCHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCcccc
Q 007442 336 VYEFMPNGTLCQHLQR-ERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLG 413 (603)
Q Consensus 336 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~ 413 (603)
||||+++|.+..+.+. .....+++..+..|+.|++.||+|||+. +|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444432 2345699999999999999999999998 999999999999999775 8999999999864
Q ss_pred cccccceeccCCCCCCCcCcccccc-CCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc-
Q 007442 414 MTEISHISTAPQGTPGYLDPQYHQN-FHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI- 491 (603)
Q Consensus 414 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~- 491 (603)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.. ....+.. ...+.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~-i~~~~g~-~~~~~~ 247 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE-IIKVLGT-PTREQI 247 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHH-HHHHHCC-CCHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHH-HHHHhCC-ChHHhh
Confidence 3322 2334579999999998765 5789999999999999999999999964322111 111 1111000 00000
Q ss_pred -------cchhhhhccCC--CCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhh
Q 007442 492 -------IDPLIIEHRGH--SDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE--LEHIR 543 (603)
Q Consensus 492 -------~d~~l~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~--L~~i~ 543 (603)
.+..+...... ..........++.+|+.+||+.||++|||+.|+++. |+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000000 000112235578899999999999999999998853 44443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=351.18 Aligned_cols=263 Identities=18% Similarity=0.235 Sum_probs=197.1
Q ss_pred cCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEee--cCceEEEE
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIE--RGEQILVY 337 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 337 (603)
++|...++||+|+||+||+|+. .+++.||||+++... .+++.+|+.+|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999998 468999999997643 467889999999996 9999999999874 35689999
Q ss_pred eeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeccCccccccc
Q 007442 338 EFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNF-KSKVADFGLSRLGMTE 416 (603)
Q Consensus 338 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~-~~kl~DFGla~~~~~~ 416 (603)
||+.+|+|.++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997664 3489999999999999999999999 999999999999998655 6999999999864332
Q ss_pred ccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHH--H-----HHHHHhhcCCc
Q 007442 417 ISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLA--A-----LAADRISKGRL 488 (603)
Q Consensus 417 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~--~-----~~~~~~~~~~~ 488 (603)
.......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||............ . ...........
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 223455789999999998765 5799999999999999999999998754332211100 0 00001111100
Q ss_pred cc--ccchhhhh------ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 489 DE--IIDPLIIE------HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 489 ~~--~~d~~l~~------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
.. .....+.. ..............++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000 000011112234567889999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=353.10 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=191.0
Q ss_pred cCCCccCcccCCCceEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEeec------Cc
Q 007442 262 IGFSEKQRLGTGAFGTVYAGKLQ-NDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIER------GE 332 (603)
Q Consensus 262 ~~f~~~~~LG~G~~g~Vykg~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 332 (603)
++|...++||+|+||+||+|... +|+.||||+++.. +....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999985 6899999999754 345567789999999999999999999998643 57
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++||||+.++ |.+.++ ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 89999999654 555553 3489999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhh--------
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRIS-------- 484 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~-------- 484 (603)
... ....+...+|+.|+|||++.+..++.++||||+||+++||++|+.||..... ..........+.
T Consensus 169 ~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 169 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHT
T ss_pred ccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHHHH
Confidence 332 2333455799999999999999999999999999999999999999853221 111111111000
Q ss_pred ----------cCC--cccccchhhhh--ccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 007442 485 ----------KGR--LDEIIDPLIIE--HRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEVATE 538 (603)
Q Consensus 485 ----------~~~--~~~~~d~~l~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~~ 538 (603)
.+. ....-.+.+.. ...............+.+|+.+||+.||++|||++||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000 0001112233456788999999999999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=355.04 Aligned_cols=263 Identities=20% Similarity=0.282 Sum_probs=194.9
Q ss_pred hcCCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhccCCCceeeeeeeEee-----cCc
Q 007442 261 TIGFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHR--DTDGIQQVVNEIKLISCVSHPNLVRLLGCSIE-----RGE 332 (603)
Q Consensus 261 t~~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~~ 332 (603)
.++|...++||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+++|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999997 46899999999754 34455788999999999999999999999863 334
Q ss_pred eEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 333 QILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.++|+||+.+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 5777888899999999964 3599999999999999999999999 999999999999999999999999999975
Q ss_pred ccccccceeccCCCCCCCcCccccccC-CCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHHHHhhcCCcccc
Q 007442 413 GMTEISHISTAPQGTPGYLDPQYHQNF-HLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAADRISKGRLDEI 491 (603)
Q Consensus 413 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 491 (603)
... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+....... ..++
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~-~~~~ 242 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTP-GAEL 242 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC-CHHH
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC-ChHH
Confidence 322 23345789999999987665 568899999999999999999999863221 11111111111100 0000
Q ss_pred c----ch---hhhhccCCCCc-----cchHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 007442 492 I----DP---LIIEHRGHSDA-----GTLASVHKVAELAFRCLAFHRDMRPSMTEVAT 537 (603)
Q Consensus 492 ~----d~---~l~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV~~ 537 (603)
. .. ........... .......++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00 00000000000 01123456889999999999999999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-37 Score=320.70 Aligned_cols=267 Identities=18% Similarity=0.198 Sum_probs=190.1
Q ss_pred CCCccCcccCCCceEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-----------CCceeeeeeeEeec
Q 007442 263 GFSEKQRLGTGAFGTVYAGKL-QNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-----------HPNLVRLLGCSIER 330 (603)
Q Consensus 263 ~f~~~~~LG~G~~g~Vykg~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~ 330 (603)
+|...++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999997 46899999999864 334567888999988875 47899999987653
Q ss_pred --CceEEEEeeCCCCCHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCC------
Q 007442 331 --GEQILVYEFMPNGTLCQH-LQRERGDGLSWPIRLTVAMETAQAIAHLHS-AINPPIYHRDIKSSNILLDYNF------ 400 (603)
Q Consensus 331 --~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~ivH~Dik~~NILld~~~------ 400 (603)
...++++++...+..... ........+++..+..++.|++.||+|||+ . +|+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 456677777665544333 333444568999999999999999999998 5 899999999999997654
Q ss_pred cEEEeeccCcccccccccceeccCCCCCCCcCccccccCCCCcccccccHHHHHHHHHhCCCccCCCCCcchhhHHHHHH
Q 007442 401 KSKVADFGLSRLGMTEISHISTAPQGTPGYLDPQYHQNFHLSDKSDVYSFGVVLVEIITALKVVDFSRPPNEVNLAALAA 480 (603)
Q Consensus 401 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvL~elltg~~p~~~~~~~~~~~l~~~~~ 480 (603)
.+|++|||.+..... ......||+.|+|||++....++.++||||+|++++||++|+.||................
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 389999999875322 2344579999999999999999999999999999999999999986432221111111111
Q ss_pred HHhh-cCCc-----------ccccch-------------hhhhccCCCCccchHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 007442 481 DRIS-KGRL-----------DEIIDP-------------LIIEHRGHSDAGTLASVHKVAELAFRCLAFHRDMRPSMTEV 535 (603)
Q Consensus 481 ~~~~-~~~~-----------~~~~d~-------------~l~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV 535 (603)
..+. -|.. ....+. ..................++.+|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1000 0000 000000 00000000112234567889999999999999999999998
Q ss_pred HH
Q 007442 536 AT 537 (603)
Q Consensus 536 ~~ 537 (603)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 65
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.1e-23 Score=197.04 Aligned_cols=164 Identities=16% Similarity=0.105 Sum_probs=120.7
Q ss_pred CccCcccCCCceEEEEEEEcCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhccCCCceeeeeee
Q 007442 265 SEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDT------------------DGIQQVVNEIKLISCVSHPNLVRLLGC 326 (603)
Q Consensus 265 ~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 326 (603)
...++||+|+||+||+|...+|+.||||.++.... .....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34678999999999999999999999998763210 112345578899999999999998765
Q ss_pred EeecCceEEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 007442 327 SIERGEQILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAINPPIYHRDIKSSNILLDYNFKSKVAD 406 (603)
Q Consensus 327 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ivH~Dik~~NILld~~~~~kl~D 406 (603)
. ..+|+|||++++.+.+ +++.....++.|++++|+|||+. +|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 3 2479999998765432 44455678999999999999998 99999999999999965 589999
Q ss_pred ccCcccccccccceeccCCCCCCCcCc------cccccCCCCcccccccHHHHHH
Q 007442 407 FGLSRLGMTEISHISTAPQGTPGYLDP------QYHQNFHLSDKSDVYSFGVVLV 455 (603)
Q Consensus 407 FGla~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~s~ksDVySfGvvL~ 455 (603)
||+|........ ..|+.. |++ ...|+.++||||..--++
T Consensus 146 FG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999875321111 011111 111 346788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.1e-07 Score=91.73 Aligned_cols=150 Identities=17% Similarity=0.082 Sum_probs=104.1
Q ss_pred HHHHHHhcCCCccCcccCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCce
Q 007442 255 REIEKATIGFSEKQRLGTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQ 333 (603)
Q Consensus 255 ~el~~at~~f~~~~~LG~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 333 (603)
.|+++.-..|...+..+.++...||+... ++..++||+...........+.+|...+..+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666666676655544445578998865 44567788876554444455678888887774 44467788888888889
Q ss_pred EEEEeeCCCCCHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 007442 334 ILVYEFMPNGTLCQHLQRERGDGLSWPIRLTVAMETAQAIAHLHSAI--------------------------------- 380 (603)
Q Consensus 334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------- 380 (603)
++||+++++.++.+..... .....++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886654221 113345566666666676531
Q ss_pred -----------------------CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 -----------------------NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 -----------------------~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|+.|.|||++++...-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999877678999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=5.3e-06 Score=79.09 Aligned_cols=141 Identities=18% Similarity=0.180 Sum_probs=86.6
Q ss_pred cccCCC-ceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccC--CCceeeeeeeEeecCceEEEEeeCCCCCH
Q 007442 269 RLGTGA-FGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVS--HPNLVRLLGCSIERGEQILVYEFMPNGTL 345 (603)
Q Consensus 269 ~LG~G~-~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL 345 (603)
.+..|. -..||+....++..+++|....... ..+..|+..++.+. .-.+.+++++..+.+..++||||+++-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 3689999988888889998765533 34566777777664 33467788888888899999999987655
Q ss_pred HH--------------Hhhhhc-----CCCCC--HHHHHHHH--------------------HHHHHHHHHHHhcC----
Q 007442 346 CQ--------------HLQRER-----GDGLS--WPIRLTVA--------------------METAQAIAHLHSAI---- 380 (603)
Q Consensus 346 ~~--------------~l~~~~-----~~~l~--~~~~~~ia--------------------~~ia~~L~yLH~~~---- 380 (603)
.+ .|.+-. ..++. +...+.-. ......+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 32 111100 00011 11111000 01122233333321
Q ss_pred CCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 381 NPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 381 ~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+.++|+|+.|.|||++++..+-|.||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12389999999999999886678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.45 E-value=0.00022 Score=72.50 Aligned_cols=75 Identities=19% Similarity=0.116 Sum_probs=47.9
Q ss_pred CcccCCCceEEEEEEEcC-CcEEEEEEeccC-------ChhhHHHHHHHHHHHhccC-C--CceeeeeeeEeecCceEEE
Q 007442 268 QRLGTGAFGTVYAGKLQN-DLLVAIKRIKHR-------DTDGIQQVVNEIKLISCVS-H--PNLVRLLGCSIERGEQILV 336 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~-~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 336 (603)
+.||.|....||+....+ ++.|+||.-... -....+....|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 578999965321 0112234456777777663 2 345556554 45567899
Q ss_pred EeeCCCCC
Q 007442 337 YEFMPNGT 344 (603)
Q Consensus 337 ~E~~~~gs 344 (603)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.0011 Score=65.23 Aligned_cols=135 Identities=13% Similarity=0.103 Sum_probs=78.7
Q ss_pred ceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCCCce--eeeee-----eEeecCceEEEEeeCCCCCH--
Q 007442 275 FGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSHPNL--VRLLG-----CSIERGEQILVYEFMPNGTL-- 345 (603)
Q Consensus 275 ~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL-- 345 (603)
--.||+...++|..|++|..+.. ....+++..|...+..|....+ +..+. .....+..+.+++++++..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999988754 2234667788888877742222 21111 12345567889999876432
Q ss_pred ---HH---------Hhhhhc-------CCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCC
Q 007442 346 ---CQ---------HLQRER-------GDGLSWPI-------------------RLTVAMETAQAIAHLHSA----INPP 383 (603)
Q Consensus 346 ---~~---------~l~~~~-------~~~l~~~~-------------------~~~ia~~ia~~L~yLH~~----~~~~ 383 (603)
.. .+|... ...+++.. +-.+...+.+.++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 111110 01122111 111222233334444332 2346
Q ss_pred eEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 384 IYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 384 ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.43 E-value=0.00037 Score=45.63 Aligned_cols=28 Identities=36% Similarity=0.929 Sum_probs=24.1
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGDGY 172 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gnpy 172 (603)
.|+.++.|.+. .++|.|.|+.||.|||+
T Consensus 8 ~C~~~A~C~Nt-----~Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSVHAECRDY-----ATGFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCTTEEEEEC-----SSCEEEEECTTEEECSS
T ss_pred CCCCCCEeecC-----CCCeEeECCCCCcCCCC
Confidence 68999999864 36799999999999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0055 Score=61.68 Aligned_cols=72 Identities=17% Similarity=0.181 Sum_probs=48.3
Q ss_pred CcccCCCceEEEEEEEcCC--------cEEEEEEeccCChhhHHHHHHHHHHHhccC-CCceeeeeeeEeecCceEEEEe
Q 007442 268 QRLGTGAFGTVYAGKLQND--------LLVAIKRIKHRDTDGIQQVVNEIKLISCVS-HPNLVRLLGCSIERGEQILVYE 338 (603)
Q Consensus 268 ~~LG~G~~g~Vykg~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 338 (603)
+.|+.|-.-.+|+....++ ..|.++..- .. ....+..+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788889999987643 456666654 22 22345568888888885 4334477777643 68999
Q ss_pred eCCCCCH
Q 007442 339 FMPNGTL 345 (603)
Q Consensus 339 ~~~~gsL 345 (603)
|+++-+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.97 E-value=0.022 Score=54.93 Aligned_cols=158 Identities=13% Similarity=0.058 Sum_probs=82.7
Q ss_pred CChHHHHHHhcCCCccCcc-----cCCCceEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhccCC-----Ccee
Q 007442 252 YPYREIEKATIGFSEKQRL-----GTGAFGTVYAGKLQNDLLVAIKRIKHRDTDGIQQVVNEIKLISCVSH-----PNLV 321 (603)
Q Consensus 252 ~~~~el~~at~~f~~~~~L-----G~G~~g~Vykg~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-----~niv 321 (603)
.+.+|++....+|...+.. ..|---+.|+.+..+|+ +++|+...... .+++..|++++..+.+ |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4677888888888775443 35556788999887774 88898865321 1233445555555532 2222
Q ss_pred eee-e--eEeecCceEEEEeeCCCCCHH--------------HHhhhhcC----C----CCCH-HHHH------------
Q 007442 322 RLL-G--CSIERGEQILVYEFMPNGTLC--------------QHLQRERG----D----GLSW-PIRL------------ 363 (603)
Q Consensus 322 ~l~-g--~~~~~~~~~lV~E~~~~gsL~--------------~~l~~~~~----~----~l~~-~~~~------------ 363 (603)
... | +.........++.++.+.... ..++.... . ...+ ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 1 112234556677766553221 11111000 0 0000 0000
Q ss_pred -HHHHHHHHHHHHHHhc----CCCCeEecCCCCCCeeecCCCcEEEeeccCccc
Q 007442 364 -TVAMETAQAIAHLHSA----INPPIYHRDIKSSNILLDYNFKSKVADFGLSRL 412 (603)
Q Consensus 364 -~ia~~ia~~L~yLH~~----~~~~ivH~Dik~~NILld~~~~~kl~DFGla~~ 412 (603)
.+...+...++.+-.. ...++||+|+.+.|||++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111122222333221 234799999999999999887778999998753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.11 E-value=0.028 Score=36.82 Aligned_cols=26 Identities=27% Similarity=0.856 Sum_probs=21.3
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. .++|+|.|..||.|.
T Consensus 12 pC~n~g~C~n~-----~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 12 PCEHAGKCINT-----LGSFECQCLQGYTGP 37 (42)
T ss_dssp SSSTTCEEEEC-----SSSEEEECCTTEEST
T ss_pred CCCCCcEeECC-----CCCEEeECCCCCcCC
Confidence 47889999864 467999999999764
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.16 E-value=0.091 Score=33.60 Aligned_cols=26 Identities=31% Similarity=0.798 Sum_probs=21.2
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|.|.|..||.|.
T Consensus 10 PC~ngg~C~~~-----~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 10 PCLNGGSCKDD-----INSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTCEEEEE-----TTEEEEECCTTCCST
T ss_pred CCCCCcEEEcC-----CCCEEEECCCCCCCC
Confidence 57788999864 478999999999764
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.06 E-value=0.073 Score=34.06 Aligned_cols=26 Identities=35% Similarity=0.830 Sum_probs=21.1
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|+|.|..||.|.
T Consensus 8 PC~n~g~C~~~-----~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 8 PCQNDATCLDQ-----IGEFQCICMPGYEGV 33 (39)
T ss_dssp CCCSSCEEEEC-----SSCEEEECCTTEESS
T ss_pred CCCCCCEEECC-----CCCEEEeCCCCCccC
Confidence 47888999863 468999999999763
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.87 E-value=0.12 Score=33.48 Aligned_cols=28 Identities=32% Similarity=0.762 Sum_probs=21.9
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
-|.+++.|.+. ....+|+|.|..||.|.
T Consensus 5 PC~ngG~C~~~---~~~~~y~C~C~~g~~G~ 32 (41)
T d1tpga1 5 RCFNGGTCQQA---LYFSDFVCQCPEGFAGK 32 (41)
T ss_dssp CSCTTCEEEEE---SSSSCEEEECCTTCBSS
T ss_pred CCCCCCEEecC---CCCCCeEECCCCCCCCC
Confidence 48889999864 23568999999999763
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.66 E-value=0.084 Score=32.89 Aligned_cols=26 Identities=35% Similarity=0.897 Sum_probs=21.1
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|.|.|..||.|.
T Consensus 7 PC~ngg~C~~~-----~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 7 PCLHNGRCLDK-----INEFQCECPTGFTGH 32 (35)
T ss_dssp CSTTTCEEEEC-----SSCEEEECCTTEESS
T ss_pred CCCCCcEEECC-----CCCeEEECCCCCCCC
Confidence 47888999863 467999999999773
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.86 E-value=0.079 Score=34.70 Aligned_cols=23 Identities=26% Similarity=0.748 Sum_probs=18.0
Q ss_pred CCcccccCCCCCCCceeecCCCCCCCCC
Q 007442 144 NANCTPVLTPHGRSGFRCGCNKGFEGDG 171 (603)
Q Consensus 144 ~~~C~~~~~~~~~~~~~C~C~~G~~gnp 171 (603)
++.|.+. .++|+|.|..||..++
T Consensus 16 ~~~C~Nt-----~Gsy~C~C~~Gy~~~g 38 (43)
T d1emoa1 16 HGQCINT-----DGSYRCECPFGYILAG 38 (43)
T ss_dssp SSCCCCC-----SSCCCCCCCTTEEESS
T ss_pred CCEeECC-----CCCeEeECCCCcccCC
Confidence 5677753 4789999999998764
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.46 E-value=0.11 Score=33.25 Aligned_cols=26 Identities=31% Similarity=0.866 Sum_probs=20.8
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|.|.|..||.|.
T Consensus 7 PC~ngg~C~~~-----~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 7 PCQNQGKCKDG-----LGEYTCTCLEGFEGK 32 (39)
T ss_dssp CCCSSCEECCC-----SSSCCEECCTTEETT
T ss_pred CCCCCcEEECC-----CCCEEEECCCCCCcC
Confidence 47888999853 467999999999763
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.41 E-value=0.091 Score=33.18 Aligned_cols=26 Identities=27% Similarity=0.708 Sum_probs=21.2
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|.|.|..||.|.
T Consensus 9 PC~ngg~C~~~-----~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 9 PCQNGGSCKDQ-----LQSYICFCLPAFEGR 34 (37)
T ss_dssp CCCTTCEEEEE-----TTEEEEECCTTEEST
T ss_pred CCCCCCEEECC-----CCCeEEECCCCCcCC
Confidence 57889999864 468999999999763
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.49 E-value=0.14 Score=33.58 Aligned_cols=23 Identities=26% Similarity=0.797 Sum_probs=18.9
Q ss_pred CCcccccCCCCCCCceeecCCCCCCCCC
Q 007442 144 NANCTPVLTPHGRSGFRCGCNKGFEGDG 171 (603)
Q Consensus 144 ~~~C~~~~~~~~~~~~~C~C~~G~~gnp 171 (603)
++.|.+. .++|+|.|..||.++.
T Consensus 15 ~~~C~Nt-----~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 15 RGQCVNT-----PGDFECKCDEGYESGF 37 (44)
T ss_dssp TSCEEEE-----TTEEEECCCSSEEECT
T ss_pred CCEeEcC-----CCCeEEeCCCCCccCC
Confidence 5778864 5789999999999874
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.74 E-value=0.078 Score=33.93 Aligned_cols=26 Identities=31% Similarity=0.894 Sum_probs=20.7
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. .++|.|.|..||.|.
T Consensus 8 pC~ngg~C~~~-----~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 8 SCSGHGECVET-----INNYTCKCDPGFSGL 33 (39)
T ss_dssp GGGGSEEEEEE-----TTEEEEEECTTEEST
T ss_pred cCCCCcEEECC-----CCCEEEeCCCCCcCc
Confidence 47778899864 468999999999764
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.65 E-value=0.3 Score=33.37 Aligned_cols=28 Identities=25% Similarity=0.788 Sum_probs=21.5
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
-|.+++.|... ....+|.|.|..||.|.
T Consensus 13 ~C~NgG~C~~~---~~~~~~~C~C~~gy~G~ 40 (53)
T d3egfa_ 13 YCLNGGVCMHI---ESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp CSCSSCEEEEE---SSSSCEEEECCTTCCSS
T ss_pred CCCCCcEeecc---CCCCCeEeECCCCCcCC
Confidence 47788999754 23468999999999764
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.65 E-value=0.11 Score=33.31 Aligned_cols=26 Identities=31% Similarity=0.875 Sum_probs=20.6
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
.|.+++.|.+. ..+|+|.|..||.|.
T Consensus 8 pC~ngg~C~~~-----~~~y~C~C~~g~~G~ 33 (40)
T d1g1sa2 8 SCSKQGECLET-----IGNYTCSCYPGFYGP 33 (40)
T ss_dssp GGGGSEEEEEC-----SSSEEEEECTTEEST
T ss_pred cCCCCcEEECC-----CCCeEEeCCCCccCC
Confidence 47778899863 468999999999763
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.45 E-value=0.31 Score=31.53 Aligned_cols=26 Identities=23% Similarity=0.677 Sum_probs=19.8
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGDG 171 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gnp 171 (603)
.|. ++.|.+. .++|+|.|..||.-++
T Consensus 11 ~C~-~~~C~Nt-----~Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 11 LCR-GGVCHNT-----EGSYRCECPPGHQLSP 36 (42)
T ss_dssp TTT-TSEEEEE-----TTEEEEESCTTSCCCS
T ss_pred CCC-CCEeECC-----CCCeEEeCCCCCeECc
Confidence 353 6789864 4789999999998654
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.55 E-value=0.27 Score=34.90 Aligned_cols=31 Identities=29% Similarity=0.688 Sum_probs=22.3
Q ss_pred ccCCCCcccccCCCCCCCceeecCCCCCCCC
Q 007442 140 HCSQNANCTPVLTPHGRSGFRCGCNKGFEGD 170 (603)
Q Consensus 140 ~C~~~~~C~~~~~~~~~~~~~C~C~~G~~gn 170 (603)
-|.+++.|..........+|.|.|..||.|.
T Consensus 13 ~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G~ 43 (63)
T d1haea_ 13 FCVNGGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp TSCTTCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred cCCCCCEEeecccccCCCCEEeECCCCCCCC
Confidence 4888899964322234578999999999763
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.78 E-value=0.29 Score=31.85 Aligned_cols=23 Identities=26% Similarity=0.680 Sum_probs=18.2
Q ss_pred CCcccccCCCCCCCceeecCCCCCCCCC
Q 007442 144 NANCTPVLTPHGRSGFRCGCNKGFEGDG 171 (603)
Q Consensus 144 ~~~C~~~~~~~~~~~~~C~C~~G~~gnp 171 (603)
+..|.+. .++|+|.|..||..++
T Consensus 14 ~~~C~Nt-----~G~y~C~C~~Gy~l~~ 36 (43)
T d1uzka1 14 SGNCVNT-----PGSYICDCPPDFELNP 36 (43)
T ss_dssp TSEEEEE-----TTEEEEECCTTCEECT
T ss_pred CCEeECC-----CCCEEEecCCCCEECC
Confidence 4678764 4789999999998765
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.60 E-value=0.56 Score=30.39 Aligned_cols=23 Identities=22% Similarity=0.652 Sum_probs=18.3
Q ss_pred CCcccccCCCCCCCceeecCCCCCCCCC
Q 007442 144 NANCTPVLTPHGRSGFRCGCNKGFEGDG 171 (603)
Q Consensus 144 ~~~C~~~~~~~~~~~~~C~C~~G~~gnp 171 (603)
+..|.+. .++|+|.|..||.-++
T Consensus 15 ~~~C~Nt-----~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 15 GGKCINT-----FGSFQCRCPTGYYLNE 37 (43)
T ss_dssp TSEEEEC-----SSCEEEECCTTCCBCT
T ss_pred CCEEECC-----CCCeEeECCCCCeECc
Confidence 4678864 5789999999997664
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.06 E-value=0.39 Score=29.28 Aligned_cols=26 Identities=38% Similarity=0.838 Sum_probs=19.5
Q ss_pred CCCcccccCCCCCCCceeecCCCCCCCCCCC
Q 007442 143 QNANCTPVLTPHGRSGFRCGCNKGFEGDGYP 173 (603)
Q Consensus 143 ~~~~C~~~~~~~~~~~~~C~C~~G~~gnpy~ 173 (603)
.|..|+++ .++|.|.|.+||+--|..
T Consensus 11 GnGTCtNv-----iGgFec~C~~GFepgpmm 36 (39)
T d1emoa2 11 GNGTCKNV-----IGGFECTCEEGFEPGPMM 36 (39)
T ss_dssp SSSCEEEC-----SSSEEECCSSSSCCCSSS
T ss_pred CCceeeec-----ccceEEeecCCcCCCcce
Confidence 35677764 578999999999866543
|